data_1yjt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1yjt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 106.608 -1.627 . . . . 3.61 106.608 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.7 tp -144.01 140.13 29.41 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 105.808 -1.923 . . . . 4.09 105.808 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -106.3 135.74 47.25 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 124.449 1.093 . . . . 2.79 109.264 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.52 137.03 54.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.079 1.352 . . . . 2.27 107.888 174.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 t -82.68 114.99 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.772 -1.566 . . . . 2.38 106.772 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 m -106.66 84.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 126.747 2.019 . . . . 2.0 108.849 -166.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.76 122.41 25.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.493 -1.299 . . . . 6.16 107.493 -174.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.78 -37.0 2.41 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.548 1.07 . . . . 0.95 110.755 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.62 113.4 24.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.683 -1.599 . . . . 2.42 106.683 -172.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.84 25.46 0.27 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.245 1.202 . . . . 5.12 114.245 -167.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.6 p -147.34 167.19 24.93 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 120.957 -1.09 . . . . 1.39 108.205 161.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.08 -36.77 13.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.477 1.111 . . . . 2.4 112.059 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -59.44 -50.31 74.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 110.145 -0.317 . . . . 2.53 110.145 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -61.92 -41.35 97.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.681 -0.637 . . . . 0.71 110.929 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.0 t -51.5 -61.11 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.417 -0.957 . . . . 1.78 108.417 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.289 0.8 OUTLIER -66.65 -29.6 69.66 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 118.829 -0.605 . . . . 1.12 111.553 -174.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -52.94 -58.99 5.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.197 0.999 . . . . 4.5 109.127 170.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.8 mt -61.34 -59.0 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.761 -0.776 . . . . 1.99 108.918 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.87 -52.53 60.17 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 119.394 -0.336 . . . . 2.63 110.85 -168.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -62.04 -44.08 97.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.877 0.471 . . . . 3.12 111.561 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.8 t -64.85 -35.0 79.7 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.745 -0.597 . . . . 1.33 110.982 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -70.61 -48.36 55.49 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 118.53 -0.748 . . . . 2.77 111.407 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 p -68.06 72.75 0.18 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.052 0.93 . . . . 2.77 112.645 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.83 -38.88 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.992 2.117 . . . . 4.88 110.352 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -70.92 132.03 44.62 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.043 0.838 . . . . 3.27 109.551 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -55.21 149.56 12.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.45 -0.574 . . . . 7.07 109.45 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.01 -39.82 2.62 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.432 -1.067 . . . . 1.72 110.432 -173.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.69 111.62 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 119.086 1.443 . . . . 2.81 109.249 -172.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.1 mt -80.0 -46.81 15.97 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.698 -0.853 . . . . 3.13 108.698 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -157.18 130.99 8.15 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 109.105 -0.702 . . . . 3.37 109.105 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.8 p -97.17 152.3 18.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.038 -1.097 . . . . 3.08 108.038 165.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.9 t -155.55 150.44 26.48 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 119.534 -0.866 . . . . 2.92 108.91 140.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.36 143.61 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.72 0.808 . . . . 3.1 110.014 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.4 132.43 41.16 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.568 0.747 . . . . 2.21 110.555 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.4 -26.97 52.23 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.182 -0.917 . . . . 3.4 111.729 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -46.74 -44.53 18.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.16 0.984 . . . . 2.4 112.399 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -117.49 18.45 14.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.66 1.184 . . . . 3.86 110.866 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 35.06 54.99 0.76 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 127.144 2.178 . . . . 3.8 111.909 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -112.59 148.56 34.3 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.589 0.756 . . . . 2.64 109.551 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.83 125.73 47.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.249 -1.76 . . . . 2.02 106.249 166.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.45 129.72 54.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.122 -1.436 . . . . 3.42 107.122 169.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.2 mp -119.45 110.75 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 104.685 -2.339 . . . . 2.24 104.685 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -83.08 70.36 10.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.655 -1.239 . . . . 4.79 107.655 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -86.68 141.34 29.0 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.987 0.515 . . . . 3.82 111.976 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -57.13 112.46 4.64 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.229 -1.026 . . . . 2.43 108.229 169.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.48 48.7 2.95 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.338 2.692 . . . . 1.7 111.891 -166.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -137.29 -63.09 0.6 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.933 1.293 . . . . 3.86 109.365 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.2 pt -77.09 -24.02 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.025 0 N-CA-C 112.921 0.712 . . . . 3.07 112.921 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.2 tt -139.82 143.09 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.921 -0.77 . . . . 2.15 108.921 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -117.72 175.11 15.56 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.296 0.951 . . . . 0.88 112.177 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -61.43 -38.91 60.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.01 2.473 . . . . 0.84 110.795 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -46.43 -53.02 11.89 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.158 0.983 . . . . 8.29 110.592 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -67.62 -46.54 72.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.957 -1.127 . . . . 2.93 107.957 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.3 mm -54.46 -46.65 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.572 0.349 . . . . 3.41 111.39 172.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.0 mt -53.67 -54.32 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.432 -0.581 . . . . 2.32 109.432 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -61.22 -42.89 99.39 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.537 0.684 . . . . 3.65 110.441 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.1 m -58.33 -49.3 77.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.587 0.755 . . . . 2.33 109.832 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 mm -68.24 -43.25 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 119.289 -0.386 . . . . 2.81 110.257 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -52.62 -42.3 64.47 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.465 0.575 . . . . 5.16 110.684 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.0 m -54.8 -23.45 18.21 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.075 0.769 . . . . 2.43 113.075 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 mt -87.06 -9.94 54.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.906 0.883 . . . . 1.98 112.117 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.9 40.16 6.31 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.085 1.326 . . . . 0.86 112.489 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -142.07 141.09 32.74 Favored 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 106.529 -1.656 . . . . 3.37 106.529 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -91.13 113.83 59.56 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 119.56 1.073 . . . . 5.57 109.989 -172.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -91.96 140.27 2.29 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.974 3.116 . . . . 1.66 110.696 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.8 m -145.02 125.61 14.12 Favored 'General case' 0 C--N 1.335 -0.063 0 O-C-N 120.657 -1.277 . . . . 3.47 109.023 167.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.45 136.19 57.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.661 1.184 . . . . 3.58 111.938 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 123.993 0.917 . . . . 3.42 111.488 175.533 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 110.066 -0.346 . . . . 3.91 110.066 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -123.29 137.36 54.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.892 -1.521 . . . . 4.67 106.892 169.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -105.46 106.29 16.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.539 1.535 . . . . 4.16 108.451 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.03 126.39 52.67 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.235 -1.394 . . . . 2.5 107.235 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.98 95.36 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 106.855 -1.535 . . . . 2.03 106.855 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.16 65.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.064 1.745 . . . . 1.66 109.231 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -74.67 131.47 40.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.058 -1.089 . . . . 5.74 108.058 -172.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.51 -49.69 0.83 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.545 -1.422 . . . . 0.75 109.545 -167.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -74.94 149.81 39.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.072 0.936 . . . . 2.33 110.165 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 t -153.34 22.3 0.55 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.433 0.531 . . . . 2.81 112.433 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.16 145.41 19.39 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.775 0.716 . . . . 1.56 109.927 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.51 -40.25 37.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.976 1.31 . . . . 2.03 111.317 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -41.27 -49.6 3.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.996 1.718 . . . . 2.45 111.822 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -73.8 -42.97 60.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.848 1.055 . . . . 1.32 113.848 174.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.8 t -49.0 -57.05 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.673 0.749 . . . . 2.18 109.292 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -69.3 -24.12 63.9 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.535 -0.757 . . . . 1.38 111.956 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -58.63 -54.13 50.53 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.03 -1.47 . . . . 4.61 107.03 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.77 -59.03 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 109.316 -0.624 . . . . 1.98 109.316 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -54.64 -56.57 17.67 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.374 0.533 . . . . 2.55 111.407 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.4 t -54.56 -47.66 72.98 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.315 1.046 . . . . 2.28 110.53 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -59.63 -51.61 69.08 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.144 -0.347 . . . . 1.18 110.517 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.43 -34.15 77.52 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.786 -0.572 . . . . 3.21 111.953 -176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 p -65.49 72.12 0.05 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.422 0.555 . . . . 2.7 110.877 170.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -150.52 -43.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.447 1.899 . . . . 6.4 111.817 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -57.55 -43.37 84.41 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.429 0.9 . . . . 4.46 113.429 -168.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 131.36 -82.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 129.583 3.153 . . . . 7.7 107.841 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.19 54.24 3.9 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 123.821 0.724 . . . . 2.37 112.995 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.08 129.12 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.427 -1.694 . . . . 2.98 106.427 157.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.4 mt -85.44 -45.03 12.23 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.045 -0.724 . . . . 3.01 109.045 172.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -155.8 120.24 4.62 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.91 0.323 . . . . 3.6 110.883 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.8 m -79.89 135.7 36.5 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 106.361 -1.718 . . . . 3.07 106.361 164.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 t -140.52 96.54 3.05 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.346 0.975 . . . . 2.61 108.713 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -105.92 135.63 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.4 1.08 . . . . 3.74 109.214 -172.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.76 134.64 23.73 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.3 0.572 . . . . 1.58 111.186 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 pp -76.23 -26.48 56.09 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.006 0.922 . . . . 2.94 111.394 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.04 -36.76 41.44 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.413 1.085 . . . . 2.02 112.371 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 p -129.62 31.51 4.76 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.479 0.712 . . . . 3.58 110.343 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.7 m120 33.73 54.99 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.916 2.486 . . . . 2.17 112.408 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -133.47 157.42 45.66 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.525 0.33 . . . . 2.87 111.886 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.47 127.09 54.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.097 -1.816 . . . . 1.72 106.097 161.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.49 129.22 38.49 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 103.97 -2.604 . . . . 3.08 103.97 154.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.9 mt -118.55 118.32 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 105.229 -2.137 . . . . 2.82 105.229 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -89.88 104.94 17.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.421 -1.696 . . . . 4.36 106.421 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -132.03 151.87 51.49 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 123.576 0.547 . . . . 3.63 112.229 -171.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -90.79 112.51 53.81 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 125.104 1.362 . . . . 3.08 108.402 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -77.84 41.26 0.97 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.457 2.105 . . . . 1.88 112.243 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.68 -37.86 17.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.086 0.954 . . . . 5.46 110.249 170.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.12 -54.46 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.682 1.193 . . . . 3.02 110.896 -174.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.2 123.73 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.165 -0.68 . . . . 2.57 109.165 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.83 -175.45 22.27 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 109.565 -1.414 . . . . 0.68 109.565 170.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -59.39 -36.31 94.38 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.804 1.669 . . . . 0.98 109.949 170.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -45.56 -59.67 2.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.45 1.5 . . . . 7.59 111.777 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.84 -51.43 69.74 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.617 1.567 . . . . 2.31 110.426 -172.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 94.5 mt -52.34 -54.25 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 114.209 -1.36 . . . . 2.51 108.478 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.9 mt -60.04 -53.39 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.94 -0.573 . . . . 1.84 109.681 -172.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -58.83 -39.98 82.82 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.739 0.699 . . . . 4.11 110.655 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.0 m -56.65 -52.23 65.7 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.311 -0.404 . . . . 2.11 110.227 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.06 -40.52 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.8 -0.562 . . . . 2.13 111.149 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -47.15 -49.35 22.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.34 0.656 . . . . 3.5 109.398 169.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -58.45 -24.37 60.1 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.446 0.906 . . . . 2.12 113.446 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.1 mt -84.94 -12.85 52.46 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.092 0.86 . . . . 2.3 112.069 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.09 44.22 4.8 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.101 0.858 . . . . 0.91 112.769 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -138.61 159.47 42.02 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 106.846 -1.539 . . . . 3.28 106.846 170.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -98.35 98.85 6.28 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.433 -0.794 . . . . 2.87 110.507 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.82 80.79 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 124.314 3.343 . . . . 0.92 110.717 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 m -79.27 101.37 7.99 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.237 -1.023 . . . . 2.62 108.237 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.5 64.16 0.11 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.893 1.677 . . . . 3.8 113.22 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.4 t . . . . . 0 CA--C 1.535 0.386 0 O-C-N 121.637 -0.664 . . . . 3.2 111.237 -177.117 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 107.131 -1.433 . . . . 3.66 107.131 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.8 tp -124.13 144.28 49.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.05 -2.204 . . . . 3.6 105.05 155.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -114.19 132.42 56.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.933 -0.766 . . . . 2.19 108.933 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 mt -118.48 123.98 46.49 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.99 -1.856 . . . . 3.65 105.99 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -78.9 95.18 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.592 -2.003 . . . . 2.46 105.592 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.26 84.07 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 126.319 1.847 . . . . 1.9 108.858 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 -75.6 130.87 39.49 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.935 -1.135 . . . . 5.98 107.935 -171.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.78 -48.46 0.97 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.399 1.0 . . . . 1.25 110.945 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -64.87 127.56 32.08 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.69 0.745 . . . . 2.24 110.37 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -144.6 5.34 1.2 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.246 1.202 . . . . 2.96 114.246 -167.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 p -160.84 166.39 28.62 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.645 1.112 . . . . 1.55 109.601 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.47 -45.3 9.1 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.201 1.4 . . . . 1.68 111.503 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -42.26 -49.24 5.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.067 1.747 . . . . 2.04 112.457 172.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.3 m -72.69 -51.18 20.43 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.153 0.581 . . . . 0.94 111.136 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -46.74 -58.84 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.045 0.938 . . . . 1.85 109.039 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -69.83 -23.53 63.32 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.989 -1.005 . . . . 1.08 111.942 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -67.66 -51.69 46.88 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 107.892 -1.151 . . . . 4.67 107.892 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 mt -55.39 -58.81 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.734 -0.839 . . . . 1.84 108.734 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.07 -54.62 32.8 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.001 0.364 . . . . 2.76 111.612 -174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -60.66 -45.09 95.45 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.158 -0.339 . . . . 2.71 111.912 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 t -62.97 -49.59 74.13 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.903 -0.498 . . . . 1.25 110.226 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -51.19 -47.16 62.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.708 0.803 . . . . 2.69 110.548 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 p -62.31 -0.31 0.55 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.629 1.344 . . . . 2.75 114.629 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -57.49 -42.59 83.0 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.306 1.412 . . . . 7.16 110.66 164.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -94.12 138.92 31.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.339 -0.544 . . . . 3.45 111.867 -155.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -60.27 167.54 2.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.532 0.682 . . . . 6.57 109.905 169.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.09 -15.23 0.74 Allowed Glycine 0 CA--C 1.521 0.459 0 CA-C-O 117.669 -1.629 . . . . 1.8 113.555 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.3 139.63 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 120.365 2.083 . . . . 2.63 105.746 165.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.6 mt -102.58 -37.98 7.72 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.927 -1.033 . . . . 3.28 108.506 164.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -157.54 155.13 29.71 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.58 1.082 . . . . 3.36 109.872 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.8 t -126.04 143.08 51.25 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.397 -2.075 . . . . 2.28 105.397 162.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -149.16 148.67 29.91 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 118.097 -1.441 . . . . 2.87 109.965 144.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.9 142.41 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 123.882 0.739 . . . . 3.23 111.467 -172.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.17 128.09 44.14 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.205 1.002 . . . . 1.95 111.027 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.68 -36.67 32.01 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 114.27 -1.332 . . . . 3.24 113.209 -163.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.73 -37.8 59.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.54 0.609 . . . . 2.92 111.148 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -96.12 -7.59 35.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.318 2.247 . . . . 3.37 111.694 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.7 m120 41.95 48.08 3.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.737 1.615 . . . . 2.18 110.79 -166.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -114.38 151.24 33.38 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.434 0.561 . . . . 2.72 111.255 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -123.92 121.78 36.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.88 1.672 . . . . 1.8 106.741 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -96.03 123.32 39.58 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.615 -2.365 . . . . 4.22 104.615 168.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.9 mm -104.64 130.17 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 106.916 -1.513 . . . . 3.18 106.916 168.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -98.4 101.06 12.39 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 105.083 -2.191 . . . . 3.45 105.083 162.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -129.77 155.15 46.4 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.925 1.29 . . . . 3.39 109.147 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -75.71 110.84 11.81 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.496 1.118 . . . . 2.81 108.696 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.39 58.58 6.75 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.279 2.653 . . . . 1.68 111.363 -173.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -135.16 -68.63 0.52 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.042 1.337 . . . . 4.36 108.99 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -91.0 -40.07 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.061 0 C-N-CA 123.062 0.545 . . . . 3.26 112.108 -172.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.01 119.08 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.639 -1.245 . . . . 3.08 107.639 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.81 163.5 36.69 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.123 -0.791 . . . . 1.51 111.123 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -54.63 -30.01 63.77 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.68 2.253 . . . . 1.37 110.842 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -55.06 -49.09 72.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.344 -1.312 . . . . 6.39 113.663 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -63.1 -49.49 74.24 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 121.312 1.869 . . . . 5.65 109.85 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.5 mt -47.17 -56.08 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-O 121.443 0.639 . . . . 2.27 109.772 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.8 mt -59.07 -55.95 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.823 -0.626 . . . . 2.07 109.663 -174.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -62.96 -34.14 76.88 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.936 -0.477 . . . . 3.66 111.475 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.3 m -56.56 -53.57 56.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.948 -0.76 . . . . 2.32 108.948 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.29 -39.43 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 121.507 -0.745 . . . . 2.23 111.373 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.77 -44.72 82.07 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.715 -0.616 . . . . 3.04 109.682 172.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.7 m -61.47 -41.43 97.23 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.201 -0.312 . . . . 2.16 111.6 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.66 -41.87 91.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.495 0.588 . . . . 2.73 110.724 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.86 45.28 0.83 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.286 0.946 . . . . 0.89 111.435 175.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.07 162.12 30.52 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.077 -1.453 . . . . 3.2 107.077 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -100.15 98.28 7.41 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 118.198 -0.906 . . . . 2.61 110.099 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.38 75.41 3.87 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.609 2.872 . . . . 1.21 110.111 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.6 m -79.99 107.63 12.93 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.491 -0.929 . . . . 2.52 108.491 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.76 59.36 0.47 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.679 0.791 . . . . 3.48 112.596 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 125.512 1.525 . . . . 4.23 107.307 178.651 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.236 0.352 0 N-CA-C 108.79 -0.819 . . . . 3.85 108.79 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 tp -104.0 149.59 25.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.663 -1.977 . . . . 3.98 105.663 165.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.33 151.19 37.5 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.312 -0.996 . . . . 2.27 108.312 165.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.13 130.43 23.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.35 -1.722 . . . . 2.27 106.35 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -79.62 100.81 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 105.411 -2.07 . . . . 2.1 105.411 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.2 m -81.83 79.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 126.353 1.861 . . . . 1.87 108.161 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.2 mtp-105 -76.74 141.72 40.73 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.605 -0.887 . . . . 6.3 108.605 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.63 -45.83 1.13 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.318 -1.113 . . . . 0.84 110.318 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.03 141.44 28.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.533 0.667 . . . . 2.06 109.644 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -152.81 41.91 0.6 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.304 0.502 . . . . 5.97 110.256 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.47 144.9 12.62 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.765 -0.585 . . . . 1.83 111.039 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.98 -39.85 20.68 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.598 1.559 . . . . 2.03 112.059 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.4 t -45.26 -51.44 10.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.056 0.542 . . . . 2.27 110.458 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.3 m -76.79 -33.85 58.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.101 -1.625 . . . . 1.42 114.169 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -46.75 -56.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.642 -0.873 . . . . 1.7 108.642 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -70.39 -21.84 62.81 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.167 -0.924 . . . . 0.98 112.825 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -64.89 -54.5 29.83 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 106.781 -1.563 . . . . 5.34 106.781 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.4 -56.47 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.852 -0.796 . . . . 1.9 108.852 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.31 -53.73 54.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.999 0.818 . . . . 2.6 111.693 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.1 t -63.76 -29.17 70.41 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.059 0.39 . . . . 2.74 111.756 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.4 t -71.05 -52.96 16.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.204 -0.665 . . . . 2.12 109.204 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -53.43 -46.14 69.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.152 0.981 . . . . 2.87 110.954 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.2 p -59.51 -16.73 26.46 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.953 0.723 . . . . 2.45 112.953 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -69.92 -24.0 63.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.819 1.19 . . . . 7.27 111.515 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -68.48 87.08 0.31 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.73 0.696 . . . . 4.11 109.885 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 23.27 -66.21 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.0 2.52 . . . . 11.2 116.758 145.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.52 48.39 0.97 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.338 0.97 . . . . 2.23 112.644 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -91.08 117.82 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.022 -1.473 . . . . 3.43 107.022 154.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -80.68 -35.5 33.59 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.758 -0.589 . . . . 3.9 110.45 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -157.01 135.6 11.49 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.948 0.795 . . . . 3.19 110.466 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.8 p -114.65 155.09 27.23 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.277 1.031 . . . . 2.55 108.389 165.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.6 m -149.47 141.34 23.72 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.184 -1.413 . . . . 2.64 107.184 150.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.94 135.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.732 0.813 . . . . 2.95 110.197 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.36 134.09 55.11 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.347 0.659 . . . . 1.72 110.149 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -82.07 -37.64 26.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.255 -0.884 . . . . 2.76 111.286 -171.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.94 64.21 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.36 0.664 . . . . 2.58 112.301 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.8 t -107.05 4.63 27.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.037 1.335 . . . . 3.41 111.234 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.9 m120 42.96 48.95 5.2 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.614 1.966 . . . . 2.13 110.83 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.15 137.23 30.74 Favored 'General case' 0 CA--C 1.522 -0.109 0 O-C-N 121.735 -0.603 . . . . 3.04 112.086 -165.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.2 142.09 32.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.625 1.57 . . . . 1.82 108.232 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.07 135.14 48.06 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.481 -2.044 . . . . 3.57 105.481 152.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.2 mt -134.79 114.87 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.159 -1.793 . . . . 2.3 106.159 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -97.28 80.03 2.86 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.701 -1.592 . . . . 3.48 106.701 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -85.53 143.1 28.7 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.63 -0.714 . . . . 3.61 111.638 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -75.41 111.34 13.57 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.626 1.17 . . . . 3.09 107.914 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.63 47.56 2.6 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.356 2.704 . . . . 1.42 113.234 -163.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -134.16 -63.9 0.71 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.37 1.468 . . . . 3.8 108.554 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -70.5 -34.35 57.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 122.858 0.463 . . . . 3.18 111.462 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.6 tt -126.83 156.58 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.81 1.244 . . . . 2.98 110.406 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -154.39 178.34 31.25 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 107.198 -2.361 . . . . 1.1 107.198 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.61 -50.24 14.72 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.399 2.733 . . . . 0.97 111.485 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -52.38 -44.97 65.6 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.59 0.959 . . . . 8.36 113.59 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -59.47 -60.01 4.53 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.574 0.702 . . . . 3.91 109.429 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mt -45.78 -54.43 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.466 1.106 . . . . 2.58 109.818 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.2 mt -59.25 -48.16 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.654 -0.703 . . . . 1.82 110.415 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -57.23 -41.77 80.16 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.764 0.711 . . . . 4.47 109.265 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.8 m -62.8 -51.18 68.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.863 -0.608 . . . . 2.68 110.728 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 98.0 mt -62.86 -44.35 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 118.86 0.755 . . . . 2.37 111.278 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -49.09 -48.9 43.96 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.562 0.745 . . . . 3.36 109.188 170.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t -62.8 -17.08 60.62 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.815 1.043 . . . . 3.26 113.815 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.02 -16.15 41.72 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.06 1.3 . . . . 2.14 111.23 171.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.62 42.38 6.49 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.866 0.746 . . . . 0.98 111.685 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -132.79 153.09 51.58 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.181 -1.414 . . . . 3.32 107.181 170.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.27 109.28 32.39 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.179 0.991 . . . . 2.71 109.165 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.52 77.86 3.9 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.462 2.108 . . . . 1.0 110.249 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.8 t -78.68 98.85 6.36 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.264 -0.897 . . . . 2.55 109.417 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.05 61.26 0.19 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.42 1.888 . . . . 3.6 113.241 -173.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 CA--C 1.535 0.393 0 C-N-CA 123.172 0.589 . . . . 3.48 109.866 -179.644 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 107.238 -1.393 . . . . 4.02 107.238 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.6 tp -95.88 148.64 22.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.536 -1.653 . . . . 3.76 106.536 166.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -136.87 127.25 26.59 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.876 0.87 . . . . 2.31 108.913 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.54 150.86 48.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.504 0.722 . . . . 4.63 110.308 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.0 t -84.89 124.22 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.284 -1.376 . . . . 2.12 107.284 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.59 102.91 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 126.994 2.118 . . . . 2.7 108.374 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -87.4 148.93 24.79 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.061 -0.718 . . . . 6.21 109.061 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.11 -52.35 0.64 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.23 -1.148 . . . . 0.88 110.23 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.79 134.92 56.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 117.285 0.542 . . . . 3.09 109.611 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.4 t -155.22 11.62 0.34 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.891 1.071 . . . . 2.57 113.891 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.6 p -161.11 171.75 18.0 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.808 1.185 . . . . 1.43 109.119 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -44.28 7.81 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.371 1.469 . . . . 1.74 111.594 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 t -52.83 -48.73 66.78 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.746 0.419 . . . . 2.44 110.071 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.3 m -70.65 -53.46 15.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.473 -0.767 . . . . 0.79 109.627 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -41.33 -60.21 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 125.787 1.635 . . . . 1.82 109.137 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.255 0.6 OUTLIER -68.25 -21.3 64.83 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.803 0.668 . . . . 1.12 112.803 -171.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -70.12 -46.91 63.82 Favored 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.978 -1.119 . . . . 5.5 107.978 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.67 -57.67 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.895 -0.78 . . . . 1.91 108.895 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.75 -56.49 18.71 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.373 0.269 . . . . 2.81 110.859 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.0 t -58.34 -50.07 74.94 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.997 0.427 . . . . 2.31 110.71 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.4 t -69.2 -27.14 65.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.551 -0.718 . . . . 1.19 111.445 -173.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.11 -52.52 23.03 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.383 0.538 . . . . 3.48 110.651 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -70.06 67.68 0.29 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.398 1.094 . . . . 2.5 112.321 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -169.91 -38.03 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.968 2.507 . . . . 4.35 109.624 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -69.84 137.68 51.95 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.939 0.791 . . . . 3.04 110.205 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 -50.84 143.87 9.32 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.622 -0.51 . . . . 6.22 109.622 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.27 -20.43 37.29 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-O 118.05 -1.417 . . . . 1.34 113.407 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.52 133.98 29.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 N-CA-C 105.849 -1.908 . . . . 2.66 105.849 160.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.5 mt -97.44 -48.45 5.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.477 1.111 . . . . 3.41 108.106 168.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -156.14 153.64 29.62 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.608 -0.516 . . . . 3.63 109.608 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.9 t -132.79 145.48 51.03 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.451 -1.314 . . . . 3.16 107.451 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -136.04 153.08 51.46 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.502 -1.296 . . . . 3.35 107.502 142.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 m -125.37 143.61 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.902 0.881 . . . . 3.03 109.742 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.51 129.95 41.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.802 0.811 . . . . 1.88 111.802 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.56 -28.64 62.95 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.752 1.221 . . . . 3.44 111.33 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.78 -44.16 73.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.035 0.534 . . . . 2.0 111.064 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.52 -31.27 17.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.472 -0.566 . . . . 3.32 109.472 172.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 79.24 41.81 0.08 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.997 2.119 . . . . 4.74 107.796 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -133.6 141.66 47.76 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.741 -0.466 . . . . 3.48 109.741 -168.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.54 136.73 42.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.015 1.326 . . . . 1.78 107.949 168.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -102.36 150.15 23.62 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.085 -1.45 . . . . 4.49 107.085 159.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mp -134.63 101.35 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.543 -2.021 . . . . 2.43 105.543 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -81.18 123.6 28.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.196 -2.149 . . . . 4.52 105.196 170.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -163.72 170.48 16.94 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 120.958 0.408 . . . . 3.76 110.644 -152.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -101.51 93.82 3.69 Favored Pre-proline 0 N--CA 1.447 -0.592 0 C-N-CA 125.544 1.538 . . . . 2.97 108.733 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.82 52.93 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.679 2.92 . . . . 1.84 110.799 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -159.99 25.66 0.17 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.464 1.506 . . . . 4.72 109.287 -169.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -167.17 -50.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 126.503 1.921 . . . . 4.26 108.069 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.1 tt -118.85 157.39 20.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 124.625 1.17 . . . . 2.24 109.51 -172.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.36 -177.27 16.37 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.154 -0.778 . . . . 0.71 111.154 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.41 -39.94 42.87 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.543 2.162 . . . . 0.9 110.15 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -48.37 -53.4 17.71 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.574 1.15 . . . . 6.97 111.476 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.72 -52.09 66.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.211 0.529 . . . . 2.55 109.637 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.8 mt -55.87 -52.97 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.75 0.82 . . . . 2.55 108.974 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.2 mt -50.97 -55.1 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.246 -0.65 . . . . 1.71 109.246 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -66.02 -37.87 86.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.152 0.501 . . . . 3.96 110.703 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.3 m -55.59 -47.79 75.91 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.283 -0.417 . . . . 1.63 110.345 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 79.8 mt -70.26 -44.04 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.757 -0.589 . . . . 2.19 110.953 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -49.58 -44.61 47.09 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.645 0.778 . . . . 2.69 109.894 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -52.78 -34.7 54.58 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.147 0.579 . . . . 2.96 112.521 175.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.5 mt -76.72 -13.37 60.04 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.368 -0.832 . . . . 2.18 112.319 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.87 45.46 5.7 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.731 0.681 . . . . 0.94 111.791 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -132.81 156.56 46.89 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.182 -1.414 . . . . 3.11 107.182 171.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -96.4 99.7 5.82 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-O 117.547 -1.216 . . . . 2.63 110.406 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -79.08 143.53 17.95 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 CA-C-N 121.43 1.547 . . . . 1.69 109.389 169.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 p -155.46 121.17 5.02 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.588 -0.695 . . . . 2.63 109.484 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.464 ' CD2' ' H ' ' A' ' 71' ' ' LEU . 1.5 mm? -61.25 133.76 56.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.904 0.882 . . . . 4.05 111.584 -169.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.9 t . . . . . 0 N--CA 1.465 0.318 0 C-N-CA 123.217 0.607 . . . . 3.32 111.604 175.487 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.236 0.389 0 CA-C-O 122.47 1.128 . . . . 3.5 108.429 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mp -93.8 139.14 31.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.344 -0.844 . . . . 3.94 109.254 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.0 106.33 11.49 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.611 1.964 . . . . 3.25 107.496 -170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.24 133.28 53.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.264 -1.384 . . . . 2.3 107.264 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.88 112.37 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.706 -1.961 . . . . 2.1 105.706 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -94.66 95.42 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.365 1.866 . . . . 1.72 107.813 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.35 155.75 29.91 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 119.278 -0.969 . . . . 5.83 108.404 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 -51.85 0.68 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.631 -0.987 . . . . 0.95 110.631 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -63.22 141.03 58.92 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 117.412 0.606 . . . . 2.4 111.355 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -155.1 10.85 0.34 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.067 1.136 . . . . 2.57 114.067 -173.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -162.0 161.46 28.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.853 1.206 . . . . 1.39 109.829 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.18 -39.4 9.62 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.62 1.568 . . . . 1.88 112.0 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 m -40.13 -56.25 1.94 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.923 1.289 . . . . 2.08 111.546 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.3 m -69.98 -36.66 75.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.586 0.354 . . . . 0.8 110.902 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.4 t -55.88 -59.28 2.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.013 -1.106 . . . . 1.79 108.013 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -68.4 -35.55 77.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 118.289 -0.862 . . . . 1.5 111.348 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -51.49 -55.3 19.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.942 1.247 . . . . 4.56 110.344 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.7 mt -54.25 -62.74 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 123.702 0.801 . . . . 2.46 109.056 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -59.74 -55.69 31.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.324 -0.551 . . . . 2.6 110.333 -172.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.9 p -54.72 -47.38 73.82 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.227 0.467 . . . . 2.99 111.182 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -70.65 -32.1 69.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.052 -0.659 . . . . 1.54 111.271 -175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.6 mt -68.52 -52.04 36.44 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.464 -0.773 . . . . 3.35 110.599 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.9 p -66.81 75.84 0.11 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.009 1.324 . . . . 2.58 110.854 -174.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? 179.64 -40.02 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.964 2.505 . . . . 4.27 109.233 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.421 ' CE1' ' HB ' ' A' ' 32' ' ' ILE . 11.8 p80 -69.22 139.75 54.52 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 118.962 -1.095 . . . . 2.88 108.965 175.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -60.1 144.42 49.75 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.108 -0.701 . . . . 8.62 109.108 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.01 -28.67 13.5 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-O 118.072 -1.404 . . . . 1.46 113.184 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.421 ' HB ' ' CE1' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -76.64 122.6 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 119.953 1.876 . . . . 2.83 108.286 169.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.0 mt -85.69 -52.69 5.63 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.004 -1.11 . . . . 3.29 108.004 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -157.12 144.65 18.89 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.18 -0.674 . . . . 5.04 109.18 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 t -107.26 129.62 54.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.19 -1.411 . . . . 2.83 107.19 167.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 t -112.0 104.08 12.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.777 -1.935 . . . . 3.51 105.777 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 p -102.13 141.4 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 118.938 0.79 . . . . 2.91 111.071 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.29 132.99 36.45 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.323 0.582 . . . . 1.76 110.487 172.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -76.2 -30.4 57.98 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.103 -0.953 . . . . 3.28 111.751 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.2 -32.17 22.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.806 0.842 . . . . 2.08 112.617 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.9 t -121.75 13.19 10.72 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.268 1.427 . . . . 2.98 111.088 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 m120 34.78 47.02 0.22 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.522 2.329 . . . . 2.09 111.818 -172.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -120.85 137.94 54.31 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.276 0.631 . . . . 3.3 109.648 -169.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.47 116.65 32.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.723 1.609 . . . . 1.72 108.224 167.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -91.25 110.62 21.91 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 102.562 -3.125 . . . . 2.97 102.562 166.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.9 mt -112.84 110.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.481 -1.674 . . . . 2.33 106.481 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -83.06 70.22 9.99 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.983 -1.488 . . . . 4.11 106.983 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -90.24 144.29 25.99 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.147 -0.933 . . . . 4.19 109.697 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.36 111.17 22.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 123.557 0.535 . . . . 3.99 111.026 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -66.72 -16.51 50.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.917 2.411 . . . . 2.17 112.451 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -85.3 -5.84 59.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.11 0.868 . . . . 5.2 111.002 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.4 pt -135.07 -27.73 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 114.392 1.256 . . . . 3.87 114.392 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.7 133.8 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 107.526 -1.287 . . . . 2.67 107.526 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.43 172.39 20.31 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.529 -0.732 . . . . 0.77 112.203 -172.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -56.72 -41.47 75.37 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.22 2.614 . . . . 0.95 110.655 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -57.13 -51.06 70.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.85 0.295 . . . . 7.21 110.615 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.98 -51.14 70.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.259 -0.645 . . . . 2.63 109.259 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.4 mm -54.38 -50.93 53.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.326 0.65 . . . . 3.38 111.609 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.4 mt -54.14 -56.43 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.935 -0.765 . . . . 1.74 108.935 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -65.5 -35.13 79.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.195 0.521 . . . . 4.0 111.021 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.3 m -56.27 -54.48 44.88 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.752 -0.462 . . . . 1.87 109.752 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.39 -36.05 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.516 -0.74 . . . . 2.35 111.712 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.75 -48.65 59.06 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.94 -0.763 . . . . 2.74 108.94 166.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.8 t -65.12 -13.93 59.3 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.836 1.05 . . . . 3.0 113.836 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.4 mt -88.15 -9.8 51.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.05 1.295 . . . . 2.4 111.319 170.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.25 41.72 6.48 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.383 0.992 . . . . 0.99 112.022 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -135.74 167.38 21.26 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.236 -1.024 . . . . 3.34 108.236 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -105.71 94.6 8.99 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.489 1.115 . . . . 2.65 110.636 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.3 80.52 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.631 2.887 . . . . 1.13 112.267 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.0 p -82.98 121.34 26.88 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.15 -0.969 . . . . 2.76 111.401 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.3 mt -70.35 72.42 0.47 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.194 -0.941 . . . . 4.28 111.503 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 118.878 -0.582 . . . . 3.39 112.16 -178.565 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 109.836 -0.431 . . . . 4.14 109.836 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.9 tp -108.78 149.45 29.04 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.974 -1.862 . . . . 4.02 105.974 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -118.67 152.73 35.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.092 -0.707 . . . . 2.6 109.092 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.0 133.27 16.39 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.135 -1.061 . . . . 2.49 108.135 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.37 105.07 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.32 -2.104 . . . . 2.05 105.32 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -95.53 86.35 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 126.221 1.808 . . . . 1.74 107.994 -172.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.5 mtp-105 -77.38 132.65 38.64 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 119.899 -0.721 . . . . 7.05 109.748 -170.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.01 -4.01 5.65 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.45 1.5 . . . . 1.2 113.187 171.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 41.4 mtp -75.92 116.33 16.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.042 1.421 . . . . 3.02 110.097 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -98.91 -21.02 16.49 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.488 -1.244 . . . . 3.71 113.253 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.9 p -162.7 175.81 10.96 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.636 1.562 . . . . 1.79 112.221 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -35.94 58.72 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.586 1.154 . . . . 2.21 111.923 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -57.25 -37.03 71.69 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-O 118.368 -0.825 . . . . 2.75 110.105 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.4 m -69.07 -53.45 20.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 120.025 1.284 . . . . 0.79 109.687 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -41.67 -57.46 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.944 1.298 . . . . 1.97 110.257 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.89 -21.26 66.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.23 -0.896 . . . . 2.0 112.735 -170.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -69.1 -47.86 64.07 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 107.309 -1.367 . . . . 5.73 107.309 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 mt -64.65 -54.56 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.306 -0.998 . . . . 2.07 108.306 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -50.41 -59.99 3.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.206 0.457 . . . . 2.35 111.028 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.2 t -55.03 -52.6 62.67 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.113 0.482 . . . . 2.52 111.415 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -66.84 -28.0 68.0 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.527 0.731 . . . . 1.55 111.533 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.0 -47.7 61.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.337 -0.852 . . . . 2.99 109.701 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.5 p -70.87 68.53 0.43 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.412 0.551 . . . . 2.27 112.12 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.69 -30.83 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.906 1.283 . . . . 6.12 114.033 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -51.7 -47.84 63.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.357 0.981 . . . . 4.48 112.968 -174.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 139.59 -85.6 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 129.901 3.28 . . . . 8.37 104.836 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.58 53.84 4.87 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.695 -0.562 . . . . 1.9 111.695 -166.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.3 mt -114.61 124.17 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.555 -2.016 . . . . 3.92 105.555 160.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 mt -79.76 -44.56 20.47 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.556 -0.905 . . . . 3.06 108.556 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -156.89 157.66 35.27 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.208 -1.034 . . . . 3.84 108.208 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.9 t -128.21 145.65 50.97 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 104.899 -2.26 . . . . 2.35 104.899 163.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.52 149.8 41.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 118.587 -1.245 . . . . 2.75 110.203 153.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.1 p -143.1 108.59 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 124.586 1.179 . . . . 2.61 112.451 -162.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.78 134.26 41.92 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.032 0.444 . . . . 2.0 111.199 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.06 -33.81 70.6 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 115.542 -0.754 . . . . 2.81 110.392 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -44.92 -44.23 9.56 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.364 1.466 . . . . 2.48 113.081 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -123.59 22.13 9.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.262 0.625 . . . . 2.97 110.79 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 42.44 58.88 2.9 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.198 2.199 . . . . 3.23 109.834 177.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.8 136.46 24.27 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.882 -0.511 . . . . 2.99 111.535 -166.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.5 143.03 39.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.868 1.667 . . . . 1.68 108.987 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -106.91 140.23 40.06 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.028 -1.841 . . . . 3.75 106.028 153.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -122.99 112.44 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.627 -1.99 . . . . 2.42 105.627 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -85.96 122.6 30.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.943 -1.503 . . . . 3.83 106.943 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -144.66 164.31 31.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.502 1.297 . . . . 3.53 114.502 -169.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.26 112.1 62.51 Favored Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 125.955 1.702 . . . . 2.75 108.374 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.24 2.26 5.18 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.228 1.952 . . . . 1.87 114.001 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.0 -32.56 73.94 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.646 1.112 . . . . 5.84 111.474 171.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.62 -59.33 2.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.515 0.674 . . . . 4.81 112.036 -160.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.1 tt -100.29 151.83 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.879 -0.6 . . . . 3.18 109.704 -161.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.73 -174.24 13.64 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.078 -1.609 . . . . 1.22 109.078 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -56.66 -40.46 84.2 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.926 1.75 . . . . 1.43 109.818 168.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.25 -55.86 7.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.341 1.056 . . . . 10.16 113.461 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.52 -49.24 78.35 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.402 -0.811 . . . . 2.71 109.812 -174.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.7 mt -56.58 -51.64 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 114.878 -1.055 . . . . 2.71 108.545 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.8 mt -57.02 -52.53 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.523 -0.547 . . . . 1.98 109.523 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.5 m170 -57.47 -42.84 83.39 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.379 1.085 . . . . 4.07 109.547 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.5 m -58.99 -52.91 63.74 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.67 -0.696 . . . . 2.37 110.137 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.7 mt -71.87 -37.94 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.668 -0.645 . . . . 2.16 111.819 -169.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -60.31 -45.58 92.88 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.201 -0.599 . . . . 4.17 109.682 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 t -59.09 -36.86 75.85 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.906 -0.568 . . . . 3.16 112.238 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.65 -46.1 87.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.531 1.06 . . . . 2.07 110.276 171.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.58 46.54 0.35 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.349 0.976 . . . . 0.88 111.932 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -134.78 163.54 29.56 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 107.312 -1.366 . . . . 3.42 107.312 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -97.63 103.71 17.74 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.041 -0.981 . . . . 3.34 109.852 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.56 77.47 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.212 2.608 . . . . 0.9 111.245 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -78.71 99.68 6.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.746 -0.596 . . . . 2.77 109.52 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -67.22 59.72 0.05 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.731 1.612 . . . . 3.91 114.575 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.9 t . . . . . 0 CA--C 1.537 0.444 0 O-C-N 120.743 -1.223 . . . . 3.42 109.445 176.324 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 107.276 -1.379 . . . . 3.39 107.276 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.1 tp -139.86 144.69 37.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.453 -2.425 . . . . 4.13 104.453 166.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -116.32 140.13 49.66 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 123.776 0.673 . . . . 2.52 110.179 171.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.1 124.27 36.55 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.463 -1.68 . . . . 2.61 106.463 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.56 106.77 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 104.988 -2.227 . . . . 2.21 104.988 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -97.67 97.75 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 124.542 1.137 . . . . 1.84 108.261 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -76.99 147.29 36.92 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.245 -1.02 . . . . 9.84 108.245 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.76 -51.0 0.73 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.362 0.982 . . . . 0.82 111.02 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.44 132.28 37.24 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.419 1.109 . . . . 2.47 110.01 -171.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 t -156.53 12.8 0.28 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.571 1.323 . . . . 3.07 114.571 -166.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -161.16 165.13 29.96 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 120.212 1.369 . . . . 1.18 110.16 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.83 13.05 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.248 1.419 . . . . 1.74 111.766 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -37.81 -49.9 1.21 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.502 2.321 . . . . 3.21 112.122 170.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.1 m -71.87 -56.2 6.15 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.181 -0.463 . . . . 1.12 110.129 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -47.7 -54.75 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 124.004 0.921 . . . . 2.02 109.598 -164.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -65.58 -33.86 76.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.44 -0.8 . . . . 1.24 111.826 -174.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 pttp -71.61 -40.61 69.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.907 -0.775 . . . . 4.61 108.907 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.3 mt -57.17 -66.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.212 -1.032 . . . . 2.32 108.212 171.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -51.53 -55.75 17.25 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 119.295 0.952 . . . . 2.93 110.896 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.8 t -50.53 -54.35 23.1 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.631 0.372 . . . . 2.62 111.148 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t -72.47 -26.87 61.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 114.033 1.123 . . . . 1.6 114.033 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.17 -43.38 70.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.204 -0.665 . . . . 2.83 109.204 171.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.1 p -70.17 68.68 0.33 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.879 0.847 . . . . 2.83 110.389 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -156.0 -49.53 0.08 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.853 2.861 . . . . 5.74 107.082 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -73.45 88.59 1.61 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.458 -0.571 . . . . 3.28 109.458 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -40.63 113.83 0.41 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.414 1.086 . . . . 7.82 109.528 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.86 -34.6 2.37 Favored Glycine 0 C--O 1.224 -0.529 0 N-CA-C 109.374 -1.49 . . . . 1.86 109.374 -164.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.02 125.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.493 -1.299 . . . . 2.48 107.493 174.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.9 mt -97.67 -40.1 8.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.465 0.706 . . . . 3.36 110.43 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -157.13 146.05 19.95 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.323 0.965 . . . . 3.9 109.906 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.1 p -144.22 56.8 1.31 Allowed 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.23 1.012 . . . . 3.25 111.818 -167.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -78.21 81.71 4.56 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.373 -0.829 . . . . 2.46 110.188 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.82 76.91 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.675 0.75 . . . . 2.6 112.766 -168.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.63 123.87 27.2 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 122.441 1.115 . . . . 1.98 112.469 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.95 -28.86 27.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 113.85 -1.523 . . . . 4.42 113.048 -166.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.45 -38.81 72.14 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.471 0.653 . . . . 2.92 110.618 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.52 -4.15 57.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.459 1.904 . . . . 4.25 111.42 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.4 m120 43.26 46.55 5.35 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.322 1.849 . . . . 2.07 111.4 -167.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -117.61 155.14 30.37 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.075 0.852 . . . . 3.13 111.565 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.89 139.81 49.86 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.474 -1.306 . . . . 2.0 107.474 147.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -90.97 138.86 31.28 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 103.845 -2.65 . . . . 3.7 103.845 148.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mm -122.43 106.25 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 106.725 -1.583 . . . . 3.27 106.725 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -79.75 68.26 5.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.067 -0.716 . . . . 3.07 109.067 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -73.57 143.88 46.26 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.019 -0.426 . . . . 3.53 111.482 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -62.17 113.15 7.78 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.853 1.261 . . . . 2.94 107.993 170.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.86 48.29 2.79 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.741 2.294 . . . . 1.82 112.736 -164.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -138.15 -64.11 0.54 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.678 1.191 . . . . 4.09 110.063 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.0 pt -73.63 -24.14 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 113.539 0.941 . . . . 2.87 113.539 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.0 tt -142.6 151.55 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 124.346 1.058 . . . . 2.1 108.239 -167.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.94 -178.57 15.75 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.717 -0.553 . . . . 0.82 111.717 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.79 -41.05 49.0 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.668 2.245 . . . . 0.86 110.375 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -44.76 68.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.284 0.634 . . . . 9.23 112.0 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.98 -53.39 57.42 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.388 0.613 . . . . 2.65 110.078 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.4 mt -57.95 -49.28 81.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 108.57 -0.9 . . . . 2.83 108.57 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 mt -53.19 -52.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.323 -0.621 . . . . 1.73 109.323 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -66.49 -34.45 77.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.94 0.4 . . . . 4.11 110.883 -176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 93.3 m -58.8 -52.52 65.38 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 110.109 -0.33 . . . . 1.72 110.109 172.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.9 mm -66.16 -40.23 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 121.269 -0.894 . . . . 2.79 110.895 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -53.57 -52.44 59.74 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.713 0.805 . . . . 3.1 109.195 170.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.7 t -55.46 -43.47 75.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.946 0.499 . . . . 2.56 111.109 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.12 -10.38 53.59 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.374 0.879 . . . . 2.06 113.374 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.25 30.53 8.16 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.577 1.084 . . . . 0.74 112.896 169.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -131.8 165.2 24.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.351 1.076 . . . . 3.32 110.219 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -107.95 100.16 34.45 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 124.307 1.043 . . . . 3.31 110.569 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.87 99.07 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.629 2.886 . . . . 1.06 111.069 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t -90.59 119.47 30.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.35 -1.352 . . . . 3.13 107.35 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 mt -71.14 118.93 14.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.343 -0.984 . . . . 3.72 108.343 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 109.494 -0.558 . . . . 3.16 109.494 173.849 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.232 0.174 0 N-CA-C 109.46 -0.57 . . . . 3.74 109.46 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.61 126.86 7.16 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.804 0.668 . . . . 4.56 112.804 162.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -79.56 97.16 6.35 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.674 1.99 . . . . 3.6 109.378 169.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mt -92.61 116.48 29.04 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.074 -1.454 . . . . 3.57 107.074 172.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.5 t -77.27 97.54 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 105.978 -1.86 . . . . 2.55 105.978 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.0 m -78.48 74.63 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 125.438 1.495 . . . . 1.87 107.666 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -74.38 146.35 43.04 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.926 -1.509 . . . . 5.94 106.926 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.19 23.77 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.571 -1.127 . . . . 1.23 112.126 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.58 130.15 42.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.547 1.673 . . . . 2.33 108.974 -171.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 p -116.41 -48.7 2.69 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.545 0.943 . . . . 3.64 113.545 -158.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.87 164.87 14.79 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.777 0.831 . . . . 1.34 111.498 -166.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.18 -40.07 10.65 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.887 1.275 . . . . 1.85 111.622 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -41.22 -51.29 3.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.602 1.561 . . . . 1.93 111.992 170.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.2 m -70.45 -43.63 69.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.943 0.497 . . . . 0.73 111.101 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -53.18 -55.46 12.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.506 -0.924 . . . . 1.85 108.506 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -69.26 -29.61 67.56 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.654 -0.703 . . . . 1.06 111.722 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -49.73 -54.84 16.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.472 1.033 . . . . 4.98 109.016 166.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mt -59.77 -61.56 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.285 -0.635 . . . . 2.07 109.285 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -57.43 -55.25 37.17 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.65 0.659 . . . . 2.35 111.58 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.1 m -59.85 -39.34 84.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.754 -0.591 . . . . 2.33 111.835 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 t -70.34 -46.08 64.86 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.585 -0.697 . . . . 1.55 111.092 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 mp -71.62 -61.02 1.93 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.147 0.579 . . . . 4.0 111.201 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.4 m -69.65 72.18 0.35 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.11 1.764 . . . . 3.78 110.746 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -176.17 -35.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 129.18 2.992 . . . . 4.41 109.335 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -65.3 120.93 13.67 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 119.344 0.975 . . . . 3.15 108.505 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 134.76 51.39 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.714 -1.587 . . . . 8.78 106.714 169.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.74 -41.28 2.0 Favored Glycine 0 C--O 1.225 -0.43 0 N-CA-C 110.047 -1.221 . . . . 1.53 110.047 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.14 131.55 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.647 -1.612 . . . . 3.2 106.647 164.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -96.02 -30.43 13.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.076 -0.713 . . . . 3.55 109.076 170.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -156.23 164.97 37.7 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.926 0.785 . . . . 4.32 110.392 169.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.8 t -130.47 149.87 51.94 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 105.687 -1.968 . . . . 2.29 105.687 162.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 m -139.66 104.83 5.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.406 -1.331 . . . . 3.05 107.406 162.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -114.16 141.91 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.012 0.525 . . . . 2.6 112.09 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.39 139.71 30.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.244 0.545 . . . . 2.27 110.992 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.48 -33.08 60.78 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.201 1.0 . . . . 2.77 111.606 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.33 -34.31 60.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.227 0.611 . . . . 2.82 112.217 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.8 t -106.87 3.16 26.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.284 1.434 . . . . 4.01 111.48 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.6 m120 37.31 51.21 1.1 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 127.52 2.328 . . . . 2.16 110.814 -169.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.27 137.59 27.37 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.003 -0.435 . . . . 3.07 111.925 -166.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.94 117.46 32.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.298 2.239 . . . . 1.86 108.741 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -86.34 103.74 15.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.42 -2.437 . . . . 3.0 104.42 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.21 134.58 27.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.01 -1.478 . . . . 2.24 107.01 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -112.94 118.22 34.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.485 -1.302 . . . . 3.49 107.485 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -128.08 148.61 50.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.057 0.943 . . . . 3.79 111.514 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -76.99 117.01 62.14 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 106.55 -1.648 . . . . 3.11 106.55 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.39 69.64 7.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.606 2.204 . . . . 2.17 110.77 -172.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.6 -92.88 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.582 1.153 . . . . 5.02 110.154 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.1 pt -64.05 -31.28 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.128 0.788 . . . . 3.36 113.128 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 tp -114.07 137.78 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.958 1.303 . . . . 2.02 108.517 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.54 176.94 16.3 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.147 -0.781 . . . . 0.68 111.147 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.19 -41.39 74.4 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.791 2.994 . . . . 1.09 110.923 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -56.43 -53.75 53.78 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.211 0.459 . . . . 7.37 110.779 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.45 -50.4 69.94 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.078 -0.712 . . . . 2.88 109.078 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mm -53.69 -52.81 30.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 123.334 0.654 . . . . 3.26 111.306 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.4 mt -52.66 -53.53 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.879 -0.786 . . . . 2.18 108.879 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -64.27 -37.34 87.13 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.315 0.578 . . . . 4.28 110.795 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.3 m -57.36 -46.81 82.95 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.091 -0.504 . . . . 2.37 109.754 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.41 -43.08 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 118.654 0.661 . . . . 2.38 111.323 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -52.59 -41.56 63.75 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.97 0.804 . . . . 3.42 110.087 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.4 m -53.7 -29.07 37.3 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.978 0.733 . . . . 2.67 112.978 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 mt -81.18 -15.37 55.93 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.761 0.824 . . . . 1.91 112.07 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.68 42.83 4.37 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.825 1.203 . . . . 0.71 112.662 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.96 162.21 33.49 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 107.372 -1.344 . . . . 3.16 107.372 173.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -105.74 94.08 8.31 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 118.955 0.798 . . . . 2.56 110.397 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.93 85.2 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.804 3.003 . . . . 1.33 110.989 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 m -84.68 97.03 9.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.401 1.08 . . . . 2.8 110.223 -170.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.87 102.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.875 0.87 . . . . 5.62 110.817 171.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 CA--C 1.529 0.144 0 N-CA-C 111.846 0.313 . . . . 4.62 111.846 -170.964 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.83 -0.433 . . . . 4.07 109.83 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mp -143.63 155.19 44.18 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.046 -1.094 . . . . 4.13 108.046 166.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.467 ' CD ' ' HZ2' ' A' ' 43' ' ' LYS . 15.1 mt-10 -107.61 102.24 11.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.254 -1.758 . . . . 2.96 106.254 163.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.52 130.92 40.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.267 -1.383 . . . . 2.48 107.267 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.2 t -84.11 102.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 125.225 1.41 . . . . 2.15 107.362 -174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 m -89.53 96.69 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.518 1.527 . . . . 1.93 109.082 -172.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -76.14 151.02 37.08 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 118.775 -1.17 . . . . 9.3 107.932 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.2 -27.3 10.93 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.225 0.917 . . . . 0.78 111.986 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.0 mtm -65.79 94.68 0.22 Allowed 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.556 1.178 . . . . 2.73 111.546 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -77.85 -38.77 45.4 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.685 0.394 . . . . 3.51 111.49 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.23 174.7 13.44 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 119.071 0.85 . . . . 1.17 112.199 -168.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.5 -38.94 14.9 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.17 1.388 . . . . 2.34 112.183 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 m -51.94 -40.99 61.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.682 0.793 . . . . 2.77 111.42 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.4 m -70.1 -47.95 59.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.019 0.528 . . . . 0.84 110.239 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -51.12 -58.5 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 123.737 0.815 . . . . 2.29 108.977 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.17 -25.16 66.02 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.662 -0.699 . . . . 1.11 111.631 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -56.73 -56.18 24.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.291 -1.004 . . . . 4.04 108.291 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -58.61 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.239 -1.023 . . . . 2.1 108.239 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -55.78 -54.51 43.51 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.322 0.249 . . . . 2.95 110.599 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -57.45 -48.27 79.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.862 0.465 . . . . 2.17 110.237 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 t -69.91 -34.06 73.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 118.905 -1.118 . . . . 1.22 111.22 -173.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.31 -50.36 63.9 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.124 -0.465 . . . . 3.8 110.65 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.0 p -70.91 63.65 0.31 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.982 0.896 . . . . 2.56 112.42 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -165.93 -36.22 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.42 1.888 . . . . 4.5 110.895 172.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -65.97 133.72 51.43 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.359 0.981 . . . . 2.88 109.54 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -53.04 143.13 18.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.554 -0.906 . . . . 7.73 108.554 172.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.68 -32.68 7.26 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-O 118.142 -1.366 . . . . 1.46 111.977 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.49 128.01 38.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 120.006 1.903 . . . . 2.9 108.024 172.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 mt -92.6 -45.55 8.03 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.114 1.366 . . . . 4.12 108.526 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -156.07 163.54 39.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.476 -0.564 . . . . 3.33 109.476 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.7 m -135.82 154.45 51.19 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.103 0.961 . . . . 3.59 108.742 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -149.89 97.78 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.055 -1.091 . . . . 3.11 108.055 162.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -101.39 135.65 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 122.91 0.484 . . . . 2.63 110.399 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.79 135.21 19.47 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.98 0.912 . . . . 1.86 112.457 -167.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.51 -28.63 66.21 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 125.789 1.636 . . . . 3.64 111.053 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -34.45 -45.15 0.22 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.193 1.797 . . . . 3.05 113.501 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 t -131.58 10.32 4.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 122.235 1.017 . . . . 3.61 111.503 169.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 56.94 59.18 3.59 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.958 1.703 . . . . 2.22 108.758 -167.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.467 ' HZ2' ' CD ' ' A' ' 7' ' ' GLU . 16.1 ptpt -103.49 154.69 19.18 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.974 0.91 . . . . 3.02 110.961 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.97 114.27 17.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.251 1.421 . . . . 1.68 108.001 162.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -80.1 113.39 18.23 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 104.86 -2.274 . . . . 4.0 104.86 169.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.69 126.17 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 105.563 -2.014 . . . . 2.29 105.563 174.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -114.01 123.93 50.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.586 -1.635 . . . . 3.76 106.586 169.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -144.87 148.12 33.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.752 0.821 . . . . 3.49 111.989 -160.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -56.5 117.61 17.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 107.231 -1.396 . . . . 4.75 107.231 164.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.71 -3.27 13.4 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.192 1.928 . . . . 1.98 113.003 -170.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -103.27 -54.45 2.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.17 0.895 . . . . 4.58 109.975 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.7 pt -79.95 -36.22 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.694 0.628 . . . . 3.16 112.694 -167.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.06 132.06 66.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.28 1.432 . . . . 2.01 107.669 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.63 172.72 17.84 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 118.683 0.674 . . . . 0.73 111.612 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.95 -36.31 97.07 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.232 2.621 . . . . 0.89 110.737 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -55.93 -57.0 13.92 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.094 0.406 . . . . 7.37 110.032 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.52 -49.9 66.58 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.071 -0.714 . . . . 2.68 109.071 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.6 mm -53.58 -52.0 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.281 0.632 . . . . 3.2 111.468 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.88 -52.56 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 122.73 0.412 . . . . 1.7 109.96 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -65.51 -38.95 91.19 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.53 0.681 . . . . 3.82 110.471 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.3 m -55.24 -51.42 66.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.346 -0.613 . . . . 2.09 109.346 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 89.8 mt -69.51 -39.85 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 119.407 -0.33 . . . . 2.5 111.186 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -56.65 -44.06 80.94 Favored 'General case' 0 CA--C 1.526 0.049 0 CA-C-N 118.727 0.694 . . . . 3.78 109.226 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 t -58.66 -15.02 9.87 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.994 1.109 . . . . 2.94 113.994 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.5 mt -95.84 -9.86 30.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.898 1.226 . . . . 2.33 111.694 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.36 47.05 3.63 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.299 0.952 . . . . 0.85 112.462 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -137.99 163.87 30.46 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.56 -0.904 . . . . 3.53 108.56 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.53 86.98 3.07 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.552 1.141 . . . . 3.06 110.303 -176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.59 82.36 0.93 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.879 3.053 . . . . 1.0 111.538 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 m -81.05 103.84 11.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.168 0.987 . . . . 2.56 109.022 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.06 70.97 0.16 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.558 1.143 . . . . 3.74 113.238 -175.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 107.114 -1.439 . . . . 3.18 107.114 160.745 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 106.624 -1.621 . . . . 3.79 106.624 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -155.47 158.19 38.16 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.752 0.706 . . . . 4.52 110.216 160.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.0 123.97 50.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.137 0.975 . . . . 2.4 108.911 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.54 123.94 50.89 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.285 -2.117 . . . . 2.7 105.285 167.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.29 100.35 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.298 -2.112 . . . . 2.33 105.298 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.77 84.0 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.04 1.736 . . . . 1.83 108.088 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.5 mtt85 -76.72 147.15 37.56 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.717 -1.216 . . . . 8.11 107.717 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.55 -16.61 26.39 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 119.3 -0.722 . . . . 0.81 112.849 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.1 mtp -64.05 167.34 6.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.978 1.389 . . . . 2.78 110.788 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 t -152.19 -45.54 0.1 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.076 0.55 . . . . 3.1 111.675 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.4 p -133.61 170.92 14.82 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.909 0.777 . . . . 1.25 111.917 -169.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.85 -33.94 8.12 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.856 1.263 . . . . 1.72 111.981 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -64.95 -37.61 88.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 121.491 -0.756 . . . . 2.91 111.615 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -61.36 -46.86 88.44 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.326 -0.62 . . . . 0.88 109.326 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.8 t -50.33 -59.67 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.73 -0.841 . . . . 1.8 108.73 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 0.6 OUTLIER -66.11 -28.96 69.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 116.028 -0.533 . . . . 1.17 111.725 -174.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -62.17 -54.65 38.06 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 108.809 -0.811 . . . . 5.41 108.809 173.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.29 -54.3 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 120.169 -0.612 . . . . 1.94 109.572 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -60.71 -53.99 50.7 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.367 0.531 . . . . 2.29 111.143 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.5 t -58.59 -34.9 71.61 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.742 -0.599 . . . . 2.67 111.209 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.5 t -70.38 -42.67 71.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.042 -0.411 . . . . 1.75 110.772 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.2 mt -71.22 -60.12 2.4 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.112 0.565 . . . . 3.7 112.232 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 m -69.64 67.98 0.24 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.072 1.749 . . . . 3.37 111.162 -166.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.16 -35.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.483 2.313 . . . . 4.93 110.575 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -68.03 132.43 47.26 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.471 1.032 . . . . 2.93 108.8 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -54.74 148.07 13.58 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.452 -0.573 . . . . 7.26 109.452 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.47 -28.37 10.12 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 117.382 -1.788 . . . . 1.32 112.705 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.31 126.75 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 120.544 2.172 . . . . 2.73 106.506 166.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 mt -86.79 -44.22 11.92 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.22 -1.4 . . . . 3.99 107.22 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -156.13 164.69 38.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.573 -0.899 . . . . 3.34 108.573 174.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 p -138.94 161.5 37.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.783 -1.562 . . . . 2.08 106.783 160.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.5 t -143.68 134.16 24.79 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.455 -1.683 . . . . 2.31 106.455 153.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.2 145.67 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 123.401 0.68 . . . . 2.83 109.941 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.04 134.96 26.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.073 0.463 . . . . 1.81 110.676 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.82 -29.49 65.66 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.665 1.186 . . . . 4.07 111.538 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.76 -39.11 36.69 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.631 1.172 . . . . 2.16 112.141 -174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 p -129.88 32.15 4.6 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.717 0.807 . . . . 3.32 110.192 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 27.0 62.04 0.09 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 128.226 2.611 . . . . 3.32 112.546 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -132.49 145.55 51.26 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.84 0.456 . . . . 2.77 111.462 -173.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.06 118.06 35.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.505 -1.665 . . . . 2.08 106.505 163.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -85.68 109.84 18.87 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 101.606 -3.479 . . . . 3.06 101.606 165.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.8 mt -101.94 139.22 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.329 -0.989 . . . . 3.02 108.329 175.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -117.78 104.86 11.38 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 105.707 -1.961 . . . . 3.79 105.707 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -120.11 162.49 19.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.818 0.847 . . . . 3.97 110.322 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -100.22 114.76 65.82 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.556 0.743 . . . . 3.79 110.397 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -69.4 -5.32 15.7 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.607 2.205 . . . . 2.26 113.492 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -65.01 -22.65 67.03 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.951 1.705 . . . . 5.26 112.068 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 pt -129.82 -60.08 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.499 0.926 . . . . 3.02 113.499 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 tp -87.85 137.32 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.548 -0.72 . . . . 2.12 110.031 -165.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.15 166.74 12.32 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.988 0.804 . . . . 0.84 111.57 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -57.87 -38.61 91.82 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.148 2.565 . . . . 0.84 110.872 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -53.74 -44.42 69.91 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.003 0.372 . . . . 8.78 112.003 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.3 -51.99 66.58 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.994 0.815 . . . . 2.43 109.191 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.7 mt -50.38 -54.16 9.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 C-N-CA 123.32 0.648 . . . . 2.63 109.358 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.9 mt -56.72 -51.01 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 119.119 -0.467 . . . . 1.71 110.036 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -68.55 -27.35 66.0 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-O 120.978 0.418 . . . . 4.33 112.067 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.8 m -64.62 -52.26 58.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.733 -0.469 . . . . 2.05 109.733 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -72.07 -45.28 63.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.874 -0.517 . . . . 2.37 112.151 -171.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.04 -43.23 63.65 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.65 0.659 . . . . 3.95 111.388 -176.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.3 t -48.35 -37.2 16.09 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.38 1.472 . . . . 2.62 112.395 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.4 mt -74.8 -17.27 60.65 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.363 -0.836 . . . . 2.05 112.188 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.61 45.68 3.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.159 0.885 . . . . 0.89 112.022 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -136.38 155.63 49.77 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.721 -1.215 . . . . 3.36 107.721 170.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -101.39 96.47 6.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.768 1.227 . . . . 2.83 109.41 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.2 77.66 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.352 2.701 . . . . 1.19 110.479 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.6 p -78.91 106.84 11.22 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.18 -0.674 . . . . 3.04 109.18 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.3 mt -74.94 56.55 0.75 Allowed 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.596 -0.69 . . . . 4.95 111.19 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 123.73 1.729 . . . . 4.29 107.492 173.114 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 109.912 -0.403 . . . . 3.49 109.912 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -127.01 133.25 50.58 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.361 0.665 . . . . 3.51 109.608 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -103.61 99.85 9.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.283 1.033 . . . . 2.66 108.217 169.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.94 134.02 41.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.123 -1.436 . . . . 2.35 107.123 173.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.9 t -85.32 113.81 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.143 -1.799 . . . . 1.93 106.143 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.02 96.78 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 126.04 1.736 . . . . 1.93 108.321 -172.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.02 137.66 39.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.645 -1.613 . . . . 6.47 106.645 -174.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.55 -26.49 10.14 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.768 -1.018 . . . . 0.98 112.66 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 ptm -78.65 85.71 4.67 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.534 1.667 . . . . 2.46 110.232 -176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 p -76.5 -34.6 58.61 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.881 0.872 . . . . 3.59 112.962 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.0 p -145.45 172.82 12.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.81 0.732 . . . . 1.14 112.39 -162.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.8 -39.43 8.36 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.518 1.527 . . . . 1.87 112.299 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -53.53 -53.14 55.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.491 -0.559 . . . . 2.55 109.491 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.3 m -64.77 -42.59 94.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.589 0.356 . . . . 0.68 111.003 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.6 t -48.99 -61.04 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.199 -1.037 . . . . 1.66 108.199 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.287 1.1 p-80 -70.32 -28.77 65.43 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.185 -0.916 . . . . 1.03 111.457 -174.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -51.58 -60.06 3.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.057 0.844 . . . . 4.78 110.052 168.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 mt -62.59 -59.23 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.761 -0.829 . . . . 1.92 108.761 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -56.65 -53.78 53.69 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.743 0.417 . . . . 2.68 110.001 -167.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 t -62.44 -42.48 99.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.396 -0.335 . . . . 2.28 110.872 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.0 t -65.88 -50.74 63.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.902 0.774 . . . . 1.14 110.934 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.83 -43.93 78.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.647 0.779 . . . . 3.3 111.033 -173.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.1 m -71.24 65.77 0.41 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.685 0.675 . . . . 3.78 111.457 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -147.9 -51.78 0.19 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 128.021 2.528 . . . . 8.65 108.182 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -66.11 114.62 5.38 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.845 -0.798 . . . . 2.96 108.845 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -48.95 -30.68 6.25 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.412 1.085 . . . . 7.85 113.582 -171.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.8 -33.13 55.63 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.088 -0.84 . . . . 1.72 113.208 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.76 124.17 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.783 -1.562 . . . . 2.87 106.783 169.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.47 -20.26 18.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 119.153 -0.451 . . . . 3.69 110.153 171.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -155.44 158.35 38.45 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.085 0.857 . . . . 3.34 109.964 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -139.02 146.98 41.51 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.698 -1.593 . . . . 2.17 106.698 165.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -145.77 122.89 11.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.582 -1.266 . . . . 2.66 107.582 159.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 m -111.35 151.87 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.158 0.89 . . . . 2.97 111.042 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.62 133.48 20.14 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 122.734 0.414 . . . . 1.75 111.713 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -69.46 -27.34 65.15 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.301 1.041 . . . . 2.96 111.402 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.05 -39.33 1.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.742 1.617 . . . . 2.18 113.215 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.5 t -141.62 36.47 1.64 Allowed 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.754 0.422 . . . . 3.1 110.246 168.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.4 m120 33.9 56.71 0.59 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 127.649 2.379 . . . . 2.42 110.418 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -110.78 153.15 25.74 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.16 0.984 . . . . 3.26 110.187 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.11 113.16 13.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.73 1.212 . . . . 1.81 108.019 171.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -92.44 97.93 11.15 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.384 -3.191 . . . . 2.92 102.384 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.74 141.16 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.071 -1.825 . . . . 2.34 106.071 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -122.38 114.27 20.52 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.257 -1.016 . . . . 4.15 108.257 167.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -126.29 152.51 46.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.958 0.786 . . . . 3.35 111.778 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -78.56 113.77 37.5 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 108.659 -0.867 . . . . 2.83 108.659 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.76 65.32 8.74 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.635 2.89 . . . . 1.47 110.267 -170.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -138.39 -72.47 0.41 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.845 1.258 . . . . 3.2 108.706 -170.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.26 -36.53 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.043 0.937 . . . . 3.67 111.721 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 tp -104.02 153.32 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.669 1.587 . . . . 1.96 107.963 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.47 173.56 23.82 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.236 -1.146 . . . . 0.74 110.236 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.63 -38.19 42.43 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.147 2.565 . . . . 0.82 110.327 -175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -57.43 -42.16 81.84 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.518 0.327 . . . . 6.63 111.214 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -62.15 -59.15 5.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.576 -0.898 . . . . 4.02 108.576 178.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 mm -42.9 -51.2 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.419 0.688 . . . . 3.07 110.651 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.4 mt -54.2 -59.6 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 118.661 -0.685 . . . . 1.6 110.672 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.98 -35.95 81.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.487 1.04 . . . . 7.4 111.9 -176.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.3 m -68.02 -39.21 83.19 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.6 1.16 . . . . 2.71 109.681 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.28 -46.02 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.644 -0.66 . . . . 2.32 110.677 170.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -50.13 -43.24 51.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.644 0.656 . . . . 4.93 110.905 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.1 m -51.12 -28.83 11.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.449 0.907 . . . . 2.45 113.449 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.06 -12.18 48.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.377 1.071 . . . . 2.05 112.248 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.82 48.94 3.5 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.871 1.224 . . . . 0.75 112.31 174.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -139.45 153.71 47.62 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 106.97 -1.492 . . . . 3.4 106.97 170.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -98.79 101.43 12.03 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-O 118.434 -0.793 . . . . 2.88 110.478 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.17 93.51 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.714 2.276 . . . . 0.9 111.642 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.2 m -78.45 116.86 19.14 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.574 -0.898 . . . . 2.21 108.574 167.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.6 60.67 0.34 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.462 1.105 . . . . 3.71 111.73 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 t . . . . . 0 C--O 1.228 -0.066 0 O-C-N 121.775 -0.578 . . . . 3.16 110.197 -175.679 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 107.127 -1.434 . . . . 3.45 107.127 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.49 141.53 49.78 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.14 -1.43 . . . . 4.02 107.14 166.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -103.37 145.41 30.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.446 1.098 . . . . 3.02 109.704 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.21 119.76 17.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.39 1.476 . . . . 2.88 107.318 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.65 118.94 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 103.798 -2.667 . . . . 2.38 103.798 171.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 p -124.81 87.18 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.679 1.192 . . . . 4.15 108.528 -167.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -79.44 152.36 30.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.458 -0.792 . . . . 6.02 109.306 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.77 -28.85 6.85 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.319 0.961 . . . . 0.85 111.073 -175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 30.1 mtp -66.06 110.13 2.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.84 0.82 . . . . 2.5 110.12 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.8 t -90.8 -43.06 10.3 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.253 1.021 . . . . 3.72 111.677 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.3 p -141.56 174.6 10.4 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.874 0.761 . . . . 1.31 111.963 -167.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.25 -35.76 12.63 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.994 1.318 . . . . 1.96 112.072 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -60.48 -37.5 81.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.61 -0.681 . . . . 3.21 111.344 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 78.8 m -63.76 -37.92 89.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.633 -0.667 . . . . 0.83 110.571 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.8 t -58.58 -60.94 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.405 -0.961 . . . . 2.07 108.405 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.306 0.9 OUTLIER -60.06 -35.88 76.1 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.752 -0.379 . . . . 0.98 111.589 -175.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -61.11 -46.93 88.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.901 1.68 . . . . 4.5 109.848 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mt -58.95 -65.92 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.651 -0.5 . . . . 2.04 109.651 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.86 -50.61 71.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.608 -0.437 . . . . 3.23 111.146 -168.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.0 m -56.55 -43.52 79.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.376 -0.231 . . . . 3.06 110.376 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 t -70.63 -38.99 73.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 118.802 -1.159 . . . . 1.18 111.226 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 mt -56.98 -48.94 77.22 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.186 0.903 . . . . 3.67 110.066 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.6 p -62.63 80.47 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.909 0.884 . . . . 2.74 111.631 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 pttm 176.7 -34.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 129.193 2.997 . . . . 4.46 109.944 172.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -69.13 141.93 54.51 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 119.199 -1.0 . . . . 3.02 109.037 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -62.13 145.14 54.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.552 -0.907 . . . . 6.89 108.552 175.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.05 -53.77 0.57 Allowed Glycine 0 CA--C 1.521 0.407 0 CA-C-O 119.316 -0.713 . . . . 1.41 111.528 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.74 112.25 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 118.66 1.23 . . . . 2.98 112.312 -166.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -94.1 -30.79 14.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.232 1.013 . . . . 3.95 111.2 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -153.93 147.25 24.84 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.509 1.049 . . . . 4.34 109.427 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -117.87 140.41 49.74 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 107.176 -1.416 . . . . 2.33 107.176 172.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.5 t -128.52 59.58 1.53 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.234 1.014 . . . . 4.53 108.664 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.86 133.85 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.553 0.741 . . . . 2.55 110.844 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.34 137.88 37.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.946 0.898 . . . . 2.18 112.408 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.96 -35.02 79.46 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.005 1.322 . . . . 3.77 110.072 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -37.25 -39.69 0.29 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.531 1.932 . . . . 2.74 113.831 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t -143.29 34.96 1.33 Allowed 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.393 0.277 . . . . 3.33 111.059 172.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.7 m120 41.66 61.82 1.75 Allowed 'General case' 0 CA--C 1.523 -0.077 0 C-N-CA 126.092 1.757 . . . . 2.58 110.068 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.13 140.53 18.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.329 -0.619 . . . . 3.47 109.329 -166.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.45 154.92 28.41 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.202 0.601 . . . . 2.3 110.03 166.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.28 141.33 40.22 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 104.91 -2.256 . . . . 2.77 104.91 150.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.59 134.49 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.965 -1.494 . . . . 2.78 106.965 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -102.83 85.48 2.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.508 -2.034 . . . . 4.08 105.508 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -114.01 146.36 40.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.934 1.294 . . . . 3.61 110.799 172.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -59.64 107.32 0.96 Allowed Pre-proline 0 CA--C 1.537 0.46 0 O-C-N 124.283 0.99 . . . . 2.51 108.792 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -82.44 45.57 1.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.319 2.679 . . . . 1.94 110.974 -169.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -139.31 -60.29 0.57 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.533 1.133 . . . . 4.23 108.965 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 pt -74.9 -25.87 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 112.34 0.496 . . . . 3.26 112.34 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.2 tt -143.0 154.78 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.085 -1.079 . . . . 2.65 108.085 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.08 -176.76 17.05 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.626 -0.589 . . . . 0.69 111.626 -172.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.11 -32.72 33.6 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.371 2.047 . . . . 0.87 110.174 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -53.65 -51.7 62.32 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.131 0.572 . . . . 7.34 110.95 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.81 -50.3 72.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.095 0.474 . . . . 2.31 109.745 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.0 mt -54.61 -51.94 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.08 0 C-N-CA 123.441 0.696 . . . . 2.23 109.893 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.4 mt -51.74 -53.04 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.133 -0.691 . . . . 1.83 109.133 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -66.3 -34.89 79.0 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.914 0.485 . . . . 3.75 110.785 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -60.77 -48.52 81.42 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.715 -0.476 . . . . 1.79 109.715 174.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 94.0 mt -70.89 -35.69 60.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.365 -0.834 . . . . 2.18 111.366 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -54.44 -49.45 69.97 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.557 -0.714 . . . . 2.62 109.21 167.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 t -58.12 -43.07 87.01 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.651 0.38 . . . . 2.96 111.143 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -58.18 -37.64 75.15 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.506 -0.746 . . . . 2.33 111.64 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.67 38.42 2.22 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.628 1.109 . . . . 0.88 111.726 176.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -129.28 163.45 25.65 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 107.702 -1.222 . . . . 3.5 107.702 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -109.93 98.72 35.58 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.183 0.593 . . . . 2.83 110.118 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.52 148.31 20.55 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.779 2.986 . . . . 1.63 110.168 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.1 m -153.71 118.03 4.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.457 1.103 . . . . 2.88 108.404 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.22 59.94 1.86 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.767 0.827 . . . . 3.12 111.538 -176.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 107.608 -1.256 . . . . 5.25 107.608 -178.918 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 105.808 -1.923 . . . . 4.12 105.808 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.25 145.09 51.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.816 -0.809 . . . . 4.0 108.816 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -123.92 139.13 54.26 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.949 -1.5 . . . . 2.21 106.949 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.34 152.57 51.93 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.905 -1.146 . . . . 3.92 107.905 164.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -93.92 101.66 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.792 -1.929 . . . . 2.26 105.792 -173.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.2 m -79.38 65.86 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.076 1.75 . . . . 1.81 108.581 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.39 125.86 29.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 118.95 -1.1 . . . . 5.66 108.579 -162.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.51 -44.69 0.96 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.217 0.913 . . . . 0.89 110.888 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -64.16 152.15 41.44 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.408 0.683 . . . . 2.73 111.508 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -140.65 -34.97 0.5 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.983 0.734 . . . . 2.97 112.983 -167.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 p -145.97 175.14 10.67 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.305 0.957 . . . . 1.32 111.683 -166.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.52 -47.89 3.82 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.0 1.72 . . . . 1.91 112.032 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 m -57.14 -40.29 76.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.331 0.652 . . . . 2.11 111.818 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.7 m -72.14 -53.11 13.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.619 0.645 . . . . 0.78 110.523 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.2 t -44.1 -55.77 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.482 1.513 . . . . 1.86 109.275 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -21.63 63.4 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 120.175 -0.61 . . . . 1.71 112.26 -173.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -47.97 59.98 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.933 -1.506 . . . . 6.88 106.933 173.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mt -56.33 -53.38 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.788 -0.625 . . . . 1.84 110.101 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -57.25 -61.58 2.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.841 0.746 . . . . 3.42 111.473 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -55.44 -41.75 73.26 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.771 -0.581 . . . . 2.08 111.579 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 t -65.45 -48.61 72.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.818 -0.438 . . . . 1.65 109.818 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.8 mt -54.04 -46.04 71.79 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.355 -0.841 . . . . 4.13 110.074 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -61.28 -14.16 24.43 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.695 0.998 . . . . 2.62 113.695 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -26.36 68.79 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.166 1.348 . . . . 6.68 111.275 173.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -77.86 100.17 6.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.317 -0.623 . . . . 4.12 109.317 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -61.23 82.87 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.871 -1.159 . . . . 6.81 107.871 163.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.82 -26.95 0.39 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.231 0.92 . . . . 2.26 110.932 -166.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.67 120.03 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 105.773 -1.936 . . . . 2.98 105.773 165.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.9 mt -79.91 -47.48 14.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.708 -1.219 . . . . 3.66 107.708 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -156.09 124.2 5.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.898 -0.408 . . . . 4.57 109.898 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.2 p -97.61 151.82 19.69 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.088 0.955 . . . . 3.47 108.719 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -152.56 102.48 2.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.794 -0.817 . . . . 2.75 108.794 159.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.16 148.16 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 124.102 0.961 . . . . 3.07 110.946 167.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.65 131.95 18.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.385 0.674 . . . . 1.9 109.635 171.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.46 -32.63 54.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.038 -0.983 . . . . 3.22 112.939 -167.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.95 -49.41 40.53 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.093 0.957 . . . . 2.41 111.783 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.1 p -101.77 6.48 41.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.897 0.879 . . . . 3.33 111.326 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.02 42.72 21.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.3 1.44 . . . . 3.22 110.362 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -98.81 149.12 23.21 Favored 'General case' 0 C--N 1.344 0.326 0 O-C-N 121.371 -0.83 . . . . 2.83 110.159 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.8 117.93 30.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.014 -1.106 . . . . 1.66 108.014 155.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -83.4 119.94 25.27 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.122 -2.177 . . . . 5.28 105.122 164.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 mp -113.68 118.22 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.098 -1.815 . . . . 2.44 106.098 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -103.75 97.7 7.67 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.258 -1.756 . . . . 4.17 106.258 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -112.11 169.94 8.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.185 1.394 . . . . 3.5 111.339 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -76.56 115.2 45.59 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.112 -0.699 . . . . 4.47 109.112 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.62 49.43 3.08 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-N 120.748 1.303 . . . . 1.43 111.148 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.7 -63.52 1.02 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.58 1.152 . . . . 3.81 110.052 170.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pp -75.92 -32.32 23.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 CA-C-N 118.631 0.65 . . . . 2.82 112.689 -168.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.9 tt -128.37 157.66 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.608 1.163 . . . . 2.18 110.806 -168.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -124.86 -173.87 13.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.471 -0.651 . . . . 0.73 111.471 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.84 -39.47 51.82 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.82 2.347 . . . . 1.06 110.336 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -51.15 -49.38 60.98 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.859 0.864 . . . . 6.86 112.198 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.28 -47.49 84.09 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.956 0.884 . . . . 2.22 110.209 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.7 mt -56.45 -54.06 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 114.926 -1.034 . . . . 2.6 108.22 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.9 mt -54.08 -53.0 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 116.376 -0.375 . . . . 1.74 110.146 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -64.23 -34.21 77.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.279 -0.263 . . . . 3.8 110.627 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.1 m -58.58 -53.53 57.24 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.073 -0.392 . . . . 2.25 110.697 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.4 mm -66.01 -39.81 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.168 -0.957 . . . . 3.22 111.476 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.32 -46.03 76.31 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.874 -0.517 . . . . 2.75 109.772 171.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.3 t -59.6 -42.62 92.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.828 0.451 . . . . 2.91 111.262 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.24 -43.38 87.77 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.726 0.694 . . . . 2.4 110.936 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.95 43.41 0.94 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.059 0.837 . . . . 0.74 111.436 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -130.92 157.58 42.56 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 105.608 -1.997 . . . . 3.29 105.608 166.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -102.11 108.01 55.06 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 119.37 0.986 . . . . 2.61 109.812 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.75 83.28 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 124.068 3.178 . . . . 0.9 110.918 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.5 t -78.75 112.34 15.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.171 -0.677 . . . . 2.98 109.171 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.2 57.49 1.86 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.679 0.792 . . . . 3.9 111.562 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 CA--C 1.532 0.267 0 C-N-CA 123.831 0.852 . . . . 4.19 110.482 173.375 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 107.993 -1.114 . . . . 3.85 107.993 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.7 tp -144.89 143.86 30.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.305 -1.368 . . . . 3.89 107.305 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -117.14 123.98 48.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.508 -0.923 . . . . 2.75 108.508 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.16 133.95 52.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.023 -1.473 . . . . 2.38 107.023 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.11 105.84 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.964 -1.495 . . . . 2.4 106.964 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.84 81.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.697 1.199 . . . . 1.99 108.077 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 -76.45 142.84 40.87 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 5.23 107.752 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.77 -31.84 5.57 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.36 -0.696 . . . . 0.99 111.36 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.6 ptm -60.5 159.35 10.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.181 0.991 . . . . 3.06 110.781 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 p -136.09 -65.64 0.57 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.757 0.823 . . . . 4.32 108.995 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 p -119.55 172.88 7.34 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.518 1.127 . . . . 1.77 111.579 -166.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.08 -41.2 7.5 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.958 1.303 . . . . 2.03 112.058 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m -48.96 -46.9 44.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.354 1.062 . . . . 2.77 111.325 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.8 m -68.61 -47.95 65.37 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.612 0.365 . . . . 0.92 110.128 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.5 t -50.44 -58.61 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 108.769 -0.826 . . . . 2.14 108.769 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -66.59 -28.66 68.68 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.606 -0.724 . . . . 1.13 111.687 -174.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.09 -52.71 60.1 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.231 1.012 . . . . 4.65 109.235 171.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mt -61.52 -59.8 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 108.462 -0.94 . . . . 1.98 108.462 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -51.19 -58.58 5.76 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.446 0.466 . . . . 2.64 110.744 -171.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.0 p -55.36 -50.56 69.36 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.617 0.246 . . . . 3.32 110.886 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -70.92 -26.31 63.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.039 0.385 . . . . 1.35 112.039 -171.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.38 -49.65 53.38 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.572 -0.705 . . . . 2.56 109.532 169.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.4 p -70.11 72.9 0.45 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.282 0.492 . . . . 2.62 111.835 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.58 -44.3 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.972 1.309 . . . . 5.03 110.866 176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -73.32 121.93 21.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.272 -1.011 . . . . 2.79 108.272 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -66.82 0.51 2.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.78 0.718 . . . . 10.04 112.603 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.53 -41.27 99.53 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 120.046 -1.659 . . . . 2.59 111.047 161.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.19 147.92 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.901 -1.148 . . . . 2.93 107.901 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.35 -32.44 4.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.514 1.125 . . . . 3.31 110.404 171.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -155.27 138.58 15.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.813 -1.18 . . . . 3.06 107.813 169.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.4 t -128.5 147.59 50.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.017 -1.475 . . . . 3.29 107.017 170.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 t -147.91 147.58 29.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.886 -0.783 . . . . 2.68 108.886 156.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.0 151.03 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.52 1.128 . . . . 3.51 111.13 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.8 133.36 31.99 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.027 0.531 . . . . 1.78 111.091 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.75 -37.16 86.66 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.613 1.165 . . . . 4.14 110.475 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.27 -39.99 1.52 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.164 1.786 . . . . 2.73 113.644 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.1 t -139.96 38.13 1.96 Allowed 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 121.907 0.86 . . . . 3.32 109.608 172.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.2 m120 35.99 46.78 0.38 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 127.955 2.502 . . . . 2.39 111.672 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -102.65 146.09 28.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.679 -0.489 . . . . 3.22 109.679 -168.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.19 119.86 37.81 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.227 -1.768 . . . . 1.61 106.227 161.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -86.78 120.25 27.87 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 103.947 -2.612 . . . . 4.5 103.947 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.5 128.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.379 -2.082 . . . . 2.28 105.379 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -111.46 96.92 6.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.109 -1.441 . . . . 2.98 107.109 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -106.68 148.1 28.78 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.708 0.803 . . . . 3.65 111.217 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.51 110.32 8.59 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.214 -1.402 . . . . 2.84 107.214 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -82.12 67.28 8.19 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.462 2.108 . . . . 1.59 111.909 -162.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.93 -83.72 0.14 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.086 0.954 . . . . 3.5 110.54 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.29 -47.46 84.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 122.098 -0.376 . . . . 3.39 110.825 -175.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 tp -86.2 154.16 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.241 -1.022 . . . . 2.66 108.241 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.03 168.5 23.67 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.657 -0.977 . . . . 0.78 110.657 173.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -54.9 -34.14 84.74 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.551 2.834 . . . . 0.93 110.658 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -42.26 -51.35 4.8 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.3 1.04 . . . . 10.57 111.045 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -71.79 -48.42 46.71 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.393 -0.965 . . . . 2.56 108.393 -168.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 mm -47.46 -51.25 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 124.404 1.082 . . . . 3.15 109.516 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.8 mt -61.75 -52.99 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.887 -0.597 . . . . 1.73 110.002 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -55.83 -42.35 75.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 122.052 0.93 . . . . 4.7 109.808 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 84.1 m -59.52 -58.58 7.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.218 -0.901 . . . . 1.67 108.999 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.95 -38.54 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 121.39 -0.819 . . . . 2.31 111.693 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -53.38 -51.54 62.21 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.309 -0.626 . . . . 2.84 109.309 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -57.14 -37.07 71.49 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.023 -0.423 . . . . 2.52 112.029 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.5 mt -67.98 -15.22 63.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.422 -0.799 . . . . 2.54 112.964 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.12 41.67 5.18 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.204 0.906 . . . . 1.0 112.196 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -138.54 164.72 28.72 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.94 -1.133 . . . . 3.27 107.94 170.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -100.52 99.66 10.44 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.24 1.416 . . . . 2.64 109.956 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.71 80.4 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 124.14 3.227 . . . . 1.02 110.269 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.8 m -81.95 94.63 7.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.837 0.855 . . . . 3.09 109.328 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.4 65.18 0.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.662 1.185 . . . . 3.53 112.794 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.454 -0.254 0 O-C-N 121.094 -1.004 . . . . 4.18 111.842 -176.173 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 N-CA-C 108.948 -0.76 . . . . 4.3 108.948 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mp -137.82 158.33 44.58 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.095 -1.076 . . . . 4.07 108.095 160.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -137.86 132.91 33.23 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.221 1.008 . . . . 2.87 108.465 -169.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.79 139.46 32.77 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.438 1.095 . . . . 2.39 108.64 -169.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.8 t -85.57 100.42 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 107.737 -1.208 . . . . 2.04 107.737 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.5 m -84.15 76.5 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 125.608 1.563 . . . . 1.93 108.904 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -76.29 141.14 41.72 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.11 -1.036 . . . . 5.56 108.351 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.19 -43.05 1.35 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.823 -0.911 . . . . 0.7 110.823 -176.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -64.98 149.69 49.36 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.967 0.884 . . . . 2.35 110.217 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -139.97 -37.6 0.48 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.679 0.622 . . . . 3.07 112.679 -168.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 p -135.4 168.59 18.93 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.006 0.821 . . . . 1.21 110.965 -177.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.74 -38.45 15.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.939 1.296 . . . . 1.8 112.0 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 m -45.84 -44.31 14.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.128 1.371 . . . . 2.26 112.218 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.4 m -71.68 -51.89 20.67 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.503 0.721 . . . . 0.73 110.745 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.7 t -46.6 -60.87 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 125.205 1.402 . . . . 1.66 108.946 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -67.29 -23.27 65.64 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.879 -1.055 . . . . 1.1 111.523 -175.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -66.29 -53.26 38.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.059 -1.089 . . . . 4.94 108.059 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mt -58.73 -55.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 N-CA-C 108.669 -0.863 . . . . 2.02 108.669 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.27 -57.68 10.81 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.226 0.467 . . . . 2.35 110.965 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -56.12 -48.82 75.48 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.681 0.393 . . . . 2.45 110.564 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.3 t -60.07 -57.1 14.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.933 -0.395 . . . . 1.18 109.933 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.01 -40.16 66.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.078 0.551 . . . . 2.9 111.168 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.2 m -49.3 -26.62 3.18 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.655 0.983 . . . . 3.69 113.655 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -62.55 -27.33 69.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.14 1.336 . . . . 5.13 112.505 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -68.36 107.99 3.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.126 -0.694 . . . . 4.09 109.126 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -46.34 -36.93 6.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.756 0.823 . . . . 6.32 113.083 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.62 -11.87 84.89 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.197 -0.779 . . . . 1.74 113.772 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.95 120.1 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 119.134 1.467 . . . . 2.88 108.977 173.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -91.03 -31.45 16.29 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.856 -0.593 . . . . 3.76 110.97 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -157.74 130.87 7.6 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.727 1.149 . . . . 3.74 109.91 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.0 t -103.25 144.58 31.15 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 106.856 -1.535 . . . . 2.26 106.856 164.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -147.07 149.1 32.4 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 118.322 -1.351 . . . . 2.99 109.693 144.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.09 138.84 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.727 0.811 . . . . 2.95 111.029 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.31 131.32 53.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.492 1.117 . . . . 1.96 111.972 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.6 mt -68.78 -47.88 65.07 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 126.105 1.762 . . . . 3.74 111.783 -173.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.97 -46.71 52.7 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.018 0.527 . . . . 2.48 110.862 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 m -79.7 -39.87 30.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.327 0.651 . . . . 3.28 109.25 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 79.55 43.12 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 127.466 2.306 . . . . 3.81 107.688 -168.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.2 139.25 53.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.067 0.547 . . . . 3.54 111.356 -165.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.6 125.36 53.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.776 1.63 . . . . 1.58 109.106 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -96.28 114.87 26.6 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.355 -2.832 . . . . 2.86 103.355 166.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 mt -119.43 106.98 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.446 -1.687 . . . . 2.75 106.446 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -82.34 71.27 9.4 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.077 -1.453 . . . . 3.26 107.077 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -95.22 130.1 42.09 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.942 -0.572 . . . . 4.39 109.994 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -76.76 116.04 53.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 108.22 -1.03 . . . . 3.6 108.22 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -80.38 54.96 5.46 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.424 2.75 . . . . 2.19 112.262 -163.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -125.34 -71.92 0.68 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.783 1.233 . . . . 3.58 109.137 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -75.08 -34.6 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 O-C-N 122.282 -0.261 . . . . 2.82 111.188 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.36 137.47 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 126.116 1.767 . . . . 2.08 108.347 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.95 177.67 16.41 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.774 0.702 . . . . 0.72 111.617 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -57.67 -44.67 39.24 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.458 2.772 . . . . 0.87 110.679 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -58.81 -42.92 90.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.681 -0.408 . . . . 8.5 111.175 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.81 -53.48 57.85 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.5 0.667 . . . . 2.5 109.661 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mm -52.14 -50.91 34.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.158 0.983 . . . . 3.38 110.112 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.4 mt -57.61 -49.83 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.285 -0.416 . . . . 1.71 110.05 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -62.31 -39.32 92.63 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.939 0.876 . . . . 5.03 110.365 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.0 m -56.47 -52.55 64.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.315 -0.624 . . . . 1.93 109.315 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.3 mt -72.31 -40.76 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 121.892 -0.505 . . . . 2.37 111.638 -171.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -59.77 -48.6 81.03 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 118.273 0.488 . . . . 4.21 110.296 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.3 m -56.6 -40.73 75.8 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.877 0.325 . . . . 2.97 111.877 175.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.69 -38.62 91.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.107 0.867 . . . . 2.18 111.566 173.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.93 36.33 0.89 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.837 0.732 . . . . 0.71 112.451 172.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -130.23 157.73 41.68 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.368 -1.345 . . . . 3.37 107.368 168.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -99.48 104.99 30.62 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 119.538 1.063 . . . . 2.66 110.297 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.34 90.19 1.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.934 3.089 . . . . 0.87 111.1 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.9 t -78.95 111.48 15.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.153 -0.684 . . . . 3.2 109.153 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.18 60.18 1.04 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.899 1.28 . . . . 4.09 111.52 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.453 -0.307 0 O-C-N 121.795 -0.566 . . . . 4.27 111.984 -173.486 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.106 0.479 . . . . 3.29 112.196 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.68 129.4 34.95 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.345 -0.847 . . . . 3.58 110.049 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -92.94 105.46 17.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.741 1.217 . . . . 2.49 107.92 168.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.6 127.44 40.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.287 -1.375 . . . . 2.56 107.287 171.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.44 100.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.169 -1.789 . . . . 1.87 106.169 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.52 71.42 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.994 1.718 . . . . 1.71 107.995 -173.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -74.82 136.92 41.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.035 -1.468 . . . . 6.21 107.035 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.28 -42.53 1.91 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.573 -1.011 . . . . 0.81 110.573 -167.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.51 130.65 39.99 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.374 1.087 . . . . 2.57 108.919 -174.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 t -123.57 -41.52 2.26 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.968 1.099 . . . . 3.34 113.968 -155.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.2 p -138.65 175.46 9.54 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 119.498 1.044 . . . . 1.19 111.85 -168.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.97 -40.3 10.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.19 1.396 . . . . 1.97 112.222 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -55.0 -50.15 69.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.339 0.59 . . . . 2.79 110.006 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.48 -40.28 89.22 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.894 -1.129 . . . . 0.71 109.93 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.6 t -52.34 -61.58 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 108.733 -0.84 . . . . 1.84 108.733 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.284 1.0 OUTLIER -69.58 -30.39 68.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 119.999 -0.681 . . . . 1.15 112.137 -171.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -63.3 -47.1 83.72 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.804 0.729 . . . . 5.01 109.999 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.4 mt -56.81 -62.02 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.872 -0.788 . . . . 2.14 108.872 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -56.54 -52.87 63.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.225 -0.287 . . . . 2.45 110.225 -171.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.6 t -57.85 -55.25 37.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.658 0.266 . . . . 2.41 110.782 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 t -71.12 -32.76 69.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.563 -0.711 . . . . 1.76 112.478 -169.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -70.94 -51.98 22.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.574 0.624 . . . . 3.04 109.66 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.2 m -70.59 70.49 0.45 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.174 0.99 . . . . 3.03 110.978 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -175.38 -35.08 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.88 2.472 . . . . 4.4 110.091 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -65.34 136.55 56.68 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.31 0.959 . . . . 2.7 109.828 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -51.45 138.7 21.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.702 -0.481 . . . . 6.78 109.702 176.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.37 -31.46 8.28 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.338 -0.701 . . . . 1.3 112.74 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.21 136.86 23.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 107.488 -1.301 . . . . 3.73 107.488 167.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 pp -103.42 -35.76 8.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.475 0.71 . . . . 3.61 110.396 175.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -157.35 163.66 38.4 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.179 -1.045 . . . . 3.87 108.179 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.1 m -139.62 163.6 32.13 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.516 -1.29 . . . . 2.63 107.516 161.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.2 t -148.17 145.43 28.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.679 -0.808 . . . . 2.92 108.823 142.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.59 137.59 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.12 0.968 . . . . 3.19 111.277 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.41 134.33 55.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.158 0.983 . . . . 1.89 110.702 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.19 -41.57 99.21 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.154 1.382 . . . . 3.28 111.1 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.82 -37.87 20.54 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.032 1.333 . . . . 2.28 113.261 -166.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -130.16 24.56 5.23 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.231 1.012 . . . . 3.89 110.535 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 m120 35.68 48.28 0.45 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.329 2.252 . . . . 2.2 111.769 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -106.68 135.14 48.73 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.53 -0.545 . . . . 3.04 109.53 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.48 114.81 28.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.39 -1.337 . . . . 1.89 107.39 168.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -89.95 105.0 17.51 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.014 -2.588 . . . . 2.88 104.014 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.55 137.03 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.317 -1.734 . . . . 2.58 106.317 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -118.05 126.77 52.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.394 -1.336 . . . . 3.68 107.394 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -153.56 154.61 34.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.095 0.558 . . . . 4.02 110.572 -165.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -69.69 144.96 94.43 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 108.939 -0.763 . . . . 4.98 108.939 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.35 24.79 0.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.259 2.639 . . . . 1.64 111.432 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -113.02 -58.66 2.13 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.847 0.859 . . . . 3.55 109.969 -164.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 pt -95.42 -50.15 11.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.528 0.731 . . . . 3.17 110.295 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 tp -91.27 151.68 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.151 -1.055 . . . . 2.52 108.151 -173.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.56 169.07 23.62 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.643 -0.983 . . . . 0.7 110.643 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -50.09 -42.48 45.95 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.585 2.856 . . . . 0.88 110.73 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -38.0 -51.06 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.373 1.469 . . . . 10.64 111.925 173.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -71.67 -49.78 36.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.587 -0.894 . . . . 2.4 108.587 -166.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.58 -47.31 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 114.884 -1.053 . . . . 2.5 108.374 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.0 mt -58.17 -53.24 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 109.746 -0.465 . . . . 1.91 109.746 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -56.72 -41.34 77.27 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 121.64 0.733 . . . . 4.69 109.442 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.4 m -61.42 -54.35 44.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.823 -0.626 . . . . 1.79 110.583 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 mm -63.02 -41.6 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 121.367 -0.833 . . . . 2.89 110.501 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.56 -46.47 77.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.684 0.393 . . . . 3.31 109.992 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -61.43 -39.27 90.18 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.287 -0.387 . . . . 2.77 111.586 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.47 -35.67 81.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.835 0.743 . . . . 2.01 110.848 173.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.78 40.54 0.99 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.051 0.834 . . . . 0.83 112.409 170.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -131.94 162.02 31.69 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 107.131 -1.433 . . . . 3.11 107.131 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -99.48 109.1 53.84 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 119.001 0.819 . . . . 2.79 109.363 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.05 88.34 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.753 2.969 . . . . 1.0 110.54 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.15 96.78 5.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.866 -1.161 . . . . 2.85 107.866 -178.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pp -59.98 107.34 0.61 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.195 0.907 . . . . 3.33 110.481 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.2 t . . . . . 0 C--N 1.34 0.185 0 N-CA-C 109.231 -0.655 . . . . 3.52 109.231 178.537 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 108.662 -0.866 . . . . 4.48 108.662 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.86 156.68 39.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.849 -1.167 . . . . 4.7 107.849 165.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -126.79 139.15 53.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.335 1.054 . . . . 2.93 109.76 -175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.41 143.43 31.62 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.369 1.068 . . . . 2.42 108.189 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.07 123.08 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.962 -1.866 . . . . 2.13 105.962 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 m -106.59 74.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 106.656 -1.609 . . . . 1.76 106.656 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.44 HH12 ' CD ' ' A' ' 68' ' ' GLU . 10.4 ptt85 -76.1 129.59 37.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.305 -1.368 . . . . 5.77 107.305 -170.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.85 -48.54 0.95 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.427 -1.069 . . . . 0.79 110.427 -165.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -73.57 144.78 45.91 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.847 1.323 . . . . 2.45 111.287 -174.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -148.16 -1.6 0.55 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.775 1.398 . . . . 2.86 114.775 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.62 168.51 25.88 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.554 1.525 . . . . 1.42 110.165 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.91 -42.71 13.09 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.517 1.527 . . . . 2.0 112.259 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.3 m -43.52 -51.08 6.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.681 1.193 . . . . 2.02 111.401 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -71.06 -41.6 70.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 122.993 0.517 . . . . 0.79 111.83 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.3 t -50.79 -59.0 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.232 -1.025 . . . . 2.07 108.232 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -68.36 -30.34 69.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.139 -0.937 . . . . 1.22 111.155 -176.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -53.61 -43.54 68.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 119.271 0.941 . . . . 5.57 110.313 170.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.1 mt -71.82 -80.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 118.751 0.705 . . . . 1.94 109.606 169.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -62.4 -43.69 98.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.709 -0.619 . . . . 2.62 112.542 -153.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -63.08 -28.74 70.29 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.543 0.571 . . . . 3.45 112.543 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 t -71.79 -53.19 14.13 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.376 0.989 . . . . 1.77 110.399 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.04 -46.39 65.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.152 0.981 . . . . 2.87 111.278 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.3 p -67.13 64.01 0.06 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.142 1.377 . . . . 2.22 112.114 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -160.05 -50.02 0.05 Allowed 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 128.406 2.682 . . . . 7.38 108.929 -175.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -68.02 138.54 55.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.151 -0.619 . . . . 3.21 109.789 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -56.66 149.41 17.82 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.035 0.445 . . . . 6.92 109.813 175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.07 -24.38 16.2 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-O 118.339 -1.256 . . . . 1.55 112.764 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.95 120.46 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 120.128 1.964 . . . . 3.0 108.221 171.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.8 mt -81.78 -52.99 6.57 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.193 -1.04 . . . . 3.17 108.193 170.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -157.84 147.61 20.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.586 -0.894 . . . . 4.75 108.586 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.3 t -117.97 144.67 45.31 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 105.751 -1.944 . . . . 2.5 105.751 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.4 t -147.21 151.03 36.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 118.159 -1.416 . . . . 3.29 110.441 153.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.8 133.19 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 124.532 1.145 . . . . 2.94 110.509 -171.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.47 132.34 55.77 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.695 0.628 . . . . 1.84 112.695 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.56 -45.05 84.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.232 1.413 . . . . 4.55 111.606 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.04 -30.08 23.99 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.712 0.805 . . . . 2.4 112.932 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -114.36 2.13 14.63 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.495 1.518 . . . . 3.27 111.705 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.3 m120 41.16 43.59 1.97 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.465 2.306 . . . . 2.13 110.881 -172.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.57 140.3 49.42 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 122.691 0.396 . . . . 2.97 111.34 -166.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.41 139.52 44.27 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.179 1.792 . . . . 1.78 108.929 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -104.38 137.43 42.27 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.726 -1.953 . . . . 4.63 105.726 156.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.8 112.88 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.445 -1.687 . . . . 2.39 106.445 174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -83.7 68.27 9.8 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.373 -1.343 . . . . 3.76 107.373 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -90.83 140.03 30.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.226 -0.443 . . . . 4.19 110.705 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.2 106.5 0.73 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.19 1.396 . . . . 2.54 108.591 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.5 61.31 7.99 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.299 2.666 . . . . 2.36 110.421 -166.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -163.98 -60.47 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.01 0.924 . . . . 4.41 109.805 -169.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 pt -82.94 -26.88 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 122.768 0.427 . . . . 3.79 111.991 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 tp -131.12 140.26 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.261 -1.755 . . . . 2.64 106.261 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.32 176.34 16.08 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 121.781 0.656 . . . . 0.96 112.156 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.04 -41.59 51.2 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.168 2.579 . . . . 1.25 110.52 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.59 -46.05 90.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.309 0.244 . . . . 8.28 110.602 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.15 -51.31 69.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.394 -0.595 . . . . 3.26 109.394 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 mm -55.14 -48.92 75.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 122.779 0.432 . . . . 3.0 111.533 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.1 mt -53.14 -57.02 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.037 -0.727 . . . . 2.05 109.037 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -65.89 -33.92 76.95 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.806 -0.559 . . . . 4.59 111.153 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -57.56 -58.64 7.4 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.34 -0.615 . . . . 2.31 109.34 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.7 mt -65.66 -35.43 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.25 -0.906 . . . . 2.21 111.293 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.13 -51.63 61.32 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.437 -0.579 . . . . 3.4 109.437 168.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 m -57.65 -38.22 74.69 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.025 -0.422 . . . . 2.96 111.922 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.4 mt -67.94 -10.63 54.94 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.918 0.71 . . . . 2.76 112.918 174.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.98 60.09 3.0 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.673 -0.971 . . . . 1.62 110.673 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -141.5 171.48 14.0 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 106.826 -1.546 . . . . 3.42 106.826 155.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.44 ' CD ' HH12 ' A' ' 11' ' ' ARG . 32.9 mt-10 -101.46 100.96 15.23 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 108.837 -0.801 . . . . 2.51 108.837 172.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.21 145.11 59.25 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 N-CA-C 108.238 -1.485 . . . . 1.94 108.238 166.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -150.8 110.97 4.14 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.464 -1.68 . . . . 2.43 106.464 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.02 142.41 53.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.28 0.562 . . . . 4.65 109.502 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 124.836 1.254 . . . . 3.28 111.133 172.834 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 108.444 -0.947 . . . . 4.48 108.444 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -79.14 108.99 13.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.606 -1.257 . . . . 3.89 107.606 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -93.27 83.23 4.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 113.601 -1.636 . . . . 3.0 107.102 166.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.76 129.67 35.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.569 -1.641 . . . . 2.43 106.569 174.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.89 119.97 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.738 -1.949 . . . . 2.06 105.738 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.78 84.39 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 128.124 2.57 . . . . 2.05 108.331 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.79 140.16 39.41 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 108.872 -0.788 . . . . 5.6 108.872 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.84 -19.78 8.3 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.881 0.753 . . . . 0.72 112.084 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.5 mtp -62.15 150.7 37.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.572 1.186 . . . . 2.71 109.691 175.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -139.33 -39.21 0.48 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.131 0.973 . . . . 3.42 111.771 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.1 p -145.48 173.5 11.97 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.212 0.914 . . . . 1.63 111.405 -169.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.58 -39.71 3.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.048 1.739 . . . . 2.58 112.563 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.0 m -49.86 -50.87 44.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.204 0.602 . . . . 2.12 111.017 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.1 m -65.1 -41.11 95.28 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.196 0.598 . . . . 0.74 110.172 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 t -55.27 -61.76 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.458 -0.942 . . . . 2.06 108.458 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.2 -28.93 67.69 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 118.866 -0.588 . . . . 1.71 111.533 -173.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -56.81 -56.61 19.34 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.462 -0.94 . . . . 5.14 108.462 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.55 -59.63 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 109.158 -0.682 . . . . 2.23 109.158 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.67 -45.3 94.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.766 -0.635 . . . . 2.59 111.927 -169.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m -61.14 -47.45 86.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.793 0.724 . . . . 2.44 111.066 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.3 t -58.82 -42.57 89.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.944 -0.472 . . . . 2.17 110.094 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.35 -48.29 61.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.425 0.69 . . . . 2.95 111.842 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.3 p -56.49 -32.11 64.71 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.868 1.213 . . . . 2.47 111.62 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -54.51 -36.26 64.04 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.824 -0.548 . . . . 5.74 112.057 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -69.84 96.67 1.02 Allowed 'General case' 0 C--O 1.225 -0.234 0 O-C-N 121.325 -0.859 . . . . 4.05 109.1 171.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -41.42 -40.02 1.64 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.914 1.285 . . . . 8.26 114.099 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.0 -2.19 70.8 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.072 -0.849 . . . . 1.49 114.211 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.52 121.8 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.865 -1.532 . . . . 3.21 106.865 167.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.7 mt -79.9 -46.74 16.24 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.129 0.971 . . . . 3.44 108.882 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -155.96 129.03 8.05 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.387 0.539 . . . . 4.32 110.435 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.6 p -104.27 154.31 19.95 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.535 0.734 . . . . 2.89 109.664 169.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -151.5 110.33 3.85 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.603 -1.258 . . . . 2.59 107.603 155.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.64 157.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 118.134 0.425 . . . . 2.9 110.652 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.92 134.5 14.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.602 -0.687 . . . . 1.94 110.764 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.09 -32.15 71.38 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.941 0.896 . . . . 2.53 110.289 175.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.97 -37.8 2.01 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.005 1.722 . . . . 2.33 113.565 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.9 t -140.83 37.87 1.8 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 121.507 0.67 . . . . 3.05 109.913 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 m120 35.45 58.84 0.82 Allowed 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.002 1.721 . . . . 3.15 110.879 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -121.87 142.83 49.85 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 122.819 0.448 . . . . 3.34 110.605 -171.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.84 105.27 10.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.8 1.24 . . . . 1.85 108.843 167.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -79.8 108.68 13.55 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 104.356 -2.461 . . . . 4.17 104.356 169.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.8 mt -119.99 111.4 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 106.749 -1.574 . . . . 2.11 106.749 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -103.12 109.7 21.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.051 -1.833 . . . . 3.89 106.051 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -137.29 162.74 32.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.881 1.672 . . . . 3.51 109.999 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -83.25 112.76 41.45 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 107.162 -1.422 . . . . 3.24 107.162 171.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.64 68.38 8.31 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.975 2.45 . . . . 2.05 110.852 -170.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.68 -92.66 0.17 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.672 1.189 . . . . 3.8 109.363 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.97 -30.3 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 N-CA-C 112.873 0.694 . . . . 2.98 112.873 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.72 125.24 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.52 -1.659 . . . . 3.18 106.52 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.98 -179.41 19.04 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.789 1.185 . . . . 0.85 111.424 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -59.52 -39.82 71.93 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.643 2.228 . . . . 0.82 110.464 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -56.51 -49.61 74.24 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.754 0.421 . . . . 6.3 111.683 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -48.49 81.46 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.413 -0.588 . . . . 2.26 109.413 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.5 mt -51.28 -56.15 5.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 108.776 -0.824 . . . . 2.51 108.776 173.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.6 mt -54.52 -52.68 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 110.005 -0.368 . . . . 1.69 110.005 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -56.47 -42.73 78.73 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 121.53 0.681 . . . . 4.01 109.221 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.7 m -63.36 -50.34 70.31 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.076 -0.511 . . . . 2.09 110.782 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.8 mm -61.94 -42.74 95.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.445 -0.784 . . . . 2.86 110.41 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -56.23 -44.6 79.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.692 0.397 . . . . 3.23 110.099 173.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 m -61.24 -40.29 93.5 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.083 -0.386 . . . . 2.43 111.837 176.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.98 -41.26 96.11 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.72 0.691 . . . . 2.26 110.585 172.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.81 44.98 0.73 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.367 0.984 . . . . 0.81 111.587 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -131.74 162.78 29.66 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.552 -1.277 . . . . 3.41 107.552 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -95.03 101.51 7.38 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 117.61 -1.186 . . . . 2.66 109.861 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -77.74 137.73 16.33 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.103 1.869 . . . . 1.33 108.823 172.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 t -154.79 109.29 2.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.706 -0.85 . . . . 2.98 108.706 -171.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.42 66.02 1.78 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.784 0.834 . . . . 3.55 110.375 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t . . . . . 0 CA--C 1.532 0.251 0 C-N-CA 123.879 0.872 . . . . 3.52 109.766 177.579 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 109.114 -0.699 . . . . 3.72 109.114 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 135.66 29.65 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.926 0.49 . . . . 3.42 109.833 169.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -90.85 93.01 9.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.442 1.497 . . . . 3.13 107.046 165.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.2 121.85 34.98 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 107.997 -1.112 . . . . 2.55 107.997 173.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.63 111.09 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.337 -1.357 . . . . 2.57 107.337 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -94.17 92.16 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.252 1.421 . . . . 1.71 108.326 -168.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -77.71 137.29 38.41 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.433 -0.951 . . . . 6.73 108.433 -174.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.58 -53.15 0.77 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.499 -1.041 . . . . 1.14 110.499 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -61.58 143.7 55.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 122.938 0.495 . . . . 2.66 111.756 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -157.28 14.8 0.25 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.891 1.071 . . . . 2.88 113.891 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 p -162.85 161.04 25.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.761 1.164 . . . . 1.74 109.772 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -39.64 5.56 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.701 1.6 . . . . 2.3 111.449 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -36.16 -47.63 0.57 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.512 2.325 . . . . 3.84 113.13 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.0 m -73.85 -52.46 12.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.151 0.981 . . . . 1.0 111.685 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.5 t -45.99 -58.13 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 126.179 1.791 . . . . 2.0 109.679 -166.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -61.47 -32.51 72.51 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.21 -1.359 . . . . 2.35 110.794 -174.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -71.23 -47.3 58.13 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.852 -0.796 . . . . 5.43 108.852 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 99.1 mt -54.05 -58.88 2.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.053 -0.721 . . . . 2.26 109.053 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -61.97 -47.77 83.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.531 -0.271 . . . . 2.13 111.196 -174.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.6 m -55.49 -58.22 8.65 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.201 0.455 . . . . 2.45 110.517 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 t -49.31 -49.89 41.83 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.951 1.3 . . . . 1.3 110.698 -177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.94 -51.23 57.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 119.161 -0.447 . . . . 3.89 111.721 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.4 p -55.4 -28.35 53.54 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.159 0.436 . . . . 2.28 111.635 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -58.17 -40.85 82.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.424 0.557 . . . . 5.83 111.909 174.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -79.28 120.0 23.14 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.899 0.857 . . . . 3.24 110.142 -169.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -57.84 157.68 7.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.111 -0.7 . . . . 8.74 109.111 170.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.3 -15.05 25.37 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 117.896 -1.502 . . . . 1.73 112.785 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.51 125.05 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 119.777 1.789 . . . . 2.83 106.536 154.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.2 mt -80.44 -43.46 20.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.675 -1.231 . . . . 3.78 107.675 169.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -155.63 155.95 34.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.487 -0.561 . . . . 3.91 109.487 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 p -131.32 158.18 41.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 106.955 -1.498 . . . . 2.44 106.955 156.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -150.79 145.2 25.57 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.028 -1.101 . . . . 2.93 108.028 139.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 p -112.57 148.29 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.168 0.987 . . . . 3.01 110.653 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.54 136.11 35.73 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.14 0.576 . . . . 1.75 110.943 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.2 mt -65.82 -36.12 82.6 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.043 1.337 . . . . 3.61 110.091 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.3 -39.06 1.3 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.188 1.795 . . . . 2.5 113.88 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 t -140.96 35.68 1.75 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 122.154 0.978 . . . . 2.99 109.644 172.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 m120 36.06 57.36 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.984 2.514 . . . . 2.09 111.917 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.64 153.73 51.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 121.926 -0.484 . . . . 4.54 111.994 -170.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.82 117.05 28.67 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.058 1.743 . . . . 1.76 108.657 174.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -85.08 101.45 12.44 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 103.46 -2.792 . . . . 4.06 103.46 169.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.22 143.91 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.026 -1.472 . . . . 2.44 107.026 170.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -126.8 112.5 15.45 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 106.092 -1.818 . . . . 3.55 106.092 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -127.48 173.49 9.8 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.369 0.668 . . . . 3.53 111.254 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -96.4 101.33 8.57 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.411 1.085 . . . . 2.43 109.275 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.54 58.08 6.6 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.663 2.909 . . . . 1.71 113.029 -169.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.13 -63.75 0.4 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.027 1.731 . . . . 4.12 107.987 169.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.0 pt -65.28 -26.83 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.977 0.911 . . . . 3.95 112.432 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 tt -143.96 150.67 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.07 -1.085 . . . . 2.48 108.07 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -114.43 -176.26 18.91 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.187 -0.765 . . . . 0.92 111.187 -174.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.16 -38.72 20.5 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.337 2.024 . . . . 1.01 109.795 172.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -47.52 -49.59 25.71 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.755 1.222 . . . . 6.84 111.382 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.89 -54.09 50.27 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.227 0.611 . . . . 2.54 110.124 -174.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.6 mt -53.14 -52.28 31.55 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 N-CA-C 108.555 -0.905 . . . . 2.41 108.555 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mt -55.54 -53.28 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.89 -0.595 . . . . 1.94 110.277 -174.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -67.84 -31.87 72.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.626 0.648 . . . . 8.05 110.362 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.7 m -59.29 -46.4 88.65 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.532 -0.544 . . . . 1.64 109.532 172.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.57 -36.98 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.27 -0.894 . . . . 2.22 111.315 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -55.22 -43.96 74.97 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.507 -0.746 . . . . 2.86 109.882 169.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.7 m -60.93 -38.81 87.08 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.295 -0.253 . . . . 2.31 111.576 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.24 -40.27 95.67 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.225 0.466 . . . . 2.33 110.831 171.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.8 45.02 0.85 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 124.526 1.06 . . . . 1.01 111.752 173.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -131.89 163.06 29.15 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.748 -0.834 . . . . 3.3 108.748 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -99.12 100.7 10.62 Favored Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 124.576 1.15 . . . . 4.5 110.539 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.71 81.77 2.59 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.815 3.01 . . . . 1.39 111.107 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.2 m -78.66 109.91 13.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.402 -0.811 . . . . 2.03 109.564 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.56 58.47 0.59 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.488 0.715 . . . . 2.95 111.76 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 CA--C 1.53 0.191 0 C-N-CA 125.605 1.562 . . . . 4.08 108.67 -179.362 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.232 0.161 0 N-CA-C 107.65 -1.241 . . . . 3.84 107.65 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.95 121.38 40.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.519 0.676 . . . . 3.7 109.566 178.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -91.1 90.75 7.96 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.784 2.034 . . . . 4.22 107.348 177.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -82.35 106.77 14.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.15 -1.796 . . . . 3.67 106.15 172.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 t -78.49 101.37 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.438 -1.69 . . . . 2.5 106.438 -176.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 m -89.44 88.3 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.997 1.319 . . . . 2.08 109.912 -164.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -77.8 96.57 4.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.652 -1.61 . . . . 9.61 106.652 -176.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.69 -38.83 0.35 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.878 -0.957 . . . . 0.98 112.527 177.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -70.56 162.26 29.19 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.126 1.463 . . . . 2.21 111.218 -173.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -145.09 -37.41 0.28 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.435 0.902 . . . . 3.21 113.435 -170.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 p -141.09 173.83 11.11 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 119.789 1.177 . . . . 1.69 111.705 -172.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.78 -41.8 15.96 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.025 1.33 . . . . 2.09 111.799 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.7 m -57.25 -38.46 73.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.825 0.45 . . . . 2.42 111.665 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.0 m -71.07 -52.63 18.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.264 0.484 . . . . 0.76 110.176 173.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.8 t -44.2 -58.44 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 124.753 1.221 . . . . 1.89 109.212 -176.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.6 -22.24 63.52 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.515 -0.766 . . . . 1.72 112.368 -174.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -68.48 -50.87 49.16 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 107.413 -1.328 . . . . 6.14 107.413 173.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mt -56.54 -57.01 10.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 109.104 -0.702 . . . . 1.81 109.104 177.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.98 -54.66 44.14 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.423 0.556 . . . . 2.18 111.488 -174.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.7 t -62.33 -39.1 91.96 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.502 0.321 . . . . 3.12 111.007 -178.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -63.5 -53.42 52.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.141 -0.688 . . . . 2.29 109.141 177.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -47.6 -46.21 28.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.662 1.185 . . . . 2.91 111.528 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.43 -15.16 2.4 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.491 1.293 . . . . 2.86 114.491 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -56.59 -37.02 70.05 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.904 1.229 . . . . 5.9 111.288 170.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -76.72 100.78 5.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.596 -0.891 . . . . 4.33 108.596 -176.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -50.92 -30.21 14.16 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.204 0.816 . . . . 7.64 113.204 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.81 -20.64 70.59 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.95 -0.916 . . . . 1.71 113.677 177.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.09 124.87 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 118.682 1.241 . . . . 2.88 108.393 178.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.5 mt -94.46 -36.93 11.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.591 1.556 . . . . 3.32 109.507 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -155.7 125.59 6.52 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.8 0.727 . . . . 3.13 111.048 178.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.84 144.79 34.55 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.528 1.131 . . . . 3.16 108.732 167.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 m -151.48 143.06 23.61 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.901 -1.518 . . . . 2.68 106.901 152.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 m -127.18 136.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.29 0.496 . . . . 2.82 110.223 178.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.82 131.59 54.13 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.835 0.854 . . . . 1.73 111.691 -174.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.63 -43.47 80.3 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.296 1.838 . . . . 4.06 111.414 -175.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.09 -46.06 33.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.166 0.587 . . . . 2.05 111.453 -179.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -82.92 -25.16 32.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.671 1.189 . . . . 4.1 111.839 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 41.69 66.9 0.62 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.523 1.529 . . . . 3.37 109.609 -151.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.41 141.3 33.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.504 -1.226 . . . . 2.94 110.453 -177.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.28 124.08 49.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.039 2.136 . . . . 1.96 108.31 174.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -98.16 106.99 19.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.249 -2.871 . . . . 2.8 103.249 174.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.3 mp -102.25 127.83 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.546 -1.65 . . . . 2.42 106.546 175.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -112.03 114.43 27.3 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.631 -1.248 . . . . 3.01 107.631 167.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -130.9 163.47 27.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.566 1.546 . . . . 3.28 111.47 176.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -87.98 129.32 50.63 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.239 1.016 . . . . 3.93 110.548 175.239 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -59.2 -58.76 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.781 2.321 . . . . 2.36 115.294 -165.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -78.07 37.27 0.25 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.168 1.349 . . . . 4.15 113.911 -165.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.63 -52.63 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.241 1.416 . . . . 4.73 109.111 170.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.19 144.83 33.84 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 122.624 0.37 . . . . 2.39 110.958 -171.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.47 -176.76 22.56 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.326 -1.11 . . . . 0.89 110.326 176.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.0 -39.74 18.23 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.189 1.926 . . . . 1.07 110.11 174.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -53.38 -49.43 67.21 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.004 0.922 . . . . 7.77 111.989 -176.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.12 -52.0 38.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 122.491 1.139 . . . . 2.83 109.464 -178.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.2 mt -65.55 -52.29 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 114.554 -1.203 . . . . 2.41 109.059 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.2 mt -48.08 -54.25 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.765 0.826 . . . . 1.93 110.222 -177.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -65.86 -35.6 81.11 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 119.809 -0.756 . . . . 7.21 110.501 -176.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.8 m -63.13 -46.91 85.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 122.1 -0.375 . . . . 1.92 110.582 178.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.6 -40.79 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.49 -0.756 . . . . 2.18 109.882 178.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -53.31 -38.44 63.17 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.539 -0.725 . . . . 5.24 111.207 170.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -64.44 -22.54 66.99 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.935 0.717 . . . . 2.42 112.935 176.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.6 mt -78.74 -43.61 25.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.982 0.81 . . . . 2.1 109.243 168.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.21 49.11 0.37 Allowed Glycine 0 C--N 1.338 0.659 0 C-N-CA 124.467 1.032 . . . . 1.04 112.173 169.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.28 134.73 26.19 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 117.419 -1.277 . . . . 3.31 108.014 175.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -78.86 112.02 24.15 Favored Pre-proline 0 C--N 1.34 0.156 0 CA-C-N 119.49 1.041 . . . . 5.48 108.893 -170.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -89.55 78.98 0.87 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.38 2.72 . . . . 1.39 110.066 -171.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.39 115.53 20.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.547 -0.721 . . . . 2.14 109.633 -170.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.6 mt -53.61 111.52 0.74 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.996 0.816 . . . . 4.39 110.724 174.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.469 0.495 0 CA-C-N 118.896 0.771 . . . . 5.58 111.89 176.945 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 107.836 -1.172 . . . . 3.84 107.836 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -149.25 163.5 37.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.256 -0.646 . . . . 4.36 109.256 162.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -120.03 145.41 46.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.217 -1.031 . . . . 2.35 108.217 168.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.07 130.13 28.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.759 -1.2 . . . . 2.48 107.759 177.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.3 t -79.67 104.72 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.901 -1.889 . . . . 2.08 105.901 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.05 89.22 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.428 1.491 . . . . 1.78 108.216 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -75.57 131.4 39.99 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 107.763 -1.199 . . . . 6.09 107.763 -170.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.05 -43.13 1.39 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.088 0.852 . . . . 0.71 111.404 177.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.46 132.58 40.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.454 1.127 . . . . 2.44 108.633 -175.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 t -154.84 25.08 0.44 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.97 0.73 . . . . 2.91 112.97 -169.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.33 156.87 19.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.523 0.602 . . . . 1.39 109.629 178.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.53 -39.43 16.29 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.505 1.522 . . . . 2.08 111.987 -176.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.6 t -47.26 -54.23 11.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.683 0.754 . . . . 2.57 110.143 172.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.263 57.7 m -73.16 -33.56 65.55 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.355 -1.465 . . . . 1.19 112.151 -176.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.8 t -50.37 -61.33 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 108.666 -0.864 . . . . 1.71 108.666 174.084 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -69.84 -29.56 66.84 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.175 -0.921 . . . . 1.27 111.787 -174.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -62.0 -50.72 70.92 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.28 0.945 . . . . 5.15 109.655 173.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 mt -58.29 -57.76 9.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 119.218 0.917 . . . . 1.74 109.047 178.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.05 -54.14 46.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.157 0.435 . . . . 2.47 110.895 -173.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -56.98 -52.99 63.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.865 0.466 . . . . 2.19 110.437 179.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.6 t -57.34 -54.97 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.638 0.375 . . . . 1.4 110.756 -177.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.51 -32.98 71.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.534 -0.729 . . . . 3.16 111.365 -174.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.9 m -53.66 -19.97 4.71 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 112.938 0.718 . . . . 3.95 112.938 173.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -30.28 59.73 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.531 -1.355 . . . . 6.67 112.113 171.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -68.86 101.47 1.36 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.577 -0.897 . . . . 4.01 108.577 169.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -49.45 -33.25 13.68 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 111.885 0.328 . . . . 6.09 111.885 171.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.72 -11.23 77.5 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.815 -0.992 . . . . 1.63 113.796 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.16 129.67 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 119.699 1.75 . . . . 3.11 107.431 168.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 pp -99.74 -26.05 14.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.862 0.465 . . . . 3.49 110.745 175.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -156.11 149.94 25.1 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.88 0.764 . . . . 4.09 111.224 172.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.1 m -130.33 145.4 51.78 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 126.178 1.791 . . . . 2.9 107.553 174.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 m -153.34 135.22 14.62 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 107.808 -1.182 . . . . 2.41 107.808 152.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.86 151.07 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.987 0.812 . . . . 3.1 110.479 173.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.61 132.57 37.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.533 0.682 . . . . 2.0 110.779 176.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.9 -29.44 66.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.035 -0.984 . . . . 2.59 110.732 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.72 -34.97 13.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.49 1.116 . . . . 1.93 112.927 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 p -122.03 13.49 10.55 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.889 0.876 . . . . 3.27 111.299 175.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.7 m120 40.15 52.17 2.73 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.243 1.817 . . . . 2.13 110.659 -171.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.09 140.37 45.45 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 122.043 -0.411 . . . . 3.05 111.141 -164.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.85 128.22 56.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.026 1.73 . . . . 1.71 109.156 177.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -98.84 121.78 41.23 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 127.847 2.459 . . . . 3.99 105.701 172.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mt -123.72 134.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.686 -0.857 . . . . 3.01 108.686 177.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -122.95 130.82 53.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.14 -1.8 . . . . 3.32 106.14 178.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -162.05 171.31 17.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.214 0.45 . . . . 3.74 112.214 -158.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.12 100.56 25.48 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.51 1.524 . . . . 2.8 109.437 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.71 -12.79 35.56 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.323 2.682 . . . . 2.37 113.394 -168.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -52.97 -39.71 63.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.662 0.664 . . . . 4.63 111.635 176.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -120.07 -54.52 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.113 0.565 . . . . 2.85 112.133 -176.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.14 116.54 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.851 -1.166 . . . . 3.25 107.851 -172.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.71 161.55 16.75 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.523 -1.031 . . . . 0.94 110.523 -177.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -51.52 -38.1 63.82 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.995 2.463 . . . . 0.89 110.857 176.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -42.87 -52.73 4.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.422 1.089 . . . . 10.73 111.647 172.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.18 -40.52 67.86 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.083 -1.01 . . . . 2.5 109.76 -167.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 78.5 mt -52.68 -57.47 4.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 N-CA-C 107.611 -1.255 . . . . 2.7 107.611 170.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mt -55.54 -48.91 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 116.039 -0.528 . . . . 1.93 110.136 -174.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -55.54 -44.98 77.23 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 122.172 0.986 . . . . 4.92 108.953 179.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 m -62.96 -45.72 91.13 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.344 -0.843 . . . . 2.12 110.294 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -70.07 -42.42 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.377 -0.827 . . . . 2.82 110.566 -173.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -63.26 -43.18 98.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.907 -0.496 . . . . 3.38 110.138 175.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 m -54.54 -44.83 73.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 111.891 0.33 . . . . 2.41 111.891 172.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.07 -39.8 91.27 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.822 0.737 . . . . 2.43 111.14 173.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.2 41.07 0.92 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.049 0.833 . . . . 0.82 111.655 173.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -127.77 161.97 27.72 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.163 -1.051 . . . . 3.08 108.163 170.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.4 103.6 14.63 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.133 -0.937 . . . . 2.68 110.015 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.29 77.03 3.97 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.239 2.626 . . . . 1.02 110.699 -176.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -78.66 90.11 4.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.316 -0.994 . . . . 2.42 108.316 -177.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -66.1 57.44 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.021 1.728 . . . . 3.5 114.683 -176.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.454 -0.264 0 C-N-CA 126.369 1.868 . . . . 4.71 107.543 -175.512 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.236 0.373 0 N-CA-C 109.783 -0.451 . . . . 3.49 109.783 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mp -136.46 138.67 41.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.029 -0.73 . . . . 3.27 109.029 167.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -92.34 93.51 8.66 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.512 -1.292 . . . . 2.7 107.512 163.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mt -80.03 112.25 17.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.797 -1.927 . . . . 3.78 105.797 173.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.2 t -78.97 104.49 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.506 -1.665 . . . . 2.41 106.506 -177.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.3 m -79.14 80.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 124.601 1.16 . . . . 2.22 108.516 -172.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 -75.91 95.27 3.5 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.524 -1.658 . . . . 4.91 106.524 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.58 -57.41 0.11 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.643 -0.983 . . . . 1.51 110.643 177.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.28 157.45 18.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 117.363 0.582 . . . . 2.5 109.794 -177.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 t -154.31 35.82 0.42 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.624 -0.51 . . . . 4.59 109.624 170.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.43 137.0 22.76 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.686 0.795 . . . . 2.57 110.193 -170.054 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.69 -43.28 2.8 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.519 1.927 . . . . 2.16 112.002 -177.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -35.1 -58.38 0.54 Allowed 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.733 1.613 . . . . 2.99 111.931 170.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.2 m -74.52 -27.56 60.59 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.915 -1.116 . . . . 1.44 113.866 -178.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.41 -55.68 17.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.895 -1.15 . . . . 1.82 107.895 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -63.58 -32.57 74.08 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.951 -0.568 . . . . 1.34 111.913 -178.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -60.01 -54.3 47.6 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.433 -0.951 . . . . 4.71 108.433 173.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.3 mt -57.7 -56.43 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.187 -0.672 . . . . 1.84 109.187 -172.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -61.03 -50.23 74.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.789 -0.764 . . . . 3.71 111.337 -174.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.3 m -54.11 -50.11 67.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.339 0.59 . . . . 2.47 110.407 177.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.4 t -58.19 -41.88 84.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.037 0.935 . . . . 1.73 110.301 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.68 -46.3 69.42 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.59 -0.694 . . . . 3.07 111.849 178.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.2 p -53.71 -30.21 42.77 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.806 0.73 . . . . 2.42 112.926 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -58.19 -32.46 68.27 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.24 0.616 . . . . 6.43 112.082 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -73.17 106.66 5.12 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.335 0.971 . . . . 4.17 108.595 171.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -37.38 -58.01 0.87 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.067 -0.716 . . . . 9.83 109.067 167.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.97 -11.43 0.57 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.921 1.248 . . . . 1.63 116.07 -173.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.13 167.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 120.275 2.038 . . . . 3.06 107.892 171.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.87 -30.04 1.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.67 -0.644 . . . . 3.89 112.531 170.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -155.62 123.17 5.57 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.293 0.951 . . . . 4.33 108.917 170.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 p -106.52 132.81 52.1 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.996 0.918 . . . . 3.87 108.573 169.059 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -134.9 80.29 1.84 Allowed 'General case' 0 CA--C 1.522 -0.122 0 O-C-N 123.715 0.634 . . . . 3.37 109.614 167.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.85 144.1 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 122.56 0.344 . . . . 2.78 110.803 171.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.24 137.7 16.74 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.887 0.875 . . . . 2.35 109.905 178.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.75 -22.35 58.83 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.013 -0.54 . . . . 2.65 111.487 177.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.56 -39.7 2.41 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.49 1.516 . . . . 2.77 113.278 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -137.88 34.8 2.39 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.944 0.497 . . . . 2.55 110.309 168.157 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 44.78 50.51 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.765 2.026 . . . . 2.14 110.027 173.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -114.61 145.26 42.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.971 0.909 . . . . 3.56 110.354 -170.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.28 108.22 13.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.15 1.38 . . . . 1.75 108.562 163.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . 0.25 19.7 t60 -86.77 101.75 13.61 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 104.234 -2.506 . . . . 3.62 104.234 174.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 mp -103.43 119.83 52.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.858 -1.905 . . . . 2.22 105.858 174.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -102.71 140.66 36.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.069 -1.085 . . . . 3.71 108.069 166.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -159.27 159.1 33.69 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.957 0.903 . . . . 3.35 112.423 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.74 109.17 3.06 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 126.47 1.908 . . . . 2.68 107.659 173.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -81.83 54.61 5.13 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.007 2.471 . . . . 1.63 110.553 -170.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -142.52 -64.31 0.42 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.367 1.467 . . . . 3.89 109.361 -175.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.57 -38.46 17.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 N-CA-C 112.204 0.446 . . . . 2.71 112.204 -172.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 tt -113.41 146.01 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.64 1.176 . . . . 2.31 109.604 -175.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.5 -172.17 13.73 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.687 -0.965 . . . . 0.69 110.687 178.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.81 -40.56 28.08 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.479 2.119 . . . . 0.84 110.178 174.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -45.53 -58.41 3.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.313 1.045 . . . . 7.46 111.504 179.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.91 -57.62 9.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.362 0.665 . . . . 2.34 109.644 -174.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 56.0 mt -51.82 -52.71 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.921 0.888 . . . . 2.37 109.325 179.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.02 -48.67 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-O 119.034 -0.508 . . . . 1.85 110.107 -176.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -58.7 -41.57 86.6 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.88 0.848 . . . . 4.46 109.476 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.3 m -64.88 -45.44 85.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.783 -0.644 . . . . 2.43 111.044 178.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.3 mm -70.2 -51.67 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 CA-C-N 118.575 0.625 . . . . 3.21 110.682 -177.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -55.58 -36.8 67.27 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.148 0.579 . . . . 3.08 111.707 -167.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 t -38.07 -44.68 0.84 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.011 1.724 . . . . 3.2 113.039 168.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -19.66 63.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.811 0.844 . . . . 5.24 112.21 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.6 40.54 3.37 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.021 1.296 . . . . 2.09 111.782 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -124.87 155.95 38.68 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.759 -1.2 . . . . 3.36 107.759 172.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -95.63 101.12 7.23 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.012 -0.994 . . . . 3.51 108.895 169.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -70.81 81.49 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.165 2.577 . . . . 1.15 109.141 175.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 m -79.35 109.66 13.91 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.909 0.884 . . . . 2.68 108.733 -168.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.42 61.4 0.67 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.558 1.143 . . . . 3.66 112.568 -174.201 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.455 -0.211 0 N-CA-C 108.856 -0.794 . . . . 3.02 108.856 174.487 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 108.47 -0.937 . . . . 4.5 108.47 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 mt -134.31 130.29 36.79 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.335 -0.987 . . . . 4.09 108.335 170.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -114.11 91.93 3.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.454 1.502 . . . . 2.5 108.596 174.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.67 134.46 44.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.374 -1.343 . . . . 2.28 107.374 176.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -80.33 115.69 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 106.949 -1.5 . . . . 4.19 106.949 170.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.54 86.45 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 125.938 1.695 . . . . 1.69 107.698 -173.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -77.34 130.9 37.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.23 -1.026 . . . . 6.57 108.23 -170.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.16 -18.83 4.17 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.718 0.675 . . . . 1.01 112.541 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 61.5 mtp -59.19 147.67 34.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.574 1.187 . . . . 2.92 110.863 177.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -150.75 -10.93 0.24 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.761 1.393 . . . . 3.3 114.761 178.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.9 p -165.59 172.01 12.47 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 121.032 1.742 . . . . 1.46 109.371 -179.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.88 -38.99 11.28 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.379 1.472 . . . . 2.23 112.147 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -45.71 -47.0 15.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.924 0.889 . . . . 2.02 111.65 173.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.0 m -69.75 -39.84 76.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 122.79 0.436 . . . . 0.7 110.98 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.7 t -57.75 -59.58 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.998 -1.112 . . . . 1.97 107.998 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.269 1.3 p-80 -70.8 -31.46 68.21 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 118.206 -0.902 . . . . 1.03 112.521 -175.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -49.15 -58.15 5.48 Favored 'General case' 0 C--N 1.347 0.465 0 N-CA-C 108.178 -1.045 . . . . 4.72 108.178 165.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.19 -60.87 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 118.572 -0.728 . . . . 2.49 110.239 -174.298 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.03 -55.31 24.63 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.39 0.995 . . . . 2.59 110.853 -175.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.1 t -58.09 -54.21 49.52 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.538 0.685 . . . . 2.13 110.28 -177.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -66.82 -40.62 88.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.709 -0.62 . . . . 1.23 110.952 -170.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.98 -42.69 84.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.115 0.416 . . . . 2.77 109.935 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -55.27 -27.23 45.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.5 0.591 . . . . 2.91 112.354 176.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -30.57 64.19 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.09 -1.006 . . . . 4.48 112.153 173.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -63.92 108.61 1.53 Allowed 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.346 0.975 . . . . 4.12 108.808 173.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -48.4 -33.44 9.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.896 0.878 . . . . 6.89 112.37 175.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.85 -18.35 80.12 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.642 -1.088 . . . . 1.87 114.042 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.21 135.59 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.94 1.37 . . . . 3.05 107.774 172.57 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pp -98.6 -33.61 10.9 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.692 -0.67 . . . . 3.9 109.82 173.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -157.04 146.17 20.17 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.463 1.029 . . . . 4.15 109.642 162.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.6 t -112.65 112.3 23.71 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 107.382 -1.34 . . . . 2.61 107.382 164.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.11 98.29 8.25 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.837 -1.172 . . . . 2.29 107.837 171.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.0 146.28 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 110.351 -0.24 . . . . 3.09 110.351 170.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.7 130.26 15.88 Favored 'General case' 0 CA--C 1.523 -0.092 0 O-C-N 122.02 -0.425 . . . . 1.77 111.293 170.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 pp -72.14 -25.82 61.87 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 124.756 1.223 . . . . 3.01 113.074 -168.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.1 -43.46 66.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.809 0.444 . . . . 2.03 111.191 -178.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.73 -31.75 10.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.591 1.156 . . . . 3.02 110.038 173.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 76.2 30.91 0.67 Allowed 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.14 2.176 . . . . 3.53 109.464 -171.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -79.5 145.01 33.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.373 -1.343 . . . . 4.66 107.373 171.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.48 109.71 21.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 124.888 1.367 . . . . 1.73 107.406 151.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -80.38 94.3 6.13 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.705 -1.961 . . . . 5.12 105.705 166.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -92.11 116.13 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 107.216 -1.401 . . . . 2.81 107.216 176.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -108.09 128.44 54.68 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.606 -1.627 . . . . 4.33 106.606 174.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -157.24 171.8 19.76 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.421 0.688 . . . . 3.53 109.637 -166.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.76 114.36 62.85 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.169 -0.678 . . . . 3.12 109.169 177.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.25 49.68 3.24 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.41 2.74 . . . . 1.33 112.15 -174.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.96 27.24 0.54 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.748 1.219 . . . . 3.84 110.234 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.78 -51.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 125.021 1.328 . . . . 4.67 108.998 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 tt -127.67 152.59 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.241 1.016 . . . . 2.16 108.478 -174.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -133.83 -176.09 14.22 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.538 -0.625 . . . . 0.74 111.538 -178.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.92 -41.62 52.0 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.859 2.373 . . . . 0.91 111.872 -176.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -57.39 -47.49 81.55 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.629 0.65 . . . . 6.91 110.863 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.95 -52.85 63.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.818 -0.808 . . . . 2.71 108.818 -175.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 mm -51.77 -52.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.405 1.082 . . . . 3.27 109.901 175.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.1 mt -55.29 -57.3 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 109.848 -0.427 . . . . 1.94 109.848 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -65.24 -34.2 77.8 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.623 -0.673 . . . . 4.11 110.23 -171.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.5 m -59.2 -55.95 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.049 -0.523 . . . . 1.88 109.937 171.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 76.8 mt -63.86 -36.24 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.35 -0.844 . . . . 2.58 111.35 -175.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -51.2 -55.06 19.96 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.208 -0.664 . . . . 2.81 109.208 167.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -54.76 -42.08 71.23 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.696 0.398 . . . . 2.86 111.559 177.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.48 -10.94 58.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.185 0.809 . . . . 2.48 113.185 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.08 44.1 5.46 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 123.941 0.782 . . . . 0.98 111.976 172.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -140.82 163.53 32.69 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.174 -1.417 . . . . 3.88 107.174 167.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -103.91 105.01 46.31 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 125.429 1.492 . . . . 4.59 109.984 -179.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -83.49 85.29 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.538 3.492 . . . . 0.94 111.317 -173.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -94.11 111.97 23.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.851 -0.531 . . . . 2.71 110.136 -173.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 mt -62.14 106.41 0.72 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.96 0.904 . . . . 3.91 109.924 174.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.462 0.132 0 N-CA-C 109.7 -0.481 . . . . 3.25 109.7 177.526 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 106.664 -1.606 . . . . 4.05 106.664 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -155.26 175.13 14.25 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.681 -1.229 . . . . 4.56 107.681 163.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -131.83 146.45 52.14 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.725 -0.843 . . . . 2.47 108.725 168.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.42 131.41 41.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.791 -1.559 . . . . 2.22 106.791 169.178 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.5 t -79.92 100.94 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.022 -1.473 . . . . 1.96 107.022 175.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.21 87.03 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 126.056 1.742 . . . . 2.19 108.096 177.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.12 154.33 33.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.811 -1.181 . . . . 5.83 107.811 170.171 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.54 -38.42 3.21 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.628 -0.989 . . . . 0.84 110.628 -172.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 29.9 mtp -64.06 138.15 58.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.229 1.015 . . . . 2.73 109.607 178.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -140.54 -2.76 1.36 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.128 1.159 . . . . 2.93 114.128 -176.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.1 p -161.43 166.09 27.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.44 1.473 . . . . 1.17 110.063 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.89 -40.56 10.19 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.371 1.468 . . . . 2.1 111.875 -177.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.3 m -43.27 -47.04 6.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.856 0.863 . . . . 1.93 112.304 174.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.6 -33.77 75.66 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.005 0.522 . . . . 0.91 111.436 -175.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.22 -59.91 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.112 -1.44 . . . . 1.85 107.112 -178.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.25 1.5 p-80 -67.97 -30.03 69.21 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.179 -0.464 . . . . 1.2 112.062 -178.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -52.67 -44.95 66.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.57 -0.706 . . . . 4.58 110.615 168.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.6 mt -70.39 -71.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.126 -0.694 . . . . 2.04 109.126 175.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . 0.283 0.2 OUTLIER -59.15 -50.02 75.64 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.238 0.926 . . . . 4.32 112.471 -159.745 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -56.37 -46.36 80.08 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.376 0.67 . . . . 2.47 110.497 176.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -71.24 -35.27 71.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 121.232 -0.917 . . . . 1.51 112.142 -176.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.77 -54.07 50.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.004 -0.739 . . . . 2.75 109.004 172.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.2 p -65.25 71.48 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.799 1.24 . . . . 2.3 113.081 -174.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -169.83 -31.09 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.915 2.486 . . . . 4.57 111.567 171.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -67.69 147.23 52.94 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.307 1.412 . . . . 3.08 108.78 177.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 ttm105 -61.66 142.76 56.98 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.263 -1.014 . . . . 6.22 108.263 173.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.65 -56.52 0.48 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.669 -0.973 . . . . 1.53 110.669 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.11 103.95 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 118.509 1.155 . . . . 3.37 110.993 -167.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.4 pp -82.3 -29.72 30.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.589 -0.732 . . . . 3.63 110.292 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -156.44 158.04 36.6 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.573 0.624 . . . . 3.7 109.38 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -142.9 133.79 25.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.206 1.003 . . . . 2.42 108.53 169.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 m -112.19 93.14 4.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.644 -1.243 . . . . 2.78 107.644 160.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.4 p -88.82 144.94 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 122.551 0.34 . . . . 2.64 111.096 162.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.74 138.85 26.07 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.172 0.989 . . . . 1.74 110.039 171.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.74 -35.85 60.07 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.602 0.761 . . . . 2.91 110.885 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.28 -42.61 41.64 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.289 1.035 . . . . 2.47 111.849 -173.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.1 p -114.84 20.09 15.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.908 1.283 . . . . 3.4 110.615 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 m120 37.13 55.64 1.28 Allowed 'General case' 0 C--N 1.341 0.211 0 C-N-CA 126.777 2.031 . . . . 2.98 111.431 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -134.15 150.56 51.12 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 118.418 0.554 . . . . 2.7 112.488 -176.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.77 119.85 33.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.134 2.174 . . . . 1.86 107.535 167.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -101.12 101.42 12.15 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.164 -2.532 . . . . 2.86 104.164 167.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.59 143.79 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 108.116 -1.068 . . . . 2.51 108.116 177.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -120.43 91.0 3.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.937 -1.134 . . . . 3.05 107.937 175.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -102.37 149.79 24.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.003 0.921 . . . . 3.65 113.205 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -71.71 116.03 43.78 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 124.83 1.252 . . . . 3.15 108.574 171.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.41 40.21 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.264 1.976 . . . . 1.8 111.586 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -82.32 -40.33 21.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.698 -0.626 . . . . 6.35 109.818 172.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 pt -133.63 -51.09 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.717 0.807 . . . . 3.32 112.098 -168.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.76 147.0 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.307 0.643 . . . . 2.04 109.823 -166.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.12 -171.66 13.01 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.892 -0.883 . . . . 0.91 110.892 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.25 -34.47 56.03 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.46 2.107 . . . . 1.04 110.519 176.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.508 HH21 ' CE1' ' A' ' 60' ' ' HIS . 1.7 tpm_? -50.37 -54.23 23.24 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.361 1.064 . . . . 8.92 111.163 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -52.51 63.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.232 1.013 . . . . 2.66 109.183 -176.559 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 94.8 mt -52.08 -47.85 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 C-N-CA 123.647 0.779 . . . . 2.38 109.4 178.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.7 mt -55.38 -54.13 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 109.381 -0.6 . . . . 1.93 109.381 -178.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . 0.508 ' CE1' HH21 ' A' ' 56' ' ' ARG . 76.7 m-70 -65.48 -34.88 79.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.801 0.728 . . . . 4.33 111.367 -176.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -57.08 -52.23 66.11 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.076 -0.713 . . . . 1.63 109.076 173.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.9 mt -70.87 -32.37 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 121.242 -0.911 . . . . 2.1 112.242 -178.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -53.96 -49.06 69.58 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.346 -0.983 . . . . 2.75 108.346 166.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -60.5 -40.93 93.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.157 0.183 . . . . 2.19 111.34 177.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.0 mt -61.38 -34.33 75.16 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.611 -0.681 . . . . 2.26 111.582 172.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.48 43.85 1.53 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.886 1.231 . . . . 0.96 112.206 173.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -134.2 168.83 18.15 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.732 -0.84 . . . . 3.34 108.732 170.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.92 85.05 4.74 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.059 0.944 . . . . 3.57 110.982 -172.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.64 93.42 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.788 2.992 . . . . 0.89 111.37 -175.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.2 m -86.22 119.53 26.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.888 1.275 . . . . 2.58 108.116 -179.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.0 mt -74.56 58.05 0.76 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.05 1.296 . . . . 3.46 112.184 -175.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 107.604 -1.258 . . . . 3.35 107.604 177.462 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 109.768 -0.456 . . . . 3.52 109.768 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 pp -150.3 164.92 34.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.748 -0.834 . . . . 4.4 108.748 161.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 153.26 51.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.629 0.728 . . . . 4.44 109.944 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 134.63 30.43 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.669 -1.604 . . . . 2.51 106.669 -177.259 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.16 102.47 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 105.513 -2.032 . . . . 1.92 105.513 177.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 m -90.79 71.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.471 -1.678 . . . . 1.69 106.471 -172.297 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -74.72 124.13 26.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 118.883 -1.127 . . . . 5.79 108.112 -159.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.19 -26.11 3.26 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.328 -0.851 . . . . 1.11 111.946 -179.268 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.86 109.86 8.67 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.883 1.341 . . . . 2.45 110.462 -176.299 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 p -83.67 -44.6 14.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.85 -0.532 . . . . 3.79 112.186 -170.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -149.28 177.37 9.72 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 112.073 0.397 . . . . 1.41 112.073 -156.32 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.28 -48.51 3.6 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.706 1.602 . . . . 1.69 111.785 177.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 m -48.09 -46.64 34.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.326 1.451 . . . . 2.79 111.779 176.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.9 m -72.24 -53.58 12.1 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.877 0.471 . . . . 0.74 110.689 176.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -43.91 -60.07 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.281 1.432 . . . . 1.83 109.347 -176.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.52 -12.37 61.34 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 113.61 0.967 . . . . 1.19 113.61 -176.037 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -53.2 19.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.553 -1.647 . . . . 4.52 106.553 163.182 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.6 mt -65.4 -60.22 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 118.445 0.566 . . . . 1.86 109.596 -169.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . 0.264 0.2 OUTLIER -58.36 -53.58 56.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.765 -0.774 . . . . 4.51 111.311 -166.123 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -60.9 -48.87 79.83 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.225 -0.893 . . . . 2.33 109.868 177.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 t -63.75 -42.71 97.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.883 1.22 . . . . 1.42 110.837 -170.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.33 -46.17 87.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.423 -0.584 . . . . 3.23 109.423 174.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -71.73 65.45 0.5 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.256 0.55 . . . . 2.99 111.53 174.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -146.81 -49.81 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.677 2.791 . . . . 7.9 108.459 170.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -61.04 130.13 44.86 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.843 0.354 . . . . 2.85 110.938 -174.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.78 90.43 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.923 0.889 . . . . 8.01 110.079 -179.271 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.08 -29.68 0.32 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-O 119.207 -0.774 . . . . 1.56 112.037 178.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.46 134.91 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.386 -1.339 . . . . 3.1 107.386 165.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -102.49 -29.33 11.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 123.969 0.793 . . . . 3.33 110.13 172.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -156.24 162.46 40.15 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.307 0.958 . . . . 3.96 109.692 172.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.8 t -142.86 149.22 38.25 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.328 1.051 . . . . 2.18 108.229 171.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -146.5 136.73 23.68 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 107.517 -1.29 . . . . 2.73 107.517 157.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.57 141.86 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 123.397 0.679 . . . . 2.99 109.351 -178.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.99 131.48 44.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.306 0.643 . . . . 1.8 110.4 177.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.33 -33.98 67.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.812 -1.086 . . . . 3.42 110.982 -173.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.09 -47.17 68.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.372 1.069 . . . . 2.21 112.452 -175.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -102.86 14.73 31.23 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.933 0.893 . . . . 3.24 110.645 174.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 34.1 46.21 0.15 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 129.082 2.953 . . . . 3.17 112.335 -173.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -125.47 144.61 50.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.624 0.647 . . . . 4.93 112.274 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.84 130.19 48.24 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.255 1.822 . . . . 1.77 106.444 172.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.41 109.67 21.45 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 101.401 -3.555 . . . . 3.2 101.401 176.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.02 134.58 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.054 -1.832 . . . . 2.3 106.054 -179.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -112.52 116.18 29.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 106.204 -1.776 . . . . 2.9 106.204 169.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -123.62 157.56 33.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.107 0.563 . . . . 4.14 111.011 -178.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -72.58 116.54 50.64 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 106.963 -1.495 . . . . 3.04 106.963 176.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.19 27.26 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.226 2.617 . . . . 2.96 115.7 -156.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -135.55 -34.75 0.83 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.363 1.465 . . . . 3.9 112.969 -178.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -41.51 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.781 0.832 . . . . 4.37 111.312 -165.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.8 tt -136.28 158.17 38.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 C-N-CA 123.832 0.853 . . . . 2.32 108.728 -169.085 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.84 -178.89 15.86 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.484 0.584 . . . . 0.75 111.85 -174.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -57.63 -39.98 83.67 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.797 2.331 . . . . 0.85 110.472 171.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -51.66 -49.48 62.25 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.729 0.812 . . . . 7.45 112.081 -176.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.79 -51.55 66.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.377 -0.601 . . . . 2.65 109.377 -175.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.8 mt -52.27 -47.48 45.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 123.602 0.761 . . . . 2.62 108.989 175.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.7 mt -55.89 -54.99 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 109.883 -0.414 . . . . 1.71 109.883 -176.037 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -64.08 -34.74 78.72 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.026 0.441 . . . . 4.24 110.671 -178.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.6 m -58.66 -51.26 70.7 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.196 -0.315 . . . . 1.68 110.483 173.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 mm -63.98 -42.26 95.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 121.143 -0.973 . . . . 2.81 110.915 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -52.83 -47.54 67.64 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.455 -0.572 . . . . 2.66 109.455 172.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m -59.15 -42.98 91.97 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.898 0.333 . . . . 2.34 111.898 175.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.7 mt -64.47 -29.14 70.18 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.534 -0.729 . . . . 2.14 112.411 175.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.27 40.1 1.18 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.3 0.953 . . . . 0.83 113.385 167.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -136.25 164.72 27.43 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.175 0.987 . . . . 3.24 108.643 171.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -94.62 111.44 54.05 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 118.488 -0.768 . . . . 2.44 109.759 175.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.18 80.21 2.68 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.612 2.875 . . . . 0.92 110.764 -178.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.47 105.35 10.72 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.137 -0.69 . . . . 2.88 109.137 -178.605 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.82 61.68 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.606 1.562 . . . . 3.5 111.827 179.373 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 CA--C 1.531 0.222 0 C-N-CA 123.468 0.707 . . . . 3.33 111.234 -177.964 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 106.965 -1.494 . . . . 3.92 106.965 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.5 mt -130.54 126.84 37.79 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 107.874 -1.158 . . . . 3.51 107.874 153.41 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -106.71 89.47 3.03 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.373 -0.973 . . . . 3.05 108.373 173.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.23 129.79 39.16 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.388 -0.967 . . . . 2.45 108.388 178.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.04 109.33 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.029 -1.841 . . . . 2.44 106.029 173.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.42 92.53 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 125.39 1.476 . . . . 1.88 108.175 -171.051 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -76.58 139.46 40.68 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.481 -0.933 . . . . 5.9 108.481 -173.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.65 -42.39 1.95 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.319 0.961 . . . . 0.72 111.141 177.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.81 126.82 30.96 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.982 0.891 . . . . 2.89 110.135 -176.273 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -154.38 17.87 0.48 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.855 1.057 . . . . 2.66 113.855 -171.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 p -158.68 170.29 22.48 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.502 1.046 . . . . 1.39 109.234 169.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.35 -44.49 11.8 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.972 1.309 . . . . 2.68 111.961 -178.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.6 m -56.25 -43.82 79.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.574 0.349 . . . . 2.14 111.602 177.532 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.32 -45.41 66.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.716 -0.615 . . . . 0.92 110.787 178.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.22 -58.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.204 -1.035 . . . . 2.12 108.204 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.298 0.7 OUTLIER -70.72 -24.8 62.7 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 113.146 0.795 . . . . 2.03 113.146 -172.174 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -57.9 -51.73 68.43 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.392 -0.966 . . . . 4.74 108.392 169.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.6 mt -59.11 -60.32 2.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.431 -0.581 . . . . 2.2 109.431 174.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.94 -55.28 28.52 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.357 0.526 . . . . 4.57 110.9 -168.325 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.3 t -61.2 -53.04 61.89 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.122 -0.696 . . . . 2.41 109.122 -177.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.7 t -72.04 -36.51 69.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 119.089 -1.045 . . . . 1.21 112.285 -168.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.83 -59.51 2.76 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.61 -0.885 . . . . 2.59 108.61 176.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.7 m -71.98 64.95 0.53 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.665 0.786 . . . . 4.08 111.883 179.064 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -169.9 -30.89 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 128.286 2.635 . . . . 4.18 110.951 170.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -64.6 132.2 49.14 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.866 1.212 . . . . 2.92 109.458 173.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -51.89 145.39 9.92 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.867 -0.79 . . . . 6.31 108.867 174.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.6 -36.28 4.18 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.582 -1.121 . . . . 1.34 111.926 177.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.47 135.28 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.703 -1.591 . . . . 3.16 106.703 164.512 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.1 pp -99.01 -32.49 11.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.243 0.617 . . . . 3.81 109.469 171.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -156.57 161.4 39.96 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 108.68 -0.859 . . . . 3.43 108.68 172.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 p -132.93 148.34 52.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.947 -0.76 . . . . 2.59 108.947 154.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.46 88.66 2.98 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.808 -1.553 . . . . 2.47 106.808 168.608 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.28 136.21 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 124.271 1.028 . . . . 2.89 111.838 170.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.6 140.17 28.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.77 0.828 . . . . 2.31 110.314 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 pp -76.96 -22.45 53.21 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.116 -0.493 . . . . 2.74 111.617 177.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.24 -38.02 1.65 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.411 1.484 . . . . 2.76 113.212 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -139.74 30.6 2.07 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.944 0.878 . . . . 2.93 110.291 170.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.1 m120 44.13 56.74 4.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.864 2.066 . . . . 2.3 110.579 176.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.78 139.63 32.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.176 -0.328 . . . . 2.81 110.69 -164.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.38 115.82 25.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.766 1.626 . . . . 1.89 110.463 176.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -82.29 96.63 7.96 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.249 -1.76 . . . . 3.45 106.249 169.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.39 133.05 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.94 -1.134 . . . . 2.43 107.94 175.27 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -115.25 115.8 27.28 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.44 -2.059 . . . . 3.88 105.44 173.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -147.14 153.53 40.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.381 1.072 . . . . 4.24 108.405 -164.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -104.07 105.69 49.87 Favored Pre-proline 0 CA--C 1.534 0.357 0 O-C-N 124.362 1.039 . . . . 3.87 111.075 -178.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.0 60.41 6.85 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.163 2.575 . . . . 1.92 112.1 -174.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.83 -54.87 2.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.044 0.938 . . . . 3.66 109.656 161.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -96.18 -37.07 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 122.98 0.512 . . . . 2.76 112.24 -174.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 tp -104.13 148.15 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.996 1.318 . . . . 2.13 108.444 -178.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.46 -178.94 16.6 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 110.864 -0.895 . . . . 0.78 110.864 174.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -60.99 -40.45 52.18 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.873 2.382 . . . . 0.87 110.357 174.122 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -50.39 -49.99 52.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.254 0.622 . . . . 6.92 112.083 179.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.16 -55.81 28.54 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.643 0.656 . . . . 2.47 109.991 -174.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.0 mt -50.42 -54.87 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 124.654 1.182 . . . . 2.56 108.956 175.596 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.9 mt -58.07 -53.23 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.85 -0.614 . . . . 2.14 110.403 -173.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -66.58 -33.03 74.77 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.329 0.652 . . . . 4.18 110.107 -175.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.7 m -57.85 -51.83 67.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.78 -0.452 . . . . 1.69 109.78 169.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 94.6 mt -67.24 -37.93 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 121.186 -0.946 . . . . 2.21 111.733 -176.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.99 -50.01 67.52 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.939 -0.763 . . . . 3.44 108.939 169.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.3 m -58.94 -38.82 79.89 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.008 -0.433 . . . . 2.55 111.992 176.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.38 -18.57 64.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.549 -0.738 . . . . 2.12 112.511 172.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.42 33.21 6.59 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.749 1.166 . . . . 0.81 112.273 174.176 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -133.01 158.65 42.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.025 0.913 . . . . 3.58 108.846 177.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.74 105.8 29.32 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.492 -0.766 . . . . 2.9 110.083 -178.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.4 79.62 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.922 2.414 . . . . 1.29 110.291 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 t -78.97 116.79 19.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.704 -0.623 . . . . 2.68 109.632 -175.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.8 mt -74.04 63.0 0.92 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.301 1.04 . . . . 4.3 110.225 177.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.6 t . . . . . 0 CA--C 1.53 0.183 0 O-C-N 121.739 -0.6 . . . . 3.6 109.533 179.147 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 108.642 -0.873 . . . . 3.49 108.642 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -146.28 137.92 24.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.129 -1.063 . . . . 4.21 108.129 176.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -106.64 126.99 52.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.496 1.118 . . . . 2.86 109.509 173.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.25 128.59 40.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.752 1.221 . . . . 2.62 108.107 176.34 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.257 0.6 OUTLIER -79.79 115.04 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 124.384 1.074 . . . . 4.27 108.301 173.813 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 m -101.92 84.25 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 128.077 2.551 . . . . 1.84 107.221 -170.277 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -75.91 139.2 41.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 118.7 -1.2 . . . . 7.74 107.902 -167.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.28 -31.27 5.33 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.685 1.136 . . . . 0.83 111.134 -170.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.0 mtm -57.17 126.88 29.22 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.949 1.374 . . . . 2.86 110.388 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -140.47 -6.54 1.17 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.073 1.138 . . . . 2.64 114.073 -177.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 p -163.03 168.4 21.07 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 120.288 1.403 . . . . 1.12 109.834 179.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.44 -38.86 14.37 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.227 1.411 . . . . 1.71 112.172 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.8 m -43.47 -50.0 7.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.613 1.165 . . . . 1.85 111.612 172.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.7 m -68.02 -45.52 73.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 122.996 0.518 . . . . 0.71 110.536 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.1 t -52.59 -61.01 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.238 -1.023 . . . . 1.73 108.238 -176.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.252 1.3 p-80 -70.43 -28.59 65.16 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.829 -1.078 . . . . 1.03 111.964 -175.278 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -53.11 -58.62 6.38 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.446 1.021 . . . . 4.33 109.564 168.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.62 -58.51 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.739 -0.784 . . . . 2.06 109.732 -177.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -52.87 -62.23 1.78 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.382 0.426 . . . . 2.52 109.865 -174.012 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -55.2 -52.27 63.87 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.919 0.488 . . . . 2.25 110.432 -176.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -69.57 -32.08 70.64 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.621 -0.432 . . . . 1.58 111.306 -171.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.19 -46.83 63.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.09 -0.644 . . . . 2.91 111.122 172.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.8 p -66.89 78.28 0.12 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.54 0.736 . . . . 2.4 111.178 -176.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.76 -37.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 128.651 2.78 . . . . 4.91 108.763 -178.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.23 114.28 6.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.791 -0.818 . . . . 2.83 108.791 174.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -57.17 152.83 12.89 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.521 -0.918 . . . . 9.12 108.521 166.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.87 -60.15 0.64 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 108.575 -1.81 . . . . 2.42 108.575 -152.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.01 149.36 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 119.541 1.67 . . . . 2.93 108.507 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 pp -121.75 -25.07 5.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.368 -0.833 . . . . 3.65 111.035 168.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -155.68 157.57 36.86 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.313 0.96 . . . . 3.88 108.502 172.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.0 t -139.78 149.79 43.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.929 -1.137 . . . . 3.11 107.929 165.593 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 p -144.05 137.01 27.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.249 -1.389 . . . . 3.17 107.249 156.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.06 154.27 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.317 0.962 . . . . 2.88 110.213 179.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.28 137.66 32.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.027 0.931 . . . . 1.79 111.083 -176.032 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.1 mt -68.7 -34.5 75.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.677 1.191 . . . . 3.38 110.688 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -40.34 -42.36 1.54 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.904 1.682 . . . . 1.99 113.82 -174.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -138.61 35.8 2.22 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 123.086 0.554 . . . . 3.09 110.239 170.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 m120 42.23 46.93 3.98 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 127.314 2.245 . . . . 2.25 109.954 176.434 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -106.43 149.13 27.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.767 0.827 . . . . 3.43 110.927 -168.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.54 118.81 26.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.021 1.329 . . . . 1.89 107.743 172.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.64 102.44 14.18 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 102.375 -3.194 . . . . 3.12 102.375 176.794 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.83 139.04 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.193 -1.78 . . . . 2.35 106.193 176.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -122.87 115.74 22.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.288 -1.375 . . . . 4.32 107.288 169.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -121.66 161.72 22.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.837 1.655 . . . . 3.75 111.15 -173.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -92.29 119.81 67.95 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 126.246 1.818 . . . . 3.26 107.817 176.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.43 53.1 4.4 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.893 2.395 . . . . 2.6 110.195 179.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -103.17 -43.6 5.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.984 1.714 . . . . 6.39 109.62 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.06 -46.15 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.753 1.221 . . . . 3.8 112.109 -172.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 tp -81.77 150.09 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.033 0.933 . . . . 2.33 110.533 -167.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.62 -176.83 15.34 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.301 -1.12 . . . . 1.2 110.301 169.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -61.8 -38.47 59.53 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.454 2.103 . . . . 1.24 110.386 173.634 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -50.27 -50.71 49.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.372 1.069 . . . . 7.11 111.705 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.64 -54.59 45.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.742 0.817 . . . . 3.12 109.153 -177.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.6 mt -53.58 -49.11 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 123.853 0.861 . . . . 2.81 109.127 178.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.8 mt -52.81 -58.9 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 123.451 0.701 . . . . 2.21 109.956 -178.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -66.08 -34.61 78.45 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.158 0.504 . . . . 4.61 111.114 -176.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.0 m -57.13 -51.7 68.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.314 -0.625 . . . . 1.81 109.314 174.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.78 -35.05 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.548 -0.72 . . . . 2.28 111.541 -176.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -50.06 -52.98 30.13 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.329 -0.619 . . . . 2.82 109.329 166.128 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.5 t -57.61 -43.88 85.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.475 0.31 . . . . 2.49 111.574 177.232 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.3 mt -61.54 -27.58 68.71 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.207 -0.933 . . . . 2.74 112.395 176.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.55 35.69 1.39 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.52 1.057 . . . . 1.44 112.924 167.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -139.35 152.61 47.3 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.08 -1.082 . . . . 3.36 108.08 173.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -96.93 113.82 63.58 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.877 -0.786 . . . . 3.39 108.877 176.741 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -90.3 122.29 0.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.596 2.864 . . . . 1.1 111.563 -177.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.6 m -116.93 132.53 56.68 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 107.352 -1.351 . . . . 2.51 107.352 170.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mp -56.99 133.08 54.61 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.088 0.858 . . . . 5.0 110.341 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.5 t . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 108.5 -0.926 . . . . 6.44 108.5 172.17 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 108.302 -0.999 . . . . 3.93 108.302 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.3 153.17 25.25 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.779 -0.823 . . . . 3.93 108.779 171.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -126.86 138.61 53.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.993 0.917 . . . . 2.64 110.424 177.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.52 140.72 31.91 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.186 0.994 . . . . 2.35 108.907 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 t -76.57 127.04 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 105.205 -2.146 . . . . 2.3 105.205 173.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 m -114.69 88.31 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 124.989 1.316 . . . . 1.72 107.606 -175.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.9 mtp-105 -77.04 137.5 39.0 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.559 -0.904 . . . . 7.0 108.559 -173.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.68 -41.72 1.47 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.938 -0.865 . . . . 0.89 110.938 177.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -68.88 152.2 45.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.906 0.853 . . . . 2.39 110.881 -176.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -152.34 1.15 0.32 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.392 1.256 . . . . 2.86 114.392 -175.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 p -162.33 164.8 27.24 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 120.18 1.355 . . . . 1.22 109.725 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.21 -41.14 12.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.169 1.388 . . . . 1.95 111.403 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -36.93 -51.83 0.92 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.28 2.232 . . . . 2.9 112.152 170.174 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.8 m -72.5 -51.49 19.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.862 0.865 . . . . 0.83 110.983 176.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -46.97 -60.46 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 C-N-CA 125.199 1.4 . . . . 1.58 109.017 -171.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -65.54 -24.81 67.2 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.872 -1.058 . . . . 1.24 111.329 -175.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -55.07 20.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.224 -1.028 . . . . 6.03 108.224 174.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 mt -58.05 -54.57 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.271 -0.641 . . . . 2.05 109.271 -179.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -55.67 -59.39 4.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.928 0.491 . . . . 2.43 110.565 -177.521 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.5 t -53.24 -52.12 60.0 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.688 -0.486 . . . . 2.22 109.688 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 t -59.0 -40.61 85.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.958 0.503 . . . . 1.42 111.376 -176.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.16 -43.93 90.17 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.635 -0.698 . . . . 3.54 110.891 176.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.3 p -70.7 60.66 0.23 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.772 0.829 . . . . 2.28 112.057 178.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -153.78 -50.33 0.09 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 129.497 3.119 . . . . 8.14 107.709 -176.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -69.52 137.47 52.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.701 -0.481 . . . . 3.15 109.701 -177.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -56.69 150.88 15.0 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.463 -0.569 . . . . 7.09 109.463 174.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.39 -28.38 8.31 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-O 117.609 -1.662 . . . . 1.35 112.675 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.41 130.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 120.861 2.331 . . . . 2.56 107.159 172.691 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.4 mt -96.71 -48.75 5.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.902 1.281 . . . . 3.56 108.479 172.121 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -156.38 147.53 22.24 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 118.838 0.744 . . . . 4.27 109.646 177.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -121.34 150.81 40.89 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 107.197 -1.409 . . . . 2.39 107.197 170.395 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t -143.42 150.11 38.59 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 118.491 -1.284 . . . . 3.25 108.79 141.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.74 132.77 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.737 0.815 . . . . 2.89 110.279 177.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.48 134.93 54.64 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.72 0.808 . . . . 1.72 110.569 -177.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.81 -34.58 77.04 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.65 1.18 . . . . 3.45 110.349 177.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -39.33 -41.87 0.97 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.227 1.811 . . . . 2.16 113.922 -176.164 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -137.72 33.0 2.46 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.898 0.856 . . . . 3.87 110.026 173.447 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 31.22 64.19 0.19 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 128.08 2.552 . . . . 2.9 111.964 -174.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.72 135.07 36.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.966 -0.561 . . . . 3.09 110.971 -166.487 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.12 140.78 34.94 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.604 1.962 . . . . 1.76 108.949 177.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -109.21 141.15 41.89 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.652 -1.61 . . . . 4.49 106.652 158.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.32 114.48 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.837 -1.912 . . . . 2.58 105.837 176.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -93.4 99.59 12.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.217 -2.142 . . . . 4.36 105.217 171.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -125.99 167.07 15.81 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.047 1.339 . . . . 3.38 111.845 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -77.73 109.62 10.33 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.958 1.703 . . . . 2.97 109.82 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.32 63.24 8.7 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.363 2.709 . . . . 1.91 112.105 -167.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.74 -74.35 0.1 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.968 0.907 . . . . 3.26 110.04 177.807 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.5 pt -58.38 -26.93 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.084 0.954 . . . . 3.05 113.229 -177.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 tt -135.44 162.91 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.609 1.163 . . . . 2.01 108.297 -178.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.96 179.16 27.89 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.46 -1.456 . . . . 1.22 109.46 -174.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.13 -40.66 67.87 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.795 2.33 . . . . 1.1 111.608 -172.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -59.88 -37.04 78.22 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.453 0.538 . . . . 8.38 112.453 -175.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.3 -50.96 70.89 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.341 0.591 . . . . 3.93 109.805 179.136 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.9 mt -55.23 -50.18 66.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.643 -0.873 . . . . 2.68 108.643 176.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 mt -54.63 -53.16 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-O 119.382 -0.342 . . . . 1.75 110.206 -178.08 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -56.47 -43.76 79.89 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.275 0.559 . . . . 4.07 109.74 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.3 m -58.63 -53.96 52.4 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.034 -0.53 . . . . 1.63 110.331 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 mm -65.55 -39.98 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.335 -0.853 . . . . 3.33 111.186 -177.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -53.39 -48.92 68.22 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.6 -0.519 . . . . 2.98 109.6 169.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 m -61.6 -42.57 99.05 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.93 0.344 . . . . 2.79 111.93 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.9 mt -61.43 -36.83 81.45 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.518 0.599 . . . . 2.06 110.948 175.039 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.81 47.42 0.73 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 123.97 0.795 . . . . 0.85 111.763 172.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -134.86 160.86 36.9 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 106.571 -1.64 . . . . 3.37 106.571 168.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -97.84 105.5 27.68 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.234 -0.889 . . . . 3.26 109.774 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -84.25 136.17 6.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.699 2.266 . . . . 1.56 110.123 176.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t -146.79 129.84 16.42 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.968 -0.752 . . . . 3.2 108.968 171.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.435 ' CD2' ' H ' ' A' ' 71' ' ' LEU . 1.7 mm? -54.33 127.74 28.55 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.939 1.295 . . . . 3.7 110.593 -174.66 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 118.311 0.505 . . . . 5.79 110.319 -179.694 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 106.945 -1.502 . . . . 4.11 106.945 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.8 mp -128.45 151.34 49.5 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.297 -1.001 . . . . 4.17 108.297 177.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -125.06 129.55 50.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.189 0.996 . . . . 3.12 109.983 -166.607 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.71 136.63 36.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.532 1.133 . . . . 2.28 108.603 -174.102 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.33 124.6 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 104.671 -2.344 . . . . 2.45 104.671 174.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 m -106.31 67.53 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 106.973 -1.491 . . . . 1.79 106.973 -178.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -76.72 132.93 39.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.818 -0.808 . . . . 6.67 108.818 -166.307 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.63 -47.66 1.0 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.399 -1.48 . . . . 0.68 109.399 -169.284 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 142.09 36.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.683 0.741 . . . . 2.21 109.392 -176.766 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -156.75 19.05 0.32 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.529 0.937 . . . . 2.98 113.529 -173.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.78 153.73 25.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.355 0.98 . . . . 1.47 110.018 179.499 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.34 -37.7 7.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.105 1.762 . . . . 2.07 112.812 -173.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 t -47.01 -54.73 9.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.173 0.589 . . . . 2.4 110.167 174.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.9 m -69.02 -33.49 73.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.18 -0.325 . . . . 0.85 110.903 -176.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.8 t -57.08 -60.76 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.197 -1.038 . . . . 1.78 108.197 -178.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -68.54 -30.18 68.92 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.426 -0.807 . . . . 1.96 111.104 -176.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -56.94 -59.34 5.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 118.911 0.778 . . . . 6.53 109.991 170.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -52.17 -51.61 29.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 118.905 0.775 . . . . 2.27 108.975 -178.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -50.97 -64.24 0.87 Allowed 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 123.991 0.807 . . . . 3.3 110.657 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.0 m -58.38 -42.25 86.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.946 0.879 . . . . 2.68 111.209 -177.003 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 t -66.44 -39.11 88.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.299 1.039 . . . . 1.44 110.029 -174.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.8 mt -71.76 -55.24 8.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 118.708 -0.663 . . . . 3.25 112.1 173.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.9 p -64.13 74.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.975 1.31 . . . . 2.47 112.592 -167.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -174.88 -40.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.372 2.269 . . . . 4.32 110.076 -175.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -73.98 172.46 11.6 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.293 0.568 . . . . 2.65 112.097 -172.152 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -51.28 128.05 21.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.68 -0.691 . . . . 13.25 110.74 178.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.27 -15.23 7.17 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.583 -1.676 . . . . 1.35 116.692 160.086 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.1 109.59 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 121.805 2.802 . . . . 3.36 109.257 175.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.35 -42.03 31.73 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.157 -0.683 . . . . 3.57 109.157 -178.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -157.41 158.92 36.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.718 0.69 . . . . 4.37 109.268 177.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.445 ' HG ' ' CD1' ' A' ' 46' ' ' ILE . 11.6 t -124.16 138.78 54.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.001 1.72 . . . . 2.56 106.602 179.625 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.1 m -144.52 104.53 4.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.344 -0.984 . . . . 2.6 108.344 166.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -101.98 138.4 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 O-C-N 123.42 0.45 . . . . 3.12 111.131 172.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.83 133.15 55.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.588 0.755 . . . . 1.9 109.208 171.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -80.86 -33.67 34.27 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.35 -0.841 . . . . 3.05 111.366 -169.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.41 -34.33 61.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.171 0.588 . . . . 2.68 112.248 178.121 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -104.97 2.73 29.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.098 1.359 . . . . 3.36 111.562 176.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.4 m120 41.24 44.28 2.22 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.21 2.204 . . . . 2.14 111.351 -172.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.2 tmmt? -135.97 136.13 40.13 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 122.024 -0.423 . . . . 3.63 111.461 -165.332 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.51 139.28 34.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.653 1.981 . . . . 1.82 109.15 173.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.75 131.23 53.36 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.125 -2.176 . . . . 3.37 105.125 149.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.445 ' CD1' ' HG ' ' A' ' 35' ' ' CYS . 31.6 mm -115.57 131.01 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.367 -1.345 . . . . 3.1 107.367 172.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -93.13 64.62 3.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.385 1.074 . . . . 4.14 108.97 175.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -88.34 141.58 28.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 112.744 0.646 . . . . 4.12 112.744 175.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -62.34 115.66 17.73 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.694 -0.854 . . . . 2.47 108.694 173.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.76 65.84 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.78 2.32 . . . . 1.62 111.425 -168.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -162.18 -79.07 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.338 0.655 . . . . 3.52 112.137 -177.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -34.82 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 121.528 -0.733 . . . . 3.86 111.12 -176.762 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 tp -105.31 150.05 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.234 -1.765 . . . . 2.11 106.234 170.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -141.25 170.43 24.65 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.352 -1.099 . . . . 0.91 110.352 -177.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -57.03 -43.4 54.26 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.482 2.788 . . . . 0.84 110.489 -177.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -57.23 -44.71 84.04 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.247 0.476 . . . . 7.63 112.019 176.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -63.36 -49.15 74.98 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.972 -0.751 . . . . 3.84 108.972 -178.022 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.6 mm -50.57 -51.65 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.877 0.471 . . . . 3.22 111.036 172.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.6 mt -57.42 -52.62 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.284 0.634 . . . . 1.91 109.962 -178.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -55.8 -44.64 78.0 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 122.343 1.068 . . . . 4.64 109.298 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -61.18 -50.48 72.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.791 -1.095 . . . . 2.01 110.304 -178.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -71.86 -44.49 67.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-O 119.123 -0.465 . . . . 2.15 111.717 -175.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.31 -42.38 77.52 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.885 0.766 . . . . 3.23 110.427 -176.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -51.04 -28.67 10.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.673 0.99 . . . . 2.44 113.673 172.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.68 -16.68 58.33 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.069 0.85 . . . . 2.28 112.051 178.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.8 31.26 8.8 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.902 0.763 . . . . 0.76 112.531 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -129.99 140.4 50.9 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 105.394 -2.076 . . . . 3.33 105.394 167.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -87.59 111.25 40.6 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 117.985 -1.007 . . . . 2.82 109.586 -173.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.86 128.31 5.11 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.958 2.438 . . . . 1.42 109.838 176.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -138.2 111.93 8.28 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.563 -0.903 . . . . 3.4 108.563 177.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -56.03 131.06 46.41 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.284 1.034 . . . . 3.66 110.985 -179.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--N 1.34 0.171 0 N-CA-C 112.746 0.646 . . . . 4.9 112.746 -173.048 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 109.02 -0.733 . . . . 9.02 109.02 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.04 122.82 1.37 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.883 -1.687 . . . . 3.78 108.883 -172.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -77.13 -176.05 3.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.623 0.769 . . . . 3.85 109.358 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.78 156.65 28.68 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 108.571 -1.812 . . . . 1.71 108.571 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.6 143.85 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.608 -1.627 . . . . 3.61 106.608 171.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.7 tp -144.01 140.13 29.41 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 105.808 -1.923 . . . . 4.09 105.808 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -106.3 135.74 47.25 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 124.449 1.093 . . . . 2.79 109.264 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.52 137.03 54.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.079 1.352 . . . . 2.27 107.888 174.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 t -82.68 114.99 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.772 -1.566 . . . . 2.38 106.772 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 m -106.66 84.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 126.747 2.019 . . . . 2.0 108.849 -166.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.76 122.41 25.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.493 -1.299 . . . . 6.16 107.493 -174.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.78 -37.0 2.41 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.548 1.07 . . . . 0.95 110.755 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.62 113.4 24.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.683 -1.599 . . . . 2.42 106.683 -172.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.84 25.46 0.27 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.245 1.202 . . . . 5.12 114.245 -167.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.6 p -147.34 167.19 24.93 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 120.957 -1.09 . . . . 1.39 108.205 161.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.08 -36.77 13.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.477 1.111 . . . . 2.4 112.059 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -59.44 -50.31 74.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 110.145 -0.317 . . . . 2.53 110.145 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -61.92 -41.35 97.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.681 -0.637 . . . . 0.71 110.929 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.0 t -51.5 -61.11 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.417 -0.957 . . . . 1.78 108.417 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.289 0.8 OUTLIER -66.65 -29.6 69.66 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 118.829 -0.605 . . . . 1.12 111.553 -174.035 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -52.94 -58.99 5.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.197 0.999 . . . . 4.5 109.127 170.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.8 mt -61.34 -59.0 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.761 -0.776 . . . . 1.99 108.918 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.87 -52.53 60.17 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 119.394 -0.336 . . . . 2.63 110.85 -168.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -62.04 -44.08 97.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.877 0.471 . . . . 3.12 111.561 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.8 t -64.85 -35.0 79.7 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.745 -0.597 . . . . 1.33 110.982 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -70.61 -48.36 55.49 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 118.53 -0.748 . . . . 2.77 111.407 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 p -68.06 72.75 0.18 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.052 0.93 . . . . 2.77 112.645 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.83 -38.88 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.992 2.117 . . . . 4.88 110.352 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -70.92 132.03 44.62 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.043 0.838 . . . . 3.27 109.551 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -55.21 149.56 12.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.45 -0.574 . . . . 7.07 109.45 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.01 -39.82 2.62 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.432 -1.067 . . . . 1.72 110.432 -173.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.69 111.62 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 119.086 1.443 . . . . 2.81 109.249 -172.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.1 mt -80.0 -46.81 15.97 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.698 -0.853 . . . . 3.13 108.698 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -157.18 130.99 8.15 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 109.105 -0.702 . . . . 3.37 109.105 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.8 p -97.17 152.3 18.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.038 -1.097 . . . . 3.08 108.038 165.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.9 t -155.55 150.44 26.48 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 119.534 -0.866 . . . . 2.92 108.91 140.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.36 143.61 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.72 0.808 . . . . 3.1 110.014 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.4 132.43 41.16 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.568 0.747 . . . . 2.21 110.555 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.4 -26.97 52.23 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.182 -0.917 . . . . 3.4 111.729 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -46.74 -44.53 18.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.16 0.984 . . . . 2.4 112.399 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -117.49 18.45 14.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.66 1.184 . . . . 3.86 110.866 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 35.06 54.99 0.76 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 127.144 2.178 . . . . 3.8 111.909 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -112.59 148.56 34.3 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.589 0.756 . . . . 2.64 109.551 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.83 125.73 47.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.249 -1.76 . . . . 2.02 106.249 166.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -107.45 129.72 54.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.122 -1.436 . . . . 3.42 107.122 169.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.2 mp -119.45 110.75 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 104.685 -2.339 . . . . 2.24 104.685 -178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -83.08 70.36 10.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.655 -1.239 . . . . 4.79 107.655 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -86.68 141.34 29.0 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.987 0.515 . . . . 3.82 111.976 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -57.13 112.46 4.64 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.229 -1.026 . . . . 2.43 108.229 169.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.48 48.7 2.95 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.338 2.692 . . . . 1.7 111.891 -166.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -137.29 -63.09 0.6 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.933 1.293 . . . . 3.86 109.365 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.2 pt -77.09 -24.02 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.025 0 N-CA-C 112.921 0.712 . . . . 3.07 112.921 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.2 tt -139.82 143.09 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.921 -0.77 . . . . 2.15 108.921 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -117.72 175.11 15.56 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.296 0.951 . . . . 0.88 112.177 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -61.43 -38.91 60.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.01 2.473 . . . . 0.84 110.795 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -46.43 -53.02 11.89 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.158 0.983 . . . . 8.29 110.592 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -67.62 -46.54 72.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.957 -1.127 . . . . 2.93 107.957 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.3 mm -54.46 -46.65 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.572 0.349 . . . . 3.41 111.39 172.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.0 mt -53.67 -54.32 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.432 -0.581 . . . . 2.32 109.432 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -61.22 -42.89 99.39 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.537 0.684 . . . . 3.65 110.441 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.1 m -58.33 -49.3 77.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.587 0.755 . . . . 2.33 109.832 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 mm -68.24 -43.25 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 119.289 -0.386 . . . . 2.81 110.257 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -52.62 -42.3 64.47 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.465 0.575 . . . . 5.16 110.684 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.0 m -54.8 -23.45 18.21 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.075 0.769 . . . . 2.43 113.075 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 mt -87.06 -9.94 54.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.906 0.883 . . . . 1.98 112.117 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.9 40.16 6.31 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.085 1.326 . . . . 0.86 112.489 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -142.07 141.09 32.74 Favored 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 106.529 -1.656 . . . . 3.37 106.529 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -91.13 113.83 59.56 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 119.56 1.073 . . . . 5.57 109.989 -172.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -91.96 140.27 2.29 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.974 3.116 . . . . 1.66 110.696 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.8 m -145.02 125.61 14.12 Favored 'General case' 0 C--N 1.335 -0.063 0 O-C-N 120.657 -1.277 . . . . 3.47 109.023 167.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.45 136.19 57.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.661 1.184 . . . . 3.58 111.938 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.3 t -140.4 -52.97 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.993 0.917 . . . . 3.42 111.488 175.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.42 81.17 0.15 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.278 0.631 . . . . 6.06 110.391 -167.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.8 mt -73.84 -84.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 118.172 -0.918 . . . . 9.56 108.616 -172.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--O 1.252 1.194 0 N-CA-C 108.575 -0.898 . . . . 13.1 108.575 168.971 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttm . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 105.682 -1.97 . . . . 7.02 105.682 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.42 170.02 7.02 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 108.433 -1.867 . . . . 3.59 108.433 -136.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t0 61.64 170.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.46 1.504 . . . . 4.27 111.391 -171.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.73 85.12 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 106.314 -2.715 . . . . 2.51 106.314 -168.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 p -80.19 124.38 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 110.066 -0.346 . . . . 3.91 110.066 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -123.29 137.36 54.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.892 -1.521 . . . . 4.67 106.892 169.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -105.46 106.29 16.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.539 1.535 . . . . 4.16 108.451 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.03 126.39 52.67 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.235 -1.394 . . . . 2.5 107.235 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.98 95.36 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 106.855 -1.535 . . . . 2.03 106.855 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.16 65.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.064 1.745 . . . . 1.66 109.231 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -74.67 131.47 40.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.058 -1.089 . . . . 5.74 108.058 -172.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.51 -49.69 0.83 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.545 -1.422 . . . . 0.75 109.545 -167.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -74.94 149.81 39.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.072 0.936 . . . . 2.33 110.165 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 t -153.34 22.3 0.55 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.433 0.531 . . . . 2.81 112.433 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.16 145.41 19.39 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.775 0.716 . . . . 1.56 109.927 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.51 -40.25 37.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.976 1.31 . . . . 2.03 111.317 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -41.27 -49.6 3.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.996 1.718 . . . . 2.45 111.822 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -73.8 -42.97 60.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.848 1.055 . . . . 1.32 113.848 174.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.8 t -49.0 -57.05 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.673 0.749 . . . . 2.18 109.292 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -69.3 -24.12 63.9 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.535 -0.757 . . . . 1.38 111.956 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -58.63 -54.13 50.53 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.03 -1.47 . . . . 4.61 107.03 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.77 -59.03 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 109.316 -0.624 . . . . 1.98 109.316 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -54.64 -56.57 17.67 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.374 0.533 . . . . 2.55 111.407 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.4 t -54.56 -47.66 72.98 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.315 1.046 . . . . 2.28 110.53 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -59.63 -51.61 69.08 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.144 -0.347 . . . . 1.18 110.517 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.43 -34.15 77.52 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.786 -0.572 . . . . 3.21 111.953 -176.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 p -65.49 72.12 0.05 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.422 0.555 . . . . 2.7 110.877 170.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -150.52 -43.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.447 1.899 . . . . 6.4 111.817 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -57.55 -43.37 84.41 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.429 0.9 . . . . 4.46 113.429 -168.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 131.36 -82.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 129.583 3.153 . . . . 7.7 107.841 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.19 54.24 3.9 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 123.821 0.724 . . . . 2.37 112.995 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.08 129.12 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.427 -1.694 . . . . 2.98 106.427 157.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.4 mt -85.44 -45.03 12.23 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.045 -0.724 . . . . 3.01 109.045 172.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -155.8 120.24 4.62 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.91 0.323 . . . . 3.6 110.883 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.8 m -79.89 135.7 36.5 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 106.361 -1.718 . . . . 3.07 106.361 164.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 t -140.52 96.54 3.05 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.346 0.975 . . . . 2.61 108.713 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -105.92 135.63 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.4 1.08 . . . . 3.74 109.214 -172.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.76 134.64 23.73 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.3 0.572 . . . . 1.58 111.186 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 pp -76.23 -26.48 56.09 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.006 0.922 . . . . 2.94 111.394 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.04 -36.76 41.44 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.413 1.085 . . . . 2.02 112.371 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 p -129.62 31.51 4.76 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.479 0.712 . . . . 3.58 110.343 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.7 m120 33.73 54.99 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.916 2.486 . . . . 2.17 112.408 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -133.47 157.42 45.66 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.525 0.33 . . . . 2.87 111.886 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.47 127.09 54.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.097 -1.816 . . . . 1.72 106.097 161.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.49 129.22 38.49 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 103.97 -2.604 . . . . 3.08 103.97 154.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.9 mt -118.55 118.32 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 105.229 -2.137 . . . . 2.82 105.229 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -89.88 104.94 17.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.421 -1.696 . . . . 4.36 106.421 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -132.03 151.87 51.49 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 123.576 0.547 . . . . 3.63 112.229 -171.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -90.79 112.51 53.81 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 125.104 1.362 . . . . 3.08 108.402 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -77.84 41.26 0.97 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.457 2.105 . . . . 1.88 112.243 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.68 -37.86 17.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.086 0.954 . . . . 5.46 110.249 170.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.12 -54.46 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.682 1.193 . . . . 3.02 110.896 -174.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.2 123.73 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.165 -0.68 . . . . 2.57 109.165 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.83 -175.45 22.27 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 109.565 -1.414 . . . . 0.68 109.565 170.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -59.39 -36.31 94.38 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.804 1.669 . . . . 0.98 109.949 170.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -45.56 -59.67 2.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.45 1.5 . . . . 7.59 111.777 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.84 -51.43 69.74 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.617 1.567 . . . . 2.31 110.426 -172.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 94.5 mt -52.34 -54.25 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 114.209 -1.36 . . . . 2.51 108.478 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.9 mt -60.04 -53.39 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.94 -0.573 . . . . 1.84 109.681 -172.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -58.83 -39.98 82.82 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.739 0.699 . . . . 4.11 110.655 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.0 m -56.65 -52.23 65.7 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.311 -0.404 . . . . 2.11 110.227 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.06 -40.52 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.8 -0.562 . . . . 2.13 111.149 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -47.15 -49.35 22.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.34 0.656 . . . . 3.5 109.398 169.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -58.45 -24.37 60.1 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.446 0.906 . . . . 2.12 113.446 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.1 mt -84.94 -12.85 52.46 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.092 0.86 . . . . 2.3 112.069 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.09 44.22 4.8 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.101 0.858 . . . . 0.91 112.769 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -138.61 159.47 42.02 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 106.846 -1.539 . . . . 3.28 106.846 170.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -98.35 98.85 6.28 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.433 -0.794 . . . . 2.87 110.507 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.82 80.79 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 124.314 3.343 . . . . 0.92 110.717 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 m -79.27 101.37 7.99 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.237 -1.023 . . . . 2.62 108.237 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.5 64.16 0.11 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.893 1.677 . . . . 3.8 113.22 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.4 t -66.04 -50.24 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.637 -0.664 . . . . 3.2 111.237 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.4 tptp 68.27 136.07 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.527 1.531 . . . . 6.12 110.454 -165.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.29 143.66 39.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 106.471 -1.678 . . . . 8.53 106.471 157.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 . . . . . 0 C--O 1.253 1.244 0 N-CA-C 109.223 -0.658 . . . . 11.54 109.223 -175.081 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 mmm . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 107.836 -1.172 . . . . 6.53 107.836 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.42 -177.08 40.31 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.08 0.863 . . . . 3.85 112.449 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 52.78 -143.2 0.72 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.986 1.714 . . . . 3.94 111.553 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.76 -165.82 42.51 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 109.64 -1.384 . . . . 3.24 109.64 -161.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -147.38 145.14 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 107.131 -1.433 . . . . 3.66 107.131 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.8 tp -124.13 144.28 49.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.05 -2.204 . . . . 3.6 105.05 155.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -114.19 132.42 56.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.933 -0.766 . . . . 2.19 108.933 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 mt -118.48 123.98 46.49 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.99 -1.856 . . . . 3.65 105.99 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -78.9 95.18 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.592 -2.003 . . . . 2.46 105.592 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.26 84.07 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 126.319 1.847 . . . . 1.9 108.858 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 -75.6 130.87 39.49 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.935 -1.135 . . . . 5.98 107.935 -171.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.78 -48.46 0.97 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.399 1.0 . . . . 1.25 110.945 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -64.87 127.56 32.08 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.69 0.745 . . . . 2.24 110.37 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -144.6 5.34 1.2 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.246 1.202 . . . . 2.96 114.246 -167.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 p -160.84 166.39 28.62 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.645 1.112 . . . . 1.55 109.601 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.47 -45.3 9.1 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.201 1.4 . . . . 1.68 111.503 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -42.26 -49.24 5.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.067 1.747 . . . . 2.04 112.457 172.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.3 m -72.69 -51.18 20.43 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.153 0.581 . . . . 0.94 111.136 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -46.74 -58.84 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.045 0.938 . . . . 1.85 109.039 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -69.83 -23.53 63.32 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.989 -1.005 . . . . 1.08 111.942 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -67.66 -51.69 46.88 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 107.892 -1.151 . . . . 4.67 107.892 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 mt -55.39 -58.81 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.734 -0.839 . . . . 1.84 108.734 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.07 -54.62 32.8 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.001 0.364 . . . . 2.76 111.612 -174.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -60.66 -45.09 95.45 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.158 -0.339 . . . . 2.71 111.912 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 t -62.97 -49.59 74.13 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.903 -0.498 . . . . 1.25 110.226 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -51.19 -47.16 62.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.708 0.803 . . . . 2.69 110.548 177.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 p -62.31 -0.31 0.55 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.629 1.344 . . . . 2.75 114.629 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -57.49 -42.59 83.0 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.306 1.412 . . . . 7.16 110.66 164.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -94.12 138.92 31.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.339 -0.544 . . . . 3.45 111.867 -155.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -60.27 167.54 2.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.532 0.682 . . . . 6.57 109.905 169.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.09 -15.23 0.74 Allowed Glycine 0 CA--C 1.521 0.459 0 CA-C-O 117.669 -1.629 . . . . 1.8 113.555 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.3 139.63 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 120.365 2.083 . . . . 2.63 105.746 165.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.6 mt -102.58 -37.98 7.72 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.927 -1.033 . . . . 3.28 108.506 164.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -157.54 155.13 29.71 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.58 1.082 . . . . 3.36 109.872 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.8 t -126.04 143.08 51.25 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.397 -2.075 . . . . 2.28 105.397 162.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -149.16 148.67 29.91 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 118.097 -1.441 . . . . 2.87 109.965 144.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.9 142.41 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 123.882 0.739 . . . . 3.23 111.467 -172.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.17 128.09 44.14 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.205 1.002 . . . . 1.95 111.027 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.68 -36.67 32.01 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 114.27 -1.332 . . . . 3.24 113.209 -163.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.73 -37.8 59.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.54 0.609 . . . . 2.92 111.148 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -96.12 -7.59 35.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.318 2.247 . . . . 3.37 111.694 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.7 m120 41.95 48.08 3.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.737 1.615 . . . . 2.18 110.79 -166.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -114.38 151.24 33.38 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.434 0.561 . . . . 2.72 111.255 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -123.92 121.78 36.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.88 1.672 . . . . 1.8 106.741 169.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -96.03 123.32 39.58 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.615 -2.365 . . . . 4.22 104.615 168.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.9 mm -104.64 130.17 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 106.916 -1.513 . . . . 3.18 106.916 168.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -98.4 101.06 12.39 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 105.083 -2.191 . . . . 3.45 105.083 162.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -129.77 155.15 46.4 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.925 1.29 . . . . 3.39 109.147 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -75.71 110.84 11.81 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.496 1.118 . . . . 2.81 108.696 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.39 58.58 6.75 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.279 2.653 . . . . 1.68 111.363 -173.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -135.16 -68.63 0.52 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.042 1.337 . . . . 4.36 108.99 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -91.0 -40.07 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.061 0 C-N-CA 123.062 0.545 . . . . 3.26 112.108 -172.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -97.01 119.08 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.639 -1.245 . . . . 3.08 107.639 -178.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.81 163.5 36.69 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.123 -0.791 . . . . 1.51 111.123 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -54.63 -30.01 63.77 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.68 2.253 . . . . 1.37 110.842 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -55.06 -49.09 72.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.344 -1.312 . . . . 6.39 113.663 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -63.1 -49.49 74.24 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 121.312 1.869 . . . . 5.65 109.85 -177.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 66.5 mt -47.17 -56.08 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-O 121.443 0.639 . . . . 2.27 109.772 175.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.8 mt -59.07 -55.95 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.823 -0.626 . . . . 2.07 109.663 -174.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -62.96 -34.14 76.88 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.936 -0.477 . . . . 3.66 111.475 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.3 m -56.56 -53.57 56.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.948 -0.76 . . . . 2.32 108.948 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.29 -39.43 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 121.507 -0.745 . . . . 2.23 111.373 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.77 -44.72 82.07 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.715 -0.616 . . . . 3.04 109.682 172.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.7 m -61.47 -41.43 97.23 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.201 -0.312 . . . . 2.16 111.6 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.66 -41.87 91.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.495 0.588 . . . . 2.73 110.724 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.86 45.28 0.83 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.286 0.946 . . . . 0.89 111.435 175.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.07 162.12 30.52 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.077 -1.453 . . . . 3.2 107.077 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -100.15 98.28 7.41 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 118.198 -0.906 . . . . 2.61 110.099 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.38 75.41 3.87 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.609 2.872 . . . . 1.21 110.111 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.6 m -79.99 107.63 12.93 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.491 -0.929 . . . . 2.52 108.491 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.76 59.36 0.47 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.679 0.791 . . . . 3.48 112.596 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 t -102.71 57.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.512 1.525 . . . . 4.23 107.307 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 pttm 45.55 -137.33 0.58 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.062 1.345 . . . . 8.71 112.266 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.3 mt -57.97 -69.11 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.468 1.107 . . . . 8.08 108.314 172.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 . . . . . 0 C--O 1.246 0.921 0 C-N-CA 131.696 3.998 . . . . 13.74 100.996 171.69 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 108.767 -0.827 . . . . 7.41 108.767 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.77 65.53 2.87 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.448 -1.461 . . . . 4.15 109.448 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -166.31 -178.2 4.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.602 1.561 . . . . 4.4 108.078 -167.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.83 -147.43 14.16 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.51 -1.836 . . . . 3.39 108.51 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 p -152.42 133.3 4.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.79 -0.819 . . . . 3.85 108.79 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 tp -104.0 149.59 25.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.663 -1.977 . . . . 3.98 105.663 165.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.33 151.19 37.5 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.312 -0.996 . . . . 2.27 108.312 165.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.13 130.43 23.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.35 -1.722 . . . . 2.27 106.35 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -79.62 100.81 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 105.411 -2.07 . . . . 2.1 105.411 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.2 m -81.83 79.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 126.353 1.861 . . . . 1.87 108.161 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.2 mtp-105 -76.74 141.72 40.73 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.605 -0.887 . . . . 6.3 108.605 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.63 -45.83 1.13 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.318 -1.113 . . . . 0.84 110.318 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.03 141.44 28.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.533 0.667 . . . . 2.06 109.644 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -152.81 41.91 0.6 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.304 0.502 . . . . 5.97 110.256 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.47 144.9 12.62 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.765 -0.585 . . . . 1.83 111.039 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.98 -39.85 20.68 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.598 1.559 . . . . 2.03 112.059 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.4 t -45.26 -51.44 10.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.056 0.542 . . . . 2.27 110.458 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.3 m -76.79 -33.85 58.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.101 -1.625 . . . . 1.42 114.169 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -46.75 -56.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.642 -0.873 . . . . 1.7 108.642 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -70.39 -21.84 62.81 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.167 -0.924 . . . . 0.98 112.825 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -64.89 -54.5 29.83 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 106.781 -1.563 . . . . 5.34 106.781 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.4 -56.47 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.852 -0.796 . . . . 1.9 108.852 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.31 -53.73 54.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.999 0.818 . . . . 2.6 111.693 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.1 t -63.76 -29.17 70.41 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.059 0.39 . . . . 2.74 111.756 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.4 t -71.05 -52.96 16.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.204 -0.665 . . . . 2.12 109.204 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -53.43 -46.14 69.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.152 0.981 . . . . 2.87 110.954 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.2 p -59.51 -16.73 26.46 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.953 0.723 . . . . 2.45 112.953 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -69.92 -24.0 63.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.819 1.19 . . . . 7.27 111.515 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -68.48 87.08 0.31 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.73 0.696 . . . . 4.11 109.885 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 23.27 -66.21 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.0 2.52 . . . . 11.2 116.758 145.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.52 48.39 0.97 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.338 0.97 . . . . 2.23 112.644 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -91.08 117.82 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.022 -1.473 . . . . 3.43 107.022 154.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -80.68 -35.5 33.59 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.758 -0.589 . . . . 3.9 110.45 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -157.01 135.6 11.49 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.948 0.795 . . . . 3.19 110.466 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.8 p -114.65 155.09 27.23 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.277 1.031 . . . . 2.55 108.389 165.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.6 m -149.47 141.34 23.72 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.184 -1.413 . . . . 2.64 107.184 150.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.94 135.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.732 0.813 . . . . 2.95 110.197 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.36 134.09 55.11 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.347 0.659 . . . . 1.72 110.149 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -82.07 -37.64 26.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.255 -0.884 . . . . 2.76 111.286 -171.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.94 64.21 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.36 0.664 . . . . 2.58 112.301 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.8 t -107.05 4.63 27.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.037 1.335 . . . . 3.41 111.234 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.9 m120 42.96 48.95 5.2 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.614 1.966 . . . . 2.13 110.83 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.15 137.23 30.74 Favored 'General case' 0 CA--C 1.522 -0.109 0 O-C-N 121.735 -0.603 . . . . 3.04 112.086 -165.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.2 142.09 32.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.625 1.57 . . . . 1.82 108.232 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.07 135.14 48.06 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.481 -2.044 . . . . 3.57 105.481 152.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.2 mt -134.79 114.87 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.159 -1.793 . . . . 2.3 106.159 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -97.28 80.03 2.86 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.701 -1.592 . . . . 3.48 106.701 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -85.53 143.1 28.7 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.63 -0.714 . . . . 3.61 111.638 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -75.41 111.34 13.57 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.626 1.17 . . . . 3.09 107.914 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.63 47.56 2.6 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.356 2.704 . . . . 1.42 113.234 -163.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -134.16 -63.9 0.71 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.37 1.468 . . . . 3.8 108.554 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -70.5 -34.35 57.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 122.858 0.463 . . . . 3.18 111.462 -178.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 8.6 tt -126.83 156.58 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.81 1.244 . . . . 2.98 110.406 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -154.39 178.34 31.25 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 107.198 -2.361 . . . . 1.1 107.198 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.61 -50.24 14.72 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.399 2.733 . . . . 0.97 111.485 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -52.38 -44.97 65.6 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.59 0.959 . . . . 8.36 113.59 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -59.47 -60.01 4.53 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.574 0.702 . . . . 3.91 109.429 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mt -45.78 -54.43 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.466 1.106 . . . . 2.58 109.818 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.2 mt -59.25 -48.16 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.654 -0.703 . . . . 1.82 110.415 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -57.23 -41.77 80.16 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.764 0.711 . . . . 4.47 109.265 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.8 m -62.8 -51.18 68.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.863 -0.608 . . . . 2.68 110.728 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 98.0 mt -62.86 -44.35 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 118.86 0.755 . . . . 2.37 111.278 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -49.09 -48.9 43.96 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.562 0.745 . . . . 3.36 109.188 170.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t -62.8 -17.08 60.62 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.815 1.043 . . . . 3.26 113.815 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.02 -16.15 41.72 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.06 1.3 . . . . 2.14 111.23 171.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.62 42.38 6.49 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.866 0.746 . . . . 0.98 111.685 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -132.79 153.09 51.58 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.181 -1.414 . . . . 3.32 107.181 170.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.27 109.28 32.39 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.179 0.991 . . . . 2.71 109.165 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.52 77.86 3.9 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.462 2.108 . . . . 1.0 110.249 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.8 t -78.68 98.85 6.36 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.264 -0.897 . . . . 2.55 109.417 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.05 61.26 0.19 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.42 1.888 . . . . 3.6 113.241 -173.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -81.28 -76.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.172 0.589 . . . . 3.48 109.866 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.6 tttt 67.62 150.31 0.07 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.784 1.634 . . . . 6.86 111.685 -170.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 pp -81.11 -57.1 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 113.196 0.813 . . . . 8.1 113.196 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.873 1.669 . . . . 8.92 113.17 -171.447 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.096 -0.705 . . . . 7.93 109.096 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.75 -52.21 0.29 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 107.434 -2.266 . . . . 4.53 107.434 -165.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 35.01 75.16 0.06 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.457 1.903 . . . . 6.21 112.564 155.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.35 171.25 18.11 Favored Glycine 0 C--N 1.337 0.614 0 O-C-N 121.351 -0.843 . . . . 1.93 112.74 -158.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.87 119.84 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.238 -1.393 . . . . 4.02 107.238 166.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.6 tp -95.88 148.64 22.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.536 -1.653 . . . . 3.76 106.536 166.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -136.87 127.25 26.59 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.876 0.87 . . . . 2.31 108.913 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.54 150.86 48.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.504 0.722 . . . . 4.63 110.308 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.0 t -84.89 124.22 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.284 -1.376 . . . . 2.12 107.284 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.59 102.91 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 126.994 2.118 . . . . 2.7 108.374 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -87.4 148.93 24.79 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.061 -0.718 . . . . 6.21 109.061 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.11 -52.35 0.64 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.23 -1.148 . . . . 0.88 110.23 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.79 134.92 56.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 117.285 0.542 . . . . 3.09 109.611 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.4 t -155.22 11.62 0.34 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.891 1.071 . . . . 2.57 113.891 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.6 p -161.11 171.75 18.0 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.808 1.185 . . . . 1.43 109.119 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -44.28 7.81 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.371 1.469 . . . . 1.74 111.594 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 t -52.83 -48.73 66.78 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.746 0.419 . . . . 2.44 110.071 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.3 m -70.65 -53.46 15.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.473 -0.767 . . . . 0.79 109.627 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -41.33 -60.21 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 125.787 1.635 . . . . 1.82 109.137 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.255 0.6 OUTLIER -68.25 -21.3 64.83 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.803 0.668 . . . . 1.12 112.803 -171.225 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -70.12 -46.91 63.82 Favored 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.978 -1.119 . . . . 5.5 107.978 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.67 -57.67 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.895 -0.78 . . . . 1.91 108.895 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.75 -56.49 18.71 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.373 0.269 . . . . 2.81 110.859 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.0 t -58.34 -50.07 74.94 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.997 0.427 . . . . 2.31 110.71 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.4 t -69.2 -27.14 65.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.551 -0.718 . . . . 1.19 111.445 -173.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.11 -52.52 23.03 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.383 0.538 . . . . 3.48 110.651 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -70.06 67.68 0.29 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.398 1.094 . . . . 2.5 112.321 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -169.91 -38.03 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.968 2.507 . . . . 4.35 109.624 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -69.84 137.68 51.95 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.939 0.791 . . . . 3.04 110.205 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 -50.84 143.87 9.32 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.622 -0.51 . . . . 6.22 109.622 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.27 -20.43 37.29 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-O 118.05 -1.417 . . . . 1.34 113.407 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.52 133.98 29.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 N-CA-C 105.849 -1.908 . . . . 2.66 105.849 160.371 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.5 mt -97.44 -48.45 5.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.477 1.111 . . . . 3.41 108.106 168.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -156.14 153.64 29.62 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.608 -0.516 . . . . 3.63 109.608 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.9 t -132.79 145.48 51.03 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.451 -1.314 . . . . 3.16 107.451 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -136.04 153.08 51.46 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.502 -1.296 . . . . 3.35 107.502 142.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.2 m -125.37 143.61 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.902 0.881 . . . . 3.03 109.742 175.243 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.51 129.95 41.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.802 0.811 . . . . 1.88 111.802 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.56 -28.64 62.95 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.752 1.221 . . . . 3.44 111.33 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.78 -44.16 73.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.035 0.534 . . . . 2.0 111.064 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.52 -31.27 17.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.472 -0.566 . . . . 3.32 109.472 172.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 79.24 41.81 0.08 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.997 2.119 . . . . 4.74 107.796 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -133.6 141.66 47.76 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.741 -0.466 . . . . 3.48 109.741 -168.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.54 136.73 42.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.015 1.326 . . . . 1.78 107.949 168.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -102.36 150.15 23.62 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.085 -1.45 . . . . 4.49 107.085 159.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mp -134.63 101.35 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.543 -2.021 . . . . 2.43 105.543 178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -81.18 123.6 28.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.196 -2.149 . . . . 4.52 105.196 170.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -163.72 170.48 16.94 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 120.958 0.408 . . . . 3.76 110.644 -152.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -101.51 93.82 3.69 Favored Pre-proline 0 N--CA 1.447 -0.592 0 C-N-CA 125.544 1.538 . . . . 2.97 108.733 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.82 52.93 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.679 2.92 . . . . 1.84 110.799 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -159.99 25.66 0.17 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.464 1.506 . . . . 4.72 109.287 -169.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -167.17 -50.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 126.503 1.921 . . . . 4.26 108.069 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.1 tt -118.85 157.39 20.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 124.625 1.17 . . . . 2.24 109.51 -172.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.36 -177.27 16.37 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.154 -0.778 . . . . 0.71 111.154 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.41 -39.94 42.87 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.543 2.162 . . . . 0.9 110.15 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -48.37 -53.4 17.71 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.574 1.15 . . . . 6.97 111.476 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.72 -52.09 66.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.211 0.529 . . . . 2.55 109.637 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.8 mt -55.87 -52.97 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.75 0.82 . . . . 2.55 108.974 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.2 mt -50.97 -55.1 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.246 -0.65 . . . . 1.71 109.246 -177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -66.02 -37.87 86.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.152 0.501 . . . . 3.96 110.703 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.3 m -55.59 -47.79 75.91 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.283 -0.417 . . . . 1.63 110.345 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 79.8 mt -70.26 -44.04 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.757 -0.589 . . . . 2.19 110.953 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -49.58 -44.61 47.09 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.645 0.778 . . . . 2.69 109.894 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -52.78 -34.7 54.58 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.147 0.579 . . . . 2.96 112.521 175.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.5 mt -76.72 -13.37 60.04 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.368 -0.832 . . . . 2.18 112.319 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.87 45.46 5.7 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.731 0.681 . . . . 0.94 111.791 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -132.81 156.56 46.89 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.182 -1.414 . . . . 3.11 107.182 171.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -96.4 99.7 5.82 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-O 117.547 -1.216 . . . . 2.63 110.406 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -79.08 143.53 17.95 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 CA-C-N 121.43 1.547 . . . . 1.69 109.389 169.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 p -155.46 121.17 5.02 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.588 -0.695 . . . . 2.63 109.484 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.464 ' CD2' ' H ' ' A' ' 71' ' ' LEU . 1.5 mm? -61.25 133.76 56.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.904 0.882 . . . . 4.05 111.584 -169.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.9 t -141.81 -43.36 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.217 0.607 . . . . 3.32 111.604 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.341 0.0 OUTLIER 42.83 -123.9 0.72 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.748 0.703 . . . . 6.41 111.697 -165.869 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 mp -91.49 -71.2 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 106.606 -1.627 . . . . 7.5 106.606 167.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mp0 . . . . . 0 C--O 1.252 1.201 0 N-CA-C 105.492 -2.04 . . . . 8.89 105.492 163.688 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtm . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 119.115 -0.469 . . . . 7.84 111.092 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.31 -179.32 39.07 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 117.803 0.274 . . . . 4.32 113.269 170.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 44.0 t0 63.0 162.89 0.1 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.702 2.401 . . . . 4.21 112.673 -172.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.77 174.59 35.82 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.873 1.225 . . . . 1.98 110.466 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 p -153.98 61.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.783 1.233 . . . . 3.5 108.429 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mp -93.8 139.14 31.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.344 -0.844 . . . . 3.94 109.254 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.0 106.33 11.49 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.611 1.964 . . . . 3.25 107.496 -170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.24 133.28 53.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.264 -1.384 . . . . 2.3 107.264 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.88 112.37 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.706 -1.961 . . . . 2.1 105.706 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -94.66 95.42 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.365 1.866 . . . . 1.72 107.813 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.35 155.75 29.91 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 119.278 -0.969 . . . . 5.83 108.404 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 -51.85 0.68 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.631 -0.987 . . . . 0.95 110.631 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -63.22 141.03 58.92 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 117.412 0.606 . . . . 2.4 111.355 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -155.1 10.85 0.34 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.067 1.136 . . . . 2.57 114.067 -173.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -162.0 161.46 28.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.853 1.206 . . . . 1.39 109.829 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.18 -39.4 9.62 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.62 1.568 . . . . 1.88 112.0 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 m -40.13 -56.25 1.94 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.923 1.289 . . . . 2.08 111.546 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.3 m -69.98 -36.66 75.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.586 0.354 . . . . 0.8 110.902 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.4 t -55.88 -59.28 2.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.013 -1.106 . . . . 1.79 108.013 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -68.4 -35.55 77.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 118.289 -0.862 . . . . 1.5 111.348 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -51.49 -55.3 19.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.942 1.247 . . . . 4.56 110.344 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.7 mt -54.25 -62.74 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 123.702 0.801 . . . . 2.46 109.056 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -59.74 -55.69 31.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.324 -0.551 . . . . 2.6 110.333 -172.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.9 p -54.72 -47.38 73.82 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.227 0.467 . . . . 2.99 111.182 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -70.65 -32.1 69.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.052 -0.659 . . . . 1.54 111.271 -175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.6 mt -68.52 -52.04 36.44 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.464 -0.773 . . . . 3.35 110.599 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.9 p -66.81 75.84 0.11 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.009 1.324 . . . . 2.58 110.854 -174.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? 179.64 -40.02 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.964 2.505 . . . . 4.27 109.233 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.421 ' CE1' ' HB ' ' A' ' 32' ' ' ILE . 11.8 p80 -69.22 139.75 54.52 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 118.962 -1.095 . . . . 2.88 108.965 175.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -60.1 144.42 49.75 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.108 -0.701 . . . . 8.62 109.108 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.01 -28.67 13.5 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-O 118.072 -1.404 . . . . 1.46 113.184 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.421 ' HB ' ' CE1' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -76.64 122.6 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 119.953 1.876 . . . . 2.83 108.286 169.72 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.0 mt -85.69 -52.69 5.63 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.004 -1.11 . . . . 3.29 108.004 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -157.12 144.65 18.89 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.18 -0.674 . . . . 5.04 109.18 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 t -107.26 129.62 54.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.19 -1.411 . . . . 2.83 107.19 167.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 t -112.0 104.08 12.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.777 -1.935 . . . . 3.51 105.777 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 p -102.13 141.4 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 118.938 0.79 . . . . 2.91 111.071 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.29 132.99 36.45 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.323 0.582 . . . . 1.76 110.487 172.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -76.2 -30.4 57.98 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.103 -0.953 . . . . 3.28 111.751 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.2 -32.17 22.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.806 0.842 . . . . 2.08 112.617 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.9 t -121.75 13.19 10.72 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.268 1.427 . . . . 2.98 111.088 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 m120 34.78 47.02 0.22 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.522 2.329 . . . . 2.09 111.818 -172.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -120.85 137.94 54.31 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.276 0.631 . . . . 3.3 109.648 -169.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.47 116.65 32.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.723 1.609 . . . . 1.72 108.224 167.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -91.25 110.62 21.91 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 102.562 -3.125 . . . . 2.97 102.562 166.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.9 mt -112.84 110.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.481 -1.674 . . . . 2.33 106.481 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -83.06 70.22 9.99 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.983 -1.488 . . . . 4.11 106.983 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -90.24 144.29 25.99 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.147 -0.933 . . . . 4.19 109.697 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.36 111.17 22.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 123.557 0.535 . . . . 3.99 111.026 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -66.72 -16.51 50.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.917 2.411 . . . . 2.17 112.451 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -85.3 -5.84 59.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.11 0.868 . . . . 5.2 111.002 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.4 pt -135.07 -27.73 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 114.392 1.256 . . . . 3.87 114.392 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.7 133.8 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 107.526 -1.287 . . . . 2.67 107.526 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.43 172.39 20.31 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.529 -0.732 . . . . 0.77 112.203 -172.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -56.72 -41.47 75.37 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.22 2.614 . . . . 0.95 110.655 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -57.13 -51.06 70.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.85 0.295 . . . . 7.21 110.615 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.98 -51.14 70.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.259 -0.645 . . . . 2.63 109.259 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.4 mm -54.38 -50.93 53.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.326 0.65 . . . . 3.38 111.609 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.4 mt -54.14 -56.43 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.935 -0.765 . . . . 1.74 108.935 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -65.5 -35.13 79.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.195 0.521 . . . . 4.0 111.021 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.3 m -56.27 -54.48 44.88 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.752 -0.462 . . . . 1.87 109.752 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.39 -36.05 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.516 -0.74 . . . . 2.35 111.712 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.75 -48.65 59.06 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.94 -0.763 . . . . 2.74 108.94 166.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.8 t -65.12 -13.93 59.3 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.836 1.05 . . . . 3.0 113.836 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.4 mt -88.15 -9.8 51.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.05 1.295 . . . . 2.4 111.319 170.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.25 41.72 6.48 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.383 0.992 . . . . 0.99 112.022 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -135.74 167.38 21.26 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.236 -1.024 . . . . 3.34 108.236 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -105.71 94.6 8.99 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.489 1.115 . . . . 2.65 110.636 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.3 80.52 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.631 2.887 . . . . 1.13 112.267 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.0 p -82.98 121.34 26.88 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.15 -0.969 . . . . 2.76 111.401 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.3 mt -70.35 72.42 0.47 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.194 -0.941 . . . . 4.28 111.503 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.31 -33.62 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 118.878 -0.582 . . . . 3.39 112.16 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt 57.67 -160.43 0.24 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.365 0.984 . . . . 6.63 109.833 -166.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.9 tt -154.4 158.72 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.217 -1.771 . . . . 9.95 106.217 168.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 . . . . . 0 C--O 1.249 1.035 0 N-CA-C 104.464 -2.421 . . . . 8.83 104.464 168.483 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 112.57 0.581 . . . . 13.76 112.57 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.74 56.09 0.54 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 107.087 -2.405 . . . . 7.12 107.087 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 p30 174.8 173.73 0.21 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.228 -1.767 . . . . 3.49 106.228 -152.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.85 153.79 25.18 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 106.244 -2.742 . . . . 2.05 106.244 165.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -135.15 132.8 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 CA-C-N 118.196 0.998 . . . . 4.14 109.836 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.9 tp -108.78 149.45 29.04 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.974 -1.862 . . . . 4.02 105.974 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -118.67 152.73 35.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.092 -0.707 . . . . 2.6 109.092 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -150.0 133.27 16.39 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.135 -1.061 . . . . 2.49 108.135 177.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.37 105.07 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.32 -2.104 . . . . 2.05 105.32 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -95.53 86.35 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 126.221 1.808 . . . . 1.74 107.994 -172.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.5 mtp-105 -77.38 132.65 38.64 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 119.899 -0.721 . . . . 7.05 109.748 -170.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.01 -4.01 5.65 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.45 1.5 . . . . 1.2 113.187 171.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 41.4 mtp -75.92 116.33 16.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.042 1.421 . . . . 3.02 110.097 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -98.91 -21.02 16.49 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.488 -1.244 . . . . 3.71 113.253 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.9 p -162.7 175.81 10.96 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.636 1.562 . . . . 1.79 112.221 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -35.94 58.72 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.586 1.154 . . . . 2.21 111.923 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -57.25 -37.03 71.69 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-O 118.368 -0.825 . . . . 2.75 110.105 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.4 m -69.07 -53.45 20.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 120.025 1.284 . . . . 0.79 109.687 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -41.67 -57.46 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.944 1.298 . . . . 1.97 110.257 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.89 -21.26 66.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.23 -0.896 . . . . 2.0 112.735 -170.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -69.1 -47.86 64.07 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 107.309 -1.367 . . . . 5.73 107.309 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 mt -64.65 -54.56 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.306 -0.998 . . . . 2.07 108.306 -176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 19.3 mt-10 -50.41 -59.99 3.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.206 0.457 . . . . 2.35 111.028 176.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.2 t -55.03 -52.6 62.67 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.113 0.482 . . . . 2.52 111.415 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -66.84 -28.0 68.0 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.527 0.731 . . . . 1.55 111.533 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.0 -47.7 61.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.337 -0.852 . . . . 2.99 109.701 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.5 p -70.87 68.53 0.43 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.412 0.551 . . . . 2.27 112.12 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.69 -30.83 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.906 1.283 . . . . 6.12 114.033 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -51.7 -47.84 63.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.357 0.981 . . . . 4.48 112.968 -174.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 139.59 -85.6 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 129.901 3.28 . . . . 8.37 104.836 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.58 53.84 4.87 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.695 -0.562 . . . . 1.9 111.695 -166.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.3 mt -114.61 124.17 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.555 -2.016 . . . . 3.92 105.555 160.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 mt -79.76 -44.56 20.47 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.556 -0.905 . . . . 3.06 108.556 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -156.89 157.66 35.27 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.208 -1.034 . . . . 3.84 108.208 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.9 t -128.21 145.65 50.97 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 104.899 -2.26 . . . . 2.35 104.899 163.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.52 149.8 41.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 118.587 -1.245 . . . . 2.75 110.203 153.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 13.1 p -143.1 108.59 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 124.586 1.179 . . . . 2.61 112.451 -162.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.78 134.26 41.92 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.032 0.444 . . . . 2.0 111.199 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.06 -33.81 70.6 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 115.542 -0.754 . . . . 2.81 110.392 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -44.92 -44.23 9.56 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.364 1.466 . . . . 2.48 113.081 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -123.59 22.13 9.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.262 0.625 . . . . 2.97 110.79 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 42.44 58.88 2.9 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.198 2.199 . . . . 3.23 109.834 177.018 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.8 136.46 24.27 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.882 -0.511 . . . . 2.99 111.535 -166.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.5 143.03 39.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.868 1.667 . . . . 1.68 108.987 177.293 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -106.91 140.23 40.06 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.028 -1.841 . . . . 3.75 106.028 153.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -122.99 112.44 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.627 -1.99 . . . . 2.42 105.627 174.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -85.96 122.6 30.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.943 -1.503 . . . . 3.83 106.943 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -144.66 164.31 31.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.502 1.297 . . . . 3.53 114.502 -169.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.26 112.1 62.51 Favored Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 125.955 1.702 . . . . 2.75 108.374 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.24 2.26 5.18 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.228 1.952 . . . . 1.87 114.001 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.0 -32.56 73.94 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.646 1.112 . . . . 5.84 111.474 171.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.62 -59.33 2.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.515 0.674 . . . . 4.81 112.036 -160.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.1 tt -100.29 151.83 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.879 -0.6 . . . . 3.18 109.704 -161.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.73 -174.24 13.64 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.078 -1.609 . . . . 1.22 109.078 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -56.66 -40.46 84.2 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.926 1.75 . . . . 1.43 109.818 168.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.25 -55.86 7.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.341 1.056 . . . . 10.16 113.461 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.52 -49.24 78.35 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.402 -0.811 . . . . 2.71 109.812 -174.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.7 mt -56.58 -51.64 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 114.878 -1.055 . . . . 2.71 108.545 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.8 mt -57.02 -52.53 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.523 -0.547 . . . . 1.98 109.523 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.5 m170 -57.47 -42.84 83.39 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.379 1.085 . . . . 4.07 109.547 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.5 m -58.99 -52.91 63.74 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.67 -0.696 . . . . 2.37 110.137 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.7 mt -71.87 -37.94 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.668 -0.645 . . . . 2.16 111.819 -169.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -60.31 -45.58 92.88 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.201 -0.599 . . . . 4.17 109.682 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 t -59.09 -36.86 75.85 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.906 -0.568 . . . . 3.16 112.238 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.65 -46.1 87.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.531 1.06 . . . . 2.07 110.276 171.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.58 46.54 0.35 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.349 0.976 . . . . 0.88 111.932 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -134.78 163.54 29.56 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 107.312 -1.366 . . . . 3.42 107.312 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -97.63 103.71 17.74 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.041 -0.981 . . . . 3.34 109.852 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.56 77.47 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.212 2.608 . . . . 0.9 111.245 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -78.71 99.68 6.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.746 -0.596 . . . . 2.77 109.52 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -67.22 59.72 0.05 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.731 1.612 . . . . 3.91 114.575 -178.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.9 t -78.77 62.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 120.743 -1.223 . . . . 3.42 109.445 176.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -163.28 106.82 1.03 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.367 1.467 . . . . 5.43 107.371 174.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 tt -86.74 -140.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.788 -1.19 . . . . 11.48 107.788 173.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 124.833 1.253 . . . . 12.07 109.907 169.696 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 mtm . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 106.506 -1.665 . . . . 9.63 106.506 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.04 163.34 37.07 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 106.37 -2.692 . . . . 5.07 106.37 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -79.95 177.68 8.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.925 0.862 . . . . 3.95 108.947 171.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.84 153.57 17.29 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 107.252 -2.339 . . . . 1.83 107.252 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.3 128.84 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.276 -1.379 . . . . 3.39 107.276 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.1 tp -139.86 144.69 37.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.453 -2.425 . . . . 4.13 104.453 166.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -116.32 140.13 49.66 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 123.776 0.673 . . . . 2.52 110.179 171.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.1 124.27 36.55 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.463 -1.68 . . . . 2.61 106.463 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.56 106.77 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 104.988 -2.227 . . . . 2.21 104.988 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -97.67 97.75 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 124.542 1.137 . . . . 1.84 108.261 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -76.99 147.29 36.92 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.245 -1.02 . . . . 9.84 108.245 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.76 -51.0 0.73 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.362 0.982 . . . . 0.82 111.02 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.44 132.28 37.24 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.419 1.109 . . . . 2.47 110.01 -171.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 t -156.53 12.8 0.28 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.571 1.323 . . . . 3.07 114.571 -166.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -161.16 165.13 29.96 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 120.212 1.369 . . . . 1.18 110.16 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.83 13.05 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.248 1.419 . . . . 1.74 111.766 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -37.81 -49.9 1.21 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.502 2.321 . . . . 3.21 112.122 170.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.1 m -71.87 -56.2 6.15 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.181 -0.463 . . . . 1.12 110.129 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -47.7 -54.75 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 124.004 0.921 . . . . 2.02 109.598 -164.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -65.58 -33.86 76.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.44 -0.8 . . . . 1.24 111.826 -174.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 pttp -71.61 -40.61 69.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.907 -0.775 . . . . 4.61 108.907 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 69.3 mt -57.17 -66.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.212 -1.032 . . . . 2.32 108.212 171.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -51.53 -55.75 17.25 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 119.295 0.952 . . . . 2.93 110.896 -173.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.8 t -50.53 -54.35 23.1 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.631 0.372 . . . . 2.62 111.148 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t -72.47 -26.87 61.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 114.033 1.123 . . . . 1.6 114.033 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.17 -43.38 70.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.204 -0.665 . . . . 2.83 109.204 171.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.1 p -70.17 68.68 0.33 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.879 0.847 . . . . 2.83 110.389 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -156.0 -49.53 0.08 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.853 2.861 . . . . 5.74 107.082 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -73.45 88.59 1.61 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.458 -0.571 . . . . 3.28 109.458 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -40.63 113.83 0.41 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.414 1.086 . . . . 7.82 109.528 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.86 -34.6 2.37 Favored Glycine 0 C--O 1.224 -0.529 0 N-CA-C 109.374 -1.49 . . . . 1.86 109.374 -164.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.02 125.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.493 -1.299 . . . . 2.48 107.493 174.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.9 mt -97.67 -40.1 8.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.465 0.706 . . . . 3.36 110.43 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -157.13 146.05 19.95 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.323 0.965 . . . . 3.9 109.906 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.1 p -144.22 56.8 1.31 Allowed 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.23 1.012 . . . . 3.25 111.818 -167.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -78.21 81.71 4.56 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.373 -0.829 . . . . 2.46 110.188 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.6 p -83.82 76.91 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.675 0.75 . . . . 2.6 112.766 -168.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.63 123.87 27.2 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 122.441 1.115 . . . . 1.98 112.469 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.95 -28.86 27.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 113.85 -1.523 . . . . 4.42 113.048 -166.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.45 -38.81 72.14 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.471 0.653 . . . . 2.92 110.618 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.52 -4.15 57.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.459 1.904 . . . . 4.25 111.42 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.4 m120 43.26 46.55 5.35 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.322 1.849 . . . . 2.07 111.4 -167.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -117.61 155.14 30.37 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.075 0.852 . . . . 3.13 111.565 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.89 139.81 49.86 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.474 -1.306 . . . . 2.0 107.474 147.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -90.97 138.86 31.28 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 103.845 -2.65 . . . . 3.7 103.845 148.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mm -122.43 106.25 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 106.725 -1.583 . . . . 3.27 106.725 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -79.75 68.26 5.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.067 -0.716 . . . . 3.07 109.067 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -73.57 143.88 46.26 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.019 -0.426 . . . . 3.53 111.482 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -62.17 113.15 7.78 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.853 1.261 . . . . 2.94 107.993 170.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.86 48.29 2.79 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.741 2.294 . . . . 1.82 112.736 -164.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -138.15 -64.11 0.54 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.678 1.191 . . . . 4.09 110.063 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.0 pt -73.63 -24.14 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 113.539 0.941 . . . . 2.87 113.539 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.0 tt -142.6 151.55 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 124.346 1.058 . . . . 2.1 108.239 -167.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.94 -178.57 15.75 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.717 -0.553 . . . . 0.82 111.717 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.79 -41.05 49.0 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.668 2.245 . . . . 0.86 110.375 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -44.76 68.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.284 0.634 . . . . 9.23 112.0 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.98 -53.39 57.42 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.388 0.613 . . . . 2.65 110.078 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.4 mt -57.95 -49.28 81.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 108.57 -0.9 . . . . 2.83 108.57 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 mt -53.19 -52.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.323 -0.621 . . . . 1.73 109.323 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -66.49 -34.45 77.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.94 0.4 . . . . 4.11 110.883 -176.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 93.3 m -58.8 -52.52 65.38 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 110.109 -0.33 . . . . 1.72 110.109 172.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.9 mm -66.16 -40.23 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 121.269 -0.894 . . . . 2.79 110.895 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -53.57 -52.44 59.74 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.713 0.805 . . . . 3.1 109.195 170.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.7 t -55.46 -43.47 75.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.946 0.499 . . . . 2.56 111.109 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.12 -10.38 53.59 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.374 0.879 . . . . 2.06 113.374 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.25 30.53 8.16 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.577 1.084 . . . . 0.74 112.896 169.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -131.8 165.2 24.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.351 1.076 . . . . 3.32 110.219 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -107.95 100.16 34.45 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 124.307 1.043 . . . . 3.31 110.569 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.87 99.07 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.629 2.886 . . . . 1.06 111.069 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t -90.59 119.47 30.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.35 -1.352 . . . . 3.13 107.35 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 mt -71.14 118.93 14.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.343 -0.984 . . . . 3.72 108.343 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.87 36.18 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.494 -0.558 . . . . 3.16 109.494 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -140.61 149.02 41.8 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 104.676 -2.342 . . . . 7.34 104.676 155.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.2 mt 68.42 -72.05 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.504 -1.295 . . . . 10.82 107.504 -159.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.123 -1.418 . . . . 11.65 109.986 157.933 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 106.875 -1.528 . . . . 10.41 106.875 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.72 176.19 43.74 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 107.42 -2.272 . . . . 3.52 107.42 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.2 t70 42.27 61.21 2.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.63 1.572 . . . . 3.7 112.634 171.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.01 149.02 42.16 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.01 -1.636 . . . . 2.13 109.01 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.7 m -129.17 146.99 33.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 123.886 0.875 . . . . 3.74 109.46 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.61 126.86 7.16 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.804 0.668 . . . . 4.56 112.804 162.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -79.56 97.16 6.35 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.674 1.99 . . . . 3.6 109.378 169.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mt -92.61 116.48 29.04 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.074 -1.454 . . . . 3.57 107.074 172.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.5 t -77.27 97.54 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 105.978 -1.86 . . . . 2.55 105.978 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.0 m -78.48 74.63 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 125.438 1.495 . . . . 1.87 107.666 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -74.38 146.35 43.04 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.926 -1.509 . . . . 5.94 106.926 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.19 23.77 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.571 -1.127 . . . . 1.23 112.126 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.58 130.15 42.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.547 1.673 . . . . 2.33 108.974 -171.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 p -116.41 -48.7 2.69 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.545 0.943 . . . . 3.64 113.545 -158.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.87 164.87 14.79 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.777 0.831 . . . . 1.34 111.498 -166.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.18 -40.07 10.65 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.887 1.275 . . . . 1.85 111.622 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -41.22 -51.29 3.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.602 1.561 . . . . 1.93 111.992 170.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.2 m -70.45 -43.63 69.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.943 0.497 . . . . 0.73 111.101 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -53.18 -55.46 12.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.506 -0.924 . . . . 1.85 108.506 -174.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -69.26 -29.61 67.56 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.654 -0.703 . . . . 1.06 111.722 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -49.73 -54.84 16.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.472 1.033 . . . . 4.98 109.016 166.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.1 mt -59.77 -61.56 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.285 -0.635 . . . . 2.07 109.285 -178.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -57.43 -55.25 37.17 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.65 0.659 . . . . 2.35 111.58 -173.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.1 m -59.85 -39.34 84.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.754 -0.591 . . . . 2.33 111.835 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 t -70.34 -46.08 64.86 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.585 -0.697 . . . . 1.55 111.092 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 mp -71.62 -61.02 1.93 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.147 0.579 . . . . 4.0 111.201 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.4 m -69.65 72.18 0.35 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.11 1.764 . . . . 3.78 110.746 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -176.17 -35.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 129.18 2.992 . . . . 4.41 109.335 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -65.3 120.93 13.67 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 119.344 0.975 . . . . 3.15 108.505 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 134.76 51.39 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.714 -1.587 . . . . 8.78 106.714 169.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.74 -41.28 2.0 Favored Glycine 0 C--O 1.225 -0.43 0 N-CA-C 110.047 -1.221 . . . . 1.53 110.047 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.14 131.55 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.647 -1.612 . . . . 3.2 106.647 164.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -96.02 -30.43 13.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.076 -0.713 . . . . 3.55 109.076 170.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -156.23 164.97 37.7 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.926 0.785 . . . . 4.32 110.392 169.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.8 t -130.47 149.87 51.94 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 105.687 -1.968 . . . . 2.29 105.687 162.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 m -139.66 104.83 5.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.406 -1.331 . . . . 3.05 107.406 162.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -114.16 141.91 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.012 0.525 . . . . 2.6 112.09 -177.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.39 139.71 30.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.244 0.545 . . . . 2.27 110.992 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.48 -33.08 60.78 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.201 1.0 . . . . 2.77 111.606 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.33 -34.31 60.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.227 0.611 . . . . 2.82 112.217 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.8 t -106.87 3.16 26.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.284 1.434 . . . . 4.01 111.48 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.6 m120 37.31 51.21 1.1 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 127.52 2.328 . . . . 2.16 110.814 -169.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.27 137.59 27.37 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.003 -0.435 . . . . 3.07 111.925 -166.106 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.94 117.46 32.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.298 2.239 . . . . 1.86 108.741 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -86.34 103.74 15.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.42 -2.437 . . . . 3.0 104.42 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.21 134.58 27.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.01 -1.478 . . . . 2.24 107.01 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -112.94 118.22 34.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.485 -1.302 . . . . 3.49 107.485 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -128.08 148.61 50.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.057 0.943 . . . . 3.79 111.514 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -76.99 117.01 62.14 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 106.55 -1.648 . . . . 3.11 106.55 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.39 69.64 7.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.606 2.204 . . . . 2.17 110.77 -172.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.6 -92.88 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.582 1.153 . . . . 5.02 110.154 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.1 pt -64.05 -31.28 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.128 0.788 . . . . 3.36 113.128 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 tp -114.07 137.78 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.958 1.303 . . . . 2.02 108.517 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.54 176.94 16.3 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.147 -0.781 . . . . 0.68 111.147 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.19 -41.39 74.4 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.791 2.994 . . . . 1.09 110.923 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -56.43 -53.75 53.78 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.211 0.459 . . . . 7.37 110.779 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.45 -50.4 69.94 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.078 -0.712 . . . . 2.88 109.078 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mm -53.69 -52.81 30.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 123.334 0.654 . . . . 3.26 111.306 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.4 mt -52.66 -53.53 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.879 -0.786 . . . . 2.18 108.879 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -64.27 -37.34 87.13 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.315 0.578 . . . . 4.28 110.795 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.3 m -57.36 -46.81 82.95 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.091 -0.504 . . . . 2.37 109.754 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.41 -43.08 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 118.654 0.661 . . . . 2.38 111.323 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -52.59 -41.56 63.75 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.97 0.804 . . . . 3.42 110.087 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.4 m -53.7 -29.07 37.3 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.978 0.733 . . . . 2.67 112.978 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 mt -81.18 -15.37 55.93 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.761 0.824 . . . . 1.91 112.07 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.68 42.83 4.37 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.825 1.203 . . . . 0.71 112.662 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.96 162.21 33.49 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 107.372 -1.344 . . . . 3.16 107.372 173.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -105.74 94.08 8.31 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 118.955 0.798 . . . . 2.56 110.397 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.93 85.2 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.804 3.003 . . . . 1.33 110.989 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 m -84.68 97.03 9.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.401 1.08 . . . . 2.8 110.223 -170.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.87 102.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.875 0.87 . . . . 5.62 110.817 171.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.1 p -75.21 -43.38 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 111.846 0.313 . . . . 4.62 111.846 -170.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm 61.44 -163.59 0.26 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 122.977 0.511 . . . . 7.65 110.19 -173.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.6 tt -164.11 74.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 105.169 -2.159 . . . . 8.53 105.169 173.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 C--O 1.249 1.047 0 N-CA-C 104.365 -2.457 . . . . 9.41 104.365 -151.259 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 109.169 -0.678 . . . . 8.92 109.169 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.11 30.01 76.06 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.229 0.443 . . . . 3.48 112.736 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -144.91 66.95 1.25 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.154 1.782 . . . . 4.27 108.961 -165.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.93 144.05 48.87 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 108.573 -1.811 . . . . 2.74 108.573 173.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -150.12 132.12 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 117.818 0.809 . . . . 4.07 109.83 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mp -143.63 155.19 44.18 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.046 -1.094 . . . . 4.13 108.046 166.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.467 ' CD ' ' HZ2' ' A' ' 43' ' ' LYS . 15.1 mt-10 -107.61 102.24 11.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.254 -1.758 . . . . 2.96 106.254 163.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.52 130.92 40.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.267 -1.383 . . . . 2.48 107.267 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 65.2 t -84.11 102.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 125.225 1.41 . . . . 2.15 107.362 -174.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 m -89.53 96.69 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.518 1.527 . . . . 1.93 109.082 -172.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.8 mmm180 -76.14 151.02 37.08 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 118.775 -1.17 . . . . 9.3 107.932 177.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.2 -27.3 10.93 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.225 0.917 . . . . 0.78 111.986 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.0 mtm -65.79 94.68 0.22 Allowed 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.556 1.178 . . . . 2.73 111.546 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -77.85 -38.77 45.4 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.685 0.394 . . . . 3.51 111.49 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.23 174.7 13.44 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 119.071 0.85 . . . . 1.17 112.199 -168.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.5 -38.94 14.9 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.17 1.388 . . . . 2.34 112.183 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 m -51.94 -40.99 61.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.682 0.793 . . . . 2.77 111.42 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.4 m -70.1 -47.95 59.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.019 0.528 . . . . 0.84 110.239 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -51.12 -58.5 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 123.737 0.815 . . . . 2.29 108.977 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.17 -25.16 66.02 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.662 -0.699 . . . . 1.11 111.631 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -56.73 -56.18 24.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.291 -1.004 . . . . 4.04 108.291 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -58.61 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.239 -1.023 . . . . 2.1 108.239 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -55.78 -54.51 43.51 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.322 0.249 . . . . 2.95 110.599 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -57.45 -48.27 79.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.862 0.465 . . . . 2.17 110.237 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 t -69.91 -34.06 73.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 118.905 -1.118 . . . . 1.22 111.22 -173.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.31 -50.36 63.9 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.124 -0.465 . . . . 3.8 110.65 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.0 p -70.91 63.65 0.31 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.982 0.896 . . . . 2.56 112.42 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -165.93 -36.22 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.42 1.888 . . . . 4.5 110.895 172.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -65.97 133.72 51.43 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.359 0.981 . . . . 2.88 109.54 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -53.04 143.13 18.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.554 -0.906 . . . . 7.73 108.554 172.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.68 -32.68 7.26 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-O 118.142 -1.366 . . . . 1.46 111.977 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.49 128.01 38.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 120.006 1.903 . . . . 2.9 108.024 172.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 mt -92.6 -45.55 8.03 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.114 1.366 . . . . 4.12 108.526 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -156.07 163.54 39.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.476 -0.564 . . . . 3.33 109.476 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.7 m -135.82 154.45 51.19 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.103 0.961 . . . . 3.59 108.742 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -149.89 97.78 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.055 -1.091 . . . . 3.11 108.055 162.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -101.39 135.65 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 122.91 0.484 . . . . 2.63 110.399 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.79 135.21 19.47 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.98 0.912 . . . . 1.86 112.457 -167.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.51 -28.63 66.21 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 125.789 1.636 . . . . 3.64 111.053 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -34.45 -45.15 0.22 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.193 1.797 . . . . 3.05 113.501 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 t -131.58 10.32 4.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 122.235 1.017 . . . . 3.61 111.503 169.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 56.94 59.18 3.59 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.958 1.703 . . . . 2.22 108.758 -167.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.467 ' HZ2' ' CD ' ' A' ' 7' ' ' GLU . 16.1 ptpt -103.49 154.69 19.18 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.974 0.91 . . . . 3.02 110.961 178.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.97 114.27 17.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.251 1.421 . . . . 1.68 108.001 162.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -80.1 113.39 18.23 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 104.86 -2.274 . . . . 4.0 104.86 169.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.69 126.17 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 105.563 -2.014 . . . . 2.29 105.563 174.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -114.01 123.93 50.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.586 -1.635 . . . . 3.76 106.586 169.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -144.87 148.12 33.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.752 0.821 . . . . 3.49 111.989 -160.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -56.5 117.61 17.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 107.231 -1.396 . . . . 4.75 107.231 164.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.71 -3.27 13.4 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.192 1.928 . . . . 1.98 113.003 -170.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -103.27 -54.45 2.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.17 0.895 . . . . 4.58 109.975 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.7 pt -79.95 -36.22 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.694 0.628 . . . . 3.16 112.694 -167.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.06 132.06 66.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.28 1.432 . . . . 2.01 107.669 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.63 172.72 17.84 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 118.683 0.674 . . . . 0.73 111.612 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.95 -36.31 97.07 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.232 2.621 . . . . 0.89 110.737 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -55.93 -57.0 13.92 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.094 0.406 . . . . 7.37 110.032 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.52 -49.9 66.58 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.071 -0.714 . . . . 2.68 109.071 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.6 mm -53.58 -52.0 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.281 0.632 . . . . 3.2 111.468 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.88 -52.56 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 122.73 0.412 . . . . 1.7 109.96 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -65.51 -38.95 91.19 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.53 0.681 . . . . 3.82 110.471 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.3 m -55.24 -51.42 66.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.346 -0.613 . . . . 2.09 109.346 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 89.8 mt -69.51 -39.85 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 119.407 -0.33 . . . . 2.5 111.186 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -56.65 -44.06 80.94 Favored 'General case' 0 CA--C 1.526 0.049 0 CA-C-N 118.727 0.694 . . . . 3.78 109.226 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 t -58.66 -15.02 9.87 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.994 1.109 . . . . 2.94 113.994 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.5 mt -95.84 -9.86 30.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.898 1.226 . . . . 2.33 111.694 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.36 47.05 3.63 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.299 0.952 . . . . 0.85 112.462 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -137.99 163.87 30.46 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.56 -0.904 . . . . 3.53 108.56 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.53 86.98 3.07 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.552 1.141 . . . . 3.06 110.303 -176.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.59 82.36 0.93 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.879 3.053 . . . . 1.0 111.538 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 m -81.05 103.84 11.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.168 0.987 . . . . 2.56 109.022 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.06 70.97 0.16 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.558 1.143 . . . . 3.74 113.238 -175.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.15 -135.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.114 -1.439 . . . . 3.18 107.114 160.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.5 mmtm -138.99 -60.06 0.58 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 122.312 2.323 . . . . 7.6 113.641 -166.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.4 tp -146.38 -50.92 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 126.957 2.103 . . . . 8.93 108.023 -170.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 . . . . . 0 C--O 1.257 1.46 0 N-CA-C 103.832 -2.655 . . . . 12.74 103.832 137.4 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.345 0 N-CA-C 108.196 -1.039 . . . . 7.48 108.196 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.62 80.58 1.45 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.404 -0.678 . . . . 3.18 111.404 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -48.5 107.07 0.11 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.621 1.168 . . . . 3.89 111.546 175.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.59 170.47 54.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 121.768 0.649 . . . . 2.03 112.349 -176.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.42 129.85 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.624 -1.621 . . . . 3.79 106.624 167.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -155.47 158.19 38.16 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.752 0.706 . . . . 4.52 110.216 160.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.0 123.97 50.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.137 0.975 . . . . 2.4 108.911 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.54 123.94 50.89 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.285 -2.117 . . . . 2.7 105.285 167.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.29 100.35 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.298 -2.112 . . . . 2.33 105.298 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.77 84.0 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.04 1.736 . . . . 1.83 108.088 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.412 HH22 ' CD ' ' A' ' 75' ' ' GLU . 23.5 mtt85 -76.72 147.15 37.56 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.717 -1.216 . . . . 8.11 107.717 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.55 -16.61 26.39 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 119.3 -0.722 . . . . 0.81 112.849 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.1 mtp -64.05 167.34 6.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.978 1.389 . . . . 2.78 110.788 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 t -152.19 -45.54 0.1 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.076 0.55 . . . . 3.1 111.675 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.4 p -133.61 170.92 14.82 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.909 0.777 . . . . 1.25 111.917 -169.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.85 -33.94 8.12 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.856 1.263 . . . . 1.72 111.981 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -64.95 -37.61 88.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 121.491 -0.756 . . . . 2.91 111.615 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -61.36 -46.86 88.44 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.326 -0.62 . . . . 0.88 109.326 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.8 t -50.33 -59.67 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.73 -0.841 . . . . 1.8 108.73 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 0.6 OUTLIER -66.11 -28.96 69.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 116.028 -0.533 . . . . 1.17 111.725 -174.762 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -62.17 -54.65 38.06 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 108.809 -0.811 . . . . 5.41 108.809 173.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.29 -54.3 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 120.169 -0.612 . . . . 1.94 109.572 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -60.71 -53.99 50.7 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.367 0.531 . . . . 2.29 111.143 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.5 t -58.59 -34.9 71.61 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.742 -0.599 . . . . 2.67 111.209 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.5 t -70.38 -42.67 71.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.042 -0.411 . . . . 1.75 110.772 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.2 mt -71.22 -60.12 2.4 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.112 0.565 . . . . 3.7 112.232 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 m -69.64 67.98 0.24 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.072 1.749 . . . . 3.37 111.162 -166.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.16 -35.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.483 2.313 . . . . 4.93 110.575 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -68.03 132.43 47.26 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.471 1.032 . . . . 2.93 108.8 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -54.74 148.07 13.58 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.452 -0.573 . . . . 7.26 109.452 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.47 -28.37 10.12 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 117.382 -1.788 . . . . 1.32 112.705 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.31 126.75 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 120.544 2.172 . . . . 2.73 106.506 166.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 mt -86.79 -44.22 11.92 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.22 -1.4 . . . . 3.99 107.22 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -156.13 164.69 38.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.573 -0.899 . . . . 3.34 108.573 174.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 p -138.94 161.5 37.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.783 -1.562 . . . . 2.08 106.783 160.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.5 t -143.68 134.16 24.79 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.455 -1.683 . . . . 2.31 106.455 153.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.8 p -115.2 145.67 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 123.401 0.68 . . . . 2.83 109.941 -179.557 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.04 134.96 26.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.073 0.463 . . . . 1.81 110.676 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.82 -29.49 65.66 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.665 1.186 . . . . 4.07 111.538 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.76 -39.11 36.69 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.631 1.172 . . . . 2.16 112.141 -174.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 p -129.88 32.15 4.6 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.717 0.807 . . . . 3.32 110.192 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 27.0 62.04 0.09 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 128.226 2.611 . . . . 3.32 112.546 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -132.49 145.55 51.26 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.84 0.456 . . . . 2.77 111.462 -173.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.06 118.06 35.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.505 -1.665 . . . . 2.08 106.505 163.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -85.68 109.84 18.87 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 101.606 -3.479 . . . . 3.06 101.606 165.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 43.8 mt -101.94 139.22 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.329 -0.989 . . . . 3.02 108.329 175.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -117.78 104.86 11.38 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 105.707 -1.961 . . . . 3.79 105.707 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -120.11 162.49 19.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.818 0.847 . . . . 3.97 110.322 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -100.22 114.76 65.82 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.556 0.743 . . . . 3.79 110.397 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -69.4 -5.32 15.7 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.607 2.205 . . . . 2.26 113.492 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -65.01 -22.65 67.03 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.951 1.705 . . . . 5.26 112.068 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 pt -129.82 -60.08 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.499 0.926 . . . . 3.02 113.499 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 tp -87.85 137.32 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.548 -0.72 . . . . 2.12 110.031 -165.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.15 166.74 12.32 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.988 0.804 . . . . 0.84 111.57 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -57.87 -38.61 91.82 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.148 2.565 . . . . 0.84 110.872 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -53.74 -44.42 69.91 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.003 0.372 . . . . 8.78 112.003 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.3 -51.99 66.58 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.994 0.815 . . . . 2.43 109.191 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.7 mt -50.38 -54.16 9.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 C-N-CA 123.32 0.648 . . . . 2.63 109.358 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.9 mt -56.72 -51.01 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 119.119 -0.467 . . . . 1.71 110.036 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -68.55 -27.35 66.0 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-O 120.978 0.418 . . . . 4.33 112.067 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.8 m -64.62 -52.26 58.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.733 -0.469 . . . . 2.05 109.733 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -72.07 -45.28 63.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.874 -0.517 . . . . 2.37 112.151 -171.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.04 -43.23 63.65 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.65 0.659 . . . . 3.95 111.388 -176.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.3 t -48.35 -37.2 16.09 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.38 1.472 . . . . 2.62 112.395 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.4 mt -74.8 -17.27 60.65 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.363 -0.836 . . . . 2.05 112.188 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.61 45.68 3.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.159 0.885 . . . . 0.89 112.022 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -136.38 155.63 49.77 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.721 -1.215 . . . . 3.36 107.721 170.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -101.39 96.47 6.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.768 1.227 . . . . 2.83 109.41 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.2 77.66 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.352 2.701 . . . . 1.19 110.479 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.6 p -78.91 106.84 11.22 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.18 -0.674 . . . . 3.04 109.18 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.3 mt -74.94 56.55 0.75 Allowed 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.596 -0.69 . . . . 4.95 111.19 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.3 p -101.63 55.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 123.73 1.729 . . . . 4.29 107.492 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -39.46 110.96 0.16 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.179 -1.828 . . . . 8.04 109.259 158.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 mp 73.26 108.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 126.398 1.879 . . . . 7.23 109.531 -167.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.412 ' CD ' HH22 ' A' ' 11' ' ' ARG . 52.7 mt-10 . . . . . 0 C--O 1.256 1.396 0 N-CA-C 103.824 -2.658 . . . . 13.37 103.824 158.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 mtt . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 105.718 -1.956 . . . . 9.85 105.718 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.22 92.1 0.05 OUTLIER Glycine 0 CA--C 1.533 1.17 0 O-C-N 124.426 1.079 . . . . 3.84 112.484 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 t0 71.68 161.22 0.23 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.831 2.052 . . . . 4.09 112.685 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.92 94.82 0.1 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.068 -1.613 . . . . 2.4 109.068 -169.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -90.73 118.47 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.053 1.341 . . . . 3.49 109.912 -170.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -127.01 133.25 50.58 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.361 0.665 . . . . 3.51 109.608 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -103.61 99.85 9.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.283 1.033 . . . . 2.66 108.217 169.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.94 134.02 41.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.123 -1.436 . . . . 2.35 107.123 173.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.9 t -85.32 113.81 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.143 -1.799 . . . . 1.93 106.143 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.02 96.78 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 126.04 1.736 . . . . 1.93 108.321 -172.199 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.02 137.66 39.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.645 -1.613 . . . . 6.47 106.645 -174.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.55 -26.49 10.14 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.768 -1.018 . . . . 0.98 112.66 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 ptm -78.65 85.71 4.67 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.534 1.667 . . . . 2.46 110.232 -176.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 p -76.5 -34.6 58.61 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.881 0.872 . . . . 3.59 112.962 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.0 p -145.45 172.82 12.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.81 0.732 . . . . 1.14 112.39 -162.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.8 -39.43 8.36 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.518 1.527 . . . . 1.87 112.299 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -53.53 -53.14 55.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.491 -0.559 . . . . 2.55 109.491 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.3 m -64.77 -42.59 94.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.589 0.356 . . . . 0.68 111.003 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.6 t -48.99 -61.04 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.199 -1.037 . . . . 1.66 108.199 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.287 1.1 p-80 -70.32 -28.77 65.43 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.185 -0.916 . . . . 1.03 111.457 -174.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -51.58 -60.06 3.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.057 0.844 . . . . 4.78 110.052 168.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 mt -62.59 -59.23 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.761 -0.829 . . . . 1.92 108.761 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -56.65 -53.78 53.69 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.743 0.417 . . . . 2.68 110.001 -167.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 t -62.44 -42.48 99.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.396 -0.335 . . . . 2.28 110.872 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.0 t -65.88 -50.74 63.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.902 0.774 . . . . 1.14 110.934 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.83 -43.93 78.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.647 0.779 . . . . 3.3 111.033 -173.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.1 m -71.24 65.77 0.41 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.685 0.675 . . . . 3.78 111.457 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -147.9 -51.78 0.19 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 128.021 2.528 . . . . 8.65 108.182 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -66.11 114.62 5.38 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.845 -0.798 . . . . 2.96 108.845 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -48.95 -30.68 6.25 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.412 1.085 . . . . 7.85 113.582 -171.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.8 -33.13 55.63 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.088 -0.84 . . . . 1.72 113.208 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.76 124.17 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.783 -1.562 . . . . 2.87 106.783 169.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.47 -20.26 18.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 119.153 -0.451 . . . . 3.69 110.153 171.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -155.44 158.35 38.45 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.085 0.857 . . . . 3.34 109.964 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -139.02 146.98 41.51 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.698 -1.593 . . . . 2.17 106.698 165.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -145.77 122.89 11.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.582 -1.266 . . . . 2.66 107.582 159.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 m -111.35 151.87 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.158 0.89 . . . . 2.97 111.042 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.62 133.48 20.14 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 122.734 0.414 . . . . 1.75 111.713 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -69.46 -27.34 65.15 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.301 1.041 . . . . 2.96 111.402 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.05 -39.33 1.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.742 1.617 . . . . 2.18 113.215 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.5 t -141.62 36.47 1.64 Allowed 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.754 0.422 . . . . 3.1 110.246 168.308 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.4 m120 33.9 56.71 0.59 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 127.649 2.379 . . . . 2.42 110.418 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -110.78 153.15 25.74 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.16 0.984 . . . . 3.26 110.187 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.11 113.16 13.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.73 1.212 . . . . 1.81 108.019 171.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -92.44 97.93 11.15 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.384 -3.191 . . . . 2.92 102.384 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.74 141.16 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.071 -1.825 . . . . 2.34 106.071 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -122.38 114.27 20.52 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.257 -1.016 . . . . 4.15 108.257 167.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -126.29 152.51 46.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.958 0.786 . . . . 3.35 111.778 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -78.56 113.77 37.5 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 108.659 -0.867 . . . . 2.83 108.659 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.76 65.32 8.74 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.635 2.89 . . . . 1.47 110.267 -170.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -138.39 -72.47 0.41 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.845 1.258 . . . . 3.2 108.706 -170.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -88.26 -36.53 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.043 0.937 . . . . 3.67 111.721 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 tp -104.02 153.32 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.669 1.587 . . . . 1.96 107.963 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.47 173.56 23.82 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.236 -1.146 . . . . 0.74 110.236 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.63 -38.19 42.43 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.147 2.565 . . . . 0.82 110.327 -175.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -57.43 -42.16 81.84 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.518 0.327 . . . . 6.63 111.214 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -62.15 -59.15 5.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.576 -0.898 . . . . 4.02 108.576 178.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 mm -42.9 -51.2 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.419 0.688 . . . . 3.07 110.651 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.4 mt -54.2 -59.6 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 118.661 -0.685 . . . . 1.6 110.672 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.98 -35.95 81.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.487 1.04 . . . . 7.4 111.9 -176.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.3 m -68.02 -39.21 83.19 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.6 1.16 . . . . 2.71 109.681 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.28 -46.02 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.644 -0.66 . . . . 2.32 110.677 170.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -50.13 -43.24 51.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.644 0.656 . . . . 4.93 110.905 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.1 m -51.12 -28.83 11.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.449 0.907 . . . . 2.45 113.449 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.06 -12.18 48.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.377 1.071 . . . . 2.05 112.248 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.82 48.94 3.5 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.871 1.224 . . . . 0.75 112.31 174.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -139.45 153.71 47.62 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 106.97 -1.492 . . . . 3.4 106.97 170.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -98.79 101.43 12.03 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-O 118.434 -0.793 . . . . 2.88 110.478 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.17 93.51 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.714 2.276 . . . . 0.9 111.642 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.2 m -78.45 116.86 19.14 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.574 -0.898 . . . . 2.21 108.574 167.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.6 60.67 0.34 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.462 1.105 . . . . 3.71 111.73 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 t -64.7 -60.7 2.34 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 O-C-N 121.775 -0.578 . . . . 3.16 110.197 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 65.98 147.07 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.033 1.333 . . . . 5.45 111.307 -171.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.25 153.99 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.182 -0.949 . . . . 7.38 109.041 167.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 . . . . . 0 C--O 1.249 1.044 0 N-CA-C 104.493 -2.41 . . . . 8.62 104.493 173.108 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.4 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.031 -0.729 . . . . 9.14 109.031 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.0 178.65 15.57 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.118 -1.993 . . . . 3.63 108.118 -170.571 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.84 -123.28 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.064 0.932 . . . . 2.91 110.281 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.74 -153.68 20.1 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 106.532 -2.627 . . . . 2.97 106.532 -168.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.75 147.35 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.127 -1.434 . . . . 3.45 107.127 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.49 141.53 49.78 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.14 -1.43 . . . . 4.02 107.14 166.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -103.37 145.41 30.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.446 1.098 . . . . 3.02 109.704 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.21 119.76 17.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.39 1.476 . . . . 2.88 107.318 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.65 118.94 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 103.798 -2.667 . . . . 2.38 103.798 171.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.5 p -124.81 87.18 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.679 1.192 . . . . 4.15 108.528 -167.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -79.44 152.36 30.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.458 -0.792 . . . . 6.02 109.306 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.77 -28.85 6.85 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.319 0.961 . . . . 0.85 111.073 -175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 30.1 mtp -66.06 110.13 2.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.84 0.82 . . . . 2.5 110.12 179.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.8 t -90.8 -43.06 10.3 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.253 1.021 . . . . 3.72 111.677 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.3 p -141.56 174.6 10.4 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.874 0.761 . . . . 1.31 111.963 -167.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.25 -35.76 12.63 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.994 1.318 . . . . 1.96 112.072 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -60.48 -37.5 81.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.61 -0.681 . . . . 3.21 111.344 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 78.8 m -63.76 -37.92 89.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.633 -0.667 . . . . 0.83 110.571 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.8 t -58.58 -60.94 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.405 -0.961 . . . . 2.07 108.405 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.306 0.9 OUTLIER -60.06 -35.88 76.1 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.752 -0.379 . . . . 0.98 111.589 -175.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -61.11 -46.93 88.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.901 1.68 . . . . 4.5 109.848 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mt -58.95 -65.92 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.651 -0.5 . . . . 2.04 109.651 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.86 -50.61 71.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.608 -0.437 . . . . 3.23 111.146 -168.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.0 m -56.55 -43.52 79.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.376 -0.231 . . . . 3.06 110.376 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 t -70.63 -38.99 73.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 118.802 -1.159 . . . . 1.18 111.226 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 mt -56.98 -48.94 77.22 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.186 0.903 . . . . 3.67 110.066 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.6 p -62.63 80.47 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.909 0.884 . . . . 2.74 111.631 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 pttm 176.7 -34.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 129.193 2.997 . . . . 4.46 109.944 172.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -69.13 141.93 54.51 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 119.199 -1.0 . . . . 3.02 109.037 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -62.13 145.14 54.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.552 -0.907 . . . . 6.89 108.552 175.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.05 -53.77 0.57 Allowed Glycine 0 CA--C 1.521 0.407 0 CA-C-O 119.316 -0.713 . . . . 1.41 111.528 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.74 112.25 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 118.66 1.23 . . . . 2.98 112.312 -166.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -94.1 -30.79 14.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.232 1.013 . . . . 3.95 111.2 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -153.93 147.25 24.84 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.509 1.049 . . . . 4.34 109.427 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -117.87 140.41 49.74 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 107.176 -1.416 . . . . 2.33 107.176 172.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.5 t -128.52 59.58 1.53 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.234 1.014 . . . . 4.53 108.664 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.86 133.85 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.553 0.741 . . . . 2.55 110.844 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.34 137.88 37.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.946 0.898 . . . . 2.18 112.408 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.96 -35.02 79.46 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.005 1.322 . . . . 3.77 110.072 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -37.25 -39.69 0.29 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.531 1.932 . . . . 2.74 113.831 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t -143.29 34.96 1.33 Allowed 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.393 0.277 . . . . 3.33 111.059 172.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.7 m120 41.66 61.82 1.75 Allowed 'General case' 0 CA--C 1.523 -0.077 0 C-N-CA 126.092 1.757 . . . . 2.58 110.068 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.13 140.53 18.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.329 -0.619 . . . . 3.47 109.329 -166.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.45 154.92 28.41 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.202 0.601 . . . . 2.3 110.03 166.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.28 141.33 40.22 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 104.91 -2.256 . . . . 2.77 104.91 150.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.59 134.49 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.965 -1.494 . . . . 2.78 106.965 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -102.83 85.48 2.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.508 -2.034 . . . . 4.08 105.508 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -114.01 146.36 40.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.934 1.294 . . . . 3.61 110.799 172.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -59.64 107.32 0.96 Allowed Pre-proline 0 CA--C 1.537 0.46 0 O-C-N 124.283 0.99 . . . . 2.51 108.792 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -82.44 45.57 1.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.319 2.679 . . . . 1.94 110.974 -169.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' OE1' ' N ' ' A' ' 1' ' ' MET . 24.5 mt-10 -139.31 -60.29 0.57 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.533 1.133 . . . . 4.23 108.965 -170.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 pt -74.9 -25.87 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 112.34 0.496 . . . . 3.26 112.34 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.2 tt -143.0 154.78 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.085 -1.079 . . . . 2.65 108.085 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.08 -176.76 17.05 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.626 -0.589 . . . . 0.69 111.626 -172.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.11 -32.72 33.6 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.371 2.047 . . . . 0.87 110.174 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -53.65 -51.7 62.32 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.131 0.572 . . . . 7.34 110.95 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.81 -50.3 72.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.095 0.474 . . . . 2.31 109.745 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.0 mt -54.61 -51.94 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.08 0 C-N-CA 123.441 0.696 . . . . 2.23 109.893 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.4 mt -51.74 -53.04 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.133 -0.691 . . . . 1.83 109.133 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -66.3 -34.89 79.0 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.914 0.485 . . . . 3.75 110.785 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -60.77 -48.52 81.42 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.715 -0.476 . . . . 1.79 109.715 174.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 94.0 mt -70.89 -35.69 60.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.365 -0.834 . . . . 2.18 111.366 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -54.44 -49.45 69.97 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.557 -0.714 . . . . 2.62 109.21 167.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 t -58.12 -43.07 87.01 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.651 0.38 . . . . 2.96 111.143 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -58.18 -37.64 75.15 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.506 -0.746 . . . . 2.33 111.64 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.67 38.42 2.22 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.628 1.109 . . . . 0.88 111.726 176.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -129.28 163.45 25.65 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 107.702 -1.222 . . . . 3.5 107.702 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -109.93 98.72 35.58 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.183 0.593 . . . . 2.83 110.118 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.52 148.31 20.55 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.779 2.986 . . . . 1.63 110.168 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.1 m -153.71 118.03 4.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.457 1.103 . . . . 2.88 108.404 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.22 59.94 1.86 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.767 0.827 . . . . 3.12 111.538 -176.417 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.6 t -118.82 60.95 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.608 -1.256 . . . . 5.25 107.608 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.436 ' HZ1' ' C ' ' A' ' 75' ' ' GLU . 34.6 tptt -160.79 142.98 12.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.939 -1.134 . . . . 8.92 107.939 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.5 tt -150.1 162.58 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 105.068 -2.197 . . . . 7.39 105.068 164.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' C ' ' HZ1' ' A' ' 73' ' ' LYS . 35.3 tt0 . . . . . 0 C--O 1.249 1.072 0 C-N-CA 126.609 1.964 . . . . 11.37 111.42 169.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 107.882 -1.155 . . . . 8.58 107.882 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.19 157.31 6.06 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.427 -1.069 . . . . 3.66 110.427 -170.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -75.27 132.81 41.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.108 -0.701 . . . . 3.28 109.108 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.11 149.91 44.39 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.914 -0.874 . . . . 2.1 110.914 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -136.48 87.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 105.808 -1.923 . . . . 4.12 105.808 172.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.25 145.09 51.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.816 -0.809 . . . . 4.0 108.816 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -123.92 139.13 54.26 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.949 -1.5 . . . . 2.21 106.949 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.34 152.57 51.93 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.905 -1.146 . . . . 3.92 107.905 164.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -93.92 101.66 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.792 -1.929 . . . . 2.26 105.792 -173.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.2 m -79.38 65.86 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.076 1.75 . . . . 1.81 108.581 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.39 125.86 29.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 118.95 -1.1 . . . . 5.66 108.579 -162.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.51 -44.69 0.96 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.217 0.913 . . . . 0.89 110.888 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -64.16 152.15 41.44 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.408 0.683 . . . . 2.73 111.508 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -140.65 -34.97 0.5 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.983 0.734 . . . . 2.97 112.983 -167.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 p -145.97 175.14 10.67 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.305 0.957 . . . . 1.32 111.683 -166.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.52 -47.89 3.82 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.0 1.72 . . . . 1.91 112.032 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 m -57.14 -40.29 76.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.331 0.652 . . . . 2.11 111.818 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.7 m -72.14 -53.11 13.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.619 0.645 . . . . 0.78 110.523 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.2 t -44.1 -55.77 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.482 1.513 . . . . 1.86 109.275 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -21.63 63.4 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 120.175 -0.61 . . . . 1.71 112.26 -173.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -47.97 59.98 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.933 -1.506 . . . . 6.88 106.933 173.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mt -56.33 -53.38 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.788 -0.625 . . . . 1.84 110.101 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -57.25 -61.58 2.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.841 0.746 . . . . 3.42 111.473 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -55.44 -41.75 73.26 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.771 -0.581 . . . . 2.08 111.579 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 t -65.45 -48.61 72.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.818 -0.438 . . . . 1.65 109.818 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.8 mt -54.04 -46.04 71.79 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.355 -0.841 . . . . 4.13 110.074 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -61.28 -14.16 24.43 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.695 0.998 . . . . 2.62 113.695 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -26.36 68.79 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.166 1.348 . . . . 6.68 111.275 173.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -77.86 100.17 6.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.317 -0.623 . . . . 4.12 109.317 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -61.23 82.87 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.871 -1.159 . . . . 6.81 107.871 163.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.82 -26.95 0.39 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.231 0.92 . . . . 2.26 110.932 -166.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -74.67 120.03 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 105.773 -1.936 . . . . 2.98 105.773 165.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.9 mt -79.91 -47.48 14.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.708 -1.219 . . . . 3.66 107.708 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -156.09 124.2 5.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.898 -0.408 . . . . 4.57 109.898 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.2 p -97.61 151.82 19.69 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.088 0.955 . . . . 3.47 108.719 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -152.56 102.48 2.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.794 -0.817 . . . . 2.75 108.794 159.467 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.16 148.16 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 124.102 0.961 . . . . 3.07 110.946 167.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.65 131.95 18.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.385 0.674 . . . . 1.9 109.635 171.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.46 -32.63 54.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.038 -0.983 . . . . 3.22 112.939 -167.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.95 -49.41 40.53 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.093 0.957 . . . . 2.41 111.783 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.1 p -101.77 6.48 41.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.897 0.879 . . . . 3.33 111.326 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.02 42.72 21.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.3 1.44 . . . . 3.22 110.362 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -98.81 149.12 23.21 Favored 'General case' 0 C--N 1.344 0.326 0 O-C-N 121.371 -0.83 . . . . 2.83 110.159 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.8 117.93 30.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.014 -1.106 . . . . 1.66 108.014 155.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -83.4 119.94 25.27 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.122 -2.177 . . . . 5.28 105.122 164.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 mp -113.68 118.22 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.098 -1.815 . . . . 2.44 106.098 174.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -103.75 97.7 7.67 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.258 -1.756 . . . . 4.17 106.258 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -112.11 169.94 8.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.185 1.394 . . . . 3.5 111.339 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -76.56 115.2 45.59 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.112 -0.699 . . . . 4.47 109.112 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.62 49.43 3.08 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-N 120.748 1.303 . . . . 1.43 111.148 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.7 -63.52 1.02 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.58 1.152 . . . . 3.81 110.052 170.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pp -75.92 -32.32 23.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 CA-C-N 118.631 0.65 . . . . 2.82 112.689 -168.721 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.9 tt -128.37 157.66 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.608 1.163 . . . . 2.18 110.806 -168.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -124.86 -173.87 13.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.471 -0.651 . . . . 0.73 111.471 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.84 -39.47 51.82 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.82 2.347 . . . . 1.06 110.336 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -51.15 -49.38 60.98 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.859 0.864 . . . . 6.86 112.198 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.28 -47.49 84.09 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.956 0.884 . . . . 2.22 110.209 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.7 mt -56.45 -54.06 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 114.926 -1.034 . . . . 2.6 108.22 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.9 mt -54.08 -53.0 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 116.376 -0.375 . . . . 1.74 110.146 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -64.23 -34.21 77.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.279 -0.263 . . . . 3.8 110.627 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.1 m -58.58 -53.53 57.24 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.073 -0.392 . . . . 2.25 110.697 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.4 mm -66.01 -39.81 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.168 -0.957 . . . . 3.22 111.476 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.32 -46.03 76.31 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.874 -0.517 . . . . 2.75 109.772 171.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.3 t -59.6 -42.62 92.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.828 0.451 . . . . 2.91 111.262 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.24 -43.38 87.77 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.726 0.694 . . . . 2.4 110.936 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.95 43.41 0.94 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.059 0.837 . . . . 0.74 111.436 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -130.92 157.58 42.56 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 105.608 -1.997 . . . . 3.29 105.608 166.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -102.11 108.01 55.06 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 119.37 0.986 . . . . 2.61 109.812 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.75 83.28 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 124.068 3.178 . . . . 0.9 110.918 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.5 t -78.75 112.34 15.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.171 -0.677 . . . . 2.98 109.171 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.2 57.49 1.86 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.679 0.792 . . . . 3.9 111.562 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.1 p -88.66 -21.7 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.831 0.852 . . . . 4.19 110.482 173.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt 64.69 -177.21 0.17 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.552 1.141 . . . . 5.36 110.765 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.21 -43.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.107 0.963 . . . . 9.0 108.847 163.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 124.408 1.083 . . . . 9.17 109.775 176.198 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 107.719 -1.215 . . . . 9.82 107.719 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.21 159.61 28.0 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 107.204 -2.358 . . . . 3.28 107.204 172.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.01 111.69 0.26 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.108 1.363 . . . . 3.9 114.432 -164.035 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.95 83.36 0.5 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 107.168 -2.373 . . . . 2.56 107.168 159.372 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m -77.82 125.09 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.993 -1.114 . . . . 3.85 107.993 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.7 tp -144.89 143.86 30.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.305 -1.368 . . . . 3.89 107.305 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -117.14 123.98 48.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.508 -0.923 . . . . 2.75 108.508 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.16 133.95 52.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.023 -1.473 . . . . 2.38 107.023 177.382 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.11 105.84 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.964 -1.495 . . . . 2.4 106.964 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.84 81.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.697 1.199 . . . . 1.99 108.077 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 -76.45 142.84 40.87 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 5.23 107.752 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.77 -31.84 5.57 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.36 -0.696 . . . . 0.99 111.36 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.6 ptm -60.5 159.35 10.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.181 0.991 . . . . 3.06 110.781 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 p -136.09 -65.64 0.57 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.757 0.823 . . . . 4.32 108.995 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 p -119.55 172.88 7.34 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.518 1.127 . . . . 1.77 111.579 -166.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.08 -41.2 7.5 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.958 1.303 . . . . 2.03 112.058 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m -48.96 -46.9 44.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.354 1.062 . . . . 2.77 111.325 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.8 m -68.61 -47.95 65.37 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.612 0.365 . . . . 0.92 110.128 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.5 t -50.44 -58.61 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 108.769 -0.826 . . . . 2.14 108.769 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -66.59 -28.66 68.68 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.606 -0.724 . . . . 1.13 111.687 -174.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.09 -52.71 60.1 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.231 1.012 . . . . 4.65 109.235 171.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mt -61.52 -59.8 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 108.462 -0.94 . . . . 1.98 108.462 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -51.19 -58.58 5.76 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.446 0.466 . . . . 2.64 110.744 -171.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.0 p -55.36 -50.56 69.36 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.617 0.246 . . . . 3.32 110.886 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -70.92 -26.31 63.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.039 0.385 . . . . 1.35 112.039 -171.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.38 -49.65 53.38 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.572 -0.705 . . . . 2.56 109.532 169.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.4 p -70.11 72.9 0.45 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.282 0.492 . . . . 2.62 111.835 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.58 -44.3 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.972 1.309 . . . . 5.03 110.866 176.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -73.32 121.93 21.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.272 -1.011 . . . . 2.79 108.272 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -66.82 0.51 2.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.78 0.718 . . . . 10.04 112.603 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.53 -41.27 99.53 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 120.046 -1.659 . . . . 2.59 111.047 161.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.19 147.92 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.901 -1.148 . . . . 2.93 107.901 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.35 -32.44 4.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.514 1.125 . . . . 3.31 110.404 171.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -155.27 138.58 15.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.813 -1.18 . . . . 3.06 107.813 169.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.4 t -128.5 147.59 50.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.017 -1.475 . . . . 3.29 107.017 170.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 t -147.91 147.58 29.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.886 -0.783 . . . . 2.68 108.886 156.842 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.0 151.03 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.52 1.128 . . . . 3.51 111.13 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.8 133.36 31.99 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.027 0.531 . . . . 1.78 111.091 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.75 -37.16 86.66 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.613 1.165 . . . . 4.14 110.475 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.27 -39.99 1.52 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.164 1.786 . . . . 2.73 113.644 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.1 t -139.96 38.13 1.96 Allowed 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 121.907 0.86 . . . . 3.32 109.608 172.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.2 m120 35.99 46.78 0.38 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 127.955 2.502 . . . . 2.39 111.672 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -102.65 146.09 28.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.679 -0.489 . . . . 3.22 109.679 -168.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.19 119.86 37.81 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.227 -1.768 . . . . 1.61 106.227 161.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -86.78 120.25 27.87 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 103.947 -2.612 . . . . 4.5 103.947 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.5 128.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.379 -2.082 . . . . 2.28 105.379 174.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -111.46 96.92 6.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.109 -1.441 . . . . 2.98 107.109 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -106.68 148.1 28.78 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.708 0.803 . . . . 3.65 111.217 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.51 110.32 8.59 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.214 -1.402 . . . . 2.84 107.214 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -82.12 67.28 8.19 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.462 2.108 . . . . 1.59 111.909 -162.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.93 -83.72 0.14 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.086 0.954 . . . . 3.5 110.54 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.29 -47.46 84.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 122.098 -0.376 . . . . 3.39 110.825 -175.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 tp -86.2 154.16 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.241 -1.022 . . . . 2.66 108.241 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.03 168.5 23.67 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.657 -0.977 . . . . 0.78 110.657 173.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -54.9 -34.14 84.74 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.551 2.834 . . . . 0.93 110.658 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -42.26 -51.35 4.8 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.3 1.04 . . . . 10.57 111.045 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -71.79 -48.42 46.71 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.393 -0.965 . . . . 2.56 108.393 -168.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 mm -47.46 -51.25 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 124.404 1.082 . . . . 3.15 109.516 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.8 mt -61.75 -52.99 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.887 -0.597 . . . . 1.73 110.002 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -55.83 -42.35 75.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 122.052 0.93 . . . . 4.7 109.808 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 84.1 m -59.52 -58.58 7.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.218 -0.901 . . . . 1.67 108.999 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.95 -38.54 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 121.39 -0.819 . . . . 2.31 111.693 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -53.38 -51.54 62.21 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.309 -0.626 . . . . 2.84 109.309 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -57.14 -37.07 71.49 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.023 -0.423 . . . . 2.52 112.029 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.5 mt -67.98 -15.22 63.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.422 -0.799 . . . . 2.54 112.964 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.12 41.67 5.18 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.204 0.906 . . . . 1.0 112.196 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -138.54 164.72 28.72 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.94 -1.133 . . . . 3.27 107.94 170.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -100.52 99.66 10.44 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.24 1.416 . . . . 2.64 109.956 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.71 80.4 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 124.14 3.227 . . . . 1.02 110.269 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.8 m -81.95 94.63 7.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.837 0.855 . . . . 3.09 109.328 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.4 65.18 0.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.662 1.185 . . . . 3.53 112.794 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.8 m -60.08 -36.14 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 O-C-N 121.094 -1.004 . . . . 4.18 111.842 -176.173 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? 66.92 97.96 0.05 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.948 1.299 . . . . 5.97 108.39 -169.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 pp -61.66 140.48 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 121.762 -0.586 . . . . 7.44 111.056 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 . . . . . 0 C--O 1.249 1.066 0 N-CA-C 104.429 -2.434 . . . . 9.01 104.429 177.7 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 mtt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 111.793 0.294 . . . . 12.8 111.793 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.11 81.66 1.6 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 106.039 -2.825 . . . . 4.86 106.039 -171.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -132.1 106.34 7.94 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.079 -1.452 . . . . 4.35 107.079 -154.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.8 143.84 42.09 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 117.842 0.292 . . . . 2.74 112.965 -172.835 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -148.81 112.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 125.116 1.366 . . . . 4.3 108.948 176.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mp -137.82 158.33 44.58 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.095 -1.076 . . . . 4.07 108.095 160.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -137.86 132.91 33.23 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.221 1.008 . . . . 2.87 108.465 -169.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.79 139.46 32.77 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.438 1.095 . . . . 2.39 108.64 -169.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.8 t -85.57 100.42 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 107.737 -1.208 . . . . 2.04 107.737 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.5 m -84.15 76.5 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 125.608 1.563 . . . . 1.93 108.904 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -76.29 141.14 41.72 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.11 -1.036 . . . . 5.56 108.351 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.19 -43.05 1.35 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.823 -0.911 . . . . 0.7 110.823 -176.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -64.98 149.69 49.36 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.967 0.884 . . . . 2.35 110.217 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -139.97 -37.6 0.48 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.679 0.622 . . . . 3.07 112.679 -168.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 p -135.4 168.59 18.93 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.006 0.821 . . . . 1.21 110.965 -177.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.74 -38.45 15.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.939 1.296 . . . . 1.8 112.0 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 m -45.84 -44.31 14.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.128 1.371 . . . . 2.26 112.218 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.4 m -71.68 -51.89 20.67 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.503 0.721 . . . . 0.73 110.745 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.7 t -46.6 -60.87 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 125.205 1.402 . . . . 1.66 108.946 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -67.29 -23.27 65.64 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.879 -1.055 . . . . 1.1 111.523 -175.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -66.29 -53.26 38.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.059 -1.089 . . . . 4.94 108.059 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mt -58.73 -55.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 N-CA-C 108.669 -0.863 . . . . 2.02 108.669 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.27 -57.68 10.81 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.226 0.467 . . . . 2.35 110.965 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -56.12 -48.82 75.48 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.681 0.393 . . . . 2.45 110.564 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.3 t -60.07 -57.1 14.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.933 -0.395 . . . . 1.18 109.933 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.01 -40.16 66.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.078 0.551 . . . . 2.9 111.168 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.2 m -49.3 -26.62 3.18 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.655 0.983 . . . . 3.69 113.655 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -62.55 -27.33 69.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.14 1.336 . . . . 5.13 112.505 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -68.36 107.99 3.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.126 -0.694 . . . . 4.09 109.126 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -46.34 -36.93 6.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.756 0.823 . . . . 6.32 113.083 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.62 -11.87 84.89 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.197 -0.779 . . . . 1.74 113.772 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.95 120.1 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 119.134 1.467 . . . . 2.88 108.977 173.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -91.03 -31.45 16.29 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.856 -0.593 . . . . 3.76 110.97 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -157.74 130.87 7.6 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.727 1.149 . . . . 3.74 109.91 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.0 t -103.25 144.58 31.15 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 106.856 -1.535 . . . . 2.26 106.856 164.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -147.07 149.1 32.4 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 118.322 -1.351 . . . . 2.99 109.693 144.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.09 138.84 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.727 0.811 . . . . 2.95 111.029 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.31 131.32 53.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.492 1.117 . . . . 1.96 111.972 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.6 mt -68.78 -47.88 65.07 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 126.105 1.762 . . . . 3.74 111.783 -173.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.97 -46.71 52.7 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.018 0.527 . . . . 2.48 110.862 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 m -79.7 -39.87 30.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.327 0.651 . . . . 3.28 109.25 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 79.55 43.12 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 127.466 2.306 . . . . 3.81 107.688 -168.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.2 139.25 53.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.067 0.547 . . . . 3.54 111.356 -165.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.6 125.36 53.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.776 1.63 . . . . 1.58 109.106 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -96.28 114.87 26.6 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.355 -2.832 . . . . 2.86 103.355 166.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 mt -119.43 106.98 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.446 -1.687 . . . . 2.75 106.446 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -82.34 71.27 9.4 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.077 -1.453 . . . . 3.26 107.077 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -95.22 130.1 42.09 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.942 -0.572 . . . . 4.39 109.994 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -76.76 116.04 53.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 108.22 -1.03 . . . . 3.6 108.22 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -80.38 54.96 5.46 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.424 2.75 . . . . 2.19 112.262 -163.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -125.34 -71.92 0.68 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.783 1.233 . . . . 3.58 109.137 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -75.08 -34.6 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 O-C-N 122.282 -0.261 . . . . 2.82 111.188 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.36 137.47 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 126.116 1.767 . . . . 2.08 108.347 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.95 177.67 16.41 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.774 0.702 . . . . 0.72 111.617 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -57.67 -44.67 39.24 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.458 2.772 . . . . 0.87 110.679 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -58.81 -42.92 90.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.681 -0.408 . . . . 8.5 111.175 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.81 -53.48 57.85 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.5 0.667 . . . . 2.5 109.661 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mm -52.14 -50.91 34.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.158 0.983 . . . . 3.38 110.112 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.4 mt -57.61 -49.83 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.285 -0.416 . . . . 1.71 110.05 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 2.3 m-70 -62.31 -39.32 92.63 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.939 0.876 . . . . 5.03 110.365 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.0 m -56.47 -52.55 64.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.315 -0.624 . . . . 1.93 109.315 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.3 mt -72.31 -40.76 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 121.892 -0.505 . . . . 2.37 111.638 -171.682 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -59.77 -48.6 81.03 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 118.273 0.488 . . . . 4.21 110.296 173.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.3 m -56.6 -40.73 75.8 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.877 0.325 . . . . 2.97 111.877 175.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.69 -38.62 91.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.107 0.867 . . . . 2.18 111.566 173.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.93 36.33 0.89 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.837 0.732 . . . . 0.71 112.451 172.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -130.23 157.73 41.68 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.368 -1.345 . . . . 3.37 107.368 168.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -99.48 104.99 30.62 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 119.538 1.063 . . . . 2.66 110.297 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.34 90.19 1.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.934 3.089 . . . . 0.87 111.1 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.9 t -78.95 111.48 15.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.153 -0.684 . . . . 3.2 109.153 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.18 60.18 1.04 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.899 1.28 . . . . 4.09 111.52 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.83 -43.97 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 O-C-N 121.795 -0.566 . . . . 4.27 111.984 -173.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.84 48.86 14.82 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.183 0.993 . . . . 6.73 111.261 176.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.47 155.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.864 -0.522 . . . . 7.05 110.955 177.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 C--O 1.25 1.095 0 N-CA-C 103.811 -2.663 . . . . 9.3 103.811 166.904 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 105.014 -2.217 . . . . 7.14 105.014 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.14 -164.61 5.94 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 108.261 -1.936 . . . . 3.35 108.261 136.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 34.0 t0 72.35 166.06 0.3 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.86 1.664 . . . . 4.56 111.164 -178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.2 75.73 0.08 OUTLIER Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.408 -1.477 . . . . 2.97 109.408 -172.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.3 m -78.92 59.39 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.45 0.7 . . . . 3.29 112.196 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.68 129.4 34.95 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.345 -0.847 . . . . 3.58 110.049 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -92.94 105.46 17.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.741 1.217 . . . . 2.49 107.92 168.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.6 127.44 40.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.287 -1.375 . . . . 2.56 107.287 171.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.44 100.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.169 -1.789 . . . . 1.87 106.169 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.52 71.42 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.994 1.718 . . . . 1.71 107.995 -173.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -74.82 136.92 41.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.035 -1.468 . . . . 6.21 107.035 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.28 -42.53 1.91 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.573 -1.011 . . . . 0.81 110.573 -167.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.51 130.65 39.99 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.374 1.087 . . . . 2.57 108.919 -174.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 t -123.57 -41.52 2.26 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.968 1.099 . . . . 3.34 113.968 -155.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.2 p -138.65 175.46 9.54 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 119.498 1.044 . . . . 1.19 111.85 -168.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.97 -40.3 10.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.19 1.396 . . . . 1.97 112.222 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -55.0 -50.15 69.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.339 0.59 . . . . 2.79 110.006 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.48 -40.28 89.22 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.894 -1.129 . . . . 0.71 109.93 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.6 t -52.34 -61.58 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 108.733 -0.84 . . . . 1.84 108.733 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.284 1.0 OUTLIER -69.58 -30.39 68.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 119.999 -0.681 . . . . 1.15 112.137 -171.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -63.3 -47.1 83.72 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.804 0.729 . . . . 5.01 109.999 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.4 mt -56.81 -62.02 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.872 -0.788 . . . . 2.14 108.872 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -56.54 -52.87 63.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.225 -0.287 . . . . 2.45 110.225 -171.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.6 t -57.85 -55.25 37.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.658 0.266 . . . . 2.41 110.782 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 t -71.12 -32.76 69.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.563 -0.711 . . . . 1.76 112.478 -169.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -70.94 -51.98 22.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.574 0.624 . . . . 3.04 109.66 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.2 m -70.59 70.49 0.45 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.174 0.99 . . . . 3.03 110.978 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -175.38 -35.08 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.88 2.472 . . . . 4.4 110.091 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -65.34 136.55 56.68 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.31 0.959 . . . . 2.7 109.828 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -51.45 138.7 21.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.702 -0.481 . . . . 6.78 109.702 176.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.37 -31.46 8.28 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.338 -0.701 . . . . 1.3 112.74 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.21 136.86 23.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 107.488 -1.301 . . . . 3.73 107.488 167.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 pp -103.42 -35.76 8.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.475 0.71 . . . . 3.61 110.396 175.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -157.35 163.66 38.4 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.179 -1.045 . . . . 3.87 108.179 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.1 m -139.62 163.6 32.13 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.516 -1.29 . . . . 2.63 107.516 161.272 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.2 t -148.17 145.43 28.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.679 -0.808 . . . . 2.92 108.823 142.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.59 137.59 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.12 0.968 . . . . 3.19 111.277 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.41 134.33 55.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.158 0.983 . . . . 1.89 110.702 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.19 -41.57 99.21 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.154 1.382 . . . . 3.28 111.1 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.82 -37.87 20.54 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.032 1.333 . . . . 2.28 113.261 -166.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -130.16 24.56 5.23 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.231 1.012 . . . . 3.89 110.535 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 m120 35.68 48.28 0.45 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.329 2.252 . . . . 2.2 111.769 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -106.68 135.14 48.73 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.53 -0.545 . . . . 3.04 109.53 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -110.48 114.81 28.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.39 -1.337 . . . . 1.89 107.39 168.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -89.95 105.0 17.51 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.014 -2.588 . . . . 2.88 104.014 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.5 mp -97.55 137.03 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.317 -1.734 . . . . 2.58 106.317 175.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -118.05 126.77 52.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.394 -1.336 . . . . 3.68 107.394 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -153.56 154.61 34.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.095 0.558 . . . . 4.02 110.572 -165.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -69.69 144.96 94.43 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 108.939 -0.763 . . . . 4.98 108.939 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.35 24.79 0.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.259 2.639 . . . . 1.64 111.432 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -113.02 -58.66 2.13 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.847 0.859 . . . . 3.55 109.969 -164.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 pt -95.42 -50.15 11.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.528 0.731 . . . . 3.17 110.295 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 tp -91.27 151.68 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.151 -1.055 . . . . 2.52 108.151 -173.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.56 169.07 23.62 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.643 -0.983 . . . . 0.7 110.643 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -50.09 -42.48 45.95 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.585 2.856 . . . . 0.88 110.73 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -38.0 -51.06 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.373 1.469 . . . . 10.64 111.925 173.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -71.67 -49.78 36.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.587 -0.894 . . . . 2.4 108.587 -166.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.58 -47.31 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 114.884 -1.053 . . . . 2.5 108.374 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.0 mt -58.17 -53.24 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 109.746 -0.465 . . . . 1.91 109.746 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -56.72 -41.34 77.27 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 121.64 0.733 . . . . 4.69 109.442 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.4 m -61.42 -54.35 44.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.823 -0.626 . . . . 1.79 110.583 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 mm -63.02 -41.6 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 121.367 -0.833 . . . . 2.89 110.501 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.56 -46.47 77.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.684 0.393 . . . . 3.31 109.992 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -61.43 -39.27 90.18 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.287 -0.387 . . . . 2.77 111.586 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.47 -35.67 81.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.835 0.743 . . . . 2.01 110.848 173.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.78 40.54 0.99 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.051 0.834 . . . . 0.83 112.409 170.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -131.94 162.02 31.69 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 107.131 -1.433 . . . . 3.11 107.131 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -99.48 109.1 53.84 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 119.001 0.819 . . . . 2.79 109.363 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.05 88.34 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.753 2.969 . . . . 1.0 110.54 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.15 96.78 5.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.866 -1.161 . . . . 2.85 107.866 -178.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pp -59.98 107.34 0.61 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.195 0.907 . . . . 3.33 110.481 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.2 t -114.33 -68.08 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 109.231 -0.655 . . . . 3.52 109.231 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.08 61.08 2.89 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.251 -1.018 . . . . 5.2 108.251 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.7 mp 63.06 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 126.013 1.725 . . . . 7.4 110.781 -171.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 C--O 1.253 1.262 0 N-CA-C 102.791 -3.04 . . . . 10.12 102.791 168.877 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mmt . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 119.083 -0.484 . . . . 6.79 112.279 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.15 63.63 2.91 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.927 -0.869 . . . . 5.25 110.927 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -160.35 170.05 21.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.011 1.724 . . . . 3.74 106.737 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.05 -175.27 22.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.101 1.334 . . . . 3.46 111.252 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -155.76 148.03 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.662 -0.866 . . . . 4.48 108.662 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.86 156.68 39.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.849 -1.167 . . . . 4.7 107.849 165.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -126.79 139.15 53.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.335 1.054 . . . . 2.93 109.76 -175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.41 143.43 31.62 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.369 1.068 . . . . 2.42 108.189 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.07 123.08 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.962 -1.866 . . . . 2.13 105.962 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 m -106.59 74.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 106.656 -1.609 . . . . 1.76 106.656 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.44 HH12 ' CD ' ' A' ' 68' ' ' GLU . 10.4 ptt85 -76.1 129.59 37.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.305 -1.368 . . . . 5.77 107.305 -170.538 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.85 -48.54 0.95 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.427 -1.069 . . . . 0.79 110.427 -165.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -73.57 144.78 45.91 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.847 1.323 . . . . 2.45 111.287 -174.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -148.16 -1.6 0.55 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.775 1.398 . . . . 2.86 114.775 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.62 168.51 25.88 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.554 1.525 . . . . 1.42 110.165 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.91 -42.71 13.09 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.517 1.527 . . . . 2.0 112.259 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.3 m -43.52 -51.08 6.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.681 1.193 . . . . 2.02 111.401 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -71.06 -41.6 70.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 122.993 0.517 . . . . 0.79 111.83 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.3 t -50.79 -59.0 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.232 -1.025 . . . . 2.07 108.232 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -68.36 -30.34 69.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.139 -0.937 . . . . 1.22 111.155 -176.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -53.61 -43.54 68.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 119.271 0.941 . . . . 5.57 110.313 170.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.1 mt -71.82 -80.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 118.751 0.705 . . . . 1.94 109.606 169.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -62.4 -43.69 98.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.709 -0.619 . . . . 2.62 112.542 -153.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -63.08 -28.74 70.29 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.543 0.571 . . . . 3.45 112.543 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 t -71.79 -53.19 14.13 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.376 0.989 . . . . 1.77 110.399 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.04 -46.39 65.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.152 0.981 . . . . 2.87 111.278 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.3 p -67.13 64.01 0.06 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.142 1.377 . . . . 2.22 112.114 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -160.05 -50.02 0.05 Allowed 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 128.406 2.682 . . . . 7.38 108.929 -175.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -68.02 138.54 55.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.151 -0.619 . . . . 3.21 109.789 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -56.66 149.41 17.82 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.035 0.445 . . . . 6.92 109.813 175.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.07 -24.38 16.2 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-O 118.339 -1.256 . . . . 1.55 112.764 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.95 120.46 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 120.128 1.964 . . . . 3.0 108.221 171.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.8 mt -81.78 -52.99 6.57 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.193 -1.04 . . . . 3.17 108.193 170.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -157.84 147.61 20.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.586 -0.894 . . . . 4.75 108.586 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.3 t -117.97 144.67 45.31 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 105.751 -1.944 . . . . 2.5 105.751 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.4 t -147.21 151.03 36.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 118.159 -1.416 . . . . 3.29 110.441 153.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 m -131.8 133.19 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 124.532 1.145 . . . . 2.94 110.509 -171.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.47 132.34 55.77 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.695 0.628 . . . . 1.84 112.695 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -65.56 -45.05 84.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.232 1.413 . . . . 4.55 111.606 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.04 -30.08 23.99 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.712 0.805 . . . . 2.4 112.932 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -114.36 2.13 14.63 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.495 1.518 . . . . 3.27 111.705 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.3 m120 41.16 43.59 1.97 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.465 2.306 . . . . 2.13 110.881 -172.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.57 140.3 49.42 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 122.691 0.396 . . . . 2.97 111.34 -166.334 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -109.41 139.52 44.27 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.179 1.792 . . . . 1.78 108.929 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -104.38 137.43 42.27 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.726 -1.953 . . . . 4.63 105.726 156.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.2 mp -125.8 112.88 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.445 -1.687 . . . . 2.39 106.445 174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -83.7 68.27 9.8 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.373 -1.343 . . . . 3.76 107.373 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -90.83 140.03 30.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.226 -0.443 . . . . 4.19 110.705 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.2 106.5 0.73 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.19 1.396 . . . . 2.54 108.591 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.5 61.31 7.99 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.299 2.666 . . . . 2.36 110.421 -166.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -163.98 -60.47 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.01 0.924 . . . . 4.41 109.805 -169.227 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 pt -82.94 -26.88 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 122.768 0.427 . . . . 3.79 111.991 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 tp -131.12 140.26 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.261 -1.755 . . . . 2.64 106.261 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.32 176.34 16.08 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 121.781 0.656 . . . . 0.96 112.156 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.04 -41.59 51.2 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.168 2.579 . . . . 1.25 110.52 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.59 -46.05 90.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.309 0.244 . . . . 8.28 110.602 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.15 -51.31 69.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.394 -0.595 . . . . 3.26 109.394 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 mm -55.14 -48.92 75.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 122.779 0.432 . . . . 3.0 111.533 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.1 mt -53.14 -57.02 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.037 -0.727 . . . . 2.05 109.037 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -65.89 -33.92 76.95 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.806 -0.559 . . . . 4.59 111.153 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -57.56 -58.64 7.4 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.34 -0.615 . . . . 2.31 109.34 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.7 mt -65.66 -35.43 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.25 -0.906 . . . . 2.21 111.293 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.13 -51.63 61.32 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.437 -0.579 . . . . 3.4 109.437 168.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 m -57.65 -38.22 74.69 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.025 -0.422 . . . . 2.96 111.922 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.4 mt -67.94 -10.63 54.94 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.918 0.71 . . . . 2.76 112.918 174.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.98 60.09 3.0 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.673 -0.971 . . . . 1.62 110.673 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -141.5 171.48 14.0 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 106.826 -1.546 . . . . 3.42 106.826 155.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.44 ' CD ' HH12 ' A' ' 11' ' ' ARG . 32.9 mt-10 -101.46 100.96 15.23 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 108.837 -0.801 . . . . 2.51 108.837 172.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.21 145.11 59.25 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 N-CA-C 108.238 -1.485 . . . . 1.94 108.238 166.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -150.8 110.97 4.14 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.464 -1.68 . . . . 2.43 106.464 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.02 142.41 53.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.28 0.562 . . . . 4.65 109.502 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.89 -33.89 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.836 1.254 . . . . 3.28 111.133 172.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -74.58 67.21 1.5 Allowed 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.309 -0.869 . . . . 6.99 110.543 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 73.67 128.88 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.943 2.097 . . . . 10.21 109.689 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 C--O 1.252 1.213 0 C-N-CA 126.824 2.05 . . . . 12.11 113.789 -171.38 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ptm . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 106.526 -1.657 . . . . 9.8 106.526 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.04 -177.9 26.56 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 108.313 -1.915 . . . . 4.11 108.313 155.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.453 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 30.3 t70 -179.83 -162.34 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.021 2.929 . . . . 3.77 104.031 171.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.453 ' H ' ' CG ' ' A' ' 3' ' ' ASP . . . 153.34 159.13 8.92 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 107.671 -2.172 . . . . 3.03 107.671 -173.225 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.2 m -134.36 55.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.239 1.016 . . . . 4.48 108.444 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -79.14 108.99 13.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.606 -1.257 . . . . 3.89 107.606 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -93.27 83.23 4.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 113.601 -1.636 . . . . 3.0 107.102 166.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.76 129.67 35.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.569 -1.641 . . . . 2.43 106.569 174.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.89 119.97 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.738 -1.949 . . . . 2.06 105.738 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.78 84.39 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 128.124 2.57 . . . . 2.05 108.331 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.79 140.16 39.41 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 108.872 -0.788 . . . . 5.6 108.872 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.84 -19.78 8.3 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.881 0.753 . . . . 0.72 112.084 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.5 mtp -62.15 150.7 37.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.572 1.186 . . . . 2.71 109.691 175.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -139.33 -39.21 0.48 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.131 0.973 . . . . 3.42 111.771 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.1 p -145.48 173.5 11.97 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.212 0.914 . . . . 1.63 111.405 -169.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.58 -39.71 3.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.048 1.739 . . . . 2.58 112.563 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.0 m -49.86 -50.87 44.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.204 0.602 . . . . 2.12 111.017 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.1 m -65.1 -41.11 95.28 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.196 0.598 . . . . 0.74 110.172 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 t -55.27 -61.76 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.458 -0.942 . . . . 2.06 108.458 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.2 -28.93 67.69 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 118.866 -0.588 . . . . 1.71 111.533 -173.755 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -56.81 -56.61 19.34 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.462 -0.94 . . . . 5.14 108.462 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.55 -59.63 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 109.158 -0.682 . . . . 2.23 109.158 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.67 -45.3 94.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.766 -0.635 . . . . 2.59 111.927 -169.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m -61.14 -47.45 86.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.793 0.724 . . . . 2.44 111.066 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.3 t -58.82 -42.57 89.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.944 -0.472 . . . . 2.17 110.094 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.35 -48.29 61.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.425 0.69 . . . . 2.95 111.842 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.3 p -56.49 -32.11 64.71 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.868 1.213 . . . . 2.47 111.62 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -54.51 -36.26 64.04 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.824 -0.548 . . . . 5.74 112.057 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -69.84 96.67 1.02 Allowed 'General case' 0 C--O 1.225 -0.234 0 O-C-N 121.325 -0.859 . . . . 4.05 109.1 171.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -41.42 -40.02 1.64 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.914 1.285 . . . . 8.26 114.099 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.0 -2.19 70.8 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.072 -0.849 . . . . 1.49 114.211 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.52 121.8 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.865 -1.532 . . . . 3.21 106.865 167.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.7 mt -79.9 -46.74 16.24 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.129 0.971 . . . . 3.44 108.882 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -155.96 129.03 8.05 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.387 0.539 . . . . 4.32 110.435 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.6 p -104.27 154.31 19.95 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.535 0.734 . . . . 2.89 109.664 169.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -151.5 110.33 3.85 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.603 -1.258 . . . . 2.59 107.603 155.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.64 157.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 118.134 0.425 . . . . 2.9 110.652 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.92 134.5 14.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.602 -0.687 . . . . 1.94 110.764 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.09 -32.15 71.38 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.941 0.896 . . . . 2.53 110.289 175.468 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.97 -37.8 2.01 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.005 1.722 . . . . 2.33 113.565 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.9 t -140.83 37.87 1.8 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 121.507 0.67 . . . . 3.05 109.913 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 m120 35.45 58.84 0.82 Allowed 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.002 1.721 . . . . 3.15 110.879 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -121.87 142.83 49.85 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 122.819 0.448 . . . . 3.34 110.605 -171.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.84 105.27 10.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.8 1.24 . . . . 1.85 108.843 167.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -79.8 108.68 13.55 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 104.356 -2.461 . . . . 4.17 104.356 169.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.8 mt -119.99 111.4 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 106.749 -1.574 . . . . 2.11 106.749 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 3' ' ' ASP . 3.7 mtpm? -103.12 109.7 21.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.051 -1.833 . . . . 3.89 106.051 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -137.29 162.74 32.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.881 1.672 . . . . 3.51 109.999 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -83.25 112.76 41.45 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 107.162 -1.422 . . . . 3.24 107.162 171.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.64 68.38 8.31 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.975 2.45 . . . . 2.05 110.852 -170.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.68 -92.66 0.17 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.672 1.189 . . . . 3.8 109.363 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.97 -30.3 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 N-CA-C 112.873 0.694 . . . . 2.98 112.873 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.72 125.24 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.52 -1.659 . . . . 3.18 106.52 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.98 -179.41 19.04 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.789 1.185 . . . . 0.85 111.424 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -59.52 -39.82 71.93 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.643 2.228 . . . . 0.82 110.464 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -56.51 -49.61 74.24 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.754 0.421 . . . . 6.3 111.683 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -48.49 81.46 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.413 -0.588 . . . . 2.26 109.413 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.5 mt -51.28 -56.15 5.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 108.776 -0.824 . . . . 2.51 108.776 173.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.6 mt -54.52 -52.68 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 110.005 -0.368 . . . . 1.69 110.005 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -56.47 -42.73 78.73 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 121.53 0.681 . . . . 4.01 109.221 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.7 m -63.36 -50.34 70.31 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.076 -0.511 . . . . 2.09 110.782 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.8 mm -61.94 -42.74 95.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.445 -0.784 . . . . 2.86 110.41 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -56.23 -44.6 79.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.692 0.397 . . . . 3.23 110.099 173.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 m -61.24 -40.29 93.5 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.083 -0.386 . . . . 2.43 111.837 176.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.98 -41.26 96.11 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.72 0.691 . . . . 2.26 110.585 172.615 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.81 44.98 0.73 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.367 0.984 . . . . 0.81 111.587 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -131.74 162.78 29.66 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.552 -1.277 . . . . 3.41 107.552 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -95.03 101.51 7.38 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 117.61 -1.186 . . . . 2.66 109.861 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -77.74 137.73 16.33 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.103 1.869 . . . . 1.33 108.823 172.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 t -154.79 109.29 2.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.706 -0.85 . . . . 2.98 108.706 -171.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.42 66.02 1.78 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.784 0.834 . . . . 3.55 110.375 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.44 -38.91 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.879 0.872 . . . . 3.52 109.766 177.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.44 135.84 49.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.078 -1.453 . . . . 6.36 107.078 163.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.35 118.64 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 105.113 -2.18 . . . . 10.68 105.113 172.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 C--O 1.253 1.265 0 N-CA-C 108.765 -0.828 . . . . 12.14 108.765 -151.318 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 107.859 -1.164 . . . . 9.26 107.859 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.51 156.63 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.543 -1.023 . . . . 3.57 110.543 -169.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.78 114.12 2.15 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.709 0.804 . . . . 3.44 111.251 -172.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.55 81.47 0.3 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 108.029 -2.028 . . . . 2.69 108.029 163.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.33 127.9 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.114 -0.699 . . . . 3.72 109.114 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 135.66 29.65 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.926 0.49 . . . . 3.42 109.833 169.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -90.85 93.01 9.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.442 1.497 . . . . 3.13 107.046 165.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.2 121.85 34.98 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 107.997 -1.112 . . . . 2.55 107.997 173.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.63 111.09 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.337 -1.357 . . . . 2.57 107.337 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -94.17 92.16 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.252 1.421 . . . . 1.71 108.326 -168.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -77.71 137.29 38.41 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.433 -0.951 . . . . 6.73 108.433 -174.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.58 -53.15 0.77 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.499 -1.041 . . . . 1.14 110.499 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -61.58 143.7 55.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 122.938 0.495 . . . . 2.66 111.756 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -157.28 14.8 0.25 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.891 1.071 . . . . 2.88 113.891 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 p -162.85 161.04 25.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.761 1.164 . . . . 1.74 109.772 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -39.64 5.56 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.701 1.6 . . . . 2.3 111.449 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -36.16 -47.63 0.57 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.512 2.325 . . . . 3.84 113.13 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.0 m -73.85 -52.46 12.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.151 0.981 . . . . 1.0 111.685 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.5 t -45.99 -58.13 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 126.179 1.791 . . . . 2.0 109.679 -166.047 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -61.47 -32.51 72.51 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.21 -1.359 . . . . 2.35 110.794 -174.277 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -71.23 -47.3 58.13 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.852 -0.796 . . . . 5.43 108.852 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 99.1 mt -54.05 -58.88 2.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.053 -0.721 . . . . 2.26 109.053 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -61.97 -47.77 83.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.531 -0.271 . . . . 2.13 111.196 -174.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.6 m -55.49 -58.22 8.65 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.201 0.455 . . . . 2.45 110.517 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 t -49.31 -49.89 41.83 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.951 1.3 . . . . 1.3 110.698 -177.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.94 -51.23 57.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 119.161 -0.447 . . . . 3.89 111.721 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.4 p -55.4 -28.35 53.54 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.159 0.436 . . . . 2.28 111.635 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -58.17 -40.85 82.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.424 0.557 . . . . 5.83 111.909 174.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -79.28 120.0 23.14 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.899 0.857 . . . . 3.24 110.142 -169.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -57.84 157.68 7.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.111 -0.7 . . . . 8.74 109.111 170.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.3 -15.05 25.37 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 117.896 -1.502 . . . . 1.73 112.785 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.51 125.05 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 119.777 1.789 . . . . 2.83 106.536 154.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.2 mt -80.44 -43.46 20.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.675 -1.231 . . . . 3.78 107.675 169.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -155.63 155.95 34.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.487 -0.561 . . . . 3.91 109.487 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 p -131.32 158.18 41.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 106.955 -1.498 . . . . 2.44 106.955 156.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -150.79 145.2 25.57 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.028 -1.101 . . . . 2.93 108.028 139.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 p -112.57 148.29 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.168 0.987 . . . . 3.01 110.653 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.54 136.11 35.73 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.14 0.576 . . . . 1.75 110.943 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.2 mt -65.82 -36.12 82.6 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.043 1.337 . . . . 3.61 110.091 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.3 -39.06 1.3 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.188 1.795 . . . . 2.5 113.88 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 t -140.96 35.68 1.75 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 122.154 0.978 . . . . 2.99 109.644 172.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 m120 36.06 57.36 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.984 2.514 . . . . 2.09 111.917 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.64 153.73 51.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 121.926 -0.484 . . . . 4.54 111.994 -170.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.82 117.05 28.67 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.058 1.743 . . . . 1.76 108.657 174.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -85.08 101.45 12.44 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 103.46 -2.792 . . . . 4.06 103.46 169.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.22 143.91 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.026 -1.472 . . . . 2.44 107.026 170.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -126.8 112.5 15.45 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 106.092 -1.818 . . . . 3.55 106.092 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -127.48 173.49 9.8 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.369 0.668 . . . . 3.53 111.254 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -96.4 101.33 8.57 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.411 1.085 . . . . 2.43 109.275 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.54 58.08 6.6 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.663 2.909 . . . . 1.71 113.029 -169.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.13 -63.75 0.4 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.027 1.731 . . . . 4.12 107.987 169.054 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.0 pt -65.28 -26.83 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.977 0.911 . . . . 3.95 112.432 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 tt -143.96 150.67 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.07 -1.085 . . . . 2.48 108.07 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -114.43 -176.26 18.91 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.187 -0.765 . . . . 0.92 111.187 -174.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.16 -38.72 20.5 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.337 2.024 . . . . 1.01 109.795 172.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -47.52 -49.59 25.71 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.755 1.222 . . . . 6.84 111.382 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.89 -54.09 50.27 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.227 0.611 . . . . 2.54 110.124 -174.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.6 mt -53.14 -52.28 31.55 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 N-CA-C 108.555 -0.905 . . . . 2.41 108.555 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mt -55.54 -53.28 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.89 -0.595 . . . . 1.94 110.277 -174.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -67.84 -31.87 72.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.626 0.648 . . . . 8.05 110.362 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.7 m -59.29 -46.4 88.65 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.532 -0.544 . . . . 1.64 109.532 172.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.57 -36.98 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.27 -0.894 . . . . 2.22 111.315 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -55.22 -43.96 74.97 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.507 -0.746 . . . . 2.86 109.882 169.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.7 m -60.93 -38.81 87.08 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.295 -0.253 . . . . 2.31 111.576 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.24 -40.27 95.67 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.225 0.466 . . . . 2.33 110.831 171.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.8 45.02 0.85 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 124.526 1.06 . . . . 1.01 111.752 173.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -131.89 163.06 29.15 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.748 -0.834 . . . . 3.3 108.748 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -99.12 100.7 10.62 Favored Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 124.576 1.15 . . . . 4.5 110.539 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.71 81.77 2.59 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.815 3.01 . . . . 1.39 111.107 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.2 m -78.66 109.91 13.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.402 -0.811 . . . . 2.03 109.564 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.56 58.47 0.59 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.488 0.715 . . . . 2.95 111.76 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 p -106.56 51.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.605 1.562 . . . . 4.08 108.67 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.447 ' HZ2' ' C ' ' A' ' 75' ' ' GLU . 0.0 OUTLIER -46.29 -56.27 6.03 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.528 1.531 . . . . 6.71 112.121 -176.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 18.6 tt -165.51 127.33 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 130.157 3.383 . . . . 8.51 103.24 160.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.447 ' C ' ' HZ2' ' A' ' 73' ' ' LYS . 36.1 mt-10 . . . . . 0 C--O 1.251 1.145 0 C-N-CA 123.208 0.603 . . . . 9.6 109.489 -161.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.464 ' H3 ' ' CG ' ' A' ' 49' ' ' ASP . 23.3 ttt . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 112.407 0.521 . . . . 7.14 112.407 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.52 156.47 16.72 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.835 -0.541 . . . . 3.35 112.371 162.176 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . 0.429 ' OD2' ' NZ ' ' A' ' 47' ' ' LYS . 11.1 p-10 -71.26 101.58 2.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.523 1.129 . . . . 3.79 111.088 -176.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.04 171.53 12.18 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.299 -1.12 . . . . 1.96 110.299 166.535 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.4 t -140.89 97.87 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.65 -1.241 . . . . 3.84 107.65 178.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.95 121.38 40.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.519 0.676 . . . . 3.7 109.566 178.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -91.1 90.75 7.96 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.784 2.034 . . . . 4.22 107.348 177.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -82.35 106.77 14.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.15 -1.796 . . . . 3.67 106.15 172.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 t -78.49 101.37 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.438 -1.69 . . . . 2.5 106.438 -176.104 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 m -89.44 88.3 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.997 1.319 . . . . 2.08 109.912 -164.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -77.8 96.57 4.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.652 -1.61 . . . . 9.61 106.652 -176.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.69 -38.83 0.35 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.878 -0.957 . . . . 0.98 112.527 177.902 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -70.56 162.26 29.19 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.126 1.463 . . . . 2.21 111.218 -173.498 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -145.09 -37.41 0.28 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.435 0.902 . . . . 3.21 113.435 -170.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 p -141.09 173.83 11.11 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 119.789 1.177 . . . . 1.69 111.705 -172.773 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.78 -41.8 15.96 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.025 1.33 . . . . 2.09 111.799 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.7 m -57.25 -38.46 73.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.825 0.45 . . . . 2.42 111.665 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.0 m -71.07 -52.63 18.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.264 0.484 . . . . 0.76 110.176 173.208 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.8 t -44.2 -58.44 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 124.753 1.221 . . . . 1.89 109.212 -176.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.6 -22.24 63.52 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.515 -0.766 . . . . 1.72 112.368 -174.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -68.48 -50.87 49.16 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 107.413 -1.328 . . . . 6.14 107.413 173.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mt -56.54 -57.01 10.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 109.104 -0.702 . . . . 1.81 109.104 177.266 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.98 -54.66 44.14 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.423 0.556 . . . . 2.18 111.488 -174.572 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.7 t -62.33 -39.1 91.96 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.502 0.321 . . . . 3.12 111.007 -178.088 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -63.5 -53.42 52.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.141 -0.688 . . . . 2.29 109.141 177.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -47.6 -46.21 28.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.662 1.185 . . . . 2.91 111.528 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.43 -15.16 2.4 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.491 1.293 . . . . 2.86 114.491 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -56.59 -37.02 70.05 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.904 1.229 . . . . 5.9 111.288 170.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -76.72 100.78 5.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.596 -0.891 . . . . 4.33 108.596 -176.383 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -50.92 -30.21 14.16 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.204 0.816 . . . . 7.64 113.204 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.81 -20.64 70.59 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.95 -0.916 . . . . 1.71 113.677 177.424 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.09 124.87 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 118.682 1.241 . . . . 2.88 108.393 178.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.5 mt -94.46 -36.93 11.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.591 1.556 . . . . 3.32 109.507 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -155.7 125.59 6.52 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.8 0.727 . . . . 3.13 111.048 178.533 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.84 144.79 34.55 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.528 1.131 . . . . 3.16 108.732 167.136 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 m -151.48 143.06 23.61 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.901 -1.518 . . . . 2.68 106.901 152.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 m -127.18 136.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.29 0.496 . . . . 2.82 110.223 178.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.82 131.59 54.13 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.835 0.854 . . . . 1.73 111.691 -174.158 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.63 -43.47 80.3 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.296 1.838 . . . . 4.06 111.414 -175.761 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.09 -46.06 33.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.166 0.587 . . . . 2.05 111.453 -179.236 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -82.92 -25.16 32.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.671 1.189 . . . . 4.1 111.839 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 41.69 66.9 0.62 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.523 1.529 . . . . 3.37 109.609 -151.377 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.41 141.3 33.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.504 -1.226 . . . . 2.94 110.453 -177.885 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.28 124.08 49.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.039 2.136 . . . . 1.96 108.31 174.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -98.16 106.99 19.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.249 -2.871 . . . . 2.8 103.249 174.711 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.3 mp -102.25 127.83 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.546 -1.65 . . . . 2.42 106.546 175.955 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.429 ' NZ ' ' OD2' ' A' ' 3' ' ' ASP . 16.3 mtpt -112.03 114.43 27.3 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.631 -1.248 . . . . 3.01 107.631 167.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -130.9 163.47 27.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.566 1.546 . . . . 3.28 111.47 176.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.464 ' CG ' ' H3 ' ' A' ' 1' ' ' MET . 14.5 t70 -87.98 129.32 50.63 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.239 1.016 . . . . 3.93 110.548 175.239 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -59.2 -58.76 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.781 2.321 . . . . 2.36 115.294 -165.304 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -78.07 37.27 0.25 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.168 1.349 . . . . 4.15 113.911 -165.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.63 -52.63 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.241 1.416 . . . . 4.73 109.111 170.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.19 144.83 33.84 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 122.624 0.37 . . . . 2.39 110.958 -171.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.47 -176.76 22.56 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.326 -1.11 . . . . 0.89 110.326 176.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.0 -39.74 18.23 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.189 1.926 . . . . 1.07 110.11 174.56 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -53.38 -49.43 67.21 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.004 0.922 . . . . 7.77 111.989 -176.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.12 -52.0 38.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 122.491 1.139 . . . . 2.83 109.464 -178.706 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.2 mt -65.55 -52.29 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 114.554 -1.203 . . . . 2.41 109.059 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.2 mt -48.08 -54.25 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.765 0.826 . . . . 1.93 110.222 -177.07 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -65.86 -35.6 81.11 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 119.809 -0.756 . . . . 7.21 110.501 -176.014 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.8 m -63.13 -46.91 85.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 122.1 -0.375 . . . . 1.92 110.582 178.267 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.6 -40.79 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.49 -0.756 . . . . 2.18 109.882 178.821 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -53.31 -38.44 63.17 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.539 -0.725 . . . . 5.24 111.207 170.264 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -64.44 -22.54 66.99 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.935 0.717 . . . . 2.42 112.935 176.038 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.6 mt -78.74 -43.61 25.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.982 0.81 . . . . 2.1 109.243 168.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.21 49.11 0.37 Allowed Glycine 0 C--N 1.338 0.659 0 C-N-CA 124.467 1.032 . . . . 1.04 112.173 169.714 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.28 134.73 26.19 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 117.419 -1.277 . . . . 3.31 108.014 175.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -78.86 112.02 24.15 Favored Pre-proline 0 C--N 1.34 0.156 0 CA-C-N 119.49 1.041 . . . . 5.48 108.893 -170.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -89.55 78.98 0.87 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.38 2.72 . . . . 1.39 110.066 -171.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.39 115.53 20.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.547 -0.721 . . . . 2.14 109.633 -170.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.6 mt -53.61 111.52 0.74 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.996 0.816 . . . . 4.39 110.724 174.95 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.05 -37.62 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 118.896 0.771 . . . . 5.58 111.89 176.945 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -140.02 159.36 42.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.033 1.333 . . . . 6.21 107.81 -176.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.11 123.24 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.369 -2.456 . . . . 11.6 104.369 167.369 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.4 mp0 . . . . . 0 CA--C 1.559 1.305 1 CA-C-O 80.719 -18.753 . . . . 11.84 105.882 -171.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 107.476 -1.305 . . . . 8.0 107.476 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.24 135.88 29.97 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 105.264 -3.134 . . . . 4.56 105.264 131.593 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.7 p30 175.46 172.74 0.29 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 127.978 2.511 . . . . 4.48 106.508 176.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.89 155.74 9.97 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 106.663 -2.575 . . . . 1.96 106.663 -173.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -143.25 143.98 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.836 -1.172 . . . . 3.84 107.836 -175.152 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -149.25 163.5 37.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.256 -0.646 . . . . 4.36 109.256 162.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -120.03 145.41 46.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.217 -1.031 . . . . 2.35 108.217 168.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.07 130.13 28.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.759 -1.2 . . . . 2.48 107.759 177.47 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.3 t -79.67 104.72 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.901 -1.889 . . . . 2.08 105.901 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.05 89.22 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.428 1.491 . . . . 1.78 108.216 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -75.57 131.4 39.99 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 107.763 -1.199 . . . . 6.09 107.763 -170.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.05 -43.13 1.39 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.088 0.852 . . . . 0.71 111.404 177.054 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.46 132.58 40.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.454 1.127 . . . . 2.44 108.633 -175.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 t -154.84 25.08 0.44 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.97 0.73 . . . . 2.91 112.97 -169.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.33 156.87 19.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.523 0.602 . . . . 1.39 109.629 178.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.53 -39.43 16.29 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.505 1.522 . . . . 2.08 111.987 -176.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.6 t -47.26 -54.23 11.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.683 0.754 . . . . 2.57 110.143 172.772 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.263 57.7 m -73.16 -33.56 65.55 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.355 -1.465 . . . . 1.19 112.151 -176.668 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.8 t -50.37 -61.33 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 108.666 -0.864 . . . . 1.71 108.666 174.084 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -69.84 -29.56 66.84 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.175 -0.921 . . . . 1.27 111.787 -174.098 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -62.0 -50.72 70.92 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.28 0.945 . . . . 5.15 109.655 173.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 mt -58.29 -57.76 9.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 119.218 0.917 . . . . 1.74 109.047 178.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.05 -54.14 46.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.157 0.435 . . . . 2.47 110.895 -173.515 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -56.98 -52.99 63.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.865 0.466 . . . . 2.19 110.437 179.197 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.6 t -57.34 -54.97 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.638 0.375 . . . . 1.4 110.756 -177.458 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.51 -32.98 71.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.534 -0.729 . . . . 3.16 111.365 -174.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.9 m -53.66 -19.97 4.71 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 112.938 0.718 . . . . 3.95 112.938 173.198 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -30.28 59.73 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.531 -1.355 . . . . 6.67 112.113 171.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -68.86 101.47 1.36 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.577 -0.897 . . . . 4.01 108.577 169.319 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -49.45 -33.25 13.68 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 111.885 0.328 . . . . 6.09 111.885 171.209 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.72 -11.23 77.5 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.815 -0.992 . . . . 1.63 113.796 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.16 129.67 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 119.699 1.75 . . . . 3.11 107.431 168.919 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 pp -99.74 -26.05 14.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.862 0.465 . . . . 3.49 110.745 175.662 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -156.11 149.94 25.1 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.88 0.764 . . . . 4.09 111.224 172.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.1 m -130.33 145.4 51.78 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 126.178 1.791 . . . . 2.9 107.553 174.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 m -153.34 135.22 14.62 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 107.808 -1.182 . . . . 2.41 107.808 152.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.86 151.07 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.987 0.812 . . . . 3.1 110.479 173.586 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.61 132.57 37.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.533 0.682 . . . . 2.0 110.779 176.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.9 -29.44 66.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.035 -0.984 . . . . 2.59 110.732 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.72 -34.97 13.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.49 1.116 . . . . 1.93 112.927 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 p -122.03 13.49 10.55 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.889 0.876 . . . . 3.27 111.299 175.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.7 m120 40.15 52.17 2.73 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.243 1.817 . . . . 2.13 110.659 -171.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.09 140.37 45.45 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 122.043 -0.411 . . . . 3.05 111.141 -164.561 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.85 128.22 56.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.026 1.73 . . . . 1.71 109.156 177.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -98.84 121.78 41.23 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 127.847 2.459 . . . . 3.99 105.701 172.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mt -123.72 134.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.686 -0.857 . . . . 3.01 108.686 177.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -122.95 130.82 53.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.14 -1.8 . . . . 3.32 106.14 178.809 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -162.05 171.31 17.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.214 0.45 . . . . 3.74 112.214 -158.731 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.12 100.56 25.48 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.51 1.524 . . . . 2.8 109.437 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.71 -12.79 35.56 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.323 2.682 . . . . 2.37 113.394 -168.549 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -52.97 -39.71 63.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.662 0.664 . . . . 4.63 111.635 176.765 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -120.07 -54.52 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.113 0.565 . . . . 2.85 112.133 -176.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.14 116.54 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.851 -1.166 . . . . 3.25 107.851 -172.92 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.71 161.55 16.75 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.523 -1.031 . . . . 0.94 110.523 -177.255 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -51.52 -38.1 63.82 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.995 2.463 . . . . 0.89 110.857 176.36 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -42.87 -52.73 4.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.422 1.089 . . . . 10.73 111.647 172.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.18 -40.52 67.86 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.083 -1.01 . . . . 2.5 109.76 -167.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 78.5 mt -52.68 -57.47 4.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 N-CA-C 107.611 -1.255 . . . . 2.7 107.611 170.02 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mt -55.54 -48.91 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 116.039 -0.528 . . . . 1.93 110.136 -174.814 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -55.54 -44.98 77.23 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 122.172 0.986 . . . . 4.92 108.953 179.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 m -62.96 -45.72 91.13 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.344 -0.843 . . . . 2.12 110.294 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -70.07 -42.42 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.377 -0.827 . . . . 2.82 110.566 -173.782 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -63.26 -43.18 98.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.907 -0.496 . . . . 3.38 110.138 175.595 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 m -54.54 -44.83 73.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 111.891 0.33 . . . . 2.41 111.891 172.292 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.07 -39.8 91.27 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.822 0.737 . . . . 2.43 111.14 173.575 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.2 41.07 0.92 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.049 0.833 . . . . 0.82 111.655 173.434 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -127.77 161.97 27.72 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.163 -1.051 . . . . 3.08 108.163 170.449 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.4 103.6 14.63 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.133 -0.937 . . . . 2.68 110.015 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.29 77.03 3.97 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.239 2.626 . . . . 1.02 110.699 -176.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -78.66 90.11 4.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.316 -0.994 . . . . 2.42 108.316 -177.012 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -66.1 57.44 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.021 1.728 . . . . 3.5 114.683 -176.259 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.91 92.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.369 1.868 . . . . 4.71 107.543 -175.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 101.36 14.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.013 1.325 . . . . 7.81 107.62 177.211 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.0 pt -141.85 177.88 2.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 124.911 1.285 . . . . 9.94 108.53 -178.55 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 C--O 1.256 1.446 0 N-CA-C 105.008 -2.219 . . . . 11.07 105.008 172.802 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mtp . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 108.212 -1.033 . . . . 7.02 108.212 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.97 177.44 14.99 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.447 -1.061 . . . . 3.81 110.447 -168.128 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -94.07 123.98 37.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.748 1.219 . . . . 3.66 109.657 177.09 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.52 145.27 31.44 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 107.902 -2.079 . . . . 2.42 107.902 167.007 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -150.89 129.39 2.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 123.307 0.643 . . . . 3.49 109.783 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mp -136.46 138.67 41.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.029 -0.73 . . . . 3.27 109.029 167.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -92.34 93.51 8.66 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.512 -1.292 . . . . 2.7 107.512 163.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mt -80.03 112.25 17.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.797 -1.927 . . . . 3.78 105.797 173.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.2 t -78.97 104.49 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.506 -1.665 . . . . 2.41 106.506 -177.712 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.3 m -79.14 80.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 124.601 1.16 . . . . 2.22 108.516 -172.523 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 -75.91 95.27 3.5 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.524 -1.658 . . . . 4.91 106.524 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.58 -57.41 0.11 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.643 -0.983 . . . . 1.51 110.643 177.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.28 157.45 18.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 117.363 0.582 . . . . 2.5 109.794 -177.697 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 t -154.31 35.82 0.42 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.624 -0.51 . . . . 4.59 109.624 170.892 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.43 137.0 22.76 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.686 0.795 . . . . 2.57 110.193 -170.054 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.69 -43.28 2.8 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.519 1.927 . . . . 2.16 112.002 -177.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -35.1 -58.38 0.54 Allowed 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.733 1.613 . . . . 2.99 111.931 170.789 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.2 m -74.52 -27.56 60.59 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.915 -1.116 . . . . 1.44 113.866 -178.296 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 45.1 t -56.41 -55.68 17.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.895 -1.15 . . . . 1.82 107.895 179.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -63.58 -32.57 74.08 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.951 -0.568 . . . . 1.34 111.913 -178.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -60.01 -54.3 47.6 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.433 -0.951 . . . . 4.71 108.433 173.77 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.3 mt -57.7 -56.43 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.187 -0.672 . . . . 1.84 109.187 -172.525 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -61.03 -50.23 74.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.789 -0.764 . . . . 3.71 111.337 -174.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.3 m -54.11 -50.11 67.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.339 0.59 . . . . 2.47 110.407 177.382 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.4 t -58.19 -41.88 84.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.037 0.935 . . . . 1.73 110.301 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.68 -46.3 69.42 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.59 -0.694 . . . . 3.07 111.849 178.505 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.2 p -53.71 -30.21 42.77 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.806 0.73 . . . . 2.42 112.926 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -58.19 -32.46 68.27 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.24 0.616 . . . . 6.43 112.082 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -73.17 106.66 5.12 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.335 0.971 . . . . 4.17 108.595 171.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -37.38 -58.01 0.87 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.067 -0.716 . . . . 9.83 109.067 167.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.97 -11.43 0.57 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.921 1.248 . . . . 1.63 116.07 -173.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.13 167.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 120.275 2.038 . . . . 3.06 107.892 171.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.87 -30.04 1.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.67 -0.644 . . . . 3.89 112.531 170.537 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -155.62 123.17 5.57 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.293 0.951 . . . . 4.33 108.917 170.828 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 p -106.52 132.81 52.1 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.996 0.918 . . . . 3.87 108.573 169.059 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -134.9 80.29 1.84 Allowed 'General case' 0 CA--C 1.522 -0.122 0 O-C-N 123.715 0.634 . . . . 3.37 109.614 167.368 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.7 p -78.85 144.1 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 122.56 0.344 . . . . 2.78 110.803 171.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.24 137.7 16.74 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.887 0.875 . . . . 2.35 109.905 178.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.75 -22.35 58.83 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.013 -0.54 . . . . 2.65 111.487 177.888 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.56 -39.7 2.41 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.49 1.516 . . . . 2.77 113.278 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -137.88 34.8 2.39 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.944 0.497 . . . . 2.55 110.309 168.157 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 44.78 50.51 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.765 2.026 . . . . 2.14 110.027 173.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -114.61 145.26 42.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.971 0.909 . . . . 3.56 110.354 -170.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -122.28 108.22 13.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.15 1.38 . . . . 1.75 108.562 163.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . 0.25 19.7 t60 -86.77 101.75 13.61 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 104.234 -2.506 . . . . 3.62 104.234 174.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 2.0 mp -103.43 119.83 52.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.858 -1.905 . . . . 2.22 105.858 174.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -102.71 140.66 36.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.069 -1.085 . . . . 3.71 108.069 166.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -159.27 159.1 33.69 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.957 0.903 . . . . 3.35 112.423 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.74 109.17 3.06 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 126.47 1.908 . . . . 2.68 107.659 173.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -81.83 54.61 5.13 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.007 2.471 . . . . 1.63 110.553 -170.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -142.52 -64.31 0.42 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.367 1.467 . . . . 3.89 109.361 -175.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.57 -38.46 17.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 N-CA-C 112.204 0.446 . . . . 2.71 112.204 -172.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 tt -113.41 146.01 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.64 1.176 . . . . 2.31 109.604 -175.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.5 -172.17 13.73 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.687 -0.965 . . . . 0.69 110.687 178.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.81 -40.56 28.08 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.479 2.119 . . . . 0.84 110.178 174.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -45.53 -58.41 3.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.313 1.045 . . . . 7.46 111.504 179.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.91 -57.62 9.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.362 0.665 . . . . 2.34 109.644 -174.584 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 56.0 mt -51.82 -52.71 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.921 0.888 . . . . 2.37 109.325 179.441 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.02 -48.67 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-O 119.034 -0.508 . . . . 1.85 110.107 -176.189 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -58.7 -41.57 86.6 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.88 0.848 . . . . 4.46 109.476 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.3 m -64.88 -45.44 85.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.783 -0.644 . . . . 2.43 111.044 178.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.3 mm -70.2 -51.67 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 CA-C-N 118.575 0.625 . . . . 3.21 110.682 -177.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -55.58 -36.8 67.27 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.148 0.579 . . . . 3.08 111.707 -167.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 t -38.07 -44.68 0.84 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.011 1.724 . . . . 3.2 113.039 168.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -19.66 63.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.811 0.844 . . . . 5.24 112.21 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.6 40.54 3.37 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.021 1.296 . . . . 2.09 111.782 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -124.87 155.95 38.68 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.759 -1.2 . . . . 3.36 107.759 172.656 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -95.63 101.12 7.23 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.012 -0.994 . . . . 3.51 108.895 169.305 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -70.81 81.49 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.165 2.577 . . . . 1.15 109.141 175.208 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 m -79.35 109.66 13.91 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.909 0.884 . . . . 2.68 108.733 -168.435 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.42 61.4 0.67 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.558 1.143 . . . . 3.66 112.568 -174.201 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.77 -53.51 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.856 -0.794 . . . . 3.02 108.856 174.487 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.5 tttt 58.39 -94.13 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.088 0.555 . . . . 7.17 111.03 -168.287 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 57.9 mt -146.21 141.72 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 127.355 2.262 . . . . 7.27 105.771 177.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 . . . . . 0 C--O 1.249 1.06 0 N-CA-C 103.239 -2.875 . . . . 10.14 103.239 170.77 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 107.326 -1.361 . . . . 7.36 107.326 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.48 175.3 40.47 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 107.52 -2.232 . . . . 3.73 107.52 141.002 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -72.35 118.04 14.75 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.44 0.696 . . . . 4.11 109.538 177.024 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.46 136.1 20.61 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 106.541 -2.624 . . . . 2.2 106.541 161.442 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.91 133.53 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.47 -0.937 . . . . 4.5 108.47 -173.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 mt -134.31 130.29 36.79 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.335 -0.987 . . . . 4.09 108.335 170.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -114.11 91.93 3.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.454 1.502 . . . . 2.5 108.596 174.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.67 134.46 44.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.374 -1.343 . . . . 2.28 107.374 176.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -80.33 115.69 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 106.949 -1.5 . . . . 4.19 106.949 170.186 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.54 86.45 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 125.938 1.695 . . . . 1.69 107.698 -173.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -77.34 130.9 37.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.23 -1.026 . . . . 6.57 108.23 -170.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.16 -18.83 4.17 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.718 0.675 . . . . 1.01 112.541 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 61.5 mtp -59.19 147.67 34.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.574 1.187 . . . . 2.92 110.863 177.252 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -150.75 -10.93 0.24 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.761 1.393 . . . . 3.3 114.761 178.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.9 p -165.59 172.01 12.47 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 121.032 1.742 . . . . 1.46 109.371 -179.132 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.88 -38.99 11.28 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.379 1.472 . . . . 2.23 112.147 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -45.71 -47.0 15.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.924 0.889 . . . . 2.02 111.65 173.903 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.0 m -69.75 -39.84 76.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 122.79 0.436 . . . . 0.7 110.98 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.7 t -57.75 -59.58 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.998 -1.112 . . . . 1.97 107.998 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.269 1.3 p-80 -70.8 -31.46 68.21 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 118.206 -0.902 . . . . 1.03 112.521 -175.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -49.15 -58.15 5.48 Favored 'General case' 0 C--N 1.347 0.465 0 N-CA-C 108.178 -1.045 . . . . 4.72 108.178 165.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.19 -60.87 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 118.572 -0.728 . . . . 2.49 110.239 -174.298 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.03 -55.31 24.63 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.39 0.995 . . . . 2.59 110.853 -175.993 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.1 t -58.09 -54.21 49.52 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.538 0.685 . . . . 2.13 110.28 -177.815 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -66.82 -40.62 88.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.709 -0.62 . . . . 1.23 110.952 -170.32 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.98 -42.69 84.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.115 0.416 . . . . 2.77 109.935 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -55.27 -27.23 45.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.5 0.591 . . . . 2.91 112.354 176.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -30.57 64.19 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.09 -1.006 . . . . 4.48 112.153 173.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -63.92 108.61 1.53 Allowed 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.346 0.975 . . . . 4.12 108.808 173.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -48.4 -33.44 9.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.896 0.878 . . . . 6.89 112.37 175.255 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.85 -18.35 80.12 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.642 -1.088 . . . . 1.87 114.042 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.21 135.59 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.94 1.37 . . . . 3.05 107.774 172.57 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pp -98.6 -33.61 10.9 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.692 -0.67 . . . . 3.9 109.82 173.35 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -157.04 146.17 20.17 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.463 1.029 . . . . 4.15 109.642 162.0 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.6 t -112.65 112.3 23.71 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 107.382 -1.34 . . . . 2.61 107.382 164.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.11 98.29 8.25 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.837 -1.172 . . . . 2.29 107.837 171.714 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.0 146.28 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 110.351 -0.24 . . . . 3.09 110.351 170.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.7 130.26 15.88 Favored 'General case' 0 CA--C 1.523 -0.092 0 O-C-N 122.02 -0.425 . . . . 1.77 111.293 170.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 pp -72.14 -25.82 61.87 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 124.756 1.223 . . . . 3.01 113.074 -168.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.1 -43.46 66.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.809 0.444 . . . . 2.03 111.191 -178.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.73 -31.75 10.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.591 1.156 . . . . 3.02 110.038 173.322 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 76.2 30.91 0.67 Allowed 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.14 2.176 . . . . 3.53 109.464 -171.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -79.5 145.01 33.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.373 -1.343 . . . . 4.66 107.373 171.507 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.48 109.71 21.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 124.888 1.367 . . . . 1.73 107.406 151.239 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -80.38 94.3 6.13 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.705 -1.961 . . . . 5.12 105.705 166.637 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -92.11 116.13 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 107.216 -1.401 . . . . 2.81 107.216 176.571 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -108.09 128.44 54.68 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.606 -1.627 . . . . 4.33 106.606 174.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -157.24 171.8 19.76 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.421 0.688 . . . . 3.53 109.637 -166.67 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.76 114.36 62.85 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.169 -0.678 . . . . 3.12 109.169 177.536 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.25 49.68 3.24 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.41 2.74 . . . . 1.33 112.15 -174.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.96 27.24 0.54 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.748 1.219 . . . . 3.84 110.234 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.78 -51.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 125.021 1.328 . . . . 4.67 108.998 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 tt -127.67 152.59 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.241 1.016 . . . . 2.16 108.478 -174.973 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -133.83 -176.09 14.22 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.538 -0.625 . . . . 0.74 111.538 -178.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.92 -41.62 52.0 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.859 2.373 . . . . 0.91 111.872 -176.797 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -57.39 -47.49 81.55 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.629 0.65 . . . . 6.91 110.863 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.95 -52.85 63.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.818 -0.808 . . . . 2.71 108.818 -175.853 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 mm -51.77 -52.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.405 1.082 . . . . 3.27 109.901 175.304 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 5.1 mt -55.29 -57.3 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 109.848 -0.427 . . . . 1.94 109.848 -179.026 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -65.24 -34.2 77.8 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.623 -0.673 . . . . 4.11 110.23 -171.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.5 m -59.2 -55.95 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.049 -0.523 . . . . 1.88 109.937 171.674 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 76.8 mt -63.86 -36.24 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.35 -0.844 . . . . 2.58 111.35 -175.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -51.2 -55.06 19.96 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.208 -0.664 . . . . 2.81 109.208 167.53 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -54.76 -42.08 71.23 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.696 0.398 . . . . 2.86 111.559 177.348 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.48 -10.94 58.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.185 0.809 . . . . 2.48 113.185 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.08 44.1 5.46 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 123.941 0.782 . . . . 0.98 111.976 172.751 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -140.82 163.53 32.69 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.174 -1.417 . . . . 3.88 107.174 167.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -103.91 105.01 46.31 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 125.429 1.492 . . . . 4.59 109.984 -179.431 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -83.49 85.29 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.538 3.492 . . . . 0.94 111.317 -173.818 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -94.11 111.97 23.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.851 -0.531 . . . . 2.71 110.136 -173.057 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 mt -62.14 106.41 0.72 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.96 0.904 . . . . 3.91 109.924 174.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 t -93.3 -66.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 109.7 -0.481 . . . . 3.25 109.7 177.526 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -175.52 132.09 0.28 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.597 -1.26 . . . . 6.72 107.597 -166.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.7 pt -93.92 153.26 3.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.463 1.505 . . . . 8.96 107.036 158.309 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.911 2.084 . . . . 11.61 112.135 177.416 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtp . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 115.713 -2.089 . . . . 9.46 105.702 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.01 63.78 0.23 Allowed Glycine 0 C--N 1.334 0.419 0 CA-C-N 121.382 1.901 . . . . 3.87 109.101 -174.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 178.38 163.94 0.73 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.101 -1.814 . . . . 4.33 106.101 -162.37 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.69 158.9 31.98 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.101 -1.6 . . . . 1.87 109.101 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -147.15 136.3 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.664 -1.606 . . . . 4.05 106.664 -179.224 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -155.26 175.13 14.25 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.681 -1.229 . . . . 4.56 107.681 163.111 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -131.83 146.45 52.14 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.725 -0.843 . . . . 2.47 108.725 168.077 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -132.42 131.41 41.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.791 -1.559 . . . . 2.22 106.791 169.178 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.5 t -79.92 100.94 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.022 -1.473 . . . . 1.96 107.022 175.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.21 87.03 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 126.056 1.742 . . . . 2.19 108.096 177.952 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.12 154.33 33.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.811 -1.181 . . . . 5.83 107.811 170.171 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.54 -38.42 3.21 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.628 -0.989 . . . . 0.84 110.628 -172.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 29.9 mtp -64.06 138.15 58.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.229 1.015 . . . . 2.73 109.607 178.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -140.54 -2.76 1.36 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.128 1.159 . . . . 2.93 114.128 -176.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.1 p -161.43 166.09 27.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.44 1.473 . . . . 1.17 110.063 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.89 -40.56 10.19 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.371 1.468 . . . . 2.1 111.875 -177.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.3 m -43.27 -47.04 6.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.856 0.863 . . . . 1.93 112.304 174.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.6 -33.77 75.66 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.005 0.522 . . . . 0.91 111.436 -175.054 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.4 t -59.22 -59.91 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.112 -1.44 . . . . 1.85 107.112 -178.856 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.25 1.5 p-80 -67.97 -30.03 69.21 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.179 -0.464 . . . . 1.2 112.062 -178.261 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -52.67 -44.95 66.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.57 -0.706 . . . . 4.58 110.615 168.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.6 mt -70.39 -71.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.126 -0.694 . . . . 2.04 109.126 175.653 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . 0.283 0.2 OUTLIER -59.15 -50.02 75.64 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.238 0.926 . . . . 4.32 112.471 -159.745 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -56.37 -46.36 80.08 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.376 0.67 . . . . 2.47 110.497 176.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -71.24 -35.27 71.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 121.232 -0.917 . . . . 1.51 112.142 -176.161 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.77 -54.07 50.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.004 -0.739 . . . . 2.75 109.004 172.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.2 p -65.25 71.48 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.799 1.24 . . . . 2.3 113.081 -174.717 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -169.83 -31.09 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.915 2.486 . . . . 4.57 111.567 171.299 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -67.69 147.23 52.94 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.307 1.412 . . . . 3.08 108.78 177.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 ttm105 -61.66 142.76 56.98 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.263 -1.014 . . . . 6.22 108.263 173.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.65 -56.52 0.48 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.669 -0.973 . . . . 1.53 110.669 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.11 103.95 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 118.509 1.155 . . . . 3.37 110.993 -167.521 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.4 pp -82.3 -29.72 30.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.589 -0.732 . . . . 3.63 110.292 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -156.44 158.04 36.6 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.573 0.624 . . . . 3.7 109.38 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -142.9 133.79 25.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.206 1.003 . . . . 2.42 108.53 169.484 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 m -112.19 93.14 4.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.644 -1.243 . . . . 2.78 107.644 160.838 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 9.4 p -88.82 144.94 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 122.551 0.34 . . . . 2.64 111.096 162.378 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.74 138.85 26.07 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.172 0.989 . . . . 1.74 110.039 171.376 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.74 -35.85 60.07 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.602 0.761 . . . . 2.91 110.885 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.28 -42.61 41.64 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.289 1.035 . . . . 2.47 111.849 -173.961 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.1 p -114.84 20.09 15.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.908 1.283 . . . . 3.4 110.615 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 m120 37.13 55.64 1.28 Allowed 'General case' 0 C--N 1.341 0.211 0 C-N-CA 126.777 2.031 . . . . 2.98 111.431 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -134.15 150.56 51.12 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 118.418 0.554 . . . . 2.7 112.488 -176.213 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.77 119.85 33.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.134 2.174 . . . . 1.86 107.535 167.673 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -101.12 101.42 12.15 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.164 -2.532 . . . . 2.86 104.164 167.449 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.8 mp -94.59 143.79 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 108.116 -1.068 . . . . 2.51 108.116 177.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -120.43 91.0 3.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.937 -1.134 . . . . 3.05 107.937 175.969 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -102.37 149.79 24.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.003 0.921 . . . . 3.65 113.205 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -71.71 116.03 43.78 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 124.83 1.252 . . . . 3.15 108.574 171.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.41 40.21 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.264 1.976 . . . . 1.8 111.586 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -82.32 -40.33 21.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.698 -0.626 . . . . 6.35 109.818 172.417 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 pt -133.63 -51.09 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.717 0.807 . . . . 3.32 112.098 -168.058 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.76 147.0 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.307 0.643 . . . . 2.04 109.823 -166.546 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.12 -171.66 13.01 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.892 -0.883 . . . . 0.91 110.892 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.25 -34.47 56.03 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.46 2.107 . . . . 1.04 110.519 176.51 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.508 HH21 ' CE1' ' A' ' 60' ' ' HIS . 1.7 tpm_? -50.37 -54.23 23.24 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.361 1.064 . . . . 8.92 111.163 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -52.51 63.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.232 1.013 . . . . 2.66 109.183 -176.559 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 94.8 mt -52.08 -47.85 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 C-N-CA 123.647 0.779 . . . . 2.38 109.4 178.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.7 mt -55.38 -54.13 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 109.381 -0.6 . . . . 1.93 109.381 -178.902 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . 0.508 ' CE1' HH21 ' A' ' 56' ' ' ARG . 76.7 m-70 -65.48 -34.88 79.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.801 0.728 . . . . 4.33 111.367 -176.8 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -57.08 -52.23 66.11 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.076 -0.713 . . . . 1.63 109.076 173.897 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.9 mt -70.87 -32.37 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 121.242 -0.911 . . . . 2.1 112.242 -178.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -53.96 -49.06 69.58 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.346 -0.983 . . . . 2.75 108.346 166.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -60.5 -40.93 93.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.157 0.183 . . . . 2.19 111.34 177.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.0 mt -61.38 -34.33 75.16 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.611 -0.681 . . . . 2.26 111.582 172.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.48 43.85 1.53 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.886 1.231 . . . . 0.96 112.206 173.269 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -134.2 168.83 18.15 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.732 -0.84 . . . . 3.34 108.732 170.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.92 85.05 4.74 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.059 0.944 . . . . 3.57 110.982 -172.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.64 93.42 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.788 2.992 . . . . 0.89 111.37 -175.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.2 m -86.22 119.53 26.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.888 1.275 . . . . 2.58 108.116 -179.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.0 mt -74.56 58.05 0.76 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.05 1.296 . . . . 3.46 112.184 -175.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 t -86.42 63.26 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.604 -1.258 . . . . 3.35 107.604 177.462 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 65.71 1.67 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.767 0.827 . . . . 5.65 108.813 176.284 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.85 -41.9 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.367 1.067 . . . . 8.58 110.943 -179.476 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.084 0 C-N-CA 125.296 1.438 . . . . 9.81 109.748 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 mtt . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 106.186 -1.783 . . . . 7.77 106.186 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.68 156.37 26.66 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 107.243 -2.343 . . . . 4.88 107.243 173.462 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.59 131.9 44.65 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.968 1.307 . . . . 4.26 109.774 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.37 83.73 0.87 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.737 -1.745 . . . . 2.18 108.737 178.28 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 m -79.51 129.0 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 117.211 0.506 . . . . 3.52 109.768 177.286 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 pp -150.3 164.92 34.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.748 -0.834 . . . . 4.4 108.748 161.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 153.26 51.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.629 0.728 . . . . 4.44 109.944 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 134.63 30.43 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.669 -1.604 . . . . 2.51 106.669 -177.259 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.16 102.47 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 105.513 -2.032 . . . . 1.92 105.513 177.485 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 m -90.79 71.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.471 -1.678 . . . . 1.69 106.471 -172.297 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -74.72 124.13 26.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 118.883 -1.127 . . . . 5.79 108.112 -159.808 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.19 -26.11 3.26 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.328 -0.851 . . . . 1.11 111.946 -179.268 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.86 109.86 8.67 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.883 1.341 . . . . 2.45 110.462 -176.299 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 p -83.67 -44.6 14.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.85 -0.532 . . . . 3.79 112.186 -170.718 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -149.28 177.37 9.72 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 112.073 0.397 . . . . 1.41 112.073 -156.32 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.28 -48.51 3.6 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.706 1.602 . . . . 1.69 111.785 177.908 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 m -48.09 -46.64 34.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.326 1.451 . . . . 2.79 111.779 176.825 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.9 m -72.24 -53.58 12.1 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.877 0.471 . . . . 0.74 110.689 176.426 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -43.91 -60.07 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.281 1.432 . . . . 1.83 109.347 -176.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.52 -12.37 61.34 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 113.61 0.967 . . . . 1.19 113.61 -176.037 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -53.2 19.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.553 -1.647 . . . . 4.52 106.553 163.182 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.6 mt -65.4 -60.22 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 118.445 0.566 . . . . 1.86 109.596 -169.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . 0.264 0.2 OUTLIER -58.36 -53.58 56.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.765 -0.774 . . . . 4.51 111.311 -166.123 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -60.9 -48.87 79.83 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.225 -0.893 . . . . 2.33 109.868 177.171 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 t -63.75 -42.71 97.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.883 1.22 . . . . 1.42 110.837 -170.982 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.33 -46.17 87.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.423 -0.584 . . . . 3.23 109.423 174.842 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -71.73 65.45 0.5 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.256 0.55 . . . . 2.99 111.53 174.768 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -146.81 -49.81 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.677 2.791 . . . . 7.9 108.459 170.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -61.04 130.13 44.86 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.843 0.354 . . . . 2.85 110.938 -174.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.78 90.43 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.923 0.889 . . . . 8.01 110.079 -179.271 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.08 -29.68 0.32 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-O 119.207 -0.774 . . . . 1.56 112.037 178.393 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.46 134.91 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.386 -1.339 . . . . 3.1 107.386 165.654 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -102.49 -29.33 11.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 123.969 0.793 . . . . 3.33 110.13 172.082 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -156.24 162.46 40.15 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.307 0.958 . . . . 3.96 109.692 172.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.8 t -142.86 149.22 38.25 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.328 1.051 . . . . 2.18 108.229 171.823 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -146.5 136.73 23.68 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 107.517 -1.29 . . . . 2.73 107.517 157.148 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.1 m -122.57 141.86 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 123.397 0.679 . . . . 2.99 109.351 -178.955 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.99 131.48 44.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.306 0.643 . . . . 1.8 110.4 177.686 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.33 -33.98 67.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.812 -1.086 . . . . 3.42 110.982 -173.19 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.09 -47.17 68.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.372 1.069 . . . . 2.21 112.452 -175.646 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -102.86 14.73 31.23 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.933 0.893 . . . . 3.24 110.645 174.96 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 34.1 46.21 0.15 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 129.082 2.953 . . . . 3.17 112.335 -173.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -125.47 144.61 50.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.624 0.647 . . . . 4.93 112.274 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.84 130.19 48.24 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.255 1.822 . . . . 1.77 106.444 172.004 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.41 109.67 21.45 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 101.401 -3.555 . . . . 3.2 101.401 176.729 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.02 134.58 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.054 -1.832 . . . . 2.3 106.054 -179.362 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -112.52 116.18 29.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 106.204 -1.776 . . . . 2.9 106.204 169.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -123.62 157.56 33.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.107 0.563 . . . . 4.14 111.011 -178.589 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -72.58 116.54 50.64 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 106.963 -1.495 . . . . 3.04 106.963 176.78 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.19 27.26 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.226 2.617 . . . . 2.96 115.7 -156.655 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -135.55 -34.75 0.83 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.363 1.465 . . . . 3.9 112.969 -178.626 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -41.51 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.781 0.832 . . . . 4.37 111.312 -165.838 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.8 tt -136.28 158.17 38.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 C-N-CA 123.832 0.853 . . . . 2.32 108.728 -169.085 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.84 -178.89 15.86 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.484 0.584 . . . . 0.75 111.85 -174.916 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -57.63 -39.98 83.67 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.797 2.331 . . . . 0.85 110.472 171.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -51.66 -49.48 62.25 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.729 0.812 . . . . 7.45 112.081 -176.867 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.79 -51.55 66.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.377 -0.601 . . . . 2.65 109.377 -175.197 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.8 mt -52.27 -47.48 45.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 123.602 0.761 . . . . 2.62 108.989 175.696 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.7 mt -55.89 -54.99 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 109.883 -0.414 . . . . 1.71 109.883 -176.037 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -64.08 -34.74 78.72 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.026 0.441 . . . . 4.24 110.671 -178.298 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.6 m -58.66 -51.26 70.7 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.196 -0.315 . . . . 1.68 110.483 173.868 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 mm -63.98 -42.26 95.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 121.143 -0.973 . . . . 2.81 110.915 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -52.83 -47.54 67.64 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.455 -0.572 . . . . 2.66 109.455 172.37 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m -59.15 -42.98 91.97 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.898 0.333 . . . . 2.34 111.898 175.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.7 mt -64.47 -29.14 70.18 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.534 -0.729 . . . . 2.14 112.411 175.983 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.27 40.1 1.18 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.3 0.953 . . . . 0.83 113.385 167.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -136.25 164.72 27.43 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.175 0.987 . . . . 3.24 108.643 171.389 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -94.62 111.44 54.05 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 118.488 -0.768 . . . . 2.44 109.759 175.254 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.18 80.21 2.68 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.612 2.875 . . . . 0.92 110.764 -178.243 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.47 105.35 10.72 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.137 -0.69 . . . . 2.88 109.137 -178.605 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.82 61.68 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.606 1.562 . . . . 3.5 111.827 179.373 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.64 -33.75 63.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.468 0.707 . . . . 3.33 111.234 -177.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 57.35 -122.01 1.5 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.258 -0.645 . . . . 6.35 109.258 -173.912 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.5 tt -141.61 -59.71 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.186 0.994 . . . . 8.18 108.423 169.769 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 . . . . . 0 C--O 1.259 1.588 0 N-CA-C 102.68 -3.082 . . . . 10.0 102.68 135.793 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.1 mtm . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 105.365 -2.087 . . . . 8.71 105.365 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 140.12 -35.56 1.89 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.309 -1.517 . . . . 3.74 109.309 -168.604 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.27 -112.93 0.27 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.825 0.85 . . . . 4.73 110.291 158.182 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.25 -138.08 13.71 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.829 -1.708 . . . . 2.89 108.829 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -157.9 154.37 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.965 -1.494 . . . . 3.92 106.965 173.983 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.5 mt -130.54 126.84 37.79 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 107.874 -1.158 . . . . 3.51 107.874 153.41 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -106.71 89.47 3.03 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.373 -0.973 . . . . 3.05 108.373 173.871 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.23 129.79 39.16 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.388 -0.967 . . . . 2.45 108.388 178.869 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.04 109.33 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.029 -1.841 . . . . 2.44 106.029 173.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.42 92.53 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 125.39 1.476 . . . . 1.88 108.175 -171.051 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -76.58 139.46 40.68 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.481 -0.933 . . . . 5.9 108.481 -173.292 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.65 -42.39 1.95 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.319 0.961 . . . . 0.72 111.141 177.746 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.81 126.82 30.96 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.982 0.891 . . . . 2.89 110.135 -176.273 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -154.38 17.87 0.48 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.855 1.057 . . . . 2.66 113.855 -171.831 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 p -158.68 170.29 22.48 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.502 1.046 . . . . 1.39 109.234 169.34 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.35 -44.49 11.8 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.972 1.309 . . . . 2.68 111.961 -178.977 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.6 m -56.25 -43.82 79.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.574 0.349 . . . . 2.14 111.602 177.532 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.32 -45.41 66.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.716 -0.615 . . . . 0.92 110.787 178.035 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.22 -58.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.204 -1.035 . . . . 2.12 108.204 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.298 0.7 OUTLIER -70.72 -24.8 62.7 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 113.146 0.795 . . . . 2.03 113.146 -172.174 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -57.9 -51.73 68.43 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.392 -0.966 . . . . 4.74 108.392 169.732 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.6 mt -59.11 -60.32 2.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.431 -0.581 . . . . 2.2 109.431 174.169 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.94 -55.28 28.52 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.357 0.526 . . . . 4.57 110.9 -168.325 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.3 t -61.2 -53.04 61.89 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.122 -0.696 . . . . 2.41 109.122 -177.88 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.7 t -72.04 -36.51 69.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 119.089 -1.045 . . . . 1.21 112.285 -168.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.83 -59.51 2.76 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.61 -0.885 . . . . 2.59 108.61 176.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.7 m -71.98 64.95 0.53 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.665 0.786 . . . . 4.08 111.883 179.064 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -169.9 -30.89 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 128.286 2.635 . . . . 4.18 110.951 170.507 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -64.6 132.2 49.14 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.866 1.212 . . . . 2.92 109.458 173.583 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -51.89 145.39 9.92 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.867 -0.79 . . . . 6.31 108.867 174.075 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.6 -36.28 4.18 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.582 -1.121 . . . . 1.34 111.926 177.707 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.47 135.28 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.703 -1.591 . . . . 3.16 106.703 164.512 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.1 pp -99.01 -32.49 11.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.243 0.617 . . . . 3.81 109.469 171.093 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -156.57 161.4 39.96 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 108.68 -0.859 . . . . 3.43 108.68 172.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 p -132.93 148.34 52.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.947 -0.76 . . . . 2.59 108.947 154.598 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.46 88.66 2.98 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.808 -1.553 . . . . 2.47 106.808 168.608 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.28 136.21 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 124.271 1.028 . . . . 2.89 111.838 170.353 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.6 140.17 28.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.77 0.828 . . . . 2.31 110.314 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 pp -76.96 -22.45 53.21 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.116 -0.493 . . . . 2.74 111.617 177.794 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.24 -38.02 1.65 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.411 1.484 . . . . 2.76 113.212 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -139.74 30.6 2.07 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.944 0.878 . . . . 2.93 110.291 170.554 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.1 m120 44.13 56.74 4.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.864 2.066 . . . . 2.3 110.579 176.067 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.78 139.63 32.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.176 -0.328 . . . . 2.81 110.69 -164.984 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.38 115.82 25.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.766 1.626 . . . . 1.89 110.463 176.893 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -82.29 96.63 7.96 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.249 -1.76 . . . . 3.45 106.249 169.371 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.39 133.05 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.94 -1.134 . . . . 2.43 107.94 175.27 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -115.25 115.8 27.28 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.44 -2.059 . . . . 3.88 105.44 173.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -147.14 153.53 40.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.381 1.072 . . . . 4.24 108.405 -164.867 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -104.07 105.69 49.87 Favored Pre-proline 0 CA--C 1.534 0.357 0 O-C-N 124.362 1.039 . . . . 3.87 111.075 -178.19 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.0 60.41 6.85 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.163 2.575 . . . . 1.92 112.1 -174.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.83 -54.87 2.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.044 0.938 . . . . 3.66 109.656 161.881 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -96.18 -37.07 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 122.98 0.512 . . . . 2.76 112.24 -174.463 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 tp -104.13 148.15 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.996 1.318 . . . . 2.13 108.444 -178.434 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.46 -178.94 16.6 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 110.864 -0.895 . . . . 0.78 110.864 174.945 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -60.99 -40.45 52.18 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.873 2.382 . . . . 0.87 110.357 174.122 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -50.39 -49.99 52.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.254 0.622 . . . . 6.92 112.083 179.352 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.16 -55.81 28.54 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.643 0.656 . . . . 2.47 109.991 -174.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.0 mt -50.42 -54.87 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 124.654 1.182 . . . . 2.56 108.956 175.596 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.9 mt -58.07 -53.23 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.85 -0.614 . . . . 2.14 110.403 -173.384 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -66.58 -33.03 74.77 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.329 0.652 . . . . 4.18 110.107 -175.522 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.7 m -57.85 -51.83 67.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.78 -0.452 . . . . 1.69 109.78 169.783 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 94.6 mt -67.24 -37.93 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 121.186 -0.946 . . . . 2.21 111.733 -176.788 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.99 -50.01 67.52 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.939 -0.763 . . . . 3.44 108.939 169.148 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.3 m -58.94 -38.82 79.89 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.008 -0.433 . . . . 2.55 111.992 176.084 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.38 -18.57 64.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.549 -0.738 . . . . 2.12 112.511 172.882 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.42 33.21 6.59 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.749 1.166 . . . . 0.81 112.273 174.176 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -133.01 158.65 42.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.025 0.913 . . . . 3.58 108.846 177.549 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.74 105.8 29.32 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.492 -0.766 . . . . 2.9 110.083 -178.081 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.4 79.62 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.922 2.414 . . . . 1.29 110.291 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 t -78.97 116.79 19.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.704 -0.623 . . . . 2.68 109.632 -175.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.8 mt -74.04 63.0 0.92 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.301 1.04 . . . . 4.3 110.225 177.494 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.6 t -62.9 -42.49 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 O-C-N 121.739 -0.6 . . . . 3.6 109.533 179.147 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -76.73 64.33 2.3 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.942 -0.474 . . . . 8.48 110.069 172.446 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 tp -76.1 164.68 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.23 -1.026 . . . . 10.8 108.23 164.619 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.708 -1.139 . . . . 11.36 109.95 171.333 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 106.15 -1.796 . . . . 9.97 106.15 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.58 57.14 0.03 OUTLIER Glycine 0 CA--C 1.521 0.43 0 N-CA-C 106.67 -2.572 . . . . 3.35 106.67 -179.025 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -168.19 144.27 3.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.362 -0.977 . . . . 4.03 108.362 -158.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -145.58 90.94 0.15 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.908 -2.077 . . . . 2.13 107.908 178.149 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -81.23 133.47 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 108.642 -0.873 . . . . 3.49 108.642 171.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -146.28 137.92 24.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.129 -1.063 . . . . 4.21 108.129 176.585 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -106.64 126.99 52.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.496 1.118 . . . . 2.86 109.509 173.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.25 128.59 40.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.752 1.221 . . . . 2.62 108.107 176.34 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.257 0.6 OUTLIER -79.79 115.04 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 124.384 1.074 . . . . 4.27 108.301 173.813 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 m -101.92 84.25 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 128.077 2.551 . . . . 1.84 107.221 -170.277 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -75.91 139.2 41.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 118.7 -1.2 . . . . 7.74 107.902 -167.929 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.28 -31.27 5.33 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.685 1.136 . . . . 0.83 111.134 -170.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.0 mtm -57.17 126.88 29.22 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.949 1.374 . . . . 2.86 110.388 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -140.47 -6.54 1.17 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.073 1.138 . . . . 2.64 114.073 -177.355 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 p -163.03 168.4 21.07 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 120.288 1.403 . . . . 1.12 109.834 179.639 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.44 -38.86 14.37 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.227 1.411 . . . . 1.71 112.172 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.8 m -43.47 -50.0 7.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.613 1.165 . . . . 1.85 111.612 172.131 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.7 m -68.02 -45.52 73.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 122.996 0.518 . . . . 0.71 110.536 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.1 t -52.59 -61.01 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.238 -1.023 . . . . 1.73 108.238 -176.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.252 1.3 p-80 -70.43 -28.59 65.16 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.829 -1.078 . . . . 1.03 111.964 -175.278 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -53.11 -58.62 6.38 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.446 1.021 . . . . 4.33 109.564 168.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.62 -58.51 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.739 -0.784 . . . . 2.06 109.732 -177.437 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -52.87 -62.23 1.78 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.382 0.426 . . . . 2.52 109.865 -174.012 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -55.2 -52.27 63.87 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.919 0.488 . . . . 2.25 110.432 -176.327 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -69.57 -32.08 70.64 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.621 -0.432 . . . . 1.58 111.306 -171.011 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.19 -46.83 63.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.09 -0.644 . . . . 2.91 111.122 172.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.8 p -66.89 78.28 0.12 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.54 0.736 . . . . 2.4 111.178 -176.683 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.76 -37.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 128.651 2.78 . . . . 4.91 108.763 -178.0 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.23 114.28 6.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.791 -0.818 . . . . 2.83 108.791 174.773 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -57.17 152.83 12.89 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.521 -0.918 . . . . 9.12 108.521 166.346 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.87 -60.15 0.64 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 108.575 -1.81 . . . . 2.42 108.575 -152.79 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.01 149.36 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 119.541 1.67 . . . . 2.93 108.507 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 pp -121.75 -25.07 5.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.368 -0.833 . . . . 3.65 111.035 168.517 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -155.68 157.57 36.86 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.313 0.96 . . . . 3.88 108.502 172.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.0 t -139.78 149.79 43.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.929 -1.137 . . . . 3.11 107.929 165.593 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 p -144.05 137.01 27.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.249 -1.389 . . . . 3.17 107.249 156.071 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.06 154.27 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.317 0.962 . . . . 2.88 110.213 179.035 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.28 137.66 32.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.027 0.931 . . . . 1.79 111.083 -176.032 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.1 mt -68.7 -34.5 75.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.677 1.191 . . . . 3.38 110.688 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -40.34 -42.36 1.54 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.904 1.682 . . . . 1.99 113.82 -174.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -138.61 35.8 2.22 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 123.086 0.554 . . . . 3.09 110.239 170.579 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 m120 42.23 46.93 3.98 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 127.314 2.245 . . . . 2.25 109.954 176.434 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -106.43 149.13 27.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.767 0.827 . . . . 3.43 110.927 -168.269 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.54 118.81 26.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.021 1.329 . . . . 1.89 107.743 172.056 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.64 102.44 14.18 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 102.375 -3.194 . . . . 3.12 102.375 176.794 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.83 139.04 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.193 -1.78 . . . . 2.35 106.193 176.532 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -122.87 115.74 22.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.288 -1.375 . . . . 4.32 107.288 169.214 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -121.66 161.72 22.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.837 1.655 . . . . 3.75 111.15 -173.051 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -92.29 119.81 67.95 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 126.246 1.818 . . . . 3.26 107.817 176.704 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.43 53.1 4.4 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.893 2.395 . . . . 2.6 110.195 179.52 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -103.17 -43.6 5.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.984 1.714 . . . . 6.39 109.62 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.06 -46.15 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.753 1.221 . . . . 3.8 112.109 -172.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 tp -81.77 150.09 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.033 0.933 . . . . 2.33 110.533 -167.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.62 -176.83 15.34 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.301 -1.12 . . . . 1.2 110.301 169.847 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -61.8 -38.47 59.53 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.454 2.103 . . . . 1.24 110.386 173.634 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -50.27 -50.71 49.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.372 1.069 . . . . 7.11 111.705 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.64 -54.59 45.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.742 0.817 . . . . 3.12 109.153 -177.665 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.6 mt -53.58 -49.11 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 123.853 0.861 . . . . 2.81 109.127 178.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.8 mt -52.81 -58.9 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 123.451 0.701 . . . . 2.21 109.956 -178.672 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -66.08 -34.61 78.45 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.158 0.504 . . . . 4.61 111.114 -176.608 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.0 m -57.13 -51.7 68.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.314 -0.625 . . . . 1.81 109.314 174.245 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.78 -35.05 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.548 -0.72 . . . . 2.28 111.541 -176.441 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -50.06 -52.98 30.13 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.329 -0.619 . . . . 2.82 109.329 166.128 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.5 t -57.61 -43.88 85.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.475 0.31 . . . . 2.49 111.574 177.232 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.3 mt -61.54 -27.58 68.71 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.207 -0.933 . . . . 2.74 112.395 176.387 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.55 35.69 1.39 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.52 1.057 . . . . 1.44 112.924 167.761 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -139.35 152.61 47.3 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.08 -1.082 . . . . 3.36 108.08 173.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -96.93 113.82 63.58 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.877 -0.786 . . . . 3.39 108.877 176.741 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -90.3 122.29 0.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.596 2.864 . . . . 1.1 111.563 -177.989 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.6 m -116.93 132.53 56.68 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 107.352 -1.351 . . . . 2.51 107.352 170.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mp -56.99 133.08 54.61 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.088 0.858 . . . . 5.0 110.341 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.57 -51.1 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 108.5 -0.926 . . . . 6.44 108.5 172.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -104.86 112.05 25.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.166 0.986 . . . . 6.72 109.256 -173.338 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.283 3.4 tt 59.15 174.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.168 2.187 . . . . 10.26 112.78 176.465 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--O 1.256 1.408 0 N-CA-C 104.963 -2.236 . . . . 12.45 104.963 179.436 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.472 0.662 0 CA-C-O 119.478 -0.296 . . . . 10.35 111.795 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.09 64.0 0.55 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 106.99 -2.444 . . . . 3.83 106.99 -177.658 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.39 150.0 19.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.231 -1.396 . . . . 4.13 107.231 -156.899 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.42 118.68 0.66 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.855 -1.698 . . . . 2.84 108.855 -175.297 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -81.45 139.89 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.302 -0.999 . . . . 3.93 108.302 178.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.3 153.17 25.25 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.779 -0.823 . . . . 3.93 108.779 171.495 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -126.86 138.61 53.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.993 0.917 . . . . 2.64 110.424 177.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.52 140.72 31.91 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.186 0.994 . . . . 2.35 108.907 -179.77 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 t -76.57 127.04 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 105.205 -2.146 . . . . 2.3 105.205 173.743 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 m -114.69 88.31 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 124.989 1.316 . . . . 1.72 107.606 -175.619 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.9 mtp-105 -77.04 137.5 39.0 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.559 -0.904 . . . . 7.0 108.559 -173.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.68 -41.72 1.47 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.938 -0.865 . . . . 0.89 110.938 177.103 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -68.88 152.2 45.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.906 0.853 . . . . 2.39 110.881 -176.761 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -152.34 1.15 0.32 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.392 1.256 . . . . 2.86 114.392 -175.124 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 p -162.33 164.8 27.24 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 120.18 1.355 . . . . 1.22 109.725 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.21 -41.14 12.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.169 1.388 . . . . 1.95 111.403 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -36.93 -51.83 0.92 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.28 2.232 . . . . 2.9 112.152 170.174 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.8 m -72.5 -51.49 19.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.862 0.865 . . . . 0.83 110.983 176.588 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -46.97 -60.46 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 C-N-CA 125.199 1.4 . . . . 1.58 109.017 -171.879 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -65.54 -24.81 67.2 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.872 -1.058 . . . . 1.24 111.329 -175.746 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -55.07 20.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.224 -1.028 . . . . 6.03 108.224 174.556 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 mt -58.05 -54.57 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.271 -0.641 . . . . 2.05 109.271 -179.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -55.67 -59.39 4.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.928 0.491 . . . . 2.43 110.565 -177.521 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.5 t -53.24 -52.12 60.0 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.688 -0.486 . . . . 2.22 109.688 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 t -59.0 -40.61 85.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.958 0.503 . . . . 1.42 111.376 -176.332 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.16 -43.93 90.17 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.635 -0.698 . . . . 3.54 110.891 176.846 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.3 p -70.7 60.66 0.23 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.772 0.829 . . . . 2.28 112.057 178.966 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -153.78 -50.33 0.09 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 129.497 3.119 . . . . 8.14 107.709 -176.7 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -69.52 137.47 52.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.701 -0.481 . . . . 3.15 109.701 -177.403 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -56.69 150.88 15.0 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.463 -0.569 . . . . 7.09 109.463 174.058 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.39 -28.38 8.31 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-O 117.609 -1.662 . . . . 1.35 112.675 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.41 130.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 120.861 2.331 . . . . 2.56 107.159 172.691 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.4 mt -96.71 -48.75 5.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.902 1.281 . . . . 3.56 108.479 172.121 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -156.38 147.53 22.24 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 118.838 0.744 . . . . 4.27 109.646 177.328 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -121.34 150.81 40.89 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 107.197 -1.409 . . . . 2.39 107.197 170.395 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t -143.42 150.11 38.59 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 118.491 -1.284 . . . . 3.25 108.79 141.827 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.74 132.77 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.737 0.815 . . . . 2.89 110.279 177.235 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.48 134.93 54.64 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.72 0.808 . . . . 1.72 110.569 -177.804 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.81 -34.58 77.04 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.65 1.18 . . . . 3.45 110.349 177.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -39.33 -41.87 0.97 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.227 1.811 . . . . 2.16 113.922 -176.164 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -137.72 33.0 2.46 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.898 0.856 . . . . 3.87 110.026 173.447 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 31.22 64.19 0.19 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 128.08 2.552 . . . . 2.9 111.964 -174.86 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.72 135.07 36.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.966 -0.561 . . . . 3.09 110.971 -166.487 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.12 140.78 34.94 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.604 1.962 . . . . 1.76 108.949 177.574 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -109.21 141.15 41.89 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.652 -1.61 . . . . 4.49 106.652 158.012 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 5.1 mp -125.32 114.48 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.837 -1.912 . . . . 2.58 105.837 176.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -93.4 99.59 12.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.217 -2.142 . . . . 4.36 105.217 171.975 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -125.99 167.07 15.81 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.047 1.339 . . . . 3.38 111.845 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -77.73 109.62 10.33 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.958 1.703 . . . . 2.97 109.82 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.32 63.24 8.7 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.363 2.709 . . . . 1.91 112.105 -167.888 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.74 -74.35 0.1 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.968 0.907 . . . . 3.26 110.04 177.807 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.5 pt -58.38 -26.93 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.084 0.954 . . . . 3.05 113.229 -177.89 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 tt -135.44 162.91 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.609 1.163 . . . . 2.01 108.297 -178.422 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.96 179.16 27.89 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.46 -1.456 . . . . 1.22 109.46 -174.029 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.13 -40.66 67.87 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.795 2.33 . . . . 1.1 111.608 -172.204 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -59.88 -37.04 78.22 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.453 0.538 . . . . 8.38 112.453 -175.492 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.3 -50.96 70.89 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.341 0.591 . . . . 3.93 109.805 179.136 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.9 mt -55.23 -50.18 66.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.643 -0.873 . . . . 2.68 108.643 176.168 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 mt -54.63 -53.16 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-O 119.382 -0.342 . . . . 1.75 110.206 -178.08 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -56.47 -43.76 79.89 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.275 0.559 . . . . 4.07 109.74 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.3 m -58.63 -53.96 52.4 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.034 -0.53 . . . . 1.63 110.331 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 mm -65.55 -39.98 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.335 -0.853 . . . . 3.33 111.186 -177.252 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -53.39 -48.92 68.22 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.6 -0.519 . . . . 2.98 109.6 169.733 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 m -61.6 -42.57 99.05 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.93 0.344 . . . . 2.79 111.93 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.9 mt -61.43 -36.83 81.45 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.518 0.599 . . . . 2.06 110.948 175.039 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.81 47.42 0.73 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 123.97 0.795 . . . . 0.85 111.763 172.145 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -134.86 160.86 36.9 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 106.571 -1.64 . . . . 3.37 106.571 168.116 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -97.84 105.5 27.68 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.234 -0.889 . . . . 3.26 109.774 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -84.25 136.17 6.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.699 2.266 . . . . 1.56 110.123 176.852 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t -146.79 129.84 16.42 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.968 -0.752 . . . . 3.2 108.968 171.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.435 ' CD2' ' H ' ' A' ' 71' ' ' LEU . 1.7 mm? -54.33 127.74 28.55 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.939 1.295 . . . . 3.7 110.593 -174.66 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.76 -43.67 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.311 0.505 . . . . 5.79 110.319 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -162.94 -165.65 1.16 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.482 1.913 . . . . 7.06 107.56 175.694 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.3 mm 76.18 -55.72 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 126.815 2.046 . . . . 9.77 108.208 -165.541 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 105.928 -1.879 . . . . 11.47 105.928 154.568 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 108.667 -0.864 . . . . 8.73 108.667 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.28 170.38 39.59 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 107.438 -2.265 . . . . 3.23 107.438 177.815 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.58 150.96 4.57 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.408 1.083 . . . . 4.04 111.179 -177.248 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.64 156.06 26.59 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.869 -1.692 . . . . 1.83 108.869 173.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.18 128.91 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.945 -1.502 . . . . 4.11 106.945 170.309 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.8 mp -128.45 151.34 49.5 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.297 -1.001 . . . . 4.17 108.297 177.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -125.06 129.55 50.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.189 0.996 . . . . 3.12 109.983 -166.607 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.71 136.63 36.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.532 1.133 . . . . 2.28 108.603 -174.102 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.33 124.6 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 104.671 -2.344 . . . . 2.45 104.671 174.387 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 m -106.31 67.53 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 106.973 -1.491 . . . . 1.79 106.973 -178.611 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -76.72 132.93 39.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.818 -0.808 . . . . 6.67 108.818 -166.307 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.63 -47.66 1.0 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.399 -1.48 . . . . 0.68 109.399 -169.284 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 142.09 36.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.683 0.741 . . . . 2.21 109.392 -176.766 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -156.75 19.05 0.32 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.529 0.937 . . . . 2.98 113.529 -173.795 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.78 153.73 25.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.355 0.98 . . . . 1.47 110.018 179.499 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.34 -37.7 7.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.105 1.762 . . . . 2.07 112.812 -173.706 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 t -47.01 -54.73 9.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.173 0.589 . . . . 2.4 110.167 174.541 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.9 m -69.02 -33.49 73.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.18 -0.325 . . . . 0.85 110.903 -176.15 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.8 t -57.08 -60.76 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.197 -1.038 . . . . 1.78 108.197 -178.372 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -68.54 -30.18 68.92 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.426 -0.807 . . . . 1.96 111.104 -176.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -56.94 -59.34 5.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 118.911 0.778 . . . . 6.53 109.991 170.158 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -52.17 -51.61 29.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 118.905 0.775 . . . . 2.27 108.975 -178.435 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -50.97 -64.24 0.87 Allowed 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 123.991 0.807 . . . . 3.3 110.657 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.0 m -58.38 -42.25 86.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.946 0.879 . . . . 2.68 111.209 -177.003 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 t -66.44 -39.11 88.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.299 1.039 . . . . 1.44 110.029 -174.478 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.8 mt -71.76 -55.24 8.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 118.708 -0.663 . . . . 3.25 112.1 173.005 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.9 p -64.13 74.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.975 1.31 . . . . 2.47 112.592 -167.484 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -174.88 -40.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.372 2.269 . . . . 4.32 110.076 -175.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.0 p80 -73.98 172.46 11.6 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.293 0.568 . . . . 2.65 112.097 -172.152 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -51.28 128.05 21.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.68 -0.691 . . . . 13.25 110.74 178.125 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.27 -15.23 7.17 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.583 -1.676 . . . . 1.35 116.692 160.086 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.1 109.59 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 121.805 2.802 . . . . 3.36 109.257 175.371 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.35 -42.03 31.73 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.157 -0.683 . . . . 3.57 109.157 -178.613 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -157.41 158.92 36.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.718 0.69 . . . . 4.37 109.268 177.368 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.445 ' HG ' ' CD1' ' A' ' 46' ' ' ILE . 11.6 t -124.16 138.78 54.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.001 1.72 . . . . 2.56 106.602 179.625 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.1 m -144.52 104.53 4.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.344 -0.984 . . . . 2.6 108.344 166.619 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.5 m -101.98 138.4 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 O-C-N 123.42 0.45 . . . . 3.12 111.131 172.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.83 133.15 55.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.588 0.755 . . . . 1.9 109.208 171.474 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -80.86 -33.67 34.27 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.35 -0.841 . . . . 3.05 111.366 -169.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.41 -34.33 61.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.171 0.588 . . . . 2.68 112.248 178.121 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -104.97 2.73 29.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.098 1.359 . . . . 3.36 111.562 176.761 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.4 m120 41.24 44.28 2.22 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.21 2.204 . . . . 2.14 111.351 -172.769 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.2 tmmt? -135.97 136.13 40.13 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 122.024 -0.423 . . . . 3.63 111.461 -165.332 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.51 139.28 34.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.653 1.981 . . . . 1.82 109.15 173.57 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.75 131.23 53.36 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.125 -2.176 . . . . 3.37 105.125 149.473 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.445 ' CD1' ' HG ' ' A' ' 35' ' ' CYS . 31.6 mm -115.57 131.01 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.367 -1.345 . . . . 3.1 107.367 172.912 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -93.13 64.62 3.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.385 1.074 . . . . 4.14 108.97 175.81 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -88.34 141.58 28.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 112.744 0.646 . . . . 4.12 112.744 175.579 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -62.34 115.66 17.73 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.694 -0.854 . . . . 2.47 108.694 173.843 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.76 65.84 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.78 2.32 . . . . 1.62 111.425 -168.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -162.18 -79.07 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.338 0.655 . . . . 3.52 112.137 -177.693 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -34.82 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 121.528 -0.733 . . . . 3.86 111.12 -176.762 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 tp -105.31 150.05 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.234 -1.765 . . . . 2.11 106.234 170.88 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -141.25 170.43 24.65 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.352 -1.099 . . . . 0.91 110.352 -177.615 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -57.03 -43.4 54.26 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.482 2.788 . . . . 0.84 110.489 -177.485 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -57.23 -44.71 84.04 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.247 0.476 . . . . 7.63 112.019 176.924 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -63.36 -49.15 74.98 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.972 -0.751 . . . . 3.84 108.972 -178.022 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.6 mm -50.57 -51.65 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.877 0.471 . . . . 3.22 111.036 172.599 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.6 mt -57.42 -52.62 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.284 0.634 . . . . 1.91 109.962 -178.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -55.8 -44.64 78.0 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 122.343 1.068 . . . . 4.64 109.298 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -61.18 -50.48 72.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.791 -1.095 . . . . 2.01 110.304 -178.895 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -71.86 -44.49 67.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-O 119.123 -0.465 . . . . 2.15 111.717 -175.526 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.31 -42.38 77.52 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.885 0.766 . . . . 3.23 110.427 -176.694 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -51.04 -28.67 10.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.673 0.99 . . . . 2.44 113.673 172.782 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.68 -16.68 58.33 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.069 0.85 . . . . 2.28 112.051 178.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.8 31.26 8.8 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.902 0.763 . . . . 0.76 112.531 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -129.99 140.4 50.9 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 105.394 -2.076 . . . . 3.33 105.394 167.846 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -87.59 111.25 40.6 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 117.985 -1.007 . . . . 2.82 109.586 -173.903 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.86 128.31 5.11 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.958 2.438 . . . . 1.42 109.838 176.673 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -138.2 111.93 8.28 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.563 -0.903 . . . . 3.4 108.563 177.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -56.03 131.06 46.41 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.284 1.034 . . . . 3.66 110.985 -179.172 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -131.75 -51.12 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 112.746 0.646 . . . . 4.9 112.746 -173.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.3 tptp 56.73 -138.68 0.96 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 119.046 -0.502 . . . . 6.97 110.992 -166.283 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.2 151.21 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 105.976 -1.861 . . . . 7.52 105.976 178.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 C--O 1.251 1.157 0 N-CA-C 105.012 -2.218 . . . . 10.32 105.012 173.219 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 106.608 -1.627 . . . . 2.39 106.608 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.7 tp -144.01 140.13 29.41 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 105.808 -1.923 . . . . 3.01 105.808 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -106.3 135.74 47.25 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 124.449 1.093 . . . . 2.79 109.264 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.52 137.03 54.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.079 1.352 . . . . 1.36 107.888 174.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 t -82.68 114.99 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.772 -1.566 . . . . 1.4 106.772 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 m -106.66 84.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 126.747 2.019 . . . . 0.83 108.849 -166.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.76 122.41 25.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.493 -1.299 . . . . 5.11 107.493 -174.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.78 -37.0 2.41 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.548 1.07 . . . . 0.95 110.755 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.62 113.4 24.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.683 -1.599 . . . . 1.83 106.683 -172.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.84 25.46 0.27 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.245 1.202 . . . . 3.85 114.245 -167.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.6 p -147.34 167.19 24.93 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 120.957 -1.09 . . . . 1.27 108.205 161.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.08 -36.77 13.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.477 1.111 . . . . 1.06 112.059 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -59.44 -50.31 74.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 110.145 -0.317 . . . . 1.89 110.145 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -61.92 -41.35 97.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.681 -0.637 . . . . 0.71 110.929 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.0 t -51.5 -61.11 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.417 -0.957 . . . . 0.65 108.417 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.289 0.8 OUTLIER -66.65 -29.6 69.66 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 118.829 -0.605 . . . . 0.98 111.553 -174.035 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -52.94 -58.99 5.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.197 0.999 . . . . 3.79 109.127 170.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.8 mt -61.34 -59.0 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.761 -0.776 . . . . 0.75 108.918 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.87 -52.53 60.17 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 119.394 -0.336 . . . . 2.63 110.85 -168.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -62.04 -44.08 97.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.877 0.471 . . . . 2.39 111.561 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.8 t -64.85 -35.0 79.7 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.745 -0.597 . . . . 1.0 110.982 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -70.61 -48.36 55.49 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 118.53 -0.748 . . . . 1.7 111.407 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 p -68.06 72.75 0.18 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.052 0.93 . . . . 1.84 112.645 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.83 -38.88 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.992 2.117 . . . . 4.18 110.352 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -70.92 132.03 44.62 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.043 0.838 . . . . 2.45 109.551 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -55.21 149.56 12.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.45 -0.574 . . . . 6.07 109.45 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.01 -39.82 2.62 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.432 -1.067 . . . . 1.02 110.432 -173.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.69 111.62 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 119.086 1.443 . . . . 1.92 109.249 -172.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.1 mt -80.0 -46.81 15.97 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.698 -0.853 . . . . 2.04 108.698 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -157.18 130.99 8.15 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 109.105 -0.702 . . . . 2.28 109.105 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.8 p -97.17 152.3 18.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.038 -1.097 . . . . 2.76 108.038 165.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.9 t -155.55 150.44 26.48 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 119.534 -0.866 . . . . 2.35 108.91 140.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.36 143.61 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.72 0.808 . . . . 1.91 110.014 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.4 132.43 41.16 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.568 0.747 . . . . 0.91 110.555 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.4 -26.97 52.23 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.182 -0.917 . . . . 2.47 111.729 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -46.74 -44.53 18.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.16 0.984 . . . . 1.42 112.399 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -117.49 18.45 14.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.66 1.184 . . . . 2.69 110.866 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 35.06 54.99 0.76 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 127.144 2.178 . . . . 2.42 111.909 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -112.59 148.56 34.3 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.589 0.756 . . . . 1.66 109.551 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.83 125.73 47.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.249 -1.76 . . . . 1.0 106.249 166.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.474 ' C ' HD12 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -107.45 129.72 54.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.122 -1.436 . . . . 2.65 107.122 169.301 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.474 HD12 ' C ' ' A' ' 45' ' ' HIS . 2.2 mp -119.45 110.75 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 104.685 -2.339 . . . . 1.21 104.685 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -83.08 70.36 10.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.655 -1.239 . . . . 3.76 107.655 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -86.68 141.34 29.0 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.987 0.515 . . . . 2.54 111.976 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -57.13 112.46 4.64 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.229 -1.026 . . . . 2.43 108.229 169.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.48 48.7 2.95 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.338 2.692 . . . . 1.65 111.891 -166.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -137.29 -63.09 0.6 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.933 1.293 . . . . 3.86 109.365 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.2 pt -77.09 -24.02 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.025 0 N-CA-C 112.921 0.712 . . . . 1.93 112.921 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.2 tt -139.82 143.09 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.921 -0.77 . . . . 1.3 108.921 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -117.72 175.11 15.56 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.296 0.951 . . . . 0.87 112.177 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -61.43 -38.91 60.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.01 2.473 . . . . 0.84 110.795 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -46.43 -53.02 11.89 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.158 0.983 . . . . 7.19 110.592 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -67.62 -46.54 72.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.957 -1.127 . . . . 2.93 107.957 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.3 mm -54.46 -46.65 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.572 0.349 . . . . 2.04 111.39 172.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.0 mt -53.67 -54.32 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.432 -0.581 . . . . 0.98 109.432 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -61.22 -42.89 99.39 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.537 0.684 . . . . 2.6 110.441 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.1 m -58.33 -49.3 77.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.587 0.755 . . . . 1.09 109.832 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 mm -68.24 -43.25 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 119.289 -0.386 . . . . 1.47 110.257 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -52.62 -42.3 64.47 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.465 0.575 . . . . 5.16 110.684 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.0 m -54.8 -23.45 18.21 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.075 0.769 . . . . 1.67 113.075 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 mt -87.06 -9.94 54.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.906 0.883 . . . . 1.0 112.117 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.9 40.16 6.31 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.085 1.326 . . . . 0.82 112.489 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -142.07 141.09 32.74 Favored 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 106.529 -1.656 . . . . 2.01 106.529 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -91.13 113.83 59.56 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 119.56 1.073 . . . . 5.57 109.989 -172.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -91.96 140.27 2.29 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.974 3.116 . . . . 1.66 110.696 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.8 m -145.02 125.61 14.12 Favored 'General case' 0 C--N 1.335 -0.063 0 O-C-N 120.657 -1.277 . . . . 2.71 109.023 167.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.45 136.19 57.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.661 1.184 . . . . 2.55 111.938 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 123.993 0.917 . . . . 2.79 111.488 175.533 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 110.066 -0.346 . . . . 2.92 110.066 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -123.29 137.36 54.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.892 -1.521 . . . . 3.52 106.892 169.05 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -105.46 106.29 16.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.539 1.535 . . . . 4.16 108.451 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.03 126.39 52.67 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.235 -1.394 . . . . 1.46 107.235 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.98 95.36 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 106.855 -1.535 . . . . 1.03 106.855 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.16 65.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.064 1.745 . . . . 0.76 109.231 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -74.67 131.47 40.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.058 -1.089 . . . . 4.94 108.058 -172.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.51 -49.69 0.83 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.545 -1.422 . . . . 0.75 109.545 -167.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -74.94 149.81 39.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.072 0.936 . . . . 1.32 110.165 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 t -153.34 22.3 0.55 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.433 0.531 . . . . 2.5 112.433 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.16 145.41 19.39 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.775 0.716 . . . . 1.56 109.927 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.51 -40.25 37.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.976 1.31 . . . . 1.16 111.317 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -41.27 -49.6 3.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.996 1.718 . . . . 2.04 111.822 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -73.8 -42.97 60.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.848 1.055 . . . . 1.32 113.848 174.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.8 t -49.0 -57.05 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.673 0.749 . . . . 0.94 109.292 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -69.3 -24.12 63.9 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.535 -0.757 . . . . 1.22 111.956 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -58.63 -54.13 50.53 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.03 -1.47 . . . . 3.71 107.03 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.77 -59.03 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 109.316 -0.624 . . . . 0.74 109.316 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -54.64 -56.57 17.67 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.374 0.533 . . . . 2.55 111.407 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.4 t -54.56 -47.66 72.98 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.315 1.046 . . . . 1.67 110.53 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -59.63 -51.61 69.08 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.144 -0.347 . . . . 1.18 110.517 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.43 -34.15 77.52 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.786 -0.572 . . . . 2.16 111.953 -176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 p -65.49 72.12 0.05 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.422 0.555 . . . . 2.0 110.877 170.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -150.52 -43.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.447 1.899 . . . . 5.76 111.817 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -57.55 -43.37 84.41 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.429 0.9 . . . . 3.82 113.429 -168.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 131.36 -82.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 129.583 3.153 . . . . 6.72 107.841 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.19 54.24 3.9 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 123.821 0.724 . . . . 1.64 112.995 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.08 129.12 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.427 -1.694 . . . . 1.85 106.427 157.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.4 mt -85.44 -45.03 12.23 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.045 -0.724 . . . . 2.16 109.045 172.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -155.8 120.24 4.62 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.91 0.323 . . . . 2.56 110.883 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.8 m -79.89 135.7 36.5 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 106.361 -1.718 . . . . 2.9 106.361 164.189 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 t -140.52 96.54 3.05 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.346 0.975 . . . . 2.31 108.713 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -105.92 135.63 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.4 1.08 . . . . 2.62 109.214 -172.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.76 134.64 23.73 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.3 0.572 . . . . 0.67 111.186 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 pp -76.23 -26.48 56.09 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.006 0.922 . . . . 1.87 111.394 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.04 -36.76 41.44 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.413 1.085 . . . . 1.07 112.371 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 p -129.62 31.51 4.76 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.479 0.712 . . . . 2.4 110.343 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.7 m120 33.73 54.99 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.916 2.486 . . . . 1.88 112.408 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -133.47 157.42 45.66 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.525 0.33 . . . . 2.07 111.886 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.47 127.09 54.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.097 -1.816 . . . . 0.65 106.097 161.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.49 129.22 38.49 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 103.97 -2.604 . . . . 2.31 103.97 154.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.9 mt -118.55 118.32 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 105.229 -2.137 . . . . 1.45 105.229 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -89.88 104.94 17.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.421 -1.696 . . . . 3.37 106.421 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -132.03 151.87 51.49 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 123.576 0.547 . . . . 2.33 112.229 -171.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -90.79 112.51 53.81 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 125.104 1.362 . . . . 3.08 108.402 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -77.84 41.26 0.97 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.457 2.105 . . . . 1.63 112.243 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.68 -37.86 17.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.086 0.954 . . . . 5.46 110.249 170.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.12 -54.46 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.682 1.193 . . . . 2.07 110.896 -174.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.2 123.73 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.165 -0.68 . . . . 1.72 109.165 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.83 -175.45 22.27 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 109.565 -1.414 . . . . 0.65 109.565 170.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -59.39 -36.31 94.38 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.804 1.669 . . . . 0.85 109.949 170.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -45.56 -59.67 2.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.45 1.5 . . . . 6.33 111.777 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.84 -51.43 69.74 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.617 1.567 . . . . 2.31 110.426 -172.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 94.5 mt -52.34 -54.25 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 114.209 -1.36 . . . . 1.46 108.478 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.9 mt -60.04 -53.39 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.94 -0.573 . . . . 0.68 109.681 -172.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -58.83 -39.98 82.82 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.739 0.699 . . . . 3.0 110.655 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.0 m -56.65 -52.23 65.7 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.311 -0.404 . . . . 0.96 110.227 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.06 -40.52 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.8 -0.562 . . . . 1.05 111.149 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -47.15 -49.35 22.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.34 0.656 . . . . 3.5 109.398 169.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -58.45 -24.37 60.1 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.446 0.906 . . . . 1.33 113.446 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.1 mt -84.94 -12.85 52.46 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.092 0.86 . . . . 1.18 112.069 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.09 44.22 4.8 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.101 0.858 . . . . 0.88 112.769 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -138.61 159.47 42.02 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 106.846 -1.539 . . . . 1.96 106.846 170.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -98.35 98.85 6.28 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.433 -0.794 . . . . 2.87 110.507 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.82 80.79 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 124.314 3.343 . . . . 0.92 110.717 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 m -79.27 101.37 7.99 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.237 -1.023 . . . . 1.92 108.237 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.5 64.16 0.11 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.893 1.677 . . . . 2.93 113.22 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.4 t . . . . . 0 CA--C 1.535 0.386 0 O-C-N 121.637 -0.664 . . . . 2.42 111.237 -177.117 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 107.131 -1.433 . . . . 2.81 107.131 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.8 tp -124.13 144.28 49.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.05 -2.204 . . . . 2.6 105.05 155.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -114.19 132.42 56.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.933 -0.766 . . . . 2.19 108.933 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 mt -118.48 123.98 46.49 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.99 -1.856 . . . . 2.84 105.99 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -78.9 95.18 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.592 -2.003 . . . . 1.44 105.592 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.26 84.07 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 126.319 1.847 . . . . 0.83 108.858 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 -75.6 130.87 39.49 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.935 -1.135 . . . . 5.0 107.935 -171.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.78 -48.46 0.97 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.399 1.0 . . . . 1.25 110.945 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -64.87 127.56 32.08 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.69 0.745 . . . . 1.6 110.37 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -144.6 5.34 1.2 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.246 1.202 . . . . 2.62 114.246 -167.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 p -160.84 166.39 28.62 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.645 1.112 . . . . 1.55 109.601 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.47 -45.3 9.1 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.201 1.4 . . . . 0.75 111.503 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -42.26 -49.24 5.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.067 1.747 . . . . 1.88 112.457 172.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.3 m -72.69 -51.18 20.43 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.153 0.581 . . . . 0.94 111.136 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -46.74 -58.84 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.045 0.938 . . . . 0.66 109.039 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -69.83 -23.53 63.32 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.989 -1.005 . . . . 0.94 111.942 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -67.66 -51.69 46.88 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 107.892 -1.151 . . . . 3.82 107.892 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 mt -55.39 -58.81 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.734 -0.839 . . . . 0.74 108.734 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.07 -54.62 32.8 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.001 0.364 . . . . 2.76 111.612 -174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -60.66 -45.09 95.45 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.158 -0.339 . . . . 1.76 111.912 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 t -62.97 -49.59 74.13 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.903 -0.498 . . . . 1.25 110.226 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.461 HD11 HG23 ' A' ' 58' ' ' ILE . 3.5 mm? -51.19 -47.16 62.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.708 0.803 . . . . 1.78 110.548 177.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 p -62.31 -0.31 0.55 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.629 1.344 . . . . 2.13 114.629 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -57.49 -42.59 83.0 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.306 1.412 . . . . 6.42 110.66 164.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -94.12 138.92 31.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.339 -0.544 . . . . 2.54 111.867 -155.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -60.27 167.54 2.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.532 0.682 . . . . 5.77 109.905 169.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.09 -15.23 0.74 Allowed Glycine 0 CA--C 1.521 0.459 0 CA-C-O 117.669 -1.629 . . . . 1.11 113.555 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.3 139.63 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 120.365 2.083 . . . . 1.64 105.746 165.023 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.6 mt -102.58 -37.98 7.72 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.927 -1.033 . . . . 2.37 108.506 164.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -157.54 155.13 29.71 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.58 1.082 . . . . 2.25 109.872 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.8 t -126.04 143.08 51.25 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.397 -2.075 . . . . 2.12 105.397 162.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -149.16 148.67 29.91 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 118.097 -1.441 . . . . 2.27 109.965 144.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 44' ' ' ALA . 2.4 m -125.9 142.41 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 123.882 0.739 . . . . 1.95 111.467 -172.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.17 128.09 44.14 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.205 1.002 . . . . 0.93 111.027 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.68 -36.67 32.01 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 114.27 -1.332 . . . . 2.08 113.209 -163.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.73 -37.8 59.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.54 0.609 . . . . 1.71 111.148 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -96.12 -7.59 35.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.318 2.247 . . . . 2.73 111.694 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.7 m120 41.95 48.08 3.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.737 1.615 . . . . 2.18 110.79 -166.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -114.38 151.24 33.38 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.434 0.561 . . . . 1.64 111.255 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.439 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -123.92 121.78 36.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.88 1.672 . . . . 0.62 106.741 169.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -96.03 123.32 39.58 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.615 -2.365 . . . . 3.17 104.615 168.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.9 mm -104.64 130.17 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 106.916 -1.513 . . . . 1.76 106.916 168.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -98.4 101.06 12.39 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 105.083 -2.191 . . . . 2.68 105.083 162.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -129.77 155.15 46.4 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.925 1.29 . . . . 2.12 109.147 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -75.71 110.84 11.81 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.496 1.118 . . . . 2.81 108.696 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.39 58.58 6.75 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.279 2.653 . . . . 1.62 111.363 -173.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -135.16 -68.63 0.52 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.042 1.337 . . . . 4.36 108.99 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -91.0 -40.07 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.061 0 C-N-CA 123.062 0.545 . . . . 2.26 112.108 -172.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -97.01 119.08 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.639 -1.245 . . . . 1.57 107.639 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.81 163.5 36.69 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.123 -0.791 . . . . 1.29 111.123 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -54.63 -30.01 63.77 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.68 2.253 . . . . 1.29 110.842 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -55.06 -49.09 72.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.344 -1.312 . . . . 5.51 113.663 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.448 ' HB3' HD11 ' A' ' 53' ' ' ILE . 16.4 t0 -63.1 -49.49 74.24 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 121.312 1.869 . . . . 5.65 109.85 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.461 HG23 HD11 ' A' ' 26' ' ' LEU . 66.5 mt -47.17 -56.08 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-O 121.443 0.639 . . . . 1.27 109.772 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.8 mt -59.07 -55.95 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.823 -0.626 . . . . 0.92 109.663 -174.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -62.96 -34.14 76.88 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.936 -0.477 . . . . 2.6 111.475 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.3 m -56.56 -53.57 56.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.948 -0.76 . . . . 1.23 108.948 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.29 -39.43 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 121.507 -0.745 . . . . 1.13 111.373 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.77 -44.72 82.07 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.715 -0.616 . . . . 3.04 109.682 172.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.7 m -61.47 -41.43 97.23 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.201 -0.312 . . . . 1.36 111.6 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.66 -41.87 91.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.495 0.588 . . . . 1.44 110.724 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.86 45.28 0.83 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.286 0.946 . . . . 0.87 111.435 175.215 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.07 162.12 30.52 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.077 -1.453 . . . . 1.94 107.077 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -100.15 98.28 7.41 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 118.198 -0.906 . . . . 2.61 110.099 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.38 75.41 3.87 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.609 2.872 . . . . 1.21 110.111 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.6 m -79.99 107.63 12.93 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.491 -0.929 . . . . 1.77 108.491 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.76 59.36 0.47 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.679 0.791 . . . . 2.55 112.596 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 125.512 1.525 . . . . 3.35 107.307 178.651 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.236 0.352 0 N-CA-C 108.79 -0.819 . . . . 2.99 108.79 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 tp -104.0 149.59 25.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.663 -1.977 . . . . 2.94 105.663 165.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.33 151.19 37.5 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.312 -0.996 . . . . 2.27 108.312 165.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.13 130.43 23.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.35 -1.722 . . . . 1.38 106.35 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -79.62 100.81 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 105.411 -2.07 . . . . 1.02 105.411 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.2 m -81.83 79.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 126.353 1.861 . . . . 0.67 108.161 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.2 mtp-105 -76.74 141.72 40.73 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.605 -0.887 . . . . 5.36 108.605 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.63 -45.83 1.13 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.318 -1.113 . . . . 0.84 110.318 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.03 141.44 28.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.533 0.667 . . . . 1.7 109.644 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -152.81 41.91 0.6 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.304 0.502 . . . . 4.86 110.256 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.47 144.9 12.62 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.765 -0.585 . . . . 1.83 111.039 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.98 -39.85 20.68 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.598 1.559 . . . . 0.83 112.059 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.4 t -45.26 -51.44 10.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.056 0.542 . . . . 1.93 110.458 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.3 m -76.79 -33.85 58.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.101 -1.625 . . . . 1.42 114.169 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -46.75 -56.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.642 -0.873 . . . . 0.53 108.642 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.39 -21.84 62.81 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.167 -0.924 . . . . 0.84 112.825 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -64.89 -54.5 29.83 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 106.781 -1.563 . . . . 4.56 106.781 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.4 -56.47 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.852 -0.796 . . . . 0.75 108.852 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.31 -53.73 54.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.999 0.818 . . . . 2.6 111.693 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.1 t -63.76 -29.17 70.41 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.059 0.39 . . . . 1.59 111.756 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.4 t -71.05 -52.96 16.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.204 -0.665 . . . . 1.35 109.204 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -53.43 -46.14 69.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.152 0.981 . . . . 1.83 110.954 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.2 p -59.51 -16.73 26.46 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.953 0.723 . . . . 2.06 112.953 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -69.92 -24.0 63.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.819 1.19 . . . . 6.49 111.515 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -68.48 87.08 0.31 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.73 0.696 . . . . 3.01 109.885 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 23.27 -66.21 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.0 2.52 . . . . 10.26 116.758 145.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.52 48.39 0.97 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.338 0.97 . . . . 1.4 112.644 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -91.08 117.82 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.022 -1.473 . . . . 2.22 107.022 154.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -80.68 -35.5 33.59 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.758 -0.589 . . . . 2.67 110.45 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -157.01 135.6 11.49 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.948 0.795 . . . . 2.17 110.466 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.8 p -114.65 155.09 27.23 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.277 1.031 . . . . 2.55 108.389 165.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.6 m -149.47 141.34 23.72 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.184 -1.413 . . . . 2.03 107.184 150.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.94 135.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.732 0.813 . . . . 1.79 110.197 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.36 134.09 55.11 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.347 0.659 . . . . 0.63 110.149 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -82.07 -37.64 26.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.255 -0.884 . . . . 1.76 111.286 -171.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.94 64.21 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.36 0.664 . . . . 1.67 112.301 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.8 t -107.05 4.63 27.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.037 1.335 . . . . 2.41 111.234 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.9 m120 42.96 48.95 5.2 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.614 1.966 . . . . 1.87 110.83 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.15 137.23 30.74 Favored 'General case' 0 CA--C 1.522 -0.109 0 O-C-N 121.735 -0.603 . . . . 1.89 112.086 -165.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.2 142.09 32.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.625 1.57 . . . . 0.91 108.232 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.07 135.14 48.06 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.481 -2.044 . . . . 2.73 105.481 152.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.2 mt -134.79 114.87 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.159 -1.793 . . . . 1.07 106.159 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -97.28 80.03 2.86 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.701 -1.592 . . . . 2.55 106.701 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -85.53 143.1 28.7 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.63 -0.714 . . . . 2.33 111.638 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -75.41 111.34 13.57 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.626 1.17 . . . . 3.09 107.914 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.63 47.56 2.6 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.356 2.704 . . . . 1.42 113.234 -163.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -134.16 -63.9 0.71 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.37 1.468 . . . . 3.8 108.554 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.485 HD12 ' HB ' ' A' ' 53' ' ' ILE . 2.1 pp -70.5 -34.35 57.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 122.858 0.463 . . . . 2.23 111.462 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.485 ' HB ' HD12 ' A' ' 52' ' ' ILE . 8.6 tt -126.83 156.58 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.81 1.244 . . . . 1.86 110.406 -173.638 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -154.39 178.34 31.25 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 107.198 -2.361 . . . . 0.77 107.198 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.61 -50.24 14.72 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.399 2.733 . . . . 0.8 111.485 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -52.38 -44.97 65.6 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.59 0.959 . . . . 7.1 113.59 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -59.47 -60.01 4.53 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.574 0.702 . . . . 3.91 109.429 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mt -45.78 -54.43 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.466 1.106 . . . . 1.38 109.818 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.2 mt -59.25 -48.16 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.654 -0.703 . . . . 0.81 110.415 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -57.23 -41.77 80.16 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.764 0.711 . . . . 3.11 109.265 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.8 m -62.8 -51.18 68.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.863 -0.608 . . . . 1.19 110.728 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 98.0 mt -62.86 -44.35 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 118.86 0.755 . . . . 1.14 111.278 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -49.09 -48.9 43.96 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.562 0.745 . . . . 3.36 109.188 170.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t -62.8 -17.08 60.62 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.815 1.043 . . . . 1.98 113.815 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.02 -16.15 41.72 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.06 1.3 . . . . 1.11 111.23 171.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.62 42.38 6.49 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.866 0.746 . . . . 0.85 111.685 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -132.79 153.09 51.58 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.181 -1.414 . . . . 1.96 107.181 170.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.27 109.28 32.39 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.179 0.991 . . . . 2.71 109.165 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.52 77.86 3.9 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.462 2.108 . . . . 1.0 110.249 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.8 t -78.68 98.85 6.36 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.264 -0.897 . . . . 1.81 109.417 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.05 61.26 0.19 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.42 1.888 . . . . 2.76 113.241 -173.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 CA--C 1.535 0.393 0 C-N-CA 123.172 0.589 . . . . 2.5 109.866 -179.644 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 107.238 -1.393 . . . . 2.89 107.238 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.6 tp -95.88 148.64 22.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.536 -1.653 . . . . 2.85 106.536 166.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -136.87 127.25 26.59 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.876 0.87 . . . . 2.31 108.913 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.54 150.86 48.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.504 0.722 . . . . 3.43 110.308 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.0 t -84.89 124.22 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.284 -1.376 . . . . 1.14 107.284 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.59 102.91 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 126.994 2.118 . . . . 1.26 108.374 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -87.4 148.93 24.79 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.061 -0.718 . . . . 5.14 109.061 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.11 -52.35 0.64 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.23 -1.148 . . . . 0.77 110.23 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.79 134.92 56.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 117.285 0.542 . . . . 1.79 109.611 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.4 t -155.22 11.62 0.34 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.891 1.071 . . . . 2.17 113.891 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.6 p -161.11 171.75 18.0 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.808 1.185 . . . . 1.43 109.119 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -44.28 7.81 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.371 1.469 . . . . 0.78 111.594 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 t -52.83 -48.73 66.78 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.746 0.419 . . . . 2.05 110.071 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.3 m -70.65 -53.46 15.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.473 -0.767 . . . . 0.79 109.627 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -41.33 -60.21 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 125.787 1.635 . . . . 0.73 109.137 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.255 0.6 OUTLIER -68.25 -21.3 64.83 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.803 0.668 . . . . 0.92 112.803 -171.225 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -70.12 -46.91 63.82 Favored 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.978 -1.119 . . . . 4.4 107.978 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.67 -57.67 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.895 -0.78 . . . . 0.88 108.895 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.75 -56.49 18.71 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.373 0.269 . . . . 2.81 110.859 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.0 t -58.34 -50.07 74.94 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.997 0.427 . . . . 1.53 110.71 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.4 t -69.2 -27.14 65.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.551 -0.718 . . . . 1.02 111.445 -173.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.11 -52.52 23.03 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.383 0.538 . . . . 2.25 110.651 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -70.06 67.68 0.29 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.398 1.094 . . . . 1.73 112.321 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -169.91 -38.03 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.968 2.507 . . . . 3.73 109.624 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -69.84 137.68 51.95 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.939 0.791 . . . . 2.17 110.205 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 -50.84 143.87 9.32 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.622 -0.51 . . . . 5.49 109.622 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.27 -20.43 37.29 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-O 118.05 -1.417 . . . . 0.99 113.407 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.52 133.98 29.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 N-CA-C 105.849 -1.908 . . . . 1.53 105.849 160.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.5 mt -97.44 -48.45 5.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.477 1.111 . . . . 2.3 108.106 168.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -156.14 153.64 29.62 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.608 -0.516 . . . . 2.53 109.608 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.9 t -132.79 145.48 51.03 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.451 -1.314 . . . . 2.2 107.451 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -136.04 153.08 51.46 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.502 -1.296 . . . . 2.8 107.502 142.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.403 HG12 ' CB ' ' A' ' 44' ' ' ALA . 2.2 m -125.37 143.61 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.902 0.881 . . . . 1.89 109.742 175.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.51 129.95 41.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.802 0.811 . . . . 0.79 111.802 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.56 -28.64 62.95 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.752 1.221 . . . . 2.33 111.33 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.78 -44.16 73.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.035 0.534 . . . . 1.09 111.064 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.52 -31.27 17.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.472 -0.566 . . . . 2.25 109.472 172.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 79.24 41.81 0.08 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.997 2.119 . . . . 3.54 107.796 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -133.6 141.66 47.76 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.741 -0.466 . . . . 2.25 109.741 -168.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.403 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -103.54 136.73 42.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.015 1.326 . . . . 0.59 107.949 168.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -102.36 150.15 23.62 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.085 -1.45 . . . . 3.55 107.085 159.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.44 HG22 ' HB3' ' A' ' 48' ' ' TYR . 1.3 mp -134.63 101.35 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.543 -2.021 . . . . 1.18 105.543 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -81.18 123.6 28.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.196 -2.149 . . . . 3.57 105.196 170.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' TYR . . . . . 0.44 ' HB3' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -163.72 170.48 16.94 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 120.958 0.408 . . . . 2.5 110.644 -152.583 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -101.51 93.82 3.69 Favored Pre-proline 0 N--CA 1.447 -0.592 0 C-N-CA 125.544 1.538 . . . . 2.97 108.733 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.82 52.93 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.679 2.92 . . . . 1.73 110.799 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -159.99 25.66 0.17 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.464 1.506 . . . . 4.72 109.287 -169.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -167.17 -50.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 126.503 1.921 . . . . 3.18 108.069 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.1 tt -118.85 157.39 20.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 124.625 1.17 . . . . 1.12 109.51 -172.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.36 -177.27 16.37 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.154 -0.778 . . . . 0.62 111.154 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.41 -39.94 42.87 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.543 2.162 . . . . 0.79 110.15 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -48.37 -53.4 17.71 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.574 1.15 . . . . 6.1 111.476 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.72 -52.09 66.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.211 0.529 . . . . 2.55 109.637 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.8 mt -55.87 -52.97 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.75 0.82 . . . . 1.43 108.974 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.455 HD11 HD21 ' A' ' 71' ' ' LEU . 20.2 mt -50.97 -55.1 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.246 -0.65 . . . . 0.57 109.246 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -66.02 -37.87 86.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.152 0.501 . . . . 2.84 110.703 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.3 m -55.59 -47.79 75.91 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.283 -0.417 . . . . 0.72 110.345 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 79.8 mt -70.26 -44.04 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.757 -0.589 . . . . 1.02 110.953 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -49.58 -44.61 47.09 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.645 0.778 . . . . 2.69 109.894 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -52.78 -34.7 54.58 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.147 0.579 . . . . 2.04 112.521 175.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.5 mt -76.72 -13.37 60.04 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.368 -0.832 . . . . 1.1 112.319 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.87 45.46 5.7 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.731 0.681 . . . . 0.81 111.791 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -132.81 156.56 46.89 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.182 -1.414 . . . . 1.84 107.182 171.655 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -96.4 99.7 5.82 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-O 117.547 -1.216 . . . . 2.63 110.406 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -79.08 143.53 17.95 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 CA-C-N 121.43 1.547 . . . . 1.69 109.389 169.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 p -155.46 121.17 5.02 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.588 -0.695 . . . . 1.64 109.484 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.686 HD22 ' H ' ' A' ' 71' ' ' LEU . 1.5 mm? -61.25 133.76 56.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.904 0.882 . . . . 2.9 111.584 -169.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.9 t . . . . . 0 N--CA 1.465 0.318 0 C-N-CA 123.217 0.607 . . . . 2.45 111.604 175.487 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.236 0.389 0 CA-C-O 122.47 1.128 . . . . 2.47 108.429 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mp -93.8 139.14 31.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.344 -0.844 . . . . 3.1 109.254 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.0 106.33 11.49 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.611 1.964 . . . . 3.25 107.496 -170.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.24 133.28 53.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.264 -1.384 . . . . 1.48 107.264 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.88 112.37 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -94.66 95.42 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.365 1.866 . . . . 0.67 107.813 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.35 155.75 29.91 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 119.278 -0.969 . . . . 4.97 108.404 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 -51.85 0.68 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.631 -0.987 . . . . 0.67 110.631 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -63.22 141.03 58.92 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 117.412 0.606 . . . . 1.84 111.355 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -155.1 10.85 0.34 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.067 1.136 . . . . 2.26 114.067 -173.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -162.0 161.46 28.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.853 1.206 . . . . 1.39 109.829 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.18 -39.4 9.62 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.62 1.568 . . . . 0.92 112.0 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 m -40.13 -56.25 1.94 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.923 1.289 . . . . 1.85 111.546 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.3 m -69.98 -36.66 75.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.586 0.354 . . . . 0.8 110.902 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.4 t -55.88 -59.28 2.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.013 -1.106 . . . . 0.72 108.013 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -68.4 -35.55 77.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 118.289 -0.862 . . . . 1.28 111.348 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -51.49 -55.3 19.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.942 1.247 . . . . 3.78 110.344 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.7 mt -54.25 -62.74 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 123.702 0.801 . . . . 0.97 109.056 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -59.74 -55.69 31.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.324 -0.551 . . . . 2.6 110.333 -172.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.9 p -54.72 -47.38 73.82 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.227 0.467 . . . . 2.05 111.182 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -70.65 -32.1 69.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.052 -0.659 . . . . 1.38 111.271 -175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.6 mt -68.52 -52.04 36.44 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.464 -0.773 . . . . 2.11 110.599 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.9 p -66.81 75.84 0.11 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.009 1.324 . . . . 1.86 110.854 -174.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? 179.64 -40.02 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.964 2.505 . . . . 3.68 109.233 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.409 ' CE1' ' HB ' ' A' ' 32' ' ' ILE . 11.8 p80 -69.22 139.75 54.52 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 118.962 -1.095 . . . . 2.04 108.965 175.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -60.1 144.42 49.75 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.108 -0.701 . . . . 7.34 109.108 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.01 -28.67 13.5 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-O 118.072 -1.404 . . . . 0.75 113.184 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.409 ' HB ' ' CE1' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -76.64 122.6 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 119.953 1.876 . . . . 1.69 108.286 169.72 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.0 mt -85.69 -52.69 5.63 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.004 -1.11 . . . . 2.43 108.004 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -157.12 144.65 18.89 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.18 -0.674 . . . . 3.63 109.18 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 t -107.26 129.62 54.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.19 -1.411 . . . . 2.65 107.19 167.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 t -112.0 104.08 12.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.777 -1.935 . . . . 2.25 105.777 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 p -102.13 141.4 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 118.938 0.79 . . . . 1.84 111.071 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.29 132.99 36.45 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.323 0.582 . . . . 0.77 110.487 172.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -76.2 -30.4 57.98 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.103 -0.953 . . . . 2.13 111.751 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.2 -32.17 22.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.806 0.842 . . . . 1.09 112.617 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.9 t -121.75 13.19 10.72 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.268 1.427 . . . . 2.2 111.088 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 m120 34.78 47.02 0.22 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.522 2.329 . . . . 2.0 111.818 -172.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -120.85 137.94 54.31 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.276 0.631 . . . . 2.28 109.648 -169.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.47 116.65 32.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.723 1.609 . . . . 0.71 108.224 167.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -91.25 110.62 21.91 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 102.562 -3.125 . . . . 2.29 102.562 166.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.9 mt -112.84 110.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.481 -1.674 . . . . 1.38 106.481 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -83.06 70.22 9.99 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.983 -1.488 . . . . 3.24 106.983 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -90.24 144.29 25.99 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.147 -0.933 . . . . 2.92 109.697 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.36 111.17 22.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 123.557 0.535 . . . . 3.99 111.026 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -66.72 -16.51 50.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.917 2.411 . . . . 2.17 112.451 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -85.3 -5.84 59.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.11 0.868 . . . . 5.2 111.002 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.4 pt -135.07 -27.73 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 114.392 1.256 . . . . 2.88 114.392 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.7 133.8 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 107.526 -1.287 . . . . 1.34 107.526 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.43 172.39 20.31 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.529 -0.732 . . . . 0.65 112.203 -172.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -56.72 -41.47 75.37 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.22 2.614 . . . . 0.85 110.655 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -57.13 -51.06 70.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.85 0.295 . . . . 6.37 110.615 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.98 -51.14 70.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.259 -0.645 . . . . 2.63 109.259 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.4 mm -54.38 -50.93 53.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.326 0.65 . . . . 2.09 111.609 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.4 mt -54.14 -56.43 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.935 -0.765 . . . . 0.68 108.935 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -65.5 -35.13 79.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.195 0.521 . . . . 2.89 111.021 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.3 m -56.27 -54.48 44.88 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.752 -0.462 . . . . 0.91 109.752 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.39 -36.05 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.516 -0.74 . . . . 1.29 111.712 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.75 -48.65 59.06 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.94 -0.763 . . . . 2.74 108.94 166.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.8 t -65.12 -13.93 59.3 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.836 1.05 . . . . 1.81 113.836 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.4 mt -88.15 -9.8 51.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.05 1.295 . . . . 1.33 111.319 170.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.25 41.72 6.48 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.383 0.992 . . . . 0.9 112.022 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -135.74 167.38 21.26 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.236 -1.024 . . . . 2.06 108.236 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -105.71 94.6 8.99 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.489 1.115 . . . . 2.65 110.636 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.3 80.52 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.631 2.887 . . . . 1.13 112.267 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.0 p -82.98 121.34 26.88 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.15 -0.969 . . . . 1.83 111.401 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.3 mt -70.35 72.42 0.47 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.194 -0.941 . . . . 3.43 111.503 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 118.878 -0.582 . . . . 2.66 112.16 -178.565 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 109.836 -0.431 . . . . 3.12 109.836 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.9 tp -108.78 149.45 29.04 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.974 -1.862 . . . . 2.83 105.974 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -118.67 152.73 35.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.092 -0.707 . . . . 2.6 109.092 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.714 HD21 HD13 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -150.0 133.27 16.39 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.135 -1.061 . . . . 1.31 108.135 177.432 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.37 105.07 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.32 -2.104 . . . . 1.04 105.32 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.464 HG23 ' SD ' ' A' ' 13' ' ' MET . 3.2 m -95.53 86.35 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 126.221 1.808 . . . . 0.65 107.994 -172.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.5 mtp-105 -77.38 132.65 38.64 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 119.899 -0.721 . . . . 6.06 109.748 -170.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.01 -4.01 5.65 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.45 1.5 . . . . 1.03 113.187 171.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.464 ' SD ' HG23 ' A' ' 10' ' ' VAL . 41.4 mtp -75.92 116.33 16.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.042 1.421 . . . . 1.89 110.097 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -98.91 -21.02 16.49 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.488 -1.244 . . . . 3.13 113.253 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.9 p -162.7 175.81 10.96 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.636 1.562 . . . . 1.79 112.221 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -35.94 58.72 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.586 1.154 . . . . 0.96 111.923 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -57.25 -37.03 71.69 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-O 118.368 -0.825 . . . . 2.49 110.105 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.4 m -69.07 -53.45 20.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 120.025 1.284 . . . . 0.79 109.687 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -41.67 -57.46 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.944 1.298 . . . . 0.66 110.257 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.89 -21.26 66.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.23 -0.896 . . . . 1.66 112.735 -170.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -69.1 -47.86 64.07 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 107.309 -1.367 . . . . 4.84 107.309 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.656 ' HB ' HG11 ' A' ' 37' ' ' VAL . 2.9 mt -64.65 -54.56 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.306 -0.998 . . . . 0.97 108.306 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.574 ' HG3' HG12 ' A' ' 37' ' ' VAL . 19.3 mt-10 -50.41 -59.99 3.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.206 0.457 . . . . 2.35 111.028 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.2 t -55.03 -52.6 62.67 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.113 0.482 . . . . 2.09 111.415 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -66.84 -28.0 68.0 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.527 0.731 . . . . 1.55 111.533 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.0 -47.7 61.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.337 -0.852 . . . . 2.06 109.701 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.5 p -70.87 68.53 0.43 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.412 0.551 . . . . 1.58 112.12 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.69 -30.83 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.906 1.283 . . . . 5.08 114.033 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -51.7 -47.84 63.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.357 0.981 . . . . 3.97 112.968 -174.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 139.59 -85.6 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 129.901 3.28 . . . . 7.43 104.836 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.58 53.84 4.87 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.695 -0.562 . . . . 1.04 111.695 -166.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.3 mt -114.61 124.17 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.555 -2.016 . . . . 2.88 105.555 160.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 mt -79.76 -44.56 20.47 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.556 -0.905 . . . . 1.98 108.556 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -156.89 157.66 35.27 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.208 -1.034 . . . . 2.67 108.208 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.9 t -128.21 145.65 50.97 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 104.899 -2.26 . . . . 2.28 104.899 163.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.52 149.8 41.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 118.587 -1.245 . . . . 2.33 110.203 153.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.656 HG11 ' HB ' ' A' ' 22' ' ' ILE . 13.1 p -143.1 108.59 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 124.586 1.179 . . . . 1.64 112.451 -162.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.78 134.26 41.92 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.032 0.444 . . . . 0.8 111.199 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.06 -33.81 70.6 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 115.542 -0.754 . . . . 1.81 110.392 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -44.92 -44.23 9.56 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.364 1.466 . . . . 1.37 113.081 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -123.59 22.13 9.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.262 0.625 . . . . 2.53 110.79 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 42.44 58.88 2.9 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.198 2.199 . . . . 3.23 109.834 177.018 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.8 136.46 24.27 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.882 -0.511 . . . . 1.82 111.535 -166.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -109.5 143.03 39.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.868 1.667 . . . . 0.94 108.987 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' HIS . . . . . 0.558 ' C ' HD12 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -106.91 140.23 40.06 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.028 -1.841 . . . . 2.87 106.028 153.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.714 HD13 HD21 ' A' ' 8' ' ' LEU . 1.7 mp -122.99 112.44 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.627 -1.99 . . . . 1.29 105.627 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -85.96 122.6 30.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.943 -1.503 . . . . 2.94 106.943 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -144.66 164.31 31.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.502 1.297 . . . . 2.22 114.502 -169.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.26 112.1 62.51 Favored Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 125.955 1.702 . . . . 2.75 108.374 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.24 2.26 5.18 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.228 1.952 . . . . 1.81 114.001 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.0 -32.56 73.94 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.646 1.112 . . . . 5.84 111.474 171.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.62 -59.33 2.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.515 0.674 . . . . 3.47 112.036 -160.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.1 tt -100.29 151.83 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.879 -0.6 . . . . 1.78 109.704 -161.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.73 -174.24 13.64 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.078 -1.609 . . . . 1.1 109.078 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -56.66 -40.46 84.2 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.926 1.75 . . . . 1.24 109.818 168.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.25 -55.86 7.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.341 1.056 . . . . 8.98 113.461 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.52 -49.24 78.35 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.402 -0.811 . . . . 2.71 109.812 -174.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.7 mt -56.58 -51.64 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 114.878 -1.055 . . . . 1.62 108.545 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.8 mt -57.02 -52.53 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.523 -0.547 . . . . 0.77 109.523 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.5 m170 -57.47 -42.84 83.39 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.379 1.085 . . . . 2.79 109.547 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.5 m -58.99 -52.91 63.74 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.67 -0.696 . . . . 1.16 110.137 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.7 mt -71.87 -37.94 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.668 -0.645 . . . . 1.11 111.819 -169.752 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -60.31 -45.58 92.88 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.201 -0.599 . . . . 4.17 109.682 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 t -59.09 -36.86 75.85 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.906 -0.568 . . . . 1.84 112.238 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.65 -46.1 87.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.531 1.06 . . . . 1.08 110.276 171.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.58 46.54 0.35 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.349 0.976 . . . . 0.87 111.932 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -134.78 163.54 29.56 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 107.312 -1.366 . . . . 2.05 107.312 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -97.63 103.71 17.74 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.041 -0.981 . . . . 3.34 109.852 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.56 77.47 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.212 2.608 . . . . 0.9 111.245 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -78.71 99.68 6.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.746 -0.596 . . . . 1.83 109.52 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.2 pt? -67.22 59.72 0.05 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.731 1.612 . . . . 2.85 114.575 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.9 t . . . . . 0 CA--C 1.537 0.444 0 O-C-N 120.743 -1.223 . . . . 2.51 109.445 176.324 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 107.276 -1.379 . . . . 2.43 107.276 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.1 tp -139.86 144.69 37.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.453 -2.425 . . . . 3.11 104.453 166.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -116.32 140.13 49.66 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 123.776 0.673 . . . . 2.52 110.179 171.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.1 124.27 36.55 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.463 -1.68 . . . . 1.59 106.463 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.56 106.77 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 104.988 -2.227 . . . . 1.21 104.988 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -97.67 97.75 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 124.542 1.137 . . . . 0.79 108.261 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -76.99 147.29 36.92 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.245 -1.02 . . . . 8.24 108.245 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.76 -51.0 0.73 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.362 0.982 . . . . 0.82 111.02 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.44 132.28 37.24 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.419 1.109 . . . . 1.42 110.01 -171.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 t -156.53 12.8 0.28 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.571 1.323 . . . . 2.76 114.571 -166.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -161.16 165.13 29.96 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 120.212 1.369 . . . . 1.18 110.16 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.83 13.05 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.248 1.419 . . . . 0.82 111.766 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -37.81 -49.9 1.21 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.502 2.321 . . . . 2.13 112.122 170.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.1 m -71.87 -56.2 6.15 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.181 -0.463 . . . . 1.12 110.129 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -47.7 -54.75 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 124.004 0.921 . . . . 0.8 109.598 -164.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -65.58 -33.86 76.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.44 -0.8 . . . . 1.03 111.826 -174.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 pttp -71.61 -40.61 69.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.907 -0.775 . . . . 3.84 108.907 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.467 ' HB ' HG11 ' A' ' 37' ' ' VAL . 69.3 mt -57.17 -66.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.212 -1.032 . . . . 1.07 108.212 171.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' CG ' HG12 ' A' ' 37' ' ' VAL . 3.6 mt-10 -51.53 -55.75 17.25 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 119.295 0.952 . . . . 2.93 110.896 -173.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.8 t -50.53 -54.35 23.1 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.631 0.372 . . . . 1.97 111.148 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t -72.47 -26.87 61.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 114.033 1.123 . . . . 1.6 114.033 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.17 -43.38 70.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.204 -0.665 . . . . 1.72 109.204 171.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.1 p -70.17 68.68 0.33 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.879 0.847 . . . . 2.09 110.389 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -156.0 -49.53 0.08 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.853 2.861 . . . . 4.85 107.082 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -73.45 88.59 1.61 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.458 -0.571 . . . . 2.37 109.458 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -40.63 113.83 0.41 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.414 1.086 . . . . 6.63 109.528 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.86 -34.6 2.37 Favored Glycine 0 C--O 1.224 -0.529 0 N-CA-C 109.374 -1.49 . . . . 0.84 109.374 -164.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.02 125.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.493 -1.299 . . . . 1.61 107.493 174.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.9 mt -97.67 -40.1 8.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.465 0.706 . . . . 2.23 110.43 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -157.13 146.05 19.95 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.323 0.965 . . . . 2.6 109.906 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.1 p -144.22 56.8 1.31 Allowed 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.23 1.012 . . . . 2.8 111.818 -167.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -78.21 81.71 4.56 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.373 -0.829 . . . . 1.96 110.188 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.467 HG11 ' HB ' ' A' ' 22' ' ' ILE . 14.6 p -83.82 76.91 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.675 0.75 . . . . 1.77 112.766 -168.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.63 123.87 27.2 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 122.441 1.115 . . . . 0.87 112.469 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.95 -28.86 27.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 113.85 -1.523 . . . . 3.07 113.048 -166.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.45 -38.81 72.14 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.471 0.653 . . . . 1.73 110.618 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.52 -4.15 57.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.459 1.904 . . . . 3.77 111.42 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.4 m120 43.26 46.55 5.35 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.322 1.849 . . . . 1.9 111.4 -167.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -117.61 155.14 30.37 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.075 0.852 . . . . 2.01 111.565 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.89 139.81 49.86 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.474 -1.306 . . . . 0.72 107.474 147.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -90.97 138.86 31.28 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 103.845 -2.65 . . . . 2.84 103.845 148.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mm -122.43 106.25 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 106.725 -1.583 . . . . 2.09 106.725 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -79.75 68.26 5.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.067 -0.716 . . . . 2.26 109.067 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -73.57 143.88 46.26 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.019 -0.426 . . . . 2.25 111.482 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -62.17 113.15 7.78 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.853 1.261 . . . . 2.94 107.993 170.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.86 48.29 2.79 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.741 2.294 . . . . 1.76 112.736 -164.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -138.15 -64.11 0.54 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.678 1.191 . . . . 4.09 110.063 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.0 pt -73.63 -24.14 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 113.539 0.941 . . . . 1.85 113.539 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.0 tt -142.6 151.55 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 124.346 1.058 . . . . 1.24 108.239 -167.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.94 -178.57 15.75 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.717 -0.553 . . . . 0.74 111.717 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.79 -41.05 49.0 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.668 2.245 . . . . 0.79 110.375 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -44.76 68.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.284 0.634 . . . . 8.15 112.0 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.98 -53.39 57.42 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.388 0.613 . . . . 2.65 110.078 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.4 mt -57.95 -49.28 81.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 108.57 -0.9 . . . . 1.67 108.57 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 mt -53.19 -52.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.323 -0.621 . . . . 0.67 109.323 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -66.49 -34.45 77.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.94 0.4 . . . . 3.0 110.883 -176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 93.3 m -58.8 -52.52 65.38 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 110.109 -0.33 . . . . 0.83 110.109 172.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.9 mm -66.16 -40.23 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 121.269 -0.894 . . . . 1.51 110.895 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -53.57 -52.44 59.74 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.713 0.805 . . . . 3.1 109.195 170.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.7 t -55.46 -43.47 75.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.946 0.499 . . . . 1.69 111.109 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.12 -10.38 53.59 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.374 0.879 . . . . 1.09 113.374 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.25 30.53 8.16 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.577 1.084 . . . . 0.67 112.896 169.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -131.8 165.2 24.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.351 1.076 . . . . 2.02 110.219 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -107.95 100.16 34.45 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 124.307 1.043 . . . . 3.31 110.569 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.87 99.07 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.629 2.886 . . . . 1.06 111.069 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t -90.59 119.47 30.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.35 -1.352 . . . . 2.46 107.35 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 mt -71.14 118.93 14.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.343 -0.984 . . . . 2.82 108.343 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 109.494 -0.558 . . . . 2.59 109.494 173.849 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.232 0.174 0 N-CA-C 109.46 -0.57 . . . . 2.64 109.46 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.61 126.86 7.16 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.804 0.668 . . . . 3.45 112.804 162.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -79.56 97.16 6.35 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.674 1.99 . . . . 3.6 109.378 169.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mt -92.61 116.48 29.04 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.074 -1.454 . . . . 2.64 107.074 172.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.5 t -77.27 97.54 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 105.978 -1.86 . . . . 1.32 105.978 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.0 m -78.48 74.63 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 125.438 1.495 . . . . 0.82 107.666 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -74.38 146.35 43.04 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.926 -1.509 . . . . 5.1 106.926 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.19 23.77 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.571 -1.127 . . . . 1.04 112.126 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.58 130.15 42.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.547 1.673 . . . . 1.7 108.974 -171.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 p -116.41 -48.7 2.69 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.545 0.943 . . . . 3.27 113.545 -158.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.87 164.87 14.79 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.777 0.831 . . . . 1.34 111.498 -166.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.18 -40.07 10.65 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.887 1.275 . . . . 0.79 111.622 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -41.22 -51.29 3.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.602 1.561 . . . . 1.65 111.992 170.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.2 m -70.45 -43.63 69.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.943 0.497 . . . . 0.73 111.101 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.626 HG13 HG13 ' A' ' 37' ' ' VAL . 61.2 t -53.18 -55.46 12.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.506 -0.924 . . . . 0.62 108.506 -174.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -69.26 -29.61 67.56 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.654 -0.703 . . . . 0.9 111.722 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -49.73 -54.84 16.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.472 1.033 . . . . 4.06 109.016 166.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.497 ' HB ' HG11 ' A' ' 37' ' ' VAL . 1.1 mt -59.77 -61.56 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.285 -0.635 . . . . 0.73 109.285 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.603 ' CG ' HG12 ' A' ' 37' ' ' VAL . 31.3 mt-10 -57.43 -55.25 37.17 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.65 0.659 . . . . 2.35 111.58 -173.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.1 m -59.85 -39.34 84.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.754 -0.591 . . . . 1.88 111.835 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 t -70.34 -46.08 64.86 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.585 -0.697 . . . . 0.93 111.092 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 mp -71.62 -61.02 1.93 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.147 0.579 . . . . 2.94 111.201 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.4 m -69.65 72.18 0.35 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.11 1.764 . . . . 2.86 110.746 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -176.17 -35.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 129.18 2.992 . . . . 3.77 109.335 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -65.3 120.93 13.67 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 119.344 0.975 . . . . 2.32 108.505 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 134.76 51.39 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.714 -1.587 . . . . 7.74 106.714 169.289 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.74 -41.28 2.0 Favored Glycine 0 C--O 1.225 -0.43 0 N-CA-C 110.047 -1.221 . . . . 0.96 110.047 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.14 131.55 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.647 -1.612 . . . . 1.99 106.647 164.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -96.02 -30.43 13.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.076 -0.713 . . . . 2.34 109.076 170.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -156.23 164.97 37.7 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.926 0.785 . . . . 3.08 110.392 169.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.8 t -130.47 149.87 51.94 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 105.687 -1.968 . . . . 2.17 105.687 162.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 m -139.66 104.83 5.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.406 -1.331 . . . . 2.67 107.406 162.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.626 HG13 HG13 ' A' ' 19' ' ' VAL . 12.5 p -114.16 141.91 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.012 0.525 . . . . 1.58 112.09 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.39 139.71 30.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.244 0.545 . . . . 1.14 110.992 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.48 -33.08 60.78 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.201 1.0 . . . . 1.76 111.606 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.33 -34.31 60.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.227 0.611 . . . . 1.57 112.217 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.8 t -106.87 3.16 26.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.284 1.434 . . . . 3.09 111.48 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.6 m120 37.31 51.21 1.1 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 127.52 2.328 . . . . 1.91 110.814 -169.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.27 137.59 27.37 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.003 -0.435 . . . . 2.13 111.925 -166.106 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.94 117.46 32.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.298 2.239 . . . . 0.69 108.741 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -86.34 103.74 15.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.42 -2.437 . . . . 2.28 104.42 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.21 134.58 27.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.01 -1.478 . . . . 1.09 107.01 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -112.94 118.22 34.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.485 -1.302 . . . . 2.59 107.485 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -128.08 148.61 50.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.057 0.943 . . . . 2.72 111.514 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -76.99 117.01 62.14 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 106.55 -1.648 . . . . 3.11 106.55 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.39 69.64 7.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.606 2.204 . . . . 2.17 110.77 -172.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.6 -92.88 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.582 1.153 . . . . 5.02 110.154 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.1 pt -64.05 -31.28 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.128 0.788 . . . . 2.33 113.128 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 tp -114.07 137.78 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.958 1.303 . . . . 1.07 108.517 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.54 176.94 16.3 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.147 -0.781 . . . . 0.59 111.147 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.19 -41.39 74.4 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.791 2.994 . . . . 0.97 110.923 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -56.43 -53.75 53.78 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.211 0.459 . . . . 6.58 110.779 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.45 -50.4 69.94 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.078 -0.712 . . . . 2.88 109.078 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mm -53.69 -52.81 30.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 123.334 0.654 . . . . 2.04 111.306 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.4 mt -52.66 -53.53 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.879 -0.786 . . . . 0.83 108.879 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -64.27 -37.34 87.13 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.315 0.578 . . . . 3.17 110.795 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.3 m -57.36 -46.81 82.95 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.091 -0.504 . . . . 1.12 109.754 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.41 -43.08 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 118.654 0.661 . . . . 1.38 111.323 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -52.59 -41.56 63.75 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.97 0.804 . . . . 3.42 110.087 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.4 m -53.7 -29.07 37.3 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.978 0.733 . . . . 1.87 112.978 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 mt -81.18 -15.37 55.93 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.761 0.824 . . . . 0.97 112.07 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.68 42.83 4.37 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.825 1.203 . . . . 0.67 112.662 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.96 162.21 33.49 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 107.372 -1.344 . . . . 1.87 107.372 173.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -105.74 94.08 8.31 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 118.955 0.798 . . . . 2.56 110.397 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.93 85.2 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.804 3.003 . . . . 1.33 110.989 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 m -84.68 97.03 9.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.401 1.08 . . . . 1.97 110.223 -170.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.87 102.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.875 0.87 . . . . 4.63 110.817 171.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 CA--C 1.529 0.144 0 N-CA-C 111.846 0.313 . . . . 3.68 111.846 -170.964 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.83 -0.433 . . . . 2.8 109.83 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mp -143.63 155.19 44.18 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.046 -1.094 . . . . 2.99 108.046 166.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -107.61 102.24 11.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.254 -1.758 . . . . 2.96 106.254 163.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.52 130.92 40.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.267 -1.383 . . . . 1.5 107.267 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.419 ' CG1' HH11 ' A' ' 11' ' ' ARG . 65.2 t -84.11 102.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 125.225 1.41 . . . . 1.08 107.362 -174.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 m -89.53 96.69 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.518 1.527 . . . . 0.65 109.082 -172.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.419 HH11 ' CG1' ' A' ' 9' ' ' VAL . 21.8 mmm180 -76.14 151.02 37.08 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 118.775 -1.17 . . . . 7.7 107.932 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.2 -27.3 10.93 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.225 0.917 . . . . 0.74 111.986 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.0 mtm -65.79 94.68 0.22 Allowed 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.556 1.178 . . . . 1.47 111.546 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -77.85 -38.77 45.4 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.685 0.394 . . . . 2.59 111.49 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.23 174.7 13.44 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 119.071 0.85 . . . . 1.04 112.199 -168.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.5 -38.94 14.9 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.17 1.388 . . . . 1.13 112.183 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 m -51.94 -40.99 61.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.682 0.793 . . . . 1.86 111.42 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.4 m -70.1 -47.95 59.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.019 0.528 . . . . 0.84 110.239 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -51.12 -58.5 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 123.737 0.815 . . . . 1.05 108.977 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.17 -25.16 66.02 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.662 -0.699 . . . . 0.99 111.631 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -56.73 -56.18 24.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.291 -1.004 . . . . 3.33 108.291 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -58.61 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.239 -1.023 . . . . 0.95 108.239 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -55.78 -54.51 43.51 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.322 0.249 . . . . 2.95 110.599 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -57.45 -48.27 79.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.862 0.465 . . . . 1.32 110.237 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 t -69.91 -34.06 73.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 118.905 -1.118 . . . . 1.17 111.22 -173.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.31 -50.36 63.9 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.124 -0.465 . . . . 2.49 110.65 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.0 p -70.91 63.65 0.31 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.982 0.896 . . . . 2.02 112.42 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -165.93 -36.22 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.42 1.888 . . . . 3.79 110.895 172.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -65.97 133.72 51.43 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.359 0.981 . . . . 2.09 109.54 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -53.04 143.13 18.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.554 -0.906 . . . . 6.95 108.554 172.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.68 -32.68 7.26 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-O 118.142 -1.366 . . . . 0.8 111.977 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.49 128.01 38.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 120.006 1.903 . . . . 2.01 108.024 172.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 mt -92.6 -45.55 8.03 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.114 1.366 . . . . 2.87 108.526 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -156.07 163.54 39.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.476 -0.564 . . . . 2.31 109.476 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.7 m -135.82 154.45 51.19 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.103 0.961 . . . . 2.69 108.742 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -149.89 97.78 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.055 -1.091 . . . . 2.84 108.055 162.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -101.39 135.65 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 122.91 0.484 . . . . 1.61 110.399 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.79 135.21 19.47 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.98 0.912 . . . . 0.72 112.457 -167.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.51 -28.63 66.21 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 125.789 1.636 . . . . 2.51 111.053 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -34.45 -45.15 0.22 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.193 1.797 . . . . 2.01 113.501 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 t -131.58 10.32 4.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 122.235 1.017 . . . . 3.19 111.503 169.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 56.94 59.18 3.59 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.958 1.703 . . . . 1.75 108.758 -167.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -103.49 154.69 19.18 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.974 0.91 . . . . 1.92 110.961 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.97 114.27 17.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.251 1.421 . . . . 0.72 108.001 162.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -80.1 113.39 18.23 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 104.86 -2.274 . . . . 2.95 104.86 169.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.69 126.17 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 105.563 -2.014 . . . . 1.13 105.563 174.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -114.01 123.93 50.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.586 -1.635 . . . . 2.65 106.586 169.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -144.87 148.12 33.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.752 0.821 . . . . 2.2 111.989 -160.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -56.5 117.61 17.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 107.231 -1.396 . . . . 4.75 107.231 164.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.71 -3.27 13.4 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.192 1.928 . . . . 1.75 113.003 -170.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -103.27 -54.45 2.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.17 0.895 . . . . 4.58 109.975 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.7 pt -79.95 -36.22 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.694 0.628 . . . . 2.11 112.694 -167.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.06 132.06 66.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.28 1.432 . . . . 0.99 107.669 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.63 172.72 17.84 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 118.683 0.674 . . . . 0.6 111.612 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.95 -36.31 97.07 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.232 2.621 . . . . 0.77 110.737 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -55.93 -57.0 13.92 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.094 0.406 . . . . 6.64 110.032 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.52 -49.9 66.58 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.071 -0.714 . . . . 2.68 109.071 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.6 mm -53.58 -52.0 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.281 0.632 . . . . 1.91 111.468 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.88 -52.56 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 122.73 0.412 . . . . 0.58 109.96 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -65.51 -38.95 91.19 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.53 0.681 . . . . 2.74 110.471 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.3 m -55.24 -51.42 66.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.346 -0.613 . . . . 1.08 109.346 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 89.8 mt -69.51 -39.85 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 119.407 -0.33 . . . . 1.4 111.186 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -56.65 -44.06 80.94 Favored 'General case' 0 CA--C 1.526 0.049 0 CA-C-N 118.727 0.694 . . . . 3.55 109.226 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 t -58.66 -15.02 9.87 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.994 1.109 . . . . 1.73 113.994 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.5 mt -95.84 -9.86 30.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.898 1.226 . . . . 1.17 111.694 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.36 47.05 3.63 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.299 0.952 . . . . 0.85 112.462 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -137.99 163.87 30.46 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.56 -0.904 . . . . 2.15 108.56 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.53 86.98 3.07 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.552 1.141 . . . . 3.06 110.303 -176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.59 82.36 0.93 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.879 3.053 . . . . 1.0 111.538 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 m -81.05 103.84 11.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.168 0.987 . . . . 1.78 109.022 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.06 70.97 0.16 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.558 1.143 . . . . 2.62 113.238 -175.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 107.114 -1.439 . . . . 3.18 107.114 160.745 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 106.624 -1.621 . . . . 2.84 106.624 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -155.47 158.19 38.16 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.752 0.706 . . . . 3.34 110.216 160.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.0 123.97 50.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.137 0.975 . . . . 2.4 108.911 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.402 HD21 HD12 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -110.54 123.94 50.89 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.285 -2.117 . . . . 1.57 105.285 167.311 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.29 100.35 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.298 -2.112 . . . . 1.27 105.298 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.77 84.0 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.04 1.736 . . . . 0.81 108.088 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.5 mtt85 -76.72 147.15 37.56 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.717 -1.216 . . . . 6.73 107.717 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.55 -16.61 26.39 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 119.3 -0.722 . . . . 0.81 112.849 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.1 mtp -64.05 167.34 6.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.978 1.389 . . . . 1.88 110.788 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 t -152.19 -45.54 0.1 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.076 0.55 . . . . 2.37 111.675 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.4 p -133.61 170.92 14.82 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.909 0.777 . . . . 1.25 111.917 -169.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.85 -33.94 8.12 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.856 1.263 . . . . 0.79 111.981 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -64.95 -37.61 88.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 121.491 -0.756 . . . . 2.32 111.615 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -61.36 -46.86 88.44 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.326 -0.62 . . . . 0.88 109.326 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.441 HG13 HG13 ' A' ' 37' ' ' VAL . 43.8 t -50.33 -59.67 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.73 -0.841 . . . . 0.53 108.73 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 0.6 OUTLIER -66.11 -28.96 69.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.725 -174.762 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -62.17 -54.65 38.06 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 108.809 -0.811 . . . . 4.58 108.809 173.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.29 -54.3 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 120.169 -0.612 . . . . 0.67 109.572 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -60.71 -53.99 50.7 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.367 0.531 . . . . 2.29 111.143 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.5 t -58.59 -34.9 71.61 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.742 -0.599 . . . . 1.67 111.209 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.5 t -70.38 -42.67 71.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.042 -0.411 . . . . 1.15 110.772 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.2 mt -71.22 -60.12 2.4 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.112 0.565 . . . . 2.42 112.232 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 m -69.64 67.98 0.24 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.072 1.749 . . . . 2.39 111.162 -166.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.16 -35.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.483 2.313 . . . . 4.24 110.575 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -68.03 132.43 47.26 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.471 1.032 . . . . 2.09 108.8 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -54.74 148.07 13.58 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.452 -0.573 . . . . 6.47 109.452 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.47 -28.37 10.12 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 117.382 -1.788 . . . . 0.88 112.705 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.31 126.75 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 120.544 2.172 . . . . 1.69 106.506 166.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 mt -86.79 -44.22 11.92 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.22 -1.4 . . . . 2.75 107.22 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -156.13 164.69 38.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.573 -0.899 . . . . 2.26 108.573 174.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 p -138.94 161.5 37.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.783 -1.562 . . . . 2.03 106.783 160.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.5 t -143.68 134.16 24.79 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.455 -1.683 . . . . 1.8 106.455 153.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.441 HG13 HG13 ' A' ' 19' ' ' VAL . 2.8 p -115.2 145.67 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 123.401 0.68 . . . . 1.74 109.941 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.04 134.96 26.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.073 0.463 . . . . 0.65 110.676 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.82 -29.49 65.66 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.665 1.186 . . . . 2.62 111.538 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.76 -39.11 36.69 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.631 1.172 . . . . 1.18 112.141 -174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 p -129.88 32.15 4.6 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.717 0.807 . . . . 2.46 110.192 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 27.0 62.04 0.09 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 128.226 2.611 . . . . 2.39 112.546 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -132.49 145.55 51.26 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.84 0.456 . . . . 1.68 111.462 -173.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.06 118.06 35.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.505 -1.665 . . . . 0.78 106.505 163.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -85.68 109.84 18.87 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 101.606 -3.479 . . . . 2.32 101.606 165.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.402 HD12 HD21 ' A' ' 8' ' ' LEU . 43.8 mt -101.94 139.22 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.329 -0.989 . . . . 1.73 108.329 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -117.78 104.86 11.38 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 105.707 -1.961 . . . . 3.05 105.707 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -120.11 162.49 19.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.818 0.847 . . . . 2.63 110.322 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -100.22 114.76 65.82 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.556 0.743 . . . . 3.79 110.397 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -69.4 -5.32 15.7 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.607 2.205 . . . . 2.26 113.492 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -65.01 -22.65 67.03 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.951 1.705 . . . . 5.26 112.068 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 pt -129.82 -60.08 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.499 0.926 . . . . 2.05 113.499 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 tp -87.85 137.32 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.548 -0.72 . . . . 1.09 110.031 -165.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.15 166.74 12.32 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.988 0.804 . . . . 0.75 111.57 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -57.87 -38.61 91.82 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.148 2.565 . . . . 0.76 110.872 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -53.74 -44.42 69.91 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.003 0.372 . . . . 7.45 112.003 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.3 -51.99 66.58 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.994 0.815 . . . . 2.43 109.191 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.7 mt -50.38 -54.16 9.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 C-N-CA 123.32 0.648 . . . . 1.54 109.358 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.9 mt -56.72 -51.01 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 119.119 -0.467 . . . . 0.62 110.036 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -68.55 -27.35 66.0 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-O 120.978 0.418 . . . . 3.14 112.067 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.8 m -64.62 -52.26 58.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.733 -0.469 . . . . 0.85 109.733 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -72.07 -45.28 63.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.874 -0.517 . . . . 1.17 112.151 -171.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.04 -43.23 63.65 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.65 0.659 . . . . 3.95 111.388 -176.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.3 t -48.35 -37.2 16.09 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.38 1.472 . . . . 1.86 112.395 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.4 mt -74.8 -17.27 60.65 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.363 -0.836 . . . . 1.05 112.188 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.61 45.68 3.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.159 0.885 . . . . 0.81 112.022 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -136.38 155.63 49.77 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.721 -1.215 . . . . 1.96 107.721 170.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -101.39 96.47 6.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.768 1.227 . . . . 2.83 109.41 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.2 77.66 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.352 2.701 . . . . 1.19 110.479 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.6 p -78.91 106.84 11.22 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.18 -0.674 . . . . 2.23 109.18 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.3 mt -74.94 56.55 0.75 Allowed 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.596 -0.69 . . . . 4.01 111.19 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 123.73 1.729 . . . . 3.38 107.492 173.114 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 109.912 -0.403 . . . . 2.58 109.912 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -127.01 133.25 50.58 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.361 0.665 . . . . 2.63 109.608 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -103.61 99.85 9.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.283 1.033 . . . . 2.66 108.217 169.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.94 134.02 41.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.123 -1.436 . . . . 1.43 107.123 173.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.9 t -85.32 113.81 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.143 -1.799 . . . . 1.01 106.143 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.02 96.78 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 126.04 1.736 . . . . 0.65 108.321 -172.199 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 11' ' ' ARG . 0.1 OUTLIER -77.02 137.66 39.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.645 -1.613 . . . . 5.46 106.645 -174.956 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.55 -26.49 10.14 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.768 -1.018 . . . . 0.98 112.66 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 ptm -78.65 85.71 4.67 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.534 1.667 . . . . 1.82 110.232 -176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 p -76.5 -34.6 58.61 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.881 0.872 . . . . 3.16 112.962 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.0 p -145.45 172.82 12.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.81 0.732 . . . . 1.14 112.39 -162.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.8 -39.43 8.36 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.518 1.527 . . . . 0.73 112.299 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -53.53 -53.14 55.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.491 -0.559 . . . . 2.18 109.491 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.3 m -64.77 -42.59 94.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.589 0.356 . . . . 0.68 111.003 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.6 t -48.99 -61.04 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.199 -1.037 . . . . 0.55 108.199 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.287 1.1 p-80 -70.32 -28.77 65.43 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.185 -0.916 . . . . 0.87 111.457 -174.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -51.58 -60.06 3.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.057 0.844 . . . . 3.97 110.052 168.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 mt -62.59 -59.23 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.761 -0.829 . . . . 0.83 108.761 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -56.65 -53.78 53.69 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.743 0.417 . . . . 2.56 110.001 -167.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 t -62.44 -42.48 99.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.396 -0.335 . . . . 1.44 110.872 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.0 t -65.88 -50.74 63.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.902 0.774 . . . . 0.91 110.934 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.83 -43.93 78.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.647 0.779 . . . . 2.22 111.033 -173.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.1 m -71.24 65.77 0.41 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.685 0.675 . . . . 2.84 111.457 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -147.9 -51.78 0.19 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 128.021 2.528 . . . . 7.92 108.182 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -66.11 114.62 5.38 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.845 -0.798 . . . . 2.13 108.845 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -48.95 -30.68 6.25 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.412 1.085 . . . . 7.02 113.582 -171.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.8 -33.13 55.63 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.088 -0.84 . . . . 0.85 113.208 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.76 124.17 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.783 -1.562 . . . . 2.0 106.783 169.059 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.47 -20.26 18.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 119.153 -0.451 . . . . 2.45 110.153 171.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -155.44 158.35 38.45 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.085 0.857 . . . . 2.29 109.964 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -139.02 146.98 41.51 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.698 -1.593 . . . . 2.06 106.698 165.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -145.77 122.89 11.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.582 -1.266 . . . . 2.12 107.582 159.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 m -111.35 151.87 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.158 0.89 . . . . 1.77 111.042 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.62 133.48 20.14 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 122.734 0.414 . . . . 0.7 111.713 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -69.46 -27.34 65.15 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.301 1.041 . . . . 2.14 111.402 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.05 -39.33 1.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.742 1.617 . . . . 1.12 113.215 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.5 t -141.62 36.47 1.64 Allowed 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.754 0.422 . . . . 2.73 110.246 168.308 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.4 m120 33.9 56.71 0.59 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 127.649 2.379 . . . . 1.64 110.418 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -110.78 153.15 25.74 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.16 0.984 . . . . 2.21 110.187 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.11 113.16 13.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.73 1.212 . . . . 0.58 108.019 171.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -92.44 97.93 11.15 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.384 -3.191 . . . . 2.13 102.384 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.74 141.16 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.071 -1.825 . . . . 1.18 106.071 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -122.38 114.27 20.52 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.257 -1.016 . . . . 3.28 108.257 167.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -126.29 152.51 46.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.958 0.786 . . . . 2.1 111.778 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -78.56 113.77 37.5 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 108.659 -0.867 . . . . 2.83 108.659 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.76 65.32 8.74 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.635 2.89 . . . . 1.35 110.267 -170.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -138.39 -72.47 0.41 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.845 1.258 . . . . 3.2 108.706 -170.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -88.26 -36.53 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.043 0.937 . . . . 2.41 111.721 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 tp -104.02 153.32 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.669 1.587 . . . . 0.96 107.963 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.47 173.56 23.82 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.236 -1.146 . . . . 0.6 110.236 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.63 -38.19 42.43 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.147 2.565 . . . . 0.71 110.327 -175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -57.43 -42.16 81.84 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.518 0.327 . . . . 5.71 111.214 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -62.15 -59.15 5.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.576 -0.898 . . . . 4.02 108.576 178.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 mm -42.9 -51.2 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.419 0.688 . . . . 1.81 110.651 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.4 mt -54.2 -59.6 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 118.661 -0.685 . . . . 0.57 110.672 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.98 -35.95 81.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.487 1.04 . . . . 5.55 111.9 -176.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.3 m -68.02 -39.21 83.19 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.6 1.16 . . . . 1.46 109.681 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.28 -46.02 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.644 -0.66 . . . . 1.25 110.677 170.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -50.13 -43.24 51.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.644 0.656 . . . . 4.93 110.905 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.1 m -51.12 -28.83 11.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.449 0.907 . . . . 1.68 113.449 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.06 -12.18 48.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.377 1.071 . . . . 1.07 112.248 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.82 48.94 3.5 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.871 1.224 . . . . 0.75 112.31 174.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -139.45 153.71 47.62 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 106.97 -1.492 . . . . 2.01 106.97 170.375 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -98.79 101.43 12.03 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-O 118.434 -0.793 . . . . 2.88 110.478 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.17 93.51 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.714 2.276 . . . . 0.9 111.642 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.2 m -78.45 116.86 19.14 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.574 -0.898 . . . . 1.47 108.574 167.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.6 60.67 0.34 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.462 1.105 . . . . 2.61 111.73 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 t . . . . . 0 C--O 1.228 -0.066 0 O-C-N 121.775 -0.578 . . . . 2.32 110.197 -175.679 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 107.127 -1.434 . . . . 2.6 107.127 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.49 141.53 49.78 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.14 -1.43 . . . . 3.2 107.14 166.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -103.37 145.41 30.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.446 1.098 . . . . 3.02 109.704 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.21 119.76 17.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.39 1.476 . . . . 1.8 107.318 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.65 118.94 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 103.798 -2.667 . . . . 1.43 103.798 171.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.458 HG13 ' SD ' ' A' ' 13' ' ' MET . 2.5 p -124.81 87.18 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.679 1.192 . . . . 2.65 108.528 -167.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -79.44 152.36 30.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.458 -0.792 . . . . 5.37 109.306 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.77 -28.85 6.85 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.319 0.961 . . . . 0.85 111.073 -175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.458 ' SD ' HG13 ' A' ' 10' ' ' VAL . 30.1 mtp -66.06 110.13 2.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.84 0.82 . . . . 1.67 110.12 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.8 t -90.8 -43.06 10.3 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.253 1.021 . . . . 2.85 111.677 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.3 p -141.56 174.6 10.4 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.874 0.761 . . . . 1.31 111.963 -167.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.25 -35.76 12.63 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.994 1.318 . . . . 0.98 112.072 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -60.48 -37.5 81.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.61 -0.681 . . . . 2.51 111.344 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 78.8 m -63.76 -37.92 89.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.633 -0.667 . . . . 0.83 110.571 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.8 t -58.58 -60.94 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.405 -0.961 . . . . 0.8 108.405 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.306 0.9 OUTLIER -60.06 -35.88 76.1 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.752 -0.379 . . . . 0.83 111.589 -175.485 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -61.11 -46.93 88.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.901 1.68 . . . . 3.78 109.848 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mt -58.95 -65.92 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.651 -0.5 . . . . 0.85 109.651 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.86 -50.61 71.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.608 -0.437 . . . . 2.72 111.146 -168.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.0 m -56.55 -43.52 79.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.376 -0.231 . . . . 2.26 110.376 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 t -70.63 -38.99 73.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 118.802 -1.159 . . . . 1.13 111.226 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 mt -56.98 -48.94 77.22 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.186 0.903 . . . . 2.3 110.066 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.6 p -62.63 80.47 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.909 0.884 . . . . 2.05 111.631 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 pttm 176.7 -34.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 129.193 2.997 . . . . 3.84 109.944 172.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -69.13 141.93 54.51 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 119.199 -1.0 . . . . 2.18 109.037 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -62.13 145.14 54.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.552 -0.907 . . . . 6.14 108.552 175.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.05 -53.77 0.57 Allowed Glycine 0 CA--C 1.521 0.407 0 CA-C-O 119.316 -0.713 . . . . 1.26 111.528 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.74 112.25 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 118.66 1.23 . . . . 2.19 112.312 -166.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -94.1 -30.79 14.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.232 1.013 . . . . 2.83 111.2 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -153.93 147.25 24.84 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.509 1.049 . . . . 2.85 109.427 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -117.87 140.41 49.74 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 107.176 -1.416 . . . . 2.25 107.176 172.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.5 t -128.52 59.58 1.53 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.234 1.014 . . . . 3.53 108.664 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.86 133.85 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.553 0.741 . . . . 1.58 110.844 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.34 137.88 37.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.946 0.898 . . . . 0.85 112.408 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.96 -35.02 79.46 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.005 1.322 . . . . 2.71 110.072 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -37.25 -39.69 0.29 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.531 1.932 . . . . 1.63 113.831 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t -143.29 34.96 1.33 Allowed 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.393 0.277 . . . . 2.91 111.059 172.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.7 m120 41.66 61.82 1.75 Allowed 'General case' 0 CA--C 1.523 -0.077 0 C-N-CA 126.092 1.757 . . . . 1.82 110.068 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.13 140.53 18.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.329 -0.619 . . . . 2.29 109.329 -166.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.45 154.92 28.41 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.202 0.601 . . . . 1.18 110.03 166.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.28 141.33 40.22 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 104.91 -2.256 . . . . 2.03 104.91 150.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.59 134.49 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.965 -1.494 . . . . 1.37 106.965 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -102.83 85.48 2.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.508 -2.034 . . . . 3.16 105.508 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -114.01 146.36 40.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.934 1.294 . . . . 2.41 110.799 172.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -59.64 107.32 0.96 Allowed Pre-proline 0 CA--C 1.537 0.46 0 O-C-N 124.283 0.99 . . . . 2.51 108.792 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -82.44 45.57 1.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.319 2.679 . . . . 1.73 110.974 -169.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -139.31 -60.29 0.57 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.533 1.133 . . . . 4.23 108.965 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 pt -74.9 -25.87 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 112.34 0.496 . . . . 2.27 112.34 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.2 tt -143.0 154.78 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.085 -1.079 . . . . 1.67 108.085 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.08 -176.76 17.05 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.626 -0.589 . . . . 0.66 111.626 -172.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.11 -32.72 33.6 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.371 2.047 . . . . 0.77 110.174 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -53.65 -51.7 62.32 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.131 0.572 . . . . 6.26 110.95 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.81 -50.3 72.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.095 0.474 . . . . 2.31 109.745 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.0 mt -54.61 -51.94 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.08 0 C-N-CA 123.441 0.696 . . . . 1.2 109.893 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.4 mt -51.74 -53.04 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.133 -0.691 . . . . 0.61 109.133 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -66.3 -34.89 79.0 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.914 0.485 . . . . 2.66 110.785 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -60.77 -48.52 81.42 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.715 -0.476 . . . . 0.74 109.715 174.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 94.0 mt -70.89 -35.69 60.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.365 -0.834 . . . . 0.99 111.366 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -54.44 -49.45 69.97 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.557 -0.714 . . . . 2.62 109.21 167.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 t -58.12 -43.07 87.01 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.651 0.38 . . . . 2.12 111.143 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -58.18 -37.64 75.15 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.506 -0.746 . . . . 1.17 111.64 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.67 38.42 2.22 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.628 1.109 . . . . 0.83 111.726 176.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -129.28 163.45 25.65 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 107.702 -1.222 . . . . 2.1 107.702 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -109.93 98.72 35.58 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.183 0.593 . . . . 2.83 110.118 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.52 148.31 20.55 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.779 2.986 . . . . 1.63 110.168 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.1 m -153.71 118.03 4.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.457 1.103 . . . . 2.29 108.404 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.22 59.94 1.86 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.767 0.827 . . . . 2.29 111.538 -176.417 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 107.608 -1.256 . . . . 4.33 107.608 -178.918 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 105.808 -1.923 . . . . 3.14 105.808 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.25 145.09 51.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.816 -0.809 . . . . 3.18 108.816 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -123.92 139.13 54.26 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.949 -1.5 . . . . 2.21 106.949 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.34 152.57 51.93 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.905 -1.146 . . . . 2.59 107.905 164.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -93.92 101.66 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.792 -1.929 . . . . 1.14 105.792 -173.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.2 m -79.38 65.86 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.076 1.75 . . . . 0.8 108.581 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.39 125.86 29.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 118.95 -1.1 . . . . 4.92 108.579 -162.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.51 -44.69 0.96 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.217 0.913 . . . . 0.89 110.888 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -64.16 152.15 41.44 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.408 0.683 . . . . 1.66 111.508 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -140.65 -34.97 0.5 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.983 0.734 . . . . 2.08 112.983 -167.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 p -145.97 175.14 10.67 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.305 0.957 . . . . 1.32 111.683 -166.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.52 -47.89 3.82 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.0 1.72 . . . . 0.82 112.032 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 m -57.14 -40.29 76.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.331 0.652 . . . . 1.68 111.818 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.7 m -72.14 -53.11 13.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.619 0.645 . . . . 0.78 110.523 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.2 t -44.1 -55.77 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.482 1.513 . . . . 0.62 109.275 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -21.63 63.4 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 120.175 -0.61 . . . . 1.35 112.26 -173.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -47.97 59.98 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.933 -1.506 . . . . 5.75 106.933 173.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mt -56.33 -53.38 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.788 -0.625 . . . . 0.9 110.101 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -57.25 -61.58 2.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.841 0.746 . . . . 3.42 111.473 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -55.44 -41.75 73.26 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.771 -0.581 . . . . 1.58 111.579 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 t -65.45 -48.61 72.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.818 -0.438 . . . . 1.65 109.818 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.8 mt -54.04 -46.04 71.79 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.355 -0.841 . . . . 3.13 110.074 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -61.28 -14.16 24.43 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.695 0.998 . . . . 2.04 113.695 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -26.36 68.79 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.166 1.348 . . . . 5.66 111.275 173.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -77.86 100.17 6.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.317 -0.623 . . . . 2.87 109.317 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -61.23 82.87 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.871 -1.159 . . . . 5.91 107.871 163.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.82 -26.95 0.39 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.231 0.92 . . . . 1.33 110.932 -166.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.409 ' CG1' HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -74.67 120.03 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 105.773 -1.936 . . . . 2.07 105.773 165.457 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.9 mt -79.91 -47.48 14.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.708 -1.219 . . . . 2.5 107.708 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -156.09 124.2 5.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.898 -0.408 . . . . 3.15 109.898 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.2 p -97.61 151.82 19.69 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.088 0.955 . . . . 2.7 108.719 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -152.56 102.48 2.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.794 -0.817 . . . . 2.1 108.794 159.467 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.16 148.16 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 124.102 0.961 . . . . 1.87 110.946 167.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.65 131.95 18.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.385 0.674 . . . . 0.86 109.635 171.34 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.46 -32.63 54.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.038 -0.983 . . . . 2.05 112.939 -167.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.95 -49.41 40.53 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.093 0.957 . . . . 1.35 111.783 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.1 p -101.77 6.48 41.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.897 0.879 . . . . 2.18 111.326 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.02 42.72 21.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.3 1.44 . . . . 3.22 110.362 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -98.81 149.12 23.21 Favored 'General case' 0 C--N 1.344 0.326 0 O-C-N 121.371 -0.83 . . . . 1.73 110.159 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.8 117.93 30.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.014 -1.106 . . . . 0.78 108.014 155.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -83.4 119.94 25.27 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.122 -2.177 . . . . 3.97 105.122 164.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.409 HG23 ' CG1' ' A' ' 32' ' ' ILE . 2.0 mp -113.68 118.22 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.098 -1.815 . . . . 1.27 106.098 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -103.75 97.7 7.67 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.258 -1.756 . . . . 3.21 106.258 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -112.11 169.94 8.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.185 1.394 . . . . 2.24 111.339 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -76.56 115.2 45.59 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.112 -0.699 . . . . 4.47 109.112 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.62 49.43 3.08 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-N 120.748 1.303 . . . . 1.43 111.148 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.7 -63.52 1.02 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.58 1.152 . . . . 3.81 110.052 170.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pp -75.92 -32.32 23.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 CA-C-N 118.631 0.65 . . . . 1.94 112.689 -168.721 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.9 tt -128.37 157.66 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.608 1.163 . . . . 1.18 110.806 -168.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -124.86 -173.87 13.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.471 -0.651 . . . . 0.64 111.471 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.84 -39.47 51.82 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.82 2.347 . . . . 0.93 110.336 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -51.15 -49.38 60.98 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.859 0.864 . . . . 5.64 112.198 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.28 -47.49 84.09 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.956 0.884 . . . . 2.22 110.209 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.7 mt -56.45 -54.06 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 114.926 -1.034 . . . . 1.42 108.22 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.9 mt -54.08 -53.0 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 116.376 -0.375 . . . . 0.6 110.146 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -64.23 -34.21 77.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.279 -0.263 . . . . 2.73 110.627 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.1 m -58.58 -53.53 57.24 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.073 -0.392 . . . . 1.06 110.697 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.4 mm -66.01 -39.81 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.168 -0.957 . . . . 1.99 111.476 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.32 -46.03 76.31 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.874 -0.517 . . . . 2.75 109.772 171.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.3 t -59.6 -42.62 92.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.828 0.451 . . . . 2.01 111.262 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.24 -43.38 87.77 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.726 0.694 . . . . 1.3 110.936 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.95 43.41 0.94 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.059 0.837 . . . . 0.72 111.436 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -130.92 157.58 42.56 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 105.608 -1.997 . . . . 2.01 105.608 166.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -102.11 108.01 55.06 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 119.37 0.986 . . . . 2.61 109.812 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.75 83.28 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 124.068 3.178 . . . . 0.9 110.918 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.5 t -78.75 112.34 15.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.171 -0.677 . . . . 2.11 109.171 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.2 57.49 1.86 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.679 0.792 . . . . 2.88 111.562 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 CA--C 1.532 0.267 0 C-N-CA 123.831 0.852 . . . . 3.24 110.482 173.375 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 107.993 -1.114 . . . . 2.61 107.993 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.7 tp -144.89 143.86 30.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.305 -1.368 . . . . 2.87 107.305 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -117.14 123.98 48.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.508 -0.923 . . . . 2.75 108.508 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.424 HD21 HD13 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -125.16 133.95 52.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.023 -1.473 . . . . 1.43 107.023 177.382 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.11 105.84 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.964 -1.495 . . . . 1.08 106.964 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.84 81.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.697 1.199 . . . . 0.78 108.077 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 -76.45 142.84 40.87 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 4.33 107.752 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.77 -31.84 5.57 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.36 -0.696 . . . . 0.99 111.36 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.6 ptm -60.5 159.35 10.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.181 0.991 . . . . 1.87 110.781 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 p -136.09 -65.64 0.57 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.757 0.823 . . . . 3.64 108.995 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 p -119.55 172.88 7.34 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.518 1.127 . . . . 1.24 111.579 -166.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.08 -41.2 7.5 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.958 1.303 . . . . 0.89 112.058 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m -48.96 -46.9 44.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.354 1.062 . . . . 1.9 111.325 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.8 m -68.61 -47.95 65.37 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.612 0.365 . . . . 0.92 110.128 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.5 t -50.44 -58.61 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 108.769 -0.826 . . . . 1.02 108.769 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -66.59 -28.66 68.68 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.606 -0.724 . . . . 1.0 111.687 -174.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.09 -52.71 60.1 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.231 1.012 . . . . 3.82 109.235 171.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mt -61.52 -59.8 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 108.462 -0.94 . . . . 0.78 108.462 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -51.19 -58.58 5.76 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.446 0.466 . . . . 2.64 110.744 -171.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.0 p -55.36 -50.56 69.36 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.617 0.246 . . . . 2.39 110.886 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -70.92 -26.31 63.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.039 0.385 . . . . 0.98 112.039 -171.469 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.38 -49.65 53.38 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.572 -0.705 . . . . 1.6 109.532 169.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.4 p -70.11 72.9 0.45 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.282 0.492 . . . . 1.78 111.835 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.58 -44.3 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.972 1.309 . . . . 4.39 110.866 176.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -73.32 121.93 21.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.272 -1.011 . . . . 2.03 108.272 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -66.82 0.51 2.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.78 0.718 . . . . 8.9 112.603 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.53 -41.27 99.53 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 120.046 -1.659 . . . . 1.68 111.047 161.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.19 147.92 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.901 -1.148 . . . . 1.76 107.901 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.35 -32.44 4.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.514 1.125 . . . . 2.18 110.404 171.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -155.27 138.58 15.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.813 -1.18 . . . . 2.01 107.813 169.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.4 t -128.5 147.59 50.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.017 -1.475 . . . . 2.09 107.017 170.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 t -147.91 147.58 29.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.886 -0.783 . . . . 2.08 108.886 156.842 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.0 151.03 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.52 1.128 . . . . 2.18 111.13 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.8 133.36 31.99 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.027 0.531 . . . . 0.93 111.091 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.75 -37.16 86.66 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.613 1.165 . . . . 2.94 110.475 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.27 -39.99 1.52 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.164 1.786 . . . . 1.91 113.644 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.1 t -139.96 38.13 1.96 Allowed 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 121.907 0.86 . . . . 2.64 109.608 172.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.2 m120 35.99 46.78 0.38 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 127.955 2.502 . . . . 1.83 111.672 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -102.65 146.09 28.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.679 -0.489 . . . . 2.15 109.679 -168.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.19 119.86 37.81 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.227 -1.768 . . . . 0.62 106.227 161.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -86.78 120.25 27.87 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 103.947 -2.612 . . . . 3.22 103.947 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.424 HD13 HD21 ' A' ' 8' ' ' LEU . 1.7 mp -112.5 128.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.379 -2.082 . . . . 1.15 105.379 174.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -111.46 96.92 6.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.109 -1.441 . . . . 2.18 107.109 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -106.68 148.1 28.78 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.708 0.803 . . . . 2.39 111.217 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.51 110.32 8.59 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.214 -1.402 . . . . 2.84 107.214 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -82.12 67.28 8.19 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.462 2.108 . . . . 1.59 111.909 -162.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.93 -83.72 0.14 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.086 0.954 . . . . 3.5 110.54 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.29 -47.46 84.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 122.098 -0.376 . . . . 2.35 110.825 -175.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 tp -86.2 154.16 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.241 -1.022 . . . . 1.52 108.241 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.03 168.5 23.67 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.657 -0.977 . . . . 0.78 110.657 173.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -54.9 -34.14 84.74 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.551 2.834 . . . . 0.81 110.658 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -42.26 -51.35 4.8 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.3 1.04 . . . . 9.29 111.045 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -71.79 -48.42 46.71 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.393 -0.965 . . . . 2.56 108.393 -168.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 mm -47.46 -51.25 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 124.404 1.082 . . . . 1.92 109.516 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.8 mt -61.75 -52.99 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.887 -0.597 . . . . 0.6 110.002 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -55.83 -42.35 75.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 122.052 0.93 . . . . 3.34 109.808 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 84.1 m -59.52 -58.58 7.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.218 -0.901 . . . . 0.74 108.999 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.95 -38.54 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 121.39 -0.819 . . . . 1.18 111.693 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -53.38 -51.54 62.21 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.309 -0.626 . . . . 2.84 109.309 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -57.14 -37.07 71.49 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.023 -0.423 . . . . 1.77 112.029 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.5 mt -67.98 -15.22 63.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.422 -0.799 . . . . 1.3 112.964 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.12 41.67 5.18 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.204 0.906 . . . . 0.93 112.196 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -138.54 164.72 28.72 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.94 -1.133 . . . . 2.0 107.94 170.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -100.52 99.66 10.44 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.24 1.416 . . . . 2.64 109.956 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.71 80.4 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 124.14 3.227 . . . . 1.02 110.269 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.8 m -81.95 94.63 7.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.837 0.855 . . . . 2.34 109.328 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.4 65.18 0.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.662 1.185 . . . . 2.64 112.794 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.454 -0.254 0 O-C-N 121.094 -1.004 . . . . 3.29 111.842 -176.173 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 N-CA-C 108.948 -0.76 . . . . 3.17 108.948 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mp -137.82 158.33 44.58 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.095 -1.076 . . . . 3.15 108.095 160.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -137.86 132.91 33.23 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.221 1.008 . . . . 2.32 108.465 -169.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.79 139.46 32.77 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.438 1.095 . . . . 1.4 108.64 -169.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.8 t -85.57 100.42 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 107.737 -1.208 . . . . 1.0 107.737 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.5 m -84.15 76.5 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 125.608 1.563 . . . . 0.72 108.904 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -76.29 141.14 41.72 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.11 -1.036 . . . . 4.82 108.351 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.19 -43.05 1.35 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.823 -0.911 . . . . 0.65 110.823 -176.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -64.98 149.69 49.36 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.967 0.884 . . . . 1.32 110.217 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -139.97 -37.6 0.48 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.679 0.622 . . . . 2.16 112.679 -168.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 p -135.4 168.59 18.93 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.006 0.821 . . . . 1.21 110.965 -177.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.74 -38.45 15.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.939 1.296 . . . . 0.83 112.0 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 m -45.84 -44.31 14.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.128 1.371 . . . . 1.79 112.218 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.4 m -71.68 -51.89 20.67 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.503 0.721 . . . . 0.73 110.745 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.7 t -46.6 -60.87 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 125.205 1.402 . . . . 0.51 108.946 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -67.29 -23.27 65.64 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.879 -1.055 . . . . 0.96 111.523 -175.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -66.29 -53.26 38.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.059 -1.089 . . . . 4.02 108.059 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mt -58.73 -55.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 N-CA-C 108.669 -0.863 . . . . 0.8 108.669 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.27 -57.68 10.81 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.226 0.467 . . . . 2.35 110.965 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -56.12 -48.82 75.48 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.681 0.393 . . . . 1.6 110.564 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.3 t -60.07 -57.1 14.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.933 -0.395 . . . . 0.9 109.933 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.01 -40.16 66.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.078 0.551 . . . . 1.84 111.168 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.2 m -49.3 -26.62 3.18 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.655 0.983 . . . . 2.31 113.655 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -62.55 -27.33 69.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.14 1.336 . . . . 4.38 112.505 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -68.36 107.99 3.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.126 -0.694 . . . . 2.98 109.126 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -46.34 -36.93 6.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.756 0.823 . . . . 5.55 113.083 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.62 -11.87 84.89 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.197 -0.779 . . . . 0.75 113.772 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.95 120.1 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 119.134 1.467 . . . . 1.93 108.977 173.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -91.03 -31.45 16.29 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.856 -0.593 . . . . 2.52 110.97 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -157.74 130.87 7.6 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.727 1.149 . . . . 2.34 109.91 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.0 t -103.25 144.58 31.15 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 106.856 -1.535 . . . . 2.07 106.856 164.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -147.07 149.1 32.4 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 118.322 -1.351 . . . . 2.41 109.693 144.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.09 138.84 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.727 0.811 . . . . 1.77 111.029 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.31 131.32 53.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.492 1.117 . . . . 0.7 111.972 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.6 mt -68.78 -47.88 65.07 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 126.105 1.762 . . . . 2.46 111.783 -173.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.97 -46.71 52.7 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.018 0.527 . . . . 1.44 110.862 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 m -79.7 -39.87 30.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.327 0.651 . . . . 2.55 109.25 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 79.55 43.12 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 127.466 2.306 . . . . 2.53 107.688 -168.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.2 139.25 53.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.067 0.547 . . . . 2.28 111.356 -165.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.6 125.36 53.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.776 1.63 . . . . 0.56 109.106 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -96.28 114.87 26.6 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.355 -2.832 . . . . 2.16 103.355 166.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 mt -119.43 106.98 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.446 -1.687 . . . . 1.44 106.446 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -82.34 71.27 9.4 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.077 -1.453 . . . . 2.4 107.077 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -95.22 130.1 42.09 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.942 -0.572 . . . . 3.12 109.994 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -76.76 116.04 53.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 108.22 -1.03 . . . . 3.6 108.22 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -80.38 54.96 5.46 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.424 2.75 . . . . 1.91 112.262 -163.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -125.34 -71.92 0.68 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.783 1.233 . . . . 3.58 109.137 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -75.08 -34.6 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 O-C-N 122.282 -0.261 . . . . 2.0 111.188 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.36 137.47 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 126.116 1.767 . . . . 1.11 108.347 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.95 177.67 16.41 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.774 0.702 . . . . 0.64 111.617 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -57.67 -44.67 39.24 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.458 2.772 . . . . 0.78 110.679 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -58.81 -42.92 90.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.681 -0.408 . . . . 7.48 111.175 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.81 -53.48 57.85 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.5 0.667 . . . . 2.5 109.661 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mm -52.14 -50.91 34.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.158 0.983 . . . . 2.04 110.112 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.4 mt -57.61 -49.83 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.285 -0.416 . . . . 0.56 110.05 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.408 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 2.3 m-70 -62.31 -39.32 92.63 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.939 0.876 . . . . 3.76 110.365 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.0 m -56.47 -52.55 64.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.315 -0.624 . . . . 0.75 109.315 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.3 mt -72.31 -40.76 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 121.892 -0.505 . . . . 1.18 111.638 -171.682 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HG3' ' HA ' ' A' ' 60' ' ' HIS . 3.1 pp20? -59.77 -48.6 81.03 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 118.273 0.488 . . . . 4.21 110.296 173.141 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.3 m -56.6 -40.73 75.8 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.877 0.325 . . . . 2.16 111.877 175.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.69 -38.62 91.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.107 0.867 . . . . 1.2 111.566 173.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.93 36.33 0.89 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.837 0.732 . . . . 0.68 112.451 172.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -130.23 157.73 41.68 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.368 -1.345 . . . . 2.0 107.368 168.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -99.48 104.99 30.62 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 119.538 1.063 . . . . 2.66 110.297 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.34 90.19 1.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.934 3.089 . . . . 0.87 111.1 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.9 t -78.95 111.48 15.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.153 -0.684 . . . . 2.16 109.153 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.18 60.18 1.04 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.899 1.28 . . . . 3.05 111.52 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.453 -0.307 0 O-C-N 121.795 -0.566 . . . . 3.06 111.984 -173.486 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.106 0.479 . . . . 2.7 112.196 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.68 129.4 34.95 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.345 -0.847 . . . . 2.57 110.049 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -92.94 105.46 17.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.741 1.217 . . . . 2.49 107.92 168.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.6 127.44 40.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.287 -1.375 . . . . 1.51 107.287 171.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.44 100.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.169 -1.789 . . . . 1.02 106.169 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.52 71.42 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.994 1.718 . . . . 0.64 107.995 -173.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -74.82 136.92 41.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.035 -1.468 . . . . 5.35 107.035 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.28 -42.53 1.91 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.573 -1.011 . . . . 0.81 110.573 -167.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.51 130.65 39.99 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.374 1.087 . . . . 1.45 108.919 -174.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 t -123.57 -41.52 2.26 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.968 1.099 . . . . 2.26 113.968 -155.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.2 p -138.65 175.46 9.54 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 119.498 1.044 . . . . 1.19 111.85 -168.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.97 -40.3 10.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.19 1.396 . . . . 0.81 112.222 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -55.0 -50.15 69.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.339 0.59 . . . . 2.48 110.006 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.48 -40.28 89.22 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.894 -1.129 . . . . 0.71 109.93 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.6 t -52.34 -61.58 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 108.733 -0.84 . . . . 0.63 108.733 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.284 1.0 OUTLIER -69.58 -30.39 68.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 119.999 -0.681 . . . . 1.02 112.137 -171.663 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -63.3 -47.1 83.72 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.804 0.729 . . . . 4.15 109.999 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.4 mt -56.81 -62.02 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.872 -0.788 . . . . 0.99 108.872 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -56.54 -52.87 63.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.225 -0.287 . . . . 2.45 110.225 -171.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.6 t -57.85 -55.25 37.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.658 0.266 . . . . 1.51 110.782 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 t -71.12 -32.76 69.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.563 -0.711 . . . . 1.62 112.478 -169.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -70.94 -51.98 22.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.574 0.624 . . . . 1.92 109.66 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.2 m -70.59 70.49 0.45 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.174 0.99 . . . . 2.83 110.978 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -175.38 -35.08 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.88 2.472 . . . . 3.77 110.091 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.656 ' NE2' HD12 ' A' ' 32' ' ' ILE . 3.8 p80 -65.34 136.55 56.68 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.31 0.959 . . . . 1.89 109.828 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -51.45 138.7 21.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.702 -0.481 . . . . 6.1 109.702 176.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.37 -31.46 8.28 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.338 -0.701 . . . . 0.98 112.74 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.656 HD12 ' NE2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -78.21 136.86 23.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 107.488 -1.301 . . . . 2.42 107.488 167.712 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 pp -103.42 -35.76 8.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.475 0.71 . . . . 2.45 110.396 175.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -157.35 163.66 38.4 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.179 -1.045 . . . . 2.42 108.179 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.1 m -139.62 163.6 32.13 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.516 -1.29 . . . . 2.63 107.516 161.272 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.2 t -148.17 145.43 28.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.679 -0.808 . . . . 2.35 108.823 142.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.59 137.59 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.12 0.968 . . . . 1.94 111.277 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.41 134.33 55.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.158 0.983 . . . . 0.76 110.702 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.19 -41.57 99.21 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.154 1.382 . . . . 2.0 111.1 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.82 -37.87 20.54 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.032 1.333 . . . . 1.33 113.261 -166.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -130.16 24.56 5.23 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.231 1.012 . . . . 2.7 110.535 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 m120 35.68 48.28 0.45 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.329 2.252 . . . . 1.75 111.769 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -106.68 135.14 48.73 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.53 -0.545 . . . . 1.95 109.53 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -110.48 114.81 28.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.39 -1.337 . . . . 0.67 107.39 168.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -89.95 105.0 17.51 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.014 -2.588 . . . . 2.16 104.014 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.45 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.5 mp -97.55 137.03 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.317 -1.734 . . . . 1.34 106.317 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -118.05 126.77 52.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.394 -1.336 . . . . 2.76 107.394 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -153.56 154.61 34.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.095 0.558 . . . . 2.6 110.572 -165.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -69.69 144.96 94.43 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 108.939 -0.763 . . . . 4.98 108.939 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.35 24.79 0.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.259 2.639 . . . . 1.44 111.432 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -113.02 -58.66 2.13 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.847 0.859 . . . . 3.55 109.969 -164.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 pt -95.42 -50.15 11.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.528 0.731 . . . . 2.14 110.295 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 tp -91.27 151.68 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.151 -1.055 . . . . 1.19 108.151 -173.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.56 169.07 23.62 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.643 -0.983 . . . . 0.6 110.643 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -50.09 -42.48 45.95 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.585 2.856 . . . . 0.79 110.73 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -38.0 -51.06 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.373 1.469 . . . . 9.35 111.925 173.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -71.67 -49.78 36.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.587 -0.894 . . . . 2.4 108.587 -166.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.58 -47.31 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 114.884 -1.053 . . . . 1.45 108.374 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.0 mt -58.17 -53.24 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 109.746 -0.465 . . . . 0.66 109.746 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -56.72 -41.34 77.27 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 121.64 0.733 . . . . 3.33 109.442 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.4 m -61.42 -54.35 44.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.823 -0.626 . . . . 0.67 110.583 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 mm -63.02 -41.6 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 121.367 -0.833 . . . . 1.65 110.501 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.56 -46.47 77.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.684 0.393 . . . . 3.31 109.992 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -61.43 -39.27 90.18 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.287 -0.387 . . . . 1.55 111.586 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.47 -35.67 81.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.835 0.743 . . . . 1.02 110.848 173.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.78 40.54 0.99 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.051 0.834 . . . . 0.81 112.409 170.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -131.94 162.02 31.69 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 107.131 -1.433 . . . . 1.83 107.131 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -99.48 109.1 53.84 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 119.001 0.819 . . . . 2.79 109.363 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.05 88.34 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.753 2.969 . . . . 1.0 110.54 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.15 96.78 5.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.866 -1.161 . . . . 1.88 107.866 -178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pp -59.98 107.34 0.61 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.195 0.907 . . . . 2.34 110.481 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.2 t . . . . . 0 C--N 1.34 0.185 0 N-CA-C 109.231 -0.655 . . . . 2.64 109.231 178.537 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 108.662 -0.866 . . . . 3.5 108.662 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.86 156.68 39.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.849 -1.167 . . . . 3.55 107.849 165.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -126.79 139.15 53.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.335 1.054 . . . . 2.93 109.76 -175.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.41 143.43 31.62 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.369 1.068 . . . . 1.46 108.189 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.07 123.08 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.962 -1.866 . . . . 1.08 105.962 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 m -106.59 74.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 106.656 -1.609 . . . . 0.72 106.656 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.4 ptt85 -76.1 129.59 37.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.305 -1.368 . . . . 5.02 107.305 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.85 -48.54 0.95 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.427 -1.069 . . . . 0.79 110.427 -165.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -73.57 144.78 45.91 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.847 1.323 . . . . 1.47 111.287 -174.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -148.16 -1.6 0.55 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.775 1.398 . . . . 2.33 114.775 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.62 168.51 25.88 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.554 1.525 . . . . 1.25 110.165 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.91 -42.71 13.09 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.517 1.527 . . . . 1.0 112.259 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.3 m -43.52 -51.08 6.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.681 1.193 . . . . 1.66 111.401 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -71.06 -41.6 70.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 122.993 0.517 . . . . 0.79 111.83 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.3 t -50.79 -59.0 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.232 -1.025 . . . . 0.82 108.232 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -68.36 -30.34 69.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.139 -0.937 . . . . 1.13 111.155 -176.926 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -53.61 -43.54 68.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 119.271 0.941 . . . . 4.86 110.313 170.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.1 mt -71.82 -80.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 118.751 0.705 . . . . 0.75 109.606 169.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -62.4 -43.69 98.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.709 -0.619 . . . . 2.21 112.542 -153.919 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -63.08 -28.74 70.29 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.543 0.571 . . . . 2.93 112.543 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 t -71.79 -53.19 14.13 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.376 0.989 . . . . 1.1 110.399 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.04 -46.39 65.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.152 0.981 . . . . 1.8 111.278 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.3 p -67.13 64.01 0.06 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.142 1.377 . . . . 1.65 112.114 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -160.05 -50.02 0.05 Allowed 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 128.406 2.682 . . . . 6.47 108.929 -175.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -68.02 138.54 55.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.151 -0.619 . . . . 2.32 109.789 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -56.66 149.41 17.82 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.035 0.445 . . . . 6.12 109.813 175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.07 -24.38 16.2 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-O 118.339 -1.256 . . . . 0.79 112.764 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.532 HD11 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -76.95 120.46 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 120.128 1.964 . . . . 1.75 108.221 171.943 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.8 mt -81.78 -52.99 6.57 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.193 -1.04 . . . . 2.14 108.193 170.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -157.84 147.61 20.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.586 -0.894 . . . . 3.57 108.586 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.3 t -117.97 144.67 45.31 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 105.751 -1.944 . . . . 2.24 105.751 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.4 t -147.21 151.03 36.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 118.159 -1.416 . . . . 2.74 110.441 153.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.487 HG12 ' CB ' ' A' ' 44' ' ' ALA . 3.5 m -131.8 133.19 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 124.532 1.145 . . . . 1.76 110.509 -171.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.47 132.34 55.77 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.695 0.628 . . . . 0.83 112.695 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.505 HD22 ' H ' ' A' ' 39' ' ' LEU . 2.0 mm? -65.56 -45.05 84.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.232 1.413 . . . . 3.51 111.606 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.04 -30.08 23.99 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.712 0.805 . . . . 1.41 112.932 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -114.36 2.13 14.63 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.495 1.518 . . . . 2.46 111.705 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.3 m120 41.16 43.59 1.97 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.465 2.306 . . . . 2.06 110.881 -172.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.57 140.3 49.42 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 122.691 0.396 . . . . 1.74 111.34 -166.334 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.487 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -109.41 139.52 44.27 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.179 1.792 . . . . 0.97 108.929 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -104.38 137.43 42.27 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.726 -1.953 . . . . 3.64 105.726 156.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.532 HG23 HD11 ' A' ' 32' ' ' ILE . 4.2 mp -125.8 112.88 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.445 -1.687 . . . . 1.35 106.445 174.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -83.7 68.27 9.8 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.373 -1.343 . . . . 2.91 107.373 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -90.83 140.03 30.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.226 -0.443 . . . . 2.87 110.705 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.2 106.5 0.73 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.19 1.396 . . . . 2.54 108.591 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.5 61.31 7.99 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.299 2.666 . . . . 2.3 110.421 -166.418 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -163.98 -60.47 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.01 0.924 . . . . 4.41 109.805 -169.227 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 pt -82.94 -26.88 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 122.768 0.427 . . . . 2.62 111.991 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 tp -131.12 140.26 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.261 -1.755 . . . . 1.27 106.261 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.32 176.34 16.08 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 121.781 0.656 . . . . 0.89 112.156 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.04 -41.59 51.2 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.168 2.579 . . . . 1.15 110.52 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.59 -46.05 90.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.309 0.244 . . . . 7.48 110.602 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.15 -51.31 69.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.394 -0.595 . . . . 3.26 109.394 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 mm -55.14 -48.92 75.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 122.779 0.432 . . . . 1.81 111.533 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.1 mt -53.14 -57.02 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.037 -0.727 . . . . 0.98 109.037 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -65.89 -33.92 76.95 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.806 -0.559 . . . . 3.49 111.153 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -57.56 -58.64 7.4 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.34 -0.615 . . . . 1.22 109.34 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.7 mt -65.66 -35.43 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.25 -0.906 . . . . 1.21 111.293 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.13 -51.63 61.32 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.437 -0.579 . . . . 3.4 109.437 168.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 m -57.65 -38.22 74.69 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.025 -0.422 . . . . 2.23 111.922 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.4 mt -67.94 -10.63 54.94 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.918 0.71 . . . . 1.51 112.918 174.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.98 60.09 3.0 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.673 -0.971 . . . . 1.62 110.673 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -141.5 171.48 14.0 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 106.826 -1.546 . . . . 2.11 106.826 155.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -101.46 100.96 15.23 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 108.837 -0.801 . . . . 2.51 108.837 172.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.21 145.11 59.25 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 N-CA-C 108.238 -1.485 . . . . 1.94 108.238 166.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -150.8 110.97 4.14 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.464 -1.68 . . . . 1.78 106.464 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.02 142.41 53.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.28 0.562 . . . . 3.72 109.502 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 124.836 1.254 . . . . 2.57 111.133 172.834 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 108.444 -0.947 . . . . 3.6 108.444 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -79.14 108.99 13.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.606 -1.257 . . . . 2.8 107.606 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -93.27 83.23 4.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 113.601 -1.636 . . . . 3.0 107.102 166.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.76 129.67 35.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.569 -1.641 . . . . 1.47 106.569 174.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.89 119.97 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.738 -1.949 . . . . 1.11 105.738 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.78 84.39 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 128.124 2.57 . . . . 0.77 108.331 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.79 140.16 39.41 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 108.872 -0.788 . . . . 4.61 108.872 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.84 -19.78 8.3 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.881 0.753 . . . . 0.69 112.084 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.5 mtp -62.15 150.7 37.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.572 1.186 . . . . 1.46 109.691 175.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -139.33 -39.21 0.48 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.131 0.973 . . . . 2.65 111.771 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.1 p -145.48 173.5 11.97 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.212 0.914 . . . . 1.63 111.405 -169.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.58 -39.71 3.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.048 1.739 . . . . 1.39 112.563 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.0 m -49.86 -50.87 44.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.204 0.602 . . . . 1.54 111.017 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.1 m -65.1 -41.11 95.28 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.196 0.598 . . . . 0.72 110.172 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 t -55.27 -61.76 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.458 -0.942 . . . . 0.85 108.458 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.2 -28.93 67.69 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 118.866 -0.588 . . . . 1.52 111.533 -173.755 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -56.81 -56.61 19.34 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.462 -0.94 . . . . 4.16 108.462 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.55 -59.63 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 109.158 -0.682 . . . . 0.8 109.158 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.67 -45.3 94.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.766 -0.635 . . . . 2.59 111.927 -169.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m -61.14 -47.45 86.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.793 0.724 . . . . 1.46 111.066 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.3 t -58.82 -42.57 89.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.944 -0.472 . . . . 1.76 110.094 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.35 -48.29 61.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.425 0.69 . . . . 2.03 111.842 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.3 p -56.49 -32.11 64.71 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.868 1.213 . . . . 2.44 111.62 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -54.51 -36.26 64.04 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.824 -0.548 . . . . 4.78 112.057 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -69.84 96.67 1.02 Allowed 'General case' 0 C--O 1.225 -0.234 0 O-C-N 121.325 -0.859 . . . . 2.92 109.1 171.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -41.42 -40.02 1.64 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.914 1.285 . . . . 7.18 114.099 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.0 -2.19 70.8 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.072 -0.849 . . . . 0.99 114.211 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.52 121.8 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.865 -1.532 . . . . 2.33 106.865 167.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.7 mt -79.9 -46.74 16.24 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.129 0.971 . . . . 2.34 108.882 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -155.96 129.03 8.05 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.387 0.539 . . . . 2.95 110.435 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.6 p -104.27 154.31 19.95 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.535 0.734 . . . . 2.88 109.664 169.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -151.5 110.33 3.85 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.603 -1.258 . . . . 1.98 107.603 155.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.64 157.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 118.134 0.425 . . . . 1.82 110.652 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.92 134.5 14.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.602 -0.687 . . . . 0.87 110.764 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.09 -32.15 71.38 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.941 0.896 . . . . 1.75 110.289 175.468 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.97 -37.8 2.01 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.005 1.722 . . . . 1.36 113.565 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.9 t -140.83 37.87 1.8 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 121.507 0.67 . . . . 2.45 109.913 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 m120 35.45 58.84 0.82 Allowed 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.002 1.721 . . . . 2.4 110.879 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -121.87 142.83 49.85 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 122.819 0.448 . . . . 2.32 110.605 -171.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.84 105.27 10.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.8 1.24 . . . . 0.75 108.843 167.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -79.8 108.68 13.55 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 104.356 -2.461 . . . . 3.02 104.356 169.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.8 mt -119.99 111.4 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 106.749 -1.574 . . . . 1.07 106.749 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -103.12 109.7 21.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.051 -1.833 . . . . 2.98 106.051 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -137.29 162.74 32.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.881 1.672 . . . . 2.22 109.999 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -83.25 112.76 41.45 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 107.162 -1.422 . . . . 3.24 107.162 171.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.64 68.38 8.31 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.975 2.45 . . . . 1.73 110.852 -170.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.68 -92.66 0.17 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.672 1.189 . . . . 3.8 109.363 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.97 -30.3 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 N-CA-C 112.873 0.694 . . . . 1.99 112.873 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.72 125.24 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.52 -1.659 . . . . 1.81 106.52 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.98 -179.41 19.04 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.789 1.185 . . . . 0.84 111.424 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -59.52 -39.82 71.93 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.643 2.228 . . . . 0.72 110.464 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -56.51 -49.61 74.24 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.754 0.421 . . . . 5.41 111.683 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -48.49 81.46 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.413 -0.588 . . . . 2.26 109.413 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.5 mt -51.28 -56.15 5.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 108.776 -0.824 . . . . 1.46 108.776 173.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.6 mt -54.52 -52.68 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 110.005 -0.368 . . . . 0.49 110.005 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -56.47 -42.73 78.73 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 121.53 0.681 . . . . 2.79 109.221 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.7 m -63.36 -50.34 70.31 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.076 -0.511 . . . . 0.86 110.782 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.8 mm -61.94 -42.74 95.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.445 -0.784 . . . . 1.55 110.41 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -56.23 -44.6 79.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.692 0.397 . . . . 3.23 110.099 173.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 m -61.24 -40.29 93.5 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.083 -0.386 . . . . 1.6 111.837 176.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.98 -41.26 96.11 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.72 0.691 . . . . 1.14 110.585 172.615 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.81 44.98 0.73 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.367 0.984 . . . . 0.75 111.587 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -131.74 162.78 29.66 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.552 -1.277 . . . . 2.03 107.552 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -95.03 101.51 7.38 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 117.61 -1.186 . . . . 2.66 109.861 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -77.74 137.73 16.33 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.103 1.869 . . . . 1.33 108.823 172.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 t -154.79 109.29 2.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.706 -0.85 . . . . 2.05 108.706 -171.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.42 66.02 1.78 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.784 0.834 . . . . 2.11 110.375 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t . . . . . 0 CA--C 1.532 0.251 0 C-N-CA 123.879 0.872 . . . . 2.67 109.766 177.579 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 109.114 -0.699 . . . . 2.5 109.114 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 135.66 29.65 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.926 0.49 . . . . 2.43 109.833 169.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -90.85 93.01 9.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.442 1.497 . . . . 3.13 107.046 165.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.2 121.85 34.98 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 107.997 -1.112 . . . . 1.66 107.997 173.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.63 111.09 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.337 -1.357 . . . . 1.45 107.337 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -94.17 92.16 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.252 1.421 . . . . 0.64 108.326 -168.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -77.71 137.29 38.41 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.433 -0.951 . . . . 5.84 108.433 -174.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.58 -53.15 0.77 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.499 -1.041 . . . . 1.14 110.499 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -61.58 143.7 55.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 122.938 0.495 . . . . 1.7 111.756 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -157.28 14.8 0.25 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.891 1.071 . . . . 2.5 113.891 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 p -162.85 161.04 25.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.761 1.164 . . . . 1.74 109.772 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -39.64 5.56 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.701 1.6 . . . . 1.06 111.449 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -36.16 -47.63 0.57 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.512 2.325 . . . . 2.56 113.13 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.0 m -73.85 -52.46 12.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.151 0.981 . . . . 1.0 111.685 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.5 t -45.99 -58.13 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 126.179 1.791 . . . . 0.81 109.679 -166.047 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -61.47 -32.51 72.51 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.21 -1.359 . . . . 1.92 110.794 -174.277 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -71.23 -47.3 58.13 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.852 -0.796 . . . . 4.71 108.852 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 99.1 mt -54.05 -58.88 2.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.053 -0.721 . . . . 0.98 109.053 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -61.97 -47.77 83.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.531 -0.271 . . . . 2.13 111.196 -174.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.6 m -55.49 -58.22 8.65 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.201 0.455 . . . . 1.57 110.517 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 t -49.31 -49.89 41.83 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.951 1.3 . . . . 1.3 110.698 -177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.94 -51.23 57.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 119.161 -0.447 . . . . 2.53 111.721 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.4 p -55.4 -28.35 53.54 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.159 0.436 . . . . 1.91 111.635 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -58.17 -40.85 82.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.424 0.557 . . . . 4.99 111.909 174.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -79.28 120.0 23.14 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.899 0.857 . . . . 2.37 110.142 -169.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -57.84 157.68 7.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.111 -0.7 . . . . 7.47 109.111 170.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.3 -15.05 25.37 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 117.896 -1.502 . . . . 0.81 112.785 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.51 125.05 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 119.777 1.789 . . . . 1.66 106.536 154.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.2 mt -80.44 -43.46 20.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.675 -1.231 . . . . 2.58 107.675 169.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -155.63 155.95 34.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.487 -0.561 . . . . 2.5 109.487 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 p -131.32 158.18 41.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 106.955 -1.498 . . . . 2.41 106.955 156.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -150.79 145.2 25.57 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.028 -1.101 . . . . 2.39 108.028 139.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 p -112.57 148.29 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.168 0.987 . . . . 1.91 110.653 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.54 136.11 35.73 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.14 0.576 . . . . 0.69 110.943 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.2 mt -65.82 -36.12 82.6 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.043 1.337 . . . . 2.35 110.091 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.3 -39.06 1.3 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.188 1.795 . . . . 1.54 113.88 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 t -140.96 35.68 1.75 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 122.154 0.978 . . . . 2.29 109.644 172.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 m120 36.06 57.36 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.984 2.514 . . . . 2.03 111.917 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.64 153.73 51.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 121.926 -0.484 . . . . 3.22 111.994 -170.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.556 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -116.82 117.05 28.67 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.058 1.743 . . . . 0.7 108.657 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -85.08 101.45 12.44 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 103.46 -2.792 . . . . 2.89 103.46 169.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.556 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -99.22 143.91 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.026 -1.472 . . . . 1.24 107.026 170.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -126.8 112.5 15.45 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 106.092 -1.818 . . . . 2.5 106.092 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -127.48 173.49 9.8 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.369 0.668 . . . . 2.26 111.254 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -96.4 101.33 8.57 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.411 1.085 . . . . 2.43 109.275 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.54 58.08 6.6 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.663 2.909 . . . . 1.48 113.029 -169.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.13 -63.75 0.4 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.027 1.731 . . . . 4.12 107.987 169.054 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.0 pt -65.28 -26.83 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.977 0.911 . . . . 2.82 112.432 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 tt -143.96 150.67 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.07 -1.085 . . . . 1.36 108.07 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -114.43 -176.26 18.91 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.187 -0.765 . . . . 0.92 111.187 -174.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.16 -38.72 20.5 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.337 2.024 . . . . 0.86 109.795 172.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -47.52 -49.59 25.71 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.755 1.222 . . . . 5.98 111.382 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.89 -54.09 50.27 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.227 0.611 . . . . 2.54 110.124 -174.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.6 mt -53.14 -52.28 31.55 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 N-CA-C 108.555 -0.905 . . . . 1.42 108.555 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mt -55.54 -53.28 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.89 -0.595 . . . . 0.9 110.277 -174.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -67.84 -31.87 72.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.626 0.648 . . . . 6.19 110.362 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.7 m -59.29 -46.4 88.65 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.532 -0.544 . . . . 0.8 109.532 172.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.57 -36.98 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.27 -0.894 . . . . 1.15 111.315 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -55.22 -43.96 74.97 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.507 -0.746 . . . . 2.86 109.882 169.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.7 m -60.93 -38.81 87.08 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.295 -0.253 . . . . 1.5 111.576 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.24 -40.27 95.67 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.225 0.466 . . . . 1.2 110.831 171.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.8 45.02 0.85 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 124.526 1.06 . . . . 1.01 111.752 173.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -131.89 163.06 29.15 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.748 -0.834 . . . . 2.02 108.748 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -99.12 100.7 10.62 Favored Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 124.576 1.15 . . . . 4.5 110.539 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.71 81.77 2.59 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.815 3.01 . . . . 1.39 111.107 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.2 m -78.66 109.91 13.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.402 -0.811 . . . . 1.41 109.564 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.56 58.47 0.59 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.488 0.715 . . . . 2.12 111.76 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 CA--C 1.53 0.191 0 C-N-CA 125.605 1.562 . . . . 3.08 108.67 -179.362 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.232 0.161 0 N-CA-C 107.65 -1.241 . . . . 2.77 107.65 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.95 121.38 40.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.519 0.676 . . . . 2.79 109.566 178.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -91.1 90.75 7.96 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.784 2.034 . . . . 4.22 107.348 177.385 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -82.35 106.77 14.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.15 -1.796 . . . . 2.57 106.15 172.704 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 t -78.49 101.37 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.438 -1.69 . . . . 1.38 106.438 -176.104 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 m -89.44 88.3 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.997 1.319 . . . . 0.88 109.912 -164.69 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -77.8 96.57 4.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.652 -1.61 . . . . 8.0 106.652 -176.196 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.69 -38.83 0.35 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.878 -0.957 . . . . 0.63 112.527 177.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -70.56 162.26 29.19 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.126 1.463 . . . . 1.34 111.218 -173.498 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -145.09 -37.41 0.28 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.435 0.902 . . . . 2.39 113.435 -170.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 p -141.09 173.83 11.11 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 119.789 1.177 . . . . 1.69 111.705 -172.773 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.78 -41.8 15.96 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.025 1.33 . . . . 1.18 111.799 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.7 m -57.25 -38.46 73.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.825 0.45 . . . . 1.82 111.665 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.0 m -71.07 -52.63 18.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.264 0.484 . . . . 0.73 110.176 173.208 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.8 t -44.2 -58.44 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 124.753 1.221 . . . . 0.74 109.212 -176.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.6 -22.24 63.52 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.515 -0.766 . . . . 1.44 112.368 -174.317 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -68.48 -50.87 49.16 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 107.413 -1.328 . . . . 5.29 107.413 173.361 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mt -56.54 -57.01 10.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 109.104 -0.702 . . . . 0.76 109.104 177.266 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.98 -54.66 44.14 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.423 0.556 . . . . 2.18 111.488 -174.572 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.7 t -62.33 -39.1 91.96 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.502 0.321 . . . . 1.91 111.007 -178.088 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -63.5 -53.42 52.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.141 -0.688 . . . . 1.41 109.141 177.561 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -47.6 -46.21 28.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.662 1.185 . . . . 1.87 111.528 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.43 -15.16 2.4 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.491 1.293 . . . . 2.66 114.491 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -56.59 -37.02 70.05 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.904 1.229 . . . . 5.21 111.288 170.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -76.72 100.78 5.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.596 -0.891 . . . . 3.07 108.596 -176.383 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -50.92 -30.21 14.16 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.204 0.816 . . . . 6.79 113.204 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.81 -20.64 70.59 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.95 -0.916 . . . . 1.01 113.677 177.424 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.09 124.87 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 118.682 1.241 . . . . 2.0 108.393 178.872 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.5 mt -94.46 -36.93 11.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.591 1.556 . . . . 2.18 109.507 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -155.7 125.59 6.52 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.8 0.727 . . . . 2.07 111.048 178.533 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.84 144.79 34.55 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.528 1.131 . . . . 2.99 108.732 167.136 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 m -151.48 143.06 23.61 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.901 -1.518 . . . . 2.21 106.901 152.382 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 m -127.18 136.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.29 0.496 . . . . 1.7 110.223 178.954 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.82 131.59 54.13 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.835 0.854 . . . . 0.77 111.691 -174.158 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.63 -43.47 80.3 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.296 1.838 . . . . 2.8 111.414 -175.761 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.09 -46.06 33.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.166 0.587 . . . . 1.18 111.453 -179.236 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -82.92 -25.16 32.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.671 1.189 . . . . 3.39 111.839 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 41.69 66.9 0.62 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.523 1.529 . . . . 3.37 109.609 -151.377 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.41 141.3 33.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.504 -1.226 . . . . 1.74 110.453 -177.885 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.28 124.08 49.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.039 2.136 . . . . 0.74 108.31 174.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -98.16 106.99 19.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.249 -2.871 . . . . 2.08 103.249 174.711 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.3 mp -102.25 127.83 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.546 -1.65 . . . . 1.4 106.546 175.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -112.03 114.43 27.3 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.631 -1.248 . . . . 2.23 107.631 167.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -130.9 163.47 27.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.566 1.546 . . . . 2.02 111.47 176.369 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -87.98 129.32 50.63 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.239 1.016 . . . . 3.93 110.548 175.239 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -59.2 -58.76 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.781 2.321 . . . . 2.36 115.294 -165.304 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -78.07 37.27 0.25 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.168 1.349 . . . . 3.84 113.911 -165.965 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.63 -52.63 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.241 1.416 . . . . 3.67 109.111 170.235 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.19 144.83 33.84 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 122.624 0.37 . . . . 1.25 110.958 -171.41 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.47 -176.76 22.56 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.326 -1.11 . . . . 0.81 110.326 176.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.0 -39.74 18.23 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.189 1.926 . . . . 0.97 110.11 174.56 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -53.38 -49.43 67.21 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.004 0.922 . . . . 6.69 111.989 -176.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.12 -52.0 38.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 122.491 1.139 . . . . 2.83 109.464 -178.706 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.2 mt -65.55 -52.29 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 114.554 -1.203 . . . . 1.27 109.059 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.2 mt -48.08 -54.25 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.765 0.826 . . . . 0.69 110.222 -177.07 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -65.86 -35.6 81.11 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 119.809 -0.756 . . . . 5.36 110.501 -176.014 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.8 m -63.13 -46.91 85.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 122.1 -0.375 . . . . 0.98 110.582 178.267 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.6 -40.79 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.49 -0.756 . . . . 1.06 109.882 178.821 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -53.31 -38.44 63.17 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.539 -0.725 . . . . 5.24 111.207 170.264 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -64.44 -22.54 66.99 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.935 0.717 . . . . 1.6 112.935 176.038 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.6 mt -78.74 -43.61 25.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.982 0.81 . . . . 1.19 109.243 168.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.21 49.11 0.37 Allowed Glycine 0 C--N 1.338 0.659 0 C-N-CA 124.467 1.032 . . . . 0.93 112.173 169.714 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.28 134.73 26.19 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 117.419 -1.277 . . . . 1.99 108.014 175.888 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -78.86 112.02 24.15 Favored Pre-proline 0 C--N 1.34 0.156 0 CA-C-N 119.49 1.041 . . . . 5.48 108.893 -170.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -89.55 78.98 0.87 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.38 2.72 . . . . 1.39 110.066 -171.558 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.39 115.53 20.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.547 -0.721 . . . . 1.78 109.633 -170.203 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.6 mt -53.61 111.52 0.74 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.996 0.816 . . . . 3.41 110.724 174.95 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.469 0.495 0 CA-C-N 118.896 0.771 . . . . 4.57 111.89 176.945 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 107.836 -1.172 . . . . 2.84 107.836 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -149.25 163.5 37.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.256 -0.646 . . . . 3.4 109.256 162.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -120.03 145.41 46.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.217 -1.031 . . . . 2.35 108.217 168.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.07 130.13 28.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.759 -1.2 . . . . 1.44 107.759 177.47 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.3 t -79.67 104.72 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.901 -1.889 . . . . 1.07 105.901 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.05 89.22 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.428 1.491 . . . . 0.65 108.216 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -75.57 131.4 39.99 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 107.763 -1.199 . . . . 5.23 107.763 -170.296 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.05 -43.13 1.39 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.088 0.852 . . . . 0.71 111.404 177.054 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.46 132.58 40.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.454 1.127 . . . . 1.37 108.633 -175.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 t -154.84 25.08 0.44 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.97 0.73 . . . . 2.69 112.97 -169.972 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.33 156.87 19.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.523 0.602 . . . . 1.39 109.629 178.236 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.53 -39.43 16.29 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.505 1.522 . . . . 0.89 111.987 -176.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.6 t -47.26 -54.23 11.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.683 0.754 . . . . 2.21 110.143 172.772 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.263 57.7 m -73.16 -33.56 65.55 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.355 -1.465 . . . . 1.19 112.151 -176.668 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.8 t -50.37 -61.33 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 108.666 -0.864 . . . . 0.69 108.666 174.084 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -69.84 -29.56 66.84 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.175 -0.921 . . . . 1.12 111.787 -174.098 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -62.0 -50.72 70.92 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.28 0.945 . . . . 4.41 109.655 173.503 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 mt -58.29 -57.76 9.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 119.218 0.917 . . . . 0.65 109.047 178.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.05 -54.14 46.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.157 0.435 . . . . 2.47 110.895 -173.515 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -56.98 -52.99 63.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.865 0.466 . . . . 1.54 110.437 179.197 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.6 t -57.34 -54.97 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.638 0.375 . . . . 0.97 110.756 -177.458 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.51 -32.98 71.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.534 -0.729 . . . . 2.06 111.365 -174.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.9 m -53.66 -19.97 4.71 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 112.938 0.718 . . . . 2.54 112.938 173.198 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -30.28 59.73 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.531 -1.355 . . . . 5.72 112.113 171.385 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -68.86 101.47 1.36 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.577 -0.897 . . . . 2.82 108.577 169.319 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -49.45 -33.25 13.68 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 111.885 0.328 . . . . 5.36 111.885 171.209 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.72 -11.23 77.5 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.815 -0.992 . . . . 0.84 113.796 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.16 129.67 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 119.699 1.75 . . . . 2.09 107.431 168.919 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 pp -99.74 -26.05 14.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.862 0.465 . . . . 2.31 110.745 175.662 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -156.11 149.94 25.1 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.88 0.764 . . . . 2.68 111.224 172.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.1 m -130.33 145.4 51.78 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 126.178 1.791 . . . . 2.57 107.553 174.384 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 m -153.34 135.22 14.62 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 107.808 -1.182 . . . . 1.84 107.808 152.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.86 151.07 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.987 0.812 . . . . 1.86 110.479 173.586 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.61 132.57 37.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.533 0.682 . . . . 0.79 110.779 176.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.9 -29.44 66.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.035 -0.984 . . . . 1.75 110.732 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.72 -34.97 13.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.49 1.116 . . . . 1.09 112.927 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 p -122.03 13.49 10.55 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.889 0.876 . . . . 2.24 111.299 175.14 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.7 m120 40.15 52.17 2.73 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.243 1.817 . . . . 1.93 110.659 -171.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.09 140.37 45.45 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 122.043 -0.411 . . . . 1.92 111.141 -164.561 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.85 128.22 56.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.026 1.73 . . . . 0.58 109.156 177.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -98.84 121.78 41.23 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 127.847 2.459 . . . . 2.81 105.701 172.297 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mt -123.72 134.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.686 -0.857 . . . . 1.63 108.686 177.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -122.95 130.82 53.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.14 -1.8 . . . . 2.4 106.14 178.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -162.05 171.31 17.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.214 0.45 . . . . 2.51 112.214 -158.731 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.12 100.56 25.48 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.51 1.524 . . . . 2.8 109.437 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.71 -12.79 35.56 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.323 2.682 . . . . 2.37 113.394 -168.549 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -52.97 -39.71 63.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.662 0.664 . . . . 4.63 111.635 176.765 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -120.07 -54.52 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.113 0.565 . . . . 1.9 112.133 -176.246 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.14 116.54 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.851 -1.166 . . . . 1.84 107.851 -172.92 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.71 161.55 16.75 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.523 -1.031 . . . . 0.78 110.523 -177.255 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -51.52 -38.1 63.82 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.995 2.463 . . . . 0.81 110.857 176.36 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -42.87 -52.73 4.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.422 1.089 . . . . 9.48 111.647 172.176 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.18 -40.52 67.86 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.083 -1.01 . . . . 2.5 109.76 -167.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 78.5 mt -52.68 -57.47 4.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 N-CA-C 107.611 -1.255 . . . . 1.55 107.611 170.02 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mt -55.54 -48.91 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 116.039 -0.528 . . . . 0.64 110.136 -174.814 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -55.54 -44.98 77.23 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 122.172 0.986 . . . . 3.54 108.953 179.406 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 m -62.96 -45.72 91.13 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.344 -0.843 . . . . 0.97 110.294 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -70.07 -42.42 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.377 -0.827 . . . . 1.48 110.566 -173.782 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -63.26 -43.18 98.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.907 -0.496 . . . . 3.01 110.138 175.595 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 m -54.54 -44.83 73.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 111.891 0.33 . . . . 1.63 111.891 172.292 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.07 -39.8 91.27 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.822 0.737 . . . . 1.17 111.14 173.575 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.2 41.07 0.92 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.049 0.833 . . . . 0.82 111.655 173.434 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -127.77 161.97 27.72 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.163 -1.051 . . . . 1.8 108.163 170.449 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.4 103.6 14.63 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.133 -0.937 . . . . 2.68 110.015 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.29 77.03 3.97 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.239 2.626 . . . . 1.02 110.699 -176.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -78.66 90.11 4.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.316 -0.994 . . . . 1.69 108.316 -177.012 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.3 pt? -66.1 57.44 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.021 1.728 . . . . 2.61 114.683 -176.259 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.454 -0.264 0 C-N-CA 126.369 1.868 . . . . 3.66 107.543 -175.512 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.236 0.373 0 N-CA-C 109.783 -0.451 . . . . 2.49 109.783 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mp -136.46 138.67 41.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.029 -0.73 . . . . 2.34 109.029 167.457 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -92.34 93.51 8.66 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.512 -1.292 . . . . 2.7 107.512 163.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mt -80.03 112.25 17.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.797 -1.927 . . . . 2.82 105.797 173.798 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.2 t -78.97 104.49 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.506 -1.665 . . . . 1.34 106.506 -177.712 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.3 m -79.14 80.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 124.601 1.16 . . . . 0.97 108.516 -172.523 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 -75.91 95.27 3.5 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.524 -1.658 . . . . 4.13 106.524 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.58 -57.41 0.11 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.643 -0.983 . . . . 1.51 110.643 177.585 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.28 157.45 18.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 117.363 0.582 . . . . 2.13 109.794 -177.697 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 t -154.31 35.82 0.42 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.624 -0.51 . . . . 4.06 109.624 170.892 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.43 137.0 22.76 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.686 0.795 . . . . 2.57 110.193 -170.054 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.69 -43.28 2.8 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.519 1.927 . . . . 1.01 112.002 -177.681 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -35.1 -58.38 0.54 Allowed 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.733 1.613 . . . . 2.03 111.931 170.789 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.2 m -74.52 -27.56 60.59 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.915 -1.116 . . . . 1.44 113.866 -178.296 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.455 HG13 HG13 ' A' ' 37' ' ' VAL . 45.1 t -56.41 -55.68 17.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.895 -1.15 . . . . 0.58 107.895 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -63.58 -32.57 74.08 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.951 -0.568 . . . . 1.11 111.913 -178.684 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -60.01 -54.3 47.6 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.433 -0.951 . . . . 3.96 108.433 173.77 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.3 mt -57.7 -56.43 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.187 -0.672 . . . . 0.8 109.187 -172.525 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -61.03 -50.23 74.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.789 -0.764 . . . . 3.29 111.337 -174.725 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.3 m -54.11 -50.11 67.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.339 0.59 . . . . 1.58 110.407 177.382 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.4 t -58.19 -41.88 84.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.037 0.935 . . . . 1.32 110.301 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.68 -46.3 69.42 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.59 -0.694 . . . . 2.1 111.849 178.505 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.2 p -53.71 -30.21 42.77 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.806 0.73 . . . . 2.31 112.926 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -58.19 -32.46 68.27 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.24 0.616 . . . . 5.6 112.082 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -73.17 106.66 5.12 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.335 0.971 . . . . 3.03 108.595 171.88 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -37.38 -58.01 0.87 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.067 -0.716 . . . . 8.65 109.067 167.751 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.97 -11.43 0.57 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.921 1.248 . . . . 0.82 116.07 -173.578 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.13 167.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 120.275 2.038 . . . . 2.17 107.892 171.483 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.87 -30.04 1.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.67 -0.644 . . . . 2.54 112.531 170.537 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -155.62 123.17 5.57 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.293 0.951 . . . . 3.26 108.917 170.828 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 p -106.52 132.81 52.1 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.996 0.918 . . . . 3.03 108.573 169.059 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -134.9 80.29 1.84 Allowed 'General case' 0 CA--C 1.522 -0.122 0 O-C-N 123.715 0.634 . . . . 2.28 109.614 167.368 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.455 HG13 HG13 ' A' ' 19' ' ' VAL . 10.7 p -78.85 144.1 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 122.56 0.344 . . . . 1.83 110.803 171.593 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.24 137.7 16.74 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.887 0.875 . . . . 1.22 109.905 178.396 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.75 -22.35 58.83 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.013 -0.54 . . . . 1.7 111.487 177.888 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.56 -39.7 2.41 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.49 1.516 . . . . 1.8 113.278 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -137.88 34.8 2.39 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.944 0.497 . . . . 2.07 110.309 168.157 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 44.78 50.51 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.765 2.026 . . . . 1.96 110.027 173.747 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -114.61 145.26 42.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.971 0.909 . . . . 2.46 110.354 -170.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.491 ' HB1' HD11 ' A' ' 46' ' ' ILE . . . -122.28 108.22 13.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.15 1.38 . . . . 0.94 108.562 163.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . 0.25 19.7 t60 -86.77 101.75 13.61 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 104.234 -2.506 . . . . 2.55 104.234 174.25 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.491 HD11 ' HB1' ' A' ' 44' ' ' ALA . 2.0 mp -103.43 119.83 52.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.858 -1.905 . . . . 1.06 105.858 174.752 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -102.71 140.66 36.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.069 -1.085 . . . . 2.74 108.069 166.179 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -159.27 159.1 33.69 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.957 0.903 . . . . 2.05 112.423 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.74 109.17 3.06 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 126.47 1.908 . . . . 2.68 107.659 173.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -81.83 54.61 5.13 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.007 2.471 . . . . 1.53 110.553 -170.269 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -142.52 -64.31 0.42 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.367 1.467 . . . . 3.89 109.361 -175.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.57 -38.46 17.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 N-CA-C 112.204 0.446 . . . . 1.78 112.204 -172.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 tt -113.41 146.01 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.64 1.176 . . . . 1.17 109.604 -175.597 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.5 -172.17 13.73 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.687 -0.965 . . . . 0.69 110.687 178.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.81 -40.56 28.08 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.479 2.119 . . . . 0.76 110.178 174.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -45.53 -58.41 3.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.313 1.045 . . . . 6.29 111.504 179.258 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.91 -57.62 9.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.362 0.665 . . . . 2.34 109.644 -174.584 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 56.0 mt -51.82 -52.71 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.921 0.888 . . . . 1.26 109.325 179.441 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.02 -48.67 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-O 119.034 -0.508 . . . . 0.76 110.107 -176.189 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -58.7 -41.57 86.6 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.88 0.848 . . . . 3.11 109.476 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.3 m -64.88 -45.44 85.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.783 -0.644 . . . . 0.98 111.044 178.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.3 mm -70.2 -51.67 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 CA-C-N 118.575 0.625 . . . . 1.96 110.682 -177.158 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -55.58 -36.8 67.27 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.148 0.579 . . . . 3.08 111.707 -167.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 t -38.07 -44.68 0.84 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.011 1.724 . . . . 2.5 113.039 168.228 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -19.66 63.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.811 0.844 . . . . 3.89 112.21 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.6 40.54 3.37 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.021 1.296 . . . . 1.89 111.782 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -124.87 155.95 38.68 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.759 -1.2 . . . . 2.11 107.759 172.656 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -95.63 101.12 7.23 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.012 -0.994 . . . . 3.51 108.895 169.305 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -70.81 81.49 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.165 2.577 . . . . 1.15 109.141 175.208 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 m -79.35 109.66 13.91 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.909 0.884 . . . . 1.86 108.733 -168.435 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.42 61.4 0.67 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.558 1.143 . . . . 2.66 112.568 -174.201 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.455 -0.211 0 N-CA-C 108.856 -0.794 . . . . 2.31 108.856 174.487 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 108.47 -0.937 . . . . 3.31 108.47 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 mt -134.31 130.29 36.79 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.335 -0.987 . . . . 3.24 108.335 170.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -114.11 91.93 3.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.454 1.502 . . . . 2.5 108.596 174.529 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.67 134.46 44.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.374 -1.343 . . . . 1.32 107.374 176.789 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -80.33 115.69 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 106.949 -1.5 . . . . 2.89 106.949 170.186 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.54 86.45 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 125.938 1.695 . . . . 0.65 107.698 -173.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -77.34 130.9 37.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.23 -1.026 . . . . 5.62 108.23 -170.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.16 -18.83 4.17 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.718 0.675 . . . . 1.01 112.541 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 61.5 mtp -59.19 147.67 34.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.574 1.187 . . . . 1.88 110.863 177.252 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -150.75 -10.93 0.24 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.761 1.393 . . . . 2.87 114.761 178.61 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.9 p -165.59 172.01 12.47 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 121.032 1.742 . . . . 1.46 109.371 -179.132 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.88 -38.99 11.28 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.379 1.472 . . . . 1.0 112.147 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -45.71 -47.0 15.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.924 0.889 . . . . 1.47 111.65 173.903 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.0 m -69.75 -39.84 76.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 122.79 0.436 . . . . 0.7 110.98 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.7 t -57.75 -59.58 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.998 -1.112 . . . . 0.74 107.998 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.269 1.3 p-80 -70.8 -31.46 68.21 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 118.206 -0.902 . . . . 0.88 112.521 -175.483 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -49.15 -58.15 5.48 Favored 'General case' 0 C--N 1.347 0.465 0 N-CA-C 108.178 -1.045 . . . . 3.93 108.178 165.959 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.19 -60.87 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 118.572 -0.728 . . . . 1.1 110.239 -174.298 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.03 -55.31 24.63 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.39 0.995 . . . . 2.59 110.853 -175.993 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.1 t -58.09 -54.21 49.52 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.538 0.685 . . . . 1.53 110.28 -177.815 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -66.82 -40.62 88.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.709 -0.62 . . . . 0.93 110.952 -170.32 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.98 -42.69 84.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.115 0.416 . . . . 1.75 109.935 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -55.27 -27.23 45.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.5 0.591 . . . . 2.38 112.354 176.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -30.57 64.19 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.09 -1.006 . . . . 3.83 112.153 173.641 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -63.92 108.61 1.53 Allowed 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.346 0.975 . . . . 2.89 108.808 173.325 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -48.4 -33.44 9.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.896 0.878 . . . . 6.19 112.37 175.255 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.85 -18.35 80.12 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.642 -1.088 . . . . 0.81 114.042 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.21 135.59 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.94 1.37 . . . . 2.1 107.774 172.57 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pp -98.6 -33.61 10.9 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.692 -0.67 . . . . 2.65 109.82 173.35 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -157.04 146.17 20.17 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.463 1.029 . . . . 2.8 109.642 162.0 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.6 t -112.65 112.3 23.71 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 107.382 -1.34 . . . . 2.51 107.382 164.201 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.11 98.29 8.25 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.837 -1.172 . . . . 1.94 107.837 171.714 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.0 146.28 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 110.351 -0.24 . . . . 1.87 110.351 170.659 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.7 130.26 15.88 Favored 'General case' 0 CA--C 1.523 -0.092 0 O-C-N 122.02 -0.425 . . . . 0.83 111.293 170.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 pp -72.14 -25.82 61.87 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 124.756 1.223 . . . . 2.12 113.074 -168.89 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.1 -43.46 66.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.809 0.444 . . . . 1.11 111.191 -178.639 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.73 -31.75 10.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.591 1.156 . . . . 2.22 110.038 173.322 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 76.2 30.91 0.67 Allowed 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.14 2.176 . . . . 2.33 109.464 -171.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -79.5 145.01 33.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.373 -1.343 . . . . 4.0 107.373 171.507 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.48 109.71 21.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 124.888 1.367 . . . . 0.81 107.406 151.239 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -80.38 94.3 6.13 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.705 -1.961 . . . . 3.86 105.705 166.637 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -92.11 116.13 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 107.216 -1.401 . . . . 1.52 107.216 176.571 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -108.09 128.44 54.68 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.606 -1.627 . . . . 3.32 106.606 174.399 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -157.24 171.8 19.76 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.421 0.688 . . . . 2.26 109.637 -166.67 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.76 114.36 62.85 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.169 -0.678 . . . . 3.12 109.169 177.536 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.25 49.68 3.24 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.41 2.74 . . . . 1.33 112.15 -174.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.96 27.24 0.54 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.748 1.219 . . . . 3.84 110.234 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.78 -51.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 125.021 1.328 . . . . 3.4 108.998 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 tt -127.67 152.59 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.241 1.016 . . . . 1.11 108.478 -174.973 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -133.83 -176.09 14.22 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.538 -0.625 . . . . 0.74 111.538 -178.124 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.92 -41.62 52.0 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.859 2.373 . . . . 0.81 111.872 -176.797 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -57.39 -47.49 81.55 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.629 0.65 . . . . 6.14 110.863 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.95 -52.85 63.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.818 -0.808 . . . . 2.71 108.818 -175.853 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 mm -51.77 -52.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.405 1.082 . . . . 1.95 109.901 175.304 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.418 ' HA ' ' CG ' ' A' ' 69' ' ' PRO . 5.1 mt -55.29 -57.3 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 109.848 -0.427 . . . . 0.87 109.848 -179.026 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -65.24 -34.2 77.8 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.623 -0.673 . . . . 3.0 110.23 -171.911 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.5 m -59.2 -55.95 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.049 -0.523 . . . . 0.88 109.937 171.674 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 76.8 mt -63.86 -36.24 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.35 -0.844 . . . . 1.22 111.35 -175.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -51.2 -55.06 19.96 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.208 -0.664 . . . . 2.81 109.208 167.53 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -54.76 -42.08 71.23 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.696 0.398 . . . . 1.82 111.559 177.348 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.48 -10.94 58.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.185 0.809 . . . . 1.4 113.185 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.08 44.1 5.46 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 123.941 0.782 . . . . 0.98 111.976 172.751 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -140.82 163.53 32.69 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.174 -1.417 . . . . 2.45 107.174 167.301 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -103.91 105.01 46.31 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 125.429 1.492 . . . . 4.59 109.984 -179.431 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.418 ' CG ' ' HA ' ' A' ' 59' ' ' ILE . 60.6 Cg_endo -83.49 85.29 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.538 3.492 . . . . 0.94 111.317 -173.818 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -94.11 111.97 23.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.851 -0.531 . . . . 1.75 110.136 -173.057 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 mt -62.14 106.41 0.72 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.96 0.904 . . . . 3.01 109.924 174.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.462 0.132 0 N-CA-C 109.7 -0.481 . . . . 2.49 109.7 177.526 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 106.664 -1.606 . . . . 2.8 106.664 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -155.26 175.13 14.25 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.681 -1.229 . . . . 3.44 107.681 163.111 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -131.83 146.45 52.14 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.725 -0.843 . . . . 2.47 108.725 168.077 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.468 ' N ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -132.42 131.41 41.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.791 -1.559 . . . . 1.35 106.791 169.178 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.5 t -79.92 100.94 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.022 -1.473 . . . . 1.02 107.022 175.164 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.21 87.03 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 126.056 1.742 . . . . 0.91 108.096 177.952 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.12 154.33 33.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.811 -1.181 . . . . 5.07 107.811 170.171 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.54 -38.42 3.21 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.628 -0.989 . . . . 0.72 110.628 -172.449 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 29.9 mtp -64.06 138.15 58.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.229 1.015 . . . . 1.57 109.607 178.255 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -140.54 -2.76 1.36 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.128 1.159 . . . . 2.41 114.128 -176.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.1 p -161.43 166.09 27.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.44 1.473 . . . . 1.17 110.063 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.89 -40.56 10.19 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.371 1.468 . . . . 0.98 111.875 -177.782 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.3 m -43.27 -47.04 6.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.856 0.863 . . . . 1.53 112.304 174.951 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.6 -33.77 75.66 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.005 0.522 . . . . 0.91 111.436 -175.054 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 37' ' ' VAL . 42.4 t -59.22 -59.91 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.112 -1.44 . . . . 0.66 107.112 -178.856 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.25 1.5 p-80 -67.97 -30.03 69.21 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.179 -0.464 . . . . 1.0 112.062 -178.261 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -52.67 -44.95 66.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.57 -0.706 . . . . 3.84 110.615 168.898 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.6 mt -70.39 -71.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.126 -0.694 . . . . 1.07 109.126 175.653 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . 0.283 0.2 OUTLIER -59.15 -50.02 75.64 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.238 0.926 . . . . 4.32 112.471 -159.745 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -56.37 -46.36 80.08 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.376 0.67 . . . . 1.5 110.497 176.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -71.24 -35.27 71.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 121.232 -0.917 . . . . 1.38 112.142 -176.161 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.77 -54.07 50.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.004 -0.739 . . . . 1.77 109.004 172.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.2 p -65.25 71.48 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.799 1.24 . . . . 1.59 113.081 -174.717 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -169.83 -31.09 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.915 2.486 . . . . 3.9 111.567 171.299 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -67.69 147.23 52.94 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.307 1.412 . . . . 2.26 108.78 177.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 ttm105 -61.66 142.76 56.98 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.263 -1.014 . . . . 5.43 108.263 173.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.65 -56.52 0.48 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.669 -0.973 . . . . 1.29 110.669 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.11 103.95 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 118.509 1.155 . . . . 2.39 110.993 -167.521 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.4 pp -82.3 -29.72 30.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.589 -0.732 . . . . 2.58 110.292 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -156.44 158.04 36.6 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.573 0.624 . . . . 2.55 109.38 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -142.9 133.79 25.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.206 1.003 . . . . 2.42 108.53 169.484 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 m -112.19 93.14 4.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.644 -1.243 . . . . 2.39 107.644 160.838 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 19' ' ' VAL . 9.4 p -88.82 144.94 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 122.551 0.34 . . . . 1.55 111.096 162.378 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.74 138.85 26.07 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.172 0.989 . . . . 0.89 110.039 171.376 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.74 -35.85 60.07 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.602 0.761 . . . . 1.89 110.885 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.28 -42.61 41.64 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.289 1.035 . . . . 1.49 111.849 -173.961 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.1 p -114.84 20.09 15.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.908 1.283 . . . . 2.8 110.615 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 m120 37.13 55.64 1.28 Allowed 'General case' 0 C--N 1.341 0.211 0 C-N-CA 126.777 2.031 . . . . 2.22 111.431 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -134.15 150.56 51.12 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 118.418 0.554 . . . . 1.67 112.488 -176.213 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.77 119.85 33.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.134 2.174 . . . . 0.72 107.535 167.673 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -101.12 101.42 12.15 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.164 -2.532 . . . . 2.22 104.164 167.449 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.467 HD13 HD21 ' A' ' 8' ' ' LEU . 4.8 mp -94.59 143.79 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 108.116 -1.068 . . . . 1.34 108.116 177.657 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -120.43 91.0 3.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.937 -1.134 . . . . 2.23 107.937 175.969 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -102.37 149.79 24.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.003 0.921 . . . . 2.35 113.205 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -71.71 116.03 43.78 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 124.83 1.252 . . . . 3.15 108.574 171.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.41 40.21 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.264 1.976 . . . . 1.8 111.586 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -82.32 -40.33 21.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.698 -0.626 . . . . 6.35 109.818 172.417 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 pt -133.63 -51.09 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.717 0.807 . . . . 2.28 112.098 -168.058 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.76 147.0 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.307 0.643 . . . . 1.07 109.823 -166.546 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.12 -171.66 13.01 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.892 -0.883 . . . . 0.76 110.892 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.25 -34.47 56.03 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.46 2.107 . . . . 0.93 110.519 176.51 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.526 HH21 ' CE1' ' A' ' 60' ' ' HIS . 1.7 tpm_? -50.37 -54.23 23.24 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.361 1.064 . . . . 7.53 111.163 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -52.51 63.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.232 1.013 . . . . 2.66 109.183 -176.559 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 94.8 mt -52.08 -47.85 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 C-N-CA 123.647 0.779 . . . . 1.29 109.4 178.446 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.7 mt -55.38 -54.13 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 109.381 -0.6 . . . . 0.73 109.381 -178.902 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' HIS . . . . . 0.526 ' CE1' HH21 ' A' ' 56' ' ' ARG . 76.7 m-70 -65.48 -34.88 79.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.801 0.728 . . . . 3.19 111.367 -176.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -57.08 -52.23 66.11 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.076 -0.713 . . . . 0.7 109.076 173.897 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.9 mt -70.87 -32.37 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 121.242 -0.911 . . . . 1.01 112.242 -178.09 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -53.96 -49.06 69.58 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.346 -0.983 . . . . 2.75 108.346 166.976 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -60.5 -40.93 93.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.157 0.183 . . . . 1.4 111.34 177.551 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.0 mt -61.38 -34.33 75.16 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.611 -0.681 . . . . 1.19 111.582 172.451 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.48 43.85 1.53 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.886 1.231 . . . . 0.85 112.206 173.269 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -134.2 168.83 18.15 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.732 -0.84 . . . . 1.95 108.732 170.589 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.92 85.05 4.74 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.059 0.944 . . . . 3.57 110.982 -172.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.64 93.42 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.788 2.992 . . . . 0.89 111.37 -175.023 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.2 m -86.22 119.53 26.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.888 1.275 . . . . 1.86 108.116 -179.407 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.0 mt -74.56 58.05 0.76 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.05 1.296 . . . . 2.64 112.184 -175.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 107.604 -1.258 . . . . 2.69 107.604 177.462 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 109.768 -0.456 . . . . 2.71 109.768 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 pp -150.3 164.92 34.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.748 -0.834 . . . . 3.23 108.748 161.333 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 153.26 51.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.629 0.728 . . . . 4.44 109.944 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 134.63 30.43 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.669 -1.604 . . . . 1.39 106.669 -177.259 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.16 102.47 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 105.513 -2.032 . . . . 1.0 105.513 177.485 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 m -90.79 71.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.471 -1.678 . . . . 0.75 106.471 -172.297 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -74.72 124.13 26.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 118.883 -1.127 . . . . 4.94 108.112 -159.808 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.19 -26.11 3.26 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.328 -0.851 . . . . 0.82 111.946 -179.268 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.86 109.86 8.67 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.883 1.341 . . . . 1.59 110.462 -176.299 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 p -83.67 -44.6 14.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.85 -0.532 . . . . 3.36 112.186 -170.718 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -149.28 177.37 9.72 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 112.073 0.397 . . . . 1.41 112.073 -156.32 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.28 -48.51 3.6 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.706 1.602 . . . . 0.8 111.785 177.908 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 m -48.09 -46.64 34.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.326 1.451 . . . . 1.96 111.779 176.825 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.9 m -72.24 -53.58 12.1 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.877 0.471 . . . . 0.74 110.689 176.426 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -43.91 -60.07 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.281 1.432 . . . . 0.6 109.347 -176.69 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.52 -12.37 61.34 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 113.61 0.967 . . . . 1.04 113.61 -176.037 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -53.2 19.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.553 -1.647 . . . . 3.68 106.553 163.182 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.6 mt -65.4 -60.22 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 118.445 0.566 . . . . 0.66 109.596 -169.644 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . 0.264 0.2 OUTLIER -58.36 -53.58 56.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.765 -0.774 . . . . 4.51 111.311 -166.123 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -60.9 -48.87 79.83 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.225 -0.893 . . . . 2.01 109.868 177.171 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 t -63.75 -42.71 97.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.883 1.22 . . . . 1.16 110.837 -170.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.33 -46.17 87.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.423 -0.584 . . . . 2.14 109.423 174.842 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -71.73 65.45 0.5 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.256 0.55 . . . . 2.81 111.53 174.768 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -146.81 -49.81 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.677 2.791 . . . . 7.09 108.459 170.545 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -61.04 130.13 44.86 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.843 0.354 . . . . 1.97 110.938 -174.317 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.78 90.43 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.923 0.889 . . . . 7.15 110.079 -179.271 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.08 -29.68 0.32 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-O 119.207 -0.774 . . . . 1.24 112.037 178.393 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.46 134.91 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.386 -1.339 . . . . 2.18 107.386 165.654 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -102.49 -29.33 11.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 123.969 0.793 . . . . 2.13 110.13 172.082 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -156.24 162.46 40.15 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.307 0.958 . . . . 2.57 109.692 172.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.8 t -142.86 149.22 38.25 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.328 1.051 . . . . 2.02 108.229 171.823 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -146.5 136.73 23.68 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 107.517 -1.29 . . . . 2.14 107.517 157.148 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.407 HG12 ' CB ' ' A' ' 44' ' ' ALA . 3.1 m -122.57 141.86 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 123.397 0.679 . . . . 1.76 109.351 -178.955 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.99 131.48 44.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.306 0.643 . . . . 0.72 110.4 177.686 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.33 -33.98 67.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.812 -1.086 . . . . 2.27 110.982 -173.19 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.09 -47.17 68.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.372 1.069 . . . . 1.21 112.452 -175.646 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -102.86 14.73 31.23 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.933 0.893 . . . . 2.44 110.645 174.96 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 34.1 46.21 0.15 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 129.082 2.953 . . . . 3.17 112.335 -173.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -125.47 144.61 50.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.624 0.647 . . . . 3.61 112.274 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.407 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -101.84 130.19 48.24 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.255 1.822 . . . . 0.65 106.444 172.004 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.41 109.67 21.45 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 101.401 -3.555 . . . . 2.35 101.401 176.729 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.02 134.58 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.054 -1.832 . . . . 1.05 106.054 -179.362 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -112.52 116.18 29.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 106.204 -1.776 . . . . 2.2 106.204 169.236 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -123.62 157.56 33.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.107 0.563 . . . . 2.85 111.011 -178.589 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -72.58 116.54 50.64 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 106.963 -1.495 . . . . 3.04 106.963 176.78 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.19 27.26 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.226 2.617 . . . . 2.48 115.7 -156.655 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -135.55 -34.75 0.83 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.363 1.465 . . . . 3.9 112.969 -178.626 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -41.51 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.781 0.832 . . . . 3.34 111.312 -165.838 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.8 tt -136.28 158.17 38.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 C-N-CA 123.832 0.853 . . . . 1.43 108.728 -169.085 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.84 -178.89 15.86 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.484 0.584 . . . . 0.64 111.85 -174.916 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -57.63 -39.98 83.67 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.797 2.331 . . . . 0.75 110.472 171.533 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -51.66 -49.48 62.25 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.729 0.812 . . . . 6.63 112.081 -176.867 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.79 -51.55 66.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.377 -0.601 . . . . 2.65 109.377 -175.197 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.8 mt -52.27 -47.48 45.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 123.602 0.761 . . . . 1.42 108.989 175.696 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.7 mt -55.89 -54.99 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 109.883 -0.414 . . . . 0.54 109.883 -176.037 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -64.08 -34.74 78.72 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.026 0.441 . . . . 3.15 110.671 -178.298 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.6 m -58.66 -51.26 70.7 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.196 -0.315 . . . . 0.75 110.483 173.868 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 mm -63.98 -42.26 95.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 121.143 -0.973 . . . . 1.55 110.915 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -52.83 -47.54 67.64 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.455 -0.572 . . . . 2.66 109.455 172.37 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m -59.15 -42.98 91.97 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.898 0.333 . . . . 1.54 111.898 175.844 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.7 mt -64.47 -29.14 70.18 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.534 -0.729 . . . . 1.06 112.411 175.983 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.27 40.1 1.18 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.3 0.953 . . . . 0.68 113.385 167.047 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -136.25 164.72 27.43 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.175 0.987 . . . . 1.98 108.643 171.389 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -94.62 111.44 54.05 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 118.488 -0.768 . . . . 2.44 109.759 175.254 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.18 80.21 2.68 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.612 2.875 . . . . 0.92 110.764 -178.243 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.47 105.35 10.72 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.137 -0.69 . . . . 1.76 109.137 -178.605 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.82 61.68 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.606 1.562 . . . . 2.54 111.827 179.373 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 CA--C 1.531 0.222 0 C-N-CA 123.468 0.707 . . . . 2.55 111.234 -177.964 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 106.965 -1.494 . . . . 2.85 106.965 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.5 mt -130.54 126.84 37.79 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 107.874 -1.158 . . . . 2.63 107.874 153.41 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -106.71 89.47 3.03 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.373 -0.973 . . . . 3.05 108.373 173.871 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.23 129.79 39.16 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.388 -0.967 . . . . 1.55 108.388 178.869 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.04 109.33 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.029 -1.841 . . . . 1.35 106.029 173.688 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.42 92.53 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 125.39 1.476 . . . . 0.79 108.175 -171.051 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -76.58 139.46 40.68 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.481 -0.933 . . . . 4.97 108.481 -173.292 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.65 -42.39 1.95 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.319 0.961 . . . . 0.72 111.141 177.746 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.81 126.82 30.96 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.982 0.891 . . . . 1.69 110.135 -176.273 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -154.38 17.87 0.48 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.855 1.057 . . . . 2.26 113.855 -171.831 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 p -158.68 170.29 22.48 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.502 1.046 . . . . 1.39 109.234 169.34 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.35 -44.49 11.8 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.972 1.309 . . . . 1.75 111.961 -178.977 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.6 m -56.25 -43.82 79.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.574 0.349 . . . . 1.74 111.602 177.532 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.32 -45.41 66.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.716 -0.615 . . . . 0.92 110.787 178.035 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.22 -58.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.204 -1.035 . . . . 1.0 108.204 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.298 0.7 OUTLIER -70.72 -24.8 62.7 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 113.146 0.795 . . . . 1.76 113.146 -172.174 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -57.9 -51.73 68.43 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.392 -0.966 . . . . 4.06 108.392 169.732 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.6 mt -59.11 -60.32 2.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.431 -0.581 . . . . 0.97 109.431 174.169 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.94 -55.28 28.52 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.357 0.526 . . . . 4.48 110.9 -168.325 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.3 t -61.2 -53.04 61.89 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.122 -0.696 . . . . 1.92 109.122 -177.88 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.7 t -72.04 -36.51 69.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 119.089 -1.045 . . . . 1.13 112.285 -168.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.83 -59.51 2.76 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.61 -0.885 . . . . 1.74 108.61 176.025 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.7 m -71.98 64.95 0.53 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.665 0.786 . . . . 3.34 111.883 179.064 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -169.9 -30.89 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 128.286 2.635 . . . . 3.68 110.951 170.507 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -64.6 132.2 49.14 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.866 1.212 . . . . 2.08 109.458 173.583 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -51.89 145.39 9.92 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.867 -0.79 . . . . 5.47 108.867 174.075 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.6 -36.28 4.18 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.582 -1.121 . . . . 0.81 111.926 177.707 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.47 135.28 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.703 -1.591 . . . . 2.0 106.703 164.512 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.1 pp -99.01 -32.49 11.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.243 0.617 . . . . 2.63 109.469 171.093 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -156.57 161.4 39.96 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 108.68 -0.859 . . . . 2.33 108.68 172.668 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 p -132.93 148.34 52.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.947 -0.76 . . . . 1.93 108.947 154.598 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.46 88.66 2.98 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.808 -1.553 . . . . 1.87 106.808 168.608 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.28 136.21 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 124.271 1.028 . . . . 1.94 111.838 170.353 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.6 140.17 28.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.77 0.828 . . . . 1.24 110.314 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 pp -76.96 -22.45 53.21 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.116 -0.493 . . . . 1.81 111.617 177.794 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.24 -38.02 1.65 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.411 1.484 . . . . 1.72 113.212 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -139.74 30.6 2.07 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.944 0.878 . . . . 2.31 110.291 170.554 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.1 m120 44.13 56.74 4.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.864 2.066 . . . . 1.89 110.579 176.067 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.78 139.63 32.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.176 -0.328 . . . . 2.01 110.69 -164.984 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.38 115.82 25.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.766 1.626 . . . . 0.77 110.463 176.893 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -82.29 96.63 7.96 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.249 -1.76 . . . . 2.5 106.249 169.371 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.39 133.05 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.94 -1.134 . . . . 1.28 107.94 175.27 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -115.25 115.8 27.28 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.44 -2.059 . . . . 2.86 105.44 173.19 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -147.14 153.53 40.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.381 1.072 . . . . 2.85 108.405 -164.867 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -104.07 105.69 49.87 Favored Pre-proline 0 CA--C 1.534 0.357 0 O-C-N 124.362 1.039 . . . . 3.87 111.075 -178.19 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.0 60.41 6.85 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.163 2.575 . . . . 1.5 112.1 -174.695 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.83 -54.87 2.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.044 0.938 . . . . 3.66 109.656 161.881 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -96.18 -37.07 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 122.98 0.512 . . . . 1.84 112.24 -174.463 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 tp -104.13 148.15 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.996 1.318 . . . . 1.05 108.444 -178.434 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.46 -178.94 16.6 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 110.864 -0.895 . . . . 0.75 110.864 174.945 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -60.99 -40.45 52.18 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.873 2.382 . . . . 0.77 110.357 174.122 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -50.39 -49.99 52.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.254 0.622 . . . . 5.85 112.083 179.352 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.16 -55.81 28.54 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.643 0.656 . . . . 2.47 109.991 -174.523 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.0 mt -50.42 -54.87 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 124.654 1.182 . . . . 1.58 108.956 175.596 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.9 mt -58.07 -53.23 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.85 -0.614 . . . . 0.96 110.403 -173.384 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -66.58 -33.03 74.77 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.329 0.652 . . . . 3.08 110.107 -175.522 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.7 m -57.85 -51.83 67.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.78 -0.452 . . . . 0.78 109.78 169.783 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 94.6 mt -67.24 -37.93 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 121.186 -0.946 . . . . 1.16 111.733 -176.788 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.99 -50.01 67.52 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.939 -0.763 . . . . 3.44 108.939 169.148 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.3 m -58.94 -38.82 79.89 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.008 -0.433 . . . . 1.74 111.992 176.084 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.38 -18.57 64.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.549 -0.738 . . . . 1.06 112.511 172.882 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.42 33.21 6.59 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.749 1.166 . . . . 0.81 112.273 174.176 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -133.01 158.65 42.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.025 0.913 . . . . 2.15 108.846 177.549 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.74 105.8 29.32 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.492 -0.766 . . . . 2.9 110.083 -178.081 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.4 79.62 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.922 2.414 . . . . 1.29 110.291 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 t -78.97 116.79 19.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.704 -0.623 . . . . 2.15 109.632 -175.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.8 mt -74.04 63.0 0.92 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.301 1.04 . . . . 3.18 110.225 177.494 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.6 t . . . . . 0 CA--C 1.53 0.183 0 O-C-N 121.739 -0.6 . . . . 2.66 109.533 179.147 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 108.642 -0.873 . . . . 2.48 108.642 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -146.28 137.92 24.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.129 -1.063 . . . . 3.16 108.129 176.585 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -106.64 126.99 52.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.496 1.118 . . . . 2.86 109.509 173.511 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.25 128.59 40.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.752 1.221 . . . . 1.54 108.107 176.34 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.257 0.6 OUTLIER -79.79 115.04 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 124.384 1.074 . . . . 3.14 108.301 173.813 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 m -101.92 84.25 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 128.077 2.551 . . . . 0.65 107.221 -170.277 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -75.91 139.2 41.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 118.7 -1.2 . . . . 6.56 107.902 -167.929 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.28 -31.27 5.33 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.685 1.136 . . . . 0.83 111.134 -170.577 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.0 mtm -57.17 126.88 29.22 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.949 1.374 . . . . 1.59 110.388 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -140.47 -6.54 1.17 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.073 1.138 . . . . 2.18 114.073 -177.355 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 p -163.03 168.4 21.07 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 120.288 1.403 . . . . 1.12 109.834 179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.44 -38.86 14.37 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.227 1.411 . . . . 0.85 112.172 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.8 m -43.47 -50.0 7.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.613 1.165 . . . . 1.43 111.612 172.131 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.7 m -68.02 -45.52 73.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 122.996 0.518 . . . . 0.71 110.536 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.1 t -52.59 -61.01 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.238 -1.023 . . . . 0.55 108.238 -176.311 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.252 1.3 p-80 -70.43 -28.59 65.16 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.829 -1.078 . . . . 0.87 111.964 -175.278 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -53.11 -58.62 6.38 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.446 1.021 . . . . 3.58 109.564 168.066 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.62 -58.51 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.739 -0.784 . . . . 0.77 109.732 -177.437 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -52.87 -62.23 1.78 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.382 0.426 . . . . 2.52 109.865 -174.012 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -55.2 -52.27 63.87 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.919 0.488 . . . . 1.46 110.432 -176.327 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -69.57 -32.08 70.64 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.621 -0.432 . . . . 1.28 111.306 -171.011 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.19 -46.83 63.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.09 -0.644 . . . . 1.84 111.122 172.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.8 p -66.89 78.28 0.12 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.54 0.736 . . . . 1.69 111.178 -176.683 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.76 -37.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 128.651 2.78 . . . . 4.21 108.763 -178.0 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.23 114.28 6.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.791 -0.818 . . . . 2.04 108.791 174.773 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -57.17 152.83 12.89 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.521 -0.918 . . . . 7.88 108.521 166.346 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.87 -60.15 0.64 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 108.575 -1.81 . . . . 1.73 108.575 -152.79 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.01 149.36 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 119.541 1.67 . . . . 1.71 108.507 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 pp -121.75 -25.07 5.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.368 -0.833 . . . . 2.41 111.035 168.517 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -155.68 157.57 36.86 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.313 0.96 . . . . 2.66 108.502 172.953 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.0 t -139.78 149.79 43.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.929 -1.137 . . . . 2.14 107.929 165.593 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 p -144.05 137.01 27.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.249 -1.389 . . . . 2.12 107.249 156.071 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.06 154.27 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.317 0.962 . . . . 1.71 110.213 179.035 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.28 137.66 32.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.027 0.931 . . . . 0.72 111.083 -176.032 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.1 mt -68.7 -34.5 75.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.677 1.191 . . . . 2.31 110.688 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -40.34 -42.36 1.54 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.904 1.682 . . . . 1.09 113.82 -174.441 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -138.61 35.8 2.22 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 123.086 0.554 . . . . 2.73 110.239 170.579 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 m120 42.23 46.93 3.98 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 127.314 2.245 . . . . 1.82 109.954 176.434 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -106.43 149.13 27.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.767 0.827 . . . . 2.38 110.927 -168.269 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.54 118.81 26.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.021 1.329 . . . . 0.67 107.743 172.056 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.64 102.44 14.18 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 102.375 -3.194 . . . . 2.34 102.375 176.794 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.83 139.04 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.193 -1.78 . . . . 1.26 106.193 176.532 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -122.87 115.74 22.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.288 -1.375 . . . . 3.39 107.288 169.214 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -121.66 161.72 22.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.837 1.655 . . . . 2.47 111.15 -173.051 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -92.29 119.81 67.95 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 126.246 1.818 . . . . 3.26 107.817 176.704 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.43 53.1 4.4 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.893 2.395 . . . . 2.6 110.195 179.52 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -103.17 -43.6 5.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.984 1.714 . . . . 6.39 109.62 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.06 -46.15 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.753 1.221 . . . . 2.59 112.109 -172.872 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 tp -81.77 150.09 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.033 0.933 . . . . 1.26 110.533 -167.96 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.62 -176.83 15.34 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.301 -1.12 . . . . 1.07 110.301 169.847 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -61.8 -38.47 59.53 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.454 2.103 . . . . 1.17 110.386 173.634 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -50.27 -50.71 49.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.372 1.069 . . . . 6.3 111.705 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.64 -54.59 45.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.742 0.817 . . . . 3.12 109.153 -177.665 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.6 mt -53.58 -49.11 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 123.853 0.861 . . . . 1.7 109.127 178.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.8 mt -52.81 -58.9 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 123.451 0.701 . . . . 0.95 109.956 -178.672 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -66.08 -34.61 78.45 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.158 0.504 . . . . 3.49 111.114 -176.608 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.0 m -57.13 -51.7 68.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.314 -0.625 . . . . 1.08 109.314 174.245 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.78 -35.05 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.548 -0.72 . . . . 1.24 111.541 -176.441 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -50.06 -52.98 30.13 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.329 -0.619 . . . . 2.82 109.329 166.128 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.5 t -57.61 -43.88 85.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.475 0.31 . . . . 1.5 111.574 177.232 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.3 mt -61.54 -27.58 68.71 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.207 -0.933 . . . . 1.67 112.395 176.387 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.55 35.69 1.39 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.52 1.057 . . . . 1.17 112.924 167.761 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -139.35 152.61 47.3 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.08 -1.082 . . . . 1.98 108.08 173.935 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -96.93 113.82 63.58 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.877 -0.786 . . . . 3.39 108.877 176.741 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -90.3 122.29 0.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.596 2.864 . . . . 1.1 111.563 -177.989 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.6 m -116.93 132.53 56.68 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 107.352 -1.351 . . . . 1.47 107.352 170.627 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mp -56.99 133.08 54.61 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.088 0.858 . . . . 3.83 110.341 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.5 t . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 108.5 -0.926 . . . . 5.28 108.5 172.17 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 108.302 -0.999 . . . . 2.85 108.302 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.3 153.17 25.25 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.779 -0.823 . . . . 3.0 108.779 171.495 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.476 ' C ' HD23 ' A' ' 8' ' ' LEU . 23.5 mt-10 -126.86 138.61 53.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.993 0.917 . . . . 2.64 110.424 177.124 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.647 HD21 HD13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -142.52 140.72 31.91 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.186 0.994 . . . . 1.43 108.907 -179.77 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 t -76.57 127.04 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 105.205 -2.146 . . . . 1.18 105.205 173.743 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 m -114.69 88.31 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 124.989 1.316 . . . . 0.65 107.606 -175.619 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.9 mtp-105 -77.04 137.5 39.0 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.559 -0.904 . . . . 5.96 108.559 -173.243 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.68 -41.72 1.47 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.938 -0.865 . . . . 0.88 110.938 177.103 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -68.88 152.2 45.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.906 0.853 . . . . 1.28 110.881 -176.761 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -152.34 1.15 0.32 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.392 1.256 . . . . 2.16 114.392 -175.124 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 p -162.33 164.8 27.24 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 120.18 1.355 . . . . 1.19 109.725 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.21 -41.14 12.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.169 1.388 . . . . 0.86 111.403 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -36.93 -51.83 0.92 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.28 2.232 . . . . 2.17 112.152 170.174 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.8 m -72.5 -51.49 19.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.862 0.865 . . . . 0.83 110.983 176.588 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -46.97 -60.46 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 C-N-CA 125.199 1.4 . . . . 0.49 109.017 -171.879 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -65.54 -24.81 67.2 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.872 -1.058 . . . . 1.08 111.329 -175.746 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -55.07 20.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.224 -1.028 . . . . 5.06 108.224 174.556 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 mt -58.05 -54.57 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.271 -0.641 . . . . 0.86 109.271 -179.32 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -55.67 -59.39 4.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.928 0.491 . . . . 2.43 110.565 -177.521 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.5 t -53.24 -52.12 60.0 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.688 -0.486 . . . . 1.5 109.688 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 t -59.0 -40.61 85.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.958 0.503 . . . . 0.94 111.376 -176.332 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.16 -43.93 90.17 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.635 -0.698 . . . . 2.26 110.891 176.846 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.3 p -70.7 60.66 0.23 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.772 0.829 . . . . 1.7 112.057 178.966 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -153.78 -50.33 0.09 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 129.497 3.119 . . . . 7.42 107.709 -176.7 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -69.52 137.47 52.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.701 -0.481 . . . . 2.25 109.701 -177.403 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -56.69 150.88 15.0 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.463 -0.569 . . . . 6.3 109.463 174.058 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.39 -28.38 8.31 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-O 117.609 -1.662 . . . . 0.72 112.675 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.589 HD11 HG23 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -75.41 130.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 120.861 2.331 . . . . 1.69 107.159 172.691 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.4 mt -96.71 -48.75 5.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.902 1.281 . . . . 2.42 108.479 172.121 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -156.38 147.53 22.24 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 118.838 0.744 . . . . 2.85 109.646 177.328 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -121.34 150.81 40.89 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 107.197 -1.409 . . . . 2.24 107.197 170.395 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t -143.42 150.11 38.59 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 118.491 -1.284 . . . . 2.7 108.79 141.827 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.74 132.77 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.737 0.815 . . . . 1.75 110.279 177.235 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.48 134.93 54.64 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.72 0.808 . . . . 0.71 110.569 -177.804 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.81 -34.58 77.04 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.65 1.18 . . . . 2.21 110.349 177.842 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -39.33 -41.87 0.97 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.227 1.811 . . . . 1.24 113.922 -176.164 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -137.72 33.0 2.46 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.898 0.856 . . . . 3.01 110.026 173.447 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 31.22 64.19 0.19 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 128.08 2.552 . . . . 2.9 111.964 -174.86 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.72 135.07 36.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.966 -0.561 . . . . 1.9 110.971 -166.487 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.12 140.78 34.94 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.604 1.962 . . . . 0.87 108.949 177.574 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -109.21 141.15 41.89 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.652 -1.61 . . . . 3.54 106.652 158.012 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.647 HD13 HD21 ' A' ' 8' ' ' LEU . 5.1 mp -125.32 114.48 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.837 -1.912 . . . . 1.49 105.837 176.173 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -93.4 99.59 12.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.217 -2.142 . . . . 3.39 105.217 171.975 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -125.99 167.07 15.81 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.047 1.339 . . . . 2.13 111.845 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -77.73 109.62 10.33 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.958 1.703 . . . . 2.97 109.82 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.32 63.24 8.7 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.363 2.709 . . . . 1.91 112.105 -167.888 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.74 -74.35 0.1 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.968 0.907 . . . . 3.26 110.04 177.807 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.5 pt -58.38 -26.93 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.084 0.954 . . . . 2.13 113.229 -177.89 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 tt -135.44 162.91 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.609 1.163 . . . . 1.0 108.297 -178.422 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.96 179.16 27.89 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.46 -1.456 . . . . 0.99 109.46 -174.029 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.13 -40.66 67.87 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.795 2.33 . . . . 1.0 111.608 -172.204 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -59.88 -37.04 78.22 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.453 0.538 . . . . 7.19 112.453 -175.492 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.3 -50.96 70.89 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.341 0.591 . . . . 3.93 109.805 179.136 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.9 mt -55.23 -50.18 66.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.643 -0.873 . . . . 1.6 108.643 176.168 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 mt -54.63 -53.16 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-O 119.382 -0.342 . . . . 0.66 110.206 -178.08 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -56.47 -43.76 79.89 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.275 0.559 . . . . 2.89 109.74 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.3 m -58.63 -53.96 52.4 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.034 -0.53 . . . . 0.78 110.331 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 mm -65.55 -39.98 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.335 -0.853 . . . . 1.97 111.186 -177.252 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -53.39 -48.92 68.22 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.6 -0.519 . . . . 2.98 109.6 169.733 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 m -61.6 -42.57 99.05 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.93 0.344 . . . . 2.09 111.93 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.9 mt -61.43 -36.83 81.45 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.518 0.599 . . . . 1.23 110.948 175.039 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.81 47.42 0.73 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 123.97 0.795 . . . . 0.81 111.763 172.145 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -134.86 160.86 36.9 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 106.571 -1.64 . . . . 2.05 106.571 168.116 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -97.84 105.5 27.68 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.234 -0.889 . . . . 3.26 109.774 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -84.25 136.17 6.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.699 2.266 . . . . 1.56 110.123 176.852 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t -146.79 129.84 16.42 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.968 -0.752 . . . . 2.53 108.968 171.937 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.476 ' CD2' ' H ' ' A' ' 71' ' ' LEU . 1.7 mm? -54.33 127.74 28.55 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.939 1.295 . . . . 2.78 110.593 -174.66 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 118.311 0.505 . . . . 4.87 110.319 -179.694 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 106.945 -1.502 . . . . 3.01 106.945 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.8 mp -128.45 151.34 49.5 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.297 -1.001 . . . . 3.39 108.297 177.686 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -125.06 129.55 50.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.189 0.996 . . . . 3.12 109.983 -166.607 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.71 136.63 36.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.532 1.133 . . . . 1.37 108.603 -174.102 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.33 124.6 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 104.671 -2.344 . . . . 1.44 104.671 174.387 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 m -106.31 67.53 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 106.973 -1.491 . . . . 0.85 106.973 -178.611 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -76.72 132.93 39.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.818 -0.808 . . . . 5.59 108.818 -166.307 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.63 -47.66 1.0 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.399 -1.48 . . . . 0.65 109.399 -169.284 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 142.09 36.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.683 0.741 . . . . 1.36 109.392 -176.766 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -156.75 19.05 0.32 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.529 0.937 . . . . 2.72 113.529 -173.795 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.78 153.73 25.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.355 0.98 . . . . 1.47 110.018 179.499 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.34 -37.7 7.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.105 1.762 . . . . 1.09 112.812 -173.706 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 t -47.01 -54.73 9.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.173 0.589 . . . . 1.87 110.167 174.541 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.9 m -69.02 -33.49 73.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.18 -0.325 . . . . 0.8 110.903 -176.15 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.8 t -57.08 -60.76 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.197 -1.038 . . . . 0.69 108.197 -178.372 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -68.54 -30.18 68.92 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.426 -0.807 . . . . 1.72 111.104 -176.435 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -56.94 -59.34 5.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 118.911 0.778 . . . . 5.63 109.991 170.158 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.423 HG21 HG11 ' A' ' 37' ' ' VAL . 60.8 mt -52.17 -51.61 29.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 118.905 0.775 . . . . 0.99 108.975 -178.435 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -50.97 -64.24 0.87 Allowed 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 123.991 0.807 . . . . 3.3 110.657 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.0 m -58.38 -42.25 86.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.946 0.879 . . . . 1.97 111.209 -177.003 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 t -66.44 -39.11 88.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.299 1.039 . . . . 1.44 110.029 -174.478 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.8 mt -71.76 -55.24 8.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 118.708 -0.663 . . . . 2.01 112.1 173.005 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.9 p -64.13 74.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.975 1.31 . . . . 1.64 112.592 -167.484 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -174.88 -40.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.372 2.269 . . . . 3.68 110.076 -175.375 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' HIS . . . . . 0.41 ' CE1' ' HB ' ' A' ' 32' ' ' ILE . 24.0 p80 -73.98 172.46 11.6 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.293 0.568 . . . . 1.86 112.097 -172.152 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -51.28 128.05 21.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.68 -0.691 . . . . 12.15 110.74 178.125 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.27 -15.23 7.17 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.583 -1.676 . . . . 0.75 116.692 160.086 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.41 ' HB ' ' CE1' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -76.1 109.59 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 121.805 2.802 . . . . 2.13 109.257 175.371 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.35 -42.03 31.73 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.157 -0.683 . . . . 2.52 109.157 -178.613 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -157.41 158.92 36.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.718 0.69 . . . . 3.19 109.268 177.368 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.6 t -124.16 138.78 54.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.001 1.72 . . . . 2.23 106.602 179.625 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.1 m -144.52 104.53 4.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.344 -0.984 . . . . 2.26 108.344 166.619 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.497 HG12 ' CB ' ' A' ' 44' ' ' ALA . 1.5 m -101.98 138.4 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 O-C-N 123.42 0.45 . . . . 1.96 111.131 172.322 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.83 133.15 55.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.588 0.755 . . . . 0.9 109.208 171.474 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -80.86 -33.67 34.27 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.35 -0.841 . . . . 1.96 111.366 -169.425 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.41 -34.33 61.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.171 0.588 . . . . 1.62 112.248 178.121 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -104.97 2.73 29.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.098 1.359 . . . . 2.1 111.562 176.761 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.4 m120 41.24 44.28 2.22 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.21 2.204 . . . . 1.94 111.351 -172.769 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.2 tmmt? -135.97 136.13 40.13 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 122.024 -0.423 . . . . 2.38 111.461 -165.332 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.497 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -98.51 139.28 34.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.653 1.981 . . . . 0.94 109.15 173.57 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.75 131.23 53.36 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.125 -2.176 . . . . 2.53 105.125 149.473 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.6 mm -115.57 131.01 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.367 -1.345 . . . . 1.88 107.367 172.912 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -93.13 64.62 3.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.385 1.074 . . . . 3.18 108.97 175.81 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -88.34 141.58 28.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 112.744 0.646 . . . . 2.81 112.744 175.579 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -62.34 115.66 17.73 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.694 -0.854 . . . . 2.47 108.694 173.843 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.76 65.84 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.78 2.32 . . . . 1.54 111.425 -168.985 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -162.18 -79.07 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.338 0.655 . . . . 3.52 112.137 -177.693 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -34.82 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 121.528 -0.733 . . . . 2.83 111.12 -176.762 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 tp -105.31 150.05 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.234 -1.765 . . . . 1.18 106.234 170.88 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -141.25 170.43 24.65 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.352 -1.099 . . . . 0.68 110.352 -177.615 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -57.03 -43.4 54.26 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.482 2.788 . . . . 0.75 110.489 -177.485 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -57.23 -44.71 84.04 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.247 0.476 . . . . 6.5 112.019 176.924 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -63.36 -49.15 74.98 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.972 -0.751 . . . . 3.84 108.972 -178.022 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.6 mm -50.57 -51.65 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.877 0.471 . . . . 1.95 111.036 172.599 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.6 mt -57.42 -52.62 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.284 0.634 . . . . 0.63 109.962 -178.904 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -55.8 -44.64 78.0 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 122.343 1.068 . . . . 3.28 109.298 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -61.18 -50.48 72.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.791 -1.095 . . . . 0.85 110.304 -178.895 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -71.86 -44.49 67.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-O 119.123 -0.465 . . . . 1.14 111.717 -175.526 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.31 -42.38 77.52 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.885 0.766 . . . . 2.92 110.427 -176.694 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -51.04 -28.67 10.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.673 0.99 . . . . 1.67 113.673 172.782 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.68 -16.68 58.33 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.069 0.85 . . . . 1.05 112.051 178.048 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.8 31.26 8.8 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.902 0.763 . . . . 0.7 112.531 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -129.99 140.4 50.9 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 105.394 -2.076 . . . . 1.98 105.394 167.846 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -87.59 111.25 40.6 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 117.985 -1.007 . . . . 2.82 109.586 -173.903 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.86 128.31 5.11 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.958 2.438 . . . . 1.42 109.838 176.673 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -138.2 111.93 8.28 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.563 -0.903 . . . . 2.54 108.563 177.153 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -56.03 131.06 46.41 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.284 1.034 . . . . 2.6 110.985 -179.172 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--N 1.34 0.171 0 N-CA-C 112.746 0.646 . . . . 3.74 112.746 -173.048 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 109.02 -0.733 . . . . 8.3 109.02 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.04 122.82 1.37 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.883 -1.687 . . . . 2.84 108.883 -172.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -77.13 -176.05 3.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.623 0.769 . . . . 3.85 109.358 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.78 156.65 28.68 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 108.571 -1.812 . . . . 1.65 108.571 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.6 143.85 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.608 -1.627 . . . . 2.39 106.608 171.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.7 tp -144.01 140.13 29.41 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 105.808 -1.923 . . . . 3.01 105.808 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -106.3 135.74 47.25 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 124.449 1.093 . . . . 2.79 109.264 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.52 137.03 54.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.079 1.352 . . . . 1.36 107.888 174.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 t -82.68 114.99 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.772 -1.566 . . . . 1.4 106.772 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 m -106.66 84.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 126.747 2.019 . . . . 0.83 108.849 -166.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.76 122.41 25.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.493 -1.299 . . . . 5.11 107.493 -174.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.78 -37.0 2.41 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.548 1.07 . . . . 0.95 110.755 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.62 113.4 24.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.683 -1.599 . . . . 1.83 106.683 -172.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.84 25.46 0.27 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.245 1.202 . . . . 3.85 114.245 -167.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.6 p -147.34 167.19 24.93 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 120.957 -1.09 . . . . 1.27 108.205 161.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.08 -36.77 13.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.477 1.111 . . . . 1.06 112.059 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -59.44 -50.31 74.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 110.145 -0.317 . . . . 1.89 110.145 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -61.92 -41.35 97.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.681 -0.637 . . . . 0.71 110.929 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.0 t -51.5 -61.11 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.417 -0.957 . . . . 0.65 108.417 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.289 0.8 OUTLIER -66.65 -29.6 69.66 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 118.829 -0.605 . . . . 0.98 111.553 -174.035 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -52.94 -58.99 5.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.197 0.999 . . . . 3.79 109.127 170.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.8 mt -61.34 -59.0 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.761 -0.776 . . . . 0.75 108.918 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.87 -52.53 60.17 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 119.394 -0.336 . . . . 2.63 110.85 -168.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -62.04 -44.08 97.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.877 0.471 . . . . 2.39 111.561 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.8 t -64.85 -35.0 79.7 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.745 -0.597 . . . . 1.0 110.982 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -70.61 -48.36 55.49 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 118.53 -0.748 . . . . 1.7 111.407 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 p -68.06 72.75 0.18 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.052 0.93 . . . . 1.84 112.645 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.83 -38.88 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.992 2.117 . . . . 4.18 110.352 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -70.92 132.03 44.62 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.043 0.838 . . . . 2.45 109.551 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -55.21 149.56 12.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.45 -0.574 . . . . 6.07 109.45 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.01 -39.82 2.62 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.432 -1.067 . . . . 1.02 110.432 -173.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.69 111.62 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 119.086 1.443 . . . . 1.92 109.249 -172.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.1 mt -80.0 -46.81 15.97 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.698 -0.853 . . . . 2.04 108.698 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -157.18 130.99 8.15 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 109.105 -0.702 . . . . 2.28 109.105 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.8 p -97.17 152.3 18.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.038 -1.097 . . . . 2.76 108.038 165.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.9 t -155.55 150.44 26.48 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 119.534 -0.866 . . . . 2.35 108.91 140.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.36 143.61 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.72 0.808 . . . . 1.91 110.014 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.4 132.43 41.16 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.568 0.747 . . . . 0.91 110.555 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.4 -26.97 52.23 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.182 -0.917 . . . . 2.47 111.729 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -46.74 -44.53 18.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.16 0.984 . . . . 1.42 112.399 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -117.49 18.45 14.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.66 1.184 . . . . 2.69 110.866 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 35.06 54.99 0.76 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 127.144 2.178 . . . . 2.42 111.909 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -112.59 148.56 34.3 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.589 0.756 . . . . 1.66 109.551 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.83 125.73 47.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.249 -1.76 . . . . 1.0 106.249 166.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.474 ' C ' HD12 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -107.45 129.72 54.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.122 -1.436 . . . . 2.65 107.122 169.301 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.474 HD12 ' C ' ' A' ' 45' ' ' HIS . 2.2 mp -119.45 110.75 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 104.685 -2.339 . . . . 1.21 104.685 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -83.08 70.36 10.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.655 -1.239 . . . . 3.76 107.655 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -86.68 141.34 29.0 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.987 0.515 . . . . 2.54 111.976 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -57.13 112.46 4.64 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.229 -1.026 . . . . 2.43 108.229 169.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.48 48.7 2.95 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.338 2.692 . . . . 1.65 111.891 -166.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -137.29 -63.09 0.6 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.933 1.293 . . . . 3.86 109.365 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.2 pt -77.09 -24.02 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.025 0 N-CA-C 112.921 0.712 . . . . 1.93 112.921 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.2 tt -139.82 143.09 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.921 -0.77 . . . . 1.3 108.921 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -117.72 175.11 15.56 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.296 0.951 . . . . 0.87 112.177 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -61.43 -38.91 60.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.01 2.473 . . . . 0.84 110.795 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -46.43 -53.02 11.89 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.158 0.983 . . . . 7.19 110.592 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -67.62 -46.54 72.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.957 -1.127 . . . . 2.93 107.957 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.3 mm -54.46 -46.65 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.572 0.349 . . . . 2.04 111.39 172.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.0 mt -53.67 -54.32 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.432 -0.581 . . . . 0.98 109.432 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -61.22 -42.89 99.39 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.537 0.684 . . . . 2.6 110.441 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.1 m -58.33 -49.3 77.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.587 0.755 . . . . 1.09 109.832 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 mm -68.24 -43.25 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 119.289 -0.386 . . . . 1.47 110.257 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -52.62 -42.3 64.47 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.465 0.575 . . . . 5.16 110.684 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.0 m -54.8 -23.45 18.21 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.075 0.769 . . . . 1.67 113.075 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 mt -87.06 -9.94 54.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.906 0.883 . . . . 1.0 112.117 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.9 40.16 6.31 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.085 1.326 . . . . 0.82 112.489 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -142.07 141.09 32.74 Favored 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 106.529 -1.656 . . . . 2.01 106.529 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -91.13 113.83 59.56 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 119.56 1.073 . . . . 5.57 109.989 -172.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -91.96 140.27 2.29 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.974 3.116 . . . . 1.66 110.696 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.8 m -145.02 125.61 14.12 Favored 'General case' 0 C--N 1.335 -0.063 0 O-C-N 120.657 -1.277 . . . . 2.71 109.023 167.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.45 136.19 57.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.661 1.184 . . . . 2.55 111.938 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.3 t -140.4 -52.97 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.993 0.917 . . . . 2.79 111.488 175.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.42 81.17 0.15 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.278 0.631 . . . . 5.27 110.391 -167.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.8 mt -73.84 -84.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 118.172 -0.918 . . . . 8.88 108.616 -172.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--O 1.252 1.194 0 N-CA-C 108.575 -0.898 . . . . 13.1 108.575 168.971 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttm . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 105.682 -1.97 . . . . 6.45 105.682 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.42 170.02 7.02 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 108.433 -1.867 . . . . 2.61 108.433 -136.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t0 61.64 170.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.46 1.504 . . . . 4.27 111.391 -171.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.73 85.12 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 106.314 -2.715 . . . . 2.51 106.314 -168.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 p -80.19 124.38 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 110.066 -0.346 . . . . 2.92 110.066 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -123.29 137.36 54.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.892 -1.521 . . . . 3.52 106.892 169.05 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -105.46 106.29 16.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.539 1.535 . . . . 4.16 108.451 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.03 126.39 52.67 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.235 -1.394 . . . . 1.46 107.235 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.98 95.36 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 106.855 -1.535 . . . . 1.03 106.855 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.16 65.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.064 1.745 . . . . 0.76 109.231 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -74.67 131.47 40.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.058 -1.089 . . . . 4.94 108.058 -172.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.51 -49.69 0.83 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.545 -1.422 . . . . 0.75 109.545 -167.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -74.94 149.81 39.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.072 0.936 . . . . 1.32 110.165 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 t -153.34 22.3 0.55 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.433 0.531 . . . . 2.5 112.433 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.16 145.41 19.39 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.775 0.716 . . . . 1.56 109.927 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.51 -40.25 37.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.976 1.31 . . . . 1.16 111.317 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -41.27 -49.6 3.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.996 1.718 . . . . 2.04 111.822 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -73.8 -42.97 60.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.848 1.055 . . . . 1.32 113.848 174.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.8 t -49.0 -57.05 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.673 0.749 . . . . 0.94 109.292 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -69.3 -24.12 63.9 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.535 -0.757 . . . . 1.22 111.956 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -58.63 -54.13 50.53 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.03 -1.47 . . . . 3.71 107.03 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.77 -59.03 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 109.316 -0.624 . . . . 0.74 109.316 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -54.64 -56.57 17.67 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.374 0.533 . . . . 2.55 111.407 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.4 t -54.56 -47.66 72.98 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.315 1.046 . . . . 1.67 110.53 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -59.63 -51.61 69.08 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.144 -0.347 . . . . 1.18 110.517 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.43 -34.15 77.52 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.786 -0.572 . . . . 2.16 111.953 -176.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 p -65.49 72.12 0.05 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.422 0.555 . . . . 2.0 110.877 170.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -150.52 -43.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.447 1.899 . . . . 5.76 111.817 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -57.55 -43.37 84.41 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.429 0.9 . . . . 3.82 113.429 -168.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 131.36 -82.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 129.583 3.153 . . . . 6.72 107.841 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.19 54.24 3.9 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 123.821 0.724 . . . . 1.64 112.995 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.08 129.12 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.427 -1.694 . . . . 1.85 106.427 157.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.4 mt -85.44 -45.03 12.23 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.045 -0.724 . . . . 2.16 109.045 172.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -155.8 120.24 4.62 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.91 0.323 . . . . 2.56 110.883 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.8 m -79.89 135.7 36.5 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 106.361 -1.718 . . . . 2.9 106.361 164.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 t -140.52 96.54 3.05 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.346 0.975 . . . . 2.31 108.713 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -105.92 135.63 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.4 1.08 . . . . 2.62 109.214 -172.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.76 134.64 23.73 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.3 0.572 . . . . 0.67 111.186 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 pp -76.23 -26.48 56.09 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.006 0.922 . . . . 1.87 111.394 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.04 -36.76 41.44 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.413 1.085 . . . . 1.07 112.371 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 p -129.62 31.51 4.76 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.479 0.712 . . . . 2.4 110.343 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.7 m120 33.73 54.99 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.916 2.486 . . . . 1.88 112.408 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -133.47 157.42 45.66 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.525 0.33 . . . . 2.07 111.886 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.47 127.09 54.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.097 -1.816 . . . . 0.65 106.097 161.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.49 129.22 38.49 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 103.97 -2.604 . . . . 2.31 103.97 154.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.9 mt -118.55 118.32 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 105.229 -2.137 . . . . 1.45 105.229 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -89.88 104.94 17.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.421 -1.696 . . . . 3.37 106.421 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -132.03 151.87 51.49 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 123.576 0.547 . . . . 2.33 112.229 -171.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -90.79 112.51 53.81 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 125.104 1.362 . . . . 3.08 108.402 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -77.84 41.26 0.97 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.457 2.105 . . . . 1.63 112.243 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.68 -37.86 17.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.086 0.954 . . . . 5.46 110.249 170.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.12 -54.46 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.682 1.193 . . . . 2.07 110.896 -174.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.2 123.73 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.165 -0.68 . . . . 1.72 109.165 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.83 -175.45 22.27 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 109.565 -1.414 . . . . 0.65 109.565 170.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -59.39 -36.31 94.38 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.804 1.669 . . . . 0.85 109.949 170.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -45.56 -59.67 2.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.45 1.5 . . . . 6.33 111.777 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.84 -51.43 69.74 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.617 1.567 . . . . 2.31 110.426 -172.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 94.5 mt -52.34 -54.25 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 114.209 -1.36 . . . . 1.46 108.478 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.9 mt -60.04 -53.39 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.94 -0.573 . . . . 0.68 109.681 -172.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -58.83 -39.98 82.82 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.739 0.699 . . . . 3.0 110.655 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.0 m -56.65 -52.23 65.7 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.311 -0.404 . . . . 0.96 110.227 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.06 -40.52 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.8 -0.562 . . . . 1.05 111.149 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -47.15 -49.35 22.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.34 0.656 . . . . 3.5 109.398 169.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -58.45 -24.37 60.1 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.446 0.906 . . . . 1.33 113.446 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.1 mt -84.94 -12.85 52.46 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.092 0.86 . . . . 1.18 112.069 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.09 44.22 4.8 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.101 0.858 . . . . 0.88 112.769 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -138.61 159.47 42.02 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 106.846 -1.539 . . . . 1.96 106.846 170.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -98.35 98.85 6.28 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.433 -0.794 . . . . 2.87 110.507 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.82 80.79 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 124.314 3.343 . . . . 0.92 110.717 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 m -79.27 101.37 7.99 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.237 -1.023 . . . . 1.92 108.237 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.5 64.16 0.11 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.893 1.677 . . . . 2.93 113.22 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.4 t -66.04 -50.24 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.637 -0.664 . . . . 2.42 111.237 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.4 tptp 68.27 136.07 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.527 1.531 . . . . 5.34 110.454 -165.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.29 143.66 39.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 106.471 -1.678 . . . . 7.74 106.471 157.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 . . . . . 0 C--O 1.253 1.244 0 N-CA-C 109.223 -0.658 . . . . 11.54 109.223 -175.081 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 mmm . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 107.836 -1.172 . . . . 5.89 107.836 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.42 -177.08 40.31 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.08 0.863 . . . . 2.85 112.449 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 52.78 -143.2 0.72 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.986 1.714 . . . . 3.94 111.553 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.76 -165.82 42.51 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 109.64 -1.384 . . . . 2.55 109.64 -161.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -147.38 145.14 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 107.131 -1.433 . . . . 2.81 107.131 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.8 tp -124.13 144.28 49.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.05 -2.204 . . . . 2.6 105.05 155.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -114.19 132.42 56.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.933 -0.766 . . . . 2.19 108.933 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 mt -118.48 123.98 46.49 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.99 -1.856 . . . . 2.84 105.99 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -78.9 95.18 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.592 -2.003 . . . . 1.44 105.592 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.26 84.07 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 126.319 1.847 . . . . 0.83 108.858 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 -75.6 130.87 39.49 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.935 -1.135 . . . . 5.0 107.935 -171.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.78 -48.46 0.97 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.399 1.0 . . . . 1.25 110.945 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -64.87 127.56 32.08 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.69 0.745 . . . . 1.6 110.37 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -144.6 5.34 1.2 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.246 1.202 . . . . 2.62 114.246 -167.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 p -160.84 166.39 28.62 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.645 1.112 . . . . 1.55 109.601 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.47 -45.3 9.1 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.201 1.4 . . . . 0.75 111.503 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -42.26 -49.24 5.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.067 1.747 . . . . 1.88 112.457 172.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.3 m -72.69 -51.18 20.43 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.153 0.581 . . . . 0.94 111.136 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -46.74 -58.84 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.045 0.938 . . . . 0.66 109.039 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -69.83 -23.53 63.32 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.989 -1.005 . . . . 0.94 111.942 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -67.66 -51.69 46.88 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 107.892 -1.151 . . . . 3.82 107.892 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 mt -55.39 -58.81 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.734 -0.839 . . . . 0.74 108.734 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.07 -54.62 32.8 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.001 0.364 . . . . 2.76 111.612 -174.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -60.66 -45.09 95.45 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.158 -0.339 . . . . 1.76 111.912 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 t -62.97 -49.59 74.13 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.903 -0.498 . . . . 1.25 110.226 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.461 HD11 HG23 ' A' ' 58' ' ' ILE . 3.5 mm? -51.19 -47.16 62.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.708 0.803 . . . . 1.78 110.548 177.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 p -62.31 -0.31 0.55 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.629 1.344 . . . . 2.13 114.629 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -57.49 -42.59 83.0 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.306 1.412 . . . . 6.42 110.66 164.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -94.12 138.92 31.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.339 -0.544 . . . . 2.54 111.867 -155.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -60.27 167.54 2.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.532 0.682 . . . . 5.77 109.905 169.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.09 -15.23 0.74 Allowed Glycine 0 CA--C 1.521 0.459 0 CA-C-O 117.669 -1.629 . . . . 1.11 113.555 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.3 139.63 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 120.365 2.083 . . . . 1.64 105.746 165.023 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.6 mt -102.58 -37.98 7.72 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.927 -1.033 . . . . 2.37 108.506 164.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -157.54 155.13 29.71 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.58 1.082 . . . . 2.25 109.872 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.8 t -126.04 143.08 51.25 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.397 -2.075 . . . . 2.12 105.397 162.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -149.16 148.67 29.91 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 118.097 -1.441 . . . . 2.27 109.965 144.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 44' ' ' ALA . 2.4 m -125.9 142.41 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 123.882 0.739 . . . . 1.95 111.467 -172.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.17 128.09 44.14 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.205 1.002 . . . . 0.93 111.027 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.68 -36.67 32.01 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 114.27 -1.332 . . . . 2.08 113.209 -163.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.73 -37.8 59.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.54 0.609 . . . . 1.71 111.148 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -96.12 -7.59 35.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.318 2.247 . . . . 2.73 111.694 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.7 m120 41.95 48.08 3.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.737 1.615 . . . . 2.18 110.79 -166.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -114.38 151.24 33.38 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.434 0.561 . . . . 1.64 111.255 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.439 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -123.92 121.78 36.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.88 1.672 . . . . 0.62 106.741 169.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -96.03 123.32 39.58 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.615 -2.365 . . . . 3.17 104.615 168.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.9 mm -104.64 130.17 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 106.916 -1.513 . . . . 1.76 106.916 168.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -98.4 101.06 12.39 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 105.083 -2.191 . . . . 2.68 105.083 162.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -129.77 155.15 46.4 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.925 1.29 . . . . 2.12 109.147 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -75.71 110.84 11.81 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.496 1.118 . . . . 2.81 108.696 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.39 58.58 6.75 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.279 2.653 . . . . 1.62 111.363 -173.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -135.16 -68.63 0.52 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.042 1.337 . . . . 4.36 108.99 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -91.0 -40.07 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.061 0 C-N-CA 123.062 0.545 . . . . 2.26 112.108 -172.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -97.01 119.08 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.639 -1.245 . . . . 1.57 107.639 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.81 163.5 36.69 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.123 -0.791 . . . . 1.29 111.123 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -54.63 -30.01 63.77 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.68 2.253 . . . . 1.29 110.842 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -55.06 -49.09 72.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.344 -1.312 . . . . 5.51 113.663 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' HB3' HD11 ' A' ' 53' ' ' ILE . 16.4 t0 -63.1 -49.49 74.24 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 121.312 1.869 . . . . 5.65 109.85 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.461 HG23 HD11 ' A' ' 26' ' ' LEU . 66.5 mt -47.17 -56.08 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-O 121.443 0.639 . . . . 1.27 109.772 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.8 mt -59.07 -55.95 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.823 -0.626 . . . . 0.92 109.663 -174.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -62.96 -34.14 76.88 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.936 -0.477 . . . . 2.6 111.475 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.3 m -56.56 -53.57 56.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.948 -0.76 . . . . 1.23 108.948 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.29 -39.43 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 121.507 -0.745 . . . . 1.13 111.373 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.77 -44.72 82.07 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.715 -0.616 . . . . 3.04 109.682 172.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.7 m -61.47 -41.43 97.23 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.201 -0.312 . . . . 1.36 111.6 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.66 -41.87 91.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.495 0.588 . . . . 1.44 110.724 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.86 45.28 0.83 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.286 0.946 . . . . 0.87 111.435 175.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.07 162.12 30.52 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.077 -1.453 . . . . 1.94 107.077 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -100.15 98.28 7.41 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 118.198 -0.906 . . . . 2.61 110.099 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.38 75.41 3.87 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.609 2.872 . . . . 1.21 110.111 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.6 m -79.99 107.63 12.93 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.491 -0.929 . . . . 1.77 108.491 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.76 59.36 0.47 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.679 0.791 . . . . 2.55 112.596 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 t -102.71 57.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.512 1.525 . . . . 3.35 107.307 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 pttm 45.55 -137.33 0.58 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.062 1.345 . . . . 7.88 112.266 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.3 mt -57.97 -69.11 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.468 1.107 . . . . 7.74 108.314 172.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 . . . . . 0 C--O 1.246 0.921 0 C-N-CA 131.696 3.998 . . . . 13.74 100.996 171.69 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 108.767 -0.827 . . . . 6.88 108.767 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.77 65.53 2.87 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.448 -1.461 . . . . 3.09 109.448 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -166.31 -178.2 4.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.602 1.561 . . . . 4.4 108.078 -167.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.83 -147.43 14.16 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.51 -1.836 . . . . 2.58 108.51 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 p -152.42 133.3 4.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.79 -0.819 . . . . 2.99 108.79 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 tp -104.0 149.59 25.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.663 -1.977 . . . . 2.94 105.663 165.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.33 151.19 37.5 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.312 -0.996 . . . . 2.27 108.312 165.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.13 130.43 23.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.35 -1.722 . . . . 1.38 106.35 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -79.62 100.81 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 105.411 -2.07 . . . . 1.02 105.411 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.2 m -81.83 79.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 126.353 1.861 . . . . 0.67 108.161 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.2 mtp-105 -76.74 141.72 40.73 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.605 -0.887 . . . . 5.36 108.605 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.63 -45.83 1.13 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.318 -1.113 . . . . 0.84 110.318 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.03 141.44 28.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.533 0.667 . . . . 1.7 109.644 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -152.81 41.91 0.6 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.304 0.502 . . . . 4.86 110.256 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.47 144.9 12.62 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.765 -0.585 . . . . 1.83 111.039 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.98 -39.85 20.68 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.598 1.559 . . . . 0.83 112.059 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.4 t -45.26 -51.44 10.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.056 0.542 . . . . 1.93 110.458 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.3 m -76.79 -33.85 58.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.101 -1.625 . . . . 1.42 114.169 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -46.75 -56.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.642 -0.873 . . . . 0.53 108.642 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -70.39 -21.84 62.81 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.167 -0.924 . . . . 0.84 112.825 -178.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -64.89 -54.5 29.83 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 106.781 -1.563 . . . . 4.56 106.781 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.4 -56.47 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.852 -0.796 . . . . 0.75 108.852 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.31 -53.73 54.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.999 0.818 . . . . 2.6 111.693 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.1 t -63.76 -29.17 70.41 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.059 0.39 . . . . 1.59 111.756 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.4 t -71.05 -52.96 16.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.204 -0.665 . . . . 1.35 109.204 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -53.43 -46.14 69.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.152 0.981 . . . . 1.83 110.954 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.2 p -59.51 -16.73 26.46 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.953 0.723 . . . . 2.06 112.953 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -69.92 -24.0 63.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.819 1.19 . . . . 6.49 111.515 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -68.48 87.08 0.31 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.73 0.696 . . . . 3.01 109.885 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 23.27 -66.21 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.0 2.52 . . . . 10.26 116.758 145.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.52 48.39 0.97 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.338 0.97 . . . . 1.4 112.644 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -91.08 117.82 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.022 -1.473 . . . . 2.22 107.022 154.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -80.68 -35.5 33.59 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.758 -0.589 . . . . 2.67 110.45 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -157.01 135.6 11.49 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.948 0.795 . . . . 2.17 110.466 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.8 p -114.65 155.09 27.23 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.277 1.031 . . . . 2.55 108.389 165.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.6 m -149.47 141.34 23.72 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.184 -1.413 . . . . 2.03 107.184 150.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.94 135.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.732 0.813 . . . . 1.79 110.197 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.36 134.09 55.11 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.347 0.659 . . . . 0.63 110.149 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -82.07 -37.64 26.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.255 -0.884 . . . . 1.76 111.286 -171.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.94 64.21 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.36 0.664 . . . . 1.67 112.301 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.8 t -107.05 4.63 27.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.037 1.335 . . . . 2.41 111.234 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.9 m120 42.96 48.95 5.2 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.614 1.966 . . . . 1.87 110.83 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.15 137.23 30.74 Favored 'General case' 0 CA--C 1.522 -0.109 0 O-C-N 121.735 -0.603 . . . . 1.89 112.086 -165.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.2 142.09 32.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.625 1.57 . . . . 0.91 108.232 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.07 135.14 48.06 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.481 -2.044 . . . . 2.73 105.481 152.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.2 mt -134.79 114.87 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.159 -1.793 . . . . 1.07 106.159 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -97.28 80.03 2.86 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.701 -1.592 . . . . 2.55 106.701 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -85.53 143.1 28.7 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.63 -0.714 . . . . 2.33 111.638 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -75.41 111.34 13.57 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.626 1.17 . . . . 3.09 107.914 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.63 47.56 2.6 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.356 2.704 . . . . 1.42 113.234 -163.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -134.16 -63.9 0.71 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.37 1.468 . . . . 3.8 108.554 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.485 HD12 ' HB ' ' A' ' 53' ' ' ILE . 2.1 pp -70.5 -34.35 57.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 122.858 0.463 . . . . 2.23 111.462 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.485 ' HB ' HD12 ' A' ' 52' ' ' ILE . 8.6 tt -126.83 156.58 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.81 1.244 . . . . 1.86 110.406 -173.638 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -154.39 178.34 31.25 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 107.198 -2.361 . . . . 0.77 107.198 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.61 -50.24 14.72 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.399 2.733 . . . . 0.8 111.485 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -52.38 -44.97 65.6 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.59 0.959 . . . . 7.1 113.59 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -59.47 -60.01 4.53 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.574 0.702 . . . . 3.91 109.429 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mt -45.78 -54.43 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.466 1.106 . . . . 1.38 109.818 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.2 mt -59.25 -48.16 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.654 -0.703 . . . . 0.81 110.415 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -57.23 -41.77 80.16 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.764 0.711 . . . . 3.11 109.265 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.8 m -62.8 -51.18 68.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.863 -0.608 . . . . 1.19 110.728 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 98.0 mt -62.86 -44.35 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 118.86 0.755 . . . . 1.14 111.278 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -49.09 -48.9 43.96 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.562 0.745 . . . . 3.36 109.188 170.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t -62.8 -17.08 60.62 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.815 1.043 . . . . 1.98 113.815 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.02 -16.15 41.72 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.06 1.3 . . . . 1.11 111.23 171.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.62 42.38 6.49 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.866 0.746 . . . . 0.85 111.685 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -132.79 153.09 51.58 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.181 -1.414 . . . . 1.96 107.181 170.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.27 109.28 32.39 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.179 0.991 . . . . 2.71 109.165 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.52 77.86 3.9 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.462 2.108 . . . . 1.0 110.249 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.8 t -78.68 98.85 6.36 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.264 -0.897 . . . . 1.81 109.417 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.05 61.26 0.19 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.42 1.888 . . . . 2.76 113.241 -173.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -81.28 -76.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.172 0.589 . . . . 2.5 109.866 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.6 tttt 67.62 150.31 0.07 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.784 1.634 . . . . 6.07 111.685 -170.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 pp -81.11 -57.1 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 113.196 0.813 . . . . 7.26 113.196 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.873 1.669 . . . . 8.92 113.17 -171.447 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.096 -0.705 . . . . 7.3 109.096 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.75 -52.21 0.29 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 107.434 -2.266 . . . . 3.54 107.434 -165.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 35.01 75.16 0.06 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.457 1.903 . . . . 6.21 112.564 155.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.35 171.25 18.11 Favored Glycine 0 C--N 1.337 0.614 0 O-C-N 121.351 -0.843 . . . . 1.81 112.74 -158.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.87 119.84 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.238 -1.393 . . . . 2.89 107.238 166.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.6 tp -95.88 148.64 22.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.536 -1.653 . . . . 2.85 106.536 166.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -136.87 127.25 26.59 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.876 0.87 . . . . 2.31 108.913 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.54 150.86 48.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.504 0.722 . . . . 3.43 110.308 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.0 t -84.89 124.22 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.284 -1.376 . . . . 1.14 107.284 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.59 102.91 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 126.994 2.118 . . . . 1.26 108.374 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -87.4 148.93 24.79 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.061 -0.718 . . . . 5.14 109.061 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.11 -52.35 0.64 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.23 -1.148 . . . . 0.77 110.23 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.79 134.92 56.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 117.285 0.542 . . . . 1.79 109.611 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.4 t -155.22 11.62 0.34 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.891 1.071 . . . . 2.17 113.891 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.6 p -161.11 171.75 18.0 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.808 1.185 . . . . 1.43 109.119 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -44.28 7.81 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.371 1.469 . . . . 0.78 111.594 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 t -52.83 -48.73 66.78 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.746 0.419 . . . . 2.05 110.071 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.3 m -70.65 -53.46 15.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.473 -0.767 . . . . 0.79 109.627 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -41.33 -60.21 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 125.787 1.635 . . . . 0.73 109.137 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.255 0.6 OUTLIER -68.25 -21.3 64.83 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.803 0.668 . . . . 0.92 112.803 -171.225 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -70.12 -46.91 63.82 Favored 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.978 -1.119 . . . . 4.4 107.978 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.67 -57.67 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.895 -0.78 . . . . 0.88 108.895 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.75 -56.49 18.71 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.373 0.269 . . . . 2.81 110.859 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.0 t -58.34 -50.07 74.94 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.997 0.427 . . . . 1.53 110.71 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.4 t -69.2 -27.14 65.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.551 -0.718 . . . . 1.02 111.445 -173.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.11 -52.52 23.03 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.383 0.538 . . . . 2.25 110.651 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -70.06 67.68 0.29 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.398 1.094 . . . . 1.73 112.321 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -169.91 -38.03 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.968 2.507 . . . . 3.73 109.624 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -69.84 137.68 51.95 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.939 0.791 . . . . 2.17 110.205 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 -50.84 143.87 9.32 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.622 -0.51 . . . . 5.49 109.622 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.27 -20.43 37.29 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-O 118.05 -1.417 . . . . 0.99 113.407 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.52 133.98 29.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 N-CA-C 105.849 -1.908 . . . . 1.53 105.849 160.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.5 mt -97.44 -48.45 5.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.477 1.111 . . . . 2.3 108.106 168.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -156.14 153.64 29.62 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.608 -0.516 . . . . 2.53 109.608 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.9 t -132.79 145.48 51.03 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.451 -1.314 . . . . 2.2 107.451 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -136.04 153.08 51.46 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.502 -1.296 . . . . 2.8 107.502 142.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.403 HG12 ' CB ' ' A' ' 44' ' ' ALA . 2.2 m -125.37 143.61 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.902 0.881 . . . . 1.89 109.742 175.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.51 129.95 41.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.802 0.811 . . . . 0.79 111.802 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.56 -28.64 62.95 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.752 1.221 . . . . 2.33 111.33 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.78 -44.16 73.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.035 0.534 . . . . 1.09 111.064 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.52 -31.27 17.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.472 -0.566 . . . . 2.25 109.472 172.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 79.24 41.81 0.08 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.997 2.119 . . . . 3.54 107.796 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -133.6 141.66 47.76 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.741 -0.466 . . . . 2.25 109.741 -168.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.403 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -103.54 136.73 42.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.015 1.326 . . . . 0.59 107.949 168.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -102.36 150.15 23.62 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.085 -1.45 . . . . 3.55 107.085 159.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.44 HG22 ' HB3' ' A' ' 48' ' ' TYR . 1.3 mp -134.63 101.35 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.543 -2.021 . . . . 1.18 105.543 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -81.18 123.6 28.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.196 -2.149 . . . . 3.57 105.196 170.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' HB3' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -163.72 170.48 16.94 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 120.958 0.408 . . . . 2.5 110.644 -152.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -101.51 93.82 3.69 Favored Pre-proline 0 N--CA 1.447 -0.592 0 C-N-CA 125.544 1.538 . . . . 2.97 108.733 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.82 52.93 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.679 2.92 . . . . 1.73 110.799 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -159.99 25.66 0.17 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.464 1.506 . . . . 4.72 109.287 -169.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -167.17 -50.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 126.503 1.921 . . . . 3.18 108.069 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.1 tt -118.85 157.39 20.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 124.625 1.17 . . . . 1.12 109.51 -172.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.36 -177.27 16.37 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.154 -0.778 . . . . 0.62 111.154 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.41 -39.94 42.87 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.543 2.162 . . . . 0.79 110.15 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -48.37 -53.4 17.71 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.574 1.15 . . . . 6.1 111.476 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.72 -52.09 66.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.211 0.529 . . . . 2.55 109.637 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.8 mt -55.87 -52.97 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.75 0.82 . . . . 1.43 108.974 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.455 HD11 HD21 ' A' ' 71' ' ' LEU . 20.2 mt -50.97 -55.1 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.246 -0.65 . . . . 0.57 109.246 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -66.02 -37.87 86.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.152 0.501 . . . . 2.84 110.703 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.3 m -55.59 -47.79 75.91 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.283 -0.417 . . . . 0.72 110.345 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 79.8 mt -70.26 -44.04 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.757 -0.589 . . . . 1.02 110.953 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -49.58 -44.61 47.09 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.645 0.778 . . . . 2.69 109.894 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -52.78 -34.7 54.58 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.147 0.579 . . . . 2.04 112.521 175.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.5 mt -76.72 -13.37 60.04 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.368 -0.832 . . . . 1.1 112.319 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.87 45.46 5.7 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.731 0.681 . . . . 0.81 111.791 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -132.81 156.56 46.89 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.182 -1.414 . . . . 1.84 107.182 171.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -96.4 99.7 5.82 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-O 117.547 -1.216 . . . . 2.63 110.406 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -79.08 143.53 17.95 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 CA-C-N 121.43 1.547 . . . . 1.69 109.389 169.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 p -155.46 121.17 5.02 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.588 -0.695 . . . . 1.64 109.484 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.686 HD22 ' H ' ' A' ' 71' ' ' LEU . 1.5 mm? -61.25 133.76 56.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.904 0.882 . . . . 2.9 111.584 -169.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.9 t -141.81 -43.36 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.217 0.607 . . . . 2.45 111.604 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.341 0.0 OUTLIER 42.83 -123.9 0.72 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.748 0.703 . . . . 5.59 111.697 -165.869 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 mp -91.49 -71.2 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 106.606 -1.627 . . . . 6.68 106.606 167.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mp0 . . . . . 0 C--O 1.252 1.201 0 N-CA-C 105.492 -2.04 . . . . 8.89 105.492 163.688 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtm . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 119.115 -0.469 . . . . 7.0 111.092 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.31 -179.32 39.07 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 117.803 0.274 . . . . 3.25 113.269 170.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.407 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 44.0 t0 63.0 162.89 0.1 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.702 2.401 . . . . 4.21 112.673 -172.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.77 174.59 35.82 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.873 1.225 . . . . 1.85 110.466 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 p -153.98 61.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.783 1.233 . . . . 2.47 108.429 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mp -93.8 139.14 31.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.344 -0.844 . . . . 3.1 109.254 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.0 106.33 11.49 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.611 1.964 . . . . 3.25 107.496 -170.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.24 133.28 53.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.264 -1.384 . . . . 1.48 107.264 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.88 112.37 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -94.66 95.42 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.365 1.866 . . . . 0.67 107.813 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.35 155.75 29.91 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 119.278 -0.969 . . . . 4.97 108.404 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 -51.85 0.68 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.631 -0.987 . . . . 0.67 110.631 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -63.22 141.03 58.92 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 117.412 0.606 . . . . 1.84 111.355 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -155.1 10.85 0.34 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.067 1.136 . . . . 2.26 114.067 -173.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -162.0 161.46 28.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.853 1.206 . . . . 1.39 109.829 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.18 -39.4 9.62 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.62 1.568 . . . . 0.92 112.0 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 m -40.13 -56.25 1.94 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.923 1.289 . . . . 1.85 111.546 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.3 m -69.98 -36.66 75.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.586 0.354 . . . . 0.8 110.902 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.4 t -55.88 -59.28 2.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.013 -1.106 . . . . 0.72 108.013 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -68.4 -35.55 77.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 118.289 -0.862 . . . . 1.28 111.348 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -51.49 -55.3 19.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.942 1.247 . . . . 3.78 110.344 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.7 mt -54.25 -62.74 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 123.702 0.801 . . . . 0.97 109.056 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -59.74 -55.69 31.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.324 -0.551 . . . . 2.6 110.333 -172.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.9 p -54.72 -47.38 73.82 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.227 0.467 . . . . 2.05 111.182 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -70.65 -32.1 69.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.052 -0.659 . . . . 1.38 111.271 -175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.6 mt -68.52 -52.04 36.44 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.464 -0.773 . . . . 2.11 110.599 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.9 p -66.81 75.84 0.11 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.009 1.324 . . . . 1.86 110.854 -174.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? 179.64 -40.02 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.964 2.505 . . . . 3.68 109.233 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.409 ' CE1' ' HB ' ' A' ' 32' ' ' ILE . 11.8 p80 -69.22 139.75 54.52 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 118.962 -1.095 . . . . 2.04 108.965 175.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -60.1 144.42 49.75 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.108 -0.701 . . . . 7.34 109.108 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.01 -28.67 13.5 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-O 118.072 -1.404 . . . . 0.75 113.184 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.409 ' HB ' ' CE1' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -76.64 122.6 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 119.953 1.876 . . . . 1.69 108.286 169.72 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.0 mt -85.69 -52.69 5.63 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.004 -1.11 . . . . 2.43 108.004 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -157.12 144.65 18.89 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.18 -0.674 . . . . 3.63 109.18 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 t -107.26 129.62 54.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.19 -1.411 . . . . 2.65 107.19 167.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 t -112.0 104.08 12.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.777 -1.935 . . . . 2.25 105.777 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 p -102.13 141.4 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 118.938 0.79 . . . . 1.84 111.071 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.29 132.99 36.45 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.323 0.582 . . . . 0.77 110.487 172.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -76.2 -30.4 57.98 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.103 -0.953 . . . . 2.13 111.751 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.2 -32.17 22.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.806 0.842 . . . . 1.09 112.617 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.9 t -121.75 13.19 10.72 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.268 1.427 . . . . 2.2 111.088 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 m120 34.78 47.02 0.22 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.522 2.329 . . . . 2.0 111.818 -172.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -120.85 137.94 54.31 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.276 0.631 . . . . 2.28 109.648 -169.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.47 116.65 32.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.723 1.609 . . . . 0.71 108.224 167.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -91.25 110.62 21.91 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 102.562 -3.125 . . . . 2.29 102.562 166.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.9 mt -112.84 110.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.481 -1.674 . . . . 1.38 106.481 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' NZ ' ' OD1' ' A' ' 3' ' ' ASP . 7.0 mtpm? -83.06 70.22 9.99 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.983 -1.488 . . . . 3.24 106.983 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -90.24 144.29 25.99 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.147 -0.933 . . . . 2.92 109.697 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.36 111.17 22.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 123.557 0.535 . . . . 3.99 111.026 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -66.72 -16.51 50.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.917 2.411 . . . . 2.17 112.451 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -85.3 -5.84 59.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.11 0.868 . . . . 5.2 111.002 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.4 pt -135.07 -27.73 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 114.392 1.256 . . . . 2.88 114.392 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.7 133.8 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 107.526 -1.287 . . . . 1.34 107.526 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.43 172.39 20.31 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.529 -0.732 . . . . 0.65 112.203 -172.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -56.72 -41.47 75.37 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.22 2.614 . . . . 0.85 110.655 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -57.13 -51.06 70.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.85 0.295 . . . . 6.37 110.615 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.98 -51.14 70.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.259 -0.645 . . . . 2.63 109.259 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.4 mm -54.38 -50.93 53.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.326 0.65 . . . . 2.09 111.609 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.4 mt -54.14 -56.43 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.935 -0.765 . . . . 0.68 108.935 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -65.5 -35.13 79.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.195 0.521 . . . . 2.89 111.021 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.3 m -56.27 -54.48 44.88 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.752 -0.462 . . . . 0.91 109.752 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.39 -36.05 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.516 -0.74 . . . . 1.29 111.712 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.75 -48.65 59.06 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.94 -0.763 . . . . 2.74 108.94 166.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.8 t -65.12 -13.93 59.3 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.836 1.05 . . . . 1.81 113.836 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.4 mt -88.15 -9.8 51.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.05 1.295 . . . . 1.33 111.319 170.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.25 41.72 6.48 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.383 0.992 . . . . 0.9 112.022 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -135.74 167.38 21.26 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.236 -1.024 . . . . 2.06 108.236 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -105.71 94.6 8.99 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.489 1.115 . . . . 2.65 110.636 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.3 80.52 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.631 2.887 . . . . 1.13 112.267 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.0 p -82.98 121.34 26.88 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.15 -0.969 . . . . 1.83 111.401 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.3 mt -70.35 72.42 0.47 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.194 -0.941 . . . . 3.43 111.503 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.31 -33.62 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 118.878 -0.582 . . . . 2.66 112.16 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt 57.67 -160.43 0.24 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.365 0.984 . . . . 5.79 109.833 -166.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.9 tt -154.4 158.72 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.217 -1.771 . . . . 9.08 106.217 168.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 . . . . . 0 C--O 1.249 1.035 0 N-CA-C 104.464 -2.421 . . . . 8.83 104.464 168.483 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 112.57 0.581 . . . . 12.83 112.57 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.74 56.09 0.54 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 107.087 -2.405 . . . . 6.47 107.087 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 p30 174.8 173.73 0.21 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.228 -1.767 . . . . 3.49 106.228 -152.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.85 153.79 25.18 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 106.244 -2.742 . . . . 1.68 106.244 165.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -135.15 132.8 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 CA-C-N 118.196 0.998 . . . . 3.12 109.836 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.9 tp -108.78 149.45 29.04 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.974 -1.862 . . . . 2.83 105.974 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -118.67 152.73 35.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.092 -0.707 . . . . 2.6 109.092 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.714 HD21 HD13 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -150.0 133.27 16.39 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.135 -1.061 . . . . 1.31 108.135 177.432 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.37 105.07 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.32 -2.104 . . . . 1.04 105.32 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.464 HG23 ' SD ' ' A' ' 13' ' ' MET . 3.2 m -95.53 86.35 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 126.221 1.808 . . . . 0.65 107.994 -172.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.5 mtp-105 -77.38 132.65 38.64 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 119.899 -0.721 . . . . 6.06 109.748 -170.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.01 -4.01 5.65 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.45 1.5 . . . . 1.03 113.187 171.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.464 ' SD ' HG23 ' A' ' 10' ' ' VAL . 41.4 mtp -75.92 116.33 16.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.042 1.421 . . . . 1.89 110.097 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -98.91 -21.02 16.49 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.488 -1.244 . . . . 3.13 113.253 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.9 p -162.7 175.81 10.96 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.636 1.562 . . . . 1.79 112.221 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -35.94 58.72 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.586 1.154 . . . . 0.96 111.923 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -57.25 -37.03 71.69 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-O 118.368 -0.825 . . . . 2.49 110.105 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.4 m -69.07 -53.45 20.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 120.025 1.284 . . . . 0.79 109.687 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -41.67 -57.46 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.944 1.298 . . . . 0.66 110.257 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.89 -21.26 66.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.23 -0.896 . . . . 1.66 112.735 -170.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -69.1 -47.86 64.07 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 107.309 -1.367 . . . . 4.84 107.309 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.656 ' HB ' HG11 ' A' ' 37' ' ' VAL . 2.9 mt -64.65 -54.56 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.306 -0.998 . . . . 0.97 108.306 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.574 ' HG3' HG12 ' A' ' 37' ' ' VAL . 19.3 mt-10 -50.41 -59.99 3.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.206 0.457 . . . . 2.35 111.028 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.2 t -55.03 -52.6 62.67 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.113 0.482 . . . . 2.09 111.415 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -66.84 -28.0 68.0 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.527 0.731 . . . . 1.55 111.533 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.0 -47.7 61.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.337 -0.852 . . . . 2.06 109.701 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.5 p -70.87 68.53 0.43 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.412 0.551 . . . . 1.58 112.12 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.69 -30.83 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.906 1.283 . . . . 5.08 114.033 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -51.7 -47.84 63.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.357 0.981 . . . . 3.97 112.968 -174.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 139.59 -85.6 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 129.901 3.28 . . . . 7.43 104.836 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.58 53.84 4.87 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.695 -0.562 . . . . 1.04 111.695 -166.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.3 mt -114.61 124.17 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.555 -2.016 . . . . 2.88 105.555 160.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 mt -79.76 -44.56 20.47 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.556 -0.905 . . . . 1.98 108.556 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -156.89 157.66 35.27 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.208 -1.034 . . . . 2.67 108.208 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.9 t -128.21 145.65 50.97 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 104.899 -2.26 . . . . 2.28 104.899 163.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.52 149.8 41.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 118.587 -1.245 . . . . 2.33 110.203 153.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.656 HG11 ' HB ' ' A' ' 22' ' ' ILE . 13.1 p -143.1 108.59 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 124.586 1.179 . . . . 1.64 112.451 -162.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.78 134.26 41.92 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.032 0.444 . . . . 0.8 111.199 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.06 -33.81 70.6 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 115.542 -0.754 . . . . 1.81 110.392 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -44.92 -44.23 9.56 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.364 1.466 . . . . 1.37 113.081 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -123.59 22.13 9.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.262 0.625 . . . . 2.53 110.79 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 42.44 58.88 2.9 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.198 2.199 . . . . 3.23 109.834 177.018 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.8 136.46 24.27 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.882 -0.511 . . . . 1.82 111.535 -166.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -109.5 143.03 39.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.868 1.667 . . . . 0.94 108.987 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' HIS . . . . . 0.558 ' C ' HD12 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -106.91 140.23 40.06 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.028 -1.841 . . . . 2.87 106.028 153.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.714 HD13 HD21 ' A' ' 8' ' ' LEU . 1.7 mp -122.99 112.44 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.627 -1.99 . . . . 1.29 105.627 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -85.96 122.6 30.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.943 -1.503 . . . . 2.94 106.943 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -144.66 164.31 31.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.502 1.297 . . . . 2.22 114.502 -169.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.26 112.1 62.51 Favored Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 125.955 1.702 . . . . 2.75 108.374 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.24 2.26 5.18 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.228 1.952 . . . . 1.81 114.001 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.0 -32.56 73.94 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.646 1.112 . . . . 5.84 111.474 171.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.62 -59.33 2.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.515 0.674 . . . . 3.47 112.036 -160.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.1 tt -100.29 151.83 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.879 -0.6 . . . . 1.78 109.704 -161.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.73 -174.24 13.64 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.078 -1.609 . . . . 1.1 109.078 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -56.66 -40.46 84.2 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.926 1.75 . . . . 1.24 109.818 168.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.25 -55.86 7.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.341 1.056 . . . . 8.98 113.461 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.52 -49.24 78.35 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.402 -0.811 . . . . 2.71 109.812 -174.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.7 mt -56.58 -51.64 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 114.878 -1.055 . . . . 1.62 108.545 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.8 mt -57.02 -52.53 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.523 -0.547 . . . . 0.77 109.523 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.5 m170 -57.47 -42.84 83.39 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.379 1.085 . . . . 2.79 109.547 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.5 m -58.99 -52.91 63.74 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.67 -0.696 . . . . 1.16 110.137 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.7 mt -71.87 -37.94 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.668 -0.645 . . . . 1.11 111.819 -169.752 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -60.31 -45.58 92.88 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.201 -0.599 . . . . 4.17 109.682 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 t -59.09 -36.86 75.85 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.906 -0.568 . . . . 1.84 112.238 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.65 -46.1 87.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.531 1.06 . . . . 1.08 110.276 171.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.58 46.54 0.35 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.349 0.976 . . . . 0.87 111.932 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -134.78 163.54 29.56 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 107.312 -1.366 . . . . 2.05 107.312 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -97.63 103.71 17.74 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.041 -0.981 . . . . 3.34 109.852 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.56 77.47 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.212 2.608 . . . . 0.9 111.245 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -78.71 99.68 6.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.746 -0.596 . . . . 1.83 109.52 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.2 pt? -67.22 59.72 0.05 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.731 1.612 . . . . 2.85 114.575 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.9 t -78.77 62.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 120.743 -1.223 . . . . 2.51 109.445 176.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -163.28 106.82 1.03 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.367 1.467 . . . . 4.79 107.371 174.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 tt -86.74 -140.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.788 -1.19 . . . . 10.32 107.788 173.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 124.833 1.253 . . . . 12.07 109.907 169.696 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 mtm . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 106.506 -1.665 . . . . 8.84 106.506 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.04 163.34 37.07 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 106.37 -2.692 . . . . 3.91 106.37 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -79.95 177.68 8.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.925 0.862 . . . . 3.89 108.947 171.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.84 153.57 17.29 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 107.252 -2.339 . . . . 1.76 107.252 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.3 128.84 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.276 -1.379 . . . . 2.43 107.276 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.1 tp -139.86 144.69 37.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.453 -2.425 . . . . 3.11 104.453 166.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -116.32 140.13 49.66 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 123.776 0.673 . . . . 2.52 110.179 171.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.1 124.27 36.55 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.463 -1.68 . . . . 1.59 106.463 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.56 106.77 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 104.988 -2.227 . . . . 1.21 104.988 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -97.67 97.75 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 124.542 1.137 . . . . 0.79 108.261 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -76.99 147.29 36.92 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.245 -1.02 . . . . 8.24 108.245 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.76 -51.0 0.73 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.362 0.982 . . . . 0.82 111.02 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.44 132.28 37.24 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.419 1.109 . . . . 1.42 110.01 -171.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 t -156.53 12.8 0.28 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.571 1.323 . . . . 2.76 114.571 -166.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -161.16 165.13 29.96 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 120.212 1.369 . . . . 1.18 110.16 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.83 13.05 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.248 1.419 . . . . 0.82 111.766 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -37.81 -49.9 1.21 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.502 2.321 . . . . 2.13 112.122 170.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.1 m -71.87 -56.2 6.15 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.181 -0.463 . . . . 1.12 110.129 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -47.7 -54.75 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 124.004 0.921 . . . . 0.8 109.598 -164.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -65.58 -33.86 76.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.44 -0.8 . . . . 1.03 111.826 -174.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 pttp -71.61 -40.61 69.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.907 -0.775 . . . . 3.84 108.907 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.467 ' HB ' HG11 ' A' ' 37' ' ' VAL . 69.3 mt -57.17 -66.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.212 -1.032 . . . . 1.07 108.212 171.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' CG ' HG12 ' A' ' 37' ' ' VAL . 3.6 mt-10 -51.53 -55.75 17.25 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 119.295 0.952 . . . . 2.93 110.896 -173.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.8 t -50.53 -54.35 23.1 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.631 0.372 . . . . 1.97 111.148 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t -72.47 -26.87 61.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 114.033 1.123 . . . . 1.6 114.033 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.17 -43.38 70.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.204 -0.665 . . . . 1.72 109.204 171.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.1 p -70.17 68.68 0.33 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.879 0.847 . . . . 2.09 110.389 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -156.0 -49.53 0.08 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.853 2.861 . . . . 4.85 107.082 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -73.45 88.59 1.61 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.458 -0.571 . . . . 2.37 109.458 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -40.63 113.83 0.41 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.414 1.086 . . . . 6.63 109.528 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.86 -34.6 2.37 Favored Glycine 0 C--O 1.224 -0.529 0 N-CA-C 109.374 -1.49 . . . . 0.84 109.374 -164.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.02 125.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.493 -1.299 . . . . 1.61 107.493 174.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.9 mt -97.67 -40.1 8.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.465 0.706 . . . . 2.23 110.43 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -157.13 146.05 19.95 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.323 0.965 . . . . 2.6 109.906 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.1 p -144.22 56.8 1.31 Allowed 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.23 1.012 . . . . 2.8 111.818 -167.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -78.21 81.71 4.56 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.373 -0.829 . . . . 1.96 110.188 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.467 HG11 ' HB ' ' A' ' 22' ' ' ILE . 14.6 p -83.82 76.91 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.675 0.75 . . . . 1.77 112.766 -168.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.63 123.87 27.2 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 122.441 1.115 . . . . 0.87 112.469 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.95 -28.86 27.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 113.85 -1.523 . . . . 3.07 113.048 -166.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.45 -38.81 72.14 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.471 0.653 . . . . 1.73 110.618 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.52 -4.15 57.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.459 1.904 . . . . 3.77 111.42 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.4 m120 43.26 46.55 5.35 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.322 1.849 . . . . 1.9 111.4 -167.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -117.61 155.14 30.37 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.075 0.852 . . . . 2.01 111.565 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.89 139.81 49.86 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.474 -1.306 . . . . 0.72 107.474 147.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -90.97 138.86 31.28 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 103.845 -2.65 . . . . 2.84 103.845 148.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mm -122.43 106.25 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 106.725 -1.583 . . . . 2.09 106.725 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -79.75 68.26 5.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.067 -0.716 . . . . 2.26 109.067 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -73.57 143.88 46.26 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.019 -0.426 . . . . 2.25 111.482 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -62.17 113.15 7.78 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.853 1.261 . . . . 2.94 107.993 170.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.86 48.29 2.79 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.741 2.294 . . . . 1.76 112.736 -164.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -138.15 -64.11 0.54 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.678 1.191 . . . . 4.09 110.063 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.0 pt -73.63 -24.14 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 113.539 0.941 . . . . 1.85 113.539 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.0 tt -142.6 151.55 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 124.346 1.058 . . . . 1.24 108.239 -167.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.94 -178.57 15.75 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.717 -0.553 . . . . 0.74 111.717 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.79 -41.05 49.0 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.668 2.245 . . . . 0.79 110.375 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -44.76 68.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.284 0.634 . . . . 8.15 112.0 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.98 -53.39 57.42 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.388 0.613 . . . . 2.65 110.078 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.4 mt -57.95 -49.28 81.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 108.57 -0.9 . . . . 1.67 108.57 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 mt -53.19 -52.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.323 -0.621 . . . . 0.67 109.323 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -66.49 -34.45 77.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.94 0.4 . . . . 3.0 110.883 -176.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 93.3 m -58.8 -52.52 65.38 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 110.109 -0.33 . . . . 0.83 110.109 172.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.9 mm -66.16 -40.23 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 121.269 -0.894 . . . . 1.51 110.895 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -53.57 -52.44 59.74 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.713 0.805 . . . . 3.1 109.195 170.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.7 t -55.46 -43.47 75.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.946 0.499 . . . . 1.69 111.109 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.12 -10.38 53.59 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.374 0.879 . . . . 1.09 113.374 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.25 30.53 8.16 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.577 1.084 . . . . 0.67 112.896 169.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -131.8 165.2 24.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.351 1.076 . . . . 2.02 110.219 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -107.95 100.16 34.45 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 124.307 1.043 . . . . 3.31 110.569 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.87 99.07 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.629 2.886 . . . . 1.06 111.069 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t -90.59 119.47 30.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.35 -1.352 . . . . 2.46 107.35 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 mt -71.14 118.93 14.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.343 -0.984 . . . . 2.82 108.343 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.87 36.18 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.494 -0.558 . . . . 2.59 109.494 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -140.61 149.02 41.8 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 104.676 -2.342 . . . . 6.51 104.676 155.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.2 mt 68.42 -72.05 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.504 -1.295 . . . . 9.96 107.504 -159.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.123 -1.418 . . . . 11.65 109.986 157.933 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 106.875 -1.528 . . . . 9.39 106.875 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.72 176.19 43.74 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 107.42 -2.272 . . . . 2.79 107.42 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.2 t70 42.27 61.21 2.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.63 1.572 . . . . 3.7 112.634 171.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.01 149.02 42.16 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.01 -1.636 . . . . 1.74 109.01 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.7 m -129.17 146.99 33.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 123.886 0.875 . . . . 2.64 109.46 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.61 126.86 7.16 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.804 0.668 . . . . 3.45 112.804 162.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -79.56 97.16 6.35 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.674 1.99 . . . . 3.6 109.378 169.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mt -92.61 116.48 29.04 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.074 -1.454 . . . . 2.64 107.074 172.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.5 t -77.27 97.54 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 105.978 -1.86 . . . . 1.32 105.978 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.0 m -78.48 74.63 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 125.438 1.495 . . . . 0.82 107.666 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -74.38 146.35 43.04 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.926 -1.509 . . . . 5.1 106.926 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.19 23.77 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.571 -1.127 . . . . 1.04 112.126 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.58 130.15 42.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.547 1.673 . . . . 1.7 108.974 -171.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 p -116.41 -48.7 2.69 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.545 0.943 . . . . 3.27 113.545 -158.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.87 164.87 14.79 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.777 0.831 . . . . 1.34 111.498 -166.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.18 -40.07 10.65 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.887 1.275 . . . . 0.79 111.622 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -41.22 -51.29 3.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.602 1.561 . . . . 1.65 111.992 170.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.2 m -70.45 -43.63 69.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.943 0.497 . . . . 0.73 111.101 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.626 HG13 HG13 ' A' ' 37' ' ' VAL . 61.2 t -53.18 -55.46 12.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.506 -0.924 . . . . 0.62 108.506 -174.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -69.26 -29.61 67.56 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.654 -0.703 . . . . 0.9 111.722 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -49.73 -54.84 16.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.472 1.033 . . . . 4.06 109.016 166.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.497 ' HB ' HG11 ' A' ' 37' ' ' VAL . 1.1 mt -59.77 -61.56 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.285 -0.635 . . . . 0.73 109.285 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.603 ' CG ' HG12 ' A' ' 37' ' ' VAL . 31.3 mt-10 -57.43 -55.25 37.17 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.65 0.659 . . . . 2.35 111.58 -173.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.1 m -59.85 -39.34 84.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.754 -0.591 . . . . 1.88 111.835 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 t -70.34 -46.08 64.86 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.585 -0.697 . . . . 0.93 111.092 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 mp -71.62 -61.02 1.93 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.147 0.579 . . . . 2.94 111.201 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.4 m -69.65 72.18 0.35 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.11 1.764 . . . . 2.86 110.746 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -176.17 -35.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 129.18 2.992 . . . . 3.77 109.335 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -65.3 120.93 13.67 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 119.344 0.975 . . . . 2.32 108.505 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 134.76 51.39 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.714 -1.587 . . . . 7.74 106.714 169.289 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.74 -41.28 2.0 Favored Glycine 0 C--O 1.225 -0.43 0 N-CA-C 110.047 -1.221 . . . . 0.96 110.047 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.14 131.55 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.647 -1.612 . . . . 1.99 106.647 164.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -96.02 -30.43 13.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.076 -0.713 . . . . 2.34 109.076 170.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -156.23 164.97 37.7 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.926 0.785 . . . . 3.08 110.392 169.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.8 t -130.47 149.87 51.94 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 105.687 -1.968 . . . . 2.17 105.687 162.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 m -139.66 104.83 5.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.406 -1.331 . . . . 2.67 107.406 162.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.626 HG13 HG13 ' A' ' 19' ' ' VAL . 12.5 p -114.16 141.91 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.012 0.525 . . . . 1.58 112.09 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.39 139.71 30.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.244 0.545 . . . . 1.14 110.992 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.48 -33.08 60.78 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.201 1.0 . . . . 1.76 111.606 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.33 -34.31 60.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.227 0.611 . . . . 1.57 112.217 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.8 t -106.87 3.16 26.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.284 1.434 . . . . 3.09 111.48 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.6 m120 37.31 51.21 1.1 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 127.52 2.328 . . . . 1.91 110.814 -169.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.27 137.59 27.37 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.003 -0.435 . . . . 2.13 111.925 -166.106 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.94 117.46 32.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.298 2.239 . . . . 0.69 108.741 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -86.34 103.74 15.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.42 -2.437 . . . . 2.28 104.42 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.21 134.58 27.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.01 -1.478 . . . . 1.09 107.01 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -112.94 118.22 34.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.485 -1.302 . . . . 2.59 107.485 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -128.08 148.61 50.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.057 0.943 . . . . 2.72 111.514 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -76.99 117.01 62.14 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 106.55 -1.648 . . . . 3.11 106.55 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.39 69.64 7.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.606 2.204 . . . . 2.17 110.77 -172.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.6 -92.88 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.582 1.153 . . . . 5.02 110.154 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.1 pt -64.05 -31.28 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.128 0.788 . . . . 2.33 113.128 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 tp -114.07 137.78 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.958 1.303 . . . . 1.07 108.517 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.54 176.94 16.3 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.147 -0.781 . . . . 0.59 111.147 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.19 -41.39 74.4 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.791 2.994 . . . . 0.97 110.923 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -56.43 -53.75 53.78 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.211 0.459 . . . . 6.58 110.779 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.45 -50.4 69.94 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.078 -0.712 . . . . 2.88 109.078 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mm -53.69 -52.81 30.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 123.334 0.654 . . . . 2.04 111.306 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.4 mt -52.66 -53.53 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.879 -0.786 . . . . 0.83 108.879 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -64.27 -37.34 87.13 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.315 0.578 . . . . 3.17 110.795 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.3 m -57.36 -46.81 82.95 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.091 -0.504 . . . . 1.12 109.754 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.41 -43.08 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 118.654 0.661 . . . . 1.38 111.323 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -52.59 -41.56 63.75 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.97 0.804 . . . . 3.42 110.087 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.4 m -53.7 -29.07 37.3 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.978 0.733 . . . . 1.87 112.978 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 mt -81.18 -15.37 55.93 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.761 0.824 . . . . 0.97 112.07 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.68 42.83 4.37 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.825 1.203 . . . . 0.67 112.662 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.96 162.21 33.49 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 107.372 -1.344 . . . . 1.87 107.372 173.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -105.74 94.08 8.31 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 118.955 0.798 . . . . 2.56 110.397 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.93 85.2 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.804 3.003 . . . . 1.33 110.989 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 m -84.68 97.03 9.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.401 1.08 . . . . 1.97 110.223 -170.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.87 102.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.875 0.87 . . . . 4.63 110.817 171.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.1 p -75.21 -43.38 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 111.846 0.313 . . . . 3.68 111.846 -170.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm 61.44 -163.59 0.26 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 122.977 0.511 . . . . 6.9 110.19 -173.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.6 tt -164.11 74.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 105.169 -2.159 . . . . 7.43 105.169 173.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 C--O 1.249 1.047 0 N-CA-C 104.365 -2.457 . . . . 9.41 104.365 -151.259 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 109.169 -0.678 . . . . 8.1 109.169 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.11 30.01 76.06 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.229 0.443 . . . . 2.76 112.736 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -144.91 66.95 1.25 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.154 1.782 . . . . 4.27 108.961 -165.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.93 144.05 48.87 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 108.573 -1.811 . . . . 2.22 108.573 173.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -150.12 132.12 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 117.818 0.809 . . . . 2.8 109.83 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mp -143.63 155.19 44.18 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.046 -1.094 . . . . 2.99 108.046 166.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -107.61 102.24 11.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.254 -1.758 . . . . 2.96 106.254 163.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.52 130.92 40.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.267 -1.383 . . . . 1.5 107.267 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.419 ' CG1' HH11 ' A' ' 11' ' ' ARG . 65.2 t -84.11 102.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 125.225 1.41 . . . . 1.08 107.362 -174.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 m -89.53 96.69 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.518 1.527 . . . . 0.65 109.082 -172.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.419 HH11 ' CG1' ' A' ' 9' ' ' VAL . 21.8 mmm180 -76.14 151.02 37.08 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 118.775 -1.17 . . . . 7.7 107.932 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.2 -27.3 10.93 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.225 0.917 . . . . 0.74 111.986 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.0 mtm -65.79 94.68 0.22 Allowed 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.556 1.178 . . . . 1.47 111.546 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -77.85 -38.77 45.4 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.685 0.394 . . . . 2.59 111.49 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.23 174.7 13.44 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 119.071 0.85 . . . . 1.04 112.199 -168.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.5 -38.94 14.9 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.17 1.388 . . . . 1.13 112.183 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 m -51.94 -40.99 61.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.682 0.793 . . . . 1.86 111.42 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.4 m -70.1 -47.95 59.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.019 0.528 . . . . 0.84 110.239 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -51.12 -58.5 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 123.737 0.815 . . . . 1.05 108.977 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.17 -25.16 66.02 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.662 -0.699 . . . . 0.99 111.631 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -56.73 -56.18 24.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.291 -1.004 . . . . 3.33 108.291 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -58.61 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.239 -1.023 . . . . 0.95 108.239 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -55.78 -54.51 43.51 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.322 0.249 . . . . 2.95 110.599 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -57.45 -48.27 79.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.862 0.465 . . . . 1.32 110.237 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 t -69.91 -34.06 73.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 118.905 -1.118 . . . . 1.17 111.22 -173.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.31 -50.36 63.9 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.124 -0.465 . . . . 2.49 110.65 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.0 p -70.91 63.65 0.31 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.982 0.896 . . . . 2.02 112.42 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -165.93 -36.22 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.42 1.888 . . . . 3.79 110.895 172.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -65.97 133.72 51.43 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.359 0.981 . . . . 2.09 109.54 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -53.04 143.13 18.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.554 -0.906 . . . . 6.95 108.554 172.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.68 -32.68 7.26 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-O 118.142 -1.366 . . . . 0.8 111.977 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.49 128.01 38.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 120.006 1.903 . . . . 2.01 108.024 172.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 mt -92.6 -45.55 8.03 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.114 1.366 . . . . 2.87 108.526 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -156.07 163.54 39.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.476 -0.564 . . . . 2.31 109.476 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.7 m -135.82 154.45 51.19 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.103 0.961 . . . . 2.69 108.742 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -149.89 97.78 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.055 -1.091 . . . . 2.84 108.055 162.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -101.39 135.65 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 122.91 0.484 . . . . 1.61 110.399 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.79 135.21 19.47 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.98 0.912 . . . . 0.72 112.457 -167.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.51 -28.63 66.21 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 125.789 1.636 . . . . 2.51 111.053 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -34.45 -45.15 0.22 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.193 1.797 . . . . 2.01 113.501 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 t -131.58 10.32 4.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 122.235 1.017 . . . . 3.19 111.503 169.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 56.94 59.18 3.59 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.958 1.703 . . . . 1.75 108.758 -167.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -103.49 154.69 19.18 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.974 0.91 . . . . 1.92 110.961 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.97 114.27 17.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.251 1.421 . . . . 0.72 108.001 162.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -80.1 113.39 18.23 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 104.86 -2.274 . . . . 2.95 104.86 169.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.69 126.17 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 105.563 -2.014 . . . . 1.13 105.563 174.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -114.01 123.93 50.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.586 -1.635 . . . . 2.65 106.586 169.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -144.87 148.12 33.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.752 0.821 . . . . 2.2 111.989 -160.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -56.5 117.61 17.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 107.231 -1.396 . . . . 4.75 107.231 164.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.71 -3.27 13.4 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.192 1.928 . . . . 1.75 113.003 -170.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -103.27 -54.45 2.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.17 0.895 . . . . 4.58 109.975 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.7 pt -79.95 -36.22 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.694 0.628 . . . . 2.11 112.694 -167.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.06 132.06 66.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.28 1.432 . . . . 0.99 107.669 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.63 172.72 17.84 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 118.683 0.674 . . . . 0.6 111.612 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.95 -36.31 97.07 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.232 2.621 . . . . 0.77 110.737 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -55.93 -57.0 13.92 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.094 0.406 . . . . 6.64 110.032 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.52 -49.9 66.58 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.071 -0.714 . . . . 2.68 109.071 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.6 mm -53.58 -52.0 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.281 0.632 . . . . 1.91 111.468 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.88 -52.56 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 122.73 0.412 . . . . 0.58 109.96 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -65.51 -38.95 91.19 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.53 0.681 . . . . 2.74 110.471 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.3 m -55.24 -51.42 66.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.346 -0.613 . . . . 1.08 109.346 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 89.8 mt -69.51 -39.85 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 119.407 -0.33 . . . . 1.4 111.186 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -56.65 -44.06 80.94 Favored 'General case' 0 CA--C 1.526 0.049 0 CA-C-N 118.727 0.694 . . . . 3.55 109.226 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 t -58.66 -15.02 9.87 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.994 1.109 . . . . 1.73 113.994 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.5 mt -95.84 -9.86 30.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.898 1.226 . . . . 1.17 111.694 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.36 47.05 3.63 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.299 0.952 . . . . 0.85 112.462 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -137.99 163.87 30.46 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.56 -0.904 . . . . 2.15 108.56 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.53 86.98 3.07 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.552 1.141 . . . . 3.06 110.303 -176.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.59 82.36 0.93 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.879 3.053 . . . . 1.0 111.538 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 m -81.05 103.84 11.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.168 0.987 . . . . 1.78 109.022 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.06 70.97 0.16 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.558 1.143 . . . . 2.62 113.238 -175.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.15 -135.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.114 -1.439 . . . . 3.18 107.114 160.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.5 mmtm -138.99 -60.06 0.58 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 122.312 2.323 . . . . 6.63 113.641 -166.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.427 HG23 ' H ' ' A' ' 75' ' ' GLU . 3.4 tp -146.38 -50.92 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 126.957 2.103 . . . . 8.0 108.023 -170.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' H ' HG23 ' A' ' 74' ' ' ILE . 34.3 tt0 . . . . . 0 C--O 1.257 1.46 0 N-CA-C 103.832 -2.655 . . . . 12.74 103.832 137.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.345 0 N-CA-C 108.196 -1.039 . . . . 6.37 108.196 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.62 80.58 1.45 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.404 -0.678 . . . . 2.53 111.404 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -48.5 107.07 0.11 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.621 1.168 . . . . 3.89 111.546 175.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.59 170.47 54.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 121.768 0.649 . . . . 2.03 112.349 -176.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.42 129.85 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.624 -1.621 . . . . 2.84 106.624 167.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -155.47 158.19 38.16 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.752 0.706 . . . . 3.34 110.216 160.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.0 123.97 50.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.137 0.975 . . . . 2.4 108.911 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.402 HD21 HD12 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -110.54 123.94 50.89 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.285 -2.117 . . . . 1.57 105.285 167.311 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.29 100.35 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.298 -2.112 . . . . 1.27 105.298 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.77 84.0 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.04 1.736 . . . . 0.81 108.088 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.41 HH22 ' CD ' ' A' ' 75' ' ' GLU . 23.5 mtt85 -76.72 147.15 37.56 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.717 -1.216 . . . . 6.73 107.717 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.55 -16.61 26.39 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 119.3 -0.722 . . . . 0.81 112.849 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.1 mtp -64.05 167.34 6.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.978 1.389 . . . . 1.88 110.788 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 t -152.19 -45.54 0.1 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.076 0.55 . . . . 2.37 111.675 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.4 p -133.61 170.92 14.82 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.909 0.777 . . . . 1.25 111.917 -169.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.85 -33.94 8.12 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.856 1.263 . . . . 0.79 111.981 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -64.95 -37.61 88.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 121.491 -0.756 . . . . 2.32 111.615 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -61.36 -46.86 88.44 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.326 -0.62 . . . . 0.88 109.326 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.441 HG13 HG13 ' A' ' 37' ' ' VAL . 43.8 t -50.33 -59.67 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.73 -0.841 . . . . 0.53 108.73 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 0.6 OUTLIER -66.11 -28.96 69.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.725 -174.762 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -62.17 -54.65 38.06 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 108.809 -0.811 . . . . 4.58 108.809 173.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.29 -54.3 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 120.169 -0.612 . . . . 0.67 109.572 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -60.71 -53.99 50.7 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.367 0.531 . . . . 2.29 111.143 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.5 t -58.59 -34.9 71.61 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.742 -0.599 . . . . 1.67 111.209 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.5 t -70.38 -42.67 71.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.042 -0.411 . . . . 1.15 110.772 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.2 mt -71.22 -60.12 2.4 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.112 0.565 . . . . 2.42 112.232 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 m -69.64 67.98 0.24 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.072 1.749 . . . . 2.39 111.162 -166.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.16 -35.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.483 2.313 . . . . 4.24 110.575 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -68.03 132.43 47.26 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.471 1.032 . . . . 2.09 108.8 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -54.74 148.07 13.58 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.452 -0.573 . . . . 6.47 109.452 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.47 -28.37 10.12 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 117.382 -1.788 . . . . 0.88 112.705 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.31 126.75 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 120.544 2.172 . . . . 1.69 106.506 166.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 mt -86.79 -44.22 11.92 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.22 -1.4 . . . . 2.75 107.22 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -156.13 164.69 38.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.573 -0.899 . . . . 2.26 108.573 174.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 p -138.94 161.5 37.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.783 -1.562 . . . . 2.03 106.783 160.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.5 t -143.68 134.16 24.79 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.455 -1.683 . . . . 1.8 106.455 153.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.441 HG13 HG13 ' A' ' 19' ' ' VAL . 2.8 p -115.2 145.67 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 123.401 0.68 . . . . 1.74 109.941 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.04 134.96 26.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.073 0.463 . . . . 0.65 110.676 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.82 -29.49 65.66 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.665 1.186 . . . . 2.62 111.538 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.76 -39.11 36.69 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.631 1.172 . . . . 1.18 112.141 -174.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 p -129.88 32.15 4.6 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.717 0.807 . . . . 2.46 110.192 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 27.0 62.04 0.09 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 128.226 2.611 . . . . 2.39 112.546 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -132.49 145.55 51.26 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.84 0.456 . . . . 1.68 111.462 -173.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.06 118.06 35.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.505 -1.665 . . . . 0.78 106.505 163.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -85.68 109.84 18.87 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 101.606 -3.479 . . . . 2.32 101.606 165.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.402 HD12 HD21 ' A' ' 8' ' ' LEU . 43.8 mt -101.94 139.22 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.329 -0.989 . . . . 1.73 108.329 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -117.78 104.86 11.38 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 105.707 -1.961 . . . . 3.05 105.707 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -120.11 162.49 19.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.818 0.847 . . . . 2.63 110.322 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -100.22 114.76 65.82 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.556 0.743 . . . . 3.79 110.397 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -69.4 -5.32 15.7 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.607 2.205 . . . . 2.26 113.492 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -65.01 -22.65 67.03 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.951 1.705 . . . . 5.26 112.068 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 pt -129.82 -60.08 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.499 0.926 . . . . 2.05 113.499 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 tp -87.85 137.32 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.548 -0.72 . . . . 1.09 110.031 -165.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.15 166.74 12.32 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.988 0.804 . . . . 0.75 111.57 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -57.87 -38.61 91.82 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.148 2.565 . . . . 0.76 110.872 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -53.74 -44.42 69.91 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.003 0.372 . . . . 7.45 112.003 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.3 -51.99 66.58 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.994 0.815 . . . . 2.43 109.191 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.7 mt -50.38 -54.16 9.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 C-N-CA 123.32 0.648 . . . . 1.54 109.358 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.9 mt -56.72 -51.01 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 119.119 -0.467 . . . . 0.62 110.036 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -68.55 -27.35 66.0 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-O 120.978 0.418 . . . . 3.14 112.067 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.8 m -64.62 -52.26 58.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.733 -0.469 . . . . 0.85 109.733 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -72.07 -45.28 63.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.874 -0.517 . . . . 1.17 112.151 -171.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.04 -43.23 63.65 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.65 0.659 . . . . 3.95 111.388 -176.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.3 t -48.35 -37.2 16.09 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.38 1.472 . . . . 1.86 112.395 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.4 mt -74.8 -17.27 60.65 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.363 -0.836 . . . . 1.05 112.188 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.61 45.68 3.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.159 0.885 . . . . 0.81 112.022 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -136.38 155.63 49.77 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.721 -1.215 . . . . 1.96 107.721 170.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -101.39 96.47 6.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.768 1.227 . . . . 2.83 109.41 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.2 77.66 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.352 2.701 . . . . 1.19 110.479 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.6 p -78.91 106.84 11.22 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.18 -0.674 . . . . 2.23 109.18 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.3 mt -74.94 56.55 0.75 Allowed 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.596 -0.69 . . . . 4.01 111.19 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.3 p -101.63 55.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 123.73 1.729 . . . . 3.38 107.492 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -39.46 110.96 0.16 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.179 -1.828 . . . . 7.24 109.259 158.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 mp 73.26 108.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 126.398 1.879 . . . . 6.48 109.531 -167.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.41 ' CD ' HH22 ' A' ' 11' ' ' ARG . 52.7 mt-10 . . . . . 0 C--O 1.256 1.396 0 N-CA-C 103.824 -2.658 . . . . 13.37 103.824 158.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 mtt . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 105.718 -1.956 . . . . 9.25 105.718 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.22 92.1 0.05 OUTLIER Glycine 0 CA--C 1.533 1.17 0 O-C-N 124.426 1.079 . . . . 2.97 112.484 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 t0 71.68 161.22 0.23 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.831 2.052 . . . . 4.09 112.685 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.92 94.82 0.1 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.068 -1.613 . . . . 2.4 109.068 -169.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -90.73 118.47 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.053 1.341 . . . . 2.58 109.912 -170.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -127.01 133.25 50.58 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.361 0.665 . . . . 2.63 109.608 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -103.61 99.85 9.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.283 1.033 . . . . 2.66 108.217 169.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.94 134.02 41.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.123 -1.436 . . . . 1.43 107.123 173.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.9 t -85.32 113.81 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.143 -1.799 . . . . 1.01 106.143 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.02 96.78 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 126.04 1.736 . . . . 0.65 108.321 -172.199 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 11' ' ' ARG . 0.1 OUTLIER -77.02 137.66 39.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.645 -1.613 . . . . 5.46 106.645 -174.956 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.55 -26.49 10.14 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.768 -1.018 . . . . 0.98 112.66 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 ptm -78.65 85.71 4.67 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.534 1.667 . . . . 1.82 110.232 -176.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 p -76.5 -34.6 58.61 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.881 0.872 . . . . 3.16 112.962 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.0 p -145.45 172.82 12.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.81 0.732 . . . . 1.14 112.39 -162.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.8 -39.43 8.36 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.518 1.527 . . . . 0.73 112.299 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -53.53 -53.14 55.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.491 -0.559 . . . . 2.18 109.491 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.3 m -64.77 -42.59 94.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.589 0.356 . . . . 0.68 111.003 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.6 t -48.99 -61.04 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.199 -1.037 . . . . 0.55 108.199 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.287 1.1 p-80 -70.32 -28.77 65.43 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.185 -0.916 . . . . 0.87 111.457 -174.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -51.58 -60.06 3.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.057 0.844 . . . . 3.97 110.052 168.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 mt -62.59 -59.23 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.761 -0.829 . . . . 0.83 108.761 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -56.65 -53.78 53.69 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.743 0.417 . . . . 2.56 110.001 -167.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 t -62.44 -42.48 99.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.396 -0.335 . . . . 1.44 110.872 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.0 t -65.88 -50.74 63.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.902 0.774 . . . . 0.91 110.934 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.83 -43.93 78.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.647 0.779 . . . . 2.22 111.033 -173.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.1 m -71.24 65.77 0.41 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.685 0.675 . . . . 2.84 111.457 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -147.9 -51.78 0.19 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 128.021 2.528 . . . . 7.92 108.182 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -66.11 114.62 5.38 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.845 -0.798 . . . . 2.13 108.845 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -48.95 -30.68 6.25 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.412 1.085 . . . . 7.02 113.582 -171.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.8 -33.13 55.63 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.088 -0.84 . . . . 0.85 113.208 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.76 124.17 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.783 -1.562 . . . . 2.0 106.783 169.059 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.47 -20.26 18.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 119.153 -0.451 . . . . 2.45 110.153 171.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -155.44 158.35 38.45 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.085 0.857 . . . . 2.29 109.964 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -139.02 146.98 41.51 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.698 -1.593 . . . . 2.06 106.698 165.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -145.77 122.89 11.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.582 -1.266 . . . . 2.12 107.582 159.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 m -111.35 151.87 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.158 0.89 . . . . 1.77 111.042 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.62 133.48 20.14 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 122.734 0.414 . . . . 0.7 111.713 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -69.46 -27.34 65.15 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.301 1.041 . . . . 2.14 111.402 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.05 -39.33 1.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.742 1.617 . . . . 1.12 113.215 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.5 t -141.62 36.47 1.64 Allowed 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.754 0.422 . . . . 2.73 110.246 168.308 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.4 m120 33.9 56.71 0.59 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 127.649 2.379 . . . . 1.64 110.418 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -110.78 153.15 25.74 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.16 0.984 . . . . 2.21 110.187 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.11 113.16 13.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.73 1.212 . . . . 0.58 108.019 171.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -92.44 97.93 11.15 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.384 -3.191 . . . . 2.13 102.384 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.74 141.16 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.071 -1.825 . . . . 1.18 106.071 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.49 ' HB3' ' HZ2' ' A' ' 47' ' ' LYS . 2.8 mtmp? -122.38 114.27 20.52 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.257 -1.016 . . . . 3.28 108.257 167.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -126.29 152.51 46.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.958 0.786 . . . . 2.1 111.778 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -78.56 113.77 37.5 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 108.659 -0.867 . . . . 2.83 108.659 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.76 65.32 8.74 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.635 2.89 . . . . 1.35 110.267 -170.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -138.39 -72.47 0.41 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.845 1.258 . . . . 3.2 108.706 -170.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -88.26 -36.53 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.043 0.937 . . . . 2.41 111.721 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 tp -104.02 153.32 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.669 1.587 . . . . 0.96 107.963 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.47 173.56 23.82 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.236 -1.146 . . . . 0.6 110.236 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.63 -38.19 42.43 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.147 2.565 . . . . 0.71 110.327 -175.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -57.43 -42.16 81.84 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.518 0.327 . . . . 5.71 111.214 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -62.15 -59.15 5.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.576 -0.898 . . . . 4.02 108.576 178.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 mm -42.9 -51.2 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.419 0.688 . . . . 1.81 110.651 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.4 mt -54.2 -59.6 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 118.661 -0.685 . . . . 0.57 110.672 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.98 -35.95 81.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.487 1.04 . . . . 5.55 111.9 -176.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.3 m -68.02 -39.21 83.19 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.6 1.16 . . . . 1.46 109.681 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.28 -46.02 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.644 -0.66 . . . . 1.25 110.677 170.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -50.13 -43.24 51.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.644 0.656 . . . . 4.93 110.905 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.1 m -51.12 -28.83 11.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.449 0.907 . . . . 1.68 113.449 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.06 -12.18 48.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.377 1.071 . . . . 1.07 112.248 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.82 48.94 3.5 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.871 1.224 . . . . 0.75 112.31 174.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -139.45 153.71 47.62 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 106.97 -1.492 . . . . 2.01 106.97 170.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -98.79 101.43 12.03 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-O 118.434 -0.793 . . . . 2.88 110.478 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.17 93.51 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.714 2.276 . . . . 0.9 111.642 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.2 m -78.45 116.86 19.14 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.574 -0.898 . . . . 1.47 108.574 167.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.6 60.67 0.34 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.462 1.105 . . . . 2.61 111.73 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 t -64.7 -60.7 2.34 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 O-C-N 121.775 -0.578 . . . . 2.32 110.197 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 65.98 147.07 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.033 1.333 . . . . 4.83 111.307 -171.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.25 153.99 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.182 -0.949 . . . . 6.68 109.041 167.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 . . . . . 0 C--O 1.249 1.044 0 N-CA-C 104.493 -2.41 . . . . 8.62 104.493 173.108 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.031 -0.729 . . . . 8.43 109.031 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.0 178.65 15.57 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.118 -1.993 . . . . 2.98 108.118 -170.571 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.84 -123.28 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.064 0.932 . . . . 2.91 110.281 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.74 -153.68 20.1 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 106.532 -2.627 . . . . 2.46 106.532 -168.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.75 147.35 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.127 -1.434 . . . . 2.6 107.127 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.49 141.53 49.78 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.14 -1.43 . . . . 3.2 107.14 166.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -103.37 145.41 30.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.446 1.098 . . . . 3.02 109.704 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.21 119.76 17.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.39 1.476 . . . . 1.8 107.318 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.65 118.94 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 103.798 -2.667 . . . . 1.43 103.798 171.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.458 HG13 ' SD ' ' A' ' 13' ' ' MET . 2.5 p -124.81 87.18 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.679 1.192 . . . . 2.65 108.528 -167.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -79.44 152.36 30.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.458 -0.792 . . . . 5.37 109.306 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.77 -28.85 6.85 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.319 0.961 . . . . 0.85 111.073 -175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.458 ' SD ' HG13 ' A' ' 10' ' ' VAL . 30.1 mtp -66.06 110.13 2.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.84 0.82 . . . . 1.67 110.12 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.8 t -90.8 -43.06 10.3 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.253 1.021 . . . . 2.85 111.677 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.3 p -141.56 174.6 10.4 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.874 0.761 . . . . 1.31 111.963 -167.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.25 -35.76 12.63 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.994 1.318 . . . . 0.98 112.072 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -60.48 -37.5 81.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.61 -0.681 . . . . 2.51 111.344 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 78.8 m -63.76 -37.92 89.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.633 -0.667 . . . . 0.83 110.571 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.8 t -58.58 -60.94 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.405 -0.961 . . . . 0.8 108.405 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.306 0.9 OUTLIER -60.06 -35.88 76.1 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.752 -0.379 . . . . 0.83 111.589 -175.485 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -61.11 -46.93 88.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.901 1.68 . . . . 3.78 109.848 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mt -58.95 -65.92 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.651 -0.5 . . . . 0.85 109.651 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.86 -50.61 71.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.608 -0.437 . . . . 2.72 111.146 -168.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.0 m -56.55 -43.52 79.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.376 -0.231 . . . . 2.26 110.376 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 t -70.63 -38.99 73.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 118.802 -1.159 . . . . 1.13 111.226 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 mt -56.98 -48.94 77.22 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.186 0.903 . . . . 2.3 110.066 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.6 p -62.63 80.47 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.909 0.884 . . . . 2.05 111.631 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 pttm 176.7 -34.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 129.193 2.997 . . . . 3.84 109.944 172.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -69.13 141.93 54.51 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 119.199 -1.0 . . . . 2.18 109.037 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -62.13 145.14 54.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.552 -0.907 . . . . 6.14 108.552 175.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.05 -53.77 0.57 Allowed Glycine 0 CA--C 1.521 0.407 0 CA-C-O 119.316 -0.713 . . . . 1.26 111.528 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.74 112.25 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 118.66 1.23 . . . . 2.19 112.312 -166.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -94.1 -30.79 14.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.232 1.013 . . . . 2.83 111.2 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -153.93 147.25 24.84 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.509 1.049 . . . . 2.85 109.427 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -117.87 140.41 49.74 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 107.176 -1.416 . . . . 2.25 107.176 172.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.5 t -128.52 59.58 1.53 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.234 1.014 . . . . 3.53 108.664 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.86 133.85 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.553 0.741 . . . . 1.58 110.844 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.34 137.88 37.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.946 0.898 . . . . 0.85 112.408 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.96 -35.02 79.46 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.005 1.322 . . . . 2.71 110.072 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -37.25 -39.69 0.29 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.531 1.932 . . . . 1.63 113.831 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t -143.29 34.96 1.33 Allowed 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.393 0.277 . . . . 2.91 111.059 172.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.7 m120 41.66 61.82 1.75 Allowed 'General case' 0 CA--C 1.523 -0.077 0 C-N-CA 126.092 1.757 . . . . 1.82 110.068 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.13 140.53 18.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.329 -0.619 . . . . 2.29 109.329 -166.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.45 154.92 28.41 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.202 0.601 . . . . 1.18 110.03 166.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.28 141.33 40.22 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 104.91 -2.256 . . . . 2.03 104.91 150.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.59 134.49 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.965 -1.494 . . . . 1.37 106.965 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -102.83 85.48 2.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.508 -2.034 . . . . 3.16 105.508 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -114.01 146.36 40.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.934 1.294 . . . . 2.41 110.799 172.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -59.64 107.32 0.96 Allowed Pre-proline 0 CA--C 1.537 0.46 0 O-C-N 124.283 0.99 . . . . 2.51 108.792 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -82.44 45.57 1.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.319 2.679 . . . . 1.73 110.974 -169.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' OE1' ' N ' ' A' ' 1' ' ' MET . 24.5 mt-10 -139.31 -60.29 0.57 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.533 1.133 . . . . 4.23 108.965 -170.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 pt -74.9 -25.87 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 112.34 0.496 . . . . 2.27 112.34 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.2 tt -143.0 154.78 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.085 -1.079 . . . . 1.67 108.085 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.08 -176.76 17.05 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.626 -0.589 . . . . 0.66 111.626 -172.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.11 -32.72 33.6 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.371 2.047 . . . . 0.77 110.174 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -53.65 -51.7 62.32 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.131 0.572 . . . . 6.26 110.95 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.81 -50.3 72.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.095 0.474 . . . . 2.31 109.745 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.0 mt -54.61 -51.94 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.08 0 C-N-CA 123.441 0.696 . . . . 1.2 109.893 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.4 mt -51.74 -53.04 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.133 -0.691 . . . . 0.61 109.133 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -66.3 -34.89 79.0 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.914 0.485 . . . . 2.66 110.785 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -60.77 -48.52 81.42 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.715 -0.476 . . . . 0.74 109.715 174.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 94.0 mt -70.89 -35.69 60.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.365 -0.834 . . . . 0.99 111.366 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -54.44 -49.45 69.97 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.557 -0.714 . . . . 2.62 109.21 167.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 t -58.12 -43.07 87.01 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.651 0.38 . . . . 2.12 111.143 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -58.18 -37.64 75.15 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.506 -0.746 . . . . 1.17 111.64 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.67 38.42 2.22 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.628 1.109 . . . . 0.83 111.726 176.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -129.28 163.45 25.65 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 107.702 -1.222 . . . . 2.1 107.702 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -109.93 98.72 35.58 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.183 0.593 . . . . 2.83 110.118 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.52 148.31 20.55 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.779 2.986 . . . . 1.63 110.168 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.1 m -153.71 118.03 4.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.457 1.103 . . . . 2.29 108.404 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.22 59.94 1.86 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.767 0.827 . . . . 2.29 111.538 -176.417 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.6 t -118.82 60.95 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.608 -1.256 . . . . 4.33 107.608 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -160.79 142.98 12.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.939 -1.134 . . . . 8.25 107.939 175.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.5 tt -150.1 162.58 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 105.068 -2.197 . . . . 6.75 105.068 164.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 C--O 1.249 1.072 0 C-N-CA 126.609 1.964 . . . . 11.37 111.42 169.94 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 107.882 -1.155 . . . . 7.88 107.882 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.19 157.31 6.06 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.427 -1.069 . . . . 2.51 110.427 -170.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -75.27 132.81 41.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.108 -0.701 . . . . 3.28 109.108 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.11 149.91 44.39 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.914 -0.874 . . . . 1.81 110.914 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -136.48 87.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 105.808 -1.923 . . . . 3.14 105.808 172.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.25 145.09 51.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.816 -0.809 . . . . 3.18 108.816 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -123.92 139.13 54.26 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.949 -1.5 . . . . 2.21 106.949 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.34 152.57 51.93 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.905 -1.146 . . . . 2.59 107.905 164.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -93.92 101.66 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.792 -1.929 . . . . 1.14 105.792 -173.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.2 m -79.38 65.86 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.076 1.75 . . . . 0.8 108.581 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.39 125.86 29.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 118.95 -1.1 . . . . 4.92 108.579 -162.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.51 -44.69 0.96 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.217 0.913 . . . . 0.89 110.888 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -64.16 152.15 41.44 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.408 0.683 . . . . 1.66 111.508 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -140.65 -34.97 0.5 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.983 0.734 . . . . 2.08 112.983 -167.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 p -145.97 175.14 10.67 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.305 0.957 . . . . 1.32 111.683 -166.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.52 -47.89 3.82 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.0 1.72 . . . . 0.82 112.032 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 m -57.14 -40.29 76.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.331 0.652 . . . . 1.68 111.818 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.7 m -72.14 -53.11 13.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.619 0.645 . . . . 0.78 110.523 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.2 t -44.1 -55.77 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.482 1.513 . . . . 0.62 109.275 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.78 -21.63 63.4 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 120.175 -0.61 . . . . 1.35 112.26 -173.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -47.97 59.98 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.933 -1.506 . . . . 5.75 106.933 173.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mt -56.33 -53.38 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.788 -0.625 . . . . 0.9 110.101 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -57.25 -61.58 2.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.841 0.746 . . . . 3.42 111.473 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -55.44 -41.75 73.26 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.771 -0.581 . . . . 1.58 111.579 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 t -65.45 -48.61 72.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.818 -0.438 . . . . 1.65 109.818 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.8 mt -54.04 -46.04 71.79 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.355 -0.841 . . . . 3.13 110.074 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -61.28 -14.16 24.43 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.695 0.998 . . . . 2.04 113.695 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -26.36 68.79 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.166 1.348 . . . . 5.66 111.275 173.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -77.86 100.17 6.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.317 -0.623 . . . . 2.87 109.317 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -61.23 82.87 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.871 -1.159 . . . . 5.91 107.871 163.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.82 -26.95 0.39 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.231 0.92 . . . . 1.33 110.932 -166.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.409 ' CG1' HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -74.67 120.03 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 105.773 -1.936 . . . . 2.07 105.773 165.457 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.9 mt -79.91 -47.48 14.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.708 -1.219 . . . . 2.5 107.708 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -156.09 124.2 5.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.898 -0.408 . . . . 3.15 109.898 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.2 p -97.61 151.82 19.69 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.088 0.955 . . . . 2.7 108.719 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -152.56 102.48 2.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.794 -0.817 . . . . 2.1 108.794 159.467 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.16 148.16 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 124.102 0.961 . . . . 1.87 110.946 167.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.65 131.95 18.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.385 0.674 . . . . 0.86 109.635 171.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.46 -32.63 54.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.038 -0.983 . . . . 2.05 112.939 -167.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.95 -49.41 40.53 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.093 0.957 . . . . 1.35 111.783 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.1 p -101.77 6.48 41.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.897 0.879 . . . . 2.18 111.326 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.02 42.72 21.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.3 1.44 . . . . 3.22 110.362 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -98.81 149.12 23.21 Favored 'General case' 0 C--N 1.344 0.326 0 O-C-N 121.371 -0.83 . . . . 1.73 110.159 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.8 117.93 30.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.014 -1.106 . . . . 0.78 108.014 155.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -83.4 119.94 25.27 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.122 -2.177 . . . . 3.97 105.122 164.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.409 HG23 ' CG1' ' A' ' 32' ' ' ILE . 2.0 mp -113.68 118.22 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.098 -1.815 . . . . 1.27 106.098 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -103.75 97.7 7.67 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.258 -1.756 . . . . 3.21 106.258 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -112.11 169.94 8.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.185 1.394 . . . . 2.24 111.339 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -76.56 115.2 45.59 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.112 -0.699 . . . . 4.47 109.112 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.62 49.43 3.08 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-N 120.748 1.303 . . . . 1.43 111.148 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.7 -63.52 1.02 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.58 1.152 . . . . 3.81 110.052 170.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pp -75.92 -32.32 23.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 CA-C-N 118.631 0.65 . . . . 1.94 112.689 -168.721 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.9 tt -128.37 157.66 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.608 1.163 . . . . 1.18 110.806 -168.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -124.86 -173.87 13.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.471 -0.651 . . . . 0.64 111.471 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.84 -39.47 51.82 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.82 2.347 . . . . 0.93 110.336 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -51.15 -49.38 60.98 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.859 0.864 . . . . 5.64 112.198 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.28 -47.49 84.09 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.956 0.884 . . . . 2.22 110.209 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.7 mt -56.45 -54.06 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 114.926 -1.034 . . . . 1.42 108.22 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.9 mt -54.08 -53.0 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 116.376 -0.375 . . . . 0.6 110.146 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -64.23 -34.21 77.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.279 -0.263 . . . . 2.73 110.627 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.1 m -58.58 -53.53 57.24 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.073 -0.392 . . . . 1.06 110.697 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.4 mm -66.01 -39.81 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.168 -0.957 . . . . 1.99 111.476 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.32 -46.03 76.31 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.874 -0.517 . . . . 2.75 109.772 171.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.3 t -59.6 -42.62 92.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.828 0.451 . . . . 2.01 111.262 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.24 -43.38 87.77 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.726 0.694 . . . . 1.3 110.936 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.95 43.41 0.94 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.059 0.837 . . . . 0.72 111.436 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -130.92 157.58 42.56 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 105.608 -1.997 . . . . 2.01 105.608 166.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -102.11 108.01 55.06 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 119.37 0.986 . . . . 2.61 109.812 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.75 83.28 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 124.068 3.178 . . . . 0.9 110.918 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.5 t -78.75 112.34 15.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.171 -0.677 . . . . 2.11 109.171 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.2 57.49 1.86 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.679 0.792 . . . . 2.88 111.562 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.1 p -88.66 -21.7 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.831 0.852 . . . . 3.24 110.482 173.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt 64.69 -177.21 0.17 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.552 1.141 . . . . 4.72 110.765 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.21 -43.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.107 0.963 . . . . 8.15 108.847 163.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 124.408 1.083 . . . . 9.17 109.775 176.198 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 107.719 -1.215 . . . . 8.99 107.719 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.21 159.61 28.0 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 107.204 -2.358 . . . . 2.37 107.204 172.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.01 111.69 0.26 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.108 1.363 . . . . 3.9 114.432 -164.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.95 83.36 0.5 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 107.168 -2.373 . . . . 2.56 107.168 159.372 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m -77.82 125.09 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.993 -1.114 . . . . 2.61 107.993 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.7 tp -144.89 143.86 30.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.305 -1.368 . . . . 2.87 107.305 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -117.14 123.98 48.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.508 -0.923 . . . . 2.75 108.508 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.424 HD21 HD13 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -125.16 133.95 52.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.023 -1.473 . . . . 1.43 107.023 177.382 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.11 105.84 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.964 -1.495 . . . . 1.08 106.964 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.84 81.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.697 1.199 . . . . 0.78 108.077 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 -76.45 142.84 40.87 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 4.33 107.752 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.77 -31.84 5.57 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.36 -0.696 . . . . 0.99 111.36 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.6 ptm -60.5 159.35 10.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.181 0.991 . . . . 1.87 110.781 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 p -136.09 -65.64 0.57 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.757 0.823 . . . . 3.64 108.995 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 p -119.55 172.88 7.34 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.518 1.127 . . . . 1.24 111.579 -166.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.08 -41.2 7.5 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.958 1.303 . . . . 0.89 112.058 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m -48.96 -46.9 44.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.354 1.062 . . . . 1.9 111.325 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.8 m -68.61 -47.95 65.37 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.612 0.365 . . . . 0.92 110.128 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.5 t -50.44 -58.61 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 108.769 -0.826 . . . . 1.02 108.769 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -66.59 -28.66 68.68 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.606 -0.724 . . . . 1.0 111.687 -174.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.09 -52.71 60.1 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.231 1.012 . . . . 3.82 109.235 171.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mt -61.52 -59.8 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 108.462 -0.94 . . . . 0.78 108.462 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -51.19 -58.58 5.76 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.446 0.466 . . . . 2.64 110.744 -171.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.0 p -55.36 -50.56 69.36 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.617 0.246 . . . . 2.39 110.886 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -70.92 -26.31 63.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.039 0.385 . . . . 0.98 112.039 -171.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.38 -49.65 53.38 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.572 -0.705 . . . . 1.6 109.532 169.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.4 p -70.11 72.9 0.45 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.282 0.492 . . . . 1.78 111.835 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.58 -44.3 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.972 1.309 . . . . 4.39 110.866 176.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -73.32 121.93 21.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.272 -1.011 . . . . 2.03 108.272 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -66.82 0.51 2.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.78 0.718 . . . . 8.9 112.603 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.53 -41.27 99.53 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 120.046 -1.659 . . . . 1.68 111.047 161.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.19 147.92 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.901 -1.148 . . . . 1.76 107.901 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.35 -32.44 4.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.514 1.125 . . . . 2.18 110.404 171.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -155.27 138.58 15.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.813 -1.18 . . . . 2.01 107.813 169.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.4 t -128.5 147.59 50.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.017 -1.475 . . . . 2.09 107.017 170.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 t -147.91 147.58 29.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.886 -0.783 . . . . 2.08 108.886 156.842 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.0 151.03 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.52 1.128 . . . . 2.18 111.13 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.8 133.36 31.99 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.027 0.531 . . . . 0.93 111.091 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.75 -37.16 86.66 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.613 1.165 . . . . 2.94 110.475 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.27 -39.99 1.52 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.164 1.786 . . . . 1.91 113.644 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.1 t -139.96 38.13 1.96 Allowed 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 121.907 0.86 . . . . 2.64 109.608 172.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.2 m120 35.99 46.78 0.38 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 127.955 2.502 . . . . 1.83 111.672 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -102.65 146.09 28.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.679 -0.489 . . . . 2.15 109.679 -168.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.19 119.86 37.81 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.227 -1.768 . . . . 0.62 106.227 161.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -86.78 120.25 27.87 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 103.947 -2.612 . . . . 3.22 103.947 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.424 HD13 HD21 ' A' ' 8' ' ' LEU . 1.7 mp -112.5 128.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.379 -2.082 . . . . 1.15 105.379 174.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -111.46 96.92 6.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.109 -1.441 . . . . 2.18 107.109 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -106.68 148.1 28.78 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.708 0.803 . . . . 2.39 111.217 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.51 110.32 8.59 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.214 -1.402 . . . . 2.84 107.214 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -82.12 67.28 8.19 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.462 2.108 . . . . 1.59 111.909 -162.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.93 -83.72 0.14 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.086 0.954 . . . . 3.5 110.54 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.29 -47.46 84.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 122.098 -0.376 . . . . 2.35 110.825 -175.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 tp -86.2 154.16 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.241 -1.022 . . . . 1.52 108.241 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.03 168.5 23.67 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.657 -0.977 . . . . 0.78 110.657 173.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -54.9 -34.14 84.74 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.551 2.834 . . . . 0.81 110.658 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -42.26 -51.35 4.8 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.3 1.04 . . . . 9.29 111.045 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -71.79 -48.42 46.71 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.393 -0.965 . . . . 2.56 108.393 -168.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 mm -47.46 -51.25 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 124.404 1.082 . . . . 1.92 109.516 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.8 mt -61.75 -52.99 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.887 -0.597 . . . . 0.6 110.002 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -55.83 -42.35 75.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 122.052 0.93 . . . . 3.34 109.808 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 84.1 m -59.52 -58.58 7.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.218 -0.901 . . . . 0.74 108.999 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.95 -38.54 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 121.39 -0.819 . . . . 1.18 111.693 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -53.38 -51.54 62.21 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.309 -0.626 . . . . 2.84 109.309 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -57.14 -37.07 71.49 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.023 -0.423 . . . . 1.77 112.029 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.5 mt -67.98 -15.22 63.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.422 -0.799 . . . . 1.3 112.964 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.12 41.67 5.18 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.204 0.906 . . . . 0.93 112.196 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -138.54 164.72 28.72 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.94 -1.133 . . . . 2.0 107.94 170.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -100.52 99.66 10.44 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.24 1.416 . . . . 2.64 109.956 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.71 80.4 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 124.14 3.227 . . . . 1.02 110.269 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.8 m -81.95 94.63 7.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.837 0.855 . . . . 2.34 109.328 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.4 65.18 0.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.662 1.185 . . . . 2.64 112.794 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.8 m -60.08 -36.14 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 O-C-N 121.094 -1.004 . . . . 3.29 111.842 -176.173 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? 66.92 97.96 0.05 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.948 1.299 . . . . 5.23 108.39 -169.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 pp -61.66 140.48 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 121.762 -0.586 . . . . 6.69 111.056 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 . . . . . 0 C--O 1.249 1.066 0 N-CA-C 104.429 -2.434 . . . . 9.01 104.429 177.7 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 mtt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 111.793 0.294 . . . . 12.1 111.793 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.11 81.66 1.6 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 106.039 -2.825 . . . . 4.05 106.039 -171.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -132.1 106.34 7.94 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.079 -1.452 . . . . 4.35 107.079 -154.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.8 143.84 42.09 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 117.842 0.292 . . . . 2.12 112.965 -172.835 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -148.81 112.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 125.116 1.366 . . . . 3.17 108.948 176.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mp -137.82 158.33 44.58 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.095 -1.076 . . . . 3.15 108.095 160.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -137.86 132.91 33.23 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.221 1.008 . . . . 2.32 108.465 -169.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.79 139.46 32.77 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.438 1.095 . . . . 1.4 108.64 -169.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.8 t -85.57 100.42 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 107.737 -1.208 . . . . 1.0 107.737 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.5 m -84.15 76.5 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 125.608 1.563 . . . . 0.72 108.904 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -76.29 141.14 41.72 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.11 -1.036 . . . . 4.82 108.351 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.19 -43.05 1.35 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.823 -0.911 . . . . 0.65 110.823 -176.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -64.98 149.69 49.36 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.967 0.884 . . . . 1.32 110.217 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -139.97 -37.6 0.48 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.679 0.622 . . . . 2.16 112.679 -168.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 p -135.4 168.59 18.93 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.006 0.821 . . . . 1.21 110.965 -177.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.74 -38.45 15.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.939 1.296 . . . . 0.83 112.0 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 m -45.84 -44.31 14.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.128 1.371 . . . . 1.79 112.218 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.4 m -71.68 -51.89 20.67 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.503 0.721 . . . . 0.73 110.745 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.7 t -46.6 -60.87 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 125.205 1.402 . . . . 0.51 108.946 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -67.29 -23.27 65.64 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.879 -1.055 . . . . 0.96 111.523 -175.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -66.29 -53.26 38.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.059 -1.089 . . . . 4.02 108.059 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mt -58.73 -55.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 N-CA-C 108.669 -0.863 . . . . 0.8 108.669 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.27 -57.68 10.81 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.226 0.467 . . . . 2.35 110.965 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -56.12 -48.82 75.48 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.681 0.393 . . . . 1.6 110.564 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.3 t -60.07 -57.1 14.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.933 -0.395 . . . . 0.9 109.933 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.01 -40.16 66.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.078 0.551 . . . . 1.84 111.168 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.2 m -49.3 -26.62 3.18 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.655 0.983 . . . . 2.31 113.655 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -62.55 -27.33 69.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.14 1.336 . . . . 4.38 112.505 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -68.36 107.99 3.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.126 -0.694 . . . . 2.98 109.126 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -46.34 -36.93 6.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.756 0.823 . . . . 5.55 113.083 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.62 -11.87 84.89 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.197 -0.779 . . . . 0.75 113.772 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.95 120.1 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 119.134 1.467 . . . . 1.93 108.977 173.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -91.03 -31.45 16.29 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.856 -0.593 . . . . 2.52 110.97 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -157.74 130.87 7.6 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.727 1.149 . . . . 2.34 109.91 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.0 t -103.25 144.58 31.15 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 106.856 -1.535 . . . . 2.07 106.856 164.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -147.07 149.1 32.4 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 118.322 -1.351 . . . . 2.41 109.693 144.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.09 138.84 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.727 0.811 . . . . 1.77 111.029 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.31 131.32 53.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.492 1.117 . . . . 0.7 111.972 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.6 mt -68.78 -47.88 65.07 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 126.105 1.762 . . . . 2.46 111.783 -173.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.97 -46.71 52.7 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.018 0.527 . . . . 1.44 110.862 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 m -79.7 -39.87 30.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.327 0.651 . . . . 2.55 109.25 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 79.55 43.12 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 127.466 2.306 . . . . 2.53 107.688 -168.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.2 139.25 53.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.067 0.547 . . . . 2.28 111.356 -165.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.6 125.36 53.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.776 1.63 . . . . 0.56 109.106 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -96.28 114.87 26.6 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.355 -2.832 . . . . 2.16 103.355 166.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 mt -119.43 106.98 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.446 -1.687 . . . . 1.44 106.446 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -82.34 71.27 9.4 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.077 -1.453 . . . . 2.4 107.077 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -95.22 130.1 42.09 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.942 -0.572 . . . . 3.12 109.994 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -76.76 116.04 53.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 108.22 -1.03 . . . . 3.6 108.22 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -80.38 54.96 5.46 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.424 2.75 . . . . 1.91 112.262 -163.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -125.34 -71.92 0.68 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.783 1.233 . . . . 3.58 109.137 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -75.08 -34.6 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 O-C-N 122.282 -0.261 . . . . 2.0 111.188 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.36 137.47 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 126.116 1.767 . . . . 1.11 108.347 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.95 177.67 16.41 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.774 0.702 . . . . 0.64 111.617 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -57.67 -44.67 39.24 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.458 2.772 . . . . 0.78 110.679 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -58.81 -42.92 90.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.681 -0.408 . . . . 7.48 111.175 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.81 -53.48 57.85 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.5 0.667 . . . . 2.5 109.661 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mm -52.14 -50.91 34.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.158 0.983 . . . . 2.04 110.112 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.4 mt -57.61 -49.83 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.285 -0.416 . . . . 0.56 110.05 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.408 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 2.3 m-70 -62.31 -39.32 92.63 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.939 0.876 . . . . 3.76 110.365 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.0 m -56.47 -52.55 64.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.315 -0.624 . . . . 0.75 109.315 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.3 mt -72.31 -40.76 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 121.892 -0.505 . . . . 1.18 111.638 -171.682 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HG3' ' HA ' ' A' ' 60' ' ' HIS . 3.1 pp20? -59.77 -48.6 81.03 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 118.273 0.488 . . . . 4.21 110.296 173.141 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.3 m -56.6 -40.73 75.8 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.877 0.325 . . . . 2.16 111.877 175.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.69 -38.62 91.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.107 0.867 . . . . 1.2 111.566 173.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.93 36.33 0.89 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.837 0.732 . . . . 0.68 112.451 172.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -130.23 157.73 41.68 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.368 -1.345 . . . . 2.0 107.368 168.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -99.48 104.99 30.62 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 119.538 1.063 . . . . 2.66 110.297 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.34 90.19 1.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.934 3.089 . . . . 0.87 111.1 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.9 t -78.95 111.48 15.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.153 -0.684 . . . . 2.16 109.153 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.18 60.18 1.04 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.899 1.28 . . . . 3.05 111.52 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.83 -43.97 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 O-C-N 121.795 -0.566 . . . . 3.06 111.984 -173.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.84 48.86 14.82 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.183 0.993 . . . . 5.81 111.261 176.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.47 155.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.864 -0.522 . . . . 6.3 110.955 177.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 C--O 1.25 1.095 0 N-CA-C 103.811 -2.663 . . . . 9.3 103.811 166.904 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 105.014 -2.217 . . . . 6.43 105.014 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.14 -164.61 5.94 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 108.261 -1.936 . . . . 2.66 108.261 136.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.415 ' OD2' ' NZ ' ' A' ' 47' ' ' LYS . 34.0 t0 72.35 166.06 0.3 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.86 1.664 . . . . 4.56 111.164 -178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.2 75.73 0.08 OUTLIER Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.408 -1.477 . . . . 2.97 109.408 -172.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.3 m -78.92 59.39 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.45 0.7 . . . . 2.7 112.196 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.68 129.4 34.95 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.345 -0.847 . . . . 2.57 110.049 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -92.94 105.46 17.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.741 1.217 . . . . 2.49 107.92 168.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.6 127.44 40.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.287 -1.375 . . . . 1.51 107.287 171.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.44 100.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.169 -1.789 . . . . 1.02 106.169 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.52 71.42 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.994 1.718 . . . . 0.64 107.995 -173.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -74.82 136.92 41.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.035 -1.468 . . . . 5.35 107.035 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.28 -42.53 1.91 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.573 -1.011 . . . . 0.81 110.573 -167.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.51 130.65 39.99 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.374 1.087 . . . . 1.45 108.919 -174.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 t -123.57 -41.52 2.26 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.968 1.099 . . . . 2.26 113.968 -155.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.2 p -138.65 175.46 9.54 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 119.498 1.044 . . . . 1.19 111.85 -168.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.97 -40.3 10.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.19 1.396 . . . . 0.81 112.222 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -55.0 -50.15 69.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.339 0.59 . . . . 2.48 110.006 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.48 -40.28 89.22 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.894 -1.129 . . . . 0.71 109.93 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.6 t -52.34 -61.58 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 108.733 -0.84 . . . . 0.63 108.733 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.284 1.0 OUTLIER -69.58 -30.39 68.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 119.999 -0.681 . . . . 1.02 112.137 -171.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -63.3 -47.1 83.72 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.804 0.729 . . . . 4.15 109.999 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.4 mt -56.81 -62.02 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.872 -0.788 . . . . 0.99 108.872 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -56.54 -52.87 63.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.225 -0.287 . . . . 2.45 110.225 -171.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.6 t -57.85 -55.25 37.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.658 0.266 . . . . 1.51 110.782 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 t -71.12 -32.76 69.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.563 -0.711 . . . . 1.62 112.478 -169.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -70.94 -51.98 22.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.574 0.624 . . . . 1.92 109.66 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.2 m -70.59 70.49 0.45 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.174 0.99 . . . . 2.83 110.978 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -175.38 -35.08 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.88 2.472 . . . . 3.77 110.091 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.656 ' NE2' HD12 ' A' ' 32' ' ' ILE . 3.8 p80 -65.34 136.55 56.68 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.31 0.959 . . . . 1.89 109.828 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -51.45 138.7 21.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.702 -0.481 . . . . 6.1 109.702 176.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.37 -31.46 8.28 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.338 -0.701 . . . . 0.98 112.74 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.656 HD12 ' NE2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -78.21 136.86 23.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 107.488 -1.301 . . . . 2.42 107.488 167.712 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 pp -103.42 -35.76 8.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.475 0.71 . . . . 2.45 110.396 175.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -157.35 163.66 38.4 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.179 -1.045 . . . . 2.42 108.179 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.1 m -139.62 163.6 32.13 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.516 -1.29 . . . . 2.63 107.516 161.272 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.2 t -148.17 145.43 28.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.679 -0.808 . . . . 2.35 108.823 142.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.59 137.59 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.12 0.968 . . . . 1.94 111.277 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.41 134.33 55.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.158 0.983 . . . . 0.76 110.702 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.19 -41.57 99.21 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.154 1.382 . . . . 2.0 111.1 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.82 -37.87 20.54 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.032 1.333 . . . . 1.33 113.261 -166.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -130.16 24.56 5.23 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.231 1.012 . . . . 2.7 110.535 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 m120 35.68 48.28 0.45 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.329 2.252 . . . . 1.75 111.769 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -106.68 135.14 48.73 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.53 -0.545 . . . . 1.95 109.53 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -110.48 114.81 28.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.39 -1.337 . . . . 0.67 107.39 168.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -89.95 105.0 17.51 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.014 -2.588 . . . . 2.16 104.014 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.45 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.5 mp -97.55 137.03 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.317 -1.734 . . . . 1.34 106.317 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' NZ ' ' OD2' ' A' ' 3' ' ' ASP . 7.2 mtpm? -118.05 126.77 52.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.394 -1.336 . . . . 2.76 107.394 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -153.56 154.61 34.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.095 0.558 . . . . 2.6 110.572 -165.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -69.69 144.96 94.43 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 108.939 -0.763 . . . . 4.98 108.939 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.35 24.79 0.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.259 2.639 . . . . 1.44 111.432 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -113.02 -58.66 2.13 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.847 0.859 . . . . 3.55 109.969 -164.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 pt -95.42 -50.15 11.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.528 0.731 . . . . 2.14 110.295 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 tp -91.27 151.68 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.151 -1.055 . . . . 1.19 108.151 -173.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.56 169.07 23.62 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.643 -0.983 . . . . 0.6 110.643 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -50.09 -42.48 45.95 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.585 2.856 . . . . 0.79 110.73 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -38.0 -51.06 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.373 1.469 . . . . 9.35 111.925 173.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -71.67 -49.78 36.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.587 -0.894 . . . . 2.4 108.587 -166.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.58 -47.31 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 114.884 -1.053 . . . . 1.45 108.374 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.0 mt -58.17 -53.24 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 109.746 -0.465 . . . . 0.66 109.746 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -56.72 -41.34 77.27 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 121.64 0.733 . . . . 3.33 109.442 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.4 m -61.42 -54.35 44.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.823 -0.626 . . . . 0.67 110.583 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 mm -63.02 -41.6 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 121.367 -0.833 . . . . 1.65 110.501 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.56 -46.47 77.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.684 0.393 . . . . 3.31 109.992 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -61.43 -39.27 90.18 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.287 -0.387 . . . . 1.55 111.586 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.47 -35.67 81.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.835 0.743 . . . . 1.02 110.848 173.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.78 40.54 0.99 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.051 0.834 . . . . 0.81 112.409 170.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -131.94 162.02 31.69 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 107.131 -1.433 . . . . 1.83 107.131 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -99.48 109.1 53.84 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 119.001 0.819 . . . . 2.79 109.363 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.05 88.34 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.753 2.969 . . . . 1.0 110.54 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.15 96.78 5.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.866 -1.161 . . . . 1.88 107.866 -178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pp -59.98 107.34 0.61 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.195 0.907 . . . . 2.34 110.481 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.2 t -114.33 -68.08 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 109.231 -0.655 . . . . 2.64 109.231 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.08 61.08 2.89 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.251 -1.018 . . . . 4.68 108.251 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 74' ' ' ILE . 2.7 mp 63.06 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 126.013 1.725 . . . . 6.54 110.781 -171.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 C--O 1.253 1.262 0 N-CA-C 102.791 -3.04 . . . . 10.12 102.791 168.877 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mmt . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 119.083 -0.484 . . . . 6.17 112.279 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.15 63.63 2.91 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.927 -0.869 . . . . 4.11 110.927 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -160.35 170.05 21.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.011 1.724 . . . . 3.74 106.737 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.05 -175.27 22.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.101 1.334 . . . . 2.78 111.252 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -155.76 148.03 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.662 -0.866 . . . . 3.5 108.662 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.86 156.68 39.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.849 -1.167 . . . . 3.55 107.849 165.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -126.79 139.15 53.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.335 1.054 . . . . 2.93 109.76 -175.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.41 143.43 31.62 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.369 1.068 . . . . 1.46 108.189 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.07 123.08 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.962 -1.866 . . . . 1.08 105.962 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 m -106.59 74.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 106.656 -1.609 . . . . 0.72 106.656 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.4 ptt85 -76.1 129.59 37.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.305 -1.368 . . . . 5.02 107.305 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.85 -48.54 0.95 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.427 -1.069 . . . . 0.79 110.427 -165.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -73.57 144.78 45.91 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.847 1.323 . . . . 1.47 111.287 -174.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -148.16 -1.6 0.55 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.775 1.398 . . . . 2.33 114.775 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.62 168.51 25.88 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.554 1.525 . . . . 1.25 110.165 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.91 -42.71 13.09 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.517 1.527 . . . . 1.0 112.259 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.3 m -43.52 -51.08 6.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.681 1.193 . . . . 1.66 111.401 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -71.06 -41.6 70.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 122.993 0.517 . . . . 0.79 111.83 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.3 t -50.79 -59.0 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.232 -1.025 . . . . 0.82 108.232 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -68.36 -30.34 69.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.139 -0.937 . . . . 1.13 111.155 -176.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -53.61 -43.54 68.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 119.271 0.941 . . . . 4.86 110.313 170.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.1 mt -71.82 -80.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 118.751 0.705 . . . . 0.75 109.606 169.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -62.4 -43.69 98.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.709 -0.619 . . . . 2.21 112.542 -153.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -63.08 -28.74 70.29 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.543 0.571 . . . . 2.93 112.543 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 t -71.79 -53.19 14.13 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.376 0.989 . . . . 1.1 110.399 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.04 -46.39 65.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.152 0.981 . . . . 1.8 111.278 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.3 p -67.13 64.01 0.06 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.142 1.377 . . . . 1.65 112.114 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -160.05 -50.02 0.05 Allowed 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 128.406 2.682 . . . . 6.47 108.929 -175.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -68.02 138.54 55.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.151 -0.619 . . . . 2.32 109.789 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -56.66 149.41 17.82 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.035 0.445 . . . . 6.12 109.813 175.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.07 -24.38 16.2 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-O 118.339 -1.256 . . . . 0.79 112.764 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.532 HD11 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -76.95 120.46 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 120.128 1.964 . . . . 1.75 108.221 171.943 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.8 mt -81.78 -52.99 6.57 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.193 -1.04 . . . . 2.14 108.193 170.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -157.84 147.61 20.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.586 -0.894 . . . . 3.57 108.586 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.3 t -117.97 144.67 45.31 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 105.751 -1.944 . . . . 2.24 105.751 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.4 t -147.21 151.03 36.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 118.159 -1.416 . . . . 2.74 110.441 153.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.487 HG12 ' CB ' ' A' ' 44' ' ' ALA . 3.5 m -131.8 133.19 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 124.532 1.145 . . . . 1.76 110.509 -171.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.47 132.34 55.77 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.695 0.628 . . . . 0.83 112.695 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.505 HD22 ' H ' ' A' ' 39' ' ' LEU . 2.0 mm? -65.56 -45.05 84.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.232 1.413 . . . . 3.51 111.606 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.04 -30.08 23.99 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.712 0.805 . . . . 1.41 112.932 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -114.36 2.13 14.63 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.495 1.518 . . . . 2.46 111.705 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.3 m120 41.16 43.59 1.97 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.465 2.306 . . . . 2.06 110.881 -172.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.57 140.3 49.42 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 122.691 0.396 . . . . 1.74 111.34 -166.334 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.487 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -109.41 139.52 44.27 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.179 1.792 . . . . 0.97 108.929 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -104.38 137.43 42.27 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.726 -1.953 . . . . 3.64 105.726 156.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.532 HG23 HD11 ' A' ' 32' ' ' ILE . 4.2 mp -125.8 112.88 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.445 -1.687 . . . . 1.35 106.445 174.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -83.7 68.27 9.8 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.373 -1.343 . . . . 2.91 107.373 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -90.83 140.03 30.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.226 -0.443 . . . . 2.87 110.705 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.2 106.5 0.73 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.19 1.396 . . . . 2.54 108.591 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.5 61.31 7.99 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.299 2.666 . . . . 2.3 110.421 -166.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -163.98 -60.47 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.01 0.924 . . . . 4.41 109.805 -169.227 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 pt -82.94 -26.88 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 122.768 0.427 . . . . 2.62 111.991 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 tp -131.12 140.26 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.261 -1.755 . . . . 1.27 106.261 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.32 176.34 16.08 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 121.781 0.656 . . . . 0.89 112.156 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.04 -41.59 51.2 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.168 2.579 . . . . 1.15 110.52 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.59 -46.05 90.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.309 0.244 . . . . 7.48 110.602 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.15 -51.31 69.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.394 -0.595 . . . . 3.26 109.394 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 mm -55.14 -48.92 75.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 122.779 0.432 . . . . 1.81 111.533 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.1 mt -53.14 -57.02 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.037 -0.727 . . . . 0.98 109.037 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -65.89 -33.92 76.95 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.806 -0.559 . . . . 3.49 111.153 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -57.56 -58.64 7.4 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.34 -0.615 . . . . 1.22 109.34 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.7 mt -65.66 -35.43 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.25 -0.906 . . . . 1.21 111.293 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.13 -51.63 61.32 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.437 -0.579 . . . . 3.4 109.437 168.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 m -57.65 -38.22 74.69 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.025 -0.422 . . . . 2.23 111.922 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.4 mt -67.94 -10.63 54.94 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.918 0.71 . . . . 1.51 112.918 174.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.98 60.09 3.0 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.673 -0.971 . . . . 1.62 110.673 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -141.5 171.48 14.0 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 106.826 -1.546 . . . . 2.11 106.826 155.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -101.46 100.96 15.23 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 108.837 -0.801 . . . . 2.51 108.837 172.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.21 145.11 59.25 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 N-CA-C 108.238 -1.485 . . . . 1.94 108.238 166.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -150.8 110.97 4.14 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.464 -1.68 . . . . 1.78 106.464 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.02 142.41 53.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.28 0.562 . . . . 3.72 109.502 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.89 -33.89 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.836 1.254 . . . . 2.57 111.133 172.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -74.58 67.21 1.5 Allowed 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.309 -0.869 . . . . 6.2 110.543 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 73.67 128.88 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.943 2.097 . . . . 9.34 109.689 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 C--O 1.252 1.213 0 C-N-CA 126.824 2.05 . . . . 12.11 113.789 -171.38 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ptm . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 106.526 -1.657 . . . . 8.83 106.526 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.04 -177.9 26.56 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 108.313 -1.915 . . . . 2.84 108.313 155.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 30.3 t70 -179.83 -162.34 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.021 2.929 . . . . 3.77 104.031 171.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' A' ' 3' ' ' ASP . . . 153.34 159.13 8.92 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 107.671 -2.172 . . . . 2.63 107.671 -173.225 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.2 m -134.36 55.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.239 1.016 . . . . 3.6 108.444 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -79.14 108.99 13.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.606 -1.257 . . . . 2.8 107.606 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -93.27 83.23 4.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 113.601 -1.636 . . . . 3.0 107.102 166.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.76 129.67 35.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.569 -1.641 . . . . 1.47 106.569 174.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.89 119.97 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.738 -1.949 . . . . 1.11 105.738 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.78 84.39 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 128.124 2.57 . . . . 0.77 108.331 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.79 140.16 39.41 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 108.872 -0.788 . . . . 4.61 108.872 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.84 -19.78 8.3 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.881 0.753 . . . . 0.69 112.084 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.5 mtp -62.15 150.7 37.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.572 1.186 . . . . 1.46 109.691 175.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -139.33 -39.21 0.48 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.131 0.973 . . . . 2.65 111.771 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.1 p -145.48 173.5 11.97 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.212 0.914 . . . . 1.63 111.405 -169.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.58 -39.71 3.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.048 1.739 . . . . 1.39 112.563 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.0 m -49.86 -50.87 44.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.204 0.602 . . . . 1.54 111.017 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.1 m -65.1 -41.11 95.28 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.196 0.598 . . . . 0.72 110.172 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 t -55.27 -61.76 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.458 -0.942 . . . . 0.85 108.458 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.2 -28.93 67.69 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 118.866 -0.588 . . . . 1.52 111.533 -173.755 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -56.81 -56.61 19.34 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.462 -0.94 . . . . 4.16 108.462 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.55 -59.63 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 109.158 -0.682 . . . . 0.8 109.158 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.67 -45.3 94.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.766 -0.635 . . . . 2.59 111.927 -169.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m -61.14 -47.45 86.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.793 0.724 . . . . 1.46 111.066 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.3 t -58.82 -42.57 89.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.944 -0.472 . . . . 1.76 110.094 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.35 -48.29 61.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.425 0.69 . . . . 2.03 111.842 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.3 p -56.49 -32.11 64.71 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.868 1.213 . . . . 2.44 111.62 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -54.51 -36.26 64.04 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.824 -0.548 . . . . 4.78 112.057 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -69.84 96.67 1.02 Allowed 'General case' 0 C--O 1.225 -0.234 0 O-C-N 121.325 -0.859 . . . . 2.92 109.1 171.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -41.42 -40.02 1.64 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.914 1.285 . . . . 7.18 114.099 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.0 -2.19 70.8 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.072 -0.849 . . . . 0.99 114.211 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.52 121.8 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.865 -1.532 . . . . 2.33 106.865 167.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.7 mt -79.9 -46.74 16.24 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.129 0.971 . . . . 2.34 108.882 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -155.96 129.03 8.05 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.387 0.539 . . . . 2.95 110.435 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.6 p -104.27 154.31 19.95 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.535 0.734 . . . . 2.88 109.664 169.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -151.5 110.33 3.85 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.603 -1.258 . . . . 1.98 107.603 155.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.64 157.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 118.134 0.425 . . . . 1.82 110.652 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.92 134.5 14.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.602 -0.687 . . . . 0.87 110.764 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.09 -32.15 71.38 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.941 0.896 . . . . 1.75 110.289 175.468 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.97 -37.8 2.01 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.005 1.722 . . . . 1.36 113.565 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.9 t -140.83 37.87 1.8 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 121.507 0.67 . . . . 2.45 109.913 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 m120 35.45 58.84 0.82 Allowed 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.002 1.721 . . . . 2.4 110.879 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -121.87 142.83 49.85 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 122.819 0.448 . . . . 2.32 110.605 -171.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.84 105.27 10.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.8 1.24 . . . . 0.75 108.843 167.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -79.8 108.68 13.55 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 104.356 -2.461 . . . . 3.02 104.356 169.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.8 mt -119.99 111.4 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 106.749 -1.574 . . . . 1.07 106.749 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 3' ' ' ASP . 3.7 mtpm? -103.12 109.7 21.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.051 -1.833 . . . . 2.98 106.051 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -137.29 162.74 32.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.881 1.672 . . . . 2.22 109.999 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -83.25 112.76 41.45 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 107.162 -1.422 . . . . 3.24 107.162 171.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.64 68.38 8.31 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.975 2.45 . . . . 1.73 110.852 -170.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.68 -92.66 0.17 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.672 1.189 . . . . 3.8 109.363 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.97 -30.3 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 N-CA-C 112.873 0.694 . . . . 1.99 112.873 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.72 125.24 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.52 -1.659 . . . . 1.81 106.52 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.98 -179.41 19.04 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.789 1.185 . . . . 0.84 111.424 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -59.52 -39.82 71.93 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.643 2.228 . . . . 0.72 110.464 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -56.51 -49.61 74.24 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.754 0.421 . . . . 5.41 111.683 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -48.49 81.46 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.413 -0.588 . . . . 2.26 109.413 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.5 mt -51.28 -56.15 5.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 108.776 -0.824 . . . . 1.46 108.776 173.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.6 mt -54.52 -52.68 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 110.005 -0.368 . . . . 0.49 110.005 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -56.47 -42.73 78.73 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 121.53 0.681 . . . . 2.79 109.221 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.7 m -63.36 -50.34 70.31 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.076 -0.511 . . . . 0.86 110.782 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.8 mm -61.94 -42.74 95.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.445 -0.784 . . . . 1.55 110.41 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -56.23 -44.6 79.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.692 0.397 . . . . 3.23 110.099 173.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 m -61.24 -40.29 93.5 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.083 -0.386 . . . . 1.6 111.837 176.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.98 -41.26 96.11 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.72 0.691 . . . . 1.14 110.585 172.615 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.81 44.98 0.73 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.367 0.984 . . . . 0.75 111.587 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -131.74 162.78 29.66 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.552 -1.277 . . . . 2.03 107.552 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -95.03 101.51 7.38 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 117.61 -1.186 . . . . 2.66 109.861 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -77.74 137.73 16.33 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.103 1.869 . . . . 1.33 108.823 172.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 t -154.79 109.29 2.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.706 -0.85 . . . . 2.05 108.706 -171.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.42 66.02 1.78 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.784 0.834 . . . . 2.11 110.375 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.44 -38.91 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.879 0.872 . . . . 2.67 109.766 177.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.44 135.84 49.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.078 -1.453 . . . . 5.51 107.078 163.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.35 118.64 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 105.113 -2.18 . . . . 9.8 105.113 172.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 C--O 1.253 1.265 0 N-CA-C 108.765 -0.828 . . . . 12.14 108.765 -151.318 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 107.859 -1.164 . . . . 8.56 107.859 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.51 156.63 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.543 -1.023 . . . . 2.88 110.543 -169.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.78 114.12 2.15 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.709 0.804 . . . . 3.44 111.251 -172.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.55 81.47 0.3 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 108.029 -2.028 . . . . 2.69 108.029 163.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.33 127.9 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.114 -0.699 . . . . 2.5 109.114 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 135.66 29.65 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.926 0.49 . . . . 2.43 109.833 169.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -90.85 93.01 9.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.442 1.497 . . . . 3.13 107.046 165.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.2 121.85 34.98 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 107.997 -1.112 . . . . 1.66 107.997 173.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.63 111.09 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.337 -1.357 . . . . 1.45 107.337 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -94.17 92.16 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.252 1.421 . . . . 0.64 108.326 -168.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -77.71 137.29 38.41 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.433 -0.951 . . . . 5.84 108.433 -174.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.58 -53.15 0.77 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.499 -1.041 . . . . 1.14 110.499 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -61.58 143.7 55.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 122.938 0.495 . . . . 1.7 111.756 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -157.28 14.8 0.25 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.891 1.071 . . . . 2.5 113.891 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 p -162.85 161.04 25.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.761 1.164 . . . . 1.74 109.772 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -39.64 5.56 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.701 1.6 . . . . 1.06 111.449 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -36.16 -47.63 0.57 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.512 2.325 . . . . 2.56 113.13 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.0 m -73.85 -52.46 12.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.151 0.981 . . . . 1.0 111.685 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.5 t -45.99 -58.13 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 126.179 1.791 . . . . 0.81 109.679 -166.047 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -61.47 -32.51 72.51 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.21 -1.359 . . . . 1.92 110.794 -174.277 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -71.23 -47.3 58.13 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.852 -0.796 . . . . 4.71 108.852 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 99.1 mt -54.05 -58.88 2.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.053 -0.721 . . . . 0.98 109.053 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -61.97 -47.77 83.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.531 -0.271 . . . . 2.13 111.196 -174.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.6 m -55.49 -58.22 8.65 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.201 0.455 . . . . 1.57 110.517 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 t -49.31 -49.89 41.83 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.951 1.3 . . . . 1.3 110.698 -177.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.94 -51.23 57.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 119.161 -0.447 . . . . 2.53 111.721 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.4 p -55.4 -28.35 53.54 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.159 0.436 . . . . 1.91 111.635 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -58.17 -40.85 82.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.424 0.557 . . . . 4.99 111.909 174.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -79.28 120.0 23.14 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.899 0.857 . . . . 2.37 110.142 -169.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -57.84 157.68 7.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.111 -0.7 . . . . 7.47 109.111 170.753 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.3 -15.05 25.37 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 117.896 -1.502 . . . . 0.81 112.785 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.51 125.05 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 119.777 1.789 . . . . 1.66 106.536 154.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.2 mt -80.44 -43.46 20.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.675 -1.231 . . . . 2.58 107.675 169.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -155.63 155.95 34.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.487 -0.561 . . . . 2.5 109.487 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 p -131.32 158.18 41.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 106.955 -1.498 . . . . 2.41 106.955 156.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -150.79 145.2 25.57 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.028 -1.101 . . . . 2.39 108.028 139.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 p -112.57 148.29 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.168 0.987 . . . . 1.91 110.653 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.54 136.11 35.73 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.14 0.576 . . . . 0.69 110.943 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.2 mt -65.82 -36.12 82.6 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.043 1.337 . . . . 2.35 110.091 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.3 -39.06 1.3 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.188 1.795 . . . . 1.54 113.88 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 t -140.96 35.68 1.75 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 122.154 0.978 . . . . 2.29 109.644 172.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 m120 36.06 57.36 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.984 2.514 . . . . 2.03 111.917 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.64 153.73 51.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 121.926 -0.484 . . . . 3.22 111.994 -170.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.556 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -116.82 117.05 28.67 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.058 1.743 . . . . 0.7 108.657 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -85.08 101.45 12.44 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 103.46 -2.792 . . . . 2.89 103.46 169.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.556 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -99.22 143.91 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.026 -1.472 . . . . 1.24 107.026 170.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -126.8 112.5 15.45 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 106.092 -1.818 . . . . 2.5 106.092 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -127.48 173.49 9.8 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.369 0.668 . . . . 2.26 111.254 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -96.4 101.33 8.57 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.411 1.085 . . . . 2.43 109.275 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.54 58.08 6.6 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.663 2.909 . . . . 1.48 113.029 -169.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.13 -63.75 0.4 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.027 1.731 . . . . 4.12 107.987 169.054 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.0 pt -65.28 -26.83 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.977 0.911 . . . . 2.82 112.432 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 tt -143.96 150.67 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.07 -1.085 . . . . 1.36 108.07 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -114.43 -176.26 18.91 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.187 -0.765 . . . . 0.92 111.187 -174.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.16 -38.72 20.5 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.337 2.024 . . . . 0.86 109.795 172.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -47.52 -49.59 25.71 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.755 1.222 . . . . 5.98 111.382 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.89 -54.09 50.27 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.227 0.611 . . . . 2.54 110.124 -174.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.6 mt -53.14 -52.28 31.55 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 N-CA-C 108.555 -0.905 . . . . 1.42 108.555 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mt -55.54 -53.28 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.89 -0.595 . . . . 0.9 110.277 -174.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -67.84 -31.87 72.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.626 0.648 . . . . 6.19 110.362 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.7 m -59.29 -46.4 88.65 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.532 -0.544 . . . . 0.8 109.532 172.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.57 -36.98 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.27 -0.894 . . . . 1.15 111.315 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -55.22 -43.96 74.97 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.507 -0.746 . . . . 2.86 109.882 169.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.7 m -60.93 -38.81 87.08 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.295 -0.253 . . . . 1.5 111.576 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.24 -40.27 95.67 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.225 0.466 . . . . 1.2 110.831 171.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.8 45.02 0.85 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 124.526 1.06 . . . . 1.01 111.752 173.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -131.89 163.06 29.15 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.748 -0.834 . . . . 2.02 108.748 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -99.12 100.7 10.62 Favored Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 124.576 1.15 . . . . 4.5 110.539 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.71 81.77 2.59 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.815 3.01 . . . . 1.39 111.107 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.2 m -78.66 109.91 13.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.402 -0.811 . . . . 1.41 109.564 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.56 58.47 0.59 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.488 0.715 . . . . 2.12 111.76 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 p -106.56 51.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.605 1.562 . . . . 3.08 108.67 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -46.29 -56.27 6.03 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.528 1.531 . . . . 6.06 112.121 -176.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.4 ' H ' ' HG2' ' A' ' 73' ' ' LYS . 18.6 tt -165.51 127.33 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 130.157 3.383 . . . . 7.47 103.24 160.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 C--O 1.251 1.145 0 C-N-CA 123.208 0.603 . . . . 9.6 109.489 -161.723 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.436 ' H2 ' ' CG ' ' A' ' 49' ' ' ASP . 23.3 ttt . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 112.407 0.521 . . . . 6.35 112.407 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.52 156.47 16.72 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.835 -0.541 . . . . 2.56 112.371 162.176 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -71.26 101.58 2.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.523 1.129 . . . . 3.79 111.088 -176.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.04 171.53 12.18 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.299 -1.12 . . . . 1.96 110.299 166.535 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.4 t -140.89 97.87 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.65 -1.241 . . . . 2.77 107.65 178.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.95 121.38 40.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.519 0.676 . . . . 2.79 109.566 178.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -91.1 90.75 7.96 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.784 2.034 . . . . 4.22 107.348 177.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -82.35 106.77 14.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.15 -1.796 . . . . 2.57 106.15 172.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 t -78.49 101.37 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.438 -1.69 . . . . 1.38 106.438 -176.104 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 m -89.44 88.3 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.997 1.319 . . . . 0.88 109.912 -164.69 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -77.8 96.57 4.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.652 -1.61 . . . . 8.0 106.652 -176.196 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.69 -38.83 0.35 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.878 -0.957 . . . . 0.63 112.527 177.902 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -70.56 162.26 29.19 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.126 1.463 . . . . 1.34 111.218 -173.498 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -145.09 -37.41 0.28 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.435 0.902 . . . . 2.39 113.435 -170.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 p -141.09 173.83 11.11 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 119.789 1.177 . . . . 1.69 111.705 -172.773 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.78 -41.8 15.96 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.025 1.33 . . . . 1.18 111.799 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.7 m -57.25 -38.46 73.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.825 0.45 . . . . 1.82 111.665 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.0 m -71.07 -52.63 18.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.264 0.484 . . . . 0.73 110.176 173.208 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.8 t -44.2 -58.44 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 124.753 1.221 . . . . 0.74 109.212 -176.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.6 -22.24 63.52 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.515 -0.766 . . . . 1.44 112.368 -174.317 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -68.48 -50.87 49.16 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 107.413 -1.328 . . . . 5.29 107.413 173.361 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mt -56.54 -57.01 10.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 109.104 -0.702 . . . . 0.76 109.104 177.266 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.98 -54.66 44.14 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.423 0.556 . . . . 2.18 111.488 -174.572 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.7 t -62.33 -39.1 91.96 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.502 0.321 . . . . 1.91 111.007 -178.088 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -63.5 -53.42 52.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.141 -0.688 . . . . 1.41 109.141 177.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -47.6 -46.21 28.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.662 1.185 . . . . 1.87 111.528 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.43 -15.16 2.4 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.491 1.293 . . . . 2.66 114.491 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -56.59 -37.02 70.05 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.904 1.229 . . . . 5.21 111.288 170.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -76.72 100.78 5.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.596 -0.891 . . . . 3.07 108.596 -176.383 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -50.92 -30.21 14.16 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.204 0.816 . . . . 6.79 113.204 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.81 -20.64 70.59 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.95 -0.916 . . . . 1.01 113.677 177.424 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.09 124.87 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 118.682 1.241 . . . . 2.0 108.393 178.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.5 mt -94.46 -36.93 11.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.591 1.556 . . . . 2.18 109.507 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -155.7 125.59 6.52 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.8 0.727 . . . . 2.07 111.048 178.533 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.84 144.79 34.55 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.528 1.131 . . . . 2.99 108.732 167.136 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 m -151.48 143.06 23.61 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.901 -1.518 . . . . 2.21 106.901 152.382 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 m -127.18 136.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.29 0.496 . . . . 1.7 110.223 178.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.82 131.59 54.13 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.835 0.854 . . . . 0.77 111.691 -174.158 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.63 -43.47 80.3 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.296 1.838 . . . . 2.8 111.414 -175.761 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.09 -46.06 33.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.166 0.587 . . . . 1.18 111.453 -179.236 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -82.92 -25.16 32.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.671 1.189 . . . . 3.39 111.839 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 41.69 66.9 0.62 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.523 1.529 . . . . 3.37 109.609 -151.377 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.41 141.3 33.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.504 -1.226 . . . . 1.74 110.453 -177.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.28 124.08 49.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.039 2.136 . . . . 0.74 108.31 174.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -98.16 106.99 19.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.249 -2.871 . . . . 2.08 103.249 174.711 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.3 mp -102.25 127.83 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.546 -1.65 . . . . 1.4 106.546 175.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -112.03 114.43 27.3 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.631 -1.248 . . . . 2.23 107.631 167.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -130.9 163.47 27.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.566 1.546 . . . . 2.02 111.47 176.369 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.436 ' CG ' ' H2 ' ' A' ' 1' ' ' MET . 14.5 t70 -87.98 129.32 50.63 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.239 1.016 . . . . 3.93 110.548 175.239 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -59.2 -58.76 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.781 2.321 . . . . 2.36 115.294 -165.304 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -78.07 37.27 0.25 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.168 1.349 . . . . 3.84 113.911 -165.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.63 -52.63 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.241 1.416 . . . . 3.67 109.111 170.235 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.19 144.83 33.84 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 122.624 0.37 . . . . 1.25 110.958 -171.41 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.47 -176.76 22.56 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.326 -1.11 . . . . 0.81 110.326 176.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.0 -39.74 18.23 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.189 1.926 . . . . 0.97 110.11 174.56 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -53.38 -49.43 67.21 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.004 0.922 . . . . 6.69 111.989 -176.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.12 -52.0 38.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 122.491 1.139 . . . . 2.83 109.464 -178.706 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.2 mt -65.55 -52.29 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 114.554 -1.203 . . . . 1.27 109.059 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.2 mt -48.08 -54.25 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.765 0.826 . . . . 0.69 110.222 -177.07 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -65.86 -35.6 81.11 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 119.809 -0.756 . . . . 5.36 110.501 -176.014 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.8 m -63.13 -46.91 85.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 122.1 -0.375 . . . . 0.98 110.582 178.267 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.6 -40.79 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.49 -0.756 . . . . 1.06 109.882 178.821 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -53.31 -38.44 63.17 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.539 -0.725 . . . . 5.24 111.207 170.264 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -64.44 -22.54 66.99 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.935 0.717 . . . . 1.6 112.935 176.038 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.6 mt -78.74 -43.61 25.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.982 0.81 . . . . 1.19 109.243 168.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.21 49.11 0.37 Allowed Glycine 0 C--N 1.338 0.659 0 C-N-CA 124.467 1.032 . . . . 0.93 112.173 169.714 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.28 134.73 26.19 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 117.419 -1.277 . . . . 1.99 108.014 175.888 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -78.86 112.02 24.15 Favored Pre-proline 0 C--N 1.34 0.156 0 CA-C-N 119.49 1.041 . . . . 5.48 108.893 -170.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -89.55 78.98 0.87 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.38 2.72 . . . . 1.39 110.066 -171.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.39 115.53 20.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.547 -0.721 . . . . 1.78 109.633 -170.203 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.6 mt -53.61 111.52 0.74 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.996 0.816 . . . . 3.41 110.724 174.95 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.05 -37.62 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 118.896 0.771 . . . . 4.57 111.89 176.945 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -140.02 159.36 42.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.033 1.333 . . . . 5.36 107.81 -176.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.11 123.24 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.369 -2.456 . . . . 10.61 104.369 167.369 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.4 mp0 . . . . . 0 CA--C 1.559 1.305 1 CA-C-O 80.719 -18.753 . . . . 11.84 105.882 -171.308 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 107.476 -1.305 . . . . 7.05 107.476 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.24 135.88 29.97 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 105.264 -3.134 . . . . 3.52 105.264 131.593 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.7 p30 175.46 172.74 0.29 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 127.978 2.511 . . . . 4.48 106.508 176.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.89 155.74 9.97 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 106.663 -2.575 . . . . 1.79 106.663 -173.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -143.25 143.98 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.836 -1.172 . . . . 2.84 107.836 -175.152 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -149.25 163.5 37.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.256 -0.646 . . . . 3.4 109.256 162.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -120.03 145.41 46.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.217 -1.031 . . . . 2.35 108.217 168.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.07 130.13 28.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.759 -1.2 . . . . 1.44 107.759 177.47 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.3 t -79.67 104.72 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.901 -1.889 . . . . 1.07 105.901 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.05 89.22 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.428 1.491 . . . . 0.65 108.216 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -75.57 131.4 39.99 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 107.763 -1.199 . . . . 5.23 107.763 -170.296 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.05 -43.13 1.39 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.088 0.852 . . . . 0.71 111.404 177.054 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.46 132.58 40.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.454 1.127 . . . . 1.37 108.633 -175.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 t -154.84 25.08 0.44 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.97 0.73 . . . . 2.69 112.97 -169.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.33 156.87 19.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.523 0.602 . . . . 1.39 109.629 178.236 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.53 -39.43 16.29 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.505 1.522 . . . . 0.89 111.987 -176.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.6 t -47.26 -54.23 11.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.683 0.754 . . . . 2.21 110.143 172.772 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.263 57.7 m -73.16 -33.56 65.55 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.355 -1.465 . . . . 1.19 112.151 -176.668 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.8 t -50.37 -61.33 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 108.666 -0.864 . . . . 0.69 108.666 174.084 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -69.84 -29.56 66.84 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.175 -0.921 . . . . 1.12 111.787 -174.098 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -62.0 -50.72 70.92 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.28 0.945 . . . . 4.41 109.655 173.503 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 mt -58.29 -57.76 9.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 119.218 0.917 . . . . 0.65 109.047 178.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.05 -54.14 46.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.157 0.435 . . . . 2.47 110.895 -173.515 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -56.98 -52.99 63.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.865 0.466 . . . . 1.54 110.437 179.197 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.6 t -57.34 -54.97 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.638 0.375 . . . . 0.97 110.756 -177.458 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.51 -32.98 71.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.534 -0.729 . . . . 2.06 111.365 -174.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.9 m -53.66 -19.97 4.71 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 112.938 0.718 . . . . 2.54 112.938 173.198 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -30.28 59.73 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.531 -1.355 . . . . 5.72 112.113 171.385 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -68.86 101.47 1.36 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.577 -0.897 . . . . 2.82 108.577 169.319 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -49.45 -33.25 13.68 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 111.885 0.328 . . . . 5.36 111.885 171.209 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.72 -11.23 77.5 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.815 -0.992 . . . . 0.84 113.796 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.16 129.67 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 119.699 1.75 . . . . 2.09 107.431 168.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 pp -99.74 -26.05 14.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.862 0.465 . . . . 2.31 110.745 175.662 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -156.11 149.94 25.1 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.88 0.764 . . . . 2.68 111.224 172.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.1 m -130.33 145.4 51.78 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 126.178 1.791 . . . . 2.57 107.553 174.384 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 m -153.34 135.22 14.62 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 107.808 -1.182 . . . . 1.84 107.808 152.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.86 151.07 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.987 0.812 . . . . 1.86 110.479 173.586 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.61 132.57 37.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.533 0.682 . . . . 0.79 110.779 176.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.9 -29.44 66.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.035 -0.984 . . . . 1.75 110.732 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.72 -34.97 13.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.49 1.116 . . . . 1.09 112.927 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 p -122.03 13.49 10.55 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.889 0.876 . . . . 2.24 111.299 175.14 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.7 m120 40.15 52.17 2.73 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.243 1.817 . . . . 1.93 110.659 -171.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.09 140.37 45.45 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 122.043 -0.411 . . . . 1.92 111.141 -164.561 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.85 128.22 56.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.026 1.73 . . . . 0.58 109.156 177.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -98.84 121.78 41.23 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 127.847 2.459 . . . . 2.81 105.701 172.297 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mt -123.72 134.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.686 -0.857 . . . . 1.63 108.686 177.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -122.95 130.82 53.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.14 -1.8 . . . . 2.4 106.14 178.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -162.05 171.31 17.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.214 0.45 . . . . 2.51 112.214 -158.731 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.12 100.56 25.48 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.51 1.524 . . . . 2.8 109.437 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.71 -12.79 35.56 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.323 2.682 . . . . 2.37 113.394 -168.549 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -52.97 -39.71 63.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.662 0.664 . . . . 4.63 111.635 176.765 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -120.07 -54.52 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.113 0.565 . . . . 1.9 112.133 -176.246 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.14 116.54 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.851 -1.166 . . . . 1.84 107.851 -172.92 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.71 161.55 16.75 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.523 -1.031 . . . . 0.78 110.523 -177.255 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -51.52 -38.1 63.82 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.995 2.463 . . . . 0.81 110.857 176.36 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -42.87 -52.73 4.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.422 1.089 . . . . 9.48 111.647 172.176 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.18 -40.52 67.86 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.083 -1.01 . . . . 2.5 109.76 -167.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 78.5 mt -52.68 -57.47 4.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 N-CA-C 107.611 -1.255 . . . . 1.55 107.611 170.02 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mt -55.54 -48.91 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 116.039 -0.528 . . . . 0.64 110.136 -174.814 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -55.54 -44.98 77.23 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 122.172 0.986 . . . . 3.54 108.953 179.406 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 m -62.96 -45.72 91.13 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.344 -0.843 . . . . 0.97 110.294 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -70.07 -42.42 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.377 -0.827 . . . . 1.48 110.566 -173.782 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -63.26 -43.18 98.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.907 -0.496 . . . . 3.01 110.138 175.595 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 m -54.54 -44.83 73.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 111.891 0.33 . . . . 1.63 111.891 172.292 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.07 -39.8 91.27 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.822 0.737 . . . . 1.17 111.14 173.575 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.2 41.07 0.92 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.049 0.833 . . . . 0.82 111.655 173.434 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -127.77 161.97 27.72 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.163 -1.051 . . . . 1.8 108.163 170.449 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.4 103.6 14.63 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.133 -0.937 . . . . 2.68 110.015 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.29 77.03 3.97 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.239 2.626 . . . . 1.02 110.699 -176.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -78.66 90.11 4.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.316 -0.994 . . . . 1.69 108.316 -177.012 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.3 pt? -66.1 57.44 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.021 1.728 . . . . 2.61 114.683 -176.259 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.91 92.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.369 1.868 . . . . 3.66 107.543 -175.512 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 101.36 14.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.013 1.325 . . . . 7.14 107.62 177.211 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.0 pt -141.85 177.88 2.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 124.911 1.285 . . . . 9.03 108.53 -178.55 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 C--O 1.256 1.446 0 N-CA-C 105.008 -2.219 . . . . 11.07 105.008 172.802 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mtp . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 108.212 -1.033 . . . . 6.29 108.212 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.97 177.44 14.99 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.447 -1.061 . . . . 2.66 110.447 -168.128 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -94.07 123.98 37.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.748 1.219 . . . . 3.66 109.657 177.09 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.52 145.27 31.44 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 107.902 -2.079 . . . . 2.0 107.902 167.007 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -150.89 129.39 2.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 123.307 0.643 . . . . 2.49 109.783 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mp -136.46 138.67 41.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.029 -0.73 . . . . 2.34 109.029 167.457 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -92.34 93.51 8.66 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.512 -1.292 . . . . 2.7 107.512 163.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mt -80.03 112.25 17.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.797 -1.927 . . . . 2.82 105.797 173.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.2 t -78.97 104.49 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.506 -1.665 . . . . 1.34 106.506 -177.712 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.3 m -79.14 80.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 124.601 1.16 . . . . 0.97 108.516 -172.523 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 -75.91 95.27 3.5 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.524 -1.658 . . . . 4.13 106.524 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.58 -57.41 0.11 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.643 -0.983 . . . . 1.51 110.643 177.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.28 157.45 18.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 117.363 0.582 . . . . 2.13 109.794 -177.697 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 t -154.31 35.82 0.42 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.624 -0.51 . . . . 4.06 109.624 170.892 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.43 137.0 22.76 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.686 0.795 . . . . 2.57 110.193 -170.054 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.69 -43.28 2.8 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.519 1.927 . . . . 1.01 112.002 -177.681 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -35.1 -58.38 0.54 Allowed 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.733 1.613 . . . . 2.03 111.931 170.789 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.2 m -74.52 -27.56 60.59 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.915 -1.116 . . . . 1.44 113.866 -178.296 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.455 HG13 HG13 ' A' ' 37' ' ' VAL . 45.1 t -56.41 -55.68 17.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.895 -1.15 . . . . 0.58 107.895 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -63.58 -32.57 74.08 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.951 -0.568 . . . . 1.11 111.913 -178.684 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -60.01 -54.3 47.6 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.433 -0.951 . . . . 3.96 108.433 173.77 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.3 mt -57.7 -56.43 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.187 -0.672 . . . . 0.8 109.187 -172.525 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -61.03 -50.23 74.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.789 -0.764 . . . . 3.29 111.337 -174.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.3 m -54.11 -50.11 67.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.339 0.59 . . . . 1.58 110.407 177.382 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.4 t -58.19 -41.88 84.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.037 0.935 . . . . 1.32 110.301 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.68 -46.3 69.42 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.59 -0.694 . . . . 2.1 111.849 178.505 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.2 p -53.71 -30.21 42.77 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.806 0.73 . . . . 2.31 112.926 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -58.19 -32.46 68.27 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.24 0.616 . . . . 5.6 112.082 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -73.17 106.66 5.12 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.335 0.971 . . . . 3.03 108.595 171.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -37.38 -58.01 0.87 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.067 -0.716 . . . . 8.65 109.067 167.751 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.97 -11.43 0.57 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.921 1.248 . . . . 0.82 116.07 -173.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.13 167.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 120.275 2.038 . . . . 2.17 107.892 171.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.87 -30.04 1.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.67 -0.644 . . . . 2.54 112.531 170.537 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -155.62 123.17 5.57 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.293 0.951 . . . . 3.26 108.917 170.828 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 p -106.52 132.81 52.1 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.996 0.918 . . . . 3.03 108.573 169.059 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -134.9 80.29 1.84 Allowed 'General case' 0 CA--C 1.522 -0.122 0 O-C-N 123.715 0.634 . . . . 2.28 109.614 167.368 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.455 HG13 HG13 ' A' ' 19' ' ' VAL . 10.7 p -78.85 144.1 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 122.56 0.344 . . . . 1.83 110.803 171.593 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.24 137.7 16.74 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.887 0.875 . . . . 1.22 109.905 178.396 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.75 -22.35 58.83 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.013 -0.54 . . . . 1.7 111.487 177.888 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.56 -39.7 2.41 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.49 1.516 . . . . 1.8 113.278 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -137.88 34.8 2.39 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.944 0.497 . . . . 2.07 110.309 168.157 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 44.78 50.51 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.765 2.026 . . . . 1.96 110.027 173.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -114.61 145.26 42.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.971 0.909 . . . . 2.46 110.354 -170.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.491 ' HB1' HD11 ' A' ' 46' ' ' ILE . . . -122.28 108.22 13.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.15 1.38 . . . . 0.94 108.562 163.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . 0.25 19.7 t60 -86.77 101.75 13.61 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 104.234 -2.506 . . . . 2.55 104.234 174.25 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.491 HD11 ' HB1' ' A' ' 44' ' ' ALA . 2.0 mp -103.43 119.83 52.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.858 -1.905 . . . . 1.06 105.858 174.752 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -102.71 140.66 36.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.069 -1.085 . . . . 2.74 108.069 166.179 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -159.27 159.1 33.69 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.957 0.903 . . . . 2.05 112.423 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.74 109.17 3.06 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 126.47 1.908 . . . . 2.68 107.659 173.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -81.83 54.61 5.13 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.007 2.471 . . . . 1.53 110.553 -170.269 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -142.52 -64.31 0.42 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.367 1.467 . . . . 3.89 109.361 -175.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.57 -38.46 17.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 N-CA-C 112.204 0.446 . . . . 1.78 112.204 -172.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 tt -113.41 146.01 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.64 1.176 . . . . 1.17 109.604 -175.597 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.5 -172.17 13.73 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.687 -0.965 . . . . 0.69 110.687 178.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.81 -40.56 28.08 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.479 2.119 . . . . 0.76 110.178 174.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -45.53 -58.41 3.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.313 1.045 . . . . 6.29 111.504 179.258 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.91 -57.62 9.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.362 0.665 . . . . 2.34 109.644 -174.584 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 56.0 mt -51.82 -52.71 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.921 0.888 . . . . 1.26 109.325 179.441 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.02 -48.67 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-O 119.034 -0.508 . . . . 0.76 110.107 -176.189 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -58.7 -41.57 86.6 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.88 0.848 . . . . 3.11 109.476 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.3 m -64.88 -45.44 85.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.783 -0.644 . . . . 0.98 111.044 178.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.3 mm -70.2 -51.67 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 CA-C-N 118.575 0.625 . . . . 1.96 110.682 -177.158 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -55.58 -36.8 67.27 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.148 0.579 . . . . 3.08 111.707 -167.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 t -38.07 -44.68 0.84 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.011 1.724 . . . . 2.5 113.039 168.228 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -19.66 63.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.811 0.844 . . . . 3.89 112.21 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.6 40.54 3.37 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.021 1.296 . . . . 1.89 111.782 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -124.87 155.95 38.68 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.759 -1.2 . . . . 2.11 107.759 172.656 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -95.63 101.12 7.23 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.012 -0.994 . . . . 3.51 108.895 169.305 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -70.81 81.49 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.165 2.577 . . . . 1.15 109.141 175.208 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 m -79.35 109.66 13.91 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.909 0.884 . . . . 1.86 108.733 -168.435 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.42 61.4 0.67 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.558 1.143 . . . . 2.66 112.568 -174.201 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.77 -53.51 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.856 -0.794 . . . . 2.31 108.856 174.487 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.5 tttt 58.39 -94.13 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.088 0.555 . . . . 6.54 111.03 -168.287 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 57.9 mt -146.21 141.72 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 127.355 2.262 . . . . 6.58 105.771 177.168 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 . . . . . 0 C--O 1.249 1.06 0 N-CA-C 103.239 -2.875 . . . . 10.14 103.239 170.77 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 107.326 -1.361 . . . . 6.77 107.326 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.48 175.3 40.47 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 107.52 -2.232 . . . . 2.71 107.52 141.002 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -72.35 118.04 14.75 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.44 0.696 . . . . 4.11 109.538 177.024 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.46 136.1 20.61 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 106.541 -2.624 . . . . 1.96 106.541 161.442 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.91 133.53 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.47 -0.937 . . . . 3.31 108.47 -173.198 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 mt -134.31 130.29 36.79 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.335 -0.987 . . . . 3.24 108.335 170.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -114.11 91.93 3.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.454 1.502 . . . . 2.5 108.596 174.529 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.67 134.46 44.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.374 -1.343 . . . . 1.32 107.374 176.789 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -80.33 115.69 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 106.949 -1.5 . . . . 2.89 106.949 170.186 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.54 86.45 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 125.938 1.695 . . . . 0.65 107.698 -173.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -77.34 130.9 37.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.23 -1.026 . . . . 5.62 108.23 -170.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.16 -18.83 4.17 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.718 0.675 . . . . 1.01 112.541 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 61.5 mtp -59.19 147.67 34.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.574 1.187 . . . . 1.88 110.863 177.252 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -150.75 -10.93 0.24 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.761 1.393 . . . . 2.87 114.761 178.61 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.9 p -165.59 172.01 12.47 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 121.032 1.742 . . . . 1.46 109.371 -179.132 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.88 -38.99 11.28 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.379 1.472 . . . . 1.0 112.147 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -45.71 -47.0 15.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.924 0.889 . . . . 1.47 111.65 173.903 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.0 m -69.75 -39.84 76.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 122.79 0.436 . . . . 0.7 110.98 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.7 t -57.75 -59.58 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.998 -1.112 . . . . 0.74 107.998 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.269 1.3 p-80 -70.8 -31.46 68.21 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 118.206 -0.902 . . . . 0.88 112.521 -175.483 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -49.15 -58.15 5.48 Favored 'General case' 0 C--N 1.347 0.465 0 N-CA-C 108.178 -1.045 . . . . 3.93 108.178 165.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.19 -60.87 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 118.572 -0.728 . . . . 1.1 110.239 -174.298 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.03 -55.31 24.63 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.39 0.995 . . . . 2.59 110.853 -175.993 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.1 t -58.09 -54.21 49.52 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.538 0.685 . . . . 1.53 110.28 -177.815 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -66.82 -40.62 88.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.709 -0.62 . . . . 0.93 110.952 -170.32 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.98 -42.69 84.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.115 0.416 . . . . 1.75 109.935 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -55.27 -27.23 45.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.5 0.591 . . . . 2.38 112.354 176.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -30.57 64.19 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.09 -1.006 . . . . 3.83 112.153 173.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -63.92 108.61 1.53 Allowed 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.346 0.975 . . . . 2.89 108.808 173.325 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -48.4 -33.44 9.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.896 0.878 . . . . 6.19 112.37 175.255 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.85 -18.35 80.12 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.642 -1.088 . . . . 0.81 114.042 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.21 135.59 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.94 1.37 . . . . 2.1 107.774 172.57 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pp -98.6 -33.61 10.9 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.692 -0.67 . . . . 2.65 109.82 173.35 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -157.04 146.17 20.17 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.463 1.029 . . . . 2.8 109.642 162.0 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.6 t -112.65 112.3 23.71 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 107.382 -1.34 . . . . 2.51 107.382 164.201 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.11 98.29 8.25 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.837 -1.172 . . . . 1.94 107.837 171.714 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.0 146.28 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 110.351 -0.24 . . . . 1.87 110.351 170.659 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.7 130.26 15.88 Favored 'General case' 0 CA--C 1.523 -0.092 0 O-C-N 122.02 -0.425 . . . . 0.83 111.293 170.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 pp -72.14 -25.82 61.87 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 124.756 1.223 . . . . 2.12 113.074 -168.89 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.1 -43.46 66.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.809 0.444 . . . . 1.11 111.191 -178.639 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.73 -31.75 10.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.591 1.156 . . . . 2.22 110.038 173.322 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 76.2 30.91 0.67 Allowed 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.14 2.176 . . . . 2.33 109.464 -171.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -79.5 145.01 33.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.373 -1.343 . . . . 4.0 107.373 171.507 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.48 109.71 21.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 124.888 1.367 . . . . 0.81 107.406 151.239 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -80.38 94.3 6.13 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.705 -1.961 . . . . 3.86 105.705 166.637 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -92.11 116.13 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 107.216 -1.401 . . . . 1.52 107.216 176.571 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -108.09 128.44 54.68 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.606 -1.627 . . . . 3.32 106.606 174.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -157.24 171.8 19.76 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.421 0.688 . . . . 2.26 109.637 -166.67 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.76 114.36 62.85 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.169 -0.678 . . . . 3.12 109.169 177.536 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.25 49.68 3.24 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.41 2.74 . . . . 1.33 112.15 -174.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.96 27.24 0.54 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.748 1.219 . . . . 3.84 110.234 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.78 -51.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 125.021 1.328 . . . . 3.4 108.998 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 tt -127.67 152.59 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.241 1.016 . . . . 1.11 108.478 -174.973 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -133.83 -176.09 14.22 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.538 -0.625 . . . . 0.74 111.538 -178.124 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.92 -41.62 52.0 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.859 2.373 . . . . 0.81 111.872 -176.797 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -57.39 -47.49 81.55 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.629 0.65 . . . . 6.14 110.863 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.95 -52.85 63.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.818 -0.808 . . . . 2.71 108.818 -175.853 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 mm -51.77 -52.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.405 1.082 . . . . 1.95 109.901 175.304 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.418 ' HA ' ' CG ' ' A' ' 69' ' ' PRO . 5.1 mt -55.29 -57.3 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 109.848 -0.427 . . . . 0.87 109.848 -179.026 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -65.24 -34.2 77.8 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.623 -0.673 . . . . 3.0 110.23 -171.911 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.5 m -59.2 -55.95 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.049 -0.523 . . . . 0.88 109.937 171.674 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 76.8 mt -63.86 -36.24 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.35 -0.844 . . . . 1.22 111.35 -175.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -51.2 -55.06 19.96 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.208 -0.664 . . . . 2.81 109.208 167.53 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -54.76 -42.08 71.23 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.696 0.398 . . . . 1.82 111.559 177.348 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.48 -10.94 58.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.185 0.809 . . . . 1.4 113.185 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.08 44.1 5.46 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 123.941 0.782 . . . . 0.98 111.976 172.751 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -140.82 163.53 32.69 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.174 -1.417 . . . . 2.45 107.174 167.301 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -103.91 105.01 46.31 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 125.429 1.492 . . . . 4.59 109.984 -179.431 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.418 ' CG ' ' HA ' ' A' ' 59' ' ' ILE . 60.6 Cg_endo -83.49 85.29 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.538 3.492 . . . . 0.94 111.317 -173.818 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -94.11 111.97 23.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.851 -0.531 . . . . 1.75 110.136 -173.057 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 mt -62.14 106.41 0.72 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.96 0.904 . . . . 3.01 109.924 174.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 t -93.3 -66.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 109.7 -0.481 . . . . 2.49 109.7 177.526 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -175.52 132.09 0.28 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.597 -1.26 . . . . 5.84 107.597 -166.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.7 pt -93.92 153.26 3.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.463 1.505 . . . . 8.29 107.036 158.309 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.911 2.084 . . . . 11.61 112.135 177.416 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtp . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 115.713 -2.089 . . . . 8.4 105.702 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.01 63.78 0.23 Allowed Glycine 0 C--N 1.334 0.419 0 CA-C-N 121.382 1.901 . . . . 3.55 109.101 -174.856 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 178.38 163.94 0.73 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.101 -1.814 . . . . 4.33 106.101 -162.37 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.69 158.9 31.98 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.101 -1.6 . . . . 1.72 109.101 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -147.15 136.3 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.664 -1.606 . . . . 2.8 106.664 -179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -155.26 175.13 14.25 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.681 -1.229 . . . . 3.44 107.681 163.111 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -131.83 146.45 52.14 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.725 -0.843 . . . . 2.47 108.725 168.077 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.468 ' N ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -132.42 131.41 41.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.791 -1.559 . . . . 1.35 106.791 169.178 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.5 t -79.92 100.94 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.022 -1.473 . . . . 1.02 107.022 175.164 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.21 87.03 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 126.056 1.742 . . . . 0.91 108.096 177.952 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.12 154.33 33.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.811 -1.181 . . . . 5.07 107.811 170.171 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.54 -38.42 3.21 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.628 -0.989 . . . . 0.72 110.628 -172.449 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 29.9 mtp -64.06 138.15 58.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.229 1.015 . . . . 1.57 109.607 178.255 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -140.54 -2.76 1.36 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.128 1.159 . . . . 2.41 114.128 -176.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.1 p -161.43 166.09 27.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.44 1.473 . . . . 1.17 110.063 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.89 -40.56 10.19 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.371 1.468 . . . . 0.98 111.875 -177.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.3 m -43.27 -47.04 6.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.856 0.863 . . . . 1.53 112.304 174.951 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.6 -33.77 75.66 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.005 0.522 . . . . 0.91 111.436 -175.054 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 37' ' ' VAL . 42.4 t -59.22 -59.91 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.112 -1.44 . . . . 0.66 107.112 -178.856 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.25 1.5 p-80 -67.97 -30.03 69.21 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.179 -0.464 . . . . 1.0 112.062 -178.261 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -52.67 -44.95 66.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.57 -0.706 . . . . 3.84 110.615 168.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.6 mt -70.39 -71.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.126 -0.694 . . . . 1.07 109.126 175.653 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . 0.283 0.2 OUTLIER -59.15 -50.02 75.64 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.238 0.926 . . . . 4.32 112.471 -159.745 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -56.37 -46.36 80.08 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.376 0.67 . . . . 1.5 110.497 176.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -71.24 -35.27 71.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 121.232 -0.917 . . . . 1.38 112.142 -176.161 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.77 -54.07 50.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.004 -0.739 . . . . 1.77 109.004 172.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.2 p -65.25 71.48 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.799 1.24 . . . . 1.59 113.081 -174.717 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -169.83 -31.09 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.915 2.486 . . . . 3.9 111.567 171.299 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -67.69 147.23 52.94 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.307 1.412 . . . . 2.26 108.78 177.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 ttm105 -61.66 142.76 56.98 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.263 -1.014 . . . . 5.43 108.263 173.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.65 -56.52 0.48 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.669 -0.973 . . . . 1.29 110.669 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.11 103.95 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 118.509 1.155 . . . . 2.39 110.993 -167.521 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.4 pp -82.3 -29.72 30.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.589 -0.732 . . . . 2.58 110.292 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -156.44 158.04 36.6 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.573 0.624 . . . . 2.55 109.38 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -142.9 133.79 25.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.206 1.003 . . . . 2.42 108.53 169.484 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 m -112.19 93.14 4.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.644 -1.243 . . . . 2.39 107.644 160.838 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 19' ' ' VAL . 9.4 p -88.82 144.94 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 122.551 0.34 . . . . 1.55 111.096 162.378 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.74 138.85 26.07 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.172 0.989 . . . . 0.89 110.039 171.376 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.74 -35.85 60.07 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.602 0.761 . . . . 1.89 110.885 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.28 -42.61 41.64 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.289 1.035 . . . . 1.49 111.849 -173.961 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.1 p -114.84 20.09 15.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.908 1.283 . . . . 2.8 110.615 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 m120 37.13 55.64 1.28 Allowed 'General case' 0 C--N 1.341 0.211 0 C-N-CA 126.777 2.031 . . . . 2.22 111.431 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -134.15 150.56 51.12 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 118.418 0.554 . . . . 1.67 112.488 -176.213 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.77 119.85 33.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.134 2.174 . . . . 0.72 107.535 167.673 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -101.12 101.42 12.15 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.164 -2.532 . . . . 2.22 104.164 167.449 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.467 HD13 HD21 ' A' ' 8' ' ' LEU . 4.8 mp -94.59 143.79 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 108.116 -1.068 . . . . 1.34 108.116 177.657 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -120.43 91.0 3.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.937 -1.134 . . . . 2.23 107.937 175.969 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -102.37 149.79 24.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.003 0.921 . . . . 2.35 113.205 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -71.71 116.03 43.78 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 124.83 1.252 . . . . 3.15 108.574 171.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.41 40.21 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.264 1.976 . . . . 1.8 111.586 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -82.32 -40.33 21.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.698 -0.626 . . . . 6.35 109.818 172.417 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 pt -133.63 -51.09 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.717 0.807 . . . . 2.28 112.098 -168.058 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.76 147.0 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.307 0.643 . . . . 1.07 109.823 -166.546 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.12 -171.66 13.01 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.892 -0.883 . . . . 0.76 110.892 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.25 -34.47 56.03 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.46 2.107 . . . . 0.93 110.519 176.51 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.526 HH21 ' CE1' ' A' ' 60' ' ' HIS . 1.7 tpm_? -50.37 -54.23 23.24 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.361 1.064 . . . . 7.53 111.163 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -52.51 63.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.232 1.013 . . . . 2.66 109.183 -176.559 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 94.8 mt -52.08 -47.85 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 C-N-CA 123.647 0.779 . . . . 1.29 109.4 178.446 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.7 mt -55.38 -54.13 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 109.381 -0.6 . . . . 0.73 109.381 -178.902 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' HIS . . . . . 0.526 ' CE1' HH21 ' A' ' 56' ' ' ARG . 76.7 m-70 -65.48 -34.88 79.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.801 0.728 . . . . 3.19 111.367 -176.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -57.08 -52.23 66.11 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.076 -0.713 . . . . 0.7 109.076 173.897 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.9 mt -70.87 -32.37 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 121.242 -0.911 . . . . 1.01 112.242 -178.09 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -53.96 -49.06 69.58 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.346 -0.983 . . . . 2.75 108.346 166.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -60.5 -40.93 93.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.157 0.183 . . . . 1.4 111.34 177.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.0 mt -61.38 -34.33 75.16 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.611 -0.681 . . . . 1.19 111.582 172.451 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.48 43.85 1.53 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.886 1.231 . . . . 0.85 112.206 173.269 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -134.2 168.83 18.15 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.732 -0.84 . . . . 1.95 108.732 170.589 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.92 85.05 4.74 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.059 0.944 . . . . 3.57 110.982 -172.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.64 93.42 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.788 2.992 . . . . 0.89 111.37 -175.023 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.2 m -86.22 119.53 26.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.888 1.275 . . . . 1.86 108.116 -179.407 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.0 mt -74.56 58.05 0.76 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.05 1.296 . . . . 2.64 112.184 -175.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 t -86.42 63.26 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.604 -1.258 . . . . 2.69 107.604 177.462 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 65.71 1.67 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.767 0.827 . . . . 4.86 108.813 176.284 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.85 -41.9 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.367 1.067 . . . . 7.75 110.943 -179.476 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.084 0 C-N-CA 125.296 1.438 . . . . 9.81 109.748 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 mtt . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 106.186 -1.783 . . . . 6.93 106.186 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.68 156.37 26.66 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 107.243 -2.343 . . . . 3.83 107.243 173.462 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.59 131.9 44.65 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.968 1.307 . . . . 4.26 109.774 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.37 83.73 0.87 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.737 -1.745 . . . . 2.18 108.737 178.28 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 m -79.51 129.0 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 117.211 0.506 . . . . 2.71 109.768 177.286 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 pp -150.3 164.92 34.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.748 -0.834 . . . . 3.23 108.748 161.333 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 153.26 51.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.629 0.728 . . . . 4.44 109.944 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 134.63 30.43 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.669 -1.604 . . . . 1.39 106.669 -177.259 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.16 102.47 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 105.513 -2.032 . . . . 1.0 105.513 177.485 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 m -90.79 71.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.471 -1.678 . . . . 0.75 106.471 -172.297 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -74.72 124.13 26.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 118.883 -1.127 . . . . 4.94 108.112 -159.808 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.19 -26.11 3.26 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.328 -0.851 . . . . 0.82 111.946 -179.268 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.86 109.86 8.67 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.883 1.341 . . . . 1.59 110.462 -176.299 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 p -83.67 -44.6 14.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.85 -0.532 . . . . 3.36 112.186 -170.718 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -149.28 177.37 9.72 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 112.073 0.397 . . . . 1.41 112.073 -156.32 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.28 -48.51 3.6 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.706 1.602 . . . . 0.8 111.785 177.908 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 m -48.09 -46.64 34.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.326 1.451 . . . . 1.96 111.779 176.825 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.9 m -72.24 -53.58 12.1 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.877 0.471 . . . . 0.74 110.689 176.426 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -43.91 -60.07 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.281 1.432 . . . . 0.6 109.347 -176.69 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.52 -12.37 61.34 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 113.61 0.967 . . . . 1.04 113.61 -176.037 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -53.2 19.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.553 -1.647 . . . . 3.68 106.553 163.182 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.6 mt -65.4 -60.22 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 118.445 0.566 . . . . 0.66 109.596 -169.644 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . 0.264 0.2 OUTLIER -58.36 -53.58 56.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.765 -0.774 . . . . 4.51 111.311 -166.123 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -60.9 -48.87 79.83 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.225 -0.893 . . . . 2.01 109.868 177.171 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 t -63.75 -42.71 97.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.883 1.22 . . . . 1.16 110.837 -170.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.33 -46.17 87.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.423 -0.584 . . . . 2.14 109.423 174.842 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -71.73 65.45 0.5 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.256 0.55 . . . . 2.81 111.53 174.768 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -146.81 -49.81 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.677 2.791 . . . . 7.09 108.459 170.545 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -61.04 130.13 44.86 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.843 0.354 . . . . 1.97 110.938 -174.317 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.78 90.43 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.923 0.889 . . . . 7.15 110.079 -179.271 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.08 -29.68 0.32 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-O 119.207 -0.774 . . . . 1.24 112.037 178.393 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.46 134.91 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.386 -1.339 . . . . 2.18 107.386 165.654 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -102.49 -29.33 11.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 123.969 0.793 . . . . 2.13 110.13 172.082 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -156.24 162.46 40.15 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.307 0.958 . . . . 2.57 109.692 172.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.8 t -142.86 149.22 38.25 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.328 1.051 . . . . 2.02 108.229 171.823 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -146.5 136.73 23.68 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 107.517 -1.29 . . . . 2.14 107.517 157.148 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.407 HG12 ' CB ' ' A' ' 44' ' ' ALA . 3.1 m -122.57 141.86 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 123.397 0.679 . . . . 1.76 109.351 -178.955 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.99 131.48 44.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.306 0.643 . . . . 0.72 110.4 177.686 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.33 -33.98 67.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.812 -1.086 . . . . 2.27 110.982 -173.19 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.09 -47.17 68.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.372 1.069 . . . . 1.21 112.452 -175.646 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -102.86 14.73 31.23 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.933 0.893 . . . . 2.44 110.645 174.96 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 34.1 46.21 0.15 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 129.082 2.953 . . . . 3.17 112.335 -173.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -125.47 144.61 50.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.624 0.647 . . . . 3.61 112.274 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.407 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -101.84 130.19 48.24 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.255 1.822 . . . . 0.65 106.444 172.004 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.41 109.67 21.45 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 101.401 -3.555 . . . . 2.35 101.401 176.729 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.02 134.58 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.054 -1.832 . . . . 1.05 106.054 -179.362 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -112.52 116.18 29.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 106.204 -1.776 . . . . 2.2 106.204 169.236 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -123.62 157.56 33.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.107 0.563 . . . . 2.85 111.011 -178.589 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -72.58 116.54 50.64 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 106.963 -1.495 . . . . 3.04 106.963 176.78 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.19 27.26 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.226 2.617 . . . . 2.48 115.7 -156.655 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -135.55 -34.75 0.83 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.363 1.465 . . . . 3.9 112.969 -178.626 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -41.51 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.781 0.832 . . . . 3.34 111.312 -165.838 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.8 tt -136.28 158.17 38.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 C-N-CA 123.832 0.853 . . . . 1.43 108.728 -169.085 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.84 -178.89 15.86 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.484 0.584 . . . . 0.64 111.85 -174.916 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -57.63 -39.98 83.67 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.797 2.331 . . . . 0.75 110.472 171.533 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -51.66 -49.48 62.25 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.729 0.812 . . . . 6.63 112.081 -176.867 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.79 -51.55 66.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.377 -0.601 . . . . 2.65 109.377 -175.197 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.8 mt -52.27 -47.48 45.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 123.602 0.761 . . . . 1.42 108.989 175.696 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.7 mt -55.89 -54.99 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 109.883 -0.414 . . . . 0.54 109.883 -176.037 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -64.08 -34.74 78.72 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.026 0.441 . . . . 3.15 110.671 -178.298 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.6 m -58.66 -51.26 70.7 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.196 -0.315 . . . . 0.75 110.483 173.868 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 mm -63.98 -42.26 95.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 121.143 -0.973 . . . . 1.55 110.915 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -52.83 -47.54 67.64 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.455 -0.572 . . . . 2.66 109.455 172.37 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m -59.15 -42.98 91.97 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.898 0.333 . . . . 1.54 111.898 175.844 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.7 mt -64.47 -29.14 70.18 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.534 -0.729 . . . . 1.06 112.411 175.983 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.27 40.1 1.18 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.3 0.953 . . . . 0.68 113.385 167.047 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -136.25 164.72 27.43 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.175 0.987 . . . . 1.98 108.643 171.389 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -94.62 111.44 54.05 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 118.488 -0.768 . . . . 2.44 109.759 175.254 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.18 80.21 2.68 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.612 2.875 . . . . 0.92 110.764 -178.243 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.47 105.35 10.72 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.137 -0.69 . . . . 1.76 109.137 -178.605 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.82 61.68 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.606 1.562 . . . . 2.54 111.827 179.373 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.64 -33.75 63.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.468 0.707 . . . . 2.55 111.234 -177.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 57.35 -122.01 1.5 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.258 -0.645 . . . . 5.52 109.258 -173.912 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.645 HG23 ' H ' ' A' ' 75' ' ' GLU . 15.5 tt -141.61 -59.71 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.186 0.994 . . . . 7.26 108.423 169.769 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.645 ' H ' HG23 ' A' ' 74' ' ' ILE . 50.7 mt-10 . . . . . 0 C--O 1.259 1.588 0 N-CA-C 102.68 -3.082 . . . . 10.0 102.68 135.793 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.1 mtm . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 105.365 -2.087 . . . . 8.14 105.365 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 140.12 -35.56 1.89 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.309 -1.517 . . . . 3.4 109.309 -168.604 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.27 -112.93 0.27 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.825 0.85 . . . . 4.73 110.291 158.182 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.25 -138.08 13.71 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.829 -1.708 . . . . 2.84 108.829 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -157.9 154.37 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.965 -1.494 . . . . 2.85 106.965 173.983 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.5 mt -130.54 126.84 37.79 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 107.874 -1.158 . . . . 2.63 107.874 153.41 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -106.71 89.47 3.03 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.373 -0.973 . . . . 3.05 108.373 173.871 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.23 129.79 39.16 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.388 -0.967 . . . . 1.55 108.388 178.869 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.04 109.33 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.029 -1.841 . . . . 1.35 106.029 173.688 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.42 92.53 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 125.39 1.476 . . . . 0.79 108.175 -171.051 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -76.58 139.46 40.68 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.481 -0.933 . . . . 4.97 108.481 -173.292 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.65 -42.39 1.95 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.319 0.961 . . . . 0.72 111.141 177.746 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.81 126.82 30.96 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.982 0.891 . . . . 1.69 110.135 -176.273 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -154.38 17.87 0.48 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.855 1.057 . . . . 2.26 113.855 -171.831 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 p -158.68 170.29 22.48 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.502 1.046 . . . . 1.39 109.234 169.34 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.35 -44.49 11.8 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.972 1.309 . . . . 1.75 111.961 -178.977 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.6 m -56.25 -43.82 79.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.574 0.349 . . . . 1.74 111.602 177.532 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.32 -45.41 66.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.716 -0.615 . . . . 0.92 110.787 178.035 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.22 -58.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.204 -1.035 . . . . 1.0 108.204 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.298 0.7 OUTLIER -70.72 -24.8 62.7 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 113.146 0.795 . . . . 1.76 113.146 -172.174 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -57.9 -51.73 68.43 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.392 -0.966 . . . . 4.06 108.392 169.732 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.6 mt -59.11 -60.32 2.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.431 -0.581 . . . . 0.97 109.431 174.169 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.94 -55.28 28.52 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.357 0.526 . . . . 4.48 110.9 -168.325 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.3 t -61.2 -53.04 61.89 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.122 -0.696 . . . . 1.92 109.122 -177.88 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.7 t -72.04 -36.51 69.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 119.089 -1.045 . . . . 1.13 112.285 -168.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.83 -59.51 2.76 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.61 -0.885 . . . . 1.74 108.61 176.025 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.7 m -71.98 64.95 0.53 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.665 0.786 . . . . 3.34 111.883 179.064 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -169.9 -30.89 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 128.286 2.635 . . . . 3.68 110.951 170.507 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -64.6 132.2 49.14 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.866 1.212 . . . . 2.08 109.458 173.583 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -51.89 145.39 9.92 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.867 -0.79 . . . . 5.47 108.867 174.075 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.6 -36.28 4.18 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.582 -1.121 . . . . 0.81 111.926 177.707 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.47 135.28 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.703 -1.591 . . . . 2.0 106.703 164.512 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.1 pp -99.01 -32.49 11.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.243 0.617 . . . . 2.63 109.469 171.093 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -156.57 161.4 39.96 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 108.68 -0.859 . . . . 2.33 108.68 172.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 p -132.93 148.34 52.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.947 -0.76 . . . . 1.93 108.947 154.598 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.46 88.66 2.98 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.808 -1.553 . . . . 1.87 106.808 168.608 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.28 136.21 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 124.271 1.028 . . . . 1.94 111.838 170.353 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.6 140.17 28.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.77 0.828 . . . . 1.24 110.314 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 pp -76.96 -22.45 53.21 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.116 -0.493 . . . . 1.81 111.617 177.794 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.24 -38.02 1.65 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.411 1.484 . . . . 1.72 113.212 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -139.74 30.6 2.07 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.944 0.878 . . . . 2.31 110.291 170.554 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.1 m120 44.13 56.74 4.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.864 2.066 . . . . 1.89 110.579 176.067 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.78 139.63 32.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.176 -0.328 . . . . 2.01 110.69 -164.984 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.38 115.82 25.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.766 1.626 . . . . 0.77 110.463 176.893 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -82.29 96.63 7.96 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.249 -1.76 . . . . 2.5 106.249 169.371 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.39 133.05 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.94 -1.134 . . . . 1.28 107.94 175.27 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -115.25 115.8 27.28 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.44 -2.059 . . . . 2.86 105.44 173.19 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -147.14 153.53 40.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.381 1.072 . . . . 2.85 108.405 -164.867 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -104.07 105.69 49.87 Favored Pre-proline 0 CA--C 1.534 0.357 0 O-C-N 124.362 1.039 . . . . 3.87 111.075 -178.19 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.0 60.41 6.85 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.163 2.575 . . . . 1.5 112.1 -174.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.83 -54.87 2.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.044 0.938 . . . . 3.66 109.656 161.881 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -96.18 -37.07 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 122.98 0.512 . . . . 1.84 112.24 -174.463 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 tp -104.13 148.15 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.996 1.318 . . . . 1.05 108.444 -178.434 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.46 -178.94 16.6 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 110.864 -0.895 . . . . 0.75 110.864 174.945 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -60.99 -40.45 52.18 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.873 2.382 . . . . 0.77 110.357 174.122 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -50.39 -49.99 52.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.254 0.622 . . . . 5.85 112.083 179.352 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.16 -55.81 28.54 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.643 0.656 . . . . 2.47 109.991 -174.523 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.0 mt -50.42 -54.87 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 124.654 1.182 . . . . 1.58 108.956 175.596 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.9 mt -58.07 -53.23 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.85 -0.614 . . . . 0.96 110.403 -173.384 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -66.58 -33.03 74.77 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.329 0.652 . . . . 3.08 110.107 -175.522 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.7 m -57.85 -51.83 67.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.78 -0.452 . . . . 0.78 109.78 169.783 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 94.6 mt -67.24 -37.93 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 121.186 -0.946 . . . . 1.16 111.733 -176.788 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.99 -50.01 67.52 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.939 -0.763 . . . . 3.44 108.939 169.148 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.3 m -58.94 -38.82 79.89 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.008 -0.433 . . . . 1.74 111.992 176.084 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.38 -18.57 64.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.549 -0.738 . . . . 1.06 112.511 172.882 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.42 33.21 6.59 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.749 1.166 . . . . 0.81 112.273 174.176 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -133.01 158.65 42.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.025 0.913 . . . . 2.15 108.846 177.549 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.74 105.8 29.32 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.492 -0.766 . . . . 2.9 110.083 -178.081 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.4 79.62 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.922 2.414 . . . . 1.29 110.291 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 t -78.97 116.79 19.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.704 -0.623 . . . . 2.15 109.632 -175.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.8 mt -74.04 63.0 0.92 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.301 1.04 . . . . 3.18 110.225 177.494 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.6 t -62.9 -42.49 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 O-C-N 121.739 -0.6 . . . . 2.66 109.533 179.147 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -76.73 64.33 2.3 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.942 -0.474 . . . . 7.7 110.069 172.446 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 tp -76.1 164.68 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.23 -1.026 . . . . 9.95 108.23 164.619 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.708 -1.139 . . . . 11.36 109.95 171.333 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 106.15 -1.796 . . . . 9.21 106.15 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.58 57.14 0.03 OUTLIER Glycine 0 CA--C 1.521 0.43 0 N-CA-C 106.67 -2.572 . . . . 3.05 106.67 -179.025 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -168.19 144.27 3.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.362 -0.977 . . . . 4.03 108.362 -158.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -145.58 90.94 0.15 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.908 -2.077 . . . . 2.13 107.908 178.149 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -81.23 133.47 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 108.642 -0.873 . . . . 2.48 108.642 171.294 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -146.28 137.92 24.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.129 -1.063 . . . . 3.16 108.129 176.585 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -106.64 126.99 52.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.496 1.118 . . . . 2.86 109.509 173.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.25 128.59 40.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.752 1.221 . . . . 1.54 108.107 176.34 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.257 0.6 OUTLIER -79.79 115.04 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 124.384 1.074 . . . . 3.14 108.301 173.813 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 m -101.92 84.25 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 128.077 2.551 . . . . 0.65 107.221 -170.277 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -75.91 139.2 41.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 118.7 -1.2 . . . . 6.56 107.902 -167.929 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.28 -31.27 5.33 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.685 1.136 . . . . 0.83 111.134 -170.577 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.0 mtm -57.17 126.88 29.22 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.949 1.374 . . . . 1.59 110.388 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -140.47 -6.54 1.17 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.073 1.138 . . . . 2.18 114.073 -177.355 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 p -163.03 168.4 21.07 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 120.288 1.403 . . . . 1.12 109.834 179.639 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.44 -38.86 14.37 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.227 1.411 . . . . 0.85 112.172 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.8 m -43.47 -50.0 7.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.613 1.165 . . . . 1.43 111.612 172.131 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.7 m -68.02 -45.52 73.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 122.996 0.518 . . . . 0.71 110.536 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.1 t -52.59 -61.01 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.238 -1.023 . . . . 0.55 108.238 -176.311 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.252 1.3 p-80 -70.43 -28.59 65.16 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.829 -1.078 . . . . 0.87 111.964 -175.278 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -53.11 -58.62 6.38 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.446 1.021 . . . . 3.58 109.564 168.066 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.62 -58.51 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.739 -0.784 . . . . 0.77 109.732 -177.437 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -52.87 -62.23 1.78 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.382 0.426 . . . . 2.52 109.865 -174.012 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -55.2 -52.27 63.87 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.919 0.488 . . . . 1.46 110.432 -176.327 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -69.57 -32.08 70.64 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.621 -0.432 . . . . 1.28 111.306 -171.011 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.19 -46.83 63.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.09 -0.644 . . . . 1.84 111.122 172.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.8 p -66.89 78.28 0.12 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.54 0.736 . . . . 1.69 111.178 -176.683 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.76 -37.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 128.651 2.78 . . . . 4.21 108.763 -178.0 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.23 114.28 6.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.791 -0.818 . . . . 2.04 108.791 174.773 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -57.17 152.83 12.89 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.521 -0.918 . . . . 7.88 108.521 166.346 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.87 -60.15 0.64 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 108.575 -1.81 . . . . 1.73 108.575 -152.79 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.01 149.36 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 119.541 1.67 . . . . 1.71 108.507 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 pp -121.75 -25.07 5.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.368 -0.833 . . . . 2.41 111.035 168.517 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -155.68 157.57 36.86 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.313 0.96 . . . . 2.66 108.502 172.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.0 t -139.78 149.79 43.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.929 -1.137 . . . . 2.14 107.929 165.593 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 p -144.05 137.01 27.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.249 -1.389 . . . . 2.12 107.249 156.071 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.06 154.27 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.317 0.962 . . . . 1.71 110.213 179.035 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.28 137.66 32.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.027 0.931 . . . . 0.72 111.083 -176.032 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.1 mt -68.7 -34.5 75.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.677 1.191 . . . . 2.31 110.688 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -40.34 -42.36 1.54 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.904 1.682 . . . . 1.09 113.82 -174.441 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -138.61 35.8 2.22 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 123.086 0.554 . . . . 2.73 110.239 170.579 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 m120 42.23 46.93 3.98 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 127.314 2.245 . . . . 1.82 109.954 176.434 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -106.43 149.13 27.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.767 0.827 . . . . 2.38 110.927 -168.269 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.54 118.81 26.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.021 1.329 . . . . 0.67 107.743 172.056 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.64 102.44 14.18 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 102.375 -3.194 . . . . 2.34 102.375 176.794 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.83 139.04 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.193 -1.78 . . . . 1.26 106.193 176.532 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -122.87 115.74 22.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.288 -1.375 . . . . 3.39 107.288 169.214 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -121.66 161.72 22.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.837 1.655 . . . . 2.47 111.15 -173.051 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -92.29 119.81 67.95 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 126.246 1.818 . . . . 3.26 107.817 176.704 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.43 53.1 4.4 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.893 2.395 . . . . 2.6 110.195 179.52 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -103.17 -43.6 5.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.984 1.714 . . . . 6.39 109.62 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.06 -46.15 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.753 1.221 . . . . 2.59 112.109 -172.872 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 tp -81.77 150.09 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.033 0.933 . . . . 1.26 110.533 -167.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.62 -176.83 15.34 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.301 -1.12 . . . . 1.07 110.301 169.847 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -61.8 -38.47 59.53 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.454 2.103 . . . . 1.17 110.386 173.634 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -50.27 -50.71 49.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.372 1.069 . . . . 6.3 111.705 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.64 -54.59 45.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.742 0.817 . . . . 3.12 109.153 -177.665 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.6 mt -53.58 -49.11 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 123.853 0.861 . . . . 1.7 109.127 178.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.8 mt -52.81 -58.9 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 123.451 0.701 . . . . 0.95 109.956 -178.672 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -66.08 -34.61 78.45 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.158 0.504 . . . . 3.49 111.114 -176.608 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.0 m -57.13 -51.7 68.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.314 -0.625 . . . . 1.08 109.314 174.245 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.78 -35.05 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.548 -0.72 . . . . 1.24 111.541 -176.441 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -50.06 -52.98 30.13 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.329 -0.619 . . . . 2.82 109.329 166.128 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.5 t -57.61 -43.88 85.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.475 0.31 . . . . 1.5 111.574 177.232 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.3 mt -61.54 -27.58 68.71 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.207 -0.933 . . . . 1.67 112.395 176.387 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.55 35.69 1.39 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.52 1.057 . . . . 1.17 112.924 167.761 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -139.35 152.61 47.3 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.08 -1.082 . . . . 1.98 108.08 173.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -96.93 113.82 63.58 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.877 -0.786 . . . . 3.39 108.877 176.741 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -90.3 122.29 0.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.596 2.864 . . . . 1.1 111.563 -177.989 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.6 m -116.93 132.53 56.68 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 107.352 -1.351 . . . . 1.47 107.352 170.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mp -56.99 133.08 54.61 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.088 0.858 . . . . 3.83 110.341 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.57 -51.1 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 108.5 -0.926 . . . . 5.28 108.5 172.17 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -104.86 112.05 25.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.166 0.986 . . . . 5.88 109.256 -173.338 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.283 3.4 tt 59.15 174.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.168 2.187 . . . . 9.09 112.78 176.465 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--O 1.256 1.408 0 N-CA-C 104.963 -2.236 . . . . 12.45 104.963 179.436 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.472 0.662 0 CA-C-O 119.478 -0.296 . . . . 9.66 111.795 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.09 64.0 0.55 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 106.99 -2.444 . . . . 2.95 106.99 -177.658 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.39 150.0 19.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.231 -1.396 . . . . 4.13 107.231 -156.899 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.42 118.68 0.66 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.855 -1.698 . . . . 2.22 108.855 -175.297 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -81.45 139.89 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.302 -0.999 . . . . 2.85 108.302 178.231 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.3 153.17 25.25 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.779 -0.823 . . . . 3.0 108.779 171.495 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.476 ' C ' HD23 ' A' ' 8' ' ' LEU . 23.5 mt-10 -126.86 138.61 53.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.993 0.917 . . . . 2.64 110.424 177.124 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.647 HD21 HD13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -142.52 140.72 31.91 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.186 0.994 . . . . 1.43 108.907 -179.77 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 t -76.57 127.04 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 105.205 -2.146 . . . . 1.18 105.205 173.743 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 m -114.69 88.31 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 124.989 1.316 . . . . 0.65 107.606 -175.619 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.9 mtp-105 -77.04 137.5 39.0 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.559 -0.904 . . . . 5.96 108.559 -173.243 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.68 -41.72 1.47 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.938 -0.865 . . . . 0.88 110.938 177.103 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -68.88 152.2 45.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.906 0.853 . . . . 1.28 110.881 -176.761 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -152.34 1.15 0.32 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.392 1.256 . . . . 2.16 114.392 -175.124 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 p -162.33 164.8 27.24 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 120.18 1.355 . . . . 1.19 109.725 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.21 -41.14 12.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.169 1.388 . . . . 0.86 111.403 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -36.93 -51.83 0.92 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.28 2.232 . . . . 2.17 112.152 170.174 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.8 m -72.5 -51.49 19.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.862 0.865 . . . . 0.83 110.983 176.588 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -46.97 -60.46 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 C-N-CA 125.199 1.4 . . . . 0.49 109.017 -171.879 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -65.54 -24.81 67.2 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.872 -1.058 . . . . 1.08 111.329 -175.746 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -55.07 20.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.224 -1.028 . . . . 5.06 108.224 174.556 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 mt -58.05 -54.57 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.271 -0.641 . . . . 0.86 109.271 -179.32 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -55.67 -59.39 4.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.928 0.491 . . . . 2.43 110.565 -177.521 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.5 t -53.24 -52.12 60.0 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.688 -0.486 . . . . 1.5 109.688 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 t -59.0 -40.61 85.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.958 0.503 . . . . 0.94 111.376 -176.332 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.16 -43.93 90.17 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.635 -0.698 . . . . 2.26 110.891 176.846 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.3 p -70.7 60.66 0.23 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.772 0.829 . . . . 1.7 112.057 178.966 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -153.78 -50.33 0.09 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 129.497 3.119 . . . . 7.42 107.709 -176.7 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -69.52 137.47 52.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.701 -0.481 . . . . 2.25 109.701 -177.403 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -56.69 150.88 15.0 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.463 -0.569 . . . . 6.3 109.463 174.058 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.39 -28.38 8.31 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-O 117.609 -1.662 . . . . 0.72 112.675 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.589 HD11 HG23 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -75.41 130.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 120.861 2.331 . . . . 1.69 107.159 172.691 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.4 mt -96.71 -48.75 5.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.902 1.281 . . . . 2.42 108.479 172.121 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -156.38 147.53 22.24 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 118.838 0.744 . . . . 2.85 109.646 177.328 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -121.34 150.81 40.89 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 107.197 -1.409 . . . . 2.24 107.197 170.395 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t -143.42 150.11 38.59 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 118.491 -1.284 . . . . 2.7 108.79 141.827 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.74 132.77 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.737 0.815 . . . . 1.75 110.279 177.235 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.48 134.93 54.64 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.72 0.808 . . . . 0.71 110.569 -177.804 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.81 -34.58 77.04 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.65 1.18 . . . . 2.21 110.349 177.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -39.33 -41.87 0.97 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.227 1.811 . . . . 1.24 113.922 -176.164 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -137.72 33.0 2.46 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.898 0.856 . . . . 3.01 110.026 173.447 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 31.22 64.19 0.19 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 128.08 2.552 . . . . 2.9 111.964 -174.86 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.72 135.07 36.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.966 -0.561 . . . . 1.9 110.971 -166.487 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.12 140.78 34.94 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.604 1.962 . . . . 0.87 108.949 177.574 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -109.21 141.15 41.89 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.652 -1.61 . . . . 3.54 106.652 158.012 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.647 HD13 HD21 ' A' ' 8' ' ' LEU . 5.1 mp -125.32 114.48 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.837 -1.912 . . . . 1.49 105.837 176.173 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -93.4 99.59 12.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.217 -2.142 . . . . 3.39 105.217 171.975 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -125.99 167.07 15.81 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.047 1.339 . . . . 2.13 111.845 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -77.73 109.62 10.33 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.958 1.703 . . . . 2.97 109.82 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.32 63.24 8.7 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.363 2.709 . . . . 1.91 112.105 -167.888 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.74 -74.35 0.1 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.968 0.907 . . . . 3.26 110.04 177.807 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.5 pt -58.38 -26.93 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.084 0.954 . . . . 2.13 113.229 -177.89 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 tt -135.44 162.91 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.609 1.163 . . . . 1.0 108.297 -178.422 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.96 179.16 27.89 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.46 -1.456 . . . . 0.99 109.46 -174.029 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.13 -40.66 67.87 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.795 2.33 . . . . 1.0 111.608 -172.204 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -59.88 -37.04 78.22 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.453 0.538 . . . . 7.19 112.453 -175.492 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.3 -50.96 70.89 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.341 0.591 . . . . 3.93 109.805 179.136 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.9 mt -55.23 -50.18 66.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.643 -0.873 . . . . 1.6 108.643 176.168 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 mt -54.63 -53.16 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-O 119.382 -0.342 . . . . 0.66 110.206 -178.08 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -56.47 -43.76 79.89 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.275 0.559 . . . . 2.89 109.74 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.3 m -58.63 -53.96 52.4 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.034 -0.53 . . . . 0.78 110.331 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 mm -65.55 -39.98 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.335 -0.853 . . . . 1.97 111.186 -177.252 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -53.39 -48.92 68.22 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.6 -0.519 . . . . 2.98 109.6 169.733 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 m -61.6 -42.57 99.05 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.93 0.344 . . . . 2.09 111.93 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.9 mt -61.43 -36.83 81.45 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.518 0.599 . . . . 1.23 110.948 175.039 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.81 47.42 0.73 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 123.97 0.795 . . . . 0.81 111.763 172.145 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -134.86 160.86 36.9 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 106.571 -1.64 . . . . 2.05 106.571 168.116 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -97.84 105.5 27.68 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.234 -0.889 . . . . 3.26 109.774 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -84.25 136.17 6.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.699 2.266 . . . . 1.56 110.123 176.852 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t -146.79 129.84 16.42 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.968 -0.752 . . . . 2.53 108.968 171.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.476 ' CD2' ' H ' ' A' ' 71' ' ' LEU . 1.7 mm? -54.33 127.74 28.55 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.939 1.295 . . . . 2.78 110.593 -174.66 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.76 -43.67 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.311 0.505 . . . . 4.87 110.319 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -162.94 -165.65 1.16 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.482 1.913 . . . . 6.1 107.56 175.694 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.3 mm 76.18 -55.72 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 126.815 2.046 . . . . 8.8 108.208 -165.541 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 105.928 -1.879 . . . . 11.47 105.928 154.568 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 108.667 -0.864 . . . . 7.85 108.667 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.28 170.38 39.59 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 107.438 -2.265 . . . . 2.64 107.438 177.815 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.58 150.96 4.57 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.408 1.083 . . . . 4.04 111.179 -177.248 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.64 156.06 26.59 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.869 -1.692 . . . . 1.83 108.869 173.383 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.18 128.91 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.945 -1.502 . . . . 3.01 106.945 170.309 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.8 mp -128.45 151.34 49.5 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.297 -1.001 . . . . 3.39 108.297 177.686 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -125.06 129.55 50.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.189 0.996 . . . . 3.12 109.983 -166.607 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.71 136.63 36.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.532 1.133 . . . . 1.37 108.603 -174.102 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.33 124.6 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 104.671 -2.344 . . . . 1.44 104.671 174.387 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 m -106.31 67.53 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 106.973 -1.491 . . . . 0.85 106.973 -178.611 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -76.72 132.93 39.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.818 -0.808 . . . . 5.59 108.818 -166.307 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.63 -47.66 1.0 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.399 -1.48 . . . . 0.65 109.399 -169.284 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 142.09 36.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.683 0.741 . . . . 1.36 109.392 -176.766 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -156.75 19.05 0.32 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.529 0.937 . . . . 2.72 113.529 -173.795 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.78 153.73 25.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.355 0.98 . . . . 1.47 110.018 179.499 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.34 -37.7 7.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.105 1.762 . . . . 1.09 112.812 -173.706 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 t -47.01 -54.73 9.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.173 0.589 . . . . 1.87 110.167 174.541 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.9 m -69.02 -33.49 73.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.18 -0.325 . . . . 0.8 110.903 -176.15 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.8 t -57.08 -60.76 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.197 -1.038 . . . . 0.69 108.197 -178.372 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -68.54 -30.18 68.92 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.426 -0.807 . . . . 1.72 111.104 -176.435 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -56.94 -59.34 5.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 118.911 0.778 . . . . 5.63 109.991 170.158 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.423 HG21 HG11 ' A' ' 37' ' ' VAL . 60.8 mt -52.17 -51.61 29.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 118.905 0.775 . . . . 0.99 108.975 -178.435 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -50.97 -64.24 0.87 Allowed 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 123.991 0.807 . . . . 3.3 110.657 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.0 m -58.38 -42.25 86.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.946 0.879 . . . . 1.97 111.209 -177.003 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 t -66.44 -39.11 88.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.299 1.039 . . . . 1.44 110.029 -174.478 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.8 mt -71.76 -55.24 8.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 118.708 -0.663 . . . . 2.01 112.1 173.005 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.9 p -64.13 74.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.975 1.31 . . . . 1.64 112.592 -167.484 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -174.88 -40.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.372 2.269 . . . . 3.68 110.076 -175.375 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.41 ' CE1' ' HB ' ' A' ' 32' ' ' ILE . 24.0 p80 -73.98 172.46 11.6 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.293 0.568 . . . . 1.86 112.097 -172.152 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -51.28 128.05 21.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.68 -0.691 . . . . 12.15 110.74 178.125 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.27 -15.23 7.17 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.583 -1.676 . . . . 0.75 116.692 160.086 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.41 ' HB ' ' CE1' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -76.1 109.59 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 121.805 2.802 . . . . 2.13 109.257 175.371 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.35 -42.03 31.73 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.157 -0.683 . . . . 2.52 109.157 -178.613 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -157.41 158.92 36.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.718 0.69 . . . . 3.19 109.268 177.368 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.6 t -124.16 138.78 54.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.001 1.72 . . . . 2.23 106.602 179.625 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.1 m -144.52 104.53 4.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.344 -0.984 . . . . 2.26 108.344 166.619 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.497 HG12 ' CB ' ' A' ' 44' ' ' ALA . 1.5 m -101.98 138.4 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 O-C-N 123.42 0.45 . . . . 1.96 111.131 172.322 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.83 133.15 55.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.588 0.755 . . . . 0.9 109.208 171.474 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -80.86 -33.67 34.27 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.35 -0.841 . . . . 1.96 111.366 -169.425 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.41 -34.33 61.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.171 0.588 . . . . 1.62 112.248 178.121 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -104.97 2.73 29.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.098 1.359 . . . . 2.1 111.562 176.761 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.4 m120 41.24 44.28 2.22 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.21 2.204 . . . . 1.94 111.351 -172.769 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.2 tmmt? -135.97 136.13 40.13 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 122.024 -0.423 . . . . 2.38 111.461 -165.332 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.497 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -98.51 139.28 34.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.653 1.981 . . . . 0.94 109.15 173.57 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.75 131.23 53.36 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.125 -2.176 . . . . 2.53 105.125 149.473 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.6 mm -115.57 131.01 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.367 -1.345 . . . . 1.88 107.367 172.912 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -93.13 64.62 3.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.385 1.074 . . . . 3.18 108.97 175.81 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -88.34 141.58 28.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 112.744 0.646 . . . . 2.81 112.744 175.579 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -62.34 115.66 17.73 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.694 -0.854 . . . . 2.47 108.694 173.843 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.76 65.84 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.78 2.32 . . . . 1.54 111.425 -168.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -162.18 -79.07 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.338 0.655 . . . . 3.52 112.137 -177.693 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -34.82 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 121.528 -0.733 . . . . 2.83 111.12 -176.762 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 tp -105.31 150.05 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.234 -1.765 . . . . 1.18 106.234 170.88 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -141.25 170.43 24.65 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.352 -1.099 . . . . 0.68 110.352 -177.615 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -57.03 -43.4 54.26 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.482 2.788 . . . . 0.75 110.489 -177.485 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -57.23 -44.71 84.04 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.247 0.476 . . . . 6.5 112.019 176.924 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -63.36 -49.15 74.98 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.972 -0.751 . . . . 3.84 108.972 -178.022 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.6 mm -50.57 -51.65 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.877 0.471 . . . . 1.95 111.036 172.599 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.6 mt -57.42 -52.62 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.284 0.634 . . . . 0.63 109.962 -178.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -55.8 -44.64 78.0 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 122.343 1.068 . . . . 3.28 109.298 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -61.18 -50.48 72.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.791 -1.095 . . . . 0.85 110.304 -178.895 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -71.86 -44.49 67.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-O 119.123 -0.465 . . . . 1.14 111.717 -175.526 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.31 -42.38 77.52 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.885 0.766 . . . . 2.92 110.427 -176.694 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -51.04 -28.67 10.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.673 0.99 . . . . 1.67 113.673 172.782 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.68 -16.68 58.33 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.069 0.85 . . . . 1.05 112.051 178.048 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.8 31.26 8.8 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.902 0.763 . . . . 0.7 112.531 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -129.99 140.4 50.9 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 105.394 -2.076 . . . . 1.98 105.394 167.846 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -87.59 111.25 40.6 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 117.985 -1.007 . . . . 2.82 109.586 -173.903 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.86 128.31 5.11 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.958 2.438 . . . . 1.42 109.838 176.673 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -138.2 111.93 8.28 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.563 -0.903 . . . . 2.54 108.563 177.153 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -56.03 131.06 46.41 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.284 1.034 . . . . 2.6 110.985 -179.172 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -131.75 -51.12 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 112.746 0.646 . . . . 3.74 112.746 -173.048 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.3 tptp 56.73 -138.68 0.96 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 119.046 -0.502 . . . . 6.08 110.992 -166.283 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.2 151.21 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 105.976 -1.861 . . . . 6.7 105.976 178.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 C--O 1.251 1.157 0 N-CA-C 105.012 -2.218 . . . . 10.32 105.012 173.219 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 m . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 106.608 -1.627 . . . . 2.39 106.608 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.7 tp -144.01 140.13 29.41 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 105.808 -1.923 . . . . 3.01 105.808 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -106.3 135.74 47.25 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 124.449 1.093 . . . . 2.79 109.264 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.52 137.03 54.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.079 1.352 . . . . 1.36 107.888 174.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 t -82.68 114.99 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.772 -1.566 . . . . 1.4 106.772 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 m -106.66 84.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 126.747 2.019 . . . . 0.83 108.849 -166.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.76 122.41 25.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.493 -1.299 . . . . 5.11 107.493 -174.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.78 -37.0 2.41 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.548 1.07 . . . . 0.95 110.755 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.62 113.4 24.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.683 -1.599 . . . . 1.83 106.683 -172.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.84 25.46 0.27 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.245 1.202 . . . . 3.85 114.245 -167.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.6 p -147.34 167.19 24.93 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 120.957 -1.09 . . . . 1.27 108.205 161.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.08 -36.77 13.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.477 1.111 . . . . 1.06 112.059 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -59.44 -50.31 74.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 110.145 -0.317 . . . . 1.89 110.145 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -61.92 -41.35 97.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.681 -0.637 . . . . 0.71 110.929 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.0 t -51.5 -61.11 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.417 -0.957 . . . . 0.65 108.417 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.289 0.8 OUTLIER -66.65 -29.6 69.66 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 118.829 -0.605 . . . . 0.98 111.553 -174.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -52.94 -58.99 5.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.197 0.999 . . . . 3.79 109.127 170.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.8 mt -61.34 -59.0 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.761 -0.776 . . . . 0.75 108.918 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.87 -52.53 60.17 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 119.394 -0.336 . . . . 2.63 110.85 -168.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -62.04 -44.08 97.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.877 0.471 . . . . 2.39 111.561 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.8 t -64.85 -35.0 79.7 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.745 -0.597 . . . . 1.0 110.982 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -70.61 -48.36 55.49 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 118.53 -0.748 . . . . 1.7 111.407 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 p -68.06 72.75 0.18 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.052 0.93 . . . . 1.84 112.645 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.83 -38.88 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.992 2.117 . . . . 4.18 110.352 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -70.92 132.03 44.62 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.043 0.838 . . . . 2.45 109.551 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -55.21 149.56 12.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.45 -0.574 . . . . 6.07 109.45 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.01 -39.82 2.62 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.432 -1.067 . . . . 1.02 110.432 -173.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.69 111.62 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 119.086 1.443 . . . . 1.92 109.249 -172.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.1 mt -80.0 -46.81 15.97 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.698 -0.853 . . . . 2.04 108.698 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -157.18 130.99 8.15 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 109.105 -0.702 . . . . 2.28 109.105 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.8 p -97.17 152.3 18.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.038 -1.097 . . . . 2.76 108.038 165.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.9 t -155.55 150.44 26.48 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 119.534 -0.866 . . . . 2.35 108.91 140.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.36 143.61 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.72 0.808 . . . . 1.91 110.014 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.4 132.43 41.16 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.568 0.747 . . . . 0.91 110.555 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.4 -26.97 52.23 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.182 -0.917 . . . . 2.47 111.729 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -46.74 -44.53 18.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.16 0.984 . . . . 1.42 112.399 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -117.49 18.45 14.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.66 1.184 . . . . 2.69 110.866 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 35.06 54.99 0.76 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 127.144 2.178 . . . . 2.42 111.909 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -112.59 148.56 34.3 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.589 0.756 . . . . 1.66 109.551 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.83 125.73 47.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.249 -1.76 . . . . 1.0 106.249 166.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.474 ' C ' HD12 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -107.45 129.72 54.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.122 -1.436 . . . . 2.65 107.122 169.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.474 HD12 ' C ' ' A' ' 45' ' ' HIS . 2.2 mp -119.45 110.75 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 104.685 -2.339 . . . . 1.21 104.685 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -83.08 70.36 10.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.655 -1.239 . . . . 3.76 107.655 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -86.68 141.34 29.0 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.987 0.515 . . . . 2.54 111.976 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -57.13 112.46 4.64 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.229 -1.026 . . . . 2.43 108.229 169.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.48 48.7 2.95 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.338 2.692 . . . . 1.65 111.891 -166.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -137.29 -63.09 0.6 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.933 1.293 . . . . 3.86 109.365 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.2 pt -77.09 -24.02 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.025 0 N-CA-C 112.921 0.712 . . . . 1.93 112.921 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.2 tt -139.82 143.09 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.921 -0.77 . . . . 1.3 108.921 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -117.72 175.11 15.56 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.296 0.951 . . . . 0.87 112.177 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -61.43 -38.91 60.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.01 2.473 . . . . 0.84 110.795 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -46.43 -53.02 11.89 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.158 0.983 . . . . 7.19 110.592 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -67.62 -46.54 72.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.957 -1.127 . . . . 2.93 107.957 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.3 mm -54.46 -46.65 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.572 0.349 . . . . 2.04 111.39 172.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.0 mt -53.67 -54.32 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.432 -0.581 . . . . 0.98 109.432 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -61.22 -42.89 99.39 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.537 0.684 . . . . 2.6 110.441 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.1 m -58.33 -49.3 77.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.587 0.755 . . . . 1.09 109.832 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 mm -68.24 -43.25 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 119.289 -0.386 . . . . 1.47 110.257 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -52.62 -42.3 64.47 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.465 0.575 . . . . 5.16 110.684 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.0 m -54.8 -23.45 18.21 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.075 0.769 . . . . 1.67 113.075 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 mt -87.06 -9.94 54.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.906 0.883 . . . . 1.0 112.117 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.9 40.16 6.31 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.085 1.326 . . . . 0.82 112.489 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -142.07 141.09 32.74 Favored 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 106.529 -1.656 . . . . 2.01 106.529 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -91.13 113.83 59.56 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 119.56 1.073 . . . . 5.57 109.989 -172.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -91.96 140.27 2.29 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.974 3.116 . . . . 1.66 110.696 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.8 m -145.02 125.61 14.12 Favored 'General case' 0 C--N 1.335 -0.063 0 O-C-N 120.657 -1.277 . . . . 2.71 109.023 167.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.45 136.19 57.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.661 1.184 . . . . 2.55 111.938 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.3 t . . . . . 0 CA--C 1.534 0.35 0 C-N-CA 123.993 0.917 . . . . 2.79 111.488 175.533 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 p . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 110.066 -0.346 . . . . 2.92 110.066 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -123.29 137.36 54.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.892 -1.521 . . . . 3.52 106.892 169.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -105.46 106.29 16.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.539 1.535 . . . . 4.16 108.451 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.03 126.39 52.67 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.235 -1.394 . . . . 1.46 107.235 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.98 95.36 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 106.855 -1.535 . . . . 1.03 106.855 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.16 65.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.064 1.745 . . . . 0.76 109.231 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -74.67 131.47 40.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.058 -1.089 . . . . 4.94 108.058 -172.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.51 -49.69 0.83 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.545 -1.422 . . . . 0.75 109.545 -167.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -74.94 149.81 39.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.072 0.936 . . . . 1.32 110.165 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 t -153.34 22.3 0.55 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.433 0.531 . . . . 2.5 112.433 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.16 145.41 19.39 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.775 0.716 . . . . 1.56 109.927 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.51 -40.25 37.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.976 1.31 . . . . 1.16 111.317 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -41.27 -49.6 3.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.996 1.718 . . . . 2.04 111.822 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -73.8 -42.97 60.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.848 1.055 . . . . 1.32 113.848 174.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.8 t -49.0 -57.05 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.673 0.749 . . . . 0.94 109.292 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -69.3 -24.12 63.9 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.535 -0.757 . . . . 1.22 111.956 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -58.63 -54.13 50.53 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.03 -1.47 . . . . 3.71 107.03 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.77 -59.03 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 109.316 -0.624 . . . . 0.74 109.316 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -54.64 -56.57 17.67 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.374 0.533 . . . . 2.55 111.407 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.4 t -54.56 -47.66 72.98 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.315 1.046 . . . . 1.67 110.53 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -59.63 -51.61 69.08 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.144 -0.347 . . . . 1.18 110.517 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.43 -34.15 77.52 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.786 -0.572 . . . . 2.16 111.953 -176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 p -65.49 72.12 0.05 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.422 0.555 . . . . 2.0 110.877 170.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -150.52 -43.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.447 1.899 . . . . 5.76 111.817 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -57.55 -43.37 84.41 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.429 0.9 . . . . 3.82 113.429 -168.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 131.36 -82.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 129.583 3.153 . . . . 6.72 107.841 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.19 54.24 3.9 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 123.821 0.724 . . . . 1.64 112.995 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.08 129.12 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.427 -1.694 . . . . 1.85 106.427 157.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.4 mt -85.44 -45.03 12.23 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.045 -0.724 . . . . 2.16 109.045 172.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -155.8 120.24 4.62 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.91 0.323 . . . . 2.56 110.883 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.8 m -79.89 135.7 36.5 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 106.361 -1.718 . . . . 2.9 106.361 164.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 t -140.52 96.54 3.05 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.346 0.975 . . . . 2.31 108.713 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -105.92 135.63 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.4 1.08 . . . . 2.62 109.214 -172.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.76 134.64 23.73 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.3 0.572 . . . . 0.67 111.186 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 pp -76.23 -26.48 56.09 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.006 0.922 . . . . 1.87 111.394 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.04 -36.76 41.44 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.413 1.085 . . . . 1.07 112.371 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 p -129.62 31.51 4.76 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.479 0.712 . . . . 2.4 110.343 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.7 m120 33.73 54.99 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.916 2.486 . . . . 1.88 112.408 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -133.47 157.42 45.66 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.525 0.33 . . . . 2.07 111.886 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.47 127.09 54.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.097 -1.816 . . . . 0.65 106.097 161.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.49 129.22 38.49 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 103.97 -2.604 . . . . 2.31 103.97 154.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.9 mt -118.55 118.32 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 105.229 -2.137 . . . . 1.45 105.229 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -89.88 104.94 17.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.421 -1.696 . . . . 3.37 106.421 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -132.03 151.87 51.49 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 123.576 0.547 . . . . 2.33 112.229 -171.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -90.79 112.51 53.81 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 125.104 1.362 . . . . 3.08 108.402 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -77.84 41.26 0.97 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.457 2.105 . . . . 1.63 112.243 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.68 -37.86 17.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.086 0.954 . . . . 5.46 110.249 170.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.12 -54.46 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.682 1.193 . . . . 2.07 110.896 -174.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.2 123.73 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.165 -0.68 . . . . 1.72 109.165 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.83 -175.45 22.27 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 109.565 -1.414 . . . . 0.65 109.565 170.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -59.39 -36.31 94.38 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.804 1.669 . . . . 0.85 109.949 170.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -45.56 -59.67 2.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.45 1.5 . . . . 6.33 111.777 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.84 -51.43 69.74 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.617 1.567 . . . . 2.31 110.426 -172.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 94.5 mt -52.34 -54.25 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 114.209 -1.36 . . . . 1.46 108.478 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.9 mt -60.04 -53.39 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.94 -0.573 . . . . 0.68 109.681 -172.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -58.83 -39.98 82.82 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.739 0.699 . . . . 3.0 110.655 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.0 m -56.65 -52.23 65.7 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.311 -0.404 . . . . 0.96 110.227 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.06 -40.52 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.8 -0.562 . . . . 1.05 111.149 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -47.15 -49.35 22.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.34 0.656 . . . . 3.5 109.398 169.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -58.45 -24.37 60.1 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.446 0.906 . . . . 1.33 113.446 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.1 mt -84.94 -12.85 52.46 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.092 0.86 . . . . 1.18 112.069 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.09 44.22 4.8 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.101 0.858 . . . . 0.88 112.769 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -138.61 159.47 42.02 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 106.846 -1.539 . . . . 1.96 106.846 170.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -98.35 98.85 6.28 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.433 -0.794 . . . . 2.87 110.507 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.82 80.79 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 124.314 3.343 . . . . 0.92 110.717 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 m -79.27 101.37 7.99 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.237 -1.023 . . . . 1.92 108.237 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.5 64.16 0.11 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.893 1.677 . . . . 2.93 113.22 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.4 t . . . . . 0 CA--C 1.535 0.386 0 O-C-N 121.637 -0.664 . . . . 2.42 111.237 -177.117 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t . . . . . 0 N--CA 1.455 -0.194 0 N-CA-C 107.131 -1.433 . . . . 2.81 107.131 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.8 tp -124.13 144.28 49.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.05 -2.204 . . . . 2.6 105.05 155.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -114.19 132.42 56.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.933 -0.766 . . . . 2.19 108.933 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 mt -118.48 123.98 46.49 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.99 -1.856 . . . . 2.84 105.99 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -78.9 95.18 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.592 -2.003 . . . . 1.44 105.592 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.26 84.07 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 126.319 1.847 . . . . 0.83 108.858 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 -75.6 130.87 39.49 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.935 -1.135 . . . . 5.0 107.935 -171.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.78 -48.46 0.97 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.399 1.0 . . . . 1.25 110.945 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -64.87 127.56 32.08 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.69 0.745 . . . . 1.6 110.37 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -144.6 5.34 1.2 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.246 1.202 . . . . 2.62 114.246 -167.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 p -160.84 166.39 28.62 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.645 1.112 . . . . 1.55 109.601 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.47 -45.3 9.1 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.201 1.4 . . . . 0.75 111.503 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -42.26 -49.24 5.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.067 1.747 . . . . 1.88 112.457 172.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.3 m -72.69 -51.18 20.43 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.153 0.581 . . . . 0.94 111.136 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -46.74 -58.84 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.045 0.938 . . . . 0.66 109.039 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -69.83 -23.53 63.32 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.989 -1.005 . . . . 0.94 111.942 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -67.66 -51.69 46.88 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 107.892 -1.151 . . . . 3.82 107.892 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 mt -55.39 -58.81 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.734 -0.839 . . . . 0.74 108.734 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.07 -54.62 32.8 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.001 0.364 . . . . 2.76 111.612 -174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -60.66 -45.09 95.45 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.158 -0.339 . . . . 1.76 111.912 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 t -62.97 -49.59 74.13 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.903 -0.498 . . . . 1.25 110.226 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.461 HD11 HG23 ' A' ' 58' ' ' ILE . 3.5 mm? -51.19 -47.16 62.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.708 0.803 . . . . 1.78 110.548 177.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 p -62.31 -0.31 0.55 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.629 1.344 . . . . 2.13 114.629 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -57.49 -42.59 83.0 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.306 1.412 . . . . 6.42 110.66 164.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -94.12 138.92 31.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.339 -0.544 . . . . 2.54 111.867 -155.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -60.27 167.54 2.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.532 0.682 . . . . 5.77 109.905 169.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.09 -15.23 0.74 Allowed Glycine 0 CA--C 1.521 0.459 0 CA-C-O 117.669 -1.629 . . . . 1.11 113.555 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.3 139.63 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 120.365 2.083 . . . . 1.64 105.746 165.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.6 mt -102.58 -37.98 7.72 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.927 -1.033 . . . . 2.37 108.506 164.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -157.54 155.13 29.71 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.58 1.082 . . . . 2.25 109.872 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.8 t -126.04 143.08 51.25 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.397 -2.075 . . . . 2.12 105.397 162.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -149.16 148.67 29.91 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 118.097 -1.441 . . . . 2.27 109.965 144.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 44' ' ' ALA . 2.4 m -125.9 142.41 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 123.882 0.739 . . . . 1.95 111.467 -172.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.17 128.09 44.14 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.205 1.002 . . . . 0.93 111.027 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.68 -36.67 32.01 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 114.27 -1.332 . . . . 2.08 113.209 -163.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.73 -37.8 59.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.54 0.609 . . . . 1.71 111.148 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -96.12 -7.59 35.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.318 2.247 . . . . 2.73 111.694 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.7 m120 41.95 48.08 3.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.737 1.615 . . . . 2.18 110.79 -166.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -114.38 151.24 33.38 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.434 0.561 . . . . 1.64 111.255 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.439 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -123.92 121.78 36.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.88 1.672 . . . . 0.62 106.741 169.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -96.03 123.32 39.58 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.615 -2.365 . . . . 3.17 104.615 168.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.9 mm -104.64 130.17 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 106.916 -1.513 . . . . 1.76 106.916 168.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -98.4 101.06 12.39 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 105.083 -2.191 . . . . 2.68 105.083 162.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -129.77 155.15 46.4 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.925 1.29 . . . . 2.12 109.147 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -75.71 110.84 11.81 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.496 1.118 . . . . 2.81 108.696 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.39 58.58 6.75 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.279 2.653 . . . . 1.62 111.363 -173.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -135.16 -68.63 0.52 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.042 1.337 . . . . 4.36 108.99 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -91.0 -40.07 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.061 0 C-N-CA 123.062 0.545 . . . . 2.26 112.108 -172.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -97.01 119.08 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.639 -1.245 . . . . 1.57 107.639 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.81 163.5 36.69 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.123 -0.791 . . . . 1.29 111.123 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -54.63 -30.01 63.77 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.68 2.253 . . . . 1.29 110.842 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -55.06 -49.09 72.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.344 -1.312 . . . . 5.51 113.663 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.448 ' HB3' HD11 ' A' ' 53' ' ' ILE . 16.4 t0 -63.1 -49.49 74.24 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 121.312 1.869 . . . . 5.65 109.85 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.461 HG23 HD11 ' A' ' 26' ' ' LEU . 66.5 mt -47.17 -56.08 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-O 121.443 0.639 . . . . 1.27 109.772 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.8 mt -59.07 -55.95 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.823 -0.626 . . . . 0.92 109.663 -174.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -62.96 -34.14 76.88 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.936 -0.477 . . . . 2.6 111.475 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.3 m -56.56 -53.57 56.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.948 -0.76 . . . . 1.23 108.948 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.29 -39.43 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 121.507 -0.745 . . . . 1.13 111.373 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.77 -44.72 82.07 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.715 -0.616 . . . . 3.04 109.682 172.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.7 m -61.47 -41.43 97.23 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.201 -0.312 . . . . 1.36 111.6 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.66 -41.87 91.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.495 0.588 . . . . 1.44 110.724 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.86 45.28 0.83 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.286 0.946 . . . . 0.87 111.435 175.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.07 162.12 30.52 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.077 -1.453 . . . . 1.94 107.077 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -100.15 98.28 7.41 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 118.198 -0.906 . . . . 2.61 110.099 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.38 75.41 3.87 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.609 2.872 . . . . 1.21 110.111 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.6 m -79.99 107.63 12.93 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.491 -0.929 . . . . 1.77 108.491 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.76 59.36 0.47 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.679 0.791 . . . . 2.55 112.596 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 t . . . . . 0 N--CA 1.451 -0.408 0 C-N-CA 125.512 1.525 . . . . 3.35 107.307 178.651 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 p . . . . . 0 C--O 1.236 0.352 0 N-CA-C 108.79 -0.819 . . . . 2.99 108.79 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 tp -104.0 149.59 25.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.663 -1.977 . . . . 2.94 105.663 165.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.33 151.19 37.5 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.312 -0.996 . . . . 2.27 108.312 165.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.13 130.43 23.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.35 -1.722 . . . . 1.38 106.35 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -79.62 100.81 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 105.411 -2.07 . . . . 1.02 105.411 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.2 m -81.83 79.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 126.353 1.861 . . . . 0.67 108.161 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.2 mtp-105 -76.74 141.72 40.73 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.605 -0.887 . . . . 5.36 108.605 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.63 -45.83 1.13 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.318 -1.113 . . . . 0.84 110.318 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.03 141.44 28.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.533 0.667 . . . . 1.7 109.644 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -152.81 41.91 0.6 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.304 0.502 . . . . 4.86 110.256 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.47 144.9 12.62 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.765 -0.585 . . . . 1.83 111.039 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.98 -39.85 20.68 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.598 1.559 . . . . 0.83 112.059 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.4 t -45.26 -51.44 10.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.056 0.542 . . . . 1.93 110.458 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.3 m -76.79 -33.85 58.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.101 -1.625 . . . . 1.42 114.169 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -46.75 -56.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.642 -0.873 . . . . 0.53 108.642 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -70.39 -21.84 62.81 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.167 -0.924 . . . . 0.84 112.825 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -64.89 -54.5 29.83 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 106.781 -1.563 . . . . 4.56 106.781 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.4 -56.47 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.852 -0.796 . . . . 0.75 108.852 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.31 -53.73 54.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.999 0.818 . . . . 2.6 111.693 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.1 t -63.76 -29.17 70.41 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.059 0.39 . . . . 1.59 111.756 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.4 t -71.05 -52.96 16.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.204 -0.665 . . . . 1.35 109.204 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -53.43 -46.14 69.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.152 0.981 . . . . 1.83 110.954 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.2 p -59.51 -16.73 26.46 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.953 0.723 . . . . 2.06 112.953 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -69.92 -24.0 63.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.819 1.19 . . . . 6.49 111.515 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -68.48 87.08 0.31 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.73 0.696 . . . . 3.01 109.885 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 23.27 -66.21 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.0 2.52 . . . . 10.26 116.758 145.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.52 48.39 0.97 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.338 0.97 . . . . 1.4 112.644 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -91.08 117.82 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.022 -1.473 . . . . 2.22 107.022 154.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -80.68 -35.5 33.59 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.758 -0.589 . . . . 2.67 110.45 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -157.01 135.6 11.49 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.948 0.795 . . . . 2.17 110.466 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.8 p -114.65 155.09 27.23 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.277 1.031 . . . . 2.55 108.389 165.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.6 m -149.47 141.34 23.72 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.184 -1.413 . . . . 2.03 107.184 150.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.94 135.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.732 0.813 . . . . 1.79 110.197 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.36 134.09 55.11 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.347 0.659 . . . . 0.63 110.149 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -82.07 -37.64 26.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.255 -0.884 . . . . 1.76 111.286 -171.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.94 64.21 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.36 0.664 . . . . 1.67 112.301 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.8 t -107.05 4.63 27.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.037 1.335 . . . . 2.41 111.234 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.9 m120 42.96 48.95 5.2 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.614 1.966 . . . . 1.87 110.83 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.15 137.23 30.74 Favored 'General case' 0 CA--C 1.522 -0.109 0 O-C-N 121.735 -0.603 . . . . 1.89 112.086 -165.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.2 142.09 32.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.625 1.57 . . . . 0.91 108.232 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.07 135.14 48.06 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.481 -2.044 . . . . 2.73 105.481 152.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.2 mt -134.79 114.87 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.159 -1.793 . . . . 1.07 106.159 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -97.28 80.03 2.86 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.701 -1.592 . . . . 2.55 106.701 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -85.53 143.1 28.7 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.63 -0.714 . . . . 2.33 111.638 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -75.41 111.34 13.57 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.626 1.17 . . . . 3.09 107.914 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.63 47.56 2.6 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.356 2.704 . . . . 1.42 113.234 -163.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -134.16 -63.9 0.71 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.37 1.468 . . . . 3.8 108.554 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.485 HD12 ' HB ' ' A' ' 53' ' ' ILE . 2.1 pp -70.5 -34.35 57.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 122.858 0.463 . . . . 2.23 111.462 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.485 ' HB ' HD12 ' A' ' 52' ' ' ILE . 8.6 tt -126.83 156.58 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.81 1.244 . . . . 1.86 110.406 -173.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -154.39 178.34 31.25 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 107.198 -2.361 . . . . 0.77 107.198 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.61 -50.24 14.72 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.399 2.733 . . . . 0.8 111.485 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -52.38 -44.97 65.6 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.59 0.959 . . . . 7.1 113.59 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -59.47 -60.01 4.53 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.574 0.702 . . . . 3.91 109.429 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mt -45.78 -54.43 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.466 1.106 . . . . 1.38 109.818 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.2 mt -59.25 -48.16 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.654 -0.703 . . . . 0.81 110.415 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -57.23 -41.77 80.16 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.764 0.711 . . . . 3.11 109.265 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.8 m -62.8 -51.18 68.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.863 -0.608 . . . . 1.19 110.728 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 98.0 mt -62.86 -44.35 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 118.86 0.755 . . . . 1.14 111.278 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -49.09 -48.9 43.96 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.562 0.745 . . . . 3.36 109.188 170.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t -62.8 -17.08 60.62 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.815 1.043 . . . . 1.98 113.815 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.02 -16.15 41.72 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.06 1.3 . . . . 1.11 111.23 171.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.62 42.38 6.49 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.866 0.746 . . . . 0.85 111.685 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -132.79 153.09 51.58 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.181 -1.414 . . . . 1.96 107.181 170.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.27 109.28 32.39 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.179 0.991 . . . . 2.71 109.165 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.52 77.86 3.9 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.462 2.108 . . . . 1.0 110.249 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.8 t -78.68 98.85 6.36 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.264 -0.897 . . . . 1.81 109.417 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.05 61.26 0.19 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.42 1.888 . . . . 2.76 113.241 -173.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t . . . . . 0 CA--C 1.535 0.393 0 C-N-CA 123.172 0.589 . . . . 2.5 109.866 -179.644 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 107.238 -1.393 . . . . 2.89 107.238 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.6 tp -95.88 148.64 22.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.536 -1.653 . . . . 2.85 106.536 166.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -136.87 127.25 26.59 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.876 0.87 . . . . 2.31 108.913 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.54 150.86 48.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.504 0.722 . . . . 3.43 110.308 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.0 t -84.89 124.22 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.284 -1.376 . . . . 1.14 107.284 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.59 102.91 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 126.994 2.118 . . . . 1.26 108.374 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -87.4 148.93 24.79 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.061 -0.718 . . . . 5.14 109.061 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.11 -52.35 0.64 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.23 -1.148 . . . . 0.77 110.23 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.79 134.92 56.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 117.285 0.542 . . . . 1.79 109.611 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.4 t -155.22 11.62 0.34 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.891 1.071 . . . . 2.17 113.891 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.6 p -161.11 171.75 18.0 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.808 1.185 . . . . 1.43 109.119 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -44.28 7.81 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.371 1.469 . . . . 0.78 111.594 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 t -52.83 -48.73 66.78 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.746 0.419 . . . . 2.05 110.071 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.3 m -70.65 -53.46 15.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.473 -0.767 . . . . 0.79 109.627 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -41.33 -60.21 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 125.787 1.635 . . . . 0.73 109.137 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.255 0.6 OUTLIER -68.25 -21.3 64.83 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.803 0.668 . . . . 0.92 112.803 -171.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -70.12 -46.91 63.82 Favored 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.978 -1.119 . . . . 4.4 107.978 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.67 -57.67 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.895 -0.78 . . . . 0.88 108.895 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.75 -56.49 18.71 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.373 0.269 . . . . 2.81 110.859 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.0 t -58.34 -50.07 74.94 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.997 0.427 . . . . 1.53 110.71 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.4 t -69.2 -27.14 65.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.551 -0.718 . . . . 1.02 111.445 -173.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.11 -52.52 23.03 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.383 0.538 . . . . 2.25 110.651 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -70.06 67.68 0.29 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.398 1.094 . . . . 1.73 112.321 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -169.91 -38.03 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.968 2.507 . . . . 3.73 109.624 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -69.84 137.68 51.95 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.939 0.791 . . . . 2.17 110.205 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 -50.84 143.87 9.32 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.622 -0.51 . . . . 5.49 109.622 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.27 -20.43 37.29 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-O 118.05 -1.417 . . . . 0.99 113.407 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.52 133.98 29.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 N-CA-C 105.849 -1.908 . . . . 1.53 105.849 160.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.5 mt -97.44 -48.45 5.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.477 1.111 . . . . 2.3 108.106 168.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -156.14 153.64 29.62 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.608 -0.516 . . . . 2.53 109.608 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.9 t -132.79 145.48 51.03 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.451 -1.314 . . . . 2.2 107.451 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -136.04 153.08 51.46 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.502 -1.296 . . . . 2.8 107.502 142.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.403 HG12 ' CB ' ' A' ' 44' ' ' ALA . 2.2 m -125.37 143.61 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.902 0.881 . . . . 1.89 109.742 175.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.51 129.95 41.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.802 0.811 . . . . 0.79 111.802 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.56 -28.64 62.95 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.752 1.221 . . . . 2.33 111.33 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.78 -44.16 73.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.035 0.534 . . . . 1.09 111.064 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.52 -31.27 17.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.472 -0.566 . . . . 2.25 109.472 172.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 79.24 41.81 0.08 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.997 2.119 . . . . 3.54 107.796 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -133.6 141.66 47.76 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.741 -0.466 . . . . 2.25 109.741 -168.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.403 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -103.54 136.73 42.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.015 1.326 . . . . 0.59 107.949 168.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -102.36 150.15 23.62 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.085 -1.45 . . . . 3.55 107.085 159.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.44 HG22 ' HB3' ' A' ' 48' ' ' TYR . 1.3 mp -134.63 101.35 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.543 -2.021 . . . . 1.18 105.543 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -81.18 123.6 28.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.196 -2.149 . . . . 3.57 105.196 170.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . 0.44 ' HB3' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -163.72 170.48 16.94 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 120.958 0.408 . . . . 2.5 110.644 -152.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -101.51 93.82 3.69 Favored Pre-proline 0 N--CA 1.447 -0.592 0 C-N-CA 125.544 1.538 . . . . 2.97 108.733 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.82 52.93 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.679 2.92 . . . . 1.73 110.799 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -159.99 25.66 0.17 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.464 1.506 . . . . 4.72 109.287 -169.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -167.17 -50.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 126.503 1.921 . . . . 3.18 108.069 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.1 tt -118.85 157.39 20.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 124.625 1.17 . . . . 1.12 109.51 -172.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.36 -177.27 16.37 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.154 -0.778 . . . . 0.62 111.154 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.41 -39.94 42.87 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.543 2.162 . . . . 0.79 110.15 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -48.37 -53.4 17.71 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.574 1.15 . . . . 6.1 111.476 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.72 -52.09 66.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.211 0.529 . . . . 2.55 109.637 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.8 mt -55.87 -52.97 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.75 0.82 . . . . 1.43 108.974 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.455 HD11 HD21 ' A' ' 71' ' ' LEU . 20.2 mt -50.97 -55.1 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.246 -0.65 . . . . 0.57 109.246 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -66.02 -37.87 86.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.152 0.501 . . . . 2.84 110.703 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.3 m -55.59 -47.79 75.91 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.283 -0.417 . . . . 0.72 110.345 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 79.8 mt -70.26 -44.04 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.757 -0.589 . . . . 1.02 110.953 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -49.58 -44.61 47.09 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.645 0.778 . . . . 2.69 109.894 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -52.78 -34.7 54.58 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.147 0.579 . . . . 2.04 112.521 175.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.5 mt -76.72 -13.37 60.04 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.368 -0.832 . . . . 1.1 112.319 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.87 45.46 5.7 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.731 0.681 . . . . 0.81 111.791 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -132.81 156.56 46.89 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.182 -1.414 . . . . 1.84 107.182 171.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -96.4 99.7 5.82 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-O 117.547 -1.216 . . . . 2.63 110.406 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -79.08 143.53 17.95 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 CA-C-N 121.43 1.547 . . . . 1.69 109.389 169.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 p -155.46 121.17 5.02 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.588 -0.695 . . . . 1.64 109.484 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.686 HD22 ' H ' ' A' ' 71' ' ' LEU . 1.5 mm? -61.25 133.76 56.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.904 0.882 . . . . 2.9 111.584 -169.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.9 t . . . . . 0 N--CA 1.465 0.318 0 C-N-CA 123.217 0.607 . . . . 2.45 111.604 175.487 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 p . . . . . 0 C--O 1.236 0.389 0 CA-C-O 122.47 1.128 . . . . 2.47 108.429 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mp -93.8 139.14 31.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.344 -0.844 . . . . 3.1 109.254 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.0 106.33 11.49 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.611 1.964 . . . . 3.25 107.496 -170.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.24 133.28 53.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.264 -1.384 . . . . 1.48 107.264 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.88 112.37 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -94.66 95.42 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.365 1.866 . . . . 0.67 107.813 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.35 155.75 29.91 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 119.278 -0.969 . . . . 4.97 108.404 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 -51.85 0.68 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.631 -0.987 . . . . 0.67 110.631 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -63.22 141.03 58.92 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 117.412 0.606 . . . . 1.84 111.355 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -155.1 10.85 0.34 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.067 1.136 . . . . 2.26 114.067 -173.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -162.0 161.46 28.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.853 1.206 . . . . 1.39 109.829 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.18 -39.4 9.62 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.62 1.568 . . . . 0.92 112.0 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 m -40.13 -56.25 1.94 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.923 1.289 . . . . 1.85 111.546 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.3 m -69.98 -36.66 75.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.586 0.354 . . . . 0.8 110.902 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.4 t -55.88 -59.28 2.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.013 -1.106 . . . . 0.72 108.013 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -68.4 -35.55 77.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 118.289 -0.862 . . . . 1.28 111.348 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -51.49 -55.3 19.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.942 1.247 . . . . 3.78 110.344 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.7 mt -54.25 -62.74 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 123.702 0.801 . . . . 0.97 109.056 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -59.74 -55.69 31.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.324 -0.551 . . . . 2.6 110.333 -172.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.9 p -54.72 -47.38 73.82 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.227 0.467 . . . . 2.05 111.182 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -70.65 -32.1 69.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.052 -0.659 . . . . 1.38 111.271 -175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.6 mt -68.52 -52.04 36.44 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.464 -0.773 . . . . 2.11 110.599 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.9 p -66.81 75.84 0.11 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.009 1.324 . . . . 1.86 110.854 -174.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? 179.64 -40.02 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.964 2.505 . . . . 3.68 109.233 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.409 ' CE1' ' HB ' ' A' ' 32' ' ' ILE . 11.8 p80 -69.22 139.75 54.52 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 118.962 -1.095 . . . . 2.04 108.965 175.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -60.1 144.42 49.75 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.108 -0.701 . . . . 7.34 109.108 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.01 -28.67 13.5 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-O 118.072 -1.404 . . . . 0.75 113.184 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.409 ' HB ' ' CE1' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -76.64 122.6 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 119.953 1.876 . . . . 1.69 108.286 169.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.0 mt -85.69 -52.69 5.63 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.004 -1.11 . . . . 2.43 108.004 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -157.12 144.65 18.89 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.18 -0.674 . . . . 3.63 109.18 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 t -107.26 129.62 54.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.19 -1.411 . . . . 2.65 107.19 167.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 t -112.0 104.08 12.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.777 -1.935 . . . . 2.25 105.777 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 p -102.13 141.4 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 118.938 0.79 . . . . 1.84 111.071 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.29 132.99 36.45 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.323 0.582 . . . . 0.77 110.487 172.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -76.2 -30.4 57.98 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.103 -0.953 . . . . 2.13 111.751 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.2 -32.17 22.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.806 0.842 . . . . 1.09 112.617 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.9 t -121.75 13.19 10.72 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.268 1.427 . . . . 2.2 111.088 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 m120 34.78 47.02 0.22 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.522 2.329 . . . . 2.0 111.818 -172.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -120.85 137.94 54.31 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.276 0.631 . . . . 2.28 109.648 -169.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.47 116.65 32.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.723 1.609 . . . . 0.71 108.224 167.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -91.25 110.62 21.91 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 102.562 -3.125 . . . . 2.29 102.562 166.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.9 mt -112.84 110.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.481 -1.674 . . . . 1.38 106.481 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.0 mtpm? -83.06 70.22 9.99 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.983 -1.488 . . . . 3.24 106.983 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -90.24 144.29 25.99 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.147 -0.933 . . . . 2.92 109.697 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.36 111.17 22.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 123.557 0.535 . . . . 3.99 111.026 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -66.72 -16.51 50.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.917 2.411 . . . . 2.17 112.451 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -85.3 -5.84 59.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.11 0.868 . . . . 5.2 111.002 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.4 pt -135.07 -27.73 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 114.392 1.256 . . . . 2.88 114.392 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.7 133.8 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 107.526 -1.287 . . . . 1.34 107.526 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.43 172.39 20.31 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.529 -0.732 . . . . 0.65 112.203 -172.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -56.72 -41.47 75.37 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.22 2.614 . . . . 0.85 110.655 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -57.13 -51.06 70.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.85 0.295 . . . . 6.37 110.615 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.98 -51.14 70.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.259 -0.645 . . . . 2.63 109.259 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.4 mm -54.38 -50.93 53.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.326 0.65 . . . . 2.09 111.609 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.4 mt -54.14 -56.43 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.935 -0.765 . . . . 0.68 108.935 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -65.5 -35.13 79.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.195 0.521 . . . . 2.89 111.021 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.3 m -56.27 -54.48 44.88 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.752 -0.462 . . . . 0.91 109.752 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.39 -36.05 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.516 -0.74 . . . . 1.29 111.712 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.75 -48.65 59.06 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.94 -0.763 . . . . 2.74 108.94 166.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.8 t -65.12 -13.93 59.3 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.836 1.05 . . . . 1.81 113.836 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.4 mt -88.15 -9.8 51.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.05 1.295 . . . . 1.33 111.319 170.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.25 41.72 6.48 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.383 0.992 . . . . 0.9 112.022 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -135.74 167.38 21.26 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.236 -1.024 . . . . 2.06 108.236 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -105.71 94.6 8.99 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.489 1.115 . . . . 2.65 110.636 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.3 80.52 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.631 2.887 . . . . 1.13 112.267 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.0 p -82.98 121.34 26.88 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.15 -0.969 . . . . 1.83 111.401 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.3 mt -70.35 72.42 0.47 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.194 -0.941 . . . . 3.43 111.503 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t . . . . . 0 CA--C 1.534 0.36 0 CA-C-O 118.878 -0.582 . . . . 2.66 112.16 -178.565 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.455 -0.225 0 N-CA-C 109.836 -0.431 . . . . 3.12 109.836 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.9 tp -108.78 149.45 29.04 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.974 -1.862 . . . . 2.83 105.974 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -118.67 152.73 35.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.092 -0.707 . . . . 2.6 109.092 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.714 HD21 HD13 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -150.0 133.27 16.39 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.135 -1.061 . . . . 1.31 108.135 177.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.37 105.07 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.32 -2.104 . . . . 1.04 105.32 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.464 HG23 ' SD ' ' A' ' 13' ' ' MET . 3.2 m -95.53 86.35 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 126.221 1.808 . . . . 0.65 107.994 -172.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.5 mtp-105 -77.38 132.65 38.64 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 119.899 -0.721 . . . . 6.06 109.748 -170.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.01 -4.01 5.65 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.45 1.5 . . . . 1.03 113.187 171.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.464 ' SD ' HG23 ' A' ' 10' ' ' VAL . 41.4 mtp -75.92 116.33 16.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.042 1.421 . . . . 1.89 110.097 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -98.91 -21.02 16.49 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.488 -1.244 . . . . 3.13 113.253 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.9 p -162.7 175.81 10.96 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.636 1.562 . . . . 1.79 112.221 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -35.94 58.72 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.586 1.154 . . . . 0.96 111.923 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -57.25 -37.03 71.69 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-O 118.368 -0.825 . . . . 2.49 110.105 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.4 m -69.07 -53.45 20.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 120.025 1.284 . . . . 0.79 109.687 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -41.67 -57.46 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.944 1.298 . . . . 0.66 110.257 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.89 -21.26 66.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.23 -0.896 . . . . 1.66 112.735 -170.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -69.1 -47.86 64.07 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 107.309 -1.367 . . . . 4.84 107.309 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.656 ' HB ' HG11 ' A' ' 37' ' ' VAL . 2.9 mt -64.65 -54.56 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.306 -0.998 . . . . 0.97 108.306 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.574 ' HG3' HG12 ' A' ' 37' ' ' VAL . 19.3 mt-10 -50.41 -59.99 3.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.206 0.457 . . . . 2.35 111.028 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.2 t -55.03 -52.6 62.67 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.113 0.482 . . . . 2.09 111.415 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -66.84 -28.0 68.0 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.527 0.731 . . . . 1.55 111.533 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.0 -47.7 61.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.337 -0.852 . . . . 2.06 109.701 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.5 p -70.87 68.53 0.43 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.412 0.551 . . . . 1.58 112.12 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.69 -30.83 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.906 1.283 . . . . 5.08 114.033 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -51.7 -47.84 63.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.357 0.981 . . . . 3.97 112.968 -174.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 139.59 -85.6 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 129.901 3.28 . . . . 7.43 104.836 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.58 53.84 4.87 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.695 -0.562 . . . . 1.04 111.695 -166.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.3 mt -114.61 124.17 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.555 -2.016 . . . . 2.88 105.555 160.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 mt -79.76 -44.56 20.47 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.556 -0.905 . . . . 1.98 108.556 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -156.89 157.66 35.27 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.208 -1.034 . . . . 2.67 108.208 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.9 t -128.21 145.65 50.97 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 104.899 -2.26 . . . . 2.28 104.899 163.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.52 149.8 41.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 118.587 -1.245 . . . . 2.33 110.203 153.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.656 HG11 ' HB ' ' A' ' 22' ' ' ILE . 13.1 p -143.1 108.59 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 124.586 1.179 . . . . 1.64 112.451 -162.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.78 134.26 41.92 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.032 0.444 . . . . 0.8 111.199 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.06 -33.81 70.6 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 115.542 -0.754 . . . . 1.81 110.392 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -44.92 -44.23 9.56 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.364 1.466 . . . . 1.37 113.081 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -123.59 22.13 9.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.262 0.625 . . . . 2.53 110.79 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 42.44 58.88 2.9 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.198 2.199 . . . . 3.23 109.834 177.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.8 136.46 24.27 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.882 -0.511 . . . . 1.82 111.535 -166.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -109.5 143.03 39.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.868 1.667 . . . . 0.94 108.987 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . 0.558 ' C ' HD12 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -106.91 140.23 40.06 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.028 -1.841 . . . . 2.87 106.028 153.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.714 HD13 HD21 ' A' ' 8' ' ' LEU . 1.7 mp -122.99 112.44 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.627 -1.99 . . . . 1.29 105.627 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -85.96 122.6 30.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.943 -1.503 . . . . 2.94 106.943 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -144.66 164.31 31.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.502 1.297 . . . . 2.22 114.502 -169.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.26 112.1 62.51 Favored Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 125.955 1.702 . . . . 2.75 108.374 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.24 2.26 5.18 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.228 1.952 . . . . 1.81 114.001 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.0 -32.56 73.94 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.646 1.112 . . . . 5.84 111.474 171.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.62 -59.33 2.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.515 0.674 . . . . 3.47 112.036 -160.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.1 tt -100.29 151.83 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.879 -0.6 . . . . 1.78 109.704 -161.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.73 -174.24 13.64 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.078 -1.609 . . . . 1.1 109.078 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -56.66 -40.46 84.2 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.926 1.75 . . . . 1.24 109.818 168.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.25 -55.86 7.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.341 1.056 . . . . 8.98 113.461 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.52 -49.24 78.35 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.402 -0.811 . . . . 2.71 109.812 -174.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.7 mt -56.58 -51.64 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 114.878 -1.055 . . . . 1.62 108.545 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.8 mt -57.02 -52.53 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.523 -0.547 . . . . 0.77 109.523 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.5 m170 -57.47 -42.84 83.39 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.379 1.085 . . . . 2.79 109.547 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.5 m -58.99 -52.91 63.74 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.67 -0.696 . . . . 1.16 110.137 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.7 mt -71.87 -37.94 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.668 -0.645 . . . . 1.11 111.819 -169.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -60.31 -45.58 92.88 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.201 -0.599 . . . . 4.17 109.682 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 t -59.09 -36.86 75.85 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.906 -0.568 . . . . 1.84 112.238 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.65 -46.1 87.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.531 1.06 . . . . 1.08 110.276 171.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.58 46.54 0.35 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.349 0.976 . . . . 0.87 111.932 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -134.78 163.54 29.56 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 107.312 -1.366 . . . . 2.05 107.312 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -97.63 103.71 17.74 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.041 -0.981 . . . . 3.34 109.852 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.56 77.47 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.212 2.608 . . . . 0.9 111.245 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -78.71 99.68 6.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.746 -0.596 . . . . 1.83 109.52 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.2 pt? -67.22 59.72 0.05 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.731 1.612 . . . . 2.85 114.575 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.9 t . . . . . 0 CA--C 1.537 0.444 0 O-C-N 120.743 -1.223 . . . . 2.51 109.445 176.324 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t . . . . . 0 N--CA 1.454 -0.233 0 N-CA-C 107.276 -1.379 . . . . 2.43 107.276 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.1 tp -139.86 144.69 37.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.453 -2.425 . . . . 3.11 104.453 166.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -116.32 140.13 49.66 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 123.776 0.673 . . . . 2.52 110.179 171.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.1 124.27 36.55 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.463 -1.68 . . . . 1.59 106.463 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.56 106.77 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 104.988 -2.227 . . . . 1.21 104.988 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -97.67 97.75 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 124.542 1.137 . . . . 0.79 108.261 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -76.99 147.29 36.92 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.245 -1.02 . . . . 8.24 108.245 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.76 -51.0 0.73 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.362 0.982 . . . . 0.82 111.02 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.44 132.28 37.24 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.419 1.109 . . . . 1.42 110.01 -171.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 t -156.53 12.8 0.28 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.571 1.323 . . . . 2.76 114.571 -166.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -161.16 165.13 29.96 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 120.212 1.369 . . . . 1.18 110.16 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.83 13.05 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.248 1.419 . . . . 0.82 111.766 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -37.81 -49.9 1.21 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.502 2.321 . . . . 2.13 112.122 170.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.1 m -71.87 -56.2 6.15 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.181 -0.463 . . . . 1.12 110.129 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -47.7 -54.75 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 124.004 0.921 . . . . 0.8 109.598 -164.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -65.58 -33.86 76.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.44 -0.8 . . . . 1.03 111.826 -174.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 pttp -71.61 -40.61 69.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.907 -0.775 . . . . 3.84 108.907 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.467 ' HB ' HG11 ' A' ' 37' ' ' VAL . 69.3 mt -57.17 -66.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.212 -1.032 . . . . 1.07 108.212 171.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' CG ' HG12 ' A' ' 37' ' ' VAL . 3.6 mt-10 -51.53 -55.75 17.25 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 119.295 0.952 . . . . 2.93 110.896 -173.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.8 t -50.53 -54.35 23.1 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.631 0.372 . . . . 1.97 111.148 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t -72.47 -26.87 61.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 114.033 1.123 . . . . 1.6 114.033 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.17 -43.38 70.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.204 -0.665 . . . . 1.72 109.204 171.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.1 p -70.17 68.68 0.33 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.879 0.847 . . . . 2.09 110.389 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -156.0 -49.53 0.08 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.853 2.861 . . . . 4.85 107.082 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -73.45 88.59 1.61 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.458 -0.571 . . . . 2.37 109.458 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -40.63 113.83 0.41 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.414 1.086 . . . . 6.63 109.528 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.86 -34.6 2.37 Favored Glycine 0 C--O 1.224 -0.529 0 N-CA-C 109.374 -1.49 . . . . 0.84 109.374 -164.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.02 125.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.493 -1.299 . . . . 1.61 107.493 174.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.9 mt -97.67 -40.1 8.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.465 0.706 . . . . 2.23 110.43 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -157.13 146.05 19.95 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.323 0.965 . . . . 2.6 109.906 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.1 p -144.22 56.8 1.31 Allowed 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.23 1.012 . . . . 2.8 111.818 -167.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -78.21 81.71 4.56 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.373 -0.829 . . . . 1.96 110.188 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.467 HG11 ' HB ' ' A' ' 22' ' ' ILE . 14.6 p -83.82 76.91 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.675 0.75 . . . . 1.77 112.766 -168.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.63 123.87 27.2 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 122.441 1.115 . . . . 0.87 112.469 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.95 -28.86 27.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 113.85 -1.523 . . . . 3.07 113.048 -166.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.45 -38.81 72.14 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.471 0.653 . . . . 1.73 110.618 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.52 -4.15 57.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.459 1.904 . . . . 3.77 111.42 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.4 m120 43.26 46.55 5.35 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.322 1.849 . . . . 1.9 111.4 -167.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -117.61 155.14 30.37 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.075 0.852 . . . . 2.01 111.565 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.89 139.81 49.86 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.474 -1.306 . . . . 0.72 107.474 147.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -90.97 138.86 31.28 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 103.845 -2.65 . . . . 2.84 103.845 148.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mm -122.43 106.25 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 106.725 -1.583 . . . . 2.09 106.725 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -79.75 68.26 5.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.067 -0.716 . . . . 2.26 109.067 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -73.57 143.88 46.26 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.019 -0.426 . . . . 2.25 111.482 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -62.17 113.15 7.78 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.853 1.261 . . . . 2.94 107.993 170.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.86 48.29 2.79 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.741 2.294 . . . . 1.76 112.736 -164.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -138.15 -64.11 0.54 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.678 1.191 . . . . 4.09 110.063 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.0 pt -73.63 -24.14 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 113.539 0.941 . . . . 1.85 113.539 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.0 tt -142.6 151.55 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 124.346 1.058 . . . . 1.24 108.239 -167.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.94 -178.57 15.75 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.717 -0.553 . . . . 0.74 111.717 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.79 -41.05 49.0 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.668 2.245 . . . . 0.79 110.375 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -44.76 68.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.284 0.634 . . . . 8.15 112.0 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.98 -53.39 57.42 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.388 0.613 . . . . 2.65 110.078 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.4 mt -57.95 -49.28 81.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 108.57 -0.9 . . . . 1.67 108.57 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 mt -53.19 -52.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.323 -0.621 . . . . 0.67 109.323 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -66.49 -34.45 77.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.94 0.4 . . . . 3.0 110.883 -176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 93.3 m -58.8 -52.52 65.38 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 110.109 -0.33 . . . . 0.83 110.109 172.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.9 mm -66.16 -40.23 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 121.269 -0.894 . . . . 1.51 110.895 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -53.57 -52.44 59.74 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.713 0.805 . . . . 3.1 109.195 170.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.7 t -55.46 -43.47 75.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.946 0.499 . . . . 1.69 111.109 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.12 -10.38 53.59 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.374 0.879 . . . . 1.09 113.374 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.25 30.53 8.16 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.577 1.084 . . . . 0.67 112.896 169.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -131.8 165.2 24.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.351 1.076 . . . . 2.02 110.219 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -107.95 100.16 34.45 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 124.307 1.043 . . . . 3.31 110.569 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.87 99.07 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.629 2.886 . . . . 1.06 111.069 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t -90.59 119.47 30.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.35 -1.352 . . . . 2.46 107.35 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 mt -71.14 118.93 14.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.343 -0.984 . . . . 2.82 108.343 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 109.494 -0.558 . . . . 2.59 109.494 173.849 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.7 m . . . . . 0 C--O 1.232 0.174 0 N-CA-C 109.46 -0.57 . . . . 2.64 109.46 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.61 126.86 7.16 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.804 0.668 . . . . 3.45 112.804 162.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -79.56 97.16 6.35 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.674 1.99 . . . . 3.6 109.378 169.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mt -92.61 116.48 29.04 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.074 -1.454 . . . . 2.64 107.074 172.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.5 t -77.27 97.54 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 105.978 -1.86 . . . . 1.32 105.978 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.0 m -78.48 74.63 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 125.438 1.495 . . . . 0.82 107.666 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -74.38 146.35 43.04 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.926 -1.509 . . . . 5.1 106.926 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.19 23.77 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.571 -1.127 . . . . 1.04 112.126 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.58 130.15 42.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.547 1.673 . . . . 1.7 108.974 -171.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 p -116.41 -48.7 2.69 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.545 0.943 . . . . 3.27 113.545 -158.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.87 164.87 14.79 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.777 0.831 . . . . 1.34 111.498 -166.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.18 -40.07 10.65 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.887 1.275 . . . . 0.79 111.622 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -41.22 -51.29 3.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.602 1.561 . . . . 1.65 111.992 170.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.2 m -70.45 -43.63 69.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.943 0.497 . . . . 0.73 111.101 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.626 HG13 HG13 ' A' ' 37' ' ' VAL . 61.2 t -53.18 -55.46 12.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.506 -0.924 . . . . 0.62 108.506 -174.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -69.26 -29.61 67.56 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.654 -0.703 . . . . 0.9 111.722 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -49.73 -54.84 16.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.472 1.033 . . . . 4.06 109.016 166.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.497 ' HB ' HG11 ' A' ' 37' ' ' VAL . 1.1 mt -59.77 -61.56 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.285 -0.635 . . . . 0.73 109.285 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.603 ' CG ' HG12 ' A' ' 37' ' ' VAL . 31.3 mt-10 -57.43 -55.25 37.17 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.65 0.659 . . . . 2.35 111.58 -173.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.1 m -59.85 -39.34 84.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.754 -0.591 . . . . 1.88 111.835 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 t -70.34 -46.08 64.86 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.585 -0.697 . . . . 0.93 111.092 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 mp -71.62 -61.02 1.93 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.147 0.579 . . . . 2.94 111.201 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.4 m -69.65 72.18 0.35 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.11 1.764 . . . . 2.86 110.746 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -176.17 -35.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 129.18 2.992 . . . . 3.77 109.335 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -65.3 120.93 13.67 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 119.344 0.975 . . . . 2.32 108.505 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 134.76 51.39 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.714 -1.587 . . . . 7.74 106.714 169.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.74 -41.28 2.0 Favored Glycine 0 C--O 1.225 -0.43 0 N-CA-C 110.047 -1.221 . . . . 0.96 110.047 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.14 131.55 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.647 -1.612 . . . . 1.99 106.647 164.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -96.02 -30.43 13.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.076 -0.713 . . . . 2.34 109.076 170.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -156.23 164.97 37.7 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.926 0.785 . . . . 3.08 110.392 169.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.8 t -130.47 149.87 51.94 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 105.687 -1.968 . . . . 2.17 105.687 162.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 m -139.66 104.83 5.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.406 -1.331 . . . . 2.67 107.406 162.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.626 HG13 HG13 ' A' ' 19' ' ' VAL . 12.5 p -114.16 141.91 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.012 0.525 . . . . 1.58 112.09 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.39 139.71 30.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.244 0.545 . . . . 1.14 110.992 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.48 -33.08 60.78 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.201 1.0 . . . . 1.76 111.606 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.33 -34.31 60.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.227 0.611 . . . . 1.57 112.217 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.8 t -106.87 3.16 26.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.284 1.434 . . . . 3.09 111.48 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.6 m120 37.31 51.21 1.1 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 127.52 2.328 . . . . 1.91 110.814 -169.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.27 137.59 27.37 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.003 -0.435 . . . . 2.13 111.925 -166.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.94 117.46 32.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.298 2.239 . . . . 0.69 108.741 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -86.34 103.74 15.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.42 -2.437 . . . . 2.28 104.42 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.21 134.58 27.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.01 -1.478 . . . . 1.09 107.01 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -112.94 118.22 34.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.485 -1.302 . . . . 2.59 107.485 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -128.08 148.61 50.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.057 0.943 . . . . 2.72 111.514 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -76.99 117.01 62.14 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 106.55 -1.648 . . . . 3.11 106.55 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.39 69.64 7.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.606 2.204 . . . . 2.17 110.77 -172.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.6 -92.88 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.582 1.153 . . . . 5.02 110.154 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.1 pt -64.05 -31.28 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.128 0.788 . . . . 2.33 113.128 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 tp -114.07 137.78 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.958 1.303 . . . . 1.07 108.517 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.54 176.94 16.3 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.147 -0.781 . . . . 0.59 111.147 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.19 -41.39 74.4 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.791 2.994 . . . . 0.97 110.923 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -56.43 -53.75 53.78 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.211 0.459 . . . . 6.58 110.779 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.45 -50.4 69.94 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.078 -0.712 . . . . 2.88 109.078 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mm -53.69 -52.81 30.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 123.334 0.654 . . . . 2.04 111.306 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.4 mt -52.66 -53.53 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.879 -0.786 . . . . 0.83 108.879 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -64.27 -37.34 87.13 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.315 0.578 . . . . 3.17 110.795 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.3 m -57.36 -46.81 82.95 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.091 -0.504 . . . . 1.12 109.754 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.41 -43.08 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 118.654 0.661 . . . . 1.38 111.323 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -52.59 -41.56 63.75 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.97 0.804 . . . . 3.42 110.087 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.4 m -53.7 -29.07 37.3 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.978 0.733 . . . . 1.87 112.978 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 mt -81.18 -15.37 55.93 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.761 0.824 . . . . 0.97 112.07 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.68 42.83 4.37 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.825 1.203 . . . . 0.67 112.662 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.96 162.21 33.49 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 107.372 -1.344 . . . . 1.87 107.372 173.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -105.74 94.08 8.31 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 118.955 0.798 . . . . 2.56 110.397 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.93 85.2 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.804 3.003 . . . . 1.33 110.989 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 m -84.68 97.03 9.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.401 1.08 . . . . 1.97 110.223 -170.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.87 102.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.875 0.87 . . . . 4.63 110.817 171.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.1 p . . . . . 0 CA--C 1.529 0.144 0 N-CA-C 111.846 0.313 . . . . 3.68 111.846 -170.964 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.83 -0.433 . . . . 2.8 109.83 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mp -143.63 155.19 44.18 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.046 -1.094 . . . . 2.99 108.046 166.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -107.61 102.24 11.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.254 -1.758 . . . . 2.96 106.254 163.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.52 130.92 40.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.267 -1.383 . . . . 1.5 107.267 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.419 ' CG1' HH11 ' A' ' 11' ' ' ARG . 65.2 t -84.11 102.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 125.225 1.41 . . . . 1.08 107.362 -174.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 m -89.53 96.69 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.518 1.527 . . . . 0.65 109.082 -172.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.419 HH11 ' CG1' ' A' ' 9' ' ' VAL . 21.8 mmm180 -76.14 151.02 37.08 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 118.775 -1.17 . . . . 7.7 107.932 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.2 -27.3 10.93 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.225 0.917 . . . . 0.74 111.986 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.0 mtm -65.79 94.68 0.22 Allowed 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.556 1.178 . . . . 1.47 111.546 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -77.85 -38.77 45.4 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.685 0.394 . . . . 2.59 111.49 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.23 174.7 13.44 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 119.071 0.85 . . . . 1.04 112.199 -168.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.5 -38.94 14.9 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.17 1.388 . . . . 1.13 112.183 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 m -51.94 -40.99 61.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.682 0.793 . . . . 1.86 111.42 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.4 m -70.1 -47.95 59.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.019 0.528 . . . . 0.84 110.239 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -51.12 -58.5 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 123.737 0.815 . . . . 1.05 108.977 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.17 -25.16 66.02 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.662 -0.699 . . . . 0.99 111.631 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -56.73 -56.18 24.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.291 -1.004 . . . . 3.33 108.291 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -58.61 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.239 -1.023 . . . . 0.95 108.239 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -55.78 -54.51 43.51 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.322 0.249 . . . . 2.95 110.599 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -57.45 -48.27 79.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.862 0.465 . . . . 1.32 110.237 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 t -69.91 -34.06 73.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 118.905 -1.118 . . . . 1.17 111.22 -173.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.31 -50.36 63.9 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.124 -0.465 . . . . 2.49 110.65 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.0 p -70.91 63.65 0.31 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.982 0.896 . . . . 2.02 112.42 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -165.93 -36.22 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.42 1.888 . . . . 3.79 110.895 172.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -65.97 133.72 51.43 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.359 0.981 . . . . 2.09 109.54 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -53.04 143.13 18.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.554 -0.906 . . . . 6.95 108.554 172.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.68 -32.68 7.26 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-O 118.142 -1.366 . . . . 0.8 111.977 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.49 128.01 38.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 120.006 1.903 . . . . 2.01 108.024 172.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 mt -92.6 -45.55 8.03 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.114 1.366 . . . . 2.87 108.526 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -156.07 163.54 39.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.476 -0.564 . . . . 2.31 109.476 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.7 m -135.82 154.45 51.19 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.103 0.961 . . . . 2.69 108.742 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -149.89 97.78 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.055 -1.091 . . . . 2.84 108.055 162.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -101.39 135.65 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 122.91 0.484 . . . . 1.61 110.399 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.79 135.21 19.47 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.98 0.912 . . . . 0.72 112.457 -167.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.51 -28.63 66.21 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 125.789 1.636 . . . . 2.51 111.053 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -34.45 -45.15 0.22 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.193 1.797 . . . . 2.01 113.501 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 t -131.58 10.32 4.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 122.235 1.017 . . . . 3.19 111.503 169.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 56.94 59.18 3.59 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.958 1.703 . . . . 1.75 108.758 -167.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -103.49 154.69 19.18 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.974 0.91 . . . . 1.92 110.961 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.97 114.27 17.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.251 1.421 . . . . 0.72 108.001 162.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -80.1 113.39 18.23 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 104.86 -2.274 . . . . 2.95 104.86 169.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.69 126.17 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 105.563 -2.014 . . . . 1.13 105.563 174.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -114.01 123.93 50.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.586 -1.635 . . . . 2.65 106.586 169.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -144.87 148.12 33.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.752 0.821 . . . . 2.2 111.989 -160.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -56.5 117.61 17.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 107.231 -1.396 . . . . 4.75 107.231 164.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.71 -3.27 13.4 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.192 1.928 . . . . 1.75 113.003 -170.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -103.27 -54.45 2.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.17 0.895 . . . . 4.58 109.975 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.7 pt -79.95 -36.22 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.694 0.628 . . . . 2.11 112.694 -167.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.06 132.06 66.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.28 1.432 . . . . 0.99 107.669 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.63 172.72 17.84 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 118.683 0.674 . . . . 0.6 111.612 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.95 -36.31 97.07 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.232 2.621 . . . . 0.77 110.737 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -55.93 -57.0 13.92 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.094 0.406 . . . . 6.64 110.032 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.52 -49.9 66.58 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.071 -0.714 . . . . 2.68 109.071 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.6 mm -53.58 -52.0 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.281 0.632 . . . . 1.91 111.468 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.88 -52.56 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 122.73 0.412 . . . . 0.58 109.96 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -65.51 -38.95 91.19 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.53 0.681 . . . . 2.74 110.471 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.3 m -55.24 -51.42 66.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.346 -0.613 . . . . 1.08 109.346 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 89.8 mt -69.51 -39.85 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 119.407 -0.33 . . . . 1.4 111.186 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -56.65 -44.06 80.94 Favored 'General case' 0 CA--C 1.526 0.049 0 CA-C-N 118.727 0.694 . . . . 3.55 109.226 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 t -58.66 -15.02 9.87 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.994 1.109 . . . . 1.73 113.994 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.5 mt -95.84 -9.86 30.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.898 1.226 . . . . 1.17 111.694 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.36 47.05 3.63 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.299 0.952 . . . . 0.85 112.462 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -137.99 163.87 30.46 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.56 -0.904 . . . . 2.15 108.56 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.53 86.98 3.07 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.552 1.141 . . . . 3.06 110.303 -176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.59 82.36 0.93 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.879 3.053 . . . . 1.0 111.538 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 m -81.05 103.84 11.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.168 0.987 . . . . 1.78 109.022 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.06 70.97 0.16 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.558 1.143 . . . . 2.62 113.238 -175.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.541 0.604 0 N-CA-C 107.114 -1.439 . . . . 3.18 107.114 160.745 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 m . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 106.624 -1.621 . . . . 2.84 106.624 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -155.47 158.19 38.16 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.752 0.706 . . . . 3.34 110.216 160.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.0 123.97 50.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.137 0.975 . . . . 2.4 108.911 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.402 HD21 HD12 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -110.54 123.94 50.89 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.285 -2.117 . . . . 1.57 105.285 167.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.29 100.35 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.298 -2.112 . . . . 1.27 105.298 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.77 84.0 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.04 1.736 . . . . 0.81 108.088 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.5 mtt85 -76.72 147.15 37.56 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.717 -1.216 . . . . 6.73 107.717 -176.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.55 -16.61 26.39 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 119.3 -0.722 . . . . 0.81 112.849 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.1 mtp -64.05 167.34 6.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.978 1.389 . . . . 1.88 110.788 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 t -152.19 -45.54 0.1 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.076 0.55 . . . . 2.37 111.675 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.4 p -133.61 170.92 14.82 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.909 0.777 . . . . 1.25 111.917 -169.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.85 -33.94 8.12 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.856 1.263 . . . . 0.79 111.981 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -64.95 -37.61 88.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 121.491 -0.756 . . . . 2.32 111.615 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -61.36 -46.86 88.44 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.326 -0.62 . . . . 0.88 109.326 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.441 HG13 HG13 ' A' ' 37' ' ' VAL . 43.8 t -50.33 -59.67 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.73 -0.841 . . . . 0.53 108.73 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 0.6 OUTLIER -66.11 -28.96 69.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.725 -174.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -62.17 -54.65 38.06 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 108.809 -0.811 . . . . 4.58 108.809 173.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.29 -54.3 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 120.169 -0.612 . . . . 0.67 109.572 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -60.71 -53.99 50.7 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.367 0.531 . . . . 2.29 111.143 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.5 t -58.59 -34.9 71.61 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.742 -0.599 . . . . 1.67 111.209 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.5 t -70.38 -42.67 71.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.042 -0.411 . . . . 1.15 110.772 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.2 mt -71.22 -60.12 2.4 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.112 0.565 . . . . 2.42 112.232 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 m -69.64 67.98 0.24 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.072 1.749 . . . . 2.39 111.162 -166.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.16 -35.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.483 2.313 . . . . 4.24 110.575 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -68.03 132.43 47.26 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.471 1.032 . . . . 2.09 108.8 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -54.74 148.07 13.58 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.452 -0.573 . . . . 6.47 109.452 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.47 -28.37 10.12 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 117.382 -1.788 . . . . 0.88 112.705 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.31 126.75 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 120.544 2.172 . . . . 1.69 106.506 166.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 mt -86.79 -44.22 11.92 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.22 -1.4 . . . . 2.75 107.22 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -156.13 164.69 38.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.573 -0.899 . . . . 2.26 108.573 174.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 p -138.94 161.5 37.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.783 -1.562 . . . . 2.03 106.783 160.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.5 t -143.68 134.16 24.79 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.455 -1.683 . . . . 1.8 106.455 153.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.441 HG13 HG13 ' A' ' 19' ' ' VAL . 2.8 p -115.2 145.67 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 123.401 0.68 . . . . 1.74 109.941 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.04 134.96 26.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.073 0.463 . . . . 0.65 110.676 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.82 -29.49 65.66 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.665 1.186 . . . . 2.62 111.538 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.76 -39.11 36.69 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.631 1.172 . . . . 1.18 112.141 -174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 p -129.88 32.15 4.6 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.717 0.807 . . . . 2.46 110.192 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 27.0 62.04 0.09 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 128.226 2.611 . . . . 2.39 112.546 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -132.49 145.55 51.26 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.84 0.456 . . . . 1.68 111.462 -173.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.06 118.06 35.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.505 -1.665 . . . . 0.78 106.505 163.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -85.68 109.84 18.87 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 101.606 -3.479 . . . . 2.32 101.606 165.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.402 HD12 HD21 ' A' ' 8' ' ' LEU . 43.8 mt -101.94 139.22 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.329 -0.989 . . . . 1.73 108.329 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -117.78 104.86 11.38 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 105.707 -1.961 . . . . 3.05 105.707 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -120.11 162.49 19.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.818 0.847 . . . . 2.63 110.322 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -100.22 114.76 65.82 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.556 0.743 . . . . 3.79 110.397 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -69.4 -5.32 15.7 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.607 2.205 . . . . 2.26 113.492 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -65.01 -22.65 67.03 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.951 1.705 . . . . 5.26 112.068 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 pt -129.82 -60.08 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.499 0.926 . . . . 2.05 113.499 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 tp -87.85 137.32 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.548 -0.72 . . . . 1.09 110.031 -165.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.15 166.74 12.32 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.988 0.804 . . . . 0.75 111.57 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -57.87 -38.61 91.82 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.148 2.565 . . . . 0.76 110.872 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -53.74 -44.42 69.91 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.003 0.372 . . . . 7.45 112.003 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.3 -51.99 66.58 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.994 0.815 . . . . 2.43 109.191 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.7 mt -50.38 -54.16 9.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 C-N-CA 123.32 0.648 . . . . 1.54 109.358 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.9 mt -56.72 -51.01 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 119.119 -0.467 . . . . 0.62 110.036 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -68.55 -27.35 66.0 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-O 120.978 0.418 . . . . 3.14 112.067 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.8 m -64.62 -52.26 58.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.733 -0.469 . . . . 0.85 109.733 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -72.07 -45.28 63.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.874 -0.517 . . . . 1.17 112.151 -171.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.04 -43.23 63.65 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.65 0.659 . . . . 3.95 111.388 -176.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.3 t -48.35 -37.2 16.09 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.38 1.472 . . . . 1.86 112.395 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.4 mt -74.8 -17.27 60.65 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.363 -0.836 . . . . 1.05 112.188 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.61 45.68 3.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.159 0.885 . . . . 0.81 112.022 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -136.38 155.63 49.77 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.721 -1.215 . . . . 1.96 107.721 170.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -101.39 96.47 6.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.768 1.227 . . . . 2.83 109.41 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.2 77.66 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.352 2.701 . . . . 1.19 110.479 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.6 p -78.91 106.84 11.22 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.18 -0.674 . . . . 2.23 109.18 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.3 mt -74.94 56.55 0.75 Allowed 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.596 -0.69 . . . . 4.01 111.19 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.45 -0.463 0 CA-C-O 123.73 1.729 . . . . 3.38 107.492 173.114 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 109.912 -0.403 . . . . 2.58 109.912 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -127.01 133.25 50.58 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.361 0.665 . . . . 2.63 109.608 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -103.61 99.85 9.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.283 1.033 . . . . 2.66 108.217 169.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.94 134.02 41.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.123 -1.436 . . . . 1.43 107.123 173.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.9 t -85.32 113.81 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.143 -1.799 . . . . 1.01 106.143 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.02 96.78 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 126.04 1.736 . . . . 0.65 108.321 -172.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 11' ' ' ARG . 0.1 OUTLIER -77.02 137.66 39.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.645 -1.613 . . . . 5.46 106.645 -174.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.55 -26.49 10.14 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.768 -1.018 . . . . 0.98 112.66 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 ptm -78.65 85.71 4.67 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.534 1.667 . . . . 1.82 110.232 -176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 p -76.5 -34.6 58.61 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.881 0.872 . . . . 3.16 112.962 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.0 p -145.45 172.82 12.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.81 0.732 . . . . 1.14 112.39 -162.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.8 -39.43 8.36 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.518 1.527 . . . . 0.73 112.299 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -53.53 -53.14 55.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.491 -0.559 . . . . 2.18 109.491 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.3 m -64.77 -42.59 94.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.589 0.356 . . . . 0.68 111.003 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.6 t -48.99 -61.04 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.199 -1.037 . . . . 0.55 108.199 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.287 1.1 p-80 -70.32 -28.77 65.43 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.185 -0.916 . . . . 0.87 111.457 -174.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -51.58 -60.06 3.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.057 0.844 . . . . 3.97 110.052 168.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 mt -62.59 -59.23 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.761 -0.829 . . . . 0.83 108.761 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -56.65 -53.78 53.69 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.743 0.417 . . . . 2.56 110.001 -167.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 t -62.44 -42.48 99.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.396 -0.335 . . . . 1.44 110.872 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.0 t -65.88 -50.74 63.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.902 0.774 . . . . 0.91 110.934 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.83 -43.93 78.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.647 0.779 . . . . 2.22 111.033 -173.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.1 m -71.24 65.77 0.41 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.685 0.675 . . . . 2.84 111.457 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -147.9 -51.78 0.19 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 128.021 2.528 . . . . 7.92 108.182 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -66.11 114.62 5.38 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.845 -0.798 . . . . 2.13 108.845 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -48.95 -30.68 6.25 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.412 1.085 . . . . 7.02 113.582 -171.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.8 -33.13 55.63 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.088 -0.84 . . . . 0.85 113.208 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.76 124.17 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.783 -1.562 . . . . 2.0 106.783 169.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.47 -20.26 18.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 119.153 -0.451 . . . . 2.45 110.153 171.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -155.44 158.35 38.45 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.085 0.857 . . . . 2.29 109.964 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -139.02 146.98 41.51 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.698 -1.593 . . . . 2.06 106.698 165.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -145.77 122.89 11.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.582 -1.266 . . . . 2.12 107.582 159.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 m -111.35 151.87 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.158 0.89 . . . . 1.77 111.042 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.62 133.48 20.14 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 122.734 0.414 . . . . 0.7 111.713 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -69.46 -27.34 65.15 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.301 1.041 . . . . 2.14 111.402 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.05 -39.33 1.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.742 1.617 . . . . 1.12 113.215 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.5 t -141.62 36.47 1.64 Allowed 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.754 0.422 . . . . 2.73 110.246 168.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.4 m120 33.9 56.71 0.59 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 127.649 2.379 . . . . 1.64 110.418 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -110.78 153.15 25.74 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.16 0.984 . . . . 2.21 110.187 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.11 113.16 13.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.73 1.212 . . . . 0.58 108.019 171.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -92.44 97.93 11.15 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.384 -3.191 . . . . 2.13 102.384 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.74 141.16 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.071 -1.825 . . . . 1.18 106.071 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.8 mtmp? -122.38 114.27 20.52 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.257 -1.016 . . . . 3.28 108.257 167.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -126.29 152.51 46.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.958 0.786 . . . . 2.1 111.778 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -78.56 113.77 37.5 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 108.659 -0.867 . . . . 2.83 108.659 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.76 65.32 8.74 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.635 2.89 . . . . 1.35 110.267 -170.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -138.39 -72.47 0.41 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.845 1.258 . . . . 3.2 108.706 -170.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -88.26 -36.53 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.043 0.937 . . . . 2.41 111.721 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 tp -104.02 153.32 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.669 1.587 . . . . 0.96 107.963 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.47 173.56 23.82 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.236 -1.146 . . . . 0.6 110.236 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.63 -38.19 42.43 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.147 2.565 . . . . 0.71 110.327 -175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -57.43 -42.16 81.84 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.518 0.327 . . . . 5.71 111.214 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -62.15 -59.15 5.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.576 -0.898 . . . . 4.02 108.576 178.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 mm -42.9 -51.2 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.419 0.688 . . . . 1.81 110.651 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.4 mt -54.2 -59.6 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 118.661 -0.685 . . . . 0.57 110.672 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.98 -35.95 81.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.487 1.04 . . . . 5.55 111.9 -176.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.3 m -68.02 -39.21 83.19 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.6 1.16 . . . . 1.46 109.681 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.28 -46.02 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.644 -0.66 . . . . 1.25 110.677 170.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -50.13 -43.24 51.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.644 0.656 . . . . 4.93 110.905 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.1 m -51.12 -28.83 11.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.449 0.907 . . . . 1.68 113.449 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.06 -12.18 48.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.377 1.071 . . . . 1.07 112.248 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.82 48.94 3.5 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.871 1.224 . . . . 0.75 112.31 174.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -139.45 153.71 47.62 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 106.97 -1.492 . . . . 2.01 106.97 170.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -98.79 101.43 12.03 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-O 118.434 -0.793 . . . . 2.88 110.478 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.17 93.51 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.714 2.276 . . . . 0.9 111.642 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.2 m -78.45 116.86 19.14 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.574 -0.898 . . . . 1.47 108.574 167.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.6 60.67 0.34 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.462 1.105 . . . . 2.61 111.73 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 t . . . . . 0 C--O 1.228 -0.066 0 O-C-N 121.775 -0.578 . . . . 2.32 110.197 -175.679 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.451 -0.383 0 N-CA-C 107.127 -1.434 . . . . 2.6 107.127 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.49 141.53 49.78 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.14 -1.43 . . . . 3.2 107.14 166.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -103.37 145.41 30.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.446 1.098 . . . . 3.02 109.704 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.21 119.76 17.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.39 1.476 . . . . 1.8 107.318 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.65 118.94 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 103.798 -2.667 . . . . 1.43 103.798 171.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.458 HG13 ' SD ' ' A' ' 13' ' ' MET . 2.5 p -124.81 87.18 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.679 1.192 . . . . 2.65 108.528 -167.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -79.44 152.36 30.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.458 -0.792 . . . . 5.37 109.306 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.77 -28.85 6.85 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.319 0.961 . . . . 0.85 111.073 -175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.458 ' SD ' HG13 ' A' ' 10' ' ' VAL . 30.1 mtp -66.06 110.13 2.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.84 0.82 . . . . 1.67 110.12 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.8 t -90.8 -43.06 10.3 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.253 1.021 . . . . 2.85 111.677 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.3 p -141.56 174.6 10.4 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.874 0.761 . . . . 1.31 111.963 -167.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.25 -35.76 12.63 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.994 1.318 . . . . 0.98 112.072 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -60.48 -37.5 81.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.61 -0.681 . . . . 2.51 111.344 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 78.8 m -63.76 -37.92 89.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.633 -0.667 . . . . 0.83 110.571 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.8 t -58.58 -60.94 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.405 -0.961 . . . . 0.8 108.405 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.306 0.9 OUTLIER -60.06 -35.88 76.1 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.752 -0.379 . . . . 0.83 111.589 -175.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -61.11 -46.93 88.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.901 1.68 . . . . 3.78 109.848 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mt -58.95 -65.92 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.651 -0.5 . . . . 0.85 109.651 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.86 -50.61 71.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.608 -0.437 . . . . 2.72 111.146 -168.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.0 m -56.55 -43.52 79.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.376 -0.231 . . . . 2.26 110.376 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 t -70.63 -38.99 73.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 118.802 -1.159 . . . . 1.13 111.226 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 mt -56.98 -48.94 77.22 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.186 0.903 . . . . 2.3 110.066 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.6 p -62.63 80.47 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.909 0.884 . . . . 2.05 111.631 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 pttm 176.7 -34.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 129.193 2.997 . . . . 3.84 109.944 172.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -69.13 141.93 54.51 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 119.199 -1.0 . . . . 2.18 109.037 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -62.13 145.14 54.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.552 -0.907 . . . . 6.14 108.552 175.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.05 -53.77 0.57 Allowed Glycine 0 CA--C 1.521 0.407 0 CA-C-O 119.316 -0.713 . . . . 1.26 111.528 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.74 112.25 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 118.66 1.23 . . . . 2.19 112.312 -166.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -94.1 -30.79 14.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.232 1.013 . . . . 2.83 111.2 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -153.93 147.25 24.84 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.509 1.049 . . . . 2.85 109.427 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -117.87 140.41 49.74 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 107.176 -1.416 . . . . 2.25 107.176 172.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.5 t -128.52 59.58 1.53 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.234 1.014 . . . . 3.53 108.664 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.86 133.85 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.553 0.741 . . . . 1.58 110.844 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.34 137.88 37.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.946 0.898 . . . . 0.85 112.408 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.96 -35.02 79.46 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.005 1.322 . . . . 2.71 110.072 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -37.25 -39.69 0.29 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.531 1.932 . . . . 1.63 113.831 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t -143.29 34.96 1.33 Allowed 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.393 0.277 . . . . 2.91 111.059 172.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.7 m120 41.66 61.82 1.75 Allowed 'General case' 0 CA--C 1.523 -0.077 0 C-N-CA 126.092 1.757 . . . . 1.82 110.068 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.13 140.53 18.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.329 -0.619 . . . . 2.29 109.329 -166.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.45 154.92 28.41 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.202 0.601 . . . . 1.18 110.03 166.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.28 141.33 40.22 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 104.91 -2.256 . . . . 2.03 104.91 150.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.59 134.49 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.965 -1.494 . . . . 1.37 106.965 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -102.83 85.48 2.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.508 -2.034 . . . . 3.16 105.508 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -114.01 146.36 40.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.934 1.294 . . . . 2.41 110.799 172.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -59.64 107.32 0.96 Allowed Pre-proline 0 CA--C 1.537 0.46 0 O-C-N 124.283 0.99 . . . . 2.51 108.792 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -82.44 45.57 1.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.319 2.679 . . . . 1.73 110.974 -169.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -139.31 -60.29 0.57 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.533 1.133 . . . . 4.23 108.965 -170.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 pt -74.9 -25.87 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 112.34 0.496 . . . . 2.27 112.34 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.2 tt -143.0 154.78 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.085 -1.079 . . . . 1.67 108.085 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.08 -176.76 17.05 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.626 -0.589 . . . . 0.66 111.626 -172.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.11 -32.72 33.6 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.371 2.047 . . . . 0.77 110.174 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -53.65 -51.7 62.32 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.131 0.572 . . . . 6.26 110.95 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.81 -50.3 72.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.095 0.474 . . . . 2.31 109.745 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.0 mt -54.61 -51.94 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.08 0 C-N-CA 123.441 0.696 . . . . 1.2 109.893 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.4 mt -51.74 -53.04 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.133 -0.691 . . . . 0.61 109.133 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -66.3 -34.89 79.0 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.914 0.485 . . . . 2.66 110.785 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -60.77 -48.52 81.42 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.715 -0.476 . . . . 0.74 109.715 174.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 94.0 mt -70.89 -35.69 60.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.365 -0.834 . . . . 0.99 111.366 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -54.44 -49.45 69.97 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.557 -0.714 . . . . 2.62 109.21 167.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 t -58.12 -43.07 87.01 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.651 0.38 . . . . 2.12 111.143 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -58.18 -37.64 75.15 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.506 -0.746 . . . . 1.17 111.64 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.67 38.42 2.22 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.628 1.109 . . . . 0.83 111.726 176.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -129.28 163.45 25.65 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 107.702 -1.222 . . . . 2.1 107.702 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -109.93 98.72 35.58 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.183 0.593 . . . . 2.83 110.118 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.52 148.31 20.55 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.779 2.986 . . . . 1.63 110.168 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.1 m -153.71 118.03 4.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.457 1.103 . . . . 2.29 108.404 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.22 59.94 1.86 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.767 0.827 . . . . 2.29 111.538 -176.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.6 t . . . . . 0 CA--C 1.53 0.2 0 N-CA-C 107.608 -1.256 . . . . 4.33 107.608 -178.918 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 105.808 -1.923 . . . . 3.14 105.808 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.25 145.09 51.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.816 -0.809 . . . . 3.18 108.816 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -123.92 139.13 54.26 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.949 -1.5 . . . . 2.21 106.949 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.34 152.57 51.93 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.905 -1.146 . . . . 2.59 107.905 164.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -93.92 101.66 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.792 -1.929 . . . . 1.14 105.792 -173.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.2 m -79.38 65.86 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.076 1.75 . . . . 0.8 108.581 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.39 125.86 29.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 118.95 -1.1 . . . . 4.92 108.579 -162.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.51 -44.69 0.96 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.217 0.913 . . . . 0.89 110.888 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -64.16 152.15 41.44 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.408 0.683 . . . . 1.66 111.508 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -140.65 -34.97 0.5 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.983 0.734 . . . . 2.08 112.983 -167.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 p -145.97 175.14 10.67 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.305 0.957 . . . . 1.32 111.683 -166.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.52 -47.89 3.82 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.0 1.72 . . . . 0.82 112.032 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 m -57.14 -40.29 76.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.331 0.652 . . . . 1.68 111.818 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.7 m -72.14 -53.11 13.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.619 0.645 . . . . 0.78 110.523 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.2 t -44.1 -55.77 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.482 1.513 . . . . 0.62 109.275 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -21.63 63.4 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 120.175 -0.61 . . . . 1.35 112.26 -173.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -47.97 59.98 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.933 -1.506 . . . . 5.75 106.933 173.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mt -56.33 -53.38 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.788 -0.625 . . . . 0.9 110.101 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -57.25 -61.58 2.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.841 0.746 . . . . 3.42 111.473 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -55.44 -41.75 73.26 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.771 -0.581 . . . . 1.58 111.579 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 t -65.45 -48.61 72.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.818 -0.438 . . . . 1.65 109.818 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.8 mt -54.04 -46.04 71.79 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.355 -0.841 . . . . 3.13 110.074 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -61.28 -14.16 24.43 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.695 0.998 . . . . 2.04 113.695 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -26.36 68.79 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.166 1.348 . . . . 5.66 111.275 173.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -77.86 100.17 6.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.317 -0.623 . . . . 2.87 109.317 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -61.23 82.87 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.871 -1.159 . . . . 5.91 107.871 163.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.82 -26.95 0.39 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.231 0.92 . . . . 1.33 110.932 -166.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.409 ' CG1' HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -74.67 120.03 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 105.773 -1.936 . . . . 2.07 105.773 165.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.9 mt -79.91 -47.48 14.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.708 -1.219 . . . . 2.5 107.708 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -156.09 124.2 5.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.898 -0.408 . . . . 3.15 109.898 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.2 p -97.61 151.82 19.69 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.088 0.955 . . . . 2.7 108.719 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -152.56 102.48 2.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.794 -0.817 . . . . 2.1 108.794 159.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.16 148.16 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 124.102 0.961 . . . . 1.87 110.946 167.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.65 131.95 18.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.385 0.674 . . . . 0.86 109.635 171.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.46 -32.63 54.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.038 -0.983 . . . . 2.05 112.939 -167.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.95 -49.41 40.53 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.093 0.957 . . . . 1.35 111.783 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.1 p -101.77 6.48 41.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.897 0.879 . . . . 2.18 111.326 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.02 42.72 21.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.3 1.44 . . . . 3.22 110.362 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -98.81 149.12 23.21 Favored 'General case' 0 C--N 1.344 0.326 0 O-C-N 121.371 -0.83 . . . . 1.73 110.159 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.8 117.93 30.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.014 -1.106 . . . . 0.78 108.014 155.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -83.4 119.94 25.27 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.122 -2.177 . . . . 3.97 105.122 164.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.409 HG23 ' CG1' ' A' ' 32' ' ' ILE . 2.0 mp -113.68 118.22 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.098 -1.815 . . . . 1.27 106.098 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -103.75 97.7 7.67 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.258 -1.756 . . . . 3.21 106.258 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -112.11 169.94 8.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.185 1.394 . . . . 2.24 111.339 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -76.56 115.2 45.59 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.112 -0.699 . . . . 4.47 109.112 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.62 49.43 3.08 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-N 120.748 1.303 . . . . 1.43 111.148 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.7 -63.52 1.02 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.58 1.152 . . . . 3.81 110.052 170.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pp -75.92 -32.32 23.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 CA-C-N 118.631 0.65 . . . . 1.94 112.689 -168.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.9 tt -128.37 157.66 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.608 1.163 . . . . 1.18 110.806 -168.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -124.86 -173.87 13.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.471 -0.651 . . . . 0.64 111.471 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.84 -39.47 51.82 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.82 2.347 . . . . 0.93 110.336 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -51.15 -49.38 60.98 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.859 0.864 . . . . 5.64 112.198 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.28 -47.49 84.09 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.956 0.884 . . . . 2.22 110.209 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.7 mt -56.45 -54.06 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 114.926 -1.034 . . . . 1.42 108.22 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.9 mt -54.08 -53.0 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 116.376 -0.375 . . . . 0.6 110.146 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -64.23 -34.21 77.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.279 -0.263 . . . . 2.73 110.627 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.1 m -58.58 -53.53 57.24 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.073 -0.392 . . . . 1.06 110.697 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.4 mm -66.01 -39.81 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.168 -0.957 . . . . 1.99 111.476 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.32 -46.03 76.31 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.874 -0.517 . . . . 2.75 109.772 171.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.3 t -59.6 -42.62 92.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.828 0.451 . . . . 2.01 111.262 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.24 -43.38 87.77 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.726 0.694 . . . . 1.3 110.936 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.95 43.41 0.94 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.059 0.837 . . . . 0.72 111.436 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -130.92 157.58 42.56 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 105.608 -1.997 . . . . 2.01 105.608 166.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -102.11 108.01 55.06 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 119.37 0.986 . . . . 2.61 109.812 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.75 83.28 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 124.068 3.178 . . . . 0.9 110.918 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.5 t -78.75 112.34 15.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.171 -0.677 . . . . 2.11 109.171 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.2 57.49 1.86 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.679 0.792 . . . . 2.88 111.562 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.1 p . . . . . 0 CA--C 1.532 0.267 0 C-N-CA 123.831 0.852 . . . . 3.24 110.482 173.375 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.454 -0.226 0 N-CA-C 107.993 -1.114 . . . . 2.61 107.993 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.7 tp -144.89 143.86 30.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.305 -1.368 . . . . 2.87 107.305 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -117.14 123.98 48.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.508 -0.923 . . . . 2.75 108.508 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.424 HD21 HD13 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -125.16 133.95 52.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.023 -1.473 . . . . 1.43 107.023 177.382 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.11 105.84 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.964 -1.495 . . . . 1.08 106.964 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.84 81.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.697 1.199 . . . . 0.78 108.077 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 -76.45 142.84 40.87 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 4.33 107.752 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.77 -31.84 5.57 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.36 -0.696 . . . . 0.99 111.36 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.6 ptm -60.5 159.35 10.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.181 0.991 . . . . 1.87 110.781 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 p -136.09 -65.64 0.57 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.757 0.823 . . . . 3.64 108.995 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 p -119.55 172.88 7.34 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.518 1.127 . . . . 1.24 111.579 -166.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.08 -41.2 7.5 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.958 1.303 . . . . 0.89 112.058 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m -48.96 -46.9 44.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.354 1.062 . . . . 1.9 111.325 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.8 m -68.61 -47.95 65.37 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.612 0.365 . . . . 0.92 110.128 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.5 t -50.44 -58.61 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 108.769 -0.826 . . . . 1.02 108.769 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -66.59 -28.66 68.68 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.606 -0.724 . . . . 1.0 111.687 -174.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.09 -52.71 60.1 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.231 1.012 . . . . 3.82 109.235 171.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mt -61.52 -59.8 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 108.462 -0.94 . . . . 0.78 108.462 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -51.19 -58.58 5.76 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.446 0.466 . . . . 2.64 110.744 -171.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.0 p -55.36 -50.56 69.36 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.617 0.246 . . . . 2.39 110.886 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -70.92 -26.31 63.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.039 0.385 . . . . 0.98 112.039 -171.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.38 -49.65 53.38 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.572 -0.705 . . . . 1.6 109.532 169.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.4 p -70.11 72.9 0.45 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.282 0.492 . . . . 1.78 111.835 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.58 -44.3 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.972 1.309 . . . . 4.39 110.866 176.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -73.32 121.93 21.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.272 -1.011 . . . . 2.03 108.272 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -66.82 0.51 2.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.78 0.718 . . . . 8.9 112.603 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.53 -41.27 99.53 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 120.046 -1.659 . . . . 1.68 111.047 161.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.19 147.92 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.901 -1.148 . . . . 1.76 107.901 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.35 -32.44 4.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.514 1.125 . . . . 2.18 110.404 171.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -155.27 138.58 15.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.813 -1.18 . . . . 2.01 107.813 169.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.4 t -128.5 147.59 50.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.017 -1.475 . . . . 2.09 107.017 170.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 t -147.91 147.58 29.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.886 -0.783 . . . . 2.08 108.886 156.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.0 151.03 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.52 1.128 . . . . 2.18 111.13 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.8 133.36 31.99 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.027 0.531 . . . . 0.93 111.091 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.75 -37.16 86.66 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.613 1.165 . . . . 2.94 110.475 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.27 -39.99 1.52 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.164 1.786 . . . . 1.91 113.644 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.1 t -139.96 38.13 1.96 Allowed 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 121.907 0.86 . . . . 2.64 109.608 172.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.2 m120 35.99 46.78 0.38 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 127.955 2.502 . . . . 1.83 111.672 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -102.65 146.09 28.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.679 -0.489 . . . . 2.15 109.679 -168.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.19 119.86 37.81 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.227 -1.768 . . . . 0.62 106.227 161.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -86.78 120.25 27.87 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 103.947 -2.612 . . . . 3.22 103.947 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.424 HD13 HD21 ' A' ' 8' ' ' LEU . 1.7 mp -112.5 128.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.379 -2.082 . . . . 1.15 105.379 174.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -111.46 96.92 6.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.109 -1.441 . . . . 2.18 107.109 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -106.68 148.1 28.78 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.708 0.803 . . . . 2.39 111.217 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.51 110.32 8.59 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.214 -1.402 . . . . 2.84 107.214 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -82.12 67.28 8.19 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.462 2.108 . . . . 1.59 111.909 -162.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.93 -83.72 0.14 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.086 0.954 . . . . 3.5 110.54 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.29 -47.46 84.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 122.098 -0.376 . . . . 2.35 110.825 -175.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 tp -86.2 154.16 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.241 -1.022 . . . . 1.52 108.241 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.03 168.5 23.67 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.657 -0.977 . . . . 0.78 110.657 173.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -54.9 -34.14 84.74 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.551 2.834 . . . . 0.81 110.658 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -42.26 -51.35 4.8 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.3 1.04 . . . . 9.29 111.045 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -71.79 -48.42 46.71 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.393 -0.965 . . . . 2.56 108.393 -168.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 mm -47.46 -51.25 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 124.404 1.082 . . . . 1.92 109.516 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.8 mt -61.75 -52.99 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.887 -0.597 . . . . 0.6 110.002 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -55.83 -42.35 75.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 122.052 0.93 . . . . 3.34 109.808 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 84.1 m -59.52 -58.58 7.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.218 -0.901 . . . . 0.74 108.999 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.95 -38.54 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 121.39 -0.819 . . . . 1.18 111.693 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -53.38 -51.54 62.21 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.309 -0.626 . . . . 2.84 109.309 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -57.14 -37.07 71.49 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.023 -0.423 . . . . 1.77 112.029 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.5 mt -67.98 -15.22 63.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.422 -0.799 . . . . 1.3 112.964 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.12 41.67 5.18 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.204 0.906 . . . . 0.93 112.196 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -138.54 164.72 28.72 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.94 -1.133 . . . . 2.0 107.94 170.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -100.52 99.66 10.44 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.24 1.416 . . . . 2.64 109.956 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.71 80.4 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 124.14 3.227 . . . . 1.02 110.269 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.8 m -81.95 94.63 7.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.837 0.855 . . . . 2.34 109.328 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.4 65.18 0.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.662 1.185 . . . . 2.64 112.794 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.8 m . . . . . 0 N--CA 1.454 -0.254 0 O-C-N 121.094 -1.004 . . . . 3.29 111.842 -176.173 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.457 -0.097 0 N-CA-C 108.948 -0.76 . . . . 3.17 108.948 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mp -137.82 158.33 44.58 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.095 -1.076 . . . . 3.15 108.095 160.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -137.86 132.91 33.23 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.221 1.008 . . . . 2.32 108.465 -169.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.79 139.46 32.77 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.438 1.095 . . . . 1.4 108.64 -169.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.8 t -85.57 100.42 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 107.737 -1.208 . . . . 1.0 107.737 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.5 m -84.15 76.5 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 125.608 1.563 . . . . 0.72 108.904 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -76.29 141.14 41.72 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.11 -1.036 . . . . 4.82 108.351 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.19 -43.05 1.35 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.823 -0.911 . . . . 0.65 110.823 -176.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -64.98 149.69 49.36 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.967 0.884 . . . . 1.32 110.217 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -139.97 -37.6 0.48 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.679 0.622 . . . . 2.16 112.679 -168.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 p -135.4 168.59 18.93 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.006 0.821 . . . . 1.21 110.965 -177.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.74 -38.45 15.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.939 1.296 . . . . 0.83 112.0 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 m -45.84 -44.31 14.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.128 1.371 . . . . 1.79 112.218 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.4 m -71.68 -51.89 20.67 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.503 0.721 . . . . 0.73 110.745 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.7 t -46.6 -60.87 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 125.205 1.402 . . . . 0.51 108.946 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -67.29 -23.27 65.64 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.879 -1.055 . . . . 0.96 111.523 -175.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -66.29 -53.26 38.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.059 -1.089 . . . . 4.02 108.059 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mt -58.73 -55.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 N-CA-C 108.669 -0.863 . . . . 0.8 108.669 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.27 -57.68 10.81 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.226 0.467 . . . . 2.35 110.965 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -56.12 -48.82 75.48 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.681 0.393 . . . . 1.6 110.564 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.3 t -60.07 -57.1 14.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.933 -0.395 . . . . 0.9 109.933 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.01 -40.16 66.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.078 0.551 . . . . 1.84 111.168 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.2 m -49.3 -26.62 3.18 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.655 0.983 . . . . 2.31 113.655 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -62.55 -27.33 69.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.14 1.336 . . . . 4.38 112.505 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -68.36 107.99 3.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.126 -0.694 . . . . 2.98 109.126 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -46.34 -36.93 6.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.756 0.823 . . . . 5.55 113.083 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.62 -11.87 84.89 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.197 -0.779 . . . . 0.75 113.772 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.95 120.1 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 119.134 1.467 . . . . 1.93 108.977 173.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -91.03 -31.45 16.29 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.856 -0.593 . . . . 2.52 110.97 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -157.74 130.87 7.6 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.727 1.149 . . . . 2.34 109.91 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.0 t -103.25 144.58 31.15 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 106.856 -1.535 . . . . 2.07 106.856 164.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -147.07 149.1 32.4 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 118.322 -1.351 . . . . 2.41 109.693 144.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.09 138.84 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.727 0.811 . . . . 1.77 111.029 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.31 131.32 53.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.492 1.117 . . . . 0.7 111.972 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.6 mt -68.78 -47.88 65.07 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 126.105 1.762 . . . . 2.46 111.783 -173.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.97 -46.71 52.7 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.018 0.527 . . . . 1.44 110.862 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 m -79.7 -39.87 30.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.327 0.651 . . . . 2.55 109.25 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 79.55 43.12 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 127.466 2.306 . . . . 2.53 107.688 -168.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.2 139.25 53.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.067 0.547 . . . . 2.28 111.356 -165.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.6 125.36 53.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.776 1.63 . . . . 0.56 109.106 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -96.28 114.87 26.6 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.355 -2.832 . . . . 2.16 103.355 166.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 mt -119.43 106.98 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.446 -1.687 . . . . 1.44 106.446 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -82.34 71.27 9.4 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.077 -1.453 . . . . 2.4 107.077 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -95.22 130.1 42.09 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.942 -0.572 . . . . 3.12 109.994 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -76.76 116.04 53.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 108.22 -1.03 . . . . 3.6 108.22 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -80.38 54.96 5.46 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.424 2.75 . . . . 1.91 112.262 -163.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -125.34 -71.92 0.68 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.783 1.233 . . . . 3.58 109.137 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -75.08 -34.6 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 O-C-N 122.282 -0.261 . . . . 2.0 111.188 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.36 137.47 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 126.116 1.767 . . . . 1.11 108.347 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.95 177.67 16.41 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.774 0.702 . . . . 0.64 111.617 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -57.67 -44.67 39.24 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.458 2.772 . . . . 0.78 110.679 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -58.81 -42.92 90.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.681 -0.408 . . . . 7.48 111.175 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.81 -53.48 57.85 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.5 0.667 . . . . 2.5 109.661 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mm -52.14 -50.91 34.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.158 0.983 . . . . 2.04 110.112 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.4 mt -57.61 -49.83 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.285 -0.416 . . . . 0.56 110.05 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.408 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 2.3 m-70 -62.31 -39.32 92.63 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.939 0.876 . . . . 3.76 110.365 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.0 m -56.47 -52.55 64.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.315 -0.624 . . . . 0.75 109.315 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.3 mt -72.31 -40.76 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 121.892 -0.505 . . . . 1.18 111.638 -171.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HG3' ' HA ' ' A' ' 60' ' ' HIS . 3.1 pp20? -59.77 -48.6 81.03 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 118.273 0.488 . . . . 4.21 110.296 173.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.3 m -56.6 -40.73 75.8 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.877 0.325 . . . . 2.16 111.877 175.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.69 -38.62 91.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.107 0.867 . . . . 1.2 111.566 173.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.93 36.33 0.89 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.837 0.732 . . . . 0.68 112.451 172.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -130.23 157.73 41.68 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.368 -1.345 . . . . 2.0 107.368 168.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -99.48 104.99 30.62 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 119.538 1.063 . . . . 2.66 110.297 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.34 90.19 1.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.934 3.089 . . . . 0.87 111.1 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.9 t -78.95 111.48 15.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.153 -0.684 . . . . 2.16 109.153 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.18 60.18 1.04 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.899 1.28 . . . . 3.05 111.52 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.8 m . . . . . 0 N--CA 1.453 -0.307 0 O-C-N 121.795 -0.566 . . . . 3.06 111.984 -173.486 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.3 m . . . . . 0 CA--C 1.536 0.429 0 CA-C-O 121.106 0.479 . . . . 2.7 112.196 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.68 129.4 34.95 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.345 -0.847 . . . . 2.57 110.049 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -92.94 105.46 17.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.741 1.217 . . . . 2.49 107.92 168.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.6 127.44 40.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.287 -1.375 . . . . 1.51 107.287 171.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.44 100.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.169 -1.789 . . . . 1.02 106.169 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.52 71.42 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.994 1.718 . . . . 0.64 107.995 -173.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -74.82 136.92 41.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.035 -1.468 . . . . 5.35 107.035 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.28 -42.53 1.91 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.573 -1.011 . . . . 0.81 110.573 -167.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.51 130.65 39.99 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.374 1.087 . . . . 1.45 108.919 -174.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 t -123.57 -41.52 2.26 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.968 1.099 . . . . 2.26 113.968 -155.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.2 p -138.65 175.46 9.54 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 119.498 1.044 . . . . 1.19 111.85 -168.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.97 -40.3 10.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.19 1.396 . . . . 0.81 112.222 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -55.0 -50.15 69.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.339 0.59 . . . . 2.48 110.006 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.48 -40.28 89.22 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.894 -1.129 . . . . 0.71 109.93 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.6 t -52.34 -61.58 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 108.733 -0.84 . . . . 0.63 108.733 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.284 1.0 OUTLIER -69.58 -30.39 68.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 119.999 -0.681 . . . . 1.02 112.137 -171.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -63.3 -47.1 83.72 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.804 0.729 . . . . 4.15 109.999 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.4 mt -56.81 -62.02 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.872 -0.788 . . . . 0.99 108.872 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -56.54 -52.87 63.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.225 -0.287 . . . . 2.45 110.225 -171.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.6 t -57.85 -55.25 37.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.658 0.266 . . . . 1.51 110.782 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 t -71.12 -32.76 69.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.563 -0.711 . . . . 1.62 112.478 -169.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -70.94 -51.98 22.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.574 0.624 . . . . 1.92 109.66 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.2 m -70.59 70.49 0.45 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.174 0.99 . . . . 2.83 110.978 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -175.38 -35.08 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.88 2.472 . . . . 3.77 110.091 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.656 ' NE2' HD12 ' A' ' 32' ' ' ILE . 3.8 p80 -65.34 136.55 56.68 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.31 0.959 . . . . 1.89 109.828 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -51.45 138.7 21.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.702 -0.481 . . . . 6.1 109.702 176.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.37 -31.46 8.28 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.338 -0.701 . . . . 0.98 112.74 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.656 HD12 ' NE2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -78.21 136.86 23.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 107.488 -1.301 . . . . 2.42 107.488 167.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 pp -103.42 -35.76 8.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.475 0.71 . . . . 2.45 110.396 175.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -157.35 163.66 38.4 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.179 -1.045 . . . . 2.42 108.179 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.1 m -139.62 163.6 32.13 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.516 -1.29 . . . . 2.63 107.516 161.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.2 t -148.17 145.43 28.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.679 -0.808 . . . . 2.35 108.823 142.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.59 137.59 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.12 0.968 . . . . 1.94 111.277 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.41 134.33 55.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.158 0.983 . . . . 0.76 110.702 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.19 -41.57 99.21 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.154 1.382 . . . . 2.0 111.1 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.82 -37.87 20.54 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.032 1.333 . . . . 1.33 113.261 -166.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -130.16 24.56 5.23 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.231 1.012 . . . . 2.7 110.535 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 m120 35.68 48.28 0.45 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.329 2.252 . . . . 1.75 111.769 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -106.68 135.14 48.73 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.53 -0.545 . . . . 1.95 109.53 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -110.48 114.81 28.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.39 -1.337 . . . . 0.67 107.39 168.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -89.95 105.0 17.51 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.014 -2.588 . . . . 2.16 104.014 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.45 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.5 mp -97.55 137.03 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.317 -1.734 . . . . 1.34 106.317 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -118.05 126.77 52.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.394 -1.336 . . . . 2.76 107.394 177.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -153.56 154.61 34.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.095 0.558 . . . . 2.6 110.572 -165.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -69.69 144.96 94.43 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 108.939 -0.763 . . . . 4.98 108.939 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.35 24.79 0.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.259 2.639 . . . . 1.44 111.432 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -113.02 -58.66 2.13 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.847 0.859 . . . . 3.55 109.969 -164.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 pt -95.42 -50.15 11.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.528 0.731 . . . . 2.14 110.295 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 tp -91.27 151.68 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.151 -1.055 . . . . 1.19 108.151 -173.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.56 169.07 23.62 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.643 -0.983 . . . . 0.6 110.643 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -50.09 -42.48 45.95 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.585 2.856 . . . . 0.79 110.73 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -38.0 -51.06 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.373 1.469 . . . . 9.35 111.925 173.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -71.67 -49.78 36.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.587 -0.894 . . . . 2.4 108.587 -166.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.58 -47.31 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 114.884 -1.053 . . . . 1.45 108.374 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.0 mt -58.17 -53.24 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 109.746 -0.465 . . . . 0.66 109.746 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -56.72 -41.34 77.27 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 121.64 0.733 . . . . 3.33 109.442 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.4 m -61.42 -54.35 44.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.823 -0.626 . . . . 0.67 110.583 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 mm -63.02 -41.6 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 121.367 -0.833 . . . . 1.65 110.501 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.56 -46.47 77.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.684 0.393 . . . . 3.31 109.992 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -61.43 -39.27 90.18 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.287 -0.387 . . . . 1.55 111.586 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.47 -35.67 81.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.835 0.743 . . . . 1.02 110.848 173.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.78 40.54 0.99 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.051 0.834 . . . . 0.81 112.409 170.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -131.94 162.02 31.69 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 107.131 -1.433 . . . . 1.83 107.131 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -99.48 109.1 53.84 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 119.001 0.819 . . . . 2.79 109.363 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.05 88.34 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.753 2.969 . . . . 1.0 110.54 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.15 96.78 5.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.866 -1.161 . . . . 1.88 107.866 -178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pp -59.98 107.34 0.61 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.195 0.907 . . . . 2.34 110.481 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.2 t . . . . . 0 C--N 1.34 0.185 0 N-CA-C 109.231 -0.655 . . . . 2.64 109.231 178.537 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p . . . . . 0 N--CA 1.451 -0.386 0 N-CA-C 108.662 -0.866 . . . . 3.5 108.662 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.86 156.68 39.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.849 -1.167 . . . . 3.55 107.849 165.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -126.79 139.15 53.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.335 1.054 . . . . 2.93 109.76 -175.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.41 143.43 31.62 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.369 1.068 . . . . 1.46 108.189 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.07 123.08 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.962 -1.866 . . . . 1.08 105.962 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 m -106.59 74.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 106.656 -1.609 . . . . 0.72 106.656 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.4 ptt85 -76.1 129.59 37.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.305 -1.368 . . . . 5.02 107.305 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.85 -48.54 0.95 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.427 -1.069 . . . . 0.79 110.427 -165.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -73.57 144.78 45.91 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.847 1.323 . . . . 1.47 111.287 -174.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -148.16 -1.6 0.55 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.775 1.398 . . . . 2.33 114.775 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.62 168.51 25.88 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.554 1.525 . . . . 1.25 110.165 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.91 -42.71 13.09 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.517 1.527 . . . . 1.0 112.259 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.3 m -43.52 -51.08 6.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.681 1.193 . . . . 1.66 111.401 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -71.06 -41.6 70.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 122.993 0.517 . . . . 0.79 111.83 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.3 t -50.79 -59.0 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.232 -1.025 . . . . 0.82 108.232 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -68.36 -30.34 69.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.139 -0.937 . . . . 1.13 111.155 -176.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -53.61 -43.54 68.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 119.271 0.941 . . . . 4.86 110.313 170.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.1 mt -71.82 -80.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 118.751 0.705 . . . . 0.75 109.606 169.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -62.4 -43.69 98.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.709 -0.619 . . . . 2.21 112.542 -153.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -63.08 -28.74 70.29 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.543 0.571 . . . . 2.93 112.543 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 t -71.79 -53.19 14.13 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.376 0.989 . . . . 1.1 110.399 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.04 -46.39 65.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.152 0.981 . . . . 1.8 111.278 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.3 p -67.13 64.01 0.06 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.142 1.377 . . . . 1.65 112.114 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -160.05 -50.02 0.05 Allowed 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 128.406 2.682 . . . . 6.47 108.929 -175.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -68.02 138.54 55.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.151 -0.619 . . . . 2.32 109.789 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -56.66 149.41 17.82 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.035 0.445 . . . . 6.12 109.813 175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.07 -24.38 16.2 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-O 118.339 -1.256 . . . . 0.79 112.764 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.532 HD11 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -76.95 120.46 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 120.128 1.964 . . . . 1.75 108.221 171.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.8 mt -81.78 -52.99 6.57 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.193 -1.04 . . . . 2.14 108.193 170.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -157.84 147.61 20.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.586 -0.894 . . . . 3.57 108.586 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.3 t -117.97 144.67 45.31 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 105.751 -1.944 . . . . 2.24 105.751 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.4 t -147.21 151.03 36.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 118.159 -1.416 . . . . 2.74 110.441 153.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.487 HG12 ' CB ' ' A' ' 44' ' ' ALA . 3.5 m -131.8 133.19 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 124.532 1.145 . . . . 1.76 110.509 -171.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.47 132.34 55.77 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.695 0.628 . . . . 0.83 112.695 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.505 HD22 ' H ' ' A' ' 39' ' ' LEU . 2.0 mm? -65.56 -45.05 84.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.232 1.413 . . . . 3.51 111.606 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.04 -30.08 23.99 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.712 0.805 . . . . 1.41 112.932 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -114.36 2.13 14.63 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.495 1.518 . . . . 2.46 111.705 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.3 m120 41.16 43.59 1.97 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.465 2.306 . . . . 2.06 110.881 -172.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.57 140.3 49.42 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 122.691 0.396 . . . . 1.74 111.34 -166.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.487 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -109.41 139.52 44.27 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.179 1.792 . . . . 0.97 108.929 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -104.38 137.43 42.27 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.726 -1.953 . . . . 3.64 105.726 156.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.532 HG23 HD11 ' A' ' 32' ' ' ILE . 4.2 mp -125.8 112.88 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.445 -1.687 . . . . 1.35 106.445 174.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -83.7 68.27 9.8 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.373 -1.343 . . . . 2.91 107.373 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -90.83 140.03 30.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.226 -0.443 . . . . 2.87 110.705 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.2 106.5 0.73 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.19 1.396 . . . . 2.54 108.591 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.5 61.31 7.99 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.299 2.666 . . . . 2.3 110.421 -166.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -163.98 -60.47 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.01 0.924 . . . . 4.41 109.805 -169.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 pt -82.94 -26.88 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 122.768 0.427 . . . . 2.62 111.991 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 tp -131.12 140.26 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.261 -1.755 . . . . 1.27 106.261 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.32 176.34 16.08 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 121.781 0.656 . . . . 0.89 112.156 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.04 -41.59 51.2 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.168 2.579 . . . . 1.15 110.52 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.59 -46.05 90.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.309 0.244 . . . . 7.48 110.602 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.15 -51.31 69.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.394 -0.595 . . . . 3.26 109.394 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 mm -55.14 -48.92 75.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 122.779 0.432 . . . . 1.81 111.533 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.1 mt -53.14 -57.02 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.037 -0.727 . . . . 0.98 109.037 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -65.89 -33.92 76.95 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.806 -0.559 . . . . 3.49 111.153 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -57.56 -58.64 7.4 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.34 -0.615 . . . . 1.22 109.34 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.7 mt -65.66 -35.43 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.25 -0.906 . . . . 1.21 111.293 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.13 -51.63 61.32 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.437 -0.579 . . . . 3.4 109.437 168.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 m -57.65 -38.22 74.69 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.025 -0.422 . . . . 2.23 111.922 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.4 mt -67.94 -10.63 54.94 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.918 0.71 . . . . 1.51 112.918 174.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.98 60.09 3.0 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.673 -0.971 . . . . 1.62 110.673 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -141.5 171.48 14.0 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 106.826 -1.546 . . . . 2.11 106.826 155.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -101.46 100.96 15.23 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 108.837 -0.801 . . . . 2.51 108.837 172.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.21 145.11 59.25 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 N-CA-C 108.238 -1.485 . . . . 1.94 108.238 166.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -150.8 110.97 4.14 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.464 -1.68 . . . . 1.78 106.464 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.02 142.41 53.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.28 0.562 . . . . 3.72 109.502 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.7 t . . . . . 0 CA--C 1.536 0.422 0 C-N-CA 124.836 1.254 . . . . 2.57 111.133 172.834 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.2 m . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 108.444 -0.947 . . . . 3.6 108.444 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -79.14 108.99 13.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.606 -1.257 . . . . 2.8 107.606 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -93.27 83.23 4.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 113.601 -1.636 . . . . 3.0 107.102 166.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.76 129.67 35.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.569 -1.641 . . . . 1.47 106.569 174.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.89 119.97 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.738 -1.949 . . . . 1.11 105.738 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.78 84.39 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 128.124 2.57 . . . . 0.77 108.331 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.79 140.16 39.41 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 108.872 -0.788 . . . . 4.61 108.872 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.84 -19.78 8.3 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.881 0.753 . . . . 0.69 112.084 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.5 mtp -62.15 150.7 37.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.572 1.186 . . . . 1.46 109.691 175.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -139.33 -39.21 0.48 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.131 0.973 . . . . 2.65 111.771 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.1 p -145.48 173.5 11.97 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.212 0.914 . . . . 1.63 111.405 -169.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.58 -39.71 3.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.048 1.739 . . . . 1.39 112.563 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.0 m -49.86 -50.87 44.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.204 0.602 . . . . 1.54 111.017 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.1 m -65.1 -41.11 95.28 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.196 0.598 . . . . 0.72 110.172 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 t -55.27 -61.76 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.458 -0.942 . . . . 0.85 108.458 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.2 -28.93 67.69 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 118.866 -0.588 . . . . 1.52 111.533 -173.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -56.81 -56.61 19.34 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.462 -0.94 . . . . 4.16 108.462 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.55 -59.63 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 109.158 -0.682 . . . . 0.8 109.158 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.67 -45.3 94.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.766 -0.635 . . . . 2.59 111.927 -169.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m -61.14 -47.45 86.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.793 0.724 . . . . 1.46 111.066 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.3 t -58.82 -42.57 89.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.944 -0.472 . . . . 1.76 110.094 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.35 -48.29 61.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.425 0.69 . . . . 2.03 111.842 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.3 p -56.49 -32.11 64.71 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.868 1.213 . . . . 2.44 111.62 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -54.51 -36.26 64.04 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.824 -0.548 . . . . 4.78 112.057 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -69.84 96.67 1.02 Allowed 'General case' 0 C--O 1.225 -0.234 0 O-C-N 121.325 -0.859 . . . . 2.92 109.1 171.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -41.42 -40.02 1.64 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.914 1.285 . . . . 7.18 114.099 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.0 -2.19 70.8 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.072 -0.849 . . . . 0.99 114.211 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.52 121.8 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.865 -1.532 . . . . 2.33 106.865 167.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.7 mt -79.9 -46.74 16.24 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.129 0.971 . . . . 2.34 108.882 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -155.96 129.03 8.05 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.387 0.539 . . . . 2.95 110.435 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.6 p -104.27 154.31 19.95 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.535 0.734 . . . . 2.88 109.664 169.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -151.5 110.33 3.85 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.603 -1.258 . . . . 1.98 107.603 155.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.64 157.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 118.134 0.425 . . . . 1.82 110.652 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.92 134.5 14.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.602 -0.687 . . . . 0.87 110.764 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.09 -32.15 71.38 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.941 0.896 . . . . 1.75 110.289 175.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.97 -37.8 2.01 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.005 1.722 . . . . 1.36 113.565 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.9 t -140.83 37.87 1.8 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 121.507 0.67 . . . . 2.45 109.913 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 m120 35.45 58.84 0.82 Allowed 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.002 1.721 . . . . 2.4 110.879 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -121.87 142.83 49.85 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 122.819 0.448 . . . . 2.32 110.605 -171.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.84 105.27 10.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.8 1.24 . . . . 0.75 108.843 167.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -79.8 108.68 13.55 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 104.356 -2.461 . . . . 3.02 104.356 169.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.8 mt -119.99 111.4 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 106.749 -1.574 . . . . 1.07 106.749 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.7 mtpm? -103.12 109.7 21.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.051 -1.833 . . . . 2.98 106.051 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -137.29 162.74 32.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.881 1.672 . . . . 2.22 109.999 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -83.25 112.76 41.45 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 107.162 -1.422 . . . . 3.24 107.162 171.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.64 68.38 8.31 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.975 2.45 . . . . 1.73 110.852 -170.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.68 -92.66 0.17 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.672 1.189 . . . . 3.8 109.363 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.97 -30.3 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 N-CA-C 112.873 0.694 . . . . 1.99 112.873 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.72 125.24 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.52 -1.659 . . . . 1.81 106.52 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.98 -179.41 19.04 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.789 1.185 . . . . 0.84 111.424 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -59.52 -39.82 71.93 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.643 2.228 . . . . 0.72 110.464 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -56.51 -49.61 74.24 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.754 0.421 . . . . 5.41 111.683 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -48.49 81.46 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.413 -0.588 . . . . 2.26 109.413 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.5 mt -51.28 -56.15 5.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 108.776 -0.824 . . . . 1.46 108.776 173.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.6 mt -54.52 -52.68 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 110.005 -0.368 . . . . 0.49 110.005 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -56.47 -42.73 78.73 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 121.53 0.681 . . . . 2.79 109.221 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.7 m -63.36 -50.34 70.31 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.076 -0.511 . . . . 0.86 110.782 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.8 mm -61.94 -42.74 95.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.445 -0.784 . . . . 1.55 110.41 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -56.23 -44.6 79.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.692 0.397 . . . . 3.23 110.099 173.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 m -61.24 -40.29 93.5 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.083 -0.386 . . . . 1.6 111.837 176.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.98 -41.26 96.11 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.72 0.691 . . . . 1.14 110.585 172.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.81 44.98 0.73 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.367 0.984 . . . . 0.75 111.587 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -131.74 162.78 29.66 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.552 -1.277 . . . . 2.03 107.552 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -95.03 101.51 7.38 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 117.61 -1.186 . . . . 2.66 109.861 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -77.74 137.73 16.33 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.103 1.869 . . . . 1.33 108.823 172.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 t -154.79 109.29 2.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.706 -0.85 . . . . 2.05 108.706 -171.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.42 66.02 1.78 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.784 0.834 . . . . 2.11 110.375 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t . . . . . 0 CA--C 1.532 0.251 0 C-N-CA 123.879 0.872 . . . . 2.67 109.766 177.579 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.0 m . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 109.114 -0.699 . . . . 2.5 109.114 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 135.66 29.65 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.926 0.49 . . . . 2.43 109.833 169.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -90.85 93.01 9.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.442 1.497 . . . . 3.13 107.046 165.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.2 121.85 34.98 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 107.997 -1.112 . . . . 1.66 107.997 173.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.63 111.09 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.337 -1.357 . . . . 1.45 107.337 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -94.17 92.16 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.252 1.421 . . . . 0.64 108.326 -168.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -77.71 137.29 38.41 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.433 -0.951 . . . . 5.84 108.433 -174.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.58 -53.15 0.77 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.499 -1.041 . . . . 1.14 110.499 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -61.58 143.7 55.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 122.938 0.495 . . . . 1.7 111.756 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -157.28 14.8 0.25 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.891 1.071 . . . . 2.5 113.891 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 p -162.85 161.04 25.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.761 1.164 . . . . 1.74 109.772 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -39.64 5.56 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.701 1.6 . . . . 1.06 111.449 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -36.16 -47.63 0.57 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.512 2.325 . . . . 2.56 113.13 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.0 m -73.85 -52.46 12.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.151 0.981 . . . . 1.0 111.685 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.5 t -45.99 -58.13 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 126.179 1.791 . . . . 0.81 109.679 -166.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -61.47 -32.51 72.51 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.21 -1.359 . . . . 1.92 110.794 -174.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -71.23 -47.3 58.13 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.852 -0.796 . . . . 4.71 108.852 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 99.1 mt -54.05 -58.88 2.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.053 -0.721 . . . . 0.98 109.053 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -61.97 -47.77 83.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.531 -0.271 . . . . 2.13 111.196 -174.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.6 m -55.49 -58.22 8.65 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.201 0.455 . . . . 1.57 110.517 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 t -49.31 -49.89 41.83 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.951 1.3 . . . . 1.3 110.698 -177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.94 -51.23 57.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 119.161 -0.447 . . . . 2.53 111.721 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.4 p -55.4 -28.35 53.54 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.159 0.436 . . . . 1.91 111.635 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -58.17 -40.85 82.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.424 0.557 . . . . 4.99 111.909 174.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -79.28 120.0 23.14 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.899 0.857 . . . . 2.37 110.142 -169.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -57.84 157.68 7.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.111 -0.7 . . . . 7.47 109.111 170.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.3 -15.05 25.37 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 117.896 -1.502 . . . . 0.81 112.785 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.51 125.05 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 119.777 1.789 . . . . 1.66 106.536 154.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.2 mt -80.44 -43.46 20.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.675 -1.231 . . . . 2.58 107.675 169.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -155.63 155.95 34.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.487 -0.561 . . . . 2.5 109.487 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 p -131.32 158.18 41.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 106.955 -1.498 . . . . 2.41 106.955 156.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -150.79 145.2 25.57 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.028 -1.101 . . . . 2.39 108.028 139.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 p -112.57 148.29 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.168 0.987 . . . . 1.91 110.653 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.54 136.11 35.73 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.14 0.576 . . . . 0.69 110.943 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.2 mt -65.82 -36.12 82.6 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.043 1.337 . . . . 2.35 110.091 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.3 -39.06 1.3 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.188 1.795 . . . . 1.54 113.88 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 t -140.96 35.68 1.75 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 122.154 0.978 . . . . 2.29 109.644 172.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 m120 36.06 57.36 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.984 2.514 . . . . 2.03 111.917 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.64 153.73 51.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 121.926 -0.484 . . . . 3.22 111.994 -170.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.556 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -116.82 117.05 28.67 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.058 1.743 . . . . 0.7 108.657 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -85.08 101.45 12.44 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 103.46 -2.792 . . . . 2.89 103.46 169.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.556 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -99.22 143.91 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.026 -1.472 . . . . 1.24 107.026 170.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -126.8 112.5 15.45 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 106.092 -1.818 . . . . 2.5 106.092 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -127.48 173.49 9.8 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.369 0.668 . . . . 2.26 111.254 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -96.4 101.33 8.57 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.411 1.085 . . . . 2.43 109.275 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.54 58.08 6.6 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.663 2.909 . . . . 1.48 113.029 -169.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.13 -63.75 0.4 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.027 1.731 . . . . 4.12 107.987 169.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.0 pt -65.28 -26.83 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.977 0.911 . . . . 2.82 112.432 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 tt -143.96 150.67 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.07 -1.085 . . . . 1.36 108.07 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -114.43 -176.26 18.91 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.187 -0.765 . . . . 0.92 111.187 -174.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.16 -38.72 20.5 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.337 2.024 . . . . 0.86 109.795 172.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -47.52 -49.59 25.71 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.755 1.222 . . . . 5.98 111.382 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.89 -54.09 50.27 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.227 0.611 . . . . 2.54 110.124 -174.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.6 mt -53.14 -52.28 31.55 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 N-CA-C 108.555 -0.905 . . . . 1.42 108.555 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mt -55.54 -53.28 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.89 -0.595 . . . . 0.9 110.277 -174.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -67.84 -31.87 72.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.626 0.648 . . . . 6.19 110.362 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.7 m -59.29 -46.4 88.65 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.532 -0.544 . . . . 0.8 109.532 172.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.57 -36.98 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.27 -0.894 . . . . 1.15 111.315 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -55.22 -43.96 74.97 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.507 -0.746 . . . . 2.86 109.882 169.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.7 m -60.93 -38.81 87.08 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.295 -0.253 . . . . 1.5 111.576 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.24 -40.27 95.67 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.225 0.466 . . . . 1.2 110.831 171.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.8 45.02 0.85 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 124.526 1.06 . . . . 1.01 111.752 173.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -131.89 163.06 29.15 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.748 -0.834 . . . . 2.02 108.748 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -99.12 100.7 10.62 Favored Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 124.576 1.15 . . . . 4.5 110.539 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.71 81.77 2.59 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.815 3.01 . . . . 1.39 111.107 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.2 m -78.66 109.91 13.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.402 -0.811 . . . . 1.41 109.564 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.56 58.47 0.59 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.488 0.715 . . . . 2.12 111.76 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 p . . . . . 0 CA--C 1.53 0.191 0 C-N-CA 125.605 1.562 . . . . 3.08 108.67 -179.362 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.4 t . . . . . 0 C--O 1.232 0.161 0 N-CA-C 107.65 -1.241 . . . . 2.77 107.65 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.95 121.38 40.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.519 0.676 . . . . 2.79 109.566 178.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -91.1 90.75 7.96 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.784 2.034 . . . . 4.22 107.348 177.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -82.35 106.77 14.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.15 -1.796 . . . . 2.57 106.15 172.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 t -78.49 101.37 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.438 -1.69 . . . . 1.38 106.438 -176.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 m -89.44 88.3 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.997 1.319 . . . . 0.88 109.912 -164.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -77.8 96.57 4.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.652 -1.61 . . . . 8.0 106.652 -176.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.69 -38.83 0.35 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.878 -0.957 . . . . 0.63 112.527 177.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -70.56 162.26 29.19 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.126 1.463 . . . . 1.34 111.218 -173.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -145.09 -37.41 0.28 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.435 0.902 . . . . 2.39 113.435 -170.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 p -141.09 173.83 11.11 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 119.789 1.177 . . . . 1.69 111.705 -172.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.78 -41.8 15.96 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.025 1.33 . . . . 1.18 111.799 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.7 m -57.25 -38.46 73.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.825 0.45 . . . . 1.82 111.665 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.0 m -71.07 -52.63 18.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.264 0.484 . . . . 0.73 110.176 173.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.8 t -44.2 -58.44 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 124.753 1.221 . . . . 0.74 109.212 -176.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.6 -22.24 63.52 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.515 -0.766 . . . . 1.44 112.368 -174.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -68.48 -50.87 49.16 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 107.413 -1.328 . . . . 5.29 107.413 173.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mt -56.54 -57.01 10.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 109.104 -0.702 . . . . 0.76 109.104 177.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.98 -54.66 44.14 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.423 0.556 . . . . 2.18 111.488 -174.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.7 t -62.33 -39.1 91.96 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.502 0.321 . . . . 1.91 111.007 -178.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -63.5 -53.42 52.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.141 -0.688 . . . . 1.41 109.141 177.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -47.6 -46.21 28.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.662 1.185 . . . . 1.87 111.528 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.43 -15.16 2.4 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.491 1.293 . . . . 2.66 114.491 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -56.59 -37.02 70.05 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.904 1.229 . . . . 5.21 111.288 170.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -76.72 100.78 5.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.596 -0.891 . . . . 3.07 108.596 -176.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -50.92 -30.21 14.16 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.204 0.816 . . . . 6.79 113.204 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.81 -20.64 70.59 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.95 -0.916 . . . . 1.01 113.677 177.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.09 124.87 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 118.682 1.241 . . . . 2.0 108.393 178.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.5 mt -94.46 -36.93 11.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.591 1.556 . . . . 2.18 109.507 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -155.7 125.59 6.52 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.8 0.727 . . . . 2.07 111.048 178.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.84 144.79 34.55 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.528 1.131 . . . . 2.99 108.732 167.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 m -151.48 143.06 23.61 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.901 -1.518 . . . . 2.21 106.901 152.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 m -127.18 136.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.29 0.496 . . . . 1.7 110.223 178.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.82 131.59 54.13 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.835 0.854 . . . . 0.77 111.691 -174.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.63 -43.47 80.3 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.296 1.838 . . . . 2.8 111.414 -175.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.09 -46.06 33.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.166 0.587 . . . . 1.18 111.453 -179.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -82.92 -25.16 32.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.671 1.189 . . . . 3.39 111.839 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 41.69 66.9 0.62 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.523 1.529 . . . . 3.37 109.609 -151.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.41 141.3 33.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.504 -1.226 . . . . 1.74 110.453 -177.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.28 124.08 49.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.039 2.136 . . . . 0.74 108.31 174.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -98.16 106.99 19.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.249 -2.871 . . . . 2.08 103.249 174.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.3 mp -102.25 127.83 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.546 -1.65 . . . . 1.4 106.546 175.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -112.03 114.43 27.3 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.631 -1.248 . . . . 2.23 107.631 167.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -130.9 163.47 27.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.566 1.546 . . . . 2.02 111.47 176.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -87.98 129.32 50.63 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.239 1.016 . . . . 3.93 110.548 175.239 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -59.2 -58.76 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.781 2.321 . . . . 2.36 115.294 -165.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -78.07 37.27 0.25 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.168 1.349 . . . . 3.84 113.911 -165.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.63 -52.63 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.241 1.416 . . . . 3.67 109.111 170.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.19 144.83 33.84 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 122.624 0.37 . . . . 1.25 110.958 -171.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.47 -176.76 22.56 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.326 -1.11 . . . . 0.81 110.326 176.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.0 -39.74 18.23 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.189 1.926 . . . . 0.97 110.11 174.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -53.38 -49.43 67.21 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.004 0.922 . . . . 6.69 111.989 -176.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.12 -52.0 38.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 122.491 1.139 . . . . 2.83 109.464 -178.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.2 mt -65.55 -52.29 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 114.554 -1.203 . . . . 1.27 109.059 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.2 mt -48.08 -54.25 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.765 0.826 . . . . 0.69 110.222 -177.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -65.86 -35.6 81.11 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 119.809 -0.756 . . . . 5.36 110.501 -176.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.8 m -63.13 -46.91 85.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 122.1 -0.375 . . . . 0.98 110.582 178.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.6 -40.79 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.49 -0.756 . . . . 1.06 109.882 178.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -53.31 -38.44 63.17 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.539 -0.725 . . . . 5.24 111.207 170.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -64.44 -22.54 66.99 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.935 0.717 . . . . 1.6 112.935 176.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.6 mt -78.74 -43.61 25.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.982 0.81 . . . . 1.19 109.243 168.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.21 49.11 0.37 Allowed Glycine 0 C--N 1.338 0.659 0 C-N-CA 124.467 1.032 . . . . 0.93 112.173 169.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.28 134.73 26.19 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 117.419 -1.277 . . . . 1.99 108.014 175.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -78.86 112.02 24.15 Favored Pre-proline 0 C--N 1.34 0.156 0 CA-C-N 119.49 1.041 . . . . 5.48 108.893 -170.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -89.55 78.98 0.87 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.38 2.72 . . . . 1.39 110.066 -171.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.39 115.53 20.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.547 -0.721 . . . . 1.78 109.633 -170.203 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.6 mt -53.61 111.52 0.74 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.996 0.816 . . . . 3.41 110.724 174.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.469 0.495 0 CA-C-N 118.896 0.771 . . . . 4.57 111.89 176.945 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 107.836 -1.172 . . . . 2.84 107.836 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -149.25 163.5 37.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.256 -0.646 . . . . 3.4 109.256 162.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -120.03 145.41 46.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.217 -1.031 . . . . 2.35 108.217 168.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.07 130.13 28.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.759 -1.2 . . . . 1.44 107.759 177.47 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.3 t -79.67 104.72 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.901 -1.889 . . . . 1.07 105.901 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.05 89.22 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.428 1.491 . . . . 0.65 108.216 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -75.57 131.4 39.99 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 107.763 -1.199 . . . . 5.23 107.763 -170.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.05 -43.13 1.39 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.088 0.852 . . . . 0.71 111.404 177.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.46 132.58 40.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.454 1.127 . . . . 1.37 108.633 -175.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 t -154.84 25.08 0.44 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.97 0.73 . . . . 2.69 112.97 -169.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.33 156.87 19.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.523 0.602 . . . . 1.39 109.629 178.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.53 -39.43 16.29 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.505 1.522 . . . . 0.89 111.987 -176.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.6 t -47.26 -54.23 11.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.683 0.754 . . . . 2.21 110.143 172.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.263 57.7 m -73.16 -33.56 65.55 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.355 -1.465 . . . . 1.19 112.151 -176.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.8 t -50.37 -61.33 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 108.666 -0.864 . . . . 0.69 108.666 174.084 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -69.84 -29.56 66.84 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.175 -0.921 . . . . 1.12 111.787 -174.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -62.0 -50.72 70.92 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.28 0.945 . . . . 4.41 109.655 173.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 mt -58.29 -57.76 9.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 119.218 0.917 . . . . 0.65 109.047 178.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.05 -54.14 46.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.157 0.435 . . . . 2.47 110.895 -173.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -56.98 -52.99 63.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.865 0.466 . . . . 1.54 110.437 179.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.6 t -57.34 -54.97 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.638 0.375 . . . . 0.97 110.756 -177.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.51 -32.98 71.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.534 -0.729 . . . . 2.06 111.365 -174.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.9 m -53.66 -19.97 4.71 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 112.938 0.718 . . . . 2.54 112.938 173.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -30.28 59.73 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.531 -1.355 . . . . 5.72 112.113 171.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -68.86 101.47 1.36 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.577 -0.897 . . . . 2.82 108.577 169.319 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -49.45 -33.25 13.68 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 111.885 0.328 . . . . 5.36 111.885 171.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.72 -11.23 77.5 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.815 -0.992 . . . . 0.84 113.796 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.16 129.67 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 119.699 1.75 . . . . 2.09 107.431 168.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 pp -99.74 -26.05 14.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.862 0.465 . . . . 2.31 110.745 175.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -156.11 149.94 25.1 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.88 0.764 . . . . 2.68 111.224 172.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.1 m -130.33 145.4 51.78 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 126.178 1.791 . . . . 2.57 107.553 174.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 m -153.34 135.22 14.62 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 107.808 -1.182 . . . . 1.84 107.808 152.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.86 151.07 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.987 0.812 . . . . 1.86 110.479 173.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.61 132.57 37.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.533 0.682 . . . . 0.79 110.779 176.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.9 -29.44 66.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.035 -0.984 . . . . 1.75 110.732 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.72 -34.97 13.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.49 1.116 . . . . 1.09 112.927 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 p -122.03 13.49 10.55 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.889 0.876 . . . . 2.24 111.299 175.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.7 m120 40.15 52.17 2.73 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.243 1.817 . . . . 1.93 110.659 -171.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.09 140.37 45.45 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 122.043 -0.411 . . . . 1.92 111.141 -164.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.85 128.22 56.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.026 1.73 . . . . 0.58 109.156 177.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -98.84 121.78 41.23 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 127.847 2.459 . . . . 2.81 105.701 172.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mt -123.72 134.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.686 -0.857 . . . . 1.63 108.686 177.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -122.95 130.82 53.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.14 -1.8 . . . . 2.4 106.14 178.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -162.05 171.31 17.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.214 0.45 . . . . 2.51 112.214 -158.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.12 100.56 25.48 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.51 1.524 . . . . 2.8 109.437 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.71 -12.79 35.56 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.323 2.682 . . . . 2.37 113.394 -168.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -52.97 -39.71 63.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.662 0.664 . . . . 4.63 111.635 176.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -120.07 -54.52 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.113 0.565 . . . . 1.9 112.133 -176.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.14 116.54 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.851 -1.166 . . . . 1.84 107.851 -172.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.71 161.55 16.75 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.523 -1.031 . . . . 0.78 110.523 -177.255 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -51.52 -38.1 63.82 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.995 2.463 . . . . 0.81 110.857 176.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -42.87 -52.73 4.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.422 1.089 . . . . 9.48 111.647 172.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.18 -40.52 67.86 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.083 -1.01 . . . . 2.5 109.76 -167.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 78.5 mt -52.68 -57.47 4.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 N-CA-C 107.611 -1.255 . . . . 1.55 107.611 170.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mt -55.54 -48.91 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 116.039 -0.528 . . . . 0.64 110.136 -174.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -55.54 -44.98 77.23 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 122.172 0.986 . . . . 3.54 108.953 179.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 m -62.96 -45.72 91.13 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.344 -0.843 . . . . 0.97 110.294 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -70.07 -42.42 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.377 -0.827 . . . . 1.48 110.566 -173.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -63.26 -43.18 98.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.907 -0.496 . . . . 3.01 110.138 175.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 m -54.54 -44.83 73.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 111.891 0.33 . . . . 1.63 111.891 172.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.07 -39.8 91.27 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.822 0.737 . . . . 1.17 111.14 173.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.2 41.07 0.92 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.049 0.833 . . . . 0.82 111.655 173.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -127.77 161.97 27.72 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.163 -1.051 . . . . 1.8 108.163 170.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.4 103.6 14.63 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.133 -0.937 . . . . 2.68 110.015 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.29 77.03 3.97 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.239 2.626 . . . . 1.02 110.699 -176.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -78.66 90.11 4.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.316 -0.994 . . . . 1.69 108.316 -177.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.3 pt? -66.1 57.44 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.021 1.728 . . . . 2.61 114.683 -176.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.7 t . . . . . 0 N--CA 1.454 -0.264 0 C-N-CA 126.369 1.868 . . . . 3.66 107.543 -175.512 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 C--O 1.236 0.373 0 N-CA-C 109.783 -0.451 . . . . 2.49 109.783 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mp -136.46 138.67 41.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.029 -0.73 . . . . 2.34 109.029 167.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -92.34 93.51 8.66 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.512 -1.292 . . . . 2.7 107.512 163.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mt -80.03 112.25 17.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.797 -1.927 . . . . 2.82 105.797 173.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.2 t -78.97 104.49 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.506 -1.665 . . . . 1.34 106.506 -177.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.3 m -79.14 80.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 124.601 1.16 . . . . 0.97 108.516 -172.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 -75.91 95.27 3.5 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.524 -1.658 . . . . 4.13 106.524 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.58 -57.41 0.11 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.643 -0.983 . . . . 1.51 110.643 177.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.28 157.45 18.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 117.363 0.582 . . . . 2.13 109.794 -177.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 t -154.31 35.82 0.42 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.624 -0.51 . . . . 4.06 109.624 170.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.43 137.0 22.76 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.686 0.795 . . . . 2.57 110.193 -170.054 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.69 -43.28 2.8 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.519 1.927 . . . . 1.01 112.002 -177.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -35.1 -58.38 0.54 Allowed 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.733 1.613 . . . . 2.03 111.931 170.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.2 m -74.52 -27.56 60.59 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.915 -1.116 . . . . 1.44 113.866 -178.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.455 HG13 HG13 ' A' ' 37' ' ' VAL . 45.1 t -56.41 -55.68 17.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.895 -1.15 . . . . 0.58 107.895 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -63.58 -32.57 74.08 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.951 -0.568 . . . . 1.11 111.913 -178.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -60.01 -54.3 47.6 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.433 -0.951 . . . . 3.96 108.433 173.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.3 mt -57.7 -56.43 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.187 -0.672 . . . . 0.8 109.187 -172.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -61.03 -50.23 74.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.789 -0.764 . . . . 3.29 111.337 -174.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.3 m -54.11 -50.11 67.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.339 0.59 . . . . 1.58 110.407 177.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.4 t -58.19 -41.88 84.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.037 0.935 . . . . 1.32 110.301 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.68 -46.3 69.42 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.59 -0.694 . . . . 2.1 111.849 178.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.2 p -53.71 -30.21 42.77 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.806 0.73 . . . . 2.31 112.926 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -58.19 -32.46 68.27 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.24 0.616 . . . . 5.6 112.082 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -73.17 106.66 5.12 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.335 0.971 . . . . 3.03 108.595 171.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -37.38 -58.01 0.87 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.067 -0.716 . . . . 8.65 109.067 167.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.97 -11.43 0.57 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.921 1.248 . . . . 0.82 116.07 -173.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.13 167.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 120.275 2.038 . . . . 2.17 107.892 171.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.87 -30.04 1.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.67 -0.644 . . . . 2.54 112.531 170.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -155.62 123.17 5.57 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.293 0.951 . . . . 3.26 108.917 170.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 p -106.52 132.81 52.1 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.996 0.918 . . . . 3.03 108.573 169.059 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -134.9 80.29 1.84 Allowed 'General case' 0 CA--C 1.522 -0.122 0 O-C-N 123.715 0.634 . . . . 2.28 109.614 167.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.455 HG13 HG13 ' A' ' 19' ' ' VAL . 10.7 p -78.85 144.1 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 122.56 0.344 . . . . 1.83 110.803 171.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.24 137.7 16.74 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.887 0.875 . . . . 1.22 109.905 178.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.75 -22.35 58.83 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.013 -0.54 . . . . 1.7 111.487 177.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.56 -39.7 2.41 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.49 1.516 . . . . 1.8 113.278 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -137.88 34.8 2.39 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.944 0.497 . . . . 2.07 110.309 168.157 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 44.78 50.51 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.765 2.026 . . . . 1.96 110.027 173.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -114.61 145.26 42.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.971 0.909 . . . . 2.46 110.354 -170.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.491 ' HB1' HD11 ' A' ' 46' ' ' ILE . . . -122.28 108.22 13.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.15 1.38 . . . . 0.94 108.562 163.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . 0.25 19.7 t60 -86.77 101.75 13.61 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 104.234 -2.506 . . . . 2.55 104.234 174.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.491 HD11 ' HB1' ' A' ' 44' ' ' ALA . 2.0 mp -103.43 119.83 52.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.858 -1.905 . . . . 1.06 105.858 174.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -102.71 140.66 36.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.069 -1.085 . . . . 2.74 108.069 166.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -159.27 159.1 33.69 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.957 0.903 . . . . 2.05 112.423 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.74 109.17 3.06 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 126.47 1.908 . . . . 2.68 107.659 173.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -81.83 54.61 5.13 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.007 2.471 . . . . 1.53 110.553 -170.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -142.52 -64.31 0.42 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.367 1.467 . . . . 3.89 109.361 -175.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.57 -38.46 17.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 N-CA-C 112.204 0.446 . . . . 1.78 112.204 -172.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 tt -113.41 146.01 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.64 1.176 . . . . 1.17 109.604 -175.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.5 -172.17 13.73 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.687 -0.965 . . . . 0.69 110.687 178.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.81 -40.56 28.08 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.479 2.119 . . . . 0.76 110.178 174.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -45.53 -58.41 3.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.313 1.045 . . . . 6.29 111.504 179.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.91 -57.62 9.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.362 0.665 . . . . 2.34 109.644 -174.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 56.0 mt -51.82 -52.71 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.921 0.888 . . . . 1.26 109.325 179.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.02 -48.67 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-O 119.034 -0.508 . . . . 0.76 110.107 -176.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -58.7 -41.57 86.6 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.88 0.848 . . . . 3.11 109.476 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.3 m -64.88 -45.44 85.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.783 -0.644 . . . . 0.98 111.044 178.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.3 mm -70.2 -51.67 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 CA-C-N 118.575 0.625 . . . . 1.96 110.682 -177.158 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -55.58 -36.8 67.27 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.148 0.579 . . . . 3.08 111.707 -167.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 t -38.07 -44.68 0.84 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.011 1.724 . . . . 2.5 113.039 168.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -19.66 63.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.811 0.844 . . . . 3.89 112.21 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.6 40.54 3.37 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.021 1.296 . . . . 1.89 111.782 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -124.87 155.95 38.68 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.759 -1.2 . . . . 2.11 107.759 172.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -95.63 101.12 7.23 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.012 -0.994 . . . . 3.51 108.895 169.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -70.81 81.49 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.165 2.577 . . . . 1.15 109.141 175.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 m -79.35 109.66 13.91 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.909 0.884 . . . . 1.86 108.733 -168.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.42 61.4 0.67 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.558 1.143 . . . . 2.66 112.568 -174.201 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.5 t . . . . . 0 N--CA 1.455 -0.211 0 N-CA-C 108.856 -0.794 . . . . 2.31 108.856 174.487 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 m . . . . . 0 N--CA 1.454 -0.274 0 N-CA-C 108.47 -0.937 . . . . 3.31 108.47 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 mt -134.31 130.29 36.79 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.335 -0.987 . . . . 3.24 108.335 170.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -114.11 91.93 3.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.454 1.502 . . . . 2.5 108.596 174.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.67 134.46 44.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.374 -1.343 . . . . 1.32 107.374 176.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -80.33 115.69 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 106.949 -1.5 . . . . 2.89 106.949 170.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.54 86.45 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 125.938 1.695 . . . . 0.65 107.698 -173.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -77.34 130.9 37.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.23 -1.026 . . . . 5.62 108.23 -170.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.16 -18.83 4.17 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.718 0.675 . . . . 1.01 112.541 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 61.5 mtp -59.19 147.67 34.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.574 1.187 . . . . 1.88 110.863 177.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -150.75 -10.93 0.24 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.761 1.393 . . . . 2.87 114.761 178.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.9 p -165.59 172.01 12.47 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 121.032 1.742 . . . . 1.46 109.371 -179.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.88 -38.99 11.28 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.379 1.472 . . . . 1.0 112.147 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -45.71 -47.0 15.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.924 0.889 . . . . 1.47 111.65 173.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.0 m -69.75 -39.84 76.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 122.79 0.436 . . . . 0.7 110.98 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.7 t -57.75 -59.58 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.998 -1.112 . . . . 0.74 107.998 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.269 1.3 p-80 -70.8 -31.46 68.21 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 118.206 -0.902 . . . . 0.88 112.521 -175.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -49.15 -58.15 5.48 Favored 'General case' 0 C--N 1.347 0.465 0 N-CA-C 108.178 -1.045 . . . . 3.93 108.178 165.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.19 -60.87 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 118.572 -0.728 . . . . 1.1 110.239 -174.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.03 -55.31 24.63 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.39 0.995 . . . . 2.59 110.853 -175.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.1 t -58.09 -54.21 49.52 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.538 0.685 . . . . 1.53 110.28 -177.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -66.82 -40.62 88.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.709 -0.62 . . . . 0.93 110.952 -170.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.98 -42.69 84.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.115 0.416 . . . . 1.75 109.935 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -55.27 -27.23 45.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.5 0.591 . . . . 2.38 112.354 176.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -30.57 64.19 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.09 -1.006 . . . . 3.83 112.153 173.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -63.92 108.61 1.53 Allowed 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.346 0.975 . . . . 2.89 108.808 173.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -48.4 -33.44 9.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.896 0.878 . . . . 6.19 112.37 175.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.85 -18.35 80.12 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.642 -1.088 . . . . 0.81 114.042 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.21 135.59 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.94 1.37 . . . . 2.1 107.774 172.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pp -98.6 -33.61 10.9 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.692 -0.67 . . . . 2.65 109.82 173.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -157.04 146.17 20.17 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.463 1.029 . . . . 2.8 109.642 162.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.6 t -112.65 112.3 23.71 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 107.382 -1.34 . . . . 2.51 107.382 164.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.11 98.29 8.25 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.837 -1.172 . . . . 1.94 107.837 171.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.0 146.28 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 110.351 -0.24 . . . . 1.87 110.351 170.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.7 130.26 15.88 Favored 'General case' 0 CA--C 1.523 -0.092 0 O-C-N 122.02 -0.425 . . . . 0.83 111.293 170.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 pp -72.14 -25.82 61.87 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 124.756 1.223 . . . . 2.12 113.074 -168.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.1 -43.46 66.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.809 0.444 . . . . 1.11 111.191 -178.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.73 -31.75 10.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.591 1.156 . . . . 2.22 110.038 173.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 76.2 30.91 0.67 Allowed 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.14 2.176 . . . . 2.33 109.464 -171.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -79.5 145.01 33.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.373 -1.343 . . . . 4.0 107.373 171.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.48 109.71 21.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 124.888 1.367 . . . . 0.81 107.406 151.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -80.38 94.3 6.13 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.705 -1.961 . . . . 3.86 105.705 166.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -92.11 116.13 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 107.216 -1.401 . . . . 1.52 107.216 176.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -108.09 128.44 54.68 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.606 -1.627 . . . . 3.32 106.606 174.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -157.24 171.8 19.76 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.421 0.688 . . . . 2.26 109.637 -166.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.76 114.36 62.85 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.169 -0.678 . . . . 3.12 109.169 177.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.25 49.68 3.24 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.41 2.74 . . . . 1.33 112.15 -174.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.96 27.24 0.54 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.748 1.219 . . . . 3.84 110.234 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.78 -51.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 125.021 1.328 . . . . 3.4 108.998 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 tt -127.67 152.59 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.241 1.016 . . . . 1.11 108.478 -174.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -133.83 -176.09 14.22 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.538 -0.625 . . . . 0.74 111.538 -178.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.92 -41.62 52.0 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.859 2.373 . . . . 0.81 111.872 -176.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -57.39 -47.49 81.55 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.629 0.65 . . . . 6.14 110.863 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.95 -52.85 63.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.818 -0.808 . . . . 2.71 108.818 -175.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 mm -51.77 -52.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.405 1.082 . . . . 1.95 109.901 175.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.418 ' HA ' ' CG ' ' A' ' 69' ' ' PRO . 5.1 mt -55.29 -57.3 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 109.848 -0.427 . . . . 0.87 109.848 -179.026 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -65.24 -34.2 77.8 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.623 -0.673 . . . . 3.0 110.23 -171.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.5 m -59.2 -55.95 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.049 -0.523 . . . . 0.88 109.937 171.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 76.8 mt -63.86 -36.24 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.35 -0.844 . . . . 1.22 111.35 -175.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -51.2 -55.06 19.96 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.208 -0.664 . . . . 2.81 109.208 167.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -54.76 -42.08 71.23 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.696 0.398 . . . . 1.82 111.559 177.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.48 -10.94 58.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.185 0.809 . . . . 1.4 113.185 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.08 44.1 5.46 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 123.941 0.782 . . . . 0.98 111.976 172.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -140.82 163.53 32.69 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.174 -1.417 . . . . 2.45 107.174 167.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -103.91 105.01 46.31 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 125.429 1.492 . . . . 4.59 109.984 -179.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.418 ' CG ' ' HA ' ' A' ' 59' ' ' ILE . 60.6 Cg_endo -83.49 85.29 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.538 3.492 . . . . 0.94 111.317 -173.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -94.11 111.97 23.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.851 -0.531 . . . . 1.75 110.136 -173.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 mt -62.14 106.41 0.72 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.96 0.904 . . . . 3.01 109.924 174.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 t . . . . . 0 N--CA 1.462 0.132 0 N-CA-C 109.7 -0.481 . . . . 2.49 109.7 177.526 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 106.664 -1.606 . . . . 2.8 106.664 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -155.26 175.13 14.25 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.681 -1.229 . . . . 3.44 107.681 163.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -131.83 146.45 52.14 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.725 -0.843 . . . . 2.47 108.725 168.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.468 ' N ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -132.42 131.41 41.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.791 -1.559 . . . . 1.35 106.791 169.178 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.5 t -79.92 100.94 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.022 -1.473 . . . . 1.02 107.022 175.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.21 87.03 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 126.056 1.742 . . . . 0.91 108.096 177.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.12 154.33 33.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.811 -1.181 . . . . 5.07 107.811 170.171 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.54 -38.42 3.21 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.628 -0.989 . . . . 0.72 110.628 -172.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 29.9 mtp -64.06 138.15 58.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.229 1.015 . . . . 1.57 109.607 178.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -140.54 -2.76 1.36 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.128 1.159 . . . . 2.41 114.128 -176.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.1 p -161.43 166.09 27.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.44 1.473 . . . . 1.17 110.063 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.89 -40.56 10.19 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.371 1.468 . . . . 0.98 111.875 -177.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.3 m -43.27 -47.04 6.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.856 0.863 . . . . 1.53 112.304 174.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.6 -33.77 75.66 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.005 0.522 . . . . 0.91 111.436 -175.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 37' ' ' VAL . 42.4 t -59.22 -59.91 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.112 -1.44 . . . . 0.66 107.112 -178.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.25 1.5 p-80 -67.97 -30.03 69.21 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.179 -0.464 . . . . 1.0 112.062 -178.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -52.67 -44.95 66.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.57 -0.706 . . . . 3.84 110.615 168.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.6 mt -70.39 -71.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.126 -0.694 . . . . 1.07 109.126 175.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . 0.283 0.2 OUTLIER -59.15 -50.02 75.64 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.238 0.926 . . . . 4.32 112.471 -159.745 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -56.37 -46.36 80.08 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.376 0.67 . . . . 1.5 110.497 176.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -71.24 -35.27 71.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 121.232 -0.917 . . . . 1.38 112.142 -176.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.77 -54.07 50.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.004 -0.739 . . . . 1.77 109.004 172.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.2 p -65.25 71.48 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.799 1.24 . . . . 1.59 113.081 -174.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -169.83 -31.09 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.915 2.486 . . . . 3.9 111.567 171.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -67.69 147.23 52.94 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.307 1.412 . . . . 2.26 108.78 177.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 ttm105 -61.66 142.76 56.98 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.263 -1.014 . . . . 5.43 108.263 173.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.65 -56.52 0.48 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.669 -0.973 . . . . 1.29 110.669 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.11 103.95 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 118.509 1.155 . . . . 2.39 110.993 -167.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.4 pp -82.3 -29.72 30.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.589 -0.732 . . . . 2.58 110.292 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -156.44 158.04 36.6 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.573 0.624 . . . . 2.55 109.38 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -142.9 133.79 25.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.206 1.003 . . . . 2.42 108.53 169.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 m -112.19 93.14 4.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.644 -1.243 . . . . 2.39 107.644 160.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 19' ' ' VAL . 9.4 p -88.82 144.94 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 122.551 0.34 . . . . 1.55 111.096 162.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.74 138.85 26.07 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.172 0.989 . . . . 0.89 110.039 171.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.74 -35.85 60.07 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.602 0.761 . . . . 1.89 110.885 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.28 -42.61 41.64 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.289 1.035 . . . . 1.49 111.849 -173.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.1 p -114.84 20.09 15.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.908 1.283 . . . . 2.8 110.615 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 m120 37.13 55.64 1.28 Allowed 'General case' 0 C--N 1.341 0.211 0 C-N-CA 126.777 2.031 . . . . 2.22 111.431 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -134.15 150.56 51.12 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 118.418 0.554 . . . . 1.67 112.488 -176.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.77 119.85 33.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.134 2.174 . . . . 0.72 107.535 167.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -101.12 101.42 12.15 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.164 -2.532 . . . . 2.22 104.164 167.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.467 HD13 HD21 ' A' ' 8' ' ' LEU . 4.8 mp -94.59 143.79 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 108.116 -1.068 . . . . 1.34 108.116 177.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -120.43 91.0 3.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.937 -1.134 . . . . 2.23 107.937 175.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -102.37 149.79 24.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.003 0.921 . . . . 2.35 113.205 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -71.71 116.03 43.78 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 124.83 1.252 . . . . 3.15 108.574 171.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.41 40.21 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.264 1.976 . . . . 1.8 111.586 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -82.32 -40.33 21.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.698 -0.626 . . . . 6.35 109.818 172.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 pt -133.63 -51.09 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.717 0.807 . . . . 2.28 112.098 -168.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.76 147.0 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.307 0.643 . . . . 1.07 109.823 -166.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.12 -171.66 13.01 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.892 -0.883 . . . . 0.76 110.892 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.25 -34.47 56.03 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.46 2.107 . . . . 0.93 110.519 176.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.526 HH21 ' CE1' ' A' ' 60' ' ' HIS . 1.7 tpm_? -50.37 -54.23 23.24 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.361 1.064 . . . . 7.53 111.163 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -52.51 63.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.232 1.013 . . . . 2.66 109.183 -176.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 94.8 mt -52.08 -47.85 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 C-N-CA 123.647 0.779 . . . . 1.29 109.4 178.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.7 mt -55.38 -54.13 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 109.381 -0.6 . . . . 0.73 109.381 -178.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . 0.526 ' CE1' HH21 ' A' ' 56' ' ' ARG . 76.7 m-70 -65.48 -34.88 79.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.801 0.728 . . . . 3.19 111.367 -176.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -57.08 -52.23 66.11 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.076 -0.713 . . . . 0.7 109.076 173.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.9 mt -70.87 -32.37 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 121.242 -0.911 . . . . 1.01 112.242 -178.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -53.96 -49.06 69.58 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.346 -0.983 . . . . 2.75 108.346 166.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -60.5 -40.93 93.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.157 0.183 . . . . 1.4 111.34 177.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.0 mt -61.38 -34.33 75.16 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.611 -0.681 . . . . 1.19 111.582 172.451 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.48 43.85 1.53 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.886 1.231 . . . . 0.85 112.206 173.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -134.2 168.83 18.15 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.732 -0.84 . . . . 1.95 108.732 170.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.92 85.05 4.74 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.059 0.944 . . . . 3.57 110.982 -172.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.64 93.42 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.788 2.992 . . . . 0.89 111.37 -175.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.2 m -86.22 119.53 26.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.888 1.275 . . . . 1.86 108.116 -179.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.0 mt -74.56 58.05 0.76 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.05 1.296 . . . . 2.64 112.184 -175.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 t . . . . . 0 CA--C 1.53 0.209 0 N-CA-C 107.604 -1.258 . . . . 2.69 107.604 177.462 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 m . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 109.768 -0.456 . . . . 2.71 109.768 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 pp -150.3 164.92 34.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.748 -0.834 . . . . 3.23 108.748 161.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 153.26 51.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.629 0.728 . . . . 4.44 109.944 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 134.63 30.43 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.669 -1.604 . . . . 1.39 106.669 -177.259 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.16 102.47 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 105.513 -2.032 . . . . 1.0 105.513 177.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 m -90.79 71.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.471 -1.678 . . . . 0.75 106.471 -172.297 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -74.72 124.13 26.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 118.883 -1.127 . . . . 4.94 108.112 -159.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.19 -26.11 3.26 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.328 -0.851 . . . . 0.82 111.946 -179.268 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.86 109.86 8.67 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.883 1.341 . . . . 1.59 110.462 -176.299 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 p -83.67 -44.6 14.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.85 -0.532 . . . . 3.36 112.186 -170.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -149.28 177.37 9.72 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 112.073 0.397 . . . . 1.41 112.073 -156.32 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.28 -48.51 3.6 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.706 1.602 . . . . 0.8 111.785 177.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 m -48.09 -46.64 34.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.326 1.451 . . . . 1.96 111.779 176.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.9 m -72.24 -53.58 12.1 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.877 0.471 . . . . 0.74 110.689 176.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -43.91 -60.07 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.281 1.432 . . . . 0.6 109.347 -176.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.52 -12.37 61.34 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 113.61 0.967 . . . . 1.04 113.61 -176.037 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -53.2 19.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.553 -1.647 . . . . 3.68 106.553 163.182 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.6 mt -65.4 -60.22 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 118.445 0.566 . . . . 0.66 109.596 -169.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . 0.264 0.2 OUTLIER -58.36 -53.58 56.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.765 -0.774 . . . . 4.51 111.311 -166.123 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -60.9 -48.87 79.83 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.225 -0.893 . . . . 2.01 109.868 177.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 t -63.75 -42.71 97.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.883 1.22 . . . . 1.16 110.837 -170.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.33 -46.17 87.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.423 -0.584 . . . . 2.14 109.423 174.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -71.73 65.45 0.5 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.256 0.55 . . . . 2.81 111.53 174.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -146.81 -49.81 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.677 2.791 . . . . 7.09 108.459 170.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -61.04 130.13 44.86 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.843 0.354 . . . . 1.97 110.938 -174.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.78 90.43 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.923 0.889 . . . . 7.15 110.079 -179.271 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.08 -29.68 0.32 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-O 119.207 -0.774 . . . . 1.24 112.037 178.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.46 134.91 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.386 -1.339 . . . . 2.18 107.386 165.654 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -102.49 -29.33 11.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 123.969 0.793 . . . . 2.13 110.13 172.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -156.24 162.46 40.15 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.307 0.958 . . . . 2.57 109.692 172.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.8 t -142.86 149.22 38.25 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.328 1.051 . . . . 2.02 108.229 171.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -146.5 136.73 23.68 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 107.517 -1.29 . . . . 2.14 107.517 157.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.407 HG12 ' CB ' ' A' ' 44' ' ' ALA . 3.1 m -122.57 141.86 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 123.397 0.679 . . . . 1.76 109.351 -178.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.99 131.48 44.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.306 0.643 . . . . 0.72 110.4 177.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.33 -33.98 67.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.812 -1.086 . . . . 2.27 110.982 -173.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.09 -47.17 68.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.372 1.069 . . . . 1.21 112.452 -175.646 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -102.86 14.73 31.23 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.933 0.893 . . . . 2.44 110.645 174.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 34.1 46.21 0.15 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 129.082 2.953 . . . . 3.17 112.335 -173.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -125.47 144.61 50.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.624 0.647 . . . . 3.61 112.274 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.407 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -101.84 130.19 48.24 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.255 1.822 . . . . 0.65 106.444 172.004 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.41 109.67 21.45 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 101.401 -3.555 . . . . 2.35 101.401 176.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.02 134.58 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.054 -1.832 . . . . 1.05 106.054 -179.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -112.52 116.18 29.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 106.204 -1.776 . . . . 2.2 106.204 169.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -123.62 157.56 33.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.107 0.563 . . . . 2.85 111.011 -178.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -72.58 116.54 50.64 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 106.963 -1.495 . . . . 3.04 106.963 176.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.19 27.26 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.226 2.617 . . . . 2.48 115.7 -156.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -135.55 -34.75 0.83 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.363 1.465 . . . . 3.9 112.969 -178.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -41.51 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.781 0.832 . . . . 3.34 111.312 -165.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.8 tt -136.28 158.17 38.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 C-N-CA 123.832 0.853 . . . . 1.43 108.728 -169.085 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.84 -178.89 15.86 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.484 0.584 . . . . 0.64 111.85 -174.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -57.63 -39.98 83.67 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.797 2.331 . . . . 0.75 110.472 171.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -51.66 -49.48 62.25 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.729 0.812 . . . . 6.63 112.081 -176.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.79 -51.55 66.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.377 -0.601 . . . . 2.65 109.377 -175.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.8 mt -52.27 -47.48 45.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 123.602 0.761 . . . . 1.42 108.989 175.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.7 mt -55.89 -54.99 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 109.883 -0.414 . . . . 0.54 109.883 -176.037 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -64.08 -34.74 78.72 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.026 0.441 . . . . 3.15 110.671 -178.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.6 m -58.66 -51.26 70.7 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.196 -0.315 . . . . 0.75 110.483 173.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 mm -63.98 -42.26 95.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 121.143 -0.973 . . . . 1.55 110.915 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -52.83 -47.54 67.64 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.455 -0.572 . . . . 2.66 109.455 172.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m -59.15 -42.98 91.97 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.898 0.333 . . . . 1.54 111.898 175.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.7 mt -64.47 -29.14 70.18 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.534 -0.729 . . . . 1.06 112.411 175.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.27 40.1 1.18 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.3 0.953 . . . . 0.68 113.385 167.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -136.25 164.72 27.43 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.175 0.987 . . . . 1.98 108.643 171.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -94.62 111.44 54.05 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 118.488 -0.768 . . . . 2.44 109.759 175.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.18 80.21 2.68 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.612 2.875 . . . . 0.92 110.764 -178.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.47 105.35 10.72 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.137 -0.69 . . . . 1.76 109.137 -178.605 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.82 61.68 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.606 1.562 . . . . 2.54 111.827 179.373 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.9 t . . . . . 0 CA--C 1.531 0.222 0 C-N-CA 123.468 0.707 . . . . 2.55 111.234 -177.964 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 N--CA 1.455 -0.204 0 N-CA-C 106.965 -1.494 . . . . 2.85 106.965 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.5 mt -130.54 126.84 37.79 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 107.874 -1.158 . . . . 2.63 107.874 153.41 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -106.71 89.47 3.03 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.373 -0.973 . . . . 3.05 108.373 173.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.23 129.79 39.16 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.388 -0.967 . . . . 1.55 108.388 178.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.04 109.33 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.029 -1.841 . . . . 1.35 106.029 173.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.42 92.53 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 125.39 1.476 . . . . 0.79 108.175 -171.051 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -76.58 139.46 40.68 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.481 -0.933 . . . . 4.97 108.481 -173.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.65 -42.39 1.95 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.319 0.961 . . . . 0.72 111.141 177.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.81 126.82 30.96 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.982 0.891 . . . . 1.69 110.135 -176.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -154.38 17.87 0.48 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.855 1.057 . . . . 2.26 113.855 -171.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 p -158.68 170.29 22.48 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.502 1.046 . . . . 1.39 109.234 169.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.35 -44.49 11.8 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.972 1.309 . . . . 1.75 111.961 -178.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.6 m -56.25 -43.82 79.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.574 0.349 . . . . 1.74 111.602 177.532 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.32 -45.41 66.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.716 -0.615 . . . . 0.92 110.787 178.035 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.22 -58.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.204 -1.035 . . . . 1.0 108.204 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.298 0.7 OUTLIER -70.72 -24.8 62.7 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 113.146 0.795 . . . . 1.76 113.146 -172.174 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -57.9 -51.73 68.43 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.392 -0.966 . . . . 4.06 108.392 169.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.6 mt -59.11 -60.32 2.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.431 -0.581 . . . . 0.97 109.431 174.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.94 -55.28 28.52 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.357 0.526 . . . . 4.48 110.9 -168.325 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.3 t -61.2 -53.04 61.89 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.122 -0.696 . . . . 1.92 109.122 -177.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.7 t -72.04 -36.51 69.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 119.089 -1.045 . . . . 1.13 112.285 -168.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.83 -59.51 2.76 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.61 -0.885 . . . . 1.74 108.61 176.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.7 m -71.98 64.95 0.53 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.665 0.786 . . . . 3.34 111.883 179.064 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -169.9 -30.89 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 128.286 2.635 . . . . 3.68 110.951 170.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -64.6 132.2 49.14 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.866 1.212 . . . . 2.08 109.458 173.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -51.89 145.39 9.92 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.867 -0.79 . . . . 5.47 108.867 174.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.6 -36.28 4.18 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.582 -1.121 . . . . 0.81 111.926 177.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.47 135.28 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.703 -1.591 . . . . 2.0 106.703 164.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.1 pp -99.01 -32.49 11.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.243 0.617 . . . . 2.63 109.469 171.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -156.57 161.4 39.96 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 108.68 -0.859 . . . . 2.33 108.68 172.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 p -132.93 148.34 52.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.947 -0.76 . . . . 1.93 108.947 154.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.46 88.66 2.98 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.808 -1.553 . . . . 1.87 106.808 168.608 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.28 136.21 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 124.271 1.028 . . . . 1.94 111.838 170.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.6 140.17 28.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.77 0.828 . . . . 1.24 110.314 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 pp -76.96 -22.45 53.21 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.116 -0.493 . . . . 1.81 111.617 177.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.24 -38.02 1.65 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.411 1.484 . . . . 1.72 113.212 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -139.74 30.6 2.07 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.944 0.878 . . . . 2.31 110.291 170.554 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.1 m120 44.13 56.74 4.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.864 2.066 . . . . 1.89 110.579 176.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.78 139.63 32.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.176 -0.328 . . . . 2.01 110.69 -164.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.38 115.82 25.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.766 1.626 . . . . 0.77 110.463 176.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -82.29 96.63 7.96 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.249 -1.76 . . . . 2.5 106.249 169.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.39 133.05 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.94 -1.134 . . . . 1.28 107.94 175.27 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -115.25 115.8 27.28 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.44 -2.059 . . . . 2.86 105.44 173.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -147.14 153.53 40.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.381 1.072 . . . . 2.85 108.405 -164.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -104.07 105.69 49.87 Favored Pre-proline 0 CA--C 1.534 0.357 0 O-C-N 124.362 1.039 . . . . 3.87 111.075 -178.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.0 60.41 6.85 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.163 2.575 . . . . 1.5 112.1 -174.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.83 -54.87 2.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.044 0.938 . . . . 3.66 109.656 161.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -96.18 -37.07 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 122.98 0.512 . . . . 1.84 112.24 -174.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 tp -104.13 148.15 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.996 1.318 . . . . 1.05 108.444 -178.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.46 -178.94 16.6 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 110.864 -0.895 . . . . 0.75 110.864 174.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -60.99 -40.45 52.18 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.873 2.382 . . . . 0.77 110.357 174.122 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -50.39 -49.99 52.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.254 0.622 . . . . 5.85 112.083 179.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.16 -55.81 28.54 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.643 0.656 . . . . 2.47 109.991 -174.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.0 mt -50.42 -54.87 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 124.654 1.182 . . . . 1.58 108.956 175.596 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.9 mt -58.07 -53.23 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.85 -0.614 . . . . 0.96 110.403 -173.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -66.58 -33.03 74.77 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.329 0.652 . . . . 3.08 110.107 -175.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.7 m -57.85 -51.83 67.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.78 -0.452 . . . . 0.78 109.78 169.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 94.6 mt -67.24 -37.93 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 121.186 -0.946 . . . . 1.16 111.733 -176.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.99 -50.01 67.52 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.939 -0.763 . . . . 3.44 108.939 169.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.3 m -58.94 -38.82 79.89 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.008 -0.433 . . . . 1.74 111.992 176.084 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.38 -18.57 64.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.549 -0.738 . . . . 1.06 112.511 172.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.42 33.21 6.59 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.749 1.166 . . . . 0.81 112.273 174.176 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -133.01 158.65 42.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.025 0.913 . . . . 2.15 108.846 177.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.74 105.8 29.32 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.492 -0.766 . . . . 2.9 110.083 -178.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.4 79.62 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.922 2.414 . . . . 1.29 110.291 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 t -78.97 116.79 19.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.704 -0.623 . . . . 2.15 109.632 -175.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.8 mt -74.04 63.0 0.92 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.301 1.04 . . . . 3.18 110.225 177.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.6 t . . . . . 0 CA--C 1.53 0.183 0 O-C-N 121.739 -0.6 . . . . 2.66 109.533 179.147 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 CA--C 1.528 0.12 0 N-CA-C 108.642 -0.873 . . . . 2.48 108.642 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -146.28 137.92 24.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.129 -1.063 . . . . 3.16 108.129 176.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -106.64 126.99 52.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.496 1.118 . . . . 2.86 109.509 173.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.25 128.59 40.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.752 1.221 . . . . 1.54 108.107 176.34 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.257 0.6 OUTLIER -79.79 115.04 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 124.384 1.074 . . . . 3.14 108.301 173.813 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 m -101.92 84.25 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 128.077 2.551 . . . . 0.65 107.221 -170.277 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -75.91 139.2 41.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 118.7 -1.2 . . . . 6.56 107.902 -167.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.28 -31.27 5.33 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.685 1.136 . . . . 0.83 111.134 -170.577 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.0 mtm -57.17 126.88 29.22 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.949 1.374 . . . . 1.59 110.388 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -140.47 -6.54 1.17 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.073 1.138 . . . . 2.18 114.073 -177.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 p -163.03 168.4 21.07 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 120.288 1.403 . . . . 1.12 109.834 179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.44 -38.86 14.37 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.227 1.411 . . . . 0.85 112.172 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.8 m -43.47 -50.0 7.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.613 1.165 . . . . 1.43 111.612 172.131 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.7 m -68.02 -45.52 73.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 122.996 0.518 . . . . 0.71 110.536 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.1 t -52.59 -61.01 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.238 -1.023 . . . . 0.55 108.238 -176.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.252 1.3 p-80 -70.43 -28.59 65.16 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.829 -1.078 . . . . 0.87 111.964 -175.278 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -53.11 -58.62 6.38 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.446 1.021 . . . . 3.58 109.564 168.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.62 -58.51 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.739 -0.784 . . . . 0.77 109.732 -177.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -52.87 -62.23 1.78 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.382 0.426 . . . . 2.52 109.865 -174.012 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -55.2 -52.27 63.87 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.919 0.488 . . . . 1.46 110.432 -176.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -69.57 -32.08 70.64 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.621 -0.432 . . . . 1.28 111.306 -171.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.19 -46.83 63.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.09 -0.644 . . . . 1.84 111.122 172.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.8 p -66.89 78.28 0.12 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.54 0.736 . . . . 1.69 111.178 -176.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.76 -37.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 128.651 2.78 . . . . 4.21 108.763 -178.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.23 114.28 6.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.791 -0.818 . . . . 2.04 108.791 174.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -57.17 152.83 12.89 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.521 -0.918 . . . . 7.88 108.521 166.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.87 -60.15 0.64 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 108.575 -1.81 . . . . 1.73 108.575 -152.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.01 149.36 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 119.541 1.67 . . . . 1.71 108.507 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 pp -121.75 -25.07 5.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.368 -0.833 . . . . 2.41 111.035 168.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -155.68 157.57 36.86 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.313 0.96 . . . . 2.66 108.502 172.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.0 t -139.78 149.79 43.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.929 -1.137 . . . . 2.14 107.929 165.593 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 p -144.05 137.01 27.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.249 -1.389 . . . . 2.12 107.249 156.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.06 154.27 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.317 0.962 . . . . 1.71 110.213 179.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.28 137.66 32.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.027 0.931 . . . . 0.72 111.083 -176.032 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.1 mt -68.7 -34.5 75.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.677 1.191 . . . . 2.31 110.688 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -40.34 -42.36 1.54 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.904 1.682 . . . . 1.09 113.82 -174.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -138.61 35.8 2.22 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 123.086 0.554 . . . . 2.73 110.239 170.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 m120 42.23 46.93 3.98 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 127.314 2.245 . . . . 1.82 109.954 176.434 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -106.43 149.13 27.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.767 0.827 . . . . 2.38 110.927 -168.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.54 118.81 26.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.021 1.329 . . . . 0.67 107.743 172.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.64 102.44 14.18 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 102.375 -3.194 . . . . 2.34 102.375 176.794 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.83 139.04 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.193 -1.78 . . . . 1.26 106.193 176.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -122.87 115.74 22.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.288 -1.375 . . . . 3.39 107.288 169.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -121.66 161.72 22.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.837 1.655 . . . . 2.47 111.15 -173.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -92.29 119.81 67.95 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 126.246 1.818 . . . . 3.26 107.817 176.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.43 53.1 4.4 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.893 2.395 . . . . 2.6 110.195 179.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -103.17 -43.6 5.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.984 1.714 . . . . 6.39 109.62 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.06 -46.15 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.753 1.221 . . . . 2.59 112.109 -172.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 tp -81.77 150.09 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.033 0.933 . . . . 1.26 110.533 -167.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.62 -176.83 15.34 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.301 -1.12 . . . . 1.07 110.301 169.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -61.8 -38.47 59.53 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.454 2.103 . . . . 1.17 110.386 173.634 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -50.27 -50.71 49.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.372 1.069 . . . . 6.3 111.705 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.64 -54.59 45.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.742 0.817 . . . . 3.12 109.153 -177.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.6 mt -53.58 -49.11 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 123.853 0.861 . . . . 1.7 109.127 178.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.8 mt -52.81 -58.9 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 123.451 0.701 . . . . 0.95 109.956 -178.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -66.08 -34.61 78.45 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.158 0.504 . . . . 3.49 111.114 -176.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.0 m -57.13 -51.7 68.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.314 -0.625 . . . . 1.08 109.314 174.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.78 -35.05 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.548 -0.72 . . . . 1.24 111.541 -176.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -50.06 -52.98 30.13 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.329 -0.619 . . . . 2.82 109.329 166.128 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.5 t -57.61 -43.88 85.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.475 0.31 . . . . 1.5 111.574 177.232 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.3 mt -61.54 -27.58 68.71 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.207 -0.933 . . . . 1.67 112.395 176.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.55 35.69 1.39 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.52 1.057 . . . . 1.17 112.924 167.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -139.35 152.61 47.3 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.08 -1.082 . . . . 1.98 108.08 173.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -96.93 113.82 63.58 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.877 -0.786 . . . . 3.39 108.877 176.741 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -90.3 122.29 0.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.596 2.864 . . . . 1.1 111.563 -177.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.6 m -116.93 132.53 56.68 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 107.352 -1.351 . . . . 1.47 107.352 170.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mp -56.99 133.08 54.61 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.088 0.858 . . . . 3.83 110.341 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.5 t . . . . . 0 CA--C 1.529 0.148 0 N-CA-C 108.5 -0.926 . . . . 5.28 108.5 172.17 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m . . . . . 0 N--CA 1.456 -0.143 0 N-CA-C 108.302 -0.999 . . . . 2.85 108.302 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.3 153.17 25.25 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.779 -0.823 . . . . 3.0 108.779 171.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.476 ' C ' HD23 ' A' ' 8' ' ' LEU . 23.5 mt-10 -126.86 138.61 53.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.993 0.917 . . . . 2.64 110.424 177.124 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.647 HD21 HD13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -142.52 140.72 31.91 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.186 0.994 . . . . 1.43 108.907 -179.77 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 t -76.57 127.04 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 105.205 -2.146 . . . . 1.18 105.205 173.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 m -114.69 88.31 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 124.989 1.316 . . . . 0.65 107.606 -175.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.9 mtp-105 -77.04 137.5 39.0 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.559 -0.904 . . . . 5.96 108.559 -173.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.68 -41.72 1.47 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.938 -0.865 . . . . 0.88 110.938 177.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -68.88 152.2 45.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.906 0.853 . . . . 1.28 110.881 -176.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -152.34 1.15 0.32 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.392 1.256 . . . . 2.16 114.392 -175.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 p -162.33 164.8 27.24 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 120.18 1.355 . . . . 1.19 109.725 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.21 -41.14 12.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.169 1.388 . . . . 0.86 111.403 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -36.93 -51.83 0.92 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.28 2.232 . . . . 2.17 112.152 170.174 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.8 m -72.5 -51.49 19.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.862 0.865 . . . . 0.83 110.983 176.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -46.97 -60.46 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 C-N-CA 125.199 1.4 . . . . 0.49 109.017 -171.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -65.54 -24.81 67.2 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.872 -1.058 . . . . 1.08 111.329 -175.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -55.07 20.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.224 -1.028 . . . . 5.06 108.224 174.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 mt -58.05 -54.57 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.271 -0.641 . . . . 0.86 109.271 -179.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -55.67 -59.39 4.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.928 0.491 . . . . 2.43 110.565 -177.521 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.5 t -53.24 -52.12 60.0 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.688 -0.486 . . . . 1.5 109.688 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 t -59.0 -40.61 85.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.958 0.503 . . . . 0.94 111.376 -176.332 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.16 -43.93 90.17 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.635 -0.698 . . . . 2.26 110.891 176.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.3 p -70.7 60.66 0.23 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.772 0.829 . . . . 1.7 112.057 178.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -153.78 -50.33 0.09 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 129.497 3.119 . . . . 7.42 107.709 -176.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -69.52 137.47 52.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.701 -0.481 . . . . 2.25 109.701 -177.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -56.69 150.88 15.0 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.463 -0.569 . . . . 6.3 109.463 174.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.39 -28.38 8.31 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-O 117.609 -1.662 . . . . 0.72 112.675 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.589 HD11 HG23 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -75.41 130.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 120.861 2.331 . . . . 1.69 107.159 172.691 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.4 mt -96.71 -48.75 5.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.902 1.281 . . . . 2.42 108.479 172.121 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -156.38 147.53 22.24 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 118.838 0.744 . . . . 2.85 109.646 177.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -121.34 150.81 40.89 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 107.197 -1.409 . . . . 2.24 107.197 170.395 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t -143.42 150.11 38.59 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 118.491 -1.284 . . . . 2.7 108.79 141.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.74 132.77 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.737 0.815 . . . . 1.75 110.279 177.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.48 134.93 54.64 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.72 0.808 . . . . 0.71 110.569 -177.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.81 -34.58 77.04 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.65 1.18 . . . . 2.21 110.349 177.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -39.33 -41.87 0.97 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.227 1.811 . . . . 1.24 113.922 -176.164 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -137.72 33.0 2.46 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.898 0.856 . . . . 3.01 110.026 173.447 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 31.22 64.19 0.19 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 128.08 2.552 . . . . 2.9 111.964 -174.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.72 135.07 36.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.966 -0.561 . . . . 1.9 110.971 -166.487 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.12 140.78 34.94 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.604 1.962 . . . . 0.87 108.949 177.574 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -109.21 141.15 41.89 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.652 -1.61 . . . . 3.54 106.652 158.012 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.647 HD13 HD21 ' A' ' 8' ' ' LEU . 5.1 mp -125.32 114.48 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.837 -1.912 . . . . 1.49 105.837 176.173 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -93.4 99.59 12.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.217 -2.142 . . . . 3.39 105.217 171.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -125.99 167.07 15.81 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.047 1.339 . . . . 2.13 111.845 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -77.73 109.62 10.33 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.958 1.703 . . . . 2.97 109.82 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.32 63.24 8.7 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.363 2.709 . . . . 1.91 112.105 -167.888 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.74 -74.35 0.1 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.968 0.907 . . . . 3.26 110.04 177.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.5 pt -58.38 -26.93 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.084 0.954 . . . . 2.13 113.229 -177.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 tt -135.44 162.91 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.609 1.163 . . . . 1.0 108.297 -178.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.96 179.16 27.89 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.46 -1.456 . . . . 0.99 109.46 -174.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.13 -40.66 67.87 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.795 2.33 . . . . 1.0 111.608 -172.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -59.88 -37.04 78.22 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.453 0.538 . . . . 7.19 112.453 -175.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.3 -50.96 70.89 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.341 0.591 . . . . 3.93 109.805 179.136 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.9 mt -55.23 -50.18 66.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.643 -0.873 . . . . 1.6 108.643 176.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 mt -54.63 -53.16 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-O 119.382 -0.342 . . . . 0.66 110.206 -178.08 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -56.47 -43.76 79.89 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.275 0.559 . . . . 2.89 109.74 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.3 m -58.63 -53.96 52.4 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.034 -0.53 . . . . 0.78 110.331 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 mm -65.55 -39.98 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.335 -0.853 . . . . 1.97 111.186 -177.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -53.39 -48.92 68.22 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.6 -0.519 . . . . 2.98 109.6 169.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 m -61.6 -42.57 99.05 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.93 0.344 . . . . 2.09 111.93 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.9 mt -61.43 -36.83 81.45 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.518 0.599 . . . . 1.23 110.948 175.039 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.81 47.42 0.73 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 123.97 0.795 . . . . 0.81 111.763 172.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -134.86 160.86 36.9 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 106.571 -1.64 . . . . 2.05 106.571 168.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -97.84 105.5 27.68 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.234 -0.889 . . . . 3.26 109.774 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -84.25 136.17 6.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.699 2.266 . . . . 1.56 110.123 176.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t -146.79 129.84 16.42 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.968 -0.752 . . . . 2.53 108.968 171.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.476 ' CD2' ' H ' ' A' ' 71' ' ' LEU . 1.7 mm? -54.33 127.74 28.55 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.939 1.295 . . . . 2.78 110.593 -174.66 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 118.311 0.505 . . . . 4.87 110.319 -179.694 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 106.945 -1.502 . . . . 3.01 106.945 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.8 mp -128.45 151.34 49.5 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.297 -1.001 . . . . 3.39 108.297 177.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -125.06 129.55 50.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.189 0.996 . . . . 3.12 109.983 -166.607 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.71 136.63 36.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.532 1.133 . . . . 1.37 108.603 -174.102 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.33 124.6 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 104.671 -2.344 . . . . 1.44 104.671 174.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 m -106.31 67.53 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 106.973 -1.491 . . . . 0.85 106.973 -178.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -76.72 132.93 39.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.818 -0.808 . . . . 5.59 108.818 -166.307 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.63 -47.66 1.0 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.399 -1.48 . . . . 0.65 109.399 -169.284 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 142.09 36.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.683 0.741 . . . . 1.36 109.392 -176.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -156.75 19.05 0.32 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.529 0.937 . . . . 2.72 113.529 -173.795 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.78 153.73 25.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.355 0.98 . . . . 1.47 110.018 179.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.34 -37.7 7.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.105 1.762 . . . . 1.09 112.812 -173.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 t -47.01 -54.73 9.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.173 0.589 . . . . 1.87 110.167 174.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.9 m -69.02 -33.49 73.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.18 -0.325 . . . . 0.8 110.903 -176.15 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.8 t -57.08 -60.76 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.197 -1.038 . . . . 0.69 108.197 -178.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -68.54 -30.18 68.92 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.426 -0.807 . . . . 1.72 111.104 -176.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -56.94 -59.34 5.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 118.911 0.778 . . . . 5.63 109.991 170.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.423 HG21 HG11 ' A' ' 37' ' ' VAL . 60.8 mt -52.17 -51.61 29.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 118.905 0.775 . . . . 0.99 108.975 -178.435 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -50.97 -64.24 0.87 Allowed 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 123.991 0.807 . . . . 3.3 110.657 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.0 m -58.38 -42.25 86.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.946 0.879 . . . . 1.97 111.209 -177.003 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 t -66.44 -39.11 88.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.299 1.039 . . . . 1.44 110.029 -174.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.8 mt -71.76 -55.24 8.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 118.708 -0.663 . . . . 2.01 112.1 173.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.9 p -64.13 74.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.975 1.31 . . . . 1.64 112.592 -167.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -174.88 -40.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.372 2.269 . . . . 3.68 110.076 -175.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . 0.41 ' CE1' ' HB ' ' A' ' 32' ' ' ILE . 24.0 p80 -73.98 172.46 11.6 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.293 0.568 . . . . 1.86 112.097 -172.152 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -51.28 128.05 21.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.68 -0.691 . . . . 12.15 110.74 178.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.27 -15.23 7.17 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.583 -1.676 . . . . 0.75 116.692 160.086 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.41 ' HB ' ' CE1' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -76.1 109.59 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 121.805 2.802 . . . . 2.13 109.257 175.371 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.35 -42.03 31.73 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.157 -0.683 . . . . 2.52 109.157 -178.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -157.41 158.92 36.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.718 0.69 . . . . 3.19 109.268 177.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.6 t -124.16 138.78 54.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.001 1.72 . . . . 2.23 106.602 179.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.1 m -144.52 104.53 4.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.344 -0.984 . . . . 2.26 108.344 166.619 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.497 HG12 ' CB ' ' A' ' 44' ' ' ALA . 1.5 m -101.98 138.4 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 O-C-N 123.42 0.45 . . . . 1.96 111.131 172.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.83 133.15 55.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.588 0.755 . . . . 0.9 109.208 171.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -80.86 -33.67 34.27 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.35 -0.841 . . . . 1.96 111.366 -169.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.41 -34.33 61.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.171 0.588 . . . . 1.62 112.248 178.121 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -104.97 2.73 29.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.098 1.359 . . . . 2.1 111.562 176.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.4 m120 41.24 44.28 2.22 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.21 2.204 . . . . 1.94 111.351 -172.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.2 tmmt? -135.97 136.13 40.13 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 122.024 -0.423 . . . . 2.38 111.461 -165.332 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.497 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -98.51 139.28 34.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.653 1.981 . . . . 0.94 109.15 173.57 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.75 131.23 53.36 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.125 -2.176 . . . . 2.53 105.125 149.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.6 mm -115.57 131.01 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.367 -1.345 . . . . 1.88 107.367 172.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -93.13 64.62 3.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.385 1.074 . . . . 3.18 108.97 175.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -88.34 141.58 28.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 112.744 0.646 . . . . 2.81 112.744 175.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -62.34 115.66 17.73 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.694 -0.854 . . . . 2.47 108.694 173.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.76 65.84 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.78 2.32 . . . . 1.54 111.425 -168.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -162.18 -79.07 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.338 0.655 . . . . 3.52 112.137 -177.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -34.82 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 121.528 -0.733 . . . . 2.83 111.12 -176.762 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 tp -105.31 150.05 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.234 -1.765 . . . . 1.18 106.234 170.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -141.25 170.43 24.65 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.352 -1.099 . . . . 0.68 110.352 -177.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -57.03 -43.4 54.26 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.482 2.788 . . . . 0.75 110.489 -177.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -57.23 -44.71 84.04 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.247 0.476 . . . . 6.5 112.019 176.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -63.36 -49.15 74.98 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.972 -0.751 . . . . 3.84 108.972 -178.022 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.6 mm -50.57 -51.65 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.877 0.471 . . . . 1.95 111.036 172.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.6 mt -57.42 -52.62 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.284 0.634 . . . . 0.63 109.962 -178.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -55.8 -44.64 78.0 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 122.343 1.068 . . . . 3.28 109.298 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -61.18 -50.48 72.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.791 -1.095 . . . . 0.85 110.304 -178.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -71.86 -44.49 67.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-O 119.123 -0.465 . . . . 1.14 111.717 -175.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.31 -42.38 77.52 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.885 0.766 . . . . 2.92 110.427 -176.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -51.04 -28.67 10.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.673 0.99 . . . . 1.67 113.673 172.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.68 -16.68 58.33 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.069 0.85 . . . . 1.05 112.051 178.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.8 31.26 8.8 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.902 0.763 . . . . 0.7 112.531 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -129.99 140.4 50.9 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 105.394 -2.076 . . . . 1.98 105.394 167.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -87.59 111.25 40.6 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 117.985 -1.007 . . . . 2.82 109.586 -173.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.86 128.31 5.11 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.958 2.438 . . . . 1.42 109.838 176.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -138.2 111.93 8.28 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.563 -0.903 . . . . 2.54 108.563 177.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -56.03 131.06 46.41 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.284 1.034 . . . . 2.6 110.985 -179.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p . . . . . 0 C--N 1.34 0.171 0 N-CA-C 112.746 0.646 . . . . 3.74 112.746 -173.048 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.9 mtt . . . . . 0 N--CA 1.471 0.598 0 N-CA-C 109.02 -0.733 . . . . 8.3 109.02 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.04 122.82 1.37 Allowed Glycine 0 CA--C 1.526 0.754 0 N-CA-C 108.883 -1.687 . . . . 2.84 108.883 -172.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -77.13 -176.05 3.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.623 0.769 . . . . 3.85 109.358 174.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -166.78 156.65 28.68 Favored Glycine 0 N--CA 1.447 -0.604 0 N-CA-C 108.571 -1.812 . . . . 1.65 108.571 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 m -137.6 143.85 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 106.608 -1.627 . . . . 2.39 106.608 171.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 51.7 tp -144.01 140.13 29.41 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 105.808 -1.923 . . . . 3.01 105.808 176.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -106.3 135.74 47.25 Favored 'General case' 0 N--CA 1.451 -0.393 0 O-C-N 124.449 1.093 . . . . 2.79 109.264 172.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.52 137.03 54.85 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 125.079 1.352 . . . . 1.36 107.888 174.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.7 t -82.68 114.99 24.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 N-CA-C 106.772 -1.566 . . . . 1.4 106.772 178.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.0 m -106.66 84.45 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 C-N-CA 126.747 2.019 . . . . 0.83 108.849 -166.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -77.76 122.41 25.36 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.493 -1.299 . . . . 5.11 107.493 -174.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 127.78 -37.0 2.41 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.548 1.07 . . . . 0.95 110.755 -176.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.62 113.4 24.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.683 -1.599 . . . . 1.83 106.683 -172.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -157.84 25.46 0.27 Allowed 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 114.245 1.202 . . . . 3.85 114.245 -167.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.6 p -147.34 167.19 24.93 Favored 'General case' 0 C--O 1.233 0.218 0 O-C-N 120.957 -1.09 . . . . 1.27 108.205 161.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.08 -36.77 13.71 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.477 1.111 . . . . 1.06 112.059 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.2 t -59.44 -50.31 74.43 Favored 'General case' 0 N--CA 1.45 -0.47 0 N-CA-C 110.145 -0.317 . . . . 1.89 110.145 175.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.6 m -61.92 -41.35 97.83 Favored 'General case' 0 N--CA 1.452 -0.369 0 O-C-N 121.681 -0.637 . . . . 0.71 110.929 178.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 92.0 t -51.5 -61.11 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.25 0 N-CA-C 108.417 -0.957 . . . . 0.65 108.417 177.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.289 0.8 OUTLIER -66.65 -29.6 69.66 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 118.829 -0.605 . . . . 0.98 111.553 -174.035 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 56.0 tttt -52.94 -58.99 5.11 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 124.197 0.999 . . . . 3.79 109.127 170.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 18.8 mt -61.34 -59.0 4.98 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.761 -0.776 . . . . 0.75 108.918 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -53.87 -52.53 60.17 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 119.394 -0.336 . . . . 2.63 110.85 -168.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 10.4 m -62.04 -44.08 97.45 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 122.877 0.471 . . . . 2.39 111.561 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.8 t -64.85 -35.0 79.7 Favored 'General case' 0 CA--C 1.532 0.253 0 O-C-N 121.745 -0.597 . . . . 1.0 110.982 -178.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -70.61 -48.36 55.49 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-O 118.53 -0.748 . . . . 1.7 111.407 178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.1 p -68.06 72.75 0.18 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 122.052 0.93 . . . . 1.84 112.645 -175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.83 -38.88 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 126.992 2.117 . . . . 4.18 110.352 -179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.9 p80 -70.92 132.03 44.62 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.043 0.838 . . . . 2.45 109.551 178.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 60.0 mtt85 -55.21 149.56 12.36 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 109.45 -0.574 . . . . 6.07 109.45 171.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 101.01 -39.82 2.62 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 110.432 -1.067 . . . . 1.02 110.432 -173.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -76.69 111.62 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-N 119.086 1.443 . . . . 1.92 109.249 -172.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 69.1 mt -80.0 -46.81 15.97 Favored 'General case' 0 N--CA 1.447 -0.614 0 N-CA-C 108.698 -0.853 . . . . 2.04 108.698 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 58.0 t80 -157.18 130.99 8.15 Favored 'General case' 0 C--N 1.342 0.256 0 N-CA-C 109.105 -0.702 . . . . 2.28 109.105 179.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.8 p -97.17 152.3 18.95 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.038 -1.097 . . . . 2.76 108.038 165.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 34.9 t -155.55 150.44 26.48 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 119.534 -0.866 . . . . 2.35 108.91 140.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -127.36 143.61 40.05 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 123.72 0.808 . . . . 1.91 110.014 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -133.4 132.43 41.16 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 123.568 0.747 . . . . 0.91 110.555 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.9 pp -77.4 -26.97 52.23 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.182 -0.917 . . . . 2.47 111.729 -174.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -46.74 -44.53 18.97 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.16 0.984 . . . . 1.42 112.399 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.3 p -117.49 18.45 14.3 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.66 1.184 . . . . 2.69 110.866 175.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 35.06 54.99 0.76 Allowed 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 127.144 2.178 . . . . 2.42 111.909 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -112.59 148.56 34.3 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.589 0.756 . . . . 1.66 109.551 -177.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.83 125.73 47.15 Favored 'General case' 0 N--CA 1.446 -0.627 0 N-CA-C 106.249 -1.76 . . . . 1.0 106.249 166.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.474 ' C ' HD12 ' A' ' 46' ' ' ILE . 0.7 OUTLIER -107.45 129.72 54.91 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 107.122 -1.436 . . . . 2.65 107.122 169.301 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.474 HD12 ' C ' ' A' ' 45' ' ' HIS . 2.2 mp -119.45 110.75 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.609 0 N-CA-C 104.685 -2.339 . . . . 1.21 104.685 -178.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 41.0 mttp -83.08 70.36 10.03 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 107.655 -1.239 . . . . 3.76 107.655 176.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -86.68 141.34 29.0 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 122.987 0.515 . . . . 2.54 111.976 177.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -57.13 112.46 4.64 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 108.229 -1.026 . . . . 2.43 108.229 169.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -81.48 48.7 2.95 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.338 2.692 . . . . 1.65 111.891 -166.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -137.29 -63.09 0.6 Allowed 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.933 1.293 . . . . 3.86 109.365 -173.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 40.2 pt -77.09 -24.02 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.524 -0.025 0 N-CA-C 112.921 0.712 . . . . 1.93 112.921 -175.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 18.2 tt -139.82 143.09 31.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 108.921 -0.77 . . . . 1.3 108.921 -178.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -117.72 175.11 15.56 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 124.296 0.951 . . . . 0.87 112.177 -173.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -61.43 -38.91 60.21 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 123.01 2.473 . . . . 0.84 110.795 -178.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 49.7 ttp180 -46.43 -53.02 11.89 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.158 0.983 . . . . 7.19 110.592 171.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.1 m-20 -67.62 -46.54 72.21 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 107.957 -1.127 . . . . 2.93 107.957 -170.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.3 mm -54.46 -46.65 70.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.572 0.349 . . . . 2.04 111.39 172.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 8.0 mt -53.67 -54.32 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.257 0 N-CA-C 109.432 -0.581 . . . . 0.98 109.432 176.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.9 m-70 -61.22 -42.89 99.39 Favored 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 121.537 0.684 . . . . 2.6 110.441 -177.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 81.1 m -58.33 -49.3 77.69 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 123.587 0.755 . . . . 1.09 109.832 -179.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 9.1 mm -68.24 -43.25 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-O 119.289 -0.386 . . . . 1.47 110.257 179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -52.62 -42.3 64.47 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-N 118.465 0.575 . . . . 5.16 110.684 176.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.0 m -54.8 -23.45 18.21 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 113.075 0.769 . . . . 1.67 113.075 176.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 18.4 mt -87.06 -9.94 54.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 123.906 0.883 . . . . 1.0 112.117 178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.9 40.16 6.31 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.085 1.326 . . . . 0.82 112.489 174.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 m-85 -142.07 141.09 32.74 Favored 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 106.529 -1.656 . . . . 2.01 106.529 175.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -91.13 113.83 59.56 Favored Pre-proline 0 C--O 1.236 0.35 0 CA-C-N 119.56 1.073 . . . . 5.57 109.989 -172.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -91.96 140.27 2.29 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 123.974 3.116 . . . . 1.66 110.696 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.8 m -145.02 125.61 14.12 Favored 'General case' 0 C--N 1.335 -0.063 0 O-C-N 120.657 -1.277 . . . . 2.71 109.023 167.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.45 136.19 57.94 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 124.661 1.184 . . . . 2.55 111.938 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.3 t -140.4 -52.97 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 C-N-CA 123.993 0.917 . . . . 2.79 111.488 175.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.42 81.17 0.15 Allowed 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.278 0.631 . . . . 5.27 110.391 -167.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 92.8 mt -73.84 -84.62 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 CA-C-O 118.172 -0.918 . . . . 8.88 108.616 -172.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 . . . . . 0 C--O 1.252 1.194 0 N-CA-C 108.575 -0.898 . . . . 13.1 108.575 168.971 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.1 ttm . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 105.682 -1.97 . . . . 6.45 105.682 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.42 170.02 7.02 Favored Glycine 0 CA--C 1.535 1.308 0 N-CA-C 108.433 -1.867 . . . . 2.61 108.433 -136.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.6 t0 61.64 170.71 0.11 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.46 1.504 . . . . 4.27 111.391 -171.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 154.73 85.12 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 106.314 -2.715 . . . . 2.51 106.314 -168.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 p -80.19 124.38 38.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 110.066 -0.346 . . . . 2.92 110.066 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 41.1 tp -123.29 137.36 54.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 106.892 -1.521 . . . . 3.52 106.892 169.05 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -105.46 106.29 16.72 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 125.539 1.535 . . . . 4.16 108.451 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -108.03 126.39 52.67 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.235 -1.394 . . . . 1.46 107.235 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.0 t -79.98 95.36 2.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 106.855 -1.535 . . . . 1.03 106.855 178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 19.1 m -79.16 65.08 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 126.064 1.745 . . . . 0.76 109.231 -178.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.7 ptt85 -74.67 131.47 40.91 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.058 -1.089 . . . . 4.94 108.058 -172.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 138.51 -49.69 0.83 Allowed Glycine 0 CA--C 1.53 0.998 0 N-CA-C 109.545 -1.422 . . . . 0.75 109.545 -167.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -74.94 149.81 39.28 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.072 0.936 . . . . 1.32 110.165 -178.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.4 t -153.34 22.3 0.55 Allowed 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.433 0.531 . . . . 2.5 112.433 176.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -157.16 145.41 19.39 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 118.775 0.716 . . . . 1.56 109.927 -174.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.51 -40.25 37.05 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 124.976 1.31 . . . . 1.16 111.317 -179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.9 m -41.27 -49.6 3.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 125.996 1.718 . . . . 2.04 111.822 170.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 85.1 m -73.8 -42.97 60.21 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 113.848 1.055 . . . . 1.32 113.848 174.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.8 t -49.0 -57.05 1.83 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 121.673 0.749 . . . . 0.94 109.292 -177.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -69.3 -24.12 63.9 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.535 -0.757 . . . . 1.22 111.956 -176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 3.1 ttmt -58.63 -54.13 50.53 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.03 -1.47 . . . . 3.71 107.03 171.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.5 mt -55.77 -59.03 3.02 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 N-CA-C 109.316 -0.624 . . . . 0.74 109.316 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 80.6 mt-10 -54.64 -56.57 17.67 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 118.374 0.533 . . . . 2.55 111.407 -174.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.4 t -54.56 -47.66 72.98 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.315 1.046 . . . . 1.67 110.53 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.1 t -59.63 -51.61 69.08 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 122.144 -0.347 . . . . 1.18 110.517 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -64.43 -34.15 77.52 Favored 'General case' 0 CA--C 1.521 -0.172 0 O-C-N 121.786 -0.572 . . . . 2.16 111.953 -176.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 12.1 p -65.49 72.12 0.05 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 118.422 0.555 . . . . 2.0 110.877 170.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -150.52 -43.58 0.12 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 126.447 1.899 . . . . 5.76 111.817 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -57.55 -43.37 84.41 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 113.429 0.9 . . . . 3.82 113.429 -168.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 7.6 ttm180 131.36 -82.12 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 129.583 3.153 . . . . 6.72 107.841 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -78.19 54.24 3.9 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 123.821 0.724 . . . . 1.64 112.995 -169.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -104.08 129.12 56.8 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.69 0 N-CA-C 106.427 -1.694 . . . . 1.85 106.427 157.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.4 mt -85.44 -45.03 12.23 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 109.045 -0.724 . . . . 2.16 109.045 172.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -155.8 120.24 4.62 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 117.91 0.323 . . . . 2.56 110.883 -178.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 56.8 m -79.89 135.7 36.5 Favored 'General case' 0 C--O 1.226 -0.136 0 N-CA-C 106.361 -1.718 . . . . 2.9 106.361 164.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.7 t -140.52 96.54 3.05 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 119.346 0.975 . . . . 2.31 108.713 173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.9 t -105.92 135.63 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 124.4 1.08 . . . . 2.62 109.214 -172.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.76 134.64 23.73 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.3 0.572 . . . . 0.67 111.186 177.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 pp -76.23 -26.48 56.09 Favored 'General case' 0 C--O 1.226 -0.142 0 C-N-CA 124.006 0.922 . . . . 1.87 111.394 178.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.04 -36.76 41.44 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 124.413 1.085 . . . . 1.07 112.371 -176.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.2 p -129.62 31.51 4.76 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.479 0.712 . . . . 2.4 110.343 171.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.7 m120 33.73 54.99 0.54 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 127.916 2.486 . . . . 1.88 112.408 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.9 ptpt -133.47 157.42 45.66 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.525 0.33 . . . . 2.07 111.886 -172.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -116.47 127.09 54.27 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 106.097 -1.816 . . . . 0.65 106.097 161.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.49 129.22 38.49 Favored 'General case' 0 N--CA 1.442 -0.872 0 N-CA-C 103.97 -2.604 . . . . 2.31 103.97 154.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 63.9 mt -118.55 118.32 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 N-CA-C 105.229 -2.137 . . . . 1.45 105.229 176.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -89.88 104.94 17.46 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.421 -1.696 . . . . 3.37 106.421 173.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 35.2 p90 -132.03 151.87 51.49 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 123.576 0.547 . . . . 2.33 112.229 -171.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -90.79 112.51 53.81 Favored Pre-proline 0 N--CA 1.452 -0.344 0 C-N-CA 125.104 1.362 . . . . 3.08 108.402 -178.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_endo -77.84 41.26 0.97 Allowed 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 122.457 2.105 . . . . 1.63 112.243 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -86.68 -37.86 17.58 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.086 0.954 . . . . 5.46 110.249 170.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -132.12 -54.46 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 C-N-CA 124.682 1.193 . . . . 2.07 110.896 -174.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.2 123.73 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 109.165 -0.68 . . . . 1.72 109.165 -177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.83 -175.45 22.27 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 109.565 -1.414 . . . . 0.65 109.565 170.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -59.39 -36.31 94.38 Favored 'Trans proline' 0 N--CA 1.452 -0.969 0 C-N-CA 121.804 1.669 . . . . 0.85 109.949 170.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.9 mmp_? -45.56 -59.67 2.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.45 1.5 . . . . 6.33 111.777 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -59.84 -51.43 69.74 Favored 'General case' 0 C--O 1.238 0.448 0 C-N-CA 125.617 1.567 . . . . 2.31 110.426 -172.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 94.5 mt -52.34 -54.25 15.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 CA-C-N 114.209 -1.36 . . . . 1.46 108.478 176.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.9 mt -60.04 -53.39 49.22 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.815 0 CA-C-N 115.94 -0.573 . . . . 0.68 109.681 -172.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 60.7 m-70 -58.83 -39.98 82.82 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 118.739 0.699 . . . . 3.0 110.655 -179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 32.0 m -56.65 -52.23 65.7 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 116.311 -0.404 . . . . 0.96 110.227 176.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 99.0 mt -70.06 -40.52 78.52 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 O-C-N 121.8 -0.562 . . . . 1.05 111.149 -174.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 65.0 mm-40 -47.15 -49.35 22.56 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.34 0.656 . . . . 3.5 109.398 169.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -58.45 -24.37 60.1 Favored 'General case' 0 CA--C 1.538 0.504 0 N-CA-C 113.446 0.906 . . . . 1.33 113.446 178.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.1 mt -84.94 -12.85 52.46 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-N 119.092 0.86 . . . . 1.18 112.069 175.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 90.09 44.22 4.8 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 124.101 0.858 . . . . 0.88 112.769 173.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -138.61 159.47 42.02 Favored 'General case' 0 CA--C 1.527 0.079 0 N-CA-C 106.846 -1.539 . . . . 1.96 106.846 170.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -98.35 98.85 6.28 Favored Pre-proline 0 CA--C 1.54 0.567 0 CA-C-O 118.433 -0.794 . . . . 2.87 110.507 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -68.82 80.79 0.62 Allowed 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 124.314 3.343 . . . . 0.92 110.717 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.4 m -79.27 101.37 7.99 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 108.237 -1.023 . . . . 1.92 108.237 -173.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.5 64.16 0.11 Allowed 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.893 1.677 . . . . 2.93 113.22 -173.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.4 t -66.04 -50.24 70.84 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 O-C-N 121.637 -0.664 . . . . 2.42 111.237 -177.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.4 tptp 68.27 136.07 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.527 1.531 . . . . 5.34 110.454 -165.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.5 pt -127.29 143.66 39.85 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 106.471 -1.678 . . . . 7.74 106.471 157.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 . . . . . 0 C--O 1.253 1.244 0 N-CA-C 109.223 -0.658 . . . . 11.54 109.223 -175.081 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.4 mmm . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 107.836 -1.172 . . . . 5.89 107.836 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -75.42 -177.08 40.31 Favored Glycine 0 CA--C 1.532 1.101 0 O-C-N 124.08 0.863 . . . . 2.85 112.449 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 12.6 t70 52.78 -143.2 0.72 Allowed 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.986 1.714 . . . . 3.94 111.553 -177.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 83.76 -165.82 42.51 Favored Glycine 0 CA--C 1.531 1.059 0 N-CA-C 109.64 -1.384 . . . . 2.55 109.64 -161.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.0 t -147.38 145.14 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 107.131 -1.433 . . . . 2.81 107.131 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.8 tp -124.13 144.28 49.99 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.05 -2.204 . . . . 2.6 105.05 155.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 21.7 mt-10 -114.19 132.42 56.11 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.933 -0.766 . . . . 2.19 108.933 173.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.3 mt -118.48 123.98 46.49 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.99 -1.856 . . . . 2.84 105.99 178.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.5 t -78.9 95.18 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 N-CA-C 105.592 -2.003 . . . . 1.44 105.592 174.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.7 m -84.26 84.07 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.648 0 C-N-CA 126.319 1.847 . . . . 0.83 108.858 -172.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.8 mtp-105 -75.6 130.87 39.49 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 107.935 -1.135 . . . . 5.0 107.935 -171.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.78 -48.46 0.97 Allowed Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.399 1.0 . . . . 1.25 110.945 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -64.87 127.56 32.08 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 117.69 0.745 . . . . 1.6 110.37 -175.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.2 t -144.6 5.34 1.2 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 114.246 1.202 . . . . 2.62 114.246 -167.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.1 p -160.84 166.39 28.62 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 119.645 1.112 . . . . 1.55 109.601 177.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.47 -45.3 9.1 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 125.201 1.4 . . . . 0.75 111.503 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.8 m -42.26 -49.24 5.03 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 126.067 1.747 . . . . 1.88 112.457 172.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 40.3 m -72.69 -51.18 20.43 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.153 0.581 . . . . 0.94 111.136 175.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 74.4 t -46.74 -58.84 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.254 0 C-N-CA 124.045 0.938 . . . . 0.66 109.039 -173.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -69.83 -23.53 63.32 Favored 'General case' 0 N--CA 1.437 -1.096 0 CA-C-N 114.989 -1.005 . . . . 0.94 111.942 -174.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.8 mmtp -67.66 -51.69 46.88 Favored 'General case' 0 C--N 1.342 0.266 0 N-CA-C 107.892 -1.151 . . . . 3.82 107.892 174.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.3 mt -55.39 -58.81 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.19 0 N-CA-C 108.734 -0.839 . . . . 0.74 108.734 176.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -53.07 -54.62 32.8 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 118.001 0.364 . . . . 2.76 111.612 -174.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.2 m -60.66 -45.09 95.45 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 122.158 -0.339 . . . . 1.76 111.912 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 32.7 t -62.97 -49.59 74.13 Favored 'General case' 0 CA--C 1.53 0.189 0 O-C-N 121.903 -0.498 . . . . 1.25 110.226 -177.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.461 HD11 HG23 ' A' ' 58' ' ' ILE . 3.5 mm? -51.19 -47.16 62.29 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 123.708 0.803 . . . . 1.78 110.548 177.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 p -62.31 -0.31 0.55 Allowed 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 114.629 1.344 . . . . 2.13 114.629 179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.7 pttp -57.49 -42.59 83.0 Favored 'General case' 0 C--N 1.342 0.273 0 CA-C-N 120.306 1.412 . . . . 6.42 110.66 164.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 32.2 p80 -94.12 138.92 31.62 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 120.339 -0.544 . . . . 2.54 111.867 -155.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.9 mtp180 -60.27 167.54 2.4 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-O 121.532 0.682 . . . . 5.77 109.905 169.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.09 -15.23 0.74 Allowed Glycine 0 CA--C 1.521 0.459 0 CA-C-O 117.669 -1.629 . . . . 1.11 113.555 -178.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -73.3 139.63 19.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 CA-C-N 120.365 2.083 . . . . 1.64 105.746 165.023 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 42.6 mt -102.58 -37.98 7.72 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.927 -1.033 . . . . 2.37 108.506 164.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 54.7 t80 -157.54 155.13 29.71 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.58 1.082 . . . . 2.25 109.872 178.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 39.8 t -126.04 143.08 51.25 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 105.397 -2.075 . . . . 2.12 105.397 162.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -149.16 148.67 29.91 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 118.097 -1.441 . . . . 2.27 109.965 144.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.439 HG12 ' CB ' ' A' ' 44' ' ' ALA . 2.4 m -125.9 142.41 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 O-C-N 123.882 0.739 . . . . 1.95 111.467 -172.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -128.17 128.09 44.14 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 124.205 1.002 . . . . 0.93 111.027 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 pp -80.68 -36.67 32.01 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 114.27 -1.332 . . . . 2.08 113.209 -163.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.73 -37.8 59.85 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.54 0.609 . . . . 1.71 111.148 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 p -96.12 -7.59 35.56 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 127.318 2.247 . . . . 2.73 111.694 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.7 m120 41.95 48.08 3.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.737 1.615 . . . . 2.18 110.79 -166.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.4 ptpt -114.38 151.24 33.38 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.434 0.561 . . . . 1.64 111.255 -178.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.439 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -123.92 121.78 36.22 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.88 1.672 . . . . 0.62 106.741 169.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.1 p-80 -96.03 123.32 39.58 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 104.615 -2.365 . . . . 3.17 104.615 168.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 16.9 mm -104.64 130.17 55.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 106.916 -1.513 . . . . 1.76 106.916 168.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -98.4 101.06 12.39 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 105.083 -2.191 . . . . 2.68 105.083 162.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 41.2 p90 -129.77 155.15 46.4 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.925 1.29 . . . . 2.12 109.147 174.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -75.71 110.84 11.81 Favored Pre-proline 0 CA--C 1.533 0.307 0 C-N-CA 124.496 1.118 . . . . 2.81 108.696 177.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -78.39 58.58 6.75 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.279 2.653 . . . . 1.62 111.363 -173.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -135.16 -68.63 0.52 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.042 1.337 . . . . 4.36 108.99 -176.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -91.0 -40.07 12.3 Favored 'Isoleucine or valine' 0 N--CA 1.46 0.061 0 C-N-CA 123.062 0.545 . . . . 2.26 112.108 -172.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.448 HD11 ' HB3' ' A' ' 57' ' ' ASP . 0.2 OUTLIER -97.01 119.08 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 N-CA-C 107.639 -1.245 . . . . 1.57 107.639 -178.745 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -85.81 163.5 36.69 Favored Glycine 0 CA--C 1.53 0.983 0 N-CA-C 111.123 -0.791 . . . . 1.29 111.123 -179.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -54.63 -30.01 63.77 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.68 2.253 . . . . 1.29 110.842 171.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -55.06 -49.09 72.51 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 117.344 -1.312 . . . . 5.51 113.663 -177.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.448 ' HB3' HD11 ' A' ' 53' ' ' ILE . 16.4 t0 -63.1 -49.49 74.24 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-N 121.312 1.869 . . . . 5.65 109.85 -177.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.461 HG23 HD11 ' A' ' 26' ' ' LEU . 66.5 mt -47.17 -56.08 1.66 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-O 121.443 0.639 . . . . 1.27 109.772 175.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.8 mt -59.07 -55.95 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 CA-C-N 115.823 -0.626 . . . . 0.92 109.663 -174.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.3 m-70 -62.96 -34.14 76.88 Favored 'General case' 0 C--N 1.332 -0.177 0 O-C-N 121.936 -0.477 . . . . 2.6 111.475 -175.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 26.3 m -56.56 -53.57 56.0 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 108.948 -0.76 . . . . 1.23 108.948 171.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 83.6 mt -66.29 -39.43 84.21 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 O-C-N 121.507 -0.745 . . . . 1.13 111.373 -177.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -56.77 -44.72 82.07 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.715 -0.616 . . . . 3.04 109.682 172.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.7 m -61.47 -41.43 97.23 Favored 'General case' 0 CA--C 1.531 0.24 0 O-C-N 122.201 -0.312 . . . . 1.36 111.6 176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.5 mt -59.66 -41.87 91.56 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.495 0.588 . . . . 1.44 110.724 172.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.86 45.28 0.83 Allowed Glycine 0 CA--C 1.524 0.612 0 C-N-CA 124.286 0.946 . . . . 0.87 111.435 175.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -131.07 162.12 30.52 Favored 'General case' 0 CA--C 1.53 0.204 0 N-CA-C 107.077 -1.453 . . . . 1.94 107.077 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -100.15 98.28 7.41 Favored Pre-proline 0 CA--C 1.539 0.522 0 CA-C-O 118.198 -0.906 . . . . 2.61 110.099 -177.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.38 75.41 3.87 Favored 'Trans proline' 0 N--CA 1.46 -0.484 0 C-N-CA 123.609 2.872 . . . . 1.21 110.111 -177.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.6 m -79.99 107.63 12.93 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.491 -0.929 . . . . 1.77 108.491 -171.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.76 59.36 0.47 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.679 0.791 . . . . 2.55 112.596 -176.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.2 t -102.71 57.73 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 C-N-CA 125.512 1.525 . . . . 3.35 107.307 178.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.3 pttm 45.55 -137.33 0.58 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.062 1.345 . . . . 7.88 112.266 174.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.3 mt -57.97 -69.11 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 C-N-CA 124.468 1.107 . . . . 7.74 108.314 172.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 . . . . . 0 C--O 1.246 0.921 0 C-N-CA 131.696 3.998 . . . . 13.74 100.996 171.69 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.3 mtp . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 108.767 -0.827 . . . . 6.88 108.767 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.77 65.53 2.87 Favored Glycine 0 CA--C 1.527 0.803 0 N-CA-C 109.448 -1.461 . . . . 3.09 109.448 174.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -166.31 -178.2 4.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.602 1.561 . . . . 4.4 108.078 -167.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.83 -147.43 14.16 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 108.51 -1.836 . . . . 2.58 108.51 -176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.7 p -152.42 133.3 4.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 N-CA-C 108.79 -0.819 . . . . 2.99 108.79 174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.5 tp -104.0 149.59 25.01 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 105.663 -1.977 . . . . 2.94 105.663 165.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -117.33 151.19 37.5 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 108.312 -0.996 . . . . 2.27 108.312 165.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.13 130.43 23.63 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 106.35 -1.722 . . . . 1.38 106.35 174.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 17.4 t -79.62 100.81 4.39 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 105.411 -2.07 . . . . 1.02 105.411 178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.2 m -81.83 79.42 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 C-N-CA 126.353 1.861 . . . . 0.67 108.161 -175.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.2 mtp-105 -76.74 141.72 40.73 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 108.605 -0.887 . . . . 5.36 108.605 -174.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.63 -45.83 1.13 Allowed Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.318 -1.113 . . . . 0.84 110.318 -178.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.03 141.44 28.57 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 117.533 0.667 . . . . 1.7 109.644 -176.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.6 m -152.81 41.91 0.6 Allowed 'General case' 0 CA--C 1.536 0.425 0 CA-C-N 118.304 0.502 . . . . 4.86 110.256 172.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -161.47 144.9 12.62 Favored 'General case' 0 C--O 1.232 0.151 0 O-C-N 121.765 -0.585 . . . . 1.83 111.039 -176.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.98 -39.85 20.68 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 125.598 1.559 . . . . 0.83 112.059 -176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 47.4 t -45.26 -51.44 10.81 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.056 0.542 . . . . 1.93 110.458 173.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 86.3 m -76.79 -33.85 58.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 O-C-N 120.101 -1.625 . . . . 1.42 114.169 -179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.2 t -46.75 -56.27 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 N-CA-C 108.642 -0.873 . . . . 0.53 108.642 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -70.39 -21.84 62.81 Favored 'General case' 0 N--CA 1.438 -1.074 0 CA-C-N 115.167 -0.924 . . . . 0.84 112.825 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.3 mttp -64.89 -54.5 29.83 Favored 'General case' 0 C--N 1.345 0.371 0 N-CA-C 106.781 -1.563 . . . . 4.56 106.781 171.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -56.4 -56.47 13.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 N-CA-C 108.852 -0.796 . . . . 0.75 108.852 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -59.31 -53.73 54.91 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-N 118.999 0.818 . . . . 2.6 111.693 -176.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.1 t -63.76 -29.17 70.41 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.059 0.39 . . . . 1.59 111.756 -177.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 23.4 t -71.05 -52.96 16.47 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 109.204 -0.665 . . . . 1.35 109.204 173.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -53.43 -46.14 69.69 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.152 0.981 . . . . 1.83 110.954 -178.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 29.2 p -59.51 -16.73 26.46 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.953 0.723 . . . . 2.06 112.953 179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 28.3 mmmt -69.92 -24.0 63.3 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 119.819 1.19 . . . . 6.49 111.515 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -68.48 87.08 0.31 Allowed 'General case' 0 N--CA 1.452 -0.332 0 CA-C-N 118.73 0.696 . . . . 3.01 109.885 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 23.27 -66.21 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.0 2.52 . . . . 10.26 116.758 145.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -127.52 48.39 0.97 Allowed Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.338 0.97 . . . . 1.4 112.644 -178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -91.08 117.82 35.1 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.963 0 N-CA-C 107.022 -1.473 . . . . 2.22 107.022 154.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -80.68 -35.5 33.59 Favored 'General case' 0 N--CA 1.454 -0.246 0 O-C-N 121.758 -0.589 . . . . 2.67 110.45 -177.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -157.01 135.6 11.49 Favored 'General case' 0 C--N 1.344 0.366 0 CA-C-N 118.948 0.795 . . . . 2.17 110.466 173.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.8 p -114.65 155.09 27.23 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 124.277 1.031 . . . . 2.55 108.389 165.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.6 m -149.47 141.34 23.72 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.184 -1.413 . . . . 2.03 107.184 150.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -121.94 135.73 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 C-N-CA 123.732 0.813 . . . . 1.79 110.197 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.36 134.09 55.11 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 123.347 0.659 . . . . 0.63 110.149 177.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -82.07 -37.64 26.09 Favored 'General case' 0 N--CA 1.456 -0.157 0 CA-C-N 115.255 -0.884 . . . . 1.76 111.286 -171.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.34 -31.94 64.21 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.36 0.664 . . . . 1.67 112.301 -178.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.8 t -107.05 4.63 27.2 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.037 1.335 . . . . 2.41 111.234 177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 16.9 m120 42.96 48.95 5.2 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 126.614 1.966 . . . . 1.87 110.83 -176.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.15 137.23 30.74 Favored 'General case' 0 CA--C 1.522 -0.109 0 O-C-N 121.735 -0.603 . . . . 1.89 112.086 -165.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -100.2 142.09 32.15 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.625 1.57 . . . . 0.91 108.232 170.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -106.07 135.14 48.06 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 105.481 -2.044 . . . . 2.73 105.481 152.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.2 mt -134.79 114.87 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 106.159 -1.793 . . . . 1.07 106.159 -172.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 68.0 mttt -97.28 80.03 2.86 Favored 'General case' 0 N--CA 1.445 -0.724 0 N-CA-C 106.701 -1.592 . . . . 2.55 106.701 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 28.6 p90 -85.53 143.1 28.7 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.63 -0.714 . . . . 2.33 111.638 -178.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 76.8 m-20 -75.41 111.34 13.57 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.626 1.17 . . . . 3.09 107.914 176.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -80.63 47.56 2.6 Favored 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.356 2.704 . . . . 1.42 113.234 -163.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -134.16 -63.9 0.71 Allowed 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.37 1.468 . . . . 3.8 108.554 174.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.485 HD12 ' HB ' ' A' ' 53' ' ' ILE . 2.1 pp -70.5 -34.35 57.23 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 C-N-CA 122.858 0.463 . . . . 2.23 111.462 -178.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.485 ' HB ' HD12 ' A' ' 52' ' ' ILE . 8.6 tt -126.83 156.58 38.04 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 C-N-CA 124.81 1.244 . . . . 1.86 110.406 -173.638 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -154.39 178.34 31.25 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 107.198 -2.361 . . . . 0.77 107.198 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -52.61 -50.24 14.72 Favored 'Trans proline' 0 N--CA 1.454 -0.84 0 C-N-CA 123.399 2.733 . . . . 0.8 111.485 -175.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.8 mmt180 -52.38 -44.97 65.6 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 113.59 0.959 . . . . 7.1 113.59 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -59.47 -60.01 4.53 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-O 121.574 0.702 . . . . 3.91 109.429 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.3 mt -45.78 -54.43 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.14 0 C-N-CA 124.466 1.106 . . . . 1.38 109.818 174.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 42.2 mt -59.25 -48.16 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 CA-C-N 115.654 -0.703 . . . . 0.81 110.415 -173.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 62.1 m170 -57.23 -41.77 80.16 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 118.764 0.711 . . . . 3.11 109.265 -179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.8 m -62.8 -51.18 68.08 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.863 -0.608 . . . . 1.19 110.728 178.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 98.0 mt -62.86 -44.35 99.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-N 118.86 0.755 . . . . 1.14 111.278 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -49.09 -48.9 43.96 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.562 0.745 . . . . 3.36 109.188 170.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.6 t -62.8 -17.08 60.62 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 113.815 1.043 . . . . 1.98 113.815 177.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 83.5 mt -85.02 -16.15 41.72 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 120.06 1.3 . . . . 1.11 111.23 171.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 86.62 42.38 6.49 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 123.866 0.746 . . . . 0.85 111.685 -179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -132.79 153.09 51.58 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 107.181 -1.414 . . . . 1.96 107.181 170.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -90.27 109.28 32.39 Favored Pre-proline 0 CA--C 1.536 0.429 0 C-N-CA 124.179 0.991 . . . . 2.71 109.165 179.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -80.52 77.86 3.9 Favored 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.462 2.108 . . . . 1.0 110.249 177.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.8 t -78.68 98.85 6.36 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.264 -0.897 . . . . 1.81 109.417 -174.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.05 61.26 0.19 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.42 1.888 . . . . 2.76 113.241 -173.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.8 t -81.28 -76.7 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 123.172 0.589 . . . . 2.5 109.866 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.6 tttt 67.62 150.31 0.07 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.784 1.634 . . . . 6.07 111.685 -170.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 1.2 pp -81.11 -57.1 5.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 113.196 0.813 . . . . 7.26 113.196 -172.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 . . . . . 0 C--O 1.251 1.139 0 C-N-CA 125.873 1.669 . . . . 8.92 113.17 -171.447 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.5 mtt . . . . . 0 N--CA 1.472 0.672 0 N-CA-C 109.096 -0.705 . . . . 7.3 109.096 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 163.75 -52.21 0.29 Allowed Glycine 0 CA--C 1.526 0.733 0 N-CA-C 107.434 -2.266 . . . . 3.54 107.434 -165.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 35.01 75.16 0.06 Allowed 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 126.457 1.903 . . . . 6.21 112.564 155.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.35 171.25 18.11 Favored Glycine 0 C--N 1.337 0.614 0 O-C-N 121.351 -0.843 . . . . 1.81 112.74 -158.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 47.4 t -124.87 119.84 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.238 -1.393 . . . . 2.89 107.238 166.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 64.6 tp -95.88 148.64 22.41 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.536 -1.653 . . . . 2.85 106.536 166.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -136.87 127.25 26.59 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.876 0.87 . . . . 2.31 108.913 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.54 150.86 48.85 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.504 0.722 . . . . 3.43 110.308 -178.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.0 t -84.89 124.22 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 107.284 -1.376 . . . . 1.14 107.284 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.59 102.91 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 126.994 2.118 . . . . 1.26 108.374 -178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 21.5 mtt85 -87.4 148.93 24.79 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 109.061 -0.718 . . . . 5.14 109.061 174.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.11 -52.35 0.64 Allowed Glycine 0 CA--C 1.526 0.749 0 N-CA-C 110.23 -1.148 . . . . 0.77 110.23 178.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.79 134.92 56.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 CA-C-N 117.285 0.542 . . . . 1.79 109.611 178.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.4 t -155.22 11.62 0.34 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.891 1.071 . . . . 2.17 113.891 -169.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.6 p -161.11 171.75 18.0 Favored 'General case' 0 C--O 1.236 0.344 0 CA-C-N 119.808 1.185 . . . . 1.43 109.119 170.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.23 -44.28 7.81 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 125.371 1.469 . . . . 0.78 111.594 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 16.6 t -52.83 -48.73 66.78 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 122.746 0.419 . . . . 2.05 110.071 177.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.3 m -70.65 -53.46 15.72 Favored 'General case' 0 N--CA 1.45 -0.459 0 O-C-N 121.473 -0.767 . . . . 0.79 109.627 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 43.0 t -41.33 -60.21 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.214 0 C-N-CA 125.787 1.635 . . . . 0.73 109.137 -179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.255 0.6 OUTLIER -68.25 -21.3 64.83 Favored 'General case' 0 N--CA 1.439 -0.994 0 N-CA-C 112.803 0.668 . . . . 0.92 112.803 -171.225 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -70.12 -46.91 63.82 Favored 'General case' 0 C--N 1.343 0.318 0 N-CA-C 107.978 -1.119 . . . . 4.4 107.978 173.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.67 -57.67 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 N-CA-C 108.895 -0.78 . . . . 0.88 108.895 176.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.7 mt-10 -54.75 -56.49 18.71 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 122.373 0.269 . . . . 2.81 110.859 -176.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 29.0 t -58.34 -50.07 74.94 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.997 0.427 . . . . 1.53 110.71 -179.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.4 t -69.2 -27.14 65.23 Favored 'General case' 0 N--CA 1.452 -0.341 0 O-C-N 121.551 -0.718 . . . . 1.02 111.445 -173.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 85.6 mt -70.11 -52.52 23.03 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.383 0.538 . . . . 2.25 110.651 168.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 43.0 p -70.06 67.68 0.29 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 122.398 1.094 . . . . 1.73 112.321 -177.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 pttm -169.91 -38.03 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 127.968 2.507 . . . . 3.73 109.624 176.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 13.6 p80 -69.84 137.68 51.95 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-N 118.939 0.791 . . . . 2.17 110.205 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.2 mmt85 -50.84 143.87 9.32 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.622 -0.51 . . . . 5.49 109.622 171.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.27 -20.43 37.29 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-O 118.05 -1.417 . . . . 0.99 113.407 174.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.52 133.98 29.04 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 N-CA-C 105.849 -1.908 . . . . 1.53 105.849 160.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 64.5 mt -97.44 -48.45 5.29 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 124.477 1.111 . . . . 2.3 108.106 168.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -156.14 153.64 29.62 Favored 'General case' 0 C--N 1.342 0.262 0 N-CA-C 109.608 -0.516 . . . . 2.53 109.608 177.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 20.9 t -132.79 145.48 51.03 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.451 -1.314 . . . . 2.2 107.451 172.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -136.04 153.08 51.46 Favored 'General case' 0 C--O 1.238 0.492 0 N-CA-C 107.502 -1.296 . . . . 2.8 107.502 142.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.403 HG12 ' CB ' ' A' ' 44' ' ' ALA . 2.2 m -125.37 143.61 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.902 0.881 . . . . 1.89 109.742 175.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -131.51 129.95 41.74 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-O 121.802 0.811 . . . . 0.79 111.802 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -72.56 -28.64 62.95 Favored 'General case' 0 C--O 1.225 -0.235 0 C-N-CA 124.752 1.221 . . . . 2.33 111.33 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.78 -44.16 73.46 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.035 0.534 . . . . 1.09 111.064 179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -89.52 -31.27 17.71 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 109.472 -0.566 . . . . 2.25 109.472 172.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.4 m-80 79.24 41.81 0.08 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 126.997 2.119 . . . . 3.54 107.796 -174.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.3 ttmt -133.6 141.66 47.76 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.741 -0.466 . . . . 2.25 109.741 -168.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.403 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -103.54 136.73 42.71 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 125.015 1.326 . . . . 0.59 107.949 168.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -102.36 150.15 23.62 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 107.085 -1.45 . . . . 3.55 107.085 159.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.44 HG22 ' HB3' ' A' ' 48' ' ' TYR . 1.3 mp -134.63 101.35 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.543 -2.021 . . . . 1.18 105.543 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 64.4 mttt -81.18 123.6 28.58 Favored 'General case' 0 N--CA 1.449 -0.494 0 N-CA-C 105.196 -2.149 . . . . 3.57 105.196 170.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . 0.44 ' HB3' HG22 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -163.72 170.48 16.94 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 120.958 0.408 . . . . 2.5 110.644 -152.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 38.6 m-20 -101.51 93.82 3.69 Favored Pre-proline 0 N--CA 1.447 -0.592 0 C-N-CA 125.544 1.538 . . . . 2.97 108.733 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.82 52.93 2.67 Favored 'Trans proline' 0 CA--C 1.538 0.68 0 C-N-CA 123.679 2.92 . . . . 1.73 110.799 173.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -159.99 25.66 0.17 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.464 1.506 . . . . 4.72 109.287 -169.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -167.17 -50.7 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.34 0.184 0 C-N-CA 126.503 1.921 . . . . 3.18 108.069 -178.306 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.1 tt -118.85 157.39 20.53 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 C-N-CA 124.625 1.17 . . . . 1.12 109.51 -172.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.36 -177.27 16.37 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 111.154 -0.778 . . . . 0.62 111.154 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -62.41 -39.94 42.87 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.543 2.162 . . . . 0.79 110.15 173.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -48.37 -53.4 17.71 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 124.574 1.15 . . . . 6.1 111.476 -178.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -57.72 -52.09 66.87 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.211 0.529 . . . . 2.55 109.637 -173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 40.8 mt -55.87 -52.97 43.26 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.11 0 C-N-CA 123.75 0.82 . . . . 1.43 108.974 177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.455 HD11 HD21 ' A' ' 71' ' ' LEU . 20.2 mt -50.97 -55.1 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 109.246 -0.65 . . . . 0.57 109.246 -177.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 31.2 m-70 -66.02 -37.87 86.99 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.152 0.501 . . . . 2.84 110.703 -175.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 80.3 m -55.59 -47.79 75.91 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.283 -0.417 . . . . 0.72 110.345 173.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 79.8 mt -70.26 -44.04 78.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 O-C-N 121.757 -0.589 . . . . 1.02 110.953 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -49.58 -44.61 47.09 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.645 0.778 . . . . 2.69 109.894 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 5.9 t -52.78 -34.7 54.58 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.147 0.579 . . . . 2.04 112.521 175.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.5 mt -76.72 -13.37 60.04 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.368 -0.832 . . . . 1.1 112.319 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 85.87 45.46 5.7 Favored Glycine 0 CA--C 1.528 0.869 0 C-N-CA 123.731 0.681 . . . . 0.81 111.791 178.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -132.81 156.56 46.89 Favored 'General case' 0 CA--C 1.529 0.146 0 N-CA-C 107.182 -1.414 . . . . 1.84 107.182 171.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 81.5 mt-10 -96.4 99.7 5.82 Favored Pre-proline 0 C--O 1.234 0.252 0 CA-C-O 117.547 -1.216 . . . . 2.63 110.406 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -79.08 143.53 17.95 Favored 'Trans proline' 0 N--CA 1.448 -1.168 0 CA-C-N 121.43 1.547 . . . . 1.69 109.389 169.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.0 p -155.46 121.17 5.02 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 121.588 -0.695 . . . . 1.64 109.484 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.686 HD22 ' H ' ' A' ' 71' ' ' LEU . 1.5 mm? -61.25 133.76 56.25 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.904 0.882 . . . . 2.9 111.584 -169.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 97.9 t -141.81 -43.36 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 C-N-CA 123.217 0.607 . . . . 2.45 111.604 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . 0.341 0.0 OUTLIER 42.83 -123.9 0.72 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 118.748 0.703 . . . . 5.59 111.697 -165.869 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.8 mp -91.49 -71.2 0.53 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 N-CA-C 106.606 -1.627 . . . . 6.68 106.606 167.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.7 mp0 . . . . . 0 C--O 1.252 1.201 0 N-CA-C 105.492 -2.04 . . . . 8.89 105.492 163.688 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.3 mtm . . . . . 0 N--CA 1.473 0.696 0 CA-C-O 119.115 -0.469 . . . . 7.0 111.092 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.31 -179.32 39.07 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 117.803 0.274 . . . . 3.25 113.269 170.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.407 ' OD1' ' NZ ' ' A' ' 47' ' ' LYS . 44.0 t0 63.0 162.89 0.1 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 127.702 2.401 . . . . 4.21 112.673 -172.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.77 174.59 35.82 Favored Glycine 0 CA--C 1.527 0.831 0 C-N-CA 124.873 1.225 . . . . 1.85 110.466 179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.7 p -153.98 61.86 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.236 0.389 0 C-N-CA 124.783 1.233 . . . . 2.47 108.429 178.159 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.2 mp -93.8 139.14 31.22 Favored 'General case' 0 N--CA 1.451 -0.387 0 CA-C-N 115.344 -0.844 . . . . 3.1 109.254 176.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -121.0 106.33 11.49 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.611 1.964 . . . . 3.25 107.496 -170.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -110.24 133.28 53.39 Favored 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 107.264 -1.384 . . . . 1.48 107.264 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 46.1 t -78.88 112.37 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 N-CA-C 105.706 -1.961 . . . . 1.0 105.706 174.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.1 m -94.66 95.42 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.716 0 C-N-CA 126.365 1.866 . . . . 0.67 107.813 -177.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -78.35 155.75 29.91 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 119.278 -0.969 . . . . 4.97 108.404 178.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 108.93 -51.85 0.68 Allowed Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.631 -0.987 . . . . 0.67 110.631 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.0 ppp? -63.22 141.03 58.92 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 117.412 0.606 . . . . 1.84 111.355 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -155.1 10.85 0.34 Allowed 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 114.067 1.136 . . . . 2.26 114.067 -173.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -162.0 161.46 28.53 Favored 'General case' 0 N--CA 1.455 -0.181 0 CA-C-N 119.853 1.206 . . . . 1.39 109.829 -178.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.18 -39.4 9.62 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 125.62 1.568 . . . . 0.92 112.0 -178.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.0 m -40.13 -56.25 1.94 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.923 1.289 . . . . 1.85 111.546 169.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.3 m -69.98 -36.66 75.37 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 122.586 0.354 . . . . 0.8 110.902 -177.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 63.4 t -55.88 -59.28 2.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 N-CA-C 108.013 -1.106 . . . . 0.72 108.013 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -68.4 -35.55 77.82 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 118.289 -0.862 . . . . 1.28 111.348 -176.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -51.49 -55.3 19.65 Favored 'General case' 0 N--CA 1.448 -0.559 0 CA-C-N 119.942 1.247 . . . . 3.78 110.344 172.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 62.7 mt -54.25 -62.74 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 C-N-CA 123.702 0.801 . . . . 0.97 109.056 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.1 mt-10 -59.74 -55.69 31.2 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 120.324 -0.551 . . . . 2.6 110.333 -172.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 94.9 p -54.72 -47.38 73.82 Favored 'General case' 0 CA--C 1.529 0.14 0 CA-C-N 118.227 0.467 . . . . 2.05 111.182 -178.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -70.65 -32.1 69.26 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.052 -0.659 . . . . 1.38 111.271 -175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 78.6 mt -68.52 -52.04 36.44 Favored 'General case' 0 C--O 1.234 0.27 0 O-C-N 121.464 -0.773 . . . . 2.11 110.599 173.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.9 p -66.81 75.84 0.11 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 125.009 1.324 . . . . 1.86 110.854 -174.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 1.1 ptmm? 179.64 -40.02 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 127.964 2.505 . . . . 3.68 109.233 -177.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.409 ' CE1' ' HB ' ' A' ' 32' ' ' ILE . 11.8 p80 -69.22 139.75 54.52 Favored 'General case' 0 C--N 1.342 0.281 0 C-N-CA 118.962 -1.095 . . . . 2.04 108.965 175.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.3 tpm_? -60.1 144.42 49.75 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.108 -0.701 . . . . 7.34 109.108 178.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 98.01 -28.67 13.5 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-O 118.072 -1.404 . . . . 0.75 113.184 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.409 ' HB ' ' CE1' ' A' ' 29' ' ' HIS . 0.3 OUTLIER -76.64 122.6 31.35 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 119.953 1.876 . . . . 1.69 108.286 169.72 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 29.0 mt -85.69 -52.69 5.63 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 108.004 -1.11 . . . . 2.43 108.004 173.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -157.12 144.65 18.89 Favored 'General case' 0 C--N 1.342 0.25 0 N-CA-C 109.18 -0.674 . . . . 3.63 109.18 170.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 31.1 t -107.26 129.62 54.85 Favored 'General case' 0 CA--C 1.516 -0.341 0 N-CA-C 107.19 -1.411 . . . . 2.65 107.19 167.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.5 t -112.0 104.08 12.33 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 105.777 -1.935 . . . . 2.25 105.777 168.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.4 p -102.13 141.4 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 118.938 0.79 . . . . 1.84 111.071 172.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -136.29 132.99 36.45 Favored 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.323 0.582 . . . . 0.77 110.487 172.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.0 pp -76.2 -30.4 57.98 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 115.103 -0.953 . . . . 2.13 111.751 -175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -51.2 -32.17 22.76 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.806 0.842 . . . . 1.09 112.617 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.9 t -121.75 13.19 10.72 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 125.268 1.427 . . . . 2.2 111.088 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.1 m120 34.78 47.02 0.22 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 127.522 2.329 . . . . 2.0 111.818 -172.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.1 ttmt -120.85 137.94 54.31 Favored 'General case' 0 CA--C 1.515 -0.368 0 C-N-CA 123.276 0.631 . . . . 2.28 109.648 -169.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.47 116.65 32.37 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.723 1.609 . . . . 0.71 108.224 167.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.8 t-160 -91.25 110.62 21.91 Favored 'General case' 0 N--CA 1.436 -1.16 0 N-CA-C 102.562 -3.125 . . . . 2.29 102.562 166.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 35.9 mt -112.84 110.54 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.481 -1.674 . . . . 1.38 106.481 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.407 ' NZ ' ' OD1' ' A' ' 3' ' ' ASP . 7.0 mtpm? -83.06 70.22 9.99 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 106.983 -1.488 . . . . 3.24 106.983 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -90.24 144.29 25.99 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.147 -0.933 . . . . 2.92 109.697 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -81.36 111.17 22.67 Favored Pre-proline 0 CA--C 1.539 0.531 0 O-C-N 123.557 0.535 . . . . 3.99 111.026 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_endo -66.72 -16.51 50.58 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.917 2.411 . . . . 2.17 112.451 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 73.7 mt-10 -85.3 -5.84 59.29 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.11 0.868 . . . . 5.2 111.002 -176.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.4 pt -135.07 -27.73 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 114.392 1.256 . . . . 2.88 114.392 176.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.4 tp -131.7 133.8 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 N-CA-C 107.526 -1.287 . . . . 1.34 107.526 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -104.43 172.39 20.31 Favored Glycine 0 CA--C 1.529 0.91 0 O-C-N 121.529 -0.732 . . . . 0.65 112.203 -172.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -56.72 -41.47 75.37 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 123.22 2.614 . . . . 0.85 110.655 173.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -57.13 -51.06 70.82 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-N 117.85 0.295 . . . . 6.37 110.615 178.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.98 -51.14 70.39 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.259 -0.645 . . . . 2.63 109.259 -178.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 22.4 mm -54.38 -50.93 53.57 Favored 'Isoleucine or valine' 0 C--O 1.231 0.131 0 C-N-CA 123.326 0.65 . . . . 2.09 111.609 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 20.4 mt -54.14 -56.43 9.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 N-CA-C 108.935 -0.765 . . . . 0.68 108.935 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 30.1 m-70 -65.5 -35.13 79.96 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 121.195 0.521 . . . . 2.89 111.021 -173.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 70.3 m -56.27 -54.48 44.88 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 109.752 -0.462 . . . . 0.91 109.752 171.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.39 -36.05 64.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.516 -0.74 . . . . 1.29 111.712 -175.063 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -50.75 -48.65 59.06 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 108.94 -0.763 . . . . 2.74 108.94 166.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 10.8 t -65.12 -13.93 59.3 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 113.836 1.05 . . . . 1.81 113.836 176.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 73.4 mt -88.15 -9.8 51.98 Favored 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 120.05 1.295 . . . . 1.33 111.319 170.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.25 41.72 6.48 Favored Glycine 0 CA--C 1.526 0.728 0 C-N-CA 124.383 0.992 . . . . 0.9 112.022 175.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 38.3 m-85 -135.74 167.38 21.26 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.236 -1.024 . . . . 2.06 108.236 172.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.6 mt-10 -105.71 94.6 8.99 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 124.489 1.115 . . . . 2.65 110.636 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -80.3 80.52 3.02 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 123.631 2.887 . . . . 1.13 112.267 -176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 75.0 p -82.98 121.34 26.88 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 121.15 -0.969 . . . . 1.83 111.401 178.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 40.3 mt -70.35 72.42 0.47 Allowed 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.194 -0.941 . . . . 3.43 111.503 177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 58.2 t -86.31 -33.62 7.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.36 0 CA-C-O 118.878 -0.582 . . . . 2.66 112.16 -178.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 21.4 mmtt 57.67 -160.43 0.24 Allowed 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 119.365 0.984 . . . . 5.79 109.833 -166.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 15.9 tt -154.4 158.72 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 106.217 -1.771 . . . . 9.08 106.217 168.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 . . . . . 0 C--O 1.249 1.035 0 N-CA-C 104.464 -2.421 . . . . 8.83 104.464 168.483 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 112.57 0.581 . . . . 12.83 112.57 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -116.74 56.09 0.54 Allowed Glycine 0 C--N 1.336 0.562 0 N-CA-C 107.087 -2.405 . . . . 6.47 107.087 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.7 p30 174.8 173.73 0.21 Allowed 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 106.228 -1.767 . . . . 3.49 106.228 -152.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -143.85 153.79 25.18 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 106.244 -2.742 . . . . 1.68 106.244 165.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -135.15 132.8 53.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 CA-C-N 118.196 0.998 . . . . 3.12 109.836 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 54.9 tp -108.78 149.45 29.04 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 105.974 -1.862 . . . . 2.83 105.974 171.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -118.67 152.73 35.56 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.092 -0.707 . . . . 2.6 109.092 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.714 HD21 HD13 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -150.0 133.27 16.39 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 108.135 -1.061 . . . . 1.31 108.135 177.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 58.0 t -79.37 105.07 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 105.32 -2.104 . . . . 1.04 105.32 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.464 HG23 ' SD ' ' A' ' 13' ' ' MET . 3.2 m -95.53 86.35 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 C-N-CA 126.221 1.808 . . . . 0.65 107.994 -172.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.5 mtp-105 -77.38 132.65 38.64 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 119.899 -0.721 . . . . 6.06 109.748 -170.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.01 -4.01 5.65 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.45 1.5 . . . . 1.03 113.187 171.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.464 ' SD ' HG23 ' A' ' 10' ' ' VAL . 41.4 mtp -75.92 116.33 16.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 119.042 1.421 . . . . 1.89 110.097 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -98.91 -21.02 16.49 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-O 117.488 -1.244 . . . . 3.13 113.253 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 19.9 p -162.7 175.81 10.96 Favored 'General case' 0 C--N 1.344 0.327 0 CA-C-N 120.636 1.562 . . . . 1.79 112.221 -172.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -35.94 58.72 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.586 1.154 . . . . 0.96 111.923 176.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.4 t -57.25 -37.03 71.69 Favored 'General case' 0 C--O 1.222 -0.395 0 CA-C-O 118.368 -0.825 . . . . 2.49 110.105 175.085 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 81.4 m -69.07 -53.45 20.27 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-N 120.025 1.284 . . . . 0.79 109.687 175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 56.0 t -41.67 -57.46 0.47 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 124.944 1.298 . . . . 0.66 110.257 -176.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -66.89 -21.26 66.01 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.23 -0.896 . . . . 1.66 112.735 -170.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.6 mmtm -69.1 -47.86 64.07 Favored 'General case' 0 C--N 1.345 0.388 0 N-CA-C 107.309 -1.367 . . . . 4.84 107.309 176.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.656 ' HB ' HG11 ' A' ' 37' ' ' VAL . 2.9 mt -64.65 -54.56 28.81 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 108.306 -0.998 . . . . 0.97 108.306 -176.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.574 ' HG3' HG12 ' A' ' 37' ' ' VAL . 19.3 mt-10 -50.41 -59.99 3.45 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 118.206 0.457 . . . . 2.35 111.028 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 28.2 t -55.03 -52.6 62.67 Favored 'General case' 0 CA--C 1.534 0.342 0 CA-C-O 121.113 0.482 . . . . 2.09 111.415 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.7 t -66.84 -28.0 68.0 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.527 0.731 . . . . 1.55 111.533 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -70.0 -47.7 61.13 Favored 'General case' 0 N--CA 1.454 -0.274 0 O-C-N 121.337 -0.852 . . . . 2.06 109.701 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.5 p -70.87 68.53 0.43 Allowed 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 118.412 0.551 . . . . 1.58 112.12 178.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.69 -30.83 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.906 1.283 . . . . 5.08 114.033 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 56.0 m-70 -51.7 -47.84 63.76 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 119.357 0.981 . . . . 3.97 112.968 -174.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 21.2 ttt85 139.59 -85.6 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.151 0 C-N-CA 129.901 3.28 . . . . 7.43 104.836 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -84.58 53.84 4.87 Favored Glycine 0 C--N 1.334 0.446 0 N-CA-C 111.695 -0.562 . . . . 1.04 111.695 -166.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.3 mt -114.61 124.17 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 105.555 -2.016 . . . . 2.88 105.555 160.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 68.5 mt -79.76 -44.56 20.47 Favored 'General case' 0 N--CA 1.438 -1.04 0 N-CA-C 108.556 -0.905 . . . . 1.98 108.556 178.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -156.89 157.66 35.27 Favored 'General case' 0 N--CA 1.447 -0.575 0 N-CA-C 108.208 -1.034 . . . . 2.67 108.208 174.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 10.9 t -128.21 145.65 50.97 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 104.899 -2.26 . . . . 2.28 104.899 163.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -141.52 149.8 41.33 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 118.587 -1.245 . . . . 2.33 110.203 153.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.656 HG11 ' HB ' ' A' ' 22' ' ' ILE . 13.1 p -143.1 108.59 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 124.586 1.179 . . . . 1.64 112.451 -162.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.78 134.26 41.92 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.032 0.444 . . . . 0.8 111.199 -174.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.06 -33.81 70.6 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-N 115.542 -0.754 . . . . 1.81 110.392 175.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -44.92 -44.23 9.56 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 125.364 1.466 . . . . 1.37 113.081 -175.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.4 t -123.59 22.13 9.18 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.262 0.625 . . . . 2.53 110.79 174.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 42.44 58.88 2.9 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 127.198 2.199 . . . . 3.23 109.834 177.018 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -145.8 136.46 24.27 Favored 'General case' 0 N--CA 1.456 -0.143 0 O-C-N 121.882 -0.511 . . . . 1.82 111.535 -166.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.571 ' HB2' HG23 ' A' ' 37' ' ' VAL . . . -109.5 143.03 39.68 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 125.868 1.667 . . . . 0.94 108.987 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . 0.558 ' C ' HD12 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -106.91 140.23 40.06 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.028 -1.841 . . . . 2.87 106.028 153.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.714 HD13 HD21 ' A' ' 8' ' ' LEU . 1.7 mp -122.99 112.44 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 N-CA-C 105.627 -1.99 . . . . 1.29 105.627 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.8 mttt -85.96 122.6 30.24 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 106.943 -1.503 . . . . 2.94 106.943 172.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 14.0 p90 -144.66 164.31 31.35 Favored 'General case' 0 N--CA 1.454 -0.264 0 N-CA-C 114.502 1.297 . . . . 2.22 114.502 -169.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -99.26 112.1 62.51 Favored Pre-proline 0 N--CA 1.451 -0.379 0 C-N-CA 125.955 1.702 . . . . 2.75 108.374 -175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -72.24 2.26 5.18 Favored 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 122.228 1.952 . . . . 1.81 114.001 -171.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.0 -32.56 73.94 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.646 1.112 . . . . 5.84 111.474 171.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -123.62 -59.33 2.14 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 CA-C-O 121.515 0.674 . . . . 3.47 112.036 -160.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.1 tt -100.29 151.83 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.879 -0.6 . . . . 1.78 109.704 -161.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.73 -174.24 13.64 Favored Glycine 0 CA--C 1.525 0.656 0 N-CA-C 109.078 -1.609 . . . . 1.1 109.078 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -56.66 -40.46 84.2 Favored 'Trans proline' 0 N--CA 1.451 -1.025 0 C-N-CA 121.926 1.75 . . . . 1.24 109.818 168.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.25 -55.86 7.84 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 124.341 1.056 . . . . 8.98 113.461 -176.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -60.52 -49.24 78.35 Favored 'General case' 0 C--O 1.233 0.199 0 O-C-N 121.402 -0.811 . . . . 2.71 109.812 -174.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.7 mt -56.58 -51.64 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 114.878 -1.055 . . . . 1.62 108.545 179.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 43.8 mt -57.02 -52.53 54.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.662 0 N-CA-C 109.523 -0.547 . . . . 0.77 109.523 -177.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.5 m170 -57.47 -42.84 83.39 Favored 'General case' 0 CA--C 1.528 0.131 0 CA-C-O 122.379 1.085 . . . . 2.79 109.547 -178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 69.5 m -58.99 -52.91 63.74 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.67 -0.696 . . . . 1.16 110.137 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 75.7 mt -71.87 -37.94 63.35 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 O-C-N 121.668 -0.645 . . . . 1.11 111.819 -169.752 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 pp20? -60.31 -45.58 92.88 Favored 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 120.201 -0.599 . . . . 4.17 109.682 171.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.4 t -59.09 -36.86 75.85 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-O 118.906 -0.568 . . . . 1.84 112.238 175.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 91.5 mt -63.65 -46.1 87.18 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 119.531 1.06 . . . . 1.08 110.276 171.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 120.58 46.54 0.35 Allowed Glycine 0 CA--C 1.526 0.778 0 C-N-CA 124.349 0.976 . . . . 0.87 111.932 175.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -134.78 163.54 29.56 Favored 'General case' 0 C--O 1.227 -0.116 0 N-CA-C 107.312 -1.366 . . . . 2.05 107.312 169.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -97.63 103.71 17.74 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-O 118.041 -0.981 . . . . 3.34 109.852 179.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.56 77.47 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.212 2.608 . . . . 0.9 111.245 -177.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.4 m -78.71 99.68 6.74 Favored 'General case' 0 N--CA 1.451 -0.379 0 O-C-N 121.746 -0.596 . . . . 1.83 109.52 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.594 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.2 pt? -67.22 59.72 0.05 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.731 1.612 . . . . 2.85 114.575 -178.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.9 t -78.77 62.7 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 O-C-N 120.743 -1.223 . . . . 2.51 109.445 176.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 24.4 tptp -163.28 106.82 1.03 Allowed 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.367 1.467 . . . . 4.79 107.371 174.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 12.2 tt -86.74 -140.75 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 N-CA-C 107.788 -1.19 . . . . 10.32 107.788 173.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 124.833 1.253 . . . . 12.07 109.907 169.696 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 52.3 mtm . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 106.506 -1.665 . . . . 8.84 106.506 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -168.04 163.34 37.07 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 106.37 -2.692 . . . . 3.91 106.37 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 18.4 p-10 -79.95 177.68 8.75 Favored 'General case' 0 N--CA 1.451 -0.379 0 CA-C-N 117.925 0.862 . . . . 3.89 108.947 171.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -116.84 153.57 17.29 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 107.252 -2.339 . . . . 1.76 107.252 169.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 41.2 t -143.3 128.84 16.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.276 -1.379 . . . . 2.43 107.276 175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 43.1 tp -139.86 144.69 37.35 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 104.453 -2.425 . . . . 3.11 104.453 166.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -116.32 140.13 49.66 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 123.776 0.673 . . . . 2.52 110.179 171.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.1 124.27 36.55 Favored 'General case' 0 N--CA 1.44 -0.962 0 N-CA-C 106.463 -1.68 . . . . 1.59 106.463 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 98.5 t -79.56 106.77 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 N-CA-C 104.988 -2.227 . . . . 1.21 104.988 174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -97.67 97.75 6.58 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.73 0 C-N-CA 124.542 1.137 . . . . 0.79 108.261 -170.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -76.99 147.29 36.92 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.245 -1.02 . . . . 8.24 108.245 -179.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.76 -51.0 0.73 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 124.362 0.982 . . . . 0.82 111.02 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.44 132.28 37.24 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 118.419 1.109 . . . . 1.42 110.01 -171.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.6 t -156.53 12.8 0.28 Allowed 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 114.571 1.323 . . . . 2.76 114.571 -166.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.1 p -161.16 165.13 29.96 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 120.212 1.369 . . . . 1.18 110.16 174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.7 -43.83 13.05 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 125.248 1.419 . . . . 0.82 111.766 -177.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -37.81 -49.9 1.21 Allowed 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 127.502 2.321 . . . . 2.13 112.122 170.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 29.1 m -71.87 -56.2 6.15 Favored 'General case' 0 N--CA 1.444 -0.756 0 CA-C-N 116.181 -0.463 . . . . 1.12 110.129 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 96.2 t -47.7 -54.75 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 C-N-CA 124.004 0.921 . . . . 0.8 109.598 -164.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -65.58 -33.86 76.9 Favored 'General case' 0 N--CA 1.44 -0.962 0 CA-C-N 115.44 -0.8 . . . . 1.03 111.826 -174.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 8.2 pttp -71.61 -40.61 69.69 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.907 -0.775 . . . . 3.84 108.907 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.467 ' HB ' HG11 ' A' ' 37' ' ' VAL . 69.3 mt -57.17 -66.54 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.384 0 N-CA-C 108.212 -1.032 . . . . 1.07 108.212 171.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' CG ' HG12 ' A' ' 37' ' ' VAL . 3.6 mt-10 -51.53 -55.75 17.25 Favored 'General case' 0 N--CA 1.456 -0.143 0 CA-C-N 119.295 0.952 . . . . 2.93 110.896 -173.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 35.8 t -50.53 -54.35 23.1 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 122.631 0.372 . . . . 1.97 111.148 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.2 t -72.47 -26.87 61.98 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 114.033 1.123 . . . . 1.6 114.033 -173.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -70.17 -43.38 70.92 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.204 -0.665 . . . . 1.72 109.204 171.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.1 p -70.17 68.68 0.33 Allowed 'General case' 0 CA--C 1.534 0.358 0 CA-C-O 121.879 0.847 . . . . 2.09 110.389 176.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -156.0 -49.53 0.08 Allowed 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 128.853 2.861 . . . . 4.85 107.082 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.9 p80 -73.45 88.59 1.61 Allowed 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 109.458 -0.571 . . . . 2.37 109.458 -178.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 58.7 ttm-85 -40.63 113.83 0.41 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.414 1.086 . . . . 6.63 109.528 173.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 133.86 -34.6 2.37 Favored Glycine 0 C--O 1.224 -0.529 0 N-CA-C 109.374 -1.49 . . . . 0.84 109.374 -164.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -76.02 125.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 107.493 -1.299 . . . . 1.61 107.493 174.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.9 mt -97.67 -40.1 8.76 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 123.465 0.706 . . . . 2.23 110.43 175.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -157.13 146.05 19.95 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 119.323 0.965 . . . . 2.6 109.906 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.1 p -144.22 56.8 1.31 Allowed 'General case' 0 C--O 1.226 -0.139 0 C-N-CA 124.23 1.012 . . . . 2.8 111.818 -167.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.8 t -78.21 81.71 4.56 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 121.373 -0.829 . . . . 1.96 110.188 -170.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.467 HG11 ' HB ' ' A' ' 22' ' ' ILE . 14.6 p -83.82 76.91 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 CA-C-O 121.675 0.75 . . . . 1.77 112.766 -168.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -77.63 123.87 27.2 Favored 'General case' 0 C--O 1.238 0.453 0 CA-C-O 122.441 1.115 . . . . 0.87 112.469 -176.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.95 -28.86 27.52 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 113.85 -1.523 . . . . 3.07 113.048 -166.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -56.45 -38.81 72.14 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-O 121.471 0.653 . . . . 1.73 110.618 176.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -90.52 -4.15 57.11 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 126.459 1.904 . . . . 3.77 111.42 178.049 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 31.4 m120 43.26 46.55 5.35 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.322 1.849 . . . . 1.9 111.4 -167.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -117.61 155.14 30.37 Favored 'General case' 0 C--N 1.343 0.315 0 CA-C-N 119.075 0.852 . . . . 2.01 111.565 -178.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.89 139.81 49.86 Favored 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 107.474 -1.306 . . . . 0.72 107.474 147.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -90.97 138.86 31.28 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 103.845 -2.65 . . . . 2.84 103.845 148.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mm -122.43 106.25 17.48 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 N-CA-C 106.725 -1.583 . . . . 2.09 106.725 172.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -79.75 68.26 5.77 Favored 'General case' 0 N--CA 1.444 -0.739 0 N-CA-C 109.067 -0.716 . . . . 2.26 109.067 174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.5 p90 -73.57 143.88 46.26 Favored 'General case' 0 CA--C 1.533 0.312 0 O-C-N 122.019 -0.426 . . . . 2.25 111.482 170.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 24.0 m-20 -62.17 113.15 7.78 Favored Pre-proline 0 CA--C 1.533 0.321 0 C-N-CA 124.853 1.261 . . . . 2.94 107.993 170.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -81.86 48.29 2.79 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 122.741 2.294 . . . . 1.76 112.736 -164.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 57.4 mt-10 -138.15 -64.11 0.54 Allowed 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.678 1.191 . . . . 4.09 110.063 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.0 pt -73.63 -24.14 19.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 N-CA-C 113.539 0.941 . . . . 1.85 113.539 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.0 tt -142.6 151.55 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 124.346 1.058 . . . . 1.24 108.239 -167.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.94 -178.57 15.75 Favored Glycine 0 CA--C 1.528 0.863 0 N-CA-C 111.717 -0.553 . . . . 0.74 111.717 -173.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -60.79 -41.05 49.0 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 122.668 2.245 . . . . 0.79 110.375 175.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -53.15 -44.76 68.03 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 123.284 0.634 . . . . 8.15 112.0 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -55.98 -53.39 57.42 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 121.388 0.613 . . . . 2.65 110.078 179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 58.4 mt -57.95 -49.28 81.74 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.204 0 N-CA-C 108.57 -0.9 . . . . 1.67 108.57 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.0 mt -53.19 -52.76 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.567 0 N-CA-C 109.323 -0.621 . . . . 0.67 109.323 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.7 m-70 -66.49 -34.45 77.95 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 120.94 0.4 . . . . 3.0 110.883 -176.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 93.3 m -58.8 -52.52 65.38 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 110.109 -0.33 . . . . 0.83 110.109 172.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 12.9 mm -66.16 -40.23 86.47 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 O-C-N 121.269 -0.894 . . . . 1.51 110.895 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -53.57 -52.44 59.74 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.713 0.805 . . . . 3.1 109.195 170.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.7 t -55.46 -43.47 75.49 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 122.946 0.499 . . . . 1.69 111.109 176.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.5 mt -68.12 -10.38 53.59 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 113.374 0.879 . . . . 1.09 113.374 175.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.25 30.53 8.16 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 124.577 1.084 . . . . 0.67 112.896 169.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -131.8 165.2 24.33 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.351 1.076 . . . . 2.02 110.219 176.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 26.6 mt-10 -107.95 100.16 34.45 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 124.307 1.043 . . . . 3.31 110.569 -172.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -81.87 99.07 0.99 Allowed 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.629 2.886 . . . . 1.06 111.069 -177.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.7 t -90.59 119.47 30.87 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.35 -1.352 . . . . 2.46 107.35 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 32.9 mt -71.14 118.93 14.55 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.343 -0.984 . . . . 2.82 108.343 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.5 t -134.87 36.18 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 N-CA-C 109.494 -0.558 . . . . 2.59 109.494 173.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 28.6 mmtm -140.61 149.02 41.8 Favored 'General case' 0 CA--C 1.528 0.103 0 N-CA-C 104.676 -2.342 . . . . 6.51 104.676 155.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 29.2 mt 68.42 -72.05 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 107.504 -1.295 . . . . 9.96 107.504 -159.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.1 mp0 . . . . . 0 C--O 1.25 1.113 0 CA-C-O 117.123 -1.418 . . . . 11.65 109.986 157.933 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.4 mtm . . . . . 0 N--CA 1.472 0.651 0 N-CA-C 106.875 -1.528 . . . . 9.39 106.875 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 175.72 176.19 43.74 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 107.42 -2.272 . . . . 2.79 107.42 -177.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 32.2 t70 42.27 61.21 2.06 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.63 1.572 . . . . 3.7 112.634 171.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -73.01 149.02 42.16 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 109.01 -1.636 . . . . 1.74 109.01 177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.7 m -129.17 146.99 33.39 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 C-N-CA 123.886 0.875 . . . . 2.64 109.46 -178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -155.61 126.86 7.16 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 112.804 0.668 . . . . 3.45 112.804 162.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 40.0 mp0 -79.56 97.16 6.35 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.674 1.99 . . . . 3.6 109.378 169.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 6.6 mt -92.61 116.48 29.04 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.074 -1.454 . . . . 2.64 107.074 172.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.5 t -77.27 97.54 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 105.978 -1.86 . . . . 1.32 105.978 176.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.0 m -78.48 74.63 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 C-N-CA 125.438 1.495 . . . . 0.82 107.666 -176.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -74.38 146.35 43.04 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.926 -1.509 . . . . 5.1 106.926 -176.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 104.15 -26.19 23.77 Favored Glycine 0 CA--C 1.527 0.841 0 CA-C-O 118.571 -1.127 . . . . 1.04 112.126 -173.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -95.58 130.15 42.53 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 119.547 1.673 . . . . 1.7 108.974 -171.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 5.1 p -116.41 -48.7 2.69 Favored 'General case' 0 CA--C 1.531 0.23 0 N-CA-C 113.545 0.943 . . . . 3.27 113.545 -158.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -118.87 164.87 14.79 Favored 'General case' 0 N--CA 1.462 0.142 0 C-N-CA 123.777 0.831 . . . . 1.34 111.498 -166.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.18 -40.07 10.65 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.887 1.275 . . . . 0.79 111.622 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.9 m -41.22 -51.29 3.55 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.602 1.561 . . . . 1.65 111.992 170.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 69.2 m -70.45 -43.63 69.47 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 122.943 0.497 . . . . 0.73 111.101 177.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.626 HG13 HG13 ' A' ' 37' ' ' VAL . 61.2 t -53.18 -55.46 12.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 N-CA-C 108.506 -0.924 . . . . 0.62 108.506 -174.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -69.26 -29.61 67.56 Favored 'General case' 0 N--CA 1.439 -0.998 0 CA-C-N 115.654 -0.703 . . . . 0.9 111.722 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.8 tttt -49.73 -54.84 16.52 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 119.472 1.033 . . . . 4.06 109.016 166.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.497 ' HB ' HG11 ' A' ' 37' ' ' VAL . 1.1 mt -59.77 -61.56 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 109.285 -0.635 . . . . 0.73 109.285 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.603 ' CG ' HG12 ' A' ' 37' ' ' VAL . 31.3 mt-10 -57.43 -55.25 37.17 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 118.65 0.659 . . . . 2.35 111.58 -173.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 20.1 m -59.85 -39.34 84.87 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 121.754 -0.591 . . . . 1.88 111.835 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.8 t -70.34 -46.08 64.86 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 121.585 -0.697 . . . . 0.93 111.092 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.8 mp -71.62 -61.02 1.93 Allowed 'General case' 0 C--O 1.234 0.265 0 C-N-CA 123.147 0.579 . . . . 2.94 111.201 -177.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.4 m -69.65 72.18 0.35 Allowed 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.11 1.764 . . . . 2.86 110.746 -172.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 3.5 pptp? -176.17 -35.07 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 129.18 2.992 . . . . 3.77 109.335 -178.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -65.3 120.93 13.67 Favored 'General case' 0 C--N 1.348 0.501 0 CA-C-N 119.344 0.975 . . . . 2.32 108.505 169.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.65 134.76 51.39 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 106.714 -1.587 . . . . 7.74 106.714 169.289 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 119.74 -41.28 2.0 Favored Glycine 0 C--O 1.225 -0.43 0 N-CA-C 110.047 -1.221 . . . . 0.96 110.047 -172.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.14 131.55 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 106.647 -1.612 . . . . 1.99 106.647 164.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -96.02 -30.43 13.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.076 -0.713 . . . . 2.34 109.076 170.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -156.23 164.97 37.7 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.926 0.785 . . . . 3.08 110.392 169.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 40.8 t -130.47 149.87 51.94 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 105.687 -1.968 . . . . 2.17 105.687 162.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 21.2 m -139.66 104.83 5.01 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 107.406 -1.331 . . . . 2.67 107.406 162.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.626 HG13 HG13 ' A' ' 19' ' ' VAL . 12.5 p -114.16 141.91 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.184 0 C-N-CA 123.012 0.525 . . . . 1.58 112.09 -177.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.39 139.71 30.11 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.244 0.545 . . . . 1.14 110.992 178.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -75.48 -33.08 60.78 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 124.201 1.0 . . . . 1.76 111.606 -176.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.33 -34.31 60.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.227 0.611 . . . . 1.57 112.217 -179.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.8 t -106.87 3.16 26.01 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.284 1.434 . . . . 3.09 111.48 176.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 22.6 m120 37.31 51.21 1.1 Allowed 'General case' 0 CA--C 1.528 0.11 0 C-N-CA 127.52 2.328 . . . . 1.91 110.814 -169.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.27 137.59 27.37 Favored 'General case' 0 CA--C 1.519 -0.231 0 O-C-N 122.003 -0.435 . . . . 2.13 111.925 -166.106 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.94 117.46 32.79 Favored 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 127.298 2.239 . . . . 0.69 108.741 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -86.34 103.74 15.2 Favored 'General case' 0 N--CA 1.437 -1.112 0 N-CA-C 104.42 -2.437 . . . . 2.28 104.42 167.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -87.21 134.58 27.28 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 N-CA-C 107.01 -1.478 . . . . 1.09 107.01 173.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 10.4 mtpt -112.94 118.22 34.26 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 107.485 -1.302 . . . . 2.59 107.485 169.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -128.08 148.61 50.57 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.057 0.943 . . . . 2.72 111.514 -169.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 48.9 m-20 -76.99 117.01 62.14 Favored Pre-proline 0 N--CA 1.45 -0.471 0 N-CA-C 106.55 -1.648 . . . . 3.11 106.55 173.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.39 69.64 7.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.606 2.204 . . . . 2.17 110.77 -172.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -151.6 -92.88 0.06 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.582 1.153 . . . . 5.02 110.154 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 19.1 pt -64.05 -31.28 52.65 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 113.128 0.788 . . . . 2.33 113.128 -171.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.3 tp -114.07 137.78 46.16 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 124.958 1.303 . . . . 1.07 108.517 -173.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.54 176.94 16.3 Favored Glycine 0 CA--C 1.531 1.088 0 N-CA-C 111.147 -0.781 . . . . 0.59 111.147 173.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -57.19 -41.39 74.4 Favored 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 123.791 2.994 . . . . 0.97 110.923 177.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.6 mtt180 -56.43 -53.75 53.78 Favored 'General case' 0 CA--C 1.528 0.112 0 CA-C-N 118.211 0.459 . . . . 6.58 110.779 176.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -55.45 -50.4 69.94 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 109.078 -0.712 . . . . 2.88 109.078 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mm -53.69 -52.81 30.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.214 0 C-N-CA 123.334 0.654 . . . . 2.04 111.306 176.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.4 mt -52.66 -53.53 20.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 108.879 -0.786 . . . . 0.83 108.879 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.0 m-70 -64.27 -37.34 87.13 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 121.315 0.578 . . . . 3.17 110.795 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.3 m -57.36 -46.81 82.95 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 116.091 -0.504 . . . . 1.12 109.754 174.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.8 mt -70.41 -43.08 78.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 CA-C-N 118.654 0.661 . . . . 1.38 111.323 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -52.59 -41.56 63.75 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.97 0.804 . . . . 3.42 110.087 177.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 25.4 m -53.7 -29.07 37.3 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.978 0.733 . . . . 1.87 112.978 174.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 24.4 mt -81.18 -15.37 55.93 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.761 0.824 . . . . 0.97 112.07 177.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.68 42.83 4.37 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.825 1.203 . . . . 0.67 112.662 174.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.96 162.21 33.49 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 107.372 -1.344 . . . . 1.87 107.372 173.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -105.74 94.08 8.31 Favored Pre-proline 0 CA--C 1.543 0.693 0 CA-C-N 118.955 0.798 . . . . 2.56 110.397 -177.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.93 85.2 1.21 Allowed 'Trans proline' 0 N--CA 1.459 -0.518 0 C-N-CA 123.804 3.003 . . . . 1.33 110.989 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.6 m -84.68 97.03 9.42 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.401 1.08 . . . . 1.97 110.223 -170.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -48.87 102.74 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.875 0.87 . . . . 4.63 110.817 171.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.1 p -75.21 -43.38 44.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.144 0 N-CA-C 111.846 0.313 . . . . 3.68 111.846 -170.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.3 tptm 61.44 -163.59 0.26 Allowed 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 122.977 0.511 . . . . 6.9 110.19 -173.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 14.6 tt -164.11 74.65 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.527 0.079 0 N-CA-C 105.169 -2.159 . . . . 7.43 105.169 173.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 . . . . . 0 C--O 1.249 1.047 0 N-CA-C 104.365 -2.457 . . . . 9.41 104.365 -151.259 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 109.169 -0.678 . . . . 8.1 109.169 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.11 30.01 76.06 Favored Glycine 0 CA--C 1.533 1.16 0 C-N-CA 123.229 0.443 . . . . 2.76 112.736 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.6 p30 -144.91 66.95 1.25 Allowed 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 126.154 1.782 . . . . 4.27 108.961 -165.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.93 144.05 48.87 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 108.573 -1.811 . . . . 2.22 108.573 173.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.7 p -150.12 132.12 5.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 117.818 0.809 . . . . 2.8 109.83 -177.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.8 mp -143.63 155.19 44.18 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.046 -1.094 . . . . 2.99 108.046 166.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -107.61 102.24 11.5 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 106.254 -1.758 . . . . 2.96 106.254 163.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.52 130.92 40.73 Favored 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 107.267 -1.383 . . . . 1.5 107.267 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.419 ' CG1' HH11 ' A' ' 11' ' ' ARG . 65.2 t -84.11 102.44 10.07 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 C-N-CA 125.225 1.41 . . . . 1.08 107.362 -174.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 m -89.53 96.69 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 C-N-CA 125.518 1.527 . . . . 0.65 109.082 -172.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.419 HH11 ' CG1' ' A' ' 9' ' ' VAL . 21.8 mmm180 -76.14 151.02 37.08 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 118.775 -1.17 . . . . 7.7 107.932 177.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.2 -27.3 10.93 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 124.225 0.917 . . . . 0.74 111.986 -177.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.0 mtm -65.79 94.68 0.22 Allowed 'General case' 0 C--N 1.34 0.192 0 CA-C-N 118.556 1.178 . . . . 1.47 111.546 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.2 t -77.85 -38.77 45.4 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.685 0.394 . . . . 2.59 111.49 177.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 21.7 p -152.23 174.7 13.44 Favored 'General case' 0 C--N 1.343 0.31 0 CA-C-N 119.071 0.85 . . . . 1.04 112.199 -168.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.5 -38.94 14.9 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 125.17 1.388 . . . . 1.13 112.183 179.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.6 m -51.94 -40.99 61.69 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 123.682 0.793 . . . . 1.86 111.42 176.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.4 m -70.1 -47.95 59.69 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.019 0.528 . . . . 0.84 110.239 176.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 61.2 t -51.12 -58.5 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.229 0 C-N-CA 123.737 0.815 . . . . 1.05 108.977 -175.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -67.17 -25.16 66.02 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.662 -0.699 . . . . 0.99 111.631 -176.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 12.8 tttp -56.73 -56.18 24.79 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.291 -1.004 . . . . 3.33 108.291 171.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -61.18 -58.61 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 N-CA-C 108.239 -1.023 . . . . 0.95 108.239 -178.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -55.78 -54.51 43.51 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 122.322 0.249 . . . . 2.95 110.599 -171.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.6 t -57.45 -48.27 79.61 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.862 0.465 . . . . 1.32 110.237 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.0 t -69.91 -34.06 73.01 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 118.905 -1.118 . . . . 1.17 111.22 -173.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.4 mp -66.31 -50.36 63.9 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-O 119.124 -0.465 . . . . 2.49 110.65 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.0 p -70.91 63.65 0.31 Allowed 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 121.982 0.896 . . . . 2.02 112.42 -177.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 14.9 pttp -165.93 -36.22 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 126.42 1.888 . . . . 3.79 110.895 172.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -65.97 133.72 51.43 Favored 'General case' 0 C--N 1.341 0.209 0 CA-C-N 119.359 0.981 . . . . 2.09 109.54 178.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -53.04 143.13 18.17 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.554 -0.906 . . . . 6.95 108.554 172.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 104.68 -32.68 7.26 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-O 118.142 -1.366 . . . . 0.8 111.977 173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.49 128.01 38.15 Favored 'Isoleucine or valine' 0 C--N 1.34 0.172 0 CA-C-N 120.006 1.903 . . . . 2.01 108.024 172.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 62.6 mt -92.6 -45.55 8.03 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 125.114 1.366 . . . . 2.87 108.526 -178.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 51.7 t80 -156.07 163.54 39.54 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.476 -0.564 . . . . 2.31 109.476 177.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 57.7 m -135.82 154.45 51.19 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.103 0.961 . . . . 2.69 108.742 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 m -149.89 97.78 2.64 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 108.055 -1.091 . . . . 2.84 108.055 162.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.3 p -101.39 135.65 36.87 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 122.91 0.484 . . . . 1.61 110.399 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -148.79 135.21 19.47 Favored 'General case' 0 C--N 1.342 0.273 0 C-N-CA 123.98 0.912 . . . . 0.72 112.457 -167.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 45.9 mt -69.51 -28.63 66.21 Favored 'General case' 0 C--O 1.226 -0.166 0 C-N-CA 125.789 1.636 . . . . 2.51 111.053 -177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -34.45 -45.15 0.22 Allowed 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 126.193 1.797 . . . . 2.01 113.501 -178.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.9 t -131.58 10.32 4.75 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 122.235 1.017 . . . . 3.19 111.503 169.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 56.94 59.18 3.59 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 125.958 1.703 . . . . 1.75 108.758 -167.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.1 ptpt -103.49 154.69 19.18 Favored 'General case' 0 CA--C 1.52 -0.195 0 C-N-CA 123.974 0.91 . . . . 1.92 110.961 178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -126.97 114.27 17.61 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.251 1.421 . . . . 0.72 108.001 162.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 4.5 t60 -80.1 113.39 18.23 Favored 'General case' 0 N--CA 1.423 -1.783 0 N-CA-C 104.86 -2.274 . . . . 2.95 104.86 169.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -107.69 126.17 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 105.563 -2.014 . . . . 1.13 105.563 174.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.2 mttt -114.01 123.93 50.91 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.586 -1.635 . . . . 2.65 106.586 169.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.7 p90 -144.87 148.12 33.58 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.752 0.821 . . . . 2.2 111.989 -160.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 t0 -56.5 117.61 17.78 Favored Pre-proline 0 CA--C 1.533 0.313 0 N-CA-C 107.231 -1.396 . . . . 4.75 107.231 164.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.71 -3.27 13.4 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.192 1.928 . . . . 1.75 113.003 -170.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -103.27 -54.45 2.6 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 119.17 0.895 . . . . 4.58 109.975 -174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 6.7 pt -79.95 -36.22 16.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 N-CA-C 112.694 0.628 . . . . 2.11 112.694 -167.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -116.06 132.06 66.71 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.28 1.432 . . . . 0.99 107.669 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.63 172.72 17.84 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-N 118.683 0.674 . . . . 0.6 111.612 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.95 -36.31 97.07 Favored 'Trans proline' 0 N--CA 1.45 -1.064 0 C-N-CA 123.232 2.621 . . . . 0.77 110.737 173.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -55.93 -57.0 13.92 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 118.094 0.406 . . . . 6.64 110.032 174.401 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -53.52 -49.9 66.58 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 109.071 -0.714 . . . . 2.68 109.071 -177.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.6 mm -53.58 -52.0 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 C-N-CA 123.281 0.632 . . . . 1.91 111.468 175.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 16.3 mt -54.88 -52.56 41.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 122.73 0.412 . . . . 0.58 109.96 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 91.0 m-70 -65.51 -38.95 91.19 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-O 121.53 0.681 . . . . 2.74 110.471 -176.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 52.3 m -55.24 -51.42 66.68 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 109.346 -0.613 . . . . 1.08 109.346 175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 89.8 mt -69.51 -39.85 79.02 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.317 0 CA-C-O 119.407 -0.33 . . . . 1.4 111.186 -179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -56.65 -44.06 80.94 Favored 'General case' 0 CA--C 1.526 0.049 0 CA-C-N 118.727 0.694 . . . . 3.55 109.226 -179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.2 t -58.66 -15.02 9.87 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.994 1.109 . . . . 1.73 113.994 174.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 58.5 mt -95.84 -9.86 30.42 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 119.898 1.226 . . . . 1.17 111.694 174.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.36 47.05 3.63 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.299 0.952 . . . . 0.85 112.462 174.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -137.99 163.87 30.46 Favored 'General case' 0 C--N 1.339 0.114 0 N-CA-C 108.56 -0.904 . . . . 2.15 108.56 171.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -107.53 86.98 3.07 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 124.552 1.141 . . . . 3.06 110.303 -176.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -70.59 82.36 0.93 Allowed 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 123.879 3.053 . . . . 1.0 111.538 -175.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 10.0 m -81.05 103.84 11.14 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.168 0.987 . . . . 1.78 109.022 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -68.06 70.97 0.16 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.558 1.143 . . . . 2.62 113.238 -175.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 2.3 t -71.15 -135.09 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 107.114 -1.439 . . . . 3.18 107.114 160.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 20.5 mmtm -138.99 -60.06 0.58 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 122.312 2.323 . . . . 6.63 113.641 -166.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.427 HG23 ' H ' ' A' ' 75' ' ' GLU . 3.4 tp -146.38 -50.92 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 C-N-CA 126.957 2.103 . . . . 8.0 108.023 -170.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' H ' HG23 ' A' ' 74' ' ' ILE . 34.3 tt0 . . . . . 0 C--O 1.257 1.46 0 N-CA-C 103.832 -2.655 . . . . 12.74 103.832 137.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.466 0.345 0 N-CA-C 108.196 -1.039 . . . . 6.37 108.196 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.62 80.58 1.45 Allowed Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.404 -0.678 . . . . 2.53 111.404 173.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -48.5 107.07 0.11 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.621 1.168 . . . . 3.89 111.546 175.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.59 170.47 54.21 Favored Glycine 0 CA--C 1.528 0.894 0 CA-C-O 121.768 0.649 . . . . 2.03 112.349 -176.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.5 m -146.42 129.85 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 N-CA-C 106.624 -1.621 . . . . 2.84 106.624 167.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -155.47 158.19 38.16 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 118.752 0.706 . . . . 3.34 110.216 160.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -110.0 123.97 50.6 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 124.137 0.975 . . . . 2.4 108.911 178.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.402 HD21 HD12 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -110.54 123.94 50.89 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 105.285 -2.117 . . . . 1.57 105.285 167.311 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.3 t -79.29 100.35 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 N-CA-C 105.298 -2.112 . . . . 1.27 105.298 177.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -83.77 84.0 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.04 1.736 . . . . 0.81 108.088 -174.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.41 HH22 ' CD ' ' A' ' 75' ' ' GLU . 23.5 mtt85 -76.72 147.15 37.56 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.717 -1.216 . . . . 6.73 107.717 -176.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 111.55 -16.61 26.39 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-O 119.3 -0.722 . . . . 0.81 112.849 -178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 50.1 mtp -64.05 167.34 6.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 118.978 1.389 . . . . 1.88 110.788 174.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.6 t -152.19 -45.54 0.1 Allowed 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.076 0.55 . . . . 2.37 111.675 178.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.4 p -133.61 170.92 14.82 Favored 'General case' 0 C--N 1.342 0.256 0 CA-C-N 118.909 0.777 . . . . 1.25 111.917 -169.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.85 -33.94 8.12 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 124.856 1.263 . . . . 0.79 111.981 175.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.5 t -64.95 -37.61 88.23 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 121.491 -0.756 . . . . 2.32 111.615 177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 82.6 m -61.36 -46.86 88.44 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.326 -0.62 . . . . 0.88 109.326 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.441 HG13 HG13 ' A' ' 37' ' ' VAL . 43.8 t -50.33 -59.67 1.06 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.201 0 N-CA-C 108.73 -0.841 . . . . 0.53 108.73 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.261 0.6 OUTLIER -66.11 -28.96 69.21 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 116.028 -0.533 . . . . 1.0 111.725 -174.762 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.8 mttp -62.17 -54.65 38.06 Favored 'General case' 0 C--N 1.341 0.222 0 N-CA-C 108.809 -0.811 . . . . 4.58 108.809 173.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -58.29 -54.3 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.128 0 C-N-CA 120.169 -0.612 . . . . 0.67 109.572 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 76.1 mt-10 -60.71 -53.99 50.7 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 118.367 0.531 . . . . 2.29 111.143 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.5 t -58.59 -34.9 71.61 Favored 'General case' 0 CA--C 1.532 0.261 0 O-C-N 121.742 -0.599 . . . . 1.67 111.209 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.5 t -70.38 -42.67 71.43 Favored 'General case' 0 N--CA 1.452 -0.345 0 O-C-N 122.042 -0.411 . . . . 1.15 110.772 177.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.2 mt -71.22 -60.12 2.4 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 123.112 0.565 . . . . 2.42 112.232 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 3.1 m -69.64 67.98 0.24 Allowed 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 126.072 1.749 . . . . 2.39 111.162 -166.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.16 -35.12 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 127.483 2.313 . . . . 4.24 110.575 -171.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -68.03 132.43 47.26 Favored 'General case' 0 C--N 1.343 0.294 0 CA-C-N 119.471 1.032 . . . . 2.09 108.8 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.7 mtt180 -54.74 148.07 13.58 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 109.452 -0.573 . . . . 6.47 109.452 175.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 93.47 -28.37 10.12 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-O 117.382 -1.788 . . . . 0.88 112.705 178.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -76.31 126.75 37.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 120.544 2.172 . . . . 1.69 106.506 166.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.2 mt -86.79 -44.22 11.92 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 107.22 -1.4 . . . . 2.75 107.22 172.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 72.6 t80 -156.13 164.69 38.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.573 -0.899 . . . . 2.26 108.573 174.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.6 p -138.94 161.5 37.18 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.783 -1.562 . . . . 2.03 106.783 160.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 31.5 t -143.68 134.16 24.79 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 106.455 -1.683 . . . . 1.8 106.455 153.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.441 HG13 HG13 ' A' ' 19' ' ' VAL . 2.8 p -115.2 145.67 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 123.401 0.68 . . . . 1.74 109.941 -179.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -143.04 134.96 26.88 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.073 0.463 . . . . 0.65 110.676 175.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -70.82 -29.49 65.66 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.665 1.186 . . . . 2.62 111.538 177.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.76 -39.11 36.69 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.631 1.172 . . . . 1.18 112.141 -174.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 4.5 p -129.88 32.15 4.6 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 123.717 0.807 . . . . 2.46 110.192 171.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 27.0 62.04 0.09 Allowed 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 128.226 2.611 . . . . 2.39 112.546 -178.012 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -132.49 145.55 51.26 Favored 'General case' 0 CA--C 1.52 -0.199 0 C-N-CA 122.84 0.456 . . . . 1.68 111.462 -173.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.06 118.06 35.76 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 106.505 -1.665 . . . . 0.78 106.505 163.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 -85.68 109.84 18.87 Favored 'General case' 0 N--CA 1.433 -1.3 0 N-CA-C 101.606 -3.479 . . . . 2.32 101.606 165.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.402 HD12 HD21 ' A' ' 8' ' ' LEU . 43.8 mt -101.94 139.22 23.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 108.329 -0.989 . . . . 1.73 108.329 175.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 mtpm? -117.78 104.86 11.38 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 105.707 -1.961 . . . . 3.05 105.707 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 21.0 p90 -120.11 162.49 19.22 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 123.818 0.847 . . . . 2.63 110.322 -176.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -100.22 114.76 65.82 Favored Pre-proline 0 CA--C 1.534 0.365 0 C-N-CA 123.556 0.743 . . . . 3.79 110.397 175.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -69.4 -5.32 15.7 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 122.607 2.205 . . . . 2.26 113.492 -175.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 pt-20 -65.01 -22.65 67.03 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-N 120.951 1.705 . . . . 5.26 112.068 176.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 5.9 pt -129.82 -60.08 1.01 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.324 0 N-CA-C 113.499 0.926 . . . . 2.05 113.499 -179.084 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.4 tp -87.85 137.32 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.548 -0.72 . . . . 1.09 110.031 -165.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.15 166.74 12.32 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 123.988 0.804 . . . . 0.75 111.57 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -57.87 -38.61 91.82 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.148 2.565 . . . . 0.76 110.872 177.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -53.74 -44.42 69.91 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 112.003 0.372 . . . . 7.45 112.003 173.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -61.3 -51.99 66.58 Favored 'General case' 0 C--N 1.34 0.178 0 CA-C-N 118.994 0.815 . . . . 2.43 109.191 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 89.7 mt -50.38 -54.16 9.83 Favored 'Isoleucine or valine' 0 C--O 1.23 0.067 0 C-N-CA 123.32 0.648 . . . . 1.54 109.358 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 59.9 mt -56.72 -51.01 72.13 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 CA-C-O 119.119 -0.467 . . . . 0.62 110.036 -177.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 50.6 m-70 -68.55 -27.35 66.0 Favored 'General case' 0 CA--C 1.527 0.07 0 CA-C-O 120.978 0.418 . . . . 3.14 112.067 -176.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.8 m -64.62 -52.26 58.37 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.733 -0.469 . . . . 0.85 109.733 170.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -72.07 -45.28 63.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 O-C-N 121.874 -0.517 . . . . 1.17 112.151 -171.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -52.04 -43.23 63.65 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 118.65 0.659 . . . . 3.95 111.388 -176.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 18.3 t -48.35 -37.2 16.09 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.38 1.472 . . . . 1.86 112.395 173.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 30.4 mt -74.8 -17.27 60.65 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.363 -0.836 . . . . 1.05 112.188 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.61 45.68 3.64 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 124.159 0.885 . . . . 0.81 112.022 178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 45.6 m-85 -136.38 155.63 49.77 Favored 'General case' 0 C--N 1.338 0.076 0 N-CA-C 107.721 -1.215 . . . . 1.96 107.721 170.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -101.39 96.47 6.16 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.768 1.227 . . . . 2.83 109.41 179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -74.2 77.66 2.77 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.352 2.701 . . . . 1.19 110.479 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 53.6 p -78.91 106.84 11.22 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 109.18 -0.674 . . . . 2.23 109.18 -177.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.3 mt -74.94 56.55 0.75 Allowed 'General case' 0 C--O 1.237 0.399 0 O-C-N 121.596 -0.69 . . . . 4.01 111.19 178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 8.3 p -101.63 55.53 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 CA-C-O 123.73 1.729 . . . . 3.38 107.492 173.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.5 pttm -39.46 110.96 0.16 Allowed 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 113.179 -1.828 . . . . 7.24 109.259 158.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 3.3 mp 73.26 108.92 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 126.398 1.879 . . . . 6.48 109.531 -167.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.41 ' CD ' HH22 ' A' ' 11' ' ' ARG . 52.7 mt-10 . . . . . 0 C--O 1.256 1.396 0 N-CA-C 103.824 -2.658 . . . . 13.37 103.824 158.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 mtt . . . . . 0 N--CA 1.468 0.471 0 N-CA-C 105.718 -1.956 . . . . 9.25 105.718 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.22 92.1 0.05 OUTLIER Glycine 0 CA--C 1.533 1.17 0 O-C-N 124.426 1.079 . . . . 2.97 112.484 176.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 35.2 t0 71.68 161.22 0.23 Allowed 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.831 2.052 . . . . 4.09 112.685 177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.92 94.82 0.1 OUTLIER Glycine 0 CA--C 1.524 0.63 0 N-CA-C 109.068 -1.613 . . . . 2.4 109.068 -169.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 t -90.73 118.47 36.05 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 125.053 1.341 . . . . 2.58 109.912 -170.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -127.01 133.25 50.58 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 123.361 0.665 . . . . 2.63 109.608 175.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -103.61 99.85 9.67 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.283 1.033 . . . . 2.66 108.217 169.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.94 134.02 41.63 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 107.123 -1.436 . . . . 1.43 107.123 173.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.9 t -85.32 113.81 24.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 106.143 -1.799 . . . . 1.01 106.143 176.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -101.02 96.78 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.587 0 C-N-CA 126.04 1.736 . . . . 0.65 108.321 -172.199 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.422 ' HD3' ' H ' ' A' ' 11' ' ' ARG . 0.1 OUTLIER -77.02 137.66 39.11 Favored 'General case' 0 C--O 1.232 0.181 0 N-CA-C 106.645 -1.613 . . . . 5.46 106.645 -174.956 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.55 -26.49 10.14 Favored Glycine 0 CA--C 1.529 0.912 0 CA-C-O 118.768 -1.018 . . . . 0.98 112.66 177.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.3 ptm -78.65 85.71 4.67 Favored 'General case' 0 C--N 1.342 0.27 0 CA-C-N 119.534 1.667 . . . . 1.82 110.232 -176.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 p -76.5 -34.6 58.61 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.881 0.872 . . . . 3.16 112.962 -172.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 14.0 p -145.45 172.82 12.66 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.81 0.732 . . . . 1.14 112.39 -162.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.8 -39.43 8.36 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 125.518 1.527 . . . . 0.73 112.299 179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -53.53 -53.14 55.87 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.491 -0.559 . . . . 2.18 109.491 175.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.3 m -64.77 -42.59 94.98 Favored 'General case' 0 N--CA 1.444 -0.731 0 C-N-CA 122.589 0.356 . . . . 0.68 111.003 -179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 69.6 t -48.99 -61.04 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 N-CA-C 108.199 -1.037 . . . . 0.55 108.199 179.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.287 1.1 p-80 -70.32 -28.77 65.43 Favored 'General case' 0 N--CA 1.435 -1.201 0 CA-C-N 115.185 -0.916 . . . . 0.87 111.457 -174.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 45.9 tttt -51.58 -60.06 3.57 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 119.057 0.844 . . . . 3.97 110.052 168.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 12.8 mt -62.59 -59.23 4.69 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 N-CA-C 108.761 -0.829 . . . . 0.83 108.761 -178.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -56.65 -53.78 53.69 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 122.743 0.417 . . . . 2.56 110.001 -167.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 4.9 t -62.44 -42.48 99.49 Favored 'General case' 0 N--CA 1.452 -0.354 0 CA-C-O 119.396 -0.335 . . . . 1.44 110.872 -179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.0 t -65.88 -50.74 63.43 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.902 0.774 . . . . 0.91 110.934 -177.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -67.83 -43.93 78.39 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.647 0.779 . . . . 2.22 111.033 -173.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 18.1 m -71.24 65.77 0.41 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 118.685 0.675 . . . . 2.84 111.457 176.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 69.6 mmtt -147.9 -51.78 0.19 Allowed 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 128.021 2.528 . . . . 7.92 108.182 178.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 24.8 p80 -66.11 114.62 5.38 Favored 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 108.845 -0.798 . . . . 2.13 108.845 177.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -48.95 -30.68 6.25 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 124.412 1.085 . . . . 7.02 113.582 -171.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -54.8 -33.13 55.63 Favored Glycine 0 CA--C 1.528 0.905 0 CA-C-O 119.088 -0.84 . . . . 0.85 113.208 177.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -78.76 124.17 36.74 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 N-CA-C 106.783 -1.562 . . . . 2.0 106.783 169.059 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -96.47 -20.26 18.54 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-O 119.153 -0.451 . . . . 2.45 110.153 171.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -155.44 158.35 38.45 Favored 'General case' 0 C--N 1.344 0.347 0 CA-C-N 119.085 0.857 . . . . 2.29 109.964 169.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -139.02 146.98 41.51 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 106.698 -1.593 . . . . 2.06 106.698 165.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -145.77 122.89 11.46 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 107.582 -1.266 . . . . 2.12 107.582 159.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.9 m -111.35 151.87 13.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 CA-C-N 119.158 0.89 . . . . 1.77 111.042 175.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.62 133.48 20.14 Favored 'General case' 0 C--N 1.338 0.075 0 C-N-CA 122.734 0.414 . . . . 0.7 111.713 178.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -69.46 -27.34 65.15 Favored 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 124.301 1.041 . . . . 2.14 111.402 178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.05 -39.33 1.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.742 1.617 . . . . 1.12 113.215 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.5 t -141.62 36.47 1.64 Allowed 'General case' 0 C--O 1.231 0.082 0 C-N-CA 122.754 0.422 . . . . 2.73 110.246 168.308 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 24.4 m120 33.9 56.71 0.59 Allowed 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 127.649 2.379 . . . . 1.64 110.418 -177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -110.78 153.15 25.74 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.16 0.984 . . . . 2.21 110.187 -172.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -132.11 113.16 13.0 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.73 1.212 . . . . 0.58 108.019 171.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.9 t-160 -92.44 97.93 11.15 Favored 'General case' 0 N--CA 1.43 -1.459 0 N-CA-C 102.384 -3.191 . . . . 2.13 102.384 175.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -94.74 141.16 15.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.597 0 N-CA-C 106.071 -1.825 . . . . 1.18 106.071 174.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.49 ' HB3' ' HZ2' ' A' ' 47' ' ' LYS . 2.8 mtmp? -122.38 114.27 20.52 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 108.257 -1.016 . . . . 3.28 108.257 167.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 9.3 p90 -126.29 152.51 46.07 Favored 'General case' 0 N--CA 1.451 -0.385 0 O-C-N 123.958 0.786 . . . . 2.1 111.778 -179.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -78.56 113.77 37.5 Favored Pre-proline 0 CA--C 1.535 0.377 0 N-CA-C 108.659 -0.867 . . . . 2.83 108.659 173.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -78.76 65.32 8.74 Favored 'Trans proline' 0 N--CA 1.458 -0.56 0 C-N-CA 123.635 2.89 . . . . 1.35 110.267 -170.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -138.39 -72.47 0.41 Allowed 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.845 1.258 . . . . 3.2 108.706 -170.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . 0.582 ' H ' HD13 ' A' ' 52' ' ' ILE . 0.2 OUTLIER -88.26 -36.53 9.36 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 C-N-CA 124.043 0.937 . . . . 2.41 111.721 179.82 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.9 tp -104.02 153.32 6.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 C-N-CA 125.669 1.587 . . . . 0.96 107.963 -179.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.47 173.56 23.82 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 110.236 -1.146 . . . . 0.6 110.236 -179.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -63.63 -38.19 42.43 Favored 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 123.147 2.565 . . . . 0.71 110.327 -175.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -57.43 -42.16 81.84 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 122.518 0.327 . . . . 5.71 111.214 177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -62.15 -59.15 5.47 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 108.576 -0.898 . . . . 4.02 108.576 178.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 23.2 mm -42.9 -51.2 1.05 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.096 0 C-N-CA 123.419 0.688 . . . . 1.81 110.651 177.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 31.4 mt -54.2 -59.6 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.621 0 CA-C-O 118.661 -0.685 . . . . 0.57 110.672 178.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -62.98 -35.95 81.9 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 119.487 1.04 . . . . 5.55 111.9 -176.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.3 m -68.02 -39.21 83.19 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 124.6 1.16 . . . . 1.46 109.681 -175.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 95.9 mt -70.28 -46.02 73.23 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 O-C-N 121.644 -0.66 . . . . 1.25 110.677 170.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -50.13 -43.24 51.81 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.644 0.656 . . . . 4.93 110.905 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.1 m -51.12 -28.83 11.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 113.449 0.907 . . . . 1.68 113.449 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 22.6 mt -87.06 -12.18 48.02 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.377 1.071 . . . . 1.07 112.248 179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 89.82 48.94 3.5 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.871 1.224 . . . . 0.75 112.31 174.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -139.45 153.71 47.62 Favored 'General case' 0 C--O 1.227 -0.094 0 N-CA-C 106.97 -1.492 . . . . 2.01 106.97 170.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -98.79 101.43 12.03 Favored Pre-proline 0 CA--C 1.538 0.5 0 CA-C-O 118.434 -0.793 . . . . 2.88 110.478 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -80.17 93.51 1.05 Allowed 'Trans proline' 0 N--CA 1.457 -0.658 0 C-N-CA 122.714 2.276 . . . . 0.9 111.642 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.2 m -78.45 116.86 19.14 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.574 -0.898 . . . . 1.47 108.574 167.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -71.6 60.67 0.34 Allowed 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.462 1.105 . . . . 2.61 111.73 176.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 26.7 t -64.7 -60.7 2.34 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.066 0 O-C-N 121.775 -0.578 . . . . 2.32 110.197 -175.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 1.8 ttpm? 65.98 147.07 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.033 1.333 . . . . 4.83 111.307 -171.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.5 pp -63.25 153.99 6.51 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 O-C-N 121.182 -0.949 . . . . 6.68 109.041 167.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 7.0 tt0 . . . . . 0 C--O 1.249 1.044 0 N-CA-C 104.493 -2.41 . . . . 8.62 104.493 173.108 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' N ' ' OE1' ' A' ' 51' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.472 0.668 0 N-CA-C 109.031 -0.729 . . . . 8.43 109.031 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 131.0 178.65 15.57 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 108.118 -1.993 . . . . 2.98 108.118 -170.571 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -80.84 -123.28 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 118.064 0.932 . . . . 2.91 110.281 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 129.74 -153.68 20.1 Favored Glycine 0 CA--C 1.521 0.443 0 N-CA-C 106.532 -2.627 . . . . 2.46 106.532 -168.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -155.75 147.35 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 107.127 -1.434 . . . . 2.6 107.127 172.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.2 mp -131.49 141.53 49.78 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 107.14 -1.43 . . . . 3.2 107.14 166.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -103.37 145.41 30.01 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.446 1.098 . . . . 3.02 109.704 177.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -136.21 119.76 17.06 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.39 1.476 . . . . 1.8 107.318 178.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.5 t -77.65 118.94 25.39 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 N-CA-C 103.798 -2.667 . . . . 1.43 103.798 171.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.458 HG13 ' SD ' ' A' ' 13' ' ' MET . 2.5 p -124.81 87.18 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 C-N-CA 124.679 1.192 . . . . 2.65 108.528 -167.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.5 ptt180 -79.44 152.36 30.34 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 115.458 -0.792 . . . . 5.37 109.306 -178.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.77 -28.85 6.85 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 124.319 0.961 . . . . 0.85 111.073 -175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.458 ' SD ' HG13 ' A' ' 10' ' ' VAL . 30.1 mtp -66.06 110.13 2.83 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 117.84 0.82 . . . . 1.67 110.12 179.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 12.8 t -90.8 -43.06 10.3 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.253 1.021 . . . . 2.85 111.677 178.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.3 p -141.56 174.6 10.4 Favored 'General case' 0 C--N 1.342 0.262 0 CA-C-N 118.874 0.761 . . . . 1.31 111.963 -167.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.25 -35.76 12.63 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.994 1.318 . . . . 0.98 112.072 178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.7 t -60.48 -37.5 81.24 Favored 'General case' 0 N--CA 1.449 -0.5 0 O-C-N 121.61 -0.681 . . . . 2.51 111.344 179.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 78.8 m -63.76 -37.92 89.16 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.633 -0.667 . . . . 0.83 110.571 179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 14.8 t -58.58 -60.94 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 108.405 -0.961 . . . . 0.8 108.405 175.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.306 0.9 OUTLIER -60.06 -35.88 76.1 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 120.752 -0.379 . . . . 0.83 111.589 -175.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -61.11 -46.93 88.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 125.901 1.68 . . . . 3.78 109.848 177.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.1 mt -58.95 -65.92 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.165 0 N-CA-C 109.651 -0.5 . . . . 0.85 109.651 175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -61.86 -50.61 71.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 120.608 -0.437 . . . . 2.72 111.146 -168.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 18.0 m -56.55 -43.52 79.99 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 110.376 -0.231 . . . . 2.26 110.376 -179.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.2 t -70.63 -38.99 73.94 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 118.802 -1.159 . . . . 1.13 111.226 -179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 56.2 mt -56.98 -48.94 77.22 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 119.186 0.903 . . . . 2.3 110.066 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 19.6 p -62.63 80.47 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.909 0.884 . . . . 2.05 111.631 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 pttm 176.7 -34.57 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 129.193 2.997 . . . . 3.84 109.944 172.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -69.13 141.93 54.51 Favored 'General case' 0 C--N 1.343 0.311 0 C-N-CA 119.199 -1.0 . . . . 2.18 109.037 179.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -62.13 145.14 54.19 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 108.552 -0.907 . . . . 6.14 108.552 175.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 111.05 -53.77 0.57 Allowed Glycine 0 CA--C 1.521 0.407 0 CA-C-O 119.316 -0.713 . . . . 1.26 111.528 -178.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.74 112.25 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 118.66 1.23 . . . . 2.19 112.312 -166.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 pp -94.1 -30.79 14.48 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.232 1.013 . . . . 2.83 111.2 178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -153.93 147.25 24.84 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-N 119.509 1.049 . . . . 2.85 109.427 173.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.2 t -117.87 140.41 49.74 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 107.176 -1.416 . . . . 2.25 107.176 172.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.5 t -128.52 59.58 1.53 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 124.234 1.014 . . . . 3.53 108.664 177.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 4.0 p -76.86 133.85 30.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 123.553 0.741 . . . . 1.58 110.844 176.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.34 137.88 37.78 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.946 0.898 . . . . 0.85 112.408 177.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 23.8 mt -65.96 -35.02 79.46 Favored 'General case' 0 C--O 1.226 -0.157 0 C-N-CA 125.005 1.322 . . . . 2.71 110.072 170.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -37.25 -39.69 0.29 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 126.531 1.932 . . . . 1.63 113.831 -173.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 9.5 t -143.29 34.96 1.33 Allowed 'General case' 0 N--CA 1.457 -0.108 0 C-N-CA 122.393 0.277 . . . . 2.91 111.059 172.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 13.7 m120 41.66 61.82 1.75 Allowed 'General case' 0 CA--C 1.523 -0.077 0 C-N-CA 126.092 1.757 . . . . 1.82 110.068 -179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.13 140.53 18.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.329 -0.619 . . . . 2.29 109.329 -166.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.45 154.92 28.41 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 123.202 0.601 . . . . 1.18 110.03 166.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -108.28 141.33 40.22 Favored 'General case' 0 N--CA 1.442 -0.871 0 N-CA-C 104.91 -2.256 . . . . 2.03 104.91 150.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 97.1 mt -120.59 134.49 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 N-CA-C 106.965 -1.494 . . . . 1.37 106.965 175.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.2 mtpt -102.83 85.48 2.56 Favored 'General case' 0 N--CA 1.436 -1.131 0 N-CA-C 105.508 -2.034 . . . . 3.16 105.508 175.7 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 32.9 p90 -114.01 146.36 40.27 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.934 1.294 . . . . 2.41 110.799 172.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -59.64 107.32 0.96 Allowed Pre-proline 0 CA--C 1.537 0.46 0 O-C-N 124.283 0.99 . . . . 2.51 108.792 176.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -82.44 45.57 1.96 Allowed 'Trans proline' 0 N--CA 1.458 -0.586 0 C-N-CA 123.319 2.679 . . . . 1.73 110.974 -169.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.4 ' OE1' ' N ' ' A' ' 1' ' ' MET . 24.5 mt-10 -139.31 -60.29 0.57 Allowed 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.533 1.133 . . . . 4.23 108.965 -170.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 33.4 pt -74.9 -25.87 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.083 0 N-CA-C 112.34 0.496 . . . . 2.27 112.34 179.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 12.2 tt -143.0 154.78 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.085 -1.079 . . . . 1.67 108.085 -178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.08 -176.76 17.05 Favored Glycine 0 CA--C 1.527 0.794 0 N-CA-C 111.626 -0.589 . . . . 0.66 111.626 -172.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -67.11 -32.72 33.6 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.371 2.047 . . . . 0.77 110.174 173.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.6 mtt85 -53.65 -51.7 62.32 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.131 0.572 . . . . 6.26 110.95 178.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -56.81 -50.3 72.79 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 121.095 0.474 . . . . 2.31 109.745 -176.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 71.0 mt -54.61 -51.94 45.81 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.08 0 C-N-CA 123.441 0.696 . . . . 1.2 109.893 175.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.4 mt -51.74 -53.04 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 109.133 -0.691 . . . . 0.61 109.133 -178.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 15.3 m-70 -66.3 -34.89 79.0 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 122.914 0.485 . . . . 2.66 110.785 -176.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -60.77 -48.52 81.42 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.715 -0.476 . . . . 0.74 109.715 174.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 94.0 mt -70.89 -35.69 60.93 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 O-C-N 121.365 -0.834 . . . . 0.99 111.366 -178.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -54.44 -49.45 69.97 Favored 'General case' 0 CA--C 1.531 0.213 0 O-C-N 121.557 -0.714 . . . . 2.62 109.21 167.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 t -58.12 -43.07 87.01 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 122.651 0.38 . . . . 2.12 111.143 176.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.2 mt -58.18 -37.64 75.15 Favored 'General case' 0 C--O 1.233 0.205 0 O-C-N 121.506 -0.746 . . . . 1.17 111.64 172.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 106.67 38.42 2.22 Favored Glycine 0 CA--C 1.526 0.731 0 C-N-CA 124.628 1.109 . . . . 0.83 111.726 176.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -129.28 163.45 25.65 Favored 'General case' 0 CA--C 1.528 0.099 0 N-CA-C 107.702 -1.222 . . . . 2.1 107.702 168.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -109.93 98.72 35.58 Favored Pre-proline 0 CA--C 1.534 0.359 0 C-N-CA 123.183 0.593 . . . . 2.83 110.118 -174.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -79.52 148.31 20.55 Favored 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 123.779 2.986 . . . . 1.63 110.168 176.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.1 m -153.71 118.03 4.87 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.457 1.103 . . . . 2.29 108.404 176.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -77.22 59.94 1.86 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.767 0.827 . . . . 2.29 111.538 -176.417 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.6 t -118.82 60.95 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 107.608 -1.256 . . . . 4.33 107.608 -178.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.6 tptt -160.79 142.98 12.55 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 107.939 -1.134 . . . . 8.25 107.939 175.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.5 tt -150.1 162.58 3.89 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 N-CA-C 105.068 -2.197 . . . . 6.75 105.068 164.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 . . . . . 0 C--O 1.249 1.072 0 C-N-CA 126.609 1.964 . . . . 11.37 111.42 169.94 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.467 0.423 0 N-CA-C 107.882 -1.155 . . . . 7.88 107.882 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.19 157.31 6.06 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 110.427 -1.069 . . . . 2.51 110.427 -170.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 10.5 p-10 -75.27 132.81 41.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.108 -0.701 . . . . 3.28 109.108 175.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -61.11 149.91 44.39 Favored Glycine 0 CA--C 1.529 0.953 0 N-CA-C 110.914 -0.874 . . . . 1.81 110.914 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 48.5 t -136.48 87.79 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 105.808 -1.923 . . . . 3.14 105.808 172.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 mp -131.25 145.09 51.76 Favored 'General case' 0 N--CA 1.454 -0.241 0 N-CA-C 108.816 -0.809 . . . . 3.18 108.816 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -123.92 139.13 54.26 Favored 'General case' 0 N--CA 1.442 -0.83 0 N-CA-C 106.949 -1.5 . . . . 2.21 106.949 174.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -133.34 152.57 51.93 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 107.905 -1.146 . . . . 2.59 107.905 164.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.7 t -93.92 101.66 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.792 -1.929 . . . . 1.14 105.792 -173.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.2 m -79.38 65.86 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 126.076 1.75 . . . . 0.8 108.581 -174.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -75.39 125.86 29.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 118.95 -1.1 . . . . 4.92 108.579 -162.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 142.51 -44.69 0.96 Allowed Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.217 0.913 . . . . 0.89 110.888 -177.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -64.16 152.15 41.44 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 123.408 0.683 . . . . 1.66 111.508 -178.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.9 t -140.65 -34.97 0.5 Allowed 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.983 0.734 . . . . 2.08 112.983 -167.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.6 p -145.97 175.14 10.67 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 119.305 0.957 . . . . 1.32 111.683 -166.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.52 -47.89 3.82 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 126.0 1.72 . . . . 0.82 112.032 178.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.9 m -57.14 -40.29 76.88 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 123.331 0.652 . . . . 1.68 111.818 179.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.7 m -72.14 -53.11 13.7 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-N 118.619 0.645 . . . . 0.78 110.523 173.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 24.2 t -44.1 -55.77 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 125.482 1.513 . . . . 0.62 109.275 -176.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -21.63 63.4 Favored 'General case' 0 N--CA 1.438 -1.066 0 C-N-CA 120.175 -0.61 . . . . 1.35 112.26 -173.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.01 -47.97 59.98 Favored 'General case' 0 CA--C 1.514 -0.405 0 N-CA-C 106.933 -1.506 . . . . 5.75 106.933 173.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mt -56.33 -53.38 40.64 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 CA-C-O 118.788 -0.625 . . . . 0.9 110.101 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 58.8 mm-40 -57.25 -61.58 2.37 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.841 0.746 . . . . 3.42 111.473 179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 57.0 m -55.44 -41.75 73.26 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 121.771 -0.581 . . . . 1.58 111.579 -176.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 13.0 t -65.45 -48.61 72.13 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 109.818 -0.438 . . . . 1.65 109.818 179.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 52.8 mt -54.04 -46.04 71.79 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.355 -0.841 . . . . 3.13 110.074 176.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 24.6 p -61.28 -14.16 24.43 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.695 0.998 . . . . 2.04 113.695 179.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.1 -26.36 68.79 Favored 'General case' 0 C--N 1.347 0.469 0 CA-C-N 120.166 1.348 . . . . 5.66 111.275 173.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -77.86 100.17 6.24 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 109.317 -0.623 . . . . 2.87 109.317 178.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -61.23 82.87 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.871 -1.159 . . . . 5.91 107.871 163.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 158.82 -26.95 0.39 Allowed Glycine 0 CA--C 1.529 0.947 0 C-N-CA 124.231 0.92 . . . . 1.33 110.932 -166.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.409 ' CG1' HG23 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -74.67 120.03 23.29 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 N-CA-C 105.773 -1.936 . . . . 2.07 105.773 165.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.9 mt -79.91 -47.48 14.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 107.708 -1.219 . . . . 2.5 107.708 176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -156.09 124.2 5.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.898 -0.408 . . . . 3.15 109.898 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 6.2 p -97.61 151.82 19.69 Favored 'General case' 0 CA--C 1.52 -0.181 0 C-N-CA 124.088 0.955 . . . . 2.7 108.719 168.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.5 m -152.56 102.48 2.73 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.794 -0.817 . . . . 2.1 108.794 159.467 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -81.16 148.16 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.966 0 C-N-CA 124.102 0.961 . . . . 1.87 110.946 167.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -146.65 131.95 18.5 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 123.385 0.674 . . . . 0.86 109.635 171.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.46 -32.63 54.55 Favored 'General case' 0 N--CA 1.455 -0.204 0 CA-C-N 115.038 -0.983 . . . . 2.05 112.939 -167.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.95 -49.41 40.53 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.093 0.957 . . . . 1.35 111.783 -176.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.1 p -101.77 6.48 41.72 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.897 0.879 . . . . 2.18 111.326 176.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.02 42.72 21.32 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.3 1.44 . . . . 3.22 110.362 -174.047 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -98.81 149.12 23.21 Favored 'General case' 0 C--N 1.344 0.326 0 O-C-N 121.371 -0.83 . . . . 1.73 110.159 -177.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.8 117.93 30.22 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 108.014 -1.106 . . . . 0.78 108.014 155.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -83.4 119.94 25.27 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 105.122 -2.177 . . . . 3.97 105.122 164.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.409 HG23 ' CG1' ' A' ' 32' ' ' ILE . 2.0 mp -113.68 118.22 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 N-CA-C 106.098 -1.815 . . . . 1.27 106.098 174.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.6 mtpm? -103.75 97.7 7.67 Favored 'General case' 0 N--CA 1.442 -0.84 0 N-CA-C 106.258 -1.756 . . . . 3.21 106.258 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 46.4 p90 -112.11 169.94 8.51 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.185 1.394 . . . . 2.24 111.339 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.4 p-10 -76.56 115.2 45.59 Favored Pre-proline 0 CA--C 1.537 0.458 0 N-CA-C 109.112 -0.699 . . . . 4.47 109.112 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -78.62 49.43 3.08 Favored 'Trans proline' 0 N--CA 1.454 -0.852 0 CA-C-N 120.748 1.303 . . . . 1.43 111.148 178.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.7 -63.52 1.02 Allowed 'General case' 0 C--N 1.343 0.321 0 C-N-CA 124.58 1.152 . . . . 3.81 110.052 170.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.3 pp -75.92 -32.32 23.42 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 CA-C-N 118.631 0.65 . . . . 1.94 112.689 -168.721 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 13.9 tt -128.37 157.66 40.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 124.608 1.163 . . . . 1.18 110.806 -168.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -124.86 -173.87 13.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 111.471 -0.651 . . . . 0.64 111.471 -177.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -61.84 -39.47 51.82 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.82 2.347 . . . . 0.93 110.336 173.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 58.3 ttm-85 -51.15 -49.38 60.98 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.859 0.864 . . . . 5.64 112.198 -176.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.28 -47.49 84.09 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-O 121.956 0.884 . . . . 2.22 110.209 -171.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 28.7 mt -56.45 -54.06 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 CA-C-N 114.926 -1.034 . . . . 1.42 108.22 173.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.9 mt -54.08 -53.0 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.64 0 CA-C-N 116.376 -0.375 . . . . 0.6 110.146 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -64.23 -34.21 77.58 Favored 'General case' 0 N--CA 1.453 -0.285 0 O-C-N 122.279 -0.263 . . . . 2.73 110.627 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 51.1 m -58.58 -53.53 57.24 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 122.073 -0.392 . . . . 1.06 110.697 171.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 44.4 mm -66.01 -39.81 85.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 O-C-N 121.168 -0.957 . . . . 1.99 111.476 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -55.32 -46.03 76.31 Favored 'General case' 0 CA--C 1.532 0.267 0 O-C-N 121.874 -0.517 . . . . 2.75 109.772 171.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 21.3 t -59.6 -42.62 92.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 122.828 0.451 . . . . 2.01 111.262 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 87.7 mt -58.24 -43.38 87.77 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.726 0.694 . . . . 1.3 110.936 172.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.95 43.41 0.94 Allowed Glycine 0 CA--C 1.524 0.617 0 C-N-CA 124.059 0.837 . . . . 0.72 111.436 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.1 m-85 -130.92 157.58 42.56 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 105.608 -1.997 . . . . 2.01 105.608 166.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -102.11 108.01 55.06 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 119.37 0.986 . . . . 2.61 109.812 -175.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -81.75 83.28 2.15 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 124.068 3.178 . . . . 0.9 110.918 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 17.5 t -78.75 112.34 15.78 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.171 -0.677 . . . . 2.11 109.171 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.2 57.49 1.86 Allowed 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.679 0.792 . . . . 2.88 111.562 -178.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 10.1 p -88.66 -21.7 6.86 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 123.831 0.852 . . . . 3.24 110.482 173.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.6 mtpt 64.69 -177.21 0.17 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.552 1.141 . . . . 4.72 110.765 -177.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 7.9 tp -160.21 -43.53 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 124.107 0.963 . . . . 8.15 108.847 163.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.6 mt-10 . . . . . 0 C--O 1.252 1.185 0 C-N-CA 124.408 1.083 . . . . 9.17 109.775 176.198 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.47 0.568 0 N-CA-C 107.719 -1.215 . . . . 8.99 107.719 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -146.21 159.61 28.0 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 107.204 -2.358 . . . . 2.37 107.204 172.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -42.01 111.69 0.26 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.108 1.363 . . . . 3.9 114.432 -164.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -71.95 83.36 0.5 Allowed Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 107.168 -2.373 . . . . 2.56 107.168 159.372 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 32.9 m -77.82 125.09 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 107.993 -1.114 . . . . 2.61 107.993 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 52.7 tp -144.89 143.86 30.8 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.305 -1.368 . . . . 2.87 107.305 -179.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.4 mt-10 -117.14 123.98 48.05 Favored 'General case' 0 N--CA 1.45 -0.473 0 N-CA-C 108.508 -0.923 . . . . 2.75 108.508 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.424 HD21 HD13 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -125.16 133.95 52.59 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.023 -1.473 . . . . 1.43 107.023 177.382 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -83.11 105.84 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 N-CA-C 106.964 -1.495 . . . . 1.08 106.964 -178.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -82.84 81.86 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 C-N-CA 124.697 1.199 . . . . 0.78 108.077 -174.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.8 mtp-105 -76.45 142.84 40.87 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 107.752 -1.203 . . . . 4.33 107.752 -177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 117.77 -31.84 5.57 Favored Glycine 0 CA--C 1.527 0.802 0 N-CA-C 111.36 -0.696 . . . . 0.99 111.36 -176.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 16.6 ptm -60.5 159.35 10.57 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 118.181 0.991 . . . . 1.87 110.781 174.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 25.7 p -136.09 -65.64 0.57 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 123.757 0.823 . . . . 3.64 108.995 176.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 29.9 p -119.55 172.88 7.34 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.518 1.127 . . . . 1.24 111.579 -166.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.08 -41.2 7.5 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.958 1.303 . . . . 0.89 112.058 178.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.3 m -48.96 -46.9 44.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.354 1.062 . . . . 1.9 111.325 175.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.8 m -68.61 -47.95 65.37 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 122.612 0.365 . . . . 0.92 110.128 176.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 60.5 t -50.44 -58.61 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 108.769 -0.826 . . . . 1.02 108.769 -174.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -66.59 -28.66 68.68 Favored 'General case' 0 N--CA 1.437 -1.09 0 CA-C-N 115.606 -0.724 . . . . 1.0 111.687 -174.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -54.09 -52.71 60.1 Favored 'General case' 0 C--N 1.343 0.292 0 C-N-CA 124.231 1.012 . . . . 3.82 109.235 171.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 mt -61.52 -59.8 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.195 0 N-CA-C 108.462 -0.94 . . . . 0.78 108.462 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -51.19 -58.58 5.76 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 123.446 0.466 . . . . 2.64 110.744 -171.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 93.0 p -55.36 -50.56 69.36 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.617 0.246 . . . . 2.39 110.886 -179.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.6 t -70.92 -26.31 63.15 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 112.039 0.385 . . . . 0.98 112.039 -171.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -69.38 -49.65 53.38 Favored 'General case' 0 C--O 1.233 0.204 0 O-C-N 121.572 -0.705 . . . . 1.6 109.532 169.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 32.4 p -70.11 72.9 0.45 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.282 0.492 . . . . 1.78 111.835 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -164.58 -44.3 0.03 OUTLIER 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 124.972 1.309 . . . . 4.39 110.866 176.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -73.32 121.93 21.2 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 108.272 -1.011 . . . . 2.03 108.272 178.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -66.82 0.51 2.38 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 118.78 0.718 . . . . 8.9 112.603 -175.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.53 -41.27 99.53 Favored Glycine 0 CA--C 1.526 0.775 0 O-C-N 120.046 -1.659 . . . . 1.68 111.047 161.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -79.19 147.92 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 N-CA-C 107.901 -1.148 . . . . 1.76 107.901 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -119.35 -32.44 4.37 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 124.514 1.125 . . . . 2.18 110.404 171.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -155.27 138.58 15.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 107.813 -1.18 . . . . 2.01 107.813 169.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.4 t -128.5 147.59 50.69 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.017 -1.475 . . . . 2.09 107.017 170.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 48.2 t -147.91 147.58 29.88 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.886 -0.783 . . . . 2.08 108.886 156.842 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -109.0 151.03 11.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 C-N-CA 124.52 1.128 . . . . 2.18 111.13 176.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.8 133.36 31.99 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 123.027 0.531 . . . . 0.93 111.091 170.739 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 1.7 mp -64.75 -37.16 86.66 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.613 1.165 . . . . 2.94 110.475 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.27 -39.99 1.52 Allowed 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 126.164 1.786 . . . . 1.91 113.644 -174.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 14.1 t -139.96 38.13 1.96 Allowed 'General case' 0 C--O 1.225 -0.2 0 CA-C-O 121.907 0.86 . . . . 2.64 109.608 172.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 35.2 m120 35.99 46.78 0.38 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 127.955 2.502 . . . . 1.83 111.672 179.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.9 ptpt -102.65 146.09 28.7 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.679 -0.489 . . . . 2.15 109.679 -168.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.19 119.86 37.81 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 106.227 -1.768 . . . . 0.62 106.227 161.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -86.78 120.25 27.87 Favored 'General case' 0 N--CA 1.421 -1.9 0 N-CA-C 103.947 -2.612 . . . . 3.22 103.947 167.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.424 HD13 HD21 ' A' ' 8' ' ' LEU . 1.7 mp -112.5 128.91 68.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.517 0 N-CA-C 105.379 -2.082 . . . . 1.15 105.379 174.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -111.46 96.92 6.39 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 107.109 -1.441 . . . . 2.18 107.109 169.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.3 p90 -106.68 148.1 28.78 Favored 'General case' 0 C--O 1.224 -0.247 0 C-N-CA 123.708 0.803 . . . . 2.39 111.217 -177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -73.51 110.32 8.59 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.214 -1.402 . . . . 2.84 107.214 177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -82.12 67.28 8.19 Favored 'Trans proline' 0 N--CA 1.455 -0.756 0 C-N-CA 122.462 2.108 . . . . 1.59 111.909 -162.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -144.93 -83.72 0.14 Allowed 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.086 0.954 . . . . 3.5 110.54 178.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.3 pp -66.29 -47.46 84.22 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 122.098 -0.376 . . . . 2.35 110.825 -175.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.2 tp -86.2 154.16 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.342 0 N-CA-C 108.241 -1.022 . . . . 1.52 108.241 -179.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.03 168.5 23.67 Favored Glycine 0 CA--C 1.528 0.882 0 N-CA-C 110.657 -0.977 . . . . 0.78 110.657 173.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -54.9 -34.14 84.74 Favored 'Trans proline' 0 N--CA 1.457 -0.649 0 C-N-CA 123.551 2.834 . . . . 0.81 110.658 176.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 ptt180 -42.26 -51.35 4.8 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.3 1.04 . . . . 9.29 111.045 170.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -71.79 -48.42 46.71 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.393 -0.965 . . . . 2.56 108.393 -168.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 15.3 mm -47.46 -51.25 7.18 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 124.404 1.082 . . . . 1.92 109.516 172.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 40.8 mt -61.75 -52.99 54.17 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 CA-C-N 115.887 -0.597 . . . . 0.6 110.002 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -55.83 -42.35 75.58 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 122.052 0.93 . . . . 3.34 109.808 -179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 84.1 m -59.52 -58.58 7.96 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.218 -0.901 . . . . 0.74 108.999 179.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 86.8 mt -62.95 -38.54 82.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 O-C-N 121.39 -0.819 . . . . 1.18 111.693 -176.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -53.38 -51.54 62.21 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.309 -0.626 . . . . 2.84 109.309 170.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -57.14 -37.07 71.49 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 122.023 -0.423 . . . . 1.77 112.029 174.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 38.5 mt -67.98 -15.22 63.51 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 118.422 -0.799 . . . . 1.3 112.964 174.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.12 41.67 5.18 Favored Glycine 0 CA--C 1.525 0.705 0 C-N-CA 124.204 0.906 . . . . 0.93 112.196 173.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 37.2 m-85 -138.54 164.72 28.72 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.94 -1.133 . . . . 2.0 107.94 170.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -100.52 99.66 10.44 Favored Pre-proline 0 CA--C 1.541 0.615 0 C-N-CA 125.24 1.416 . . . . 2.64 109.956 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.71 80.4 2.05 Favored 'Trans proline' 0 N--CA 1.46 -0.486 0 C-N-CA 124.14 3.227 . . . . 1.02 110.269 -178.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.8 m -81.95 94.63 7.17 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 123.837 0.855 . . . . 2.34 109.328 -170.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.4 65.18 0.17 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.662 1.185 . . . . 2.64 112.794 -177.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 19.8 m -60.08 -36.14 65.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 O-C-N 121.094 -1.004 . . . . 3.29 111.842 -176.173 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? 66.92 97.96 0.05 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.948 1.299 . . . . 5.23 108.39 -169.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 2.2 pp -61.66 140.48 18.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 O-C-N 121.762 -0.586 . . . . 6.69 111.056 176.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 . . . . . 0 C--O 1.249 1.066 0 N-CA-C 104.429 -2.434 . . . . 9.01 104.429 177.7 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.2 mtt . . . . . 0 N--CA 1.473 0.718 0 N-CA-C 111.793 0.294 . . . . 12.1 111.793 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.11 81.66 1.6 Allowed Glycine 0 C--N 1.338 0.654 0 N-CA-C 106.039 -2.825 . . . . 4.05 106.039 -171.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -132.1 106.34 7.94 Favored 'General case' 0 N--CA 1.453 -0.278 0 N-CA-C 107.079 -1.452 . . . . 4.35 107.079 -154.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -57.8 143.84 42.09 Favored Glycine 0 CA--C 1.528 0.846 0 CA-C-N 117.842 0.292 . . . . 2.12 112.965 -172.835 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -148.81 112.98 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 125.116 1.366 . . . . 3.17 108.948 176.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mp -137.82 158.33 44.58 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.095 -1.076 . . . . 3.15 108.095 160.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 26.9 tt0 -137.86 132.91 33.23 Favored 'General case' 0 N--CA 1.446 -0.634 0 C-N-CA 124.221 1.008 . . . . 2.32 108.465 -169.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -141.79 139.46 32.77 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.438 1.095 . . . . 1.4 108.64 -169.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 45.8 t -85.57 100.42 8.67 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 107.737 -1.208 . . . . 1.0 107.737 179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 31.5 m -84.15 76.5 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 C-N-CA 125.608 1.563 . . . . 0.72 108.904 -179.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -76.29 141.14 41.72 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 119.11 -1.036 . . . . 4.82 108.351 -174.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.19 -43.05 1.35 Allowed Glycine 0 CA--C 1.526 0.75 0 N-CA-C 110.823 -0.911 . . . . 0.65 110.823 -176.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -64.98 149.69 49.36 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.967 0.884 . . . . 1.32 110.217 179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -139.97 -37.6 0.48 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 112.679 0.622 . . . . 2.16 112.679 -168.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 p -135.4 168.59 18.93 Favored 'General case' 0 C--N 1.34 0.166 0 CA-C-N 119.006 0.821 . . . . 1.21 110.965 -177.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.74 -38.45 15.43 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.939 1.296 . . . . 0.83 112.0 -178.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.2 m -45.84 -44.31 14.14 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.128 1.371 . . . . 1.79 112.218 173.454 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.4 m -71.68 -51.89 20.67 Favored 'General case' 0 N--CA 1.451 -0.385 0 C-N-CA 123.503 0.721 . . . . 0.73 110.745 175.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 87.7 t -46.6 -60.87 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.236 0 C-N-CA 125.205 1.402 . . . . 0.51 108.946 -173.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -67.29 -23.27 65.64 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.879 -1.055 . . . . 0.96 111.523 -175.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.1 mmtp -66.29 -53.26 38.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 108.059 -1.089 . . . . 4.02 108.059 174.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.2 mt -58.73 -55.92 19.98 Favored 'Isoleucine or valine' 0 C--N 1.339 0.149 0 N-CA-C 108.669 -0.863 . . . . 0.8 108.669 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -55.27 -57.68 10.81 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.226 0.467 . . . . 2.35 110.965 -175.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 25.3 t -56.12 -48.82 75.48 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 122.681 0.393 . . . . 1.6 110.564 -179.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.3 t -60.07 -57.1 14.29 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.933 -0.395 . . . . 0.9 109.933 -178.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -54.01 -40.16 66.74 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.078 0.551 . . . . 1.84 111.168 -177.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.2 m -49.3 -26.62 3.18 Favored 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 113.655 0.983 . . . . 2.31 113.655 177.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -62.55 -27.33 69.09 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 120.14 1.336 . . . . 4.38 112.505 176.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 29.6 m-70 -68.36 107.99 3.06 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 109.126 -0.694 . . . . 2.98 109.126 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 82.7 mtp180 -46.34 -36.93 6.8 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.756 0.823 . . . . 5.55 113.083 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.62 -11.87 84.89 Favored Glycine 0 CA--C 1.532 1.122 0 CA-C-O 119.197 -0.779 . . . . 0.75 113.772 -177.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -82.95 120.1 33.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 119.134 1.467 . . . . 1.93 108.977 173.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.8 pp -91.03 -31.45 16.29 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.856 -0.593 . . . . 2.52 110.97 174.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -157.74 130.87 7.6 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.727 1.149 . . . . 2.34 109.91 171.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 52.0 t -103.25 144.58 31.15 Favored 'General case' 0 CA--C 1.52 -0.176 0 N-CA-C 106.856 -1.535 . . . . 2.07 106.856 164.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 33.2 t -147.07 149.1 32.4 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 118.322 -1.351 . . . . 2.41 109.693 144.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -126.09 138.84 53.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 C-N-CA 123.727 0.811 . . . . 1.77 111.029 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -123.31 131.32 53.62 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 124.492 1.117 . . . . 0.7 111.972 -177.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 96.6 mt -68.78 -47.88 65.07 Favored 'General case' 0 C--O 1.225 -0.217 0 C-N-CA 126.105 1.762 . . . . 2.46 111.783 -173.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.97 -46.71 52.7 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 123.018 0.527 . . . . 1.44 110.862 -176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 m -79.7 -39.87 30.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.327 0.651 . . . . 2.55 109.25 177.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 79.55 43.12 0.06 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 127.466 2.306 . . . . 2.53 107.688 -168.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.2 139.25 53.49 Favored 'General case' 0 CA--C 1.517 -0.295 0 C-N-CA 123.067 0.547 . . . . 2.28 111.356 -165.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -111.6 125.36 53.85 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 125.776 1.63 . . . . 0.56 109.106 171.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -96.28 114.87 26.6 Favored 'General case' 0 N--CA 1.43 -1.436 0 N-CA-C 103.355 -2.832 . . . . 2.16 103.355 166.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 48.0 mt -119.43 106.98 20.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 N-CA-C 106.446 -1.687 . . . . 1.44 106.446 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.0 mtpt -82.34 71.27 9.4 Favored 'General case' 0 N--CA 1.439 -1.013 0 N-CA-C 107.077 -1.453 . . . . 2.4 107.077 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 43.9 p90 -95.22 130.1 42.09 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.942 -0.572 . . . . 3.12 109.994 178.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -76.76 116.04 53.34 Favored Pre-proline 0 C--N 1.329 -0.312 0 N-CA-C 108.22 -1.03 . . . . 3.6 108.22 -177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -80.38 54.96 5.46 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 123.424 2.75 . . . . 1.91 112.262 -163.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -125.34 -71.92 0.68 Allowed 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.783 1.233 . . . . 3.58 109.137 176.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -75.08 -34.6 32.33 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 O-C-N 122.282 -0.261 . . . . 2.0 111.188 -176.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.5 tp -116.36 137.47 50.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 C-N-CA 126.116 1.767 . . . . 1.11 108.347 -176.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.95 177.67 16.41 Favored Glycine 0 CA--C 1.53 1.01 0 C-N-CA 123.774 0.702 . . . . 0.64 111.617 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -57.67 -44.67 39.24 Favored 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.458 2.772 . . . . 0.78 110.679 176.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 47.8 ttt180 -58.81 -42.92 90.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 120.681 -0.408 . . . . 7.48 111.175 -177.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -58.81 -53.48 57.85 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-O 121.5 0.667 . . . . 2.5 109.661 -178.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.2 mm -52.14 -50.91 34.02 Favored 'Isoleucine or valine' 0 C--O 1.233 0.186 0 C-N-CA 124.158 0.983 . . . . 2.04 110.112 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.4 mt -57.61 -49.83 79.31 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.664 0 CA-C-N 116.285 -0.416 . . . . 0.56 110.05 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.408 ' HA ' ' HG3' ' A' ' 63' ' ' GLU . 2.3 m-70 -62.31 -39.32 92.63 Favored 'General case' 0 CA--C 1.521 -0.168 0 CA-C-O 121.939 0.876 . . . . 3.76 110.365 -178.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.0 m -56.47 -52.55 64.27 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.315 -0.624 . . . . 0.75 109.315 176.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 69.3 mt -72.31 -40.76 65.4 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 121.892 -0.505 . . . . 1.18 111.638 -171.682 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.408 ' HG3' ' HA ' ' A' ' 60' ' ' HIS . 3.1 pp20? -59.77 -48.6 81.03 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 118.273 0.488 . . . . 4.21 110.296 173.141 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 58.3 m -56.6 -40.73 75.8 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 111.877 0.325 . . . . 2.16 111.877 175.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 80.5 mt -62.69 -38.62 91.12 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.107 0.867 . . . . 1.2 111.566 173.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.93 36.33 0.89 Allowed Glycine 0 CA--C 1.525 0.666 0 C-N-CA 123.837 0.732 . . . . 0.68 112.451 172.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -130.23 157.73 41.68 Favored 'General case' 0 C--O 1.225 -0.212 0 N-CA-C 107.368 -1.345 . . . . 2.0 107.368 168.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -99.48 104.99 30.62 Favored Pre-proline 0 CA--C 1.538 0.485 0 CA-C-N 119.538 1.063 . . . . 2.66 110.297 -176.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -81.34 90.19 1.2 Allowed 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.934 3.089 . . . . 0.87 111.1 -178.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.9 t -78.95 111.48 15.18 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.153 -0.684 . . . . 2.16 109.153 176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.18 60.18 1.04 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.899 1.28 . . . . 3.05 111.52 -177.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 33.8 m -56.83 -43.97 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 O-C-N 121.795 -0.566 . . . . 3.06 111.984 -173.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 46.84 48.86 14.82 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.183 0.993 . . . . 5.81 111.261 176.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.47 155.44 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 O-C-N 121.864 -0.522 . . . . 6.3 110.955 177.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 . . . . . 0 C--O 1.25 1.095 0 N-CA-C 103.811 -2.663 . . . . 9.3 103.811 166.904 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.7 ttt . . . . . 0 N--CA 1.473 0.714 0 N-CA-C 105.014 -2.217 . . . . 6.43 105.014 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.14 -164.61 5.94 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 108.261 -1.936 . . . . 2.66 108.261 136.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.415 ' OD2' ' NZ ' ' A' ' 47' ' ' LYS . 34.0 t0 72.35 166.06 0.3 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.86 1.664 . . . . 4.56 111.164 -178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.2 75.73 0.08 OUTLIER Glycine 0 CA--C 1.521 0.45 0 N-CA-C 109.408 -1.477 . . . . 2.97 109.408 -172.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.3 m -78.92 59.39 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 C-N-CA 123.45 0.7 . . . . 2.7 112.196 -168.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.6 mp -82.68 129.4 34.95 Favored 'General case' 0 C--O 1.233 0.201 0 O-C-N 121.345 -0.847 . . . . 2.57 110.049 178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -92.94 105.46 17.57 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 124.741 1.217 . . . . 2.49 107.92 168.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.6 127.44 40.55 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.287 -1.375 . . . . 1.51 107.287 171.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 61.4 t -78.44 100.08 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.169 -1.789 . . . . 1.02 106.169 176.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 m -83.52 71.42 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 125.994 1.718 . . . . 0.64 107.995 -173.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.2 ptt-85 -74.82 136.92 41.6 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.035 -1.468 . . . . 5.35 107.035 -171.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 114.28 -42.53 1.91 Allowed Glycine 0 CA--C 1.528 0.892 0 N-CA-C 110.573 -1.011 . . . . 0.81 110.573 -167.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.51 130.65 39.99 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.374 1.087 . . . . 1.45 108.919 -174.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.7 t -123.57 -41.52 2.26 Favored 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.968 1.099 . . . . 2.26 113.968 -155.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.2 p -138.65 175.46 9.54 Favored 'General case' 0 C--N 1.34 0.196 0 CA-C-N 119.498 1.044 . . . . 1.19 111.85 -168.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.97 -40.3 10.19 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 125.19 1.396 . . . . 0.81 112.222 178.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.1 t -55.0 -50.15 69.72 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-O 121.339 0.59 . . . . 2.48 110.006 174.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.8 m -66.48 -40.28 89.22 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 120.894 -1.129 . . . . 0.71 109.93 -178.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 79.6 t -52.34 -61.58 0.75 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.177 0 N-CA-C 108.733 -0.84 . . . . 0.63 108.733 178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.284 1.0 OUTLIER -69.58 -30.39 68.15 Favored 'General case' 0 N--CA 1.439 -0.976 0 C-N-CA 119.999 -0.681 . . . . 1.02 112.137 -171.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -63.3 -47.1 83.72 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-N 118.804 0.729 . . . . 4.15 109.999 172.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 72.4 mt -56.81 -62.02 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 108.872 -0.788 . . . . 0.99 108.872 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -56.54 -52.87 63.12 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 110.225 -0.287 . . . . 2.45 110.225 -171.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.6 t -57.85 -55.25 37.31 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-O 120.658 0.266 . . . . 1.51 110.782 178.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.6 t -71.12 -32.76 69.41 Favored 'General case' 0 N--CA 1.452 -0.327 0 O-C-N 121.563 -0.711 . . . . 1.62 112.478 -169.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -70.94 -51.98 22.63 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.574 0.624 . . . . 1.92 109.66 172.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.2 m -70.59 70.49 0.45 Allowed 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.174 0.99 . . . . 2.83 110.978 -177.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 11.3 pttm -175.38 -35.08 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 127.88 2.472 . . . . 3.77 110.091 178.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.656 ' NE2' HD12 ' A' ' 32' ' ' ILE . 3.8 p80 -65.34 136.55 56.68 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.31 0.959 . . . . 1.89 109.828 178.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 24.1 mmt85 -51.45 138.7 21.36 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 109.702 -0.481 . . . . 6.1 109.702 176.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.37 -31.46 8.28 Favored Glycine 0 CA--C 1.527 0.806 0 CA-C-O 119.338 -0.701 . . . . 0.98 112.74 174.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.656 HD12 ' NE2' ' A' ' 29' ' ' HIS . 0.2 OUTLIER -78.21 136.86 23.18 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 N-CA-C 107.488 -1.301 . . . . 2.42 107.488 167.712 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.3 pp -103.42 -35.76 8.25 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.475 0.71 . . . . 2.45 110.396 175.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -157.35 163.66 38.4 Favored 'General case' 0 C--N 1.34 0.185 0 N-CA-C 108.179 -1.045 . . . . 2.42 108.179 177.064 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 34.1 m -139.62 163.6 32.13 Favored 'General case' 0 CA--C 1.514 -0.426 0 N-CA-C 107.516 -1.29 . . . . 2.63 107.516 161.272 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 41.2 t -148.17 145.43 28.31 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 119.679 -0.808 . . . . 2.35 108.823 142.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -114.59 137.59 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.426 0 C-N-CA 124.12 0.968 . . . . 1.94 111.277 175.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.41 134.33 55.1 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 124.158 0.983 . . . . 0.76 110.702 178.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 89.9 mt -63.19 -41.57 99.21 Favored 'General case' 0 C--O 1.226 -0.15 0 C-N-CA 125.154 1.382 . . . . 2.0 111.1 179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.82 -37.87 20.54 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 125.032 1.333 . . . . 1.33 113.261 -166.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.2 p -130.16 24.56 5.23 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.231 1.012 . . . . 2.7 110.535 177.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.1 m120 35.68 48.28 0.45 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 127.329 2.252 . . . . 1.75 111.769 -174.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.5 ptpt -106.68 135.14 48.73 Favored 'General case' 0 CA--C 1.517 -0.306 0 N-CA-C 109.53 -0.545 . . . . 1.95 109.53 -173.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.45 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -110.48 114.81 28.53 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.39 -1.337 . . . . 0.67 107.39 168.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -89.95 105.0 17.51 Favored 'General case' 0 N--CA 1.429 -1.476 0 N-CA-C 104.014 -2.588 . . . . 2.16 104.014 171.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.45 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.5 mp -97.55 137.03 26.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.265 0 N-CA-C 106.317 -1.734 . . . . 1.34 106.317 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' NZ ' ' OD2' ' A' ' 3' ' ' ASP . 7.2 mtpm? -118.05 126.77 52.93 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.394 -1.336 . . . . 2.76 107.394 177.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 30.3 p90 -153.56 154.61 34.6 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.095 0.558 . . . . 2.6 110.572 -165.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -69.69 144.96 94.43 Favored Pre-proline 0 CA--C 1.535 0.382 0 N-CA-C 108.939 -0.763 . . . . 4.98 108.939 170.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -93.35 24.79 0.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 123.259 2.639 . . . . 1.44 111.432 175.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -113.02 -58.66 2.13 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.847 0.859 . . . . 3.55 109.969 -164.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 14.2 pt -95.42 -50.15 11.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 123.528 0.731 . . . . 2.14 110.295 176.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.8 tp -91.27 151.68 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.333 0 N-CA-C 108.151 -1.055 . . . . 1.19 108.151 -173.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -135.56 169.07 23.62 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 110.643 -0.983 . . . . 0.6 110.643 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -50.09 -42.48 45.95 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.585 2.856 . . . . 0.79 110.73 177.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -38.0 -51.06 1.36 Allowed 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.373 1.469 . . . . 9.35 111.925 173.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 46.2 m-20 -71.67 -49.78 36.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.587 -0.894 . . . . 2.4 108.587 -166.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 47.2 mt -53.58 -47.31 60.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 114.884 -1.053 . . . . 1.45 108.374 175.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 45.0 mt -58.17 -53.24 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 N-CA-C 109.746 -0.465 . . . . 0.66 109.746 -178.632 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 22.9 m170 -56.72 -41.34 77.27 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 121.64 0.733 . . . . 3.33 109.442 -179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 98.4 m -61.42 -54.35 44.68 Favored 'General case' 0 CA--C 1.537 0.46 0 CA-C-N 115.823 -0.626 . . . . 0.67 110.583 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 mm -63.02 -41.6 93.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 O-C-N 121.367 -0.833 . . . . 1.65 110.501 -178.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -55.56 -46.47 77.18 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.684 0.393 . . . . 3.31 109.992 172.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.1 t -61.43 -39.27 90.18 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.287 -0.387 . . . . 1.55 111.586 176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 69.4 mt -64.47 -35.67 81.68 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.835 0.743 . . . . 1.02 110.848 173.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.78 40.54 0.99 Allowed Glycine 0 CA--C 1.526 0.729 0 C-N-CA 124.051 0.834 . . . . 0.81 112.409 170.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -131.94 162.02 31.69 Favored 'General case' 0 CA--C 1.528 0.101 0 N-CA-C 107.131 -1.433 . . . . 1.83 107.131 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.4 mt-10 -99.48 109.1 53.84 Favored Pre-proline 0 CA--C 1.541 0.597 0 CA-C-N 119.001 0.819 . . . . 2.79 109.363 -179.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -82.05 88.34 1.32 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 123.753 2.969 . . . . 1.0 110.54 -176.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.15 96.78 5.96 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 107.866 -1.161 . . . . 1.88 107.866 -178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 pp -59.98 107.34 0.61 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.195 0.907 . . . . 2.34 110.481 176.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 78.2 t -114.33 -68.08 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 109.231 -0.655 . . . . 2.64 109.231 178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.08 61.08 2.89 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 108.251 -1.018 . . . . 4.68 108.251 -173.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.406 ' N ' HD12 ' A' ' 74' ' ' ILE . 2.7 mp 63.06 -73.62 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.556 0 C-N-CA 126.013 1.725 . . . . 6.54 110.781 -171.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 . . . . . 0 C--O 1.253 1.262 0 N-CA-C 102.791 -3.04 . . . . 10.12 102.791 168.877 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 13.0 mmt . . . . . 0 N--CA 1.471 0.616 0 CA-C-O 119.083 -0.484 . . . . 6.17 112.279 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.15 63.63 2.91 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 110.927 -0.869 . . . . 4.11 110.927 -176.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 39.5 t0 -160.35 170.05 21.84 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 126.011 1.724 . . . . 3.74 106.737 176.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 104.05 -175.27 22.94 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 125.101 1.334 . . . . 2.78 111.252 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.7 p -155.76 148.03 12.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.386 0 N-CA-C 108.662 -0.866 . . . . 3.5 108.662 177.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.1 mt -125.86 156.68 39.24 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.849 -1.167 . . . . 3.55 107.849 165.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -126.79 139.15 53.33 Favored 'General case' 0 N--CA 1.446 -0.645 0 C-N-CA 124.335 1.054 . . . . 2.93 109.76 -175.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.41 143.43 31.62 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.369 1.068 . . . . 1.46 108.189 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.07 123.08 35.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 105.962 -1.866 . . . . 1.08 105.962 176.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.5 m -106.59 74.81 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 N-CA-C 106.656 -1.609 . . . . 0.72 106.656 -176.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 10.4 ptt85 -76.1 129.59 37.03 Favored 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 107.305 -1.368 . . . . 5.02 107.305 -170.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 133.85 -48.54 0.95 Allowed Glycine 0 CA--C 1.53 0.969 0 N-CA-C 110.427 -1.069 . . . . 0.79 110.427 -165.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 19.3 ptt? -73.57 144.78 45.91 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 118.847 1.323 . . . . 1.47 111.287 -174.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -148.16 -1.6 0.55 Allowed 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 114.775 1.398 . . . . 2.33 114.775 -177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.62 168.51 25.88 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 120.554 1.525 . . . . 1.25 110.165 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.91 -42.71 13.09 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.517 1.527 . . . . 1.0 112.259 -176.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.3 m -43.52 -51.08 6.95 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.681 1.193 . . . . 1.66 111.401 172.242 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 61.1 m -71.06 -41.6 70.51 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 122.993 0.517 . . . . 0.79 111.83 179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 78.3 t -50.79 -59.0 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 108.232 -1.025 . . . . 0.82 108.232 -177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -68.36 -30.34 69.26 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.139 -0.937 . . . . 1.13 111.155 -176.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.6 ttmt -53.61 -43.54 68.74 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-N 119.271 0.941 . . . . 4.86 110.313 170.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 28.1 mt -71.82 -80.42 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 CA-C-N 118.751 0.705 . . . . 0.75 109.606 169.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -62.4 -43.69 98.23 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 121.709 -0.619 . . . . 2.21 112.542 -153.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.2 m -63.08 -28.74 70.29 Favored 'General case' 0 CA--C 1.536 0.439 0 N-CA-C 112.543 0.571 . . . . 2.93 112.543 174.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 21.0 t -71.79 -53.19 14.13 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 119.376 0.989 . . . . 1.1 110.399 169.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -52.04 -46.39 65.03 Favored 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 124.152 0.981 . . . . 1.8 111.278 -176.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 21.3 p -67.13 64.01 0.06 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.142 1.377 . . . . 1.65 112.114 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.9 mttp -160.05 -50.02 0.05 Allowed 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 128.406 2.682 . . . . 6.47 108.929 -175.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -68.02 138.54 55.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 120.151 -0.619 . . . . 2.32 109.789 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -56.66 149.41 17.82 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-O 121.035 0.445 . . . . 6.12 109.813 175.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.07 -24.38 16.2 Favored Glycine 0 N--CA 1.448 -0.525 0 CA-C-O 118.339 -1.256 . . . . 0.79 112.764 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.532 HD11 HG23 ' A' ' 46' ' ' ILE . 0.4 OUTLIER -76.95 120.46 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 CA-C-N 120.128 1.964 . . . . 1.75 108.221 171.943 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 58.8 mt -81.78 -52.99 6.57 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.193 -1.04 . . . . 2.14 108.193 170.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 38.7 t80 -157.84 147.61 20.13 Favored 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 108.586 -0.894 . . . . 3.57 108.586 172.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.3 t -117.97 144.67 45.31 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 105.751 -1.944 . . . . 2.24 105.751 170.213 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 28.4 t -147.21 151.03 36.04 Favored 'General case' 0 CA--C 1.512 -0.485 0 C-N-CA 118.159 -1.416 . . . . 2.74 110.441 153.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.487 HG12 ' CB ' ' A' ' 44' ' ' ALA . 3.5 m -131.8 133.19 61.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 O-C-N 124.532 1.145 . . . . 1.76 110.509 -171.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.47 132.34 55.77 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 112.695 0.628 . . . . 0.83 112.695 -178.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.505 HD22 ' H ' ' A' ' 39' ' ' LEU . 2.0 mm? -65.56 -45.05 84.85 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.232 1.413 . . . . 3.51 111.606 -174.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.04 -30.08 23.99 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.712 0.805 . . . . 1.41 112.932 -174.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.8 t -114.36 2.13 14.63 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.495 1.518 . . . . 2.46 111.705 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 17.3 m120 41.16 43.59 1.97 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 127.465 2.306 . . . . 2.06 110.881 -172.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.57 140.3 49.42 Favored 'General case' 0 CA--C 1.519 -0.226 0 C-N-CA 122.691 0.396 . . . . 1.74 111.34 -166.334 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.487 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -109.41 139.52 44.27 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 126.179 1.792 . . . . 0.97 108.929 178.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -104.38 137.43 42.27 Favored 'General case' 0 N--CA 1.445 -0.713 0 N-CA-C 105.726 -1.953 . . . . 3.64 105.726 156.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.532 HG23 HD11 ' A' ' 32' ' ' ILE . 4.2 mp -125.8 112.88 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 N-CA-C 106.445 -1.687 . . . . 1.35 106.445 174.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 45.8 mttt -83.7 68.27 9.8 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 107.373 -1.343 . . . . 2.91 107.373 176.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 51.0 p90 -90.83 140.03 30.19 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.226 -0.443 . . . . 2.87 110.705 177.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 97.8 m-20 -59.2 106.5 0.73 Allowed Pre-proline 0 CA--C 1.534 0.344 0 C-N-CA 125.19 1.396 . . . . 2.54 108.591 174.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -81.5 61.31 7.99 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.299 2.666 . . . . 2.3 110.421 -166.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.7 pt-20 -163.98 -60.47 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.01 0.924 . . . . 4.41 109.805 -169.227 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 31.0 pt -82.94 -26.88 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.33 0 C-N-CA 122.768 0.427 . . . . 2.62 111.991 178.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 3.0 tp -131.12 140.26 49.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.271 0 N-CA-C 106.261 -1.755 . . . . 1.27 106.261 178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -118.32 176.34 16.08 Favored Glycine 0 CA--C 1.529 0.958 0 CA-C-O 121.781 0.656 . . . . 0.89 112.156 -173.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -60.04 -41.59 51.2 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.168 2.579 . . . . 1.15 110.52 177.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.59 -46.05 90.09 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 122.309 0.244 . . . . 7.48 110.602 179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -57.15 -51.31 69.82 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.394 -0.595 . . . . 3.26 109.394 177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.8 mm -55.14 -48.92 75.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 122.779 0.432 . . . . 1.81 111.533 177.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 22.1 mt -53.14 -57.02 5.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 109.037 -0.727 . . . . 0.98 109.037 176.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 29.2 m-70 -65.89 -33.92 76.95 Favored 'General case' 0 C--N 1.331 -0.199 0 O-C-N 121.806 -0.559 . . . . 3.49 111.153 -172.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 99.2 m -57.56 -58.64 7.4 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 109.34 -0.615 . . . . 1.22 109.34 171.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 92.7 mt -65.66 -35.43 75.18 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 O-C-N 121.25 -0.906 . . . . 1.21 111.293 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.13 -51.63 61.32 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.437 -0.579 . . . . 3.4 109.437 168.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 m -57.65 -38.22 74.69 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 122.025 -0.422 . . . . 2.23 111.922 176.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.4 mt -67.94 -10.63 54.94 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 112.918 0.71 . . . . 1.51 112.918 174.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 76.98 60.09 3.0 Favored Glycine 0 CA--C 1.523 0.546 0 N-CA-C 110.673 -0.971 . . . . 1.62 110.673 178.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -141.5 171.48 14.0 Favored 'General case' 0 C--N 1.335 -0.065 0 N-CA-C 106.826 -1.546 . . . . 2.11 106.826 155.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -101.46 100.96 15.23 Favored Pre-proline 0 N--CA 1.45 -0.44 0 N-CA-C 108.837 -0.801 . . . . 2.51 108.837 172.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.21 145.11 59.25 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 N-CA-C 108.238 -1.485 . . . . 1.94 108.238 166.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 66.4 m -150.8 110.97 4.14 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 106.464 -1.68 . . . . 1.78 106.464 177.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 34.8 mt -60.02 142.41 53.98 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 121.28 0.562 . . . . 3.72 109.502 175.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 93.7 t -131.89 -33.89 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 124.836 1.254 . . . . 2.57 111.133 172.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 53.5 tptt -74.58 67.21 1.5 Allowed 'General case' 0 CA--C 1.539 0.527 0 O-C-N 121.309 -0.869 . . . . 6.2 110.543 -179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER 73.67 128.88 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 C-N-CA 126.943 2.097 . . . . 9.34 109.689 -173.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 . . . . . 0 C--O 1.252 1.213 0 C-N-CA 126.824 2.05 . . . . 12.11 113.789 -171.38 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ptm . . . . . 0 N--CA 1.468 0.454 0 N-CA-C 106.526 -1.657 . . . . 8.83 106.526 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -103.04 -177.9 26.56 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 108.313 -1.915 . . . . 2.84 108.313 155.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . 0.424 ' CG ' ' H ' ' A' ' 4' ' ' GLY . 30.3 t70 -179.83 -162.34 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 129.021 2.929 . . . . 3.77 104.031 171.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.424 ' H ' ' CG ' ' A' ' 3' ' ' ASP . . . 153.34 159.13 8.92 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 107.671 -2.172 . . . . 2.63 107.671 -173.225 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 14.2 m -134.36 55.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 C-N-CA 124.239 1.016 . . . . 3.6 108.444 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.5 mt -79.14 108.99 13.04 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.606 -1.257 . . . . 2.8 107.606 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -93.27 83.23 4.58 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-N 113.601 -1.636 . . . . 3.0 107.102 166.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.76 129.67 35.78 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 106.569 -1.641 . . . . 1.47 106.569 174.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.6 t -78.89 119.97 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.713 0 N-CA-C 105.738 -1.949 . . . . 1.11 105.738 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.1 m -109.78 84.39 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 C-N-CA 128.124 2.57 . . . . 0.77 108.331 -172.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.79 140.16 39.41 Favored 'General case' 0 C--N 1.338 0.068 0 N-CA-C 108.872 -0.788 . . . . 4.61 108.872 -176.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 121.84 -19.78 8.3 Favored Glycine 0 CA--C 1.527 0.803 0 C-N-CA 123.881 0.753 . . . . 0.69 112.084 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 45.5 mtp -62.15 150.7 37.9 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 118.572 1.186 . . . . 1.46 109.691 175.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.1 t -139.33 -39.21 0.48 Allowed 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.131 0.973 . . . . 2.65 111.771 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 20.1 p -145.48 173.5 11.97 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-N 119.212 0.914 . . . . 1.63 111.405 -169.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.58 -39.71 3.63 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 126.048 1.739 . . . . 1.39 112.563 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.0 m -49.86 -50.87 44.05 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 123.204 0.602 . . . . 1.54 111.017 175.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.1 m -65.1 -41.11 95.28 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 123.196 0.598 . . . . 0.72 110.172 -177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 31.0 t -55.27 -61.76 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.458 -0.942 . . . . 0.85 108.458 178.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.2 -28.93 67.69 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 118.866 -0.588 . . . . 1.52 111.533 -173.755 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.1 mmtt -56.81 -56.61 19.34 Favored 'General case' 0 C--O 1.233 0.221 0 N-CA-C 108.462 -0.94 . . . . 4.16 108.462 172.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 89.7 mt -55.55 -59.63 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.17 0 N-CA-C 109.158 -0.682 . . . . 0.8 109.158 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -60.67 -45.3 94.69 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-O 118.766 -0.635 . . . . 2.59 111.927 -169.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 19.5 m -61.14 -47.45 86.19 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 118.793 0.724 . . . . 1.46 111.066 176.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 12.3 t -58.82 -42.57 89.51 Favored 'General case' 0 CA--C 1.535 0.377 0 O-C-N 121.944 -0.472 . . . . 1.76 110.094 -179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -69.35 -48.29 61.78 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.425 0.69 . . . . 2.03 111.842 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 27.3 p -56.49 -32.11 64.71 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.868 1.213 . . . . 2.44 111.62 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 8.7 tttt -54.51 -36.26 64.04 Favored 'General case' 0 CA--C 1.544 0.733 0 O-C-N 121.824 -0.548 . . . . 4.78 112.057 171.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -69.84 96.67 1.02 Allowed 'General case' 0 C--O 1.225 -0.234 0 O-C-N 121.325 -0.859 . . . . 2.92 109.1 171.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 76.8 mtt85 -41.42 -40.02 1.64 Allowed 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.914 1.285 . . . . 7.18 114.099 179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -76.0 -2.19 70.8 Favored Glycine 0 CA--C 1.528 0.857 0 CA-C-O 119.072 -0.849 . . . . 0.99 114.211 -176.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.52 121.8 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 N-CA-C 106.865 -1.532 . . . . 2.33 106.865 167.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 89.7 mt -79.9 -46.74 16.24 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 124.129 0.971 . . . . 2.34 108.882 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -155.96 129.03 8.05 Favored 'General case' 0 C--N 1.342 0.268 0 CA-C-N 118.387 0.539 . . . . 2.95 110.435 -178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 27.6 p -104.27 154.31 19.95 Favored 'General case' 0 C--O 1.231 0.125 0 C-N-CA 123.535 0.734 . . . . 2.88 109.664 169.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -151.5 110.33 3.85 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.603 -1.258 . . . . 1.98 107.603 155.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.64 157.41 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 CA-C-N 118.134 0.425 . . . . 1.82 110.652 171.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -152.92 134.5 14.47 Favored 'General case' 0 N--CA 1.453 -0.286 0 O-C-N 121.602 -0.687 . . . . 0.87 110.764 170.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -69.09 -32.15 71.38 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 123.941 0.896 . . . . 1.75 110.289 175.468 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.97 -37.8 2.01 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 126.005 1.722 . . . . 1.36 113.565 -176.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 6.9 t -140.83 37.87 1.8 Allowed 'General case' 0 C--O 1.227 -0.127 0 CA-C-O 121.507 0.67 . . . . 2.45 109.913 171.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.4 m120 35.45 58.84 0.82 Allowed 'General case' 0 C--O 1.226 -0.17 0 C-N-CA 126.002 1.721 . . . . 2.4 110.879 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -121.87 142.83 49.85 Favored 'General case' 0 C--O 1.225 -0.19 0 C-N-CA 122.819 0.448 . . . . 2.32 110.605 -171.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -121.84 105.27 10.21 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.8 1.24 . . . . 0.75 108.843 167.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 7.9 t60 -79.8 108.68 13.55 Favored 'General case' 0 N--CA 1.424 -1.754 0 N-CA-C 104.356 -2.461 . . . . 3.02 104.356 169.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 24.8 mt -119.99 111.4 32.44 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.436 0 N-CA-C 106.749 -1.574 . . . . 1.07 106.749 -178.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' NZ ' ' OD2' ' A' ' 3' ' ' ASP . 3.7 mtpm? -103.12 109.7 21.37 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 106.051 -1.833 . . . . 2.98 106.051 179.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -137.29 162.74 32.71 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 125.881 1.672 . . . . 2.22 109.999 -173.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -83.25 112.76 41.45 Favored Pre-proline 0 CA--C 1.535 0.398 0 N-CA-C 107.162 -1.422 . . . . 3.24 107.162 171.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -79.64 68.38 8.31 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.975 2.45 . . . . 1.73 110.852 -170.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -139.68 -92.66 0.17 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.672 1.189 . . . . 3.8 109.363 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.2 pp -60.97 -30.3 47.29 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 N-CA-C 112.873 0.694 . . . . 1.99 112.873 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -115.72 125.24 72.81 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 N-CA-C 106.52 -1.659 . . . . 1.81 106.52 174.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -113.98 -179.41 19.04 Favored Glycine 0 CA--C 1.531 1.039 0 C-N-CA 124.789 1.185 . . . . 0.84 111.424 -176.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_endo -59.52 -39.82 71.93 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.643 2.228 . . . . 0.72 110.464 174.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.9 ttm180 -56.51 -49.61 74.24 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 122.754 0.421 . . . . 5.41 111.683 -178.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -61.09 -48.49 81.46 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 109.413 -0.588 . . . . 2.26 109.413 -175.458 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 83.5 mt -51.28 -56.15 5.93 Favored 'Isoleucine or valine' 0 C--N 1.34 0.177 0 N-CA-C 108.776 -0.824 . . . . 1.46 108.776 173.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 24.6 mt -54.52 -52.68 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 110.005 -0.368 . . . . 0.49 110.005 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -56.47 -42.73 78.73 Favored 'General case' 0 N--CA 1.457 -0.098 0 CA-C-O 121.53 0.681 . . . . 2.79 109.221 -179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 75.7 m -63.36 -50.34 70.31 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.076 -0.511 . . . . 0.86 110.782 -178.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 22.8 mm -61.94 -42.74 95.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 O-C-N 121.445 -0.784 . . . . 1.55 110.41 179.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -56.23 -44.6 79.73 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.692 0.397 . . . . 3.23 110.099 173.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 41.3 m -61.24 -40.29 93.5 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 122.083 -0.386 . . . . 1.6 111.837 176.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 93.0 mt -60.98 -41.26 96.11 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 118.72 0.691 . . . . 1.14 110.585 172.615 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 113.81 44.98 0.73 Allowed Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.367 0.984 . . . . 0.75 111.587 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -131.74 162.78 29.66 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 107.552 -1.277 . . . . 2.03 107.552 172.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 90.2 mt-10 -95.03 101.51 7.38 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-O 117.61 -1.186 . . . . 2.66 109.861 178.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -77.74 137.73 16.33 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.103 1.869 . . . . 1.33 108.823 172.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.2 t -154.79 109.29 2.99 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 108.706 -0.85 . . . . 2.05 108.706 -171.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.42 66.02 1.78 Allowed 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.784 0.834 . . . . 2.11 110.375 -179.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 94.7 t -57.44 -38.91 65.63 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 C-N-CA 123.879 0.872 . . . . 2.67 109.766 177.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.44 135.84 49.06 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.078 -1.453 . . . . 5.51 107.078 163.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -100.35 118.64 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 105.113 -2.18 . . . . 9.8 105.113 172.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 . . . . . 0 C--O 1.253 1.265 0 N-CA-C 108.765 -0.828 . . . . 12.14 108.765 -151.318 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.3 mtt . . . . . 0 N--CA 1.466 0.337 0 N-CA-C 107.859 -1.164 . . . . 8.56 107.859 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 73.51 156.63 4.06 Favored Glycine 0 CA--C 1.531 1.051 0 N-CA-C 110.543 -1.023 . . . . 2.88 110.543 -169.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.78 114.12 2.15 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.709 0.804 . . . . 3.44 111.251 -172.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -69.55 81.47 0.3 Allowed Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 108.029 -2.028 . . . . 2.69 108.029 163.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.0 m -79.33 127.9 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 109.114 -0.699 . . . . 2.5 109.114 173.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -141.92 135.66 29.65 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 122.926 0.49 . . . . 2.43 109.833 169.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -90.85 93.01 9.03 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.442 1.497 . . . . 3.13 107.046 165.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.2 121.85 34.98 Favored 'General case' 0 C--N 1.333 -0.132 0 N-CA-C 107.997 -1.112 . . . . 1.66 107.997 173.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 2.6 t -80.63 111.09 16.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 107.337 -1.357 . . . . 1.45 107.337 -178.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -94.17 92.16 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.63 0 C-N-CA 125.252 1.421 . . . . 0.64 108.326 -168.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 20.8 mtt180 -77.71 137.29 38.41 Favored 'General case' 0 C--N 1.333 -0.144 0 N-CA-C 108.433 -0.951 . . . . 5.84 108.433 -174.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 124.58 -53.15 0.77 Allowed Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.499 -1.041 . . . . 1.14 110.499 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -61.58 143.7 55.61 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 122.938 0.495 . . . . 1.7 111.756 -179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.0 t -157.28 14.8 0.25 Allowed 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.891 1.071 . . . . 2.5 113.891 -175.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 p -162.85 161.04 25.79 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 119.761 1.164 . . . . 1.74 109.772 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -44.87 -39.64 5.56 Favored 'General case' 0 N--CA 1.464 0.254 0 C-N-CA 125.701 1.6 . . . . 1.06 111.449 177.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 m -36.16 -47.63 0.57 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.512 2.325 . . . . 2.56 113.13 169.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 38.0 m -73.85 -52.46 12.94 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.151 0.981 . . . . 1.0 111.685 175.292 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 66.5 t -45.99 -58.13 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 C-N-CA 126.179 1.791 . . . . 0.81 109.679 -166.047 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -61.47 -32.51 72.51 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 114.21 -1.359 . . . . 1.92 110.794 -174.277 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 54.4 mttp -71.23 -47.3 58.13 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.852 -0.796 . . . . 4.71 108.852 179.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 99.1 mt -54.05 -58.88 2.6 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 N-CA-C 109.053 -0.721 . . . . 0.98 109.053 177.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -61.97 -47.77 83.34 Favored 'General case' 0 N--CA 1.45 -0.465 0 CA-C-O 119.531 -0.271 . . . . 2.13 111.196 -174.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 53.6 m -55.49 -58.22 8.65 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 118.201 0.455 . . . . 1.57 110.517 175.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.7 t -49.31 -49.89 41.83 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.951 1.3 . . . . 1.3 110.698 -177.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 74.7 mt -66.94 -51.23 57.73 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-O 119.161 -0.447 . . . . 2.53 111.721 -178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 23.4 p -55.4 -28.35 53.54 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.159 0.436 . . . . 1.91 111.635 -177.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 17.2 mtmt -58.17 -40.85 82.51 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.424 0.557 . . . . 4.99 111.909 174.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -79.28 120.0 23.14 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-O 121.899 0.857 . . . . 2.37 110.142 -169.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 79.5 mtt85 -57.84 157.68 7.28 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.111 -0.7 . . . . 7.47 109.111 170.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 81.3 -15.05 25.37 Favored Glycine 0 CA--C 1.524 0.65 0 CA-C-O 117.896 -1.502 . . . . 0.81 112.785 -176.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.51 125.05 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 CA-C-N 119.777 1.789 . . . . 1.66 106.536 154.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 80.2 mt -80.44 -43.46 20.89 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.675 -1.231 . . . . 2.58 107.675 169.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -155.63 155.95 34.17 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 109.487 -0.561 . . . . 2.5 109.487 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 24.3 p -131.32 158.18 41.37 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 106.955 -1.498 . . . . 2.41 106.955 156.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 47.6 t -150.79 145.2 25.57 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 108.028 -1.101 . . . . 2.39 108.028 139.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 3.5 p -112.57 148.29 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 124.168 0.987 . . . . 1.91 110.653 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -138.54 136.11 35.73 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 123.14 0.576 . . . . 0.69 110.943 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 72.2 mt -65.82 -36.12 82.6 Favored 'General case' 0 C--O 1.226 -0.175 0 C-N-CA 125.043 1.337 . . . . 2.35 110.091 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.3 -39.06 1.3 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 126.188 1.795 . . . . 1.54 113.88 -173.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 12.7 t -140.96 35.68 1.75 Allowed 'General case' 0 C--O 1.225 -0.206 0 CA-C-O 122.154 0.978 . . . . 2.29 109.644 172.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 8.7 m120 36.06 57.36 1.0 Allowed 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 127.984 2.514 . . . . 2.03 111.917 178.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.64 153.73 51.54 Favored 'General case' 0 CA--C 1.515 -0.376 0 O-C-N 121.926 -0.484 . . . . 3.22 111.994 -170.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.556 ' HB1' ' CD1' ' A' ' 46' ' ' ILE . . . -116.82 117.05 28.67 Favored 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 126.058 1.743 . . . . 0.7 108.657 174.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 9.3 t60 -85.08 101.45 12.44 Favored 'General case' 0 N--CA 1.425 -1.721 0 N-CA-C 103.46 -2.792 . . . . 2.89 103.46 169.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.556 ' CD1' ' HB1' ' A' ' 44' ' ' ALA . 1.7 mp -99.22 143.91 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 107.026 -1.472 . . . . 1.24 107.026 170.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 74.8 mttt -126.8 112.5 15.45 Favored 'General case' 0 N--CA 1.442 -0.846 0 N-CA-C 106.092 -1.818 . . . . 2.5 106.092 170.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.0 p90 -127.48 173.49 9.8 Favored 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 123.369 0.668 . . . . 2.26 111.254 -176.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.9 m-20 -96.4 101.33 8.57 Favored Pre-proline 0 CA--C 1.539 0.542 0 C-N-CA 124.411 1.085 . . . . 2.43 109.275 175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -78.54 58.08 6.6 Favored 'Trans proline' 0 CA--C 1.536 0.607 0 C-N-CA 123.663 2.909 . . . . 1.48 113.029 -169.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -143.13 -63.75 0.4 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 126.027 1.731 . . . . 4.12 107.987 169.054 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 20.0 pt -65.28 -26.83 40.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 C-N-CA 123.977 0.911 . . . . 2.82 112.432 -179.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.9 tt -143.96 150.67 16.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.333 0 N-CA-C 108.07 -1.085 . . . . 1.36 108.07 178.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -114.43 -176.26 18.91 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 111.187 -0.765 . . . . 0.92 111.187 -174.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -66.16 -38.72 20.5 Favored 'Trans proline' 0 N--CA 1.451 -0.978 0 C-N-CA 122.337 2.024 . . . . 0.86 109.795 172.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -47.52 -49.59 25.71 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.755 1.222 . . . . 5.98 111.382 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -59.89 -54.09 50.27 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.227 0.611 . . . . 2.54 110.124 -174.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 36.6 mt -53.14 -52.28 31.55 Favored 'Isoleucine or valine' 0 C--N 1.338 0.089 0 N-CA-C 108.555 -0.905 . . . . 1.42 108.555 175.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.8 mt -55.54 -53.28 38.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 CA-C-N 115.89 -0.595 . . . . 0.9 110.277 -174.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -67.84 -31.87 72.01 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-N 118.626 0.648 . . . . 6.19 110.362 -175.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 96.7 m -59.29 -46.4 88.65 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 109.532 -0.544 . . . . 0.8 109.532 172.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.8 mt -68.57 -36.98 76.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.525 0 O-C-N 121.27 -0.894 . . . . 1.15 111.315 179.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -55.22 -43.96 74.97 Favored 'General case' 0 CA--C 1.531 0.241 0 O-C-N 121.507 -0.746 . . . . 2.86 109.882 169.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.7 m -60.93 -38.81 87.08 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 122.295 -0.253 . . . . 1.5 111.576 178.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 88.1 mt -64.24 -40.27 95.67 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 118.225 0.466 . . . . 1.2 110.831 171.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.8 45.02 0.85 Allowed Glycine 0 CA--C 1.524 0.62 0 C-N-CA 124.526 1.06 . . . . 1.01 111.752 173.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -131.89 163.06 29.15 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 108.748 -0.834 . . . . 2.02 108.748 174.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -99.12 100.7 10.62 Favored Pre-proline 0 N--CA 1.465 0.282 0 C-N-CA 124.576 1.15 . . . . 4.5 110.539 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -77.71 81.77 2.59 Favored 'Trans proline' 0 N--CA 1.457 -0.636 0 C-N-CA 123.815 3.01 . . . . 1.39 111.107 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.2 m -78.66 109.91 13.32 Favored 'General case' 0 N--CA 1.454 -0.255 0 O-C-N 121.402 -0.811 . . . . 1.41 109.564 177.341 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.56 58.47 0.59 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.488 0.715 . . . . 2.12 111.76 176.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.5 p -106.56 51.96 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 125.605 1.562 . . . . 3.08 108.67 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.4 ' HG2' ' H ' ' A' ' 74' ' ' ILE . 0.0 OUTLIER -46.29 -56.27 6.03 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 125.528 1.531 . . . . 6.06 112.121 -176.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.4 ' H ' ' HG2' ' A' ' 73' ' ' LYS . 18.6 tt -165.51 127.33 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 C-N-CA 130.157 3.383 . . . . 7.47 103.24 160.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 C--O 1.251 1.145 0 C-N-CA 123.208 0.603 . . . . 9.6 109.489 -161.723 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.436 ' H2 ' ' CG ' ' A' ' 49' ' ' ASP . 23.3 ttt . . . . . 0 CA--C 1.538 0.49 0 N-CA-C 112.407 0.521 . . . . 6.35 112.407 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 109.52 156.47 16.72 Favored Glycine 0 CA--C 1.526 0.719 0 O-C-N 121.835 -0.541 . . . . 2.56 112.371 162.176 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -71.26 101.58 2.36 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 124.523 1.129 . . . . 3.79 111.088 -176.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.04 171.53 12.18 Favored Glycine 0 CA--C 1.53 1.017 0 N-CA-C 110.299 -1.12 . . . . 1.96 110.299 166.535 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.4 t -140.89 97.87 0.86 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.161 0 N-CA-C 107.65 -1.241 . . . . 2.77 107.65 178.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 mp -117.95 121.38 40.52 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 121.519 0.676 . . . . 2.79 109.566 178.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.6 mp0 -91.1 90.75 7.96 Favored 'General case' 0 N--CA 1.445 -0.719 0 C-N-CA 126.784 2.034 . . . . 4.22 107.348 177.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 34.0 mt -82.35 106.77 14.5 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 106.15 -1.796 . . . . 2.57 106.15 172.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.4 t -78.49 101.37 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 N-CA-C 106.438 -1.69 . . . . 1.38 106.438 -176.104 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.7 m -89.44 88.3 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.997 1.319 . . . . 0.88 109.912 -164.69 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 18.9 mmm180 -77.8 96.57 4.97 Favored 'General case' 0 N--CA 1.446 -0.64 0 N-CA-C 106.652 -1.61 . . . . 8.0 106.652 -176.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 162.69 -38.83 0.35 Allowed Glycine 0 CA--C 1.526 0.764 0 CA-C-O 118.878 -0.957 . . . . 0.63 112.527 177.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 21.3 ptt? -70.56 162.26 29.19 Favored 'General case' 0 C--N 1.342 0.254 0 CA-C-N 119.126 1.463 . . . . 1.34 111.218 -173.498 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -145.09 -37.41 0.28 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 113.435 0.902 . . . . 2.39 113.435 -170.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 17.8 p -141.09 173.83 11.11 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 119.789 1.177 . . . . 1.69 111.705 -172.773 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.78 -41.8 15.96 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.025 1.33 . . . . 1.18 111.799 178.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.7 m -57.25 -38.46 73.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 122.825 0.45 . . . . 1.82 111.665 177.779 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 62.0 m -71.07 -52.63 18.33 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 118.264 0.484 . . . . 0.73 110.176 173.208 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 57.8 t -44.2 -58.44 0.58 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.18 0 C-N-CA 124.753 1.221 . . . . 0.74 109.212 -176.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -69.6 -22.24 63.52 Favored 'General case' 0 N--CA 1.438 -1.053 0 CA-C-N 115.515 -0.766 . . . . 1.44 112.368 -174.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 59.0 mmtt -68.48 -50.87 49.16 Favored 'General case' 0 C--N 1.344 0.339 0 N-CA-C 107.413 -1.328 . . . . 5.29 107.413 173.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 5.0 mt -56.54 -57.01 10.74 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.172 0 N-CA-C 109.104 -0.702 . . . . 0.76 109.104 177.266 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -56.98 -54.66 44.14 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.423 0.556 . . . . 2.18 111.488 -174.572 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 12.7 t -62.33 -39.1 91.96 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 122.502 0.321 . . . . 1.91 111.007 -178.088 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 37.5 t -63.5 -53.42 52.31 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 109.141 -0.688 . . . . 1.41 109.141 177.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -47.6 -46.21 28.15 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.662 1.185 . . . . 1.87 111.528 -178.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -55.43 -15.16 2.4 Favored 'General case' 0 CA--C 1.543 0.708 0 N-CA-C 114.491 1.293 . . . . 2.66 114.491 179.681 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.9 ptmt -56.59 -37.02 70.05 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-N 119.904 1.229 . . . . 5.21 111.288 170.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -76.72 100.78 5.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.596 -0.891 . . . . 3.07 108.596 -176.383 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -50.92 -30.21 14.16 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 113.204 0.816 . . . . 6.79 113.204 -179.684 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -66.81 -20.64 70.59 Favored Glycine 0 CA--C 1.527 0.783 0 CA-C-O 118.95 -0.916 . . . . 1.01 113.677 177.424 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -77.09 124.87 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 CA-C-N 118.682 1.241 . . . . 2.0 108.393 178.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 85.5 mt -94.46 -36.93 11.66 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 125.591 1.556 . . . . 2.18 109.507 -179.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 65.2 t80 -155.7 125.59 6.52 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.8 0.727 . . . . 2.07 111.048 178.533 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 18.2 p -107.84 144.79 34.55 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.528 1.131 . . . . 2.99 108.732 167.136 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 60.4 m -151.48 143.06 23.61 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.901 -1.518 . . . . 2.21 106.901 152.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.0 m -127.18 136.39 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 118.29 0.496 . . . . 1.7 110.223 178.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -121.82 131.59 54.13 Favored 'General case' 0 C--O 1.238 0.471 0 C-N-CA 123.835 0.854 . . . . 0.77 111.691 -174.158 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 95.8 mt -67.63 -43.47 80.3 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 126.296 1.838 . . . . 2.8 111.414 -175.761 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.09 -46.06 33.41 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.166 0.587 . . . . 1.18 111.453 -179.236 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 p -82.92 -25.16 32.68 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.671 1.189 . . . . 3.39 111.839 176.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 41.69 66.9 0.62 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 125.523 1.529 . . . . 3.37 109.609 -151.377 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.41 141.3 33.76 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 114.504 -1.226 . . . . 1.74 110.453 -177.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -108.28 124.08 49.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 127.039 2.136 . . . . 0.74 108.31 174.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -98.16 106.99 19.36 Favored 'General case' 0 N--CA 1.431 -1.41 0 N-CA-C 103.249 -2.871 . . . . 2.08 103.249 174.711 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.464 ' N ' HD12 ' A' ' 46' ' ' ILE . 2.3 mp -102.25 127.83 55.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 106.546 -1.65 . . . . 1.4 106.546 175.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.3 mtpt -112.03 114.43 27.3 Favored 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 107.631 -1.248 . . . . 2.23 107.631 167.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 45.6 p90 -130.9 163.47 27.39 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 125.566 1.546 . . . . 2.02 111.47 176.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.436 ' CG ' ' H2 ' ' A' ' 1' ' ' MET . 14.5 t70 -87.98 129.32 50.63 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 124.239 1.016 . . . . 3.93 110.548 175.239 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -59.2 -58.76 0.56 Allowed 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 122.781 2.321 . . . . 2.36 115.294 -165.304 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 26.6 pm0 -78.07 37.27 0.25 Allowed 'General case' 0 CA--C 1.541 0.604 0 CA-C-N 120.168 1.349 . . . . 3.84 113.911 -165.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.63 -52.63 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 125.241 1.416 . . . . 3.67 109.111 170.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.3 tt -125.19 144.83 33.84 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.112 0 C-N-CA 122.624 0.37 . . . . 1.25 110.958 -171.41 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -107.47 -176.76 22.56 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 110.326 -1.11 . . . . 0.81 110.326 176.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -66.0 -39.74 18.23 Favored 'Trans proline' 0 N--CA 1.449 -1.109 0 C-N-CA 122.189 1.926 . . . . 0.97 110.11 174.56 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 81.0 mtt85 -53.38 -49.43 67.21 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.004 0.922 . . . . 6.69 111.989 -176.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -50.12 -52.0 38.55 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 122.491 1.139 . . . . 2.83 109.464 -178.706 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 30.2 mt -65.55 -52.29 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 CA-C-N 114.554 -1.203 . . . . 1.27 109.059 -179.302 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 14.2 mt -48.08 -54.25 4.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 123.765 0.826 . . . . 0.69 110.222 -177.07 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 7.4 p80 -65.86 -35.6 81.11 Favored 'General case' 0 C--O 1.231 0.131 0 C-N-CA 119.809 -0.756 . . . . 5.36 110.501 -176.014 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 82.8 m -63.13 -46.91 85.04 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 122.1 -0.375 . . . . 0.98 110.582 178.267 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 63.3 mt -67.6 -40.79 84.83 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.412 0 O-C-N 121.49 -0.756 . . . . 1.06 109.882 178.821 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -53.31 -38.44 63.17 Favored 'General case' 0 CA--C 1.53 0.207 0 O-C-N 121.539 -0.725 . . . . 5.24 111.207 170.264 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 m -64.44 -22.54 66.99 Favored 'General case' 0 CA--C 1.537 0.462 0 N-CA-C 112.935 0.717 . . . . 1.6 112.935 176.038 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.6 mt -78.74 -43.61 25.29 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.982 0.81 . . . . 1.19 109.243 168.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 118.21 49.11 0.37 Allowed Glycine 0 C--N 1.338 0.659 0 C-N-CA 124.467 1.032 . . . . 0.93 112.173 169.714 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -143.28 134.73 26.19 Favored 'General case' 0 C--O 1.227 -0.115 0 CA-C-O 117.419 -1.277 . . . . 1.99 108.014 175.888 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -78.86 112.02 24.15 Favored Pre-proline 0 C--N 1.34 0.156 0 CA-C-N 119.49 1.041 . . . . 5.48 108.893 -170.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -89.55 78.98 0.87 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 123.38 2.72 . . . . 1.39 110.066 -171.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -81.39 115.53 20.78 Favored 'General case' 0 N--CA 1.453 -0.311 0 O-C-N 121.547 -0.721 . . . . 1.78 109.633 -170.203 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 43.6 mt -53.61 111.52 0.74 Allowed 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 118.996 0.816 . . . . 3.41 110.724 174.95 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -57.05 -37.62 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.495 0 CA-C-N 118.896 0.771 . . . . 4.57 111.89 176.945 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.2 pttm -140.02 159.36 42.34 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.033 1.333 . . . . 5.36 107.81 -176.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.11 123.24 63.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 104.369 -2.456 . . . . 10.61 104.369 167.369 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 47.4 mp0 . . . . . 0 CA--C 1.559 1.305 1 CA-C-O 80.719 -18.753 . . . . 11.84 105.882 -171.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.473 0.689 0 N-CA-C 107.476 -1.305 . . . . 7.05 107.476 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -68.24 135.88 29.97 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 105.264 -3.134 . . . . 3.52 105.264 131.593 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 3.7 p30 175.46 172.74 0.29 Allowed 'General case' 0 C--O 1.233 0.23 0 C-N-CA 127.978 2.511 . . . . 4.48 106.508 176.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.89 155.74 9.97 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 106.663 -2.575 . . . . 1.79 106.663 -173.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.6 t -143.25 143.98 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 107.836 -1.172 . . . . 2.84 107.836 -175.152 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -149.25 163.5 37.48 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.256 -0.646 . . . . 3.4 109.256 162.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -120.03 145.41 46.85 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.217 -1.031 . . . . 2.35 108.217 168.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.07 130.13 28.69 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 107.759 -1.2 . . . . 1.44 107.759 177.47 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 20.3 t -79.67 104.72 8.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 105.901 -1.889 . . . . 1.07 105.901 177.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.9 m -91.05 89.22 2.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.644 0 C-N-CA 125.428 1.491 . . . . 0.65 108.216 -172.389 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 -75.57 131.4 39.99 Favored 'General case' 0 C--O 1.231 0.108 0 N-CA-C 107.763 -1.199 . . . . 5.23 107.763 -170.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 126.05 -43.13 1.39 Allowed Glycine 0 CA--C 1.527 0.794 0 C-N-CA 124.088 0.852 . . . . 0.71 111.404 177.054 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -75.46 132.58 40.91 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 118.454 1.127 . . . . 1.37 108.633 -175.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.3 t -154.84 25.08 0.44 Allowed 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 112.97 0.73 . . . . 2.69 112.97 -169.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -163.33 156.87 19.44 Favored 'General case' 0 N--CA 1.454 -0.25 0 CA-C-N 118.523 0.602 . . . . 1.39 109.629 178.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.53 -39.43 16.29 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.505 1.522 . . . . 0.89 111.987 -176.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.6 t -47.26 -54.23 11.41 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 121.683 0.754 . . . . 2.21 110.143 172.772 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . 0.263 57.7 m -73.16 -33.56 65.55 Favored 'General case' 0 N--CA 1.448 -0.556 0 O-C-N 120.355 -1.465 . . . . 1.19 112.151 -176.668 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 82.8 t -50.37 -61.33 0.65 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.239 0 N-CA-C 108.666 -0.864 . . . . 0.69 108.666 174.084 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.2 p-80 -69.84 -29.56 66.84 Favored 'General case' 0 N--CA 1.438 -1.043 0 CA-C-N 115.175 -0.921 . . . . 1.12 111.787 -174.098 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm -62.0 -50.72 70.92 Favored 'General case' 0 C--N 1.345 0.379 0 CA-C-N 119.28 0.945 . . . . 4.41 109.655 173.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.7 mt -58.29 -57.76 9.44 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 CA-C-N 119.218 0.917 . . . . 0.65 109.047 178.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -55.05 -54.14 46.84 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.157 0.435 . . . . 2.47 110.895 -173.515 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 23.1 t -56.98 -52.99 63.04 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 122.865 0.466 . . . . 1.54 110.437 179.197 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 45.6 t -57.34 -54.97 40.77 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 122.638 0.375 . . . . 0.97 110.756 -177.458 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -60.51 -32.98 71.97 Favored 'General case' 0 N--CA 1.454 -0.248 0 O-C-N 121.534 -0.729 . . . . 2.06 111.365 -174.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.9 m -53.66 -19.97 4.71 Favored 'General case' 0 CA--C 1.548 0.886 0 N-CA-C 112.938 0.718 . . . . 2.54 112.938 173.198 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.24 -30.28 59.73 Favored 'General case' 0 CA--C 1.538 0.484 0 O-C-N 120.531 -1.355 . . . . 5.72 112.113 171.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -68.86 101.47 1.36 Allowed 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.577 -0.897 . . . . 2.82 108.577 169.319 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 53.6 mtm180 -49.45 -33.25 13.68 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 111.885 0.328 . . . . 5.36 111.885 171.209 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -72.72 -11.23 77.5 Favored Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.815 -0.992 . . . . 0.84 113.796 -179.665 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -80.16 129.67 37.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.181 0 CA-C-N 119.699 1.75 . . . . 2.09 107.431 168.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.9 pp -99.74 -26.05 14.18 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.862 0.465 . . . . 2.31 110.745 175.662 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -156.11 149.94 25.1 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 118.88 0.764 . . . . 2.68 111.224 172.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 26.1 m -130.33 145.4 51.78 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 126.178 1.791 . . . . 2.57 107.553 174.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 45.9 m -153.34 135.22 14.62 Favored 'General case' 0 CA--C 1.521 -0.154 0 N-CA-C 107.808 -1.182 . . . . 1.84 107.808 152.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.4 m -121.86 151.07 25.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 118.987 0.812 . . . . 1.86 110.479 173.586 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -135.61 132.57 37.26 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-O 121.533 0.682 . . . . 0.79 110.779 176.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.9 -29.44 66.63 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 115.035 -0.984 . . . . 1.75 110.732 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -48.72 -34.97 13.07 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.49 1.116 . . . . 1.09 112.927 179.613 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 3.5 p -122.03 13.49 10.55 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.889 0.876 . . . . 2.24 111.299 175.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 27.7 m120 40.15 52.17 2.73 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.243 1.817 . . . . 1.93 110.659 -171.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.09 140.37 45.45 Favored 'General case' 0 CA--C 1.521 -0.173 0 O-C-N 122.043 -0.411 . . . . 1.92 111.141 -164.561 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -114.85 128.22 56.16 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 126.026 1.73 . . . . 0.58 109.156 177.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 37.0 t60 -98.84 121.78 41.23 Favored 'General case' 0 N--CA 1.423 -1.786 0 C-N-CA 127.847 2.459 . . . . 2.81 105.701 172.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 4.3 mt -123.72 134.37 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 108.686 -0.857 . . . . 1.63 108.686 177.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.7 mtpt -122.95 130.82 53.3 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.14 -1.8 . . . . 2.4 106.14 178.809 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 26.6 p90 -162.05 171.31 17.75 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 112.214 0.45 . . . . 2.51 112.214 -158.731 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -105.12 100.56 25.48 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 125.51 1.524 . . . . 2.8 109.437 -179.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -68.71 -12.79 35.56 Favored 'Trans proline' 0 N--CA 1.457 -0.668 0 C-N-CA 123.323 2.682 . . . . 2.37 113.394 -168.549 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 pt-20 -52.97 -39.71 63.19 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 118.662 0.664 . . . . 4.63 111.635 176.765 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.9 pp -120.07 -54.52 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 C-N-CA 123.113 0.565 . . . . 1.9 112.133 -176.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -84.14 116.54 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.851 -1.166 . . . . 1.84 107.851 -172.92 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.71 161.55 16.75 Favored Glycine 0 CA--C 1.527 0.834 0 N-CA-C 110.523 -1.031 . . . . 0.78 110.523 -177.255 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -51.52 -38.1 63.82 Favored 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.995 2.463 . . . . 0.81 110.857 176.36 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.7 ptt-85 -42.87 -52.73 4.98 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.422 1.089 . . . . 9.48 111.647 172.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.18 -40.52 67.86 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.083 -1.01 . . . . 2.5 109.76 -167.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 78.5 mt -52.68 -57.47 4.24 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.124 0 N-CA-C 107.611 -1.255 . . . . 1.55 107.611 170.02 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 35.3 mt -55.54 -48.91 76.78 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 116.039 -0.528 . . . . 0.64 110.136 -174.814 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -55.54 -44.98 77.23 Favored 'General case' 0 C--N 1.339 0.123 0 CA-C-O 122.172 0.986 . . . . 3.54 108.953 179.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 63.7 m -62.96 -45.72 91.13 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 115.344 -0.843 . . . . 0.97 110.294 179.602 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.6 mm -70.07 -42.42 79.34 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 O-C-N 121.377 -0.827 . . . . 1.48 110.566 -173.782 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -63.26 -43.18 98.7 Favored 'General case' 0 N--CA 1.455 -0.212 0 O-C-N 121.907 -0.496 . . . . 3.01 110.138 175.595 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 59.8 m -54.54 -44.83 73.2 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 111.891 0.33 . . . . 1.63 111.891 172.292 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 86.5 mt -61.07 -39.8 91.27 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 118.822 0.737 . . . . 1.17 111.14 173.575 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.2 41.07 0.92 Allowed Glycine 0 CA--C 1.523 0.587 0 C-N-CA 124.049 0.833 . . . . 0.82 111.655 173.434 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -127.77 161.97 27.72 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.163 -1.051 . . . . 1.8 108.163 170.449 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -96.4 103.6 14.63 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-O 118.133 -0.937 . . . . 2.68 110.015 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -77.29 77.03 3.97 Favored 'Trans proline' 0 N--CA 1.459 -0.555 0 C-N-CA 123.239 2.626 . . . . 1.02 110.699 -176.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.7 m -78.66 90.11 4.58 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.316 -0.994 . . . . 1.69 108.316 -177.012 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.649 HD23 ' H ' ' A' ' 71' ' ' LEU . 2.3 pt? -66.1 57.44 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.021 1.728 . . . . 2.61 114.683 -176.259 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.7 t -115.91 92.02 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 C-N-CA 126.369 1.868 . . . . 3.66 107.543 -175.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.02 101.36 14.07 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.013 1.325 . . . . 7.14 107.62 177.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 43.0 pt -141.85 177.88 2.97 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 C-N-CA 124.911 1.285 . . . . 9.03 108.53 -178.55 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 . . . . . 0 C--O 1.256 1.446 0 N-CA-C 105.008 -2.219 . . . . 11.07 105.008 172.802 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 90.5 mtp . . . . . 0 N--CA 1.473 0.677 0 N-CA-C 108.212 -1.033 . . . . 6.29 108.212 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.97 177.44 14.99 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.447 -1.061 . . . . 2.66 110.447 -168.128 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -94.07 123.98 37.79 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.748 1.219 . . . . 3.66 109.657 177.09 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -76.52 145.27 31.44 Favored Glycine 0 CA--C 1.521 0.45 0 N-CA-C 107.902 -2.079 . . . . 2.0 107.902 167.007 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.0 p -150.89 129.39 2.81 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 123.307 0.643 . . . . 2.49 109.783 179.276 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.4 mp -136.46 138.67 41.7 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.029 -0.73 . . . . 2.34 109.029 167.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -92.34 93.51 8.66 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 107.512 -1.292 . . . . 2.7 107.512 163.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.1 mt -80.03 112.25 17.15 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.797 -1.927 . . . . 2.82 105.797 173.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 29.2 t -78.97 104.49 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 N-CA-C 106.506 -1.665 . . . . 1.34 106.506 -177.712 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.3 m -79.14 80.22 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 C-N-CA 124.601 1.16 . . . . 0.97 108.516 -172.523 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 11.0 mtp-105 -75.91 95.27 3.5 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 106.524 -1.658 . . . . 4.13 106.524 -178.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.58 -57.41 0.11 Allowed Glycine 0 CA--C 1.523 0.556 0 N-CA-C 110.643 -0.983 . . . . 1.51 110.643 177.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.28 157.45 18.21 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 117.363 0.582 . . . . 2.13 109.794 -177.697 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 2.5 t -154.31 35.82 0.42 Allowed 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 109.624 -0.51 . . . . 4.06 109.624 170.892 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -147.43 137.0 22.76 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 123.686 0.795 . . . . 2.57 110.193 -170.054 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.69 -43.28 2.8 Favored 'General case' 0 C--N 1.342 0.271 0 C-N-CA 126.519 1.927 . . . . 1.01 112.002 -177.681 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.5 m -35.1 -58.38 0.54 Allowed 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.733 1.613 . . . . 2.03 111.931 170.789 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 66.2 m -74.52 -27.56 60.59 Favored 'General case' 0 C--N 1.329 -0.295 0 O-C-N 120.915 -1.116 . . . . 1.44 113.866 -178.296 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.455 HG13 HG13 ' A' ' 37' ' ' VAL . 45.1 t -56.41 -55.68 17.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 107.895 -1.15 . . . . 0.58 107.895 179.774 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -63.58 -32.57 74.08 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-N 115.951 -0.568 . . . . 1.11 111.913 -178.684 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.2 mttt -60.01 -54.3 47.6 Favored 'General case' 0 C--N 1.344 0.326 0 N-CA-C 108.433 -0.951 . . . . 3.96 108.433 173.77 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 54.3 mt -57.7 -56.43 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 N-CA-C 109.187 -0.672 . . . . 0.8 109.187 -172.525 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -61.03 -50.23 74.2 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 119.789 -0.764 . . . . 3.29 111.337 -174.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.3 m -54.11 -50.11 67.61 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.339 0.59 . . . . 1.58 110.407 177.382 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 26.4 t -58.19 -41.88 84.9 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.037 0.935 . . . . 1.32 110.301 -178.661 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -68.68 -46.3 69.42 Favored 'General case' 0 N--CA 1.452 -0.333 0 O-C-N 121.59 -0.694 . . . . 2.1 111.849 178.505 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 62.2 p -53.71 -30.21 42.77 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 118.806 0.73 . . . . 2.31 112.926 -179.449 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 36.0 tttp -58.19 -32.46 68.27 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.24 0.616 . . . . 5.6 112.082 175.004 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 65.2 m-70 -73.17 106.66 5.12 Favored 'General case' 0 N--CA 1.456 -0.164 0 CA-C-N 119.335 0.971 . . . . 3.03 108.595 171.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -37.38 -58.01 0.87 Allowed 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 109.067 -0.716 . . . . 8.65 109.067 167.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.97 -11.43 0.57 Allowed Glycine 0 CA--C 1.526 0.74 0 C-N-CA 124.921 1.248 . . . . 0.82 116.07 -173.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -75.13 167.03 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 120.275 2.038 . . . . 2.17 107.892 171.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.5 pp -135.87 -30.04 1.0 Allowed 'General case' 0 C--N 1.33 -0.281 0 O-C-N 121.67 -0.644 . . . . 2.54 112.531 170.537 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -155.62 123.17 5.57 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 119.293 0.951 . . . . 3.26 108.917 170.828 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 7.5 p -106.52 132.81 52.1 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 123.996 0.918 . . . . 3.03 108.573 169.059 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.3 m -134.9 80.29 1.84 Allowed 'General case' 0 CA--C 1.522 -0.122 0 O-C-N 123.715 0.634 . . . . 2.28 109.614 167.368 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.455 HG13 HG13 ' A' ' 19' ' ' VAL . 10.7 p -78.85 144.1 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 C-N-CA 122.56 0.344 . . . . 1.83 110.803 171.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -153.24 137.7 16.74 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.887 0.875 . . . . 1.22 109.905 178.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.5 pp -74.75 -22.35 58.83 Favored 'General case' 0 C--O 1.225 -0.209 0 CA-C-N 116.013 -0.54 . . . . 1.7 111.487 177.888 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.56 -39.7 2.41 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.49 1.516 . . . . 1.8 113.278 -179.162 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 10.1 t -137.88 34.8 2.39 Favored 'General case' 0 N--CA 1.462 0.131 0 C-N-CA 122.944 0.497 . . . . 2.07 110.309 168.157 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 11.9 m120 44.78 50.51 8.69 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 126.765 2.026 . . . . 1.96 110.027 173.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.2 ptpt -114.61 145.26 42.2 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.971 0.909 . . . . 2.46 110.354 -170.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.491 ' HB1' HD11 ' A' ' 46' ' ' ILE . . . -122.28 108.22 13.01 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 125.15 1.38 . . . . 0.94 108.562 163.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . 0.25 19.7 t60 -86.77 101.75 13.61 Favored 'General case' 0 N--CA 1.421 -1.879 0 N-CA-C 104.234 -2.506 . . . . 2.55 104.234 174.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.491 HD11 ' HB1' ' A' ' 44' ' ' ALA . 2.0 mp -103.43 119.83 52.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.858 -1.905 . . . . 1.06 105.858 174.752 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.7 mtpt -102.71 140.66 36.69 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 108.069 -1.085 . . . . 2.74 108.069 166.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 49.6 p90 -159.27 159.1 33.69 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.957 0.903 . . . . 2.05 112.423 -168.497 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.74 109.17 3.06 Favored Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 126.47 1.908 . . . . 2.68 107.659 173.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -81.83 54.61 5.13 Favored 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.007 2.471 . . . . 1.53 110.553 -170.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -142.52 -64.31 0.42 Allowed 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 125.367 1.467 . . . . 3.89 109.361 -175.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.5 pp -80.57 -38.46 17.64 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.111 0 N-CA-C 112.204 0.446 . . . . 1.78 112.204 -172.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.7 tt -113.41 146.01 18.58 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.236 0 C-N-CA 124.64 1.176 . . . . 1.17 109.604 -175.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -123.5 -172.17 13.73 Favored Glycine 0 CA--C 1.53 1.01 0 N-CA-C 110.687 -0.965 . . . . 0.69 110.687 178.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -63.81 -40.56 28.08 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.479 2.119 . . . . 0.76 110.178 174.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -45.53 -58.41 3.4 Favored 'General case' 0 C--N 1.34 0.152 0 C-N-CA 124.313 1.045 . . . . 6.29 111.504 179.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -52.91 -57.62 9.65 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.362 0.665 . . . . 2.34 109.644 -174.584 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 56.0 mt -51.82 -52.71 20.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.921 0.888 . . . . 1.26 109.325 179.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.02 -48.67 83.64 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 CA-C-O 119.034 -0.508 . . . . 0.76 110.107 -176.189 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 35.0 m170 -58.7 -41.57 86.6 Favored 'General case' 0 C--O 1.231 0.103 0 CA-C-O 121.88 0.848 . . . . 3.11 109.476 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 54.3 m -64.88 -45.44 85.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.783 -0.644 . . . . 0.98 111.044 178.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 15.3 mm -70.2 -51.67 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.127 0 CA-C-N 118.575 0.625 . . . . 1.96 110.682 -177.158 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -55.58 -36.8 67.27 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.148 0.579 . . . . 3.08 111.707 -167.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.6 t -38.07 -44.68 0.84 Allowed 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 126.011 1.724 . . . . 2.5 113.039 168.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.59 -19.66 63.66 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.811 0.844 . . . . 3.89 112.21 -178.083 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.6 40.54 3.37 Favored Glycine 0 CA--C 1.527 0.796 0 C-N-CA 125.021 1.296 . . . . 1.89 111.782 179.187 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -124.87 155.95 38.68 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 107.759 -1.2 . . . . 2.11 107.759 172.656 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -95.63 101.12 7.23 Favored Pre-proline 0 CA--C 1.539 0.543 0 CA-C-O 118.012 -0.994 . . . . 3.51 108.895 169.305 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -70.81 81.49 1.07 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.165 2.577 . . . . 1.15 109.141 175.208 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 13.8 m -79.35 109.66 13.91 Favored 'General case' 0 N--CA 1.446 -0.668 0 C-N-CA 123.909 0.884 . . . . 1.86 108.733 -168.435 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -73.42 61.4 0.67 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.558 1.143 . . . . 2.66 112.568 -174.201 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 46.5 t -70.77 -53.51 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 108.856 -0.794 . . . . 2.31 108.856 174.487 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 81.5 tttt 58.39 -94.13 0.04 OUTLIER 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 123.088 0.555 . . . . 6.54 111.03 -168.287 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 57.9 mt -146.21 141.72 21.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 C-N-CA 127.355 2.262 . . . . 6.58 105.771 177.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.5 tt0 . . . . . 0 C--O 1.249 1.06 0 N-CA-C 103.239 -2.875 . . . . 10.14 103.239 170.77 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 ttm . . . . . 0 N--CA 1.472 0.639 0 N-CA-C 107.326 -1.361 . . . . 6.77 107.326 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.48 175.3 40.47 Favored Glycine 0 CA--C 1.531 1.082 0 N-CA-C 107.52 -2.232 . . . . 2.71 107.52 141.002 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -72.35 118.04 14.75 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 123.44 0.696 . . . . 4.11 109.538 177.024 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -74.46 136.1 20.61 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 106.541 -2.624 . . . . 1.96 106.541 161.442 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.91 133.53 69.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 108.47 -0.937 . . . . 3.31 108.47 -173.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 58.9 mt -134.31 130.29 36.79 Favored 'General case' 0 N--CA 1.454 -0.25 0 N-CA-C 108.335 -0.987 . . . . 3.24 108.335 170.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -114.11 91.93 3.8 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.454 1.502 . . . . 2.5 108.596 174.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -101.67 134.46 44.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 107.374 -1.343 . . . . 1.32 107.374 176.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 5.5 p -80.33 115.69 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 106.949 -1.5 . . . . 2.89 106.949 170.186 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.8 m -93.54 86.45 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.652 0 C-N-CA 125.938 1.695 . . . . 0.65 107.698 -173.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 63.2 mtt85 -77.34 130.9 37.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.23 -1.026 . . . . 5.62 108.23 -170.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.16 -18.83 4.17 Favored Glycine 0 CA--C 1.529 0.957 0 C-N-CA 123.718 0.675 . . . . 1.01 112.541 -179.516 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 61.5 mtp -59.19 147.67 34.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 118.574 1.187 . . . . 1.88 110.863 177.252 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.7 t -150.75 -10.93 0.24 Allowed 'General case' 0 CA--C 1.536 0.438 0 N-CA-C 114.761 1.393 . . . . 2.87 114.761 178.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 15.9 p -165.59 172.01 12.47 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 121.032 1.742 . . . . 1.46 109.371 -179.132 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.88 -38.99 11.28 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.379 1.472 . . . . 1.0 112.147 -179.609 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.5 m -45.71 -47.0 15.28 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 123.924 0.889 . . . . 1.47 111.65 173.903 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.0 m -69.75 -39.84 76.48 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 122.79 0.436 . . . . 0.7 110.98 -177.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 41.7 t -57.75 -59.58 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 107.998 -1.112 . . . . 0.74 107.998 -179.883 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.269 1.3 p-80 -70.8 -31.46 68.21 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 118.206 -0.902 . . . . 0.88 112.521 -175.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -49.15 -58.15 5.48 Favored 'General case' 0 C--N 1.347 0.465 0 N-CA-C 108.178 -1.045 . . . . 3.93 108.178 165.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 73.6 mt -61.19 -60.87 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-O 118.572 -0.728 . . . . 1.1 110.239 -174.298 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -53.03 -55.31 24.63 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 119.39 0.995 . . . . 2.59 110.853 -175.993 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 24.1 t -58.09 -54.21 49.52 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-O 121.538 0.685 . . . . 1.53 110.28 -177.815 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 8.0 t -66.82 -40.62 88.1 Favored 'General case' 0 N--CA 1.448 -0.535 0 O-C-N 121.709 -0.62 . . . . 0.93 110.952 -170.32 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -66.98 -42.69 84.64 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 118.115 0.416 . . . . 1.75 109.935 177.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 93.7 m -55.27 -27.23 45.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 118.5 0.591 . . . . 2.38 112.354 176.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.97 -30.57 64.19 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.09 -1.006 . . . . 3.83 112.153 173.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.3 m-70 -63.92 108.61 1.53 Allowed 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 119.346 0.975 . . . . 2.89 108.808 173.325 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 80.1 ttt180 -48.4 -33.44 9.15 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.896 0.878 . . . . 6.19 112.37 175.255 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -74.85 -18.35 80.12 Favored Glycine 0 CA--C 1.529 0.915 0 CA-C-O 118.642 -1.088 . . . . 0.81 114.042 -179.811 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.21 135.59 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 CA-C-N 118.94 1.37 . . . . 2.1 107.774 172.57 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.2 pp -98.6 -33.61 10.9 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 118.692 -0.67 . . . . 2.65 109.82 173.35 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 13.8 t80 -157.04 146.17 20.17 Favored 'General case' 0 C--N 1.345 0.406 0 CA-C-N 119.463 1.029 . . . . 2.8 109.642 162.0 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 22.6 t -112.65 112.3 23.71 Favored 'General case' 0 C--O 1.226 -0.178 0 N-CA-C 107.382 -1.34 . . . . 2.51 107.382 164.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -103.11 98.29 8.25 Favored 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.837 -1.172 . . . . 1.94 107.837 171.714 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 1.7 p -89.0 146.28 6.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 110.351 -0.24 . . . . 1.87 110.351 170.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.7 130.26 15.88 Favored 'General case' 0 CA--C 1.523 -0.092 0 O-C-N 122.02 -0.425 . . . . 0.83 111.293 170.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.7 pp -72.14 -25.82 61.87 Favored 'General case' 0 C--O 1.227 -0.121 0 C-N-CA 124.756 1.223 . . . . 2.12 113.074 -168.89 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.1 -43.46 66.85 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.809 0.444 . . . . 1.11 111.191 -178.639 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -101.73 -31.75 10.63 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.591 1.156 . . . . 2.22 110.038 173.322 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 76.2 30.91 0.67 Allowed 'General case' 0 C--O 1.225 -0.228 0 C-N-CA 127.14 2.176 . . . . 2.33 109.464 -171.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.3 mmtt -79.5 145.01 33.45 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 107.373 -1.343 . . . . 4.0 107.373 171.507 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -107.48 109.71 21.47 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 124.888 1.367 . . . . 0.81 107.406 151.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 5.9 t60 -80.38 94.3 6.13 Favored 'General case' 0 N--CA 1.429 -1.504 0 N-CA-C 105.705 -1.961 . . . . 3.86 105.705 166.637 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 13.8 mt -92.11 116.13 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 107.216 -1.401 . . . . 1.52 107.216 176.571 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.0 mttt -108.09 128.44 54.68 Favored 'General case' 0 N--CA 1.445 -0.687 0 N-CA-C 106.606 -1.627 . . . . 3.32 106.606 174.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 18.1 p90 -157.24 171.8 19.76 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.421 0.688 . . . . 2.26 109.637 -166.67 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -93.76 114.36 62.85 Favored Pre-proline 0 CA--C 1.535 0.373 0 N-CA-C 109.169 -0.678 . . . . 3.12 109.169 177.536 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -79.25 49.68 3.24 Favored 'Trans proline' 0 CA--C 1.536 0.612 0 C-N-CA 123.41 2.74 . . . . 1.33 112.15 -174.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -152.96 27.24 0.54 Allowed 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.748 1.219 . . . . 3.84 110.234 -179.338 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -153.78 -51.46 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.455 -0.2 0 C-N-CA 125.021 1.328 . . . . 3.4 108.998 -178.629 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 tt -127.67 152.59 35.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 C-N-CA 124.241 1.016 . . . . 1.11 108.478 -174.973 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -133.83 -176.09 14.22 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 111.538 -0.625 . . . . 0.74 111.538 -178.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -59.92 -41.62 52.0 Favored 'Trans proline' 0 N--CA 1.451 -1.015 0 C-N-CA 122.859 2.373 . . . . 0.81 111.872 -176.797 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.5 mpp_? -57.39 -47.49 81.55 Favored 'General case' 0 C--N 1.34 0.176 0 CA-C-N 118.629 0.65 . . . . 6.14 110.863 -179.846 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -58.95 -52.85 63.98 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.818 -0.808 . . . . 2.71 108.818 -175.853 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 35.1 mm -51.77 -52.25 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 C-N-CA 124.405 1.082 . . . . 1.95 109.901 175.304 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.418 ' HA ' ' CG ' ' A' ' 69' ' ' PRO . 5.1 mt -55.29 -57.3 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 109.848 -0.427 . . . . 0.87 109.848 -179.026 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 21.9 m-70 -65.24 -34.2 77.8 Favored 'General case' 0 C--N 1.33 -0.25 0 O-C-N 121.623 -0.673 . . . . 3.0 110.23 -171.911 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 97.5 m -59.2 -55.95 28.38 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.049 -0.523 . . . . 0.88 109.937 171.674 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 76.8 mt -63.86 -36.24 76.0 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 O-C-N 121.35 -0.844 . . . . 1.22 111.35 -175.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -51.2 -55.06 19.96 Favored 'General case' 0 C--N 1.34 0.168 0 N-CA-C 109.208 -0.664 . . . . 2.81 109.208 167.53 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.7 t -54.76 -42.08 71.23 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 122.696 0.398 . . . . 1.82 111.559 177.348 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 78.5 mt -68.48 -10.94 58.81 Favored 'General case' 0 CA--C 1.536 0.406 0 N-CA-C 113.185 0.809 . . . . 1.4 113.185 176.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 88.08 44.1 5.46 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 123.941 0.782 . . . . 0.98 111.976 172.751 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.0 m-85 -140.82 163.53 32.69 Favored 'General case' 0 C--O 1.226 -0.144 0 N-CA-C 107.174 -1.417 . . . . 2.45 107.174 167.301 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -103.91 105.01 46.31 Favored Pre-proline 0 N--CA 1.447 -0.602 0 C-N-CA 125.429 1.492 . . . . 4.59 109.984 -179.431 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.418 ' CG ' ' HA ' ' A' ' 59' ' ' ILE . 60.6 Cg_endo -83.49 85.29 1.52 Allowed 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 124.538 3.492 . . . . 0.94 111.317 -173.818 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 21.6 t -94.11 111.97 23.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.851 -0.531 . . . . 1.75 110.136 -173.057 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 55.8 mt -62.14 106.41 0.72 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.96 0.904 . . . . 3.01 109.924 174.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 13.7 t -93.3 -66.95 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 N-CA-C 109.7 -0.481 . . . . 2.49 109.7 177.526 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -175.52 132.09 0.28 Allowed 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.597 -1.26 . . . . 5.84 107.597 -166.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 34.7 pt -93.92 153.26 3.42 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 125.463 1.505 . . . . 8.29 107.036 158.309 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 . . . . . 0 C--O 1.253 1.26 0 C-N-CA 126.911 2.084 . . . . 11.61 112.135 177.416 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.3 mtp . . . . . 0 N--CA 1.47 0.54 0 CA-C-O 115.713 -2.089 . . . . 8.4 105.702 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -165.01 63.78 0.23 Allowed Glycine 0 C--N 1.334 0.419 0 CA-C-N 121.382 1.901 . . . . 3.55 109.101 -174.856 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 178.38 163.94 0.73 Allowed 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.101 -1.814 . . . . 4.33 106.101 -162.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -165.69 158.9 31.98 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 109.101 -1.6 . . . . 1.72 109.101 -179.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 16.3 t -147.15 136.3 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 106.664 -1.606 . . . . 2.8 106.664 -179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -155.26 175.13 14.25 Favored 'General case' 0 C--O 1.232 0.176 0 N-CA-C 107.681 -1.229 . . . . 3.44 107.681 163.111 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -131.83 146.45 52.14 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.725 -0.843 . . . . 2.47 108.725 168.077 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.468 ' N ' HD23 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -132.42 131.41 41.75 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 106.791 -1.559 . . . . 1.35 106.791 169.178 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 69.5 t -79.92 100.94 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 107.022 -1.473 . . . . 1.02 107.022 175.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.21 87.03 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 126.056 1.742 . . . . 0.91 108.096 177.952 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.12 154.33 33.37 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 107.811 -1.181 . . . . 5.07 107.811 170.171 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.54 -38.42 3.21 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 110.628 -0.989 . . . . 0.72 110.628 -172.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 29.9 mtp -64.06 138.15 58.32 Favored 'General case' 0 N--CA 1.45 -0.426 0 CA-C-N 118.229 1.015 . . . . 1.57 109.607 178.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.5 t -140.54 -2.76 1.36 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 114.128 1.159 . . . . 2.41 114.128 -176.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 7.1 p -161.43 166.09 27.81 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 120.44 1.473 . . . . 1.17 110.063 -179.725 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.89 -40.56 10.19 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.371 1.468 . . . . 0.98 111.875 -177.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 13.3 m -43.27 -47.04 6.49 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.856 0.863 . . . . 1.53 112.304 174.951 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 65.0 m -67.6 -33.77 75.66 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.005 0.522 . . . . 0.91 111.436 -175.054 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 37' ' ' VAL . 42.4 t -59.22 -59.91 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 N-CA-C 107.112 -1.44 . . . . 0.66 107.112 -178.856 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.25 1.5 p-80 -67.97 -30.03 69.21 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-N 116.179 -0.464 . . . . 1.0 112.062 -178.261 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 40.9 tttt -52.67 -44.95 66.54 Favored 'General case' 0 N--CA 1.449 -0.503 0 O-C-N 121.57 -0.706 . . . . 3.84 110.615 168.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 21.6 mt -70.39 -71.46 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.378 0 N-CA-C 109.126 -0.694 . . . . 1.07 109.126 175.653 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . 0.283 0.2 OUTLIER -59.15 -50.02 75.64 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 119.238 0.926 . . . . 4.32 112.471 -159.745 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.9 t -56.37 -46.36 80.08 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.376 0.67 . . . . 1.5 110.497 176.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.7 t -71.24 -35.27 71.39 Favored 'General case' 0 N--CA 1.455 -0.225 0 O-C-N 121.232 -0.917 . . . . 1.38 112.142 -176.161 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -59.77 -54.07 50.59 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.004 -0.739 . . . . 1.77 109.004 172.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 28.2 p -65.25 71.48 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.799 1.24 . . . . 1.59 113.081 -174.717 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 20.7 pttm -169.83 -31.09 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.915 2.486 . . . . 3.9 111.567 171.299 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 25.1 p80 -67.69 147.23 52.94 Favored 'General case' 0 C--N 1.346 0.425 0 CA-C-N 120.307 1.412 . . . . 2.26 108.78 177.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 37.8 ttm105 -61.66 142.76 56.98 Favored 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 108.263 -1.014 . . . . 5.43 108.263 173.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 113.65 -56.52 0.48 Allowed Glycine 0 N--CA 1.448 -0.552 0 N-CA-C 110.669 -0.973 . . . . 1.29 110.669 179.103 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -76.11 103.95 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.985 0 CA-C-N 118.509 1.155 . . . . 2.39 110.993 -167.521 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.4 pp -82.3 -29.72 30.97 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.589 -0.732 . . . . 2.58 110.292 177.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 88.9 t80 -156.44 158.04 36.6 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 118.573 0.624 . . . . 2.55 109.38 179.92 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 28.9 t -142.9 133.79 25.51 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 124.206 1.003 . . . . 2.42 108.53 169.484 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 2.0 m -112.19 93.14 4.3 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.644 -1.243 . . . . 2.39 107.644 160.838 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.439 HG13 HG13 ' A' ' 19' ' ' VAL . 9.4 p -88.82 144.94 8.06 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 C-N-CA 122.551 0.34 . . . . 1.55 111.096 162.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -145.74 138.85 26.07 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.172 0.989 . . . . 0.89 110.039 171.376 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.74 -35.85 60.07 Favored 'General case' 0 C--O 1.226 -0.132 0 C-N-CA 123.602 0.761 . . . . 1.89 110.885 -179.649 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -49.28 -42.61 41.64 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 124.289 1.035 . . . . 1.49 111.849 -173.961 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.1 p -114.84 20.09 15.41 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 124.908 1.283 . . . . 2.8 110.615 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.2 m120 37.13 55.64 1.28 Allowed 'General case' 0 C--N 1.341 0.211 0 C-N-CA 126.777 2.031 . . . . 2.22 111.431 -179.64 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 15.1 ptpt -134.15 150.56 51.12 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 118.418 0.554 . . . . 1.67 112.488 -176.213 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -120.77 119.85 33.92 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 127.134 2.174 . . . . 0.72 107.535 167.673 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.6 t-160 -101.12 101.42 12.15 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 104.164 -2.532 . . . . 2.22 104.164 167.449 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.467 HD13 HD21 ' A' ' 8' ' ' LEU . 4.8 mp -94.59 143.79 11.03 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.116 0 N-CA-C 108.116 -1.068 . . . . 1.34 108.116 177.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 27.3 mtpt -120.43 91.0 3.43 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.937 -1.134 . . . . 2.23 107.937 175.969 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -102.37 149.79 24.0 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 124.003 0.921 . . . . 2.35 113.205 179.337 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 53.9 m-20 -71.71 116.03 43.78 Favored Pre-proline 0 C--O 1.234 0.275 0 C-N-CA 124.83 1.252 . . . . 3.15 108.574 171.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_endo -79.41 40.21 0.92 Allowed 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.264 1.976 . . . . 1.8 111.586 -177.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.2 pt-20 -82.32 -40.33 21.59 Favored 'General case' 0 N--CA 1.455 -0.191 0 O-C-N 121.698 -0.626 . . . . 6.35 109.818 172.417 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 17.0 pt -133.63 -51.09 0.64 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 C-N-CA 123.717 0.807 . . . . 2.28 112.098 -168.058 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -90.76 147.0 5.51 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 123.307 0.643 . . . . 1.07 109.823 -166.546 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.12 -171.66 13.01 Favored Glycine 0 CA--C 1.529 0.924 0 N-CA-C 110.892 -0.883 . . . . 0.76 110.892 178.177 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -64.25 -34.47 56.03 Favored 'Trans proline' 0 N--CA 1.452 -0.938 0 C-N-CA 122.46 2.107 . . . . 0.93 110.519 176.51 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.526 HH21 ' CE1' ' A' ' 60' ' ' HIS . 1.7 tpm_? -50.37 -54.23 23.24 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.361 1.064 . . . . 7.53 111.163 179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -61.85 -52.51 63.85 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 124.232 1.013 . . . . 2.66 109.183 -176.559 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 94.8 mt -52.08 -47.85 42.52 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.136 0 C-N-CA 123.647 0.779 . . . . 1.29 109.4 178.446 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.7 mt -55.38 -54.13 28.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.689 0 N-CA-C 109.381 -0.6 . . . . 0.73 109.381 -178.902 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . 0.526 ' CE1' HH21 ' A' ' 56' ' ' ARG . 76.7 m-70 -65.48 -34.88 79.32 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 118.801 0.728 . . . . 3.19 111.367 -176.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 91.8 m -57.08 -52.23 66.11 Favored 'General case' 0 CA--C 1.538 0.483 0 N-CA-C 109.076 -0.713 . . . . 0.7 109.076 173.897 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 87.9 mt -70.87 -32.37 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 O-C-N 121.242 -0.911 . . . . 1.01 112.242 -178.09 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 87.8 mt-10 -53.96 -49.06 69.58 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 108.346 -0.983 . . . . 2.75 108.346 166.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 14.6 m -60.5 -40.93 93.15 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 122.157 0.183 . . . . 1.4 111.34 177.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 64.0 mt -61.38 -34.33 75.16 Favored 'General case' 0 N--CA 1.465 0.323 0 O-C-N 121.611 -0.681 . . . . 1.19 111.582 172.451 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 105.48 43.85 1.53 Allowed Glycine 0 CA--C 1.525 0.693 0 C-N-CA 124.886 1.231 . . . . 0.85 112.206 173.269 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -134.2 168.83 18.15 Favored 'General case' 0 N--CA 1.461 0.119 0 N-CA-C 108.732 -0.84 . . . . 1.95 108.732 170.589 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -110.92 85.05 4.74 Favored Pre-proline 0 CA--C 1.54 0.56 0 C-N-CA 124.059 0.944 . . . . 3.57 110.982 -172.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.64 93.42 0.69 Allowed 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 123.788 2.992 . . . . 0.89 111.37 -175.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.2 m -86.22 119.53 26.6 Favored 'General case' 0 N--CA 1.449 -0.498 0 C-N-CA 124.888 1.275 . . . . 1.86 108.116 -179.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 64.0 mt -74.56 58.05 0.76 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 120.05 1.296 . . . . 2.64 112.184 -175.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 16.5 t -86.42 63.26 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 107.604 -1.258 . . . . 2.69 107.604 177.462 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.32 65.71 1.67 Allowed 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 123.767 0.827 . . . . 4.86 108.813 176.284 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 8.1 tp -80.85 -41.9 19.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 124.367 1.067 . . . . 7.75 110.943 -179.476 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.084 0 C-N-CA 125.296 1.438 . . . . 9.81 109.748 -174.466 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.1 mtt . . . . . 0 N--CA 1.472 0.629 0 N-CA-C 106.186 -1.783 . . . . 6.93 106.186 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -150.68 156.37 26.66 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 107.243 -2.343 . . . . 3.83 107.243 173.462 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -70.59 131.9 44.65 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 124.968 1.307 . . . . 4.26 109.774 177.792 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.37 83.73 0.87 Allowed Glycine 0 C--N 1.335 0.491 0 N-CA-C 108.737 -1.745 . . . . 2.18 108.737 178.28 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 m -79.51 129.0 38.23 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 117.211 0.506 . . . . 2.71 109.768 177.286 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.0 pp -150.3 164.92 34.54 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.748 -0.834 . . . . 3.23 108.748 161.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.05 153.26 51.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-O 121.629 0.728 . . . . 4.44 109.944 179.803 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.82 134.63 30.43 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.669 -1.604 . . . . 1.39 106.669 -177.259 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.0 t -78.16 102.47 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 105.513 -2.032 . . . . 1.0 105.513 177.485 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 m -90.79 71.64 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.754 0 N-CA-C 106.471 -1.678 . . . . 0.75 106.471 -172.297 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 24.7 ptt-85 -74.72 124.13 26.2 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 118.883 -1.127 . . . . 4.94 108.112 -159.808 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.19 -26.11 3.26 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-N 115.328 -0.851 . . . . 0.82 111.946 -179.268 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -74.86 109.86 8.67 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 118.883 1.341 . . . . 1.59 110.462 -176.299 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 13.1 p -83.67 -44.6 14.33 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 121.85 -0.532 . . . . 3.36 112.186 -170.718 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 25.8 p -149.28 177.37 9.72 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 112.073 0.397 . . . . 1.41 112.073 -156.32 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -41.28 -48.51 3.6 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 125.706 1.602 . . . . 0.8 111.785 177.908 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 2.2 m -48.09 -46.64 34.04 Favored 'General case' 0 N--CA 1.451 -0.396 0 C-N-CA 125.326 1.451 . . . . 1.96 111.779 176.825 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 57.9 m -72.24 -53.58 12.1 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 122.877 0.471 . . . . 0.74 110.689 176.426 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 42.2 t -43.91 -60.07 0.44 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.219 0 C-N-CA 125.281 1.432 . . . . 0.6 109.347 -176.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -71.52 -12.37 61.34 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 113.61 0.967 . . . . 1.04 113.61 -176.037 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.91 -53.2 19.0 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.553 -1.647 . . . . 3.68 106.553 163.182 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.6 mt -65.4 -60.22 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.255 0 CA-C-N 118.445 0.566 . . . . 0.66 109.596 -169.644 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . 0.264 0.2 OUTLIER -58.36 -53.58 56.69 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 119.765 -0.774 . . . . 4.51 111.311 -166.123 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 22.8 t -60.9 -48.87 79.83 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 118.225 -0.893 . . . . 2.01 109.868 177.171 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.5 t -63.75 -42.71 97.81 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 119.883 1.22 . . . . 1.16 110.837 -170.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -63.33 -46.17 87.9 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.423 -0.584 . . . . 2.14 109.423 174.842 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 7.5 m -71.73 65.45 0.5 Allowed 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.256 0.55 . . . . 2.81 111.53 174.768 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.7 mmtm -146.81 -49.81 0.2 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 128.677 2.791 . . . . 7.09 108.459 170.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -61.04 130.13 44.86 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-O 120.843 0.354 . . . . 1.97 110.938 -174.317 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -61.78 90.43 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.923 0.889 . . . . 7.15 110.079 -179.271 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 161.08 -29.68 0.32 Allowed Glycine 0 N--CA 1.449 -0.472 0 CA-C-O 119.207 -0.774 . . . . 1.24 112.037 178.393 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -79.46 134.91 26.71 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.175 0 N-CA-C 107.386 -1.339 . . . . 2.18 107.386 165.654 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.3 pp -102.49 -29.33 11.66 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 123.969 0.793 . . . . 2.13 110.13 172.082 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 87.5 t80 -156.24 162.46 40.15 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-N 119.307 0.958 . . . . 2.57 109.692 172.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.8 t -142.86 149.22 38.25 Favored 'General case' 0 C--O 1.232 0.141 0 C-N-CA 124.328 1.051 . . . . 2.02 108.229 171.823 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 39.8 m -146.5 136.73 23.68 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 107.517 -1.29 . . . . 2.14 107.517 157.148 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.407 HG12 ' CB ' ' A' ' 44' ' ' ALA . 3.1 m -122.57 141.86 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 123.397 0.679 . . . . 1.76 109.351 -178.955 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -130.99 131.48 44.4 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.306 0.643 . . . . 0.72 110.4 177.686 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -72.33 -33.98 67.73 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-N 114.812 -1.086 . . . . 2.27 110.982 -173.19 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -53.09 -47.17 68.75 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.372 1.069 . . . . 1.21 112.452 -175.646 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.7 p -102.86 14.73 31.23 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.933 0.893 . . . . 2.44 110.645 174.96 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 34.1 46.21 0.15 Allowed 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 129.082 2.953 . . . . 3.17 112.335 -173.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -125.47 144.61 50.46 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 118.624 0.647 . . . . 3.61 112.274 -176.736 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.407 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -101.84 130.19 48.24 Favored 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.255 1.822 . . . . 0.65 106.444 172.004 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -107.41 109.67 21.45 Favored 'General case' 0 N--CA 1.432 -1.343 0 N-CA-C 101.401 -3.555 . . . . 2.35 101.401 176.729 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.02 134.58 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.8 0 N-CA-C 106.054 -1.832 . . . . 1.05 106.054 -179.362 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 40.5 mttt -112.52 116.18 29.82 Favored 'General case' 0 N--CA 1.44 -0.941 0 N-CA-C 106.204 -1.776 . . . . 2.2 106.204 169.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -123.62 157.56 33.47 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.107 0.563 . . . . 2.85 111.011 -178.589 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 45.1 m-20 -72.58 116.54 50.64 Favored Pre-proline 0 CA--C 1.534 0.328 0 N-CA-C 106.963 -1.495 . . . . 3.04 106.963 176.78 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.19 27.26 0.37 Allowed 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.226 2.617 . . . . 2.48 115.7 -156.655 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -135.55 -34.75 0.83 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.363 1.465 . . . . 3.9 112.969 -178.626 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.91 -41.51 18.41 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 123.781 0.832 . . . . 3.34 111.312 -165.838 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 14.8 tt -136.28 158.17 38.02 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.074 0 C-N-CA 123.832 0.853 . . . . 1.43 108.728 -169.085 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.84 -178.89 15.86 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-N 118.484 0.584 . . . . 0.64 111.85 -174.916 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -57.63 -39.98 83.67 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 122.797 2.331 . . . . 0.75 110.472 171.533 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 17.2 tpt180 -51.66 -49.48 62.25 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.729 0.812 . . . . 6.63 112.081 -176.867 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -62.79 -51.55 66.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 109.377 -0.601 . . . . 2.65 109.377 -175.197 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.8 mt -52.27 -47.48 45.24 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 C-N-CA 123.602 0.761 . . . . 1.42 108.989 175.696 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 28.7 mt -55.89 -54.99 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 N-CA-C 109.883 -0.414 . . . . 0.54 109.883 -176.037 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -64.08 -34.74 78.72 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.026 0.441 . . . . 3.15 110.671 -178.298 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 87.6 m -58.66 -51.26 70.7 Favored 'General case' 0 CA--C 1.541 0.619 0 O-C-N 122.196 -0.315 . . . . 0.75 110.483 173.868 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.8 mm -63.98 -42.26 95.16 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 O-C-N 121.143 -0.973 . . . . 1.55 110.915 -179.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -52.83 -47.54 67.64 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 109.455 -0.572 . . . . 2.66 109.455 172.37 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 16.6 m -59.15 -42.98 91.97 Favored 'General case' 0 CA--C 1.536 0.431 0 N-CA-C 111.898 0.333 . . . . 1.54 111.898 175.844 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 28.7 mt -64.47 -29.14 70.18 Favored 'General case' 0 C--O 1.238 0.467 0 O-C-N 121.534 -0.729 . . . . 1.06 112.411 175.983 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 112.27 40.1 1.18 Allowed Glycine 0 CA--C 1.529 0.907 0 C-N-CA 124.3 0.953 . . . . 0.68 113.385 167.047 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -136.25 164.72 27.43 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 118.175 0.987 . . . . 1.98 108.643 171.389 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -94.62 111.44 54.05 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-O 118.488 -0.768 . . . . 2.44 109.759 175.254 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.18 80.21 2.68 Favored 'Trans proline' 0 N--CA 1.457 -0.65 0 C-N-CA 123.612 2.875 . . . . 0.92 110.764 -178.243 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.47 105.35 10.72 Favored 'General case' 0 C--O 1.242 0.709 0 N-CA-C 109.137 -0.69 . . . . 1.76 109.137 -178.605 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.82 61.68 0.26 Allowed 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 125.606 1.562 . . . . 2.54 111.827 179.373 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 98.9 t -63.64 -33.75 63.55 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 123.468 0.707 . . . . 2.55 111.234 -177.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt 57.35 -122.01 1.5 Allowed 'General case' 0 CA--C 1.535 0.392 0 N-CA-C 109.258 -0.645 . . . . 5.52 109.258 -173.912 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.645 HG23 ' H ' ' A' ' 75' ' ' GLU . 15.5 tt -141.61 -59.71 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.186 0.994 . . . . 7.26 108.423 169.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.645 ' H ' HG23 ' A' ' 74' ' ' ILE . 50.7 mt-10 . . . . . 0 C--O 1.259 1.588 0 N-CA-C 102.68 -3.082 . . . . 10.0 102.68 135.793 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 77.1 mtm . . . . . 0 N--CA 1.467 0.388 0 N-CA-C 105.365 -2.087 . . . . 8.14 105.365 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 140.12 -35.56 1.89 Allowed Glycine 0 CA--C 1.525 0.678 0 N-CA-C 109.309 -1.517 . . . . 3.4 109.309 -168.604 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 65.27 -112.93 0.27 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.825 0.85 . . . . 4.73 110.291 158.182 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.25 -138.08 13.71 Favored Glycine 0 CA--C 1.523 0.533 0 N-CA-C 108.829 -1.708 . . . . 2.84 108.829 179.416 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -157.9 154.37 5.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 106.965 -1.494 . . . . 2.85 106.965 173.983 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 30.5 mt -130.54 126.84 37.79 Favored 'General case' 0 C--O 1.226 -0.163 0 N-CA-C 107.874 -1.158 . . . . 2.63 107.874 153.41 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -106.71 89.47 3.03 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 108.373 -0.973 . . . . 3.05 108.373 173.871 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.23 129.79 39.16 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.388 -0.967 . . . . 1.55 108.388 178.869 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 59.8 t -80.04 109.33 14.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 N-CA-C 106.029 -1.841 . . . . 1.35 106.029 173.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 2.6 m -93.42 92.53 3.69 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.758 0 C-N-CA 125.39 1.476 . . . . 0.79 108.175 -171.051 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 -76.58 139.46 40.68 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 108.481 -0.933 . . . . 4.97 108.481 -173.292 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 113.65 -42.39 1.95 Allowed Glycine 0 CA--C 1.526 0.753 0 C-N-CA 124.319 0.961 . . . . 0.72 111.141 177.746 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.81 126.82 30.96 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 117.982 0.891 . . . . 1.69 110.135 -176.273 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.1 t -154.38 17.87 0.48 Allowed 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.855 1.057 . . . . 2.26 113.855 -171.831 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.7 p -158.68 170.29 22.48 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 119.502 1.046 . . . . 1.39 109.234 169.34 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -45.35 -44.49 11.8 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.972 1.309 . . . . 1.75 111.961 -178.977 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.6 m -56.25 -43.82 79.05 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 122.574 0.349 . . . . 1.74 111.602 177.532 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 64.6 m -70.32 -45.41 66.26 Favored 'General case' 0 N--CA 1.45 -0.432 0 O-C-N 121.716 -0.615 . . . . 0.92 110.787 178.035 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 93.9 t -51.22 -58.72 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 108.204 -1.035 . . . . 1.0 108.204 179.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.298 0.7 OUTLIER -70.72 -24.8 62.7 Favored 'General case' 0 N--CA 1.441 -0.895 0 N-CA-C 113.146 0.795 . . . . 1.76 113.146 -172.174 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 9.6 mtpm? -57.9 -51.73 68.43 Favored 'General case' 0 C--N 1.345 0.372 0 N-CA-C 108.392 -0.966 . . . . 4.06 108.392 169.732 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 36.6 mt -59.11 -60.32 2.57 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.235 0 N-CA-C 109.431 -0.581 . . . . 0.97 109.431 174.169 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.94 -55.28 28.52 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 118.357 0.526 . . . . 4.48 110.9 -168.325 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 27.3 t -61.2 -53.04 61.89 Favored 'General case' 0 N--CA 1.444 -0.734 0 N-CA-C 109.122 -0.696 . . . . 1.92 109.122 -177.88 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.7 t -72.04 -36.51 69.66 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 119.089 -1.045 . . . . 1.13 112.285 -168.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -70.83 -59.51 2.76 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 108.61 -0.885 . . . . 1.74 108.61 176.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.7 m -71.98 64.95 0.53 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.665 0.786 . . . . 3.34 111.883 179.064 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 2.8 pptp? -169.9 -30.89 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 128.286 2.635 . . . . 3.68 110.951 170.507 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 6.5 p80 -64.6 132.2 49.14 Favored 'General case' 0 C--N 1.345 0.39 0 CA-C-N 119.866 1.212 . . . . 2.08 109.458 173.583 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 63.5 ttm-85 -51.89 145.39 9.92 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.867 -0.79 . . . . 5.47 108.867 174.075 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 99.6 -36.28 4.18 Favored Glycine 0 CA--C 1.523 0.541 0 CA-C-O 118.582 -1.121 . . . . 0.81 111.926 177.707 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -78.47 135.28 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 106.703 -1.591 . . . . 2.0 106.703 164.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.1 pp -99.01 -32.49 11.26 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.243 0.617 . . . . 2.63 109.469 171.093 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 52.3 t80 -156.57 161.4 39.96 Favored 'General case' 0 C--N 1.344 0.351 0 N-CA-C 108.68 -0.859 . . . . 2.33 108.68 172.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 1.1 p -132.93 148.34 52.28 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 108.947 -0.76 . . . . 1.93 108.947 154.598 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.46 88.66 2.98 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 106.808 -1.553 . . . . 1.87 106.808 168.608 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -85.28 136.21 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.601 0 C-N-CA 124.271 1.028 . . . . 1.94 111.838 170.353 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -144.6 140.17 28.57 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.77 0.828 . . . . 1.24 110.314 175.053 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 4.2 pp -76.96 -22.45 53.21 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.116 -0.493 . . . . 1.81 111.617 177.794 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -42.24 -38.02 1.65 Allowed 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.411 1.484 . . . . 1.72 113.212 -179.965 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -139.74 30.6 2.07 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.944 0.878 . . . . 2.31 110.291 170.554 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 14.1 m120 44.13 56.74 4.63 Favored 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 126.864 2.066 . . . . 1.89 110.579 176.067 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -141.78 139.63 32.84 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 122.176 -0.328 . . . . 2.01 110.69 -164.984 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -118.38 115.82 25.45 Favored 'General case' 0 N--CA 1.444 -0.725 0 C-N-CA 125.766 1.626 . . . . 0.77 110.463 176.893 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -82.29 96.63 7.96 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 106.249 -1.76 . . . . 2.5 106.249 169.371 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.7 mp -86.39 133.05 30.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 N-CA-C 107.94 -1.134 . . . . 1.28 107.94 175.27 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -115.25 115.8 27.28 Favored 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 105.44 -2.059 . . . . 2.86 105.44 173.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -147.14 153.53 40.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 C-N-CA 124.381 1.072 . . . . 2.85 108.405 -164.867 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -104.07 105.69 49.87 Favored Pre-proline 0 CA--C 1.534 0.357 0 O-C-N 124.362 1.039 . . . . 3.87 111.075 -178.19 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -77.0 60.41 6.85 Favored 'Trans proline' 0 N--CA 1.454 -0.798 0 C-N-CA 123.163 2.575 . . . . 1.5 112.1 -174.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -115.83 -54.87 2.47 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.044 0.938 . . . . 3.66 109.656 161.881 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 2.1 pp -96.18 -37.07 6.96 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 C-N-CA 122.98 0.512 . . . . 1.84 112.24 -174.463 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 1.9 tp -104.13 148.15 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.292 0 C-N-CA 124.996 1.318 . . . . 1.05 108.444 -178.434 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -119.46 -178.94 16.6 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 110.864 -0.895 . . . . 0.75 110.864 174.945 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -60.99 -40.45 52.18 Favored 'Trans proline' 0 N--CA 1.455 -0.783 0 C-N-CA 122.873 2.382 . . . . 0.77 110.357 174.122 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -50.39 -49.99 52.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.254 0.622 . . . . 5.85 112.083 179.352 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -56.16 -55.81 28.54 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 118.643 0.656 . . . . 2.47 109.991 -174.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 25.0 mt -50.42 -54.87 7.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.149 0 C-N-CA 124.654 1.182 . . . . 1.58 108.956 175.596 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 27.9 mt -58.07 -53.23 48.39 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.681 0 CA-C-N 115.85 -0.614 . . . . 0.96 110.403 -173.384 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 27.2 m-70 -66.58 -33.03 74.77 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 123.329 0.652 . . . . 3.08 110.107 -175.522 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.7 m -57.85 -51.83 67.97 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 109.78 -0.452 . . . . 0.78 109.78 169.783 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 94.6 mt -67.24 -37.93 80.06 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 O-C-N 121.186 -0.946 . . . . 1.16 111.733 -176.788 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -53.99 -50.01 67.52 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.939 -0.763 . . . . 3.44 108.939 169.148 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.3 m -58.94 -38.82 79.89 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 122.008 -0.433 . . . . 1.74 111.992 176.084 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 90.6 mt -64.38 -18.57 64.8 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.549 -0.738 . . . . 1.06 112.511 172.882 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 95.42 33.21 6.59 Favored Glycine 0 CA--C 1.526 0.743 0 C-N-CA 124.749 1.166 . . . . 0.81 112.273 174.176 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 19.8 m-85 -133.01 158.65 42.17 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 118.025 0.913 . . . . 2.15 108.846 177.549 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.74 105.8 29.32 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 118.492 -0.766 . . . . 2.9 110.083 -178.081 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.3 Cg_endo -79.4 79.62 3.32 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 122.922 2.414 . . . . 1.29 110.291 -179.856 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.8 t -78.97 116.79 19.5 Favored 'General case' 0 N--CA 1.45 -0.436 0 O-C-N 121.704 -0.623 . . . . 2.15 109.632 -175.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 67.8 mt -74.04 63.0 0.92 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.301 1.04 . . . . 3.18 110.225 177.494 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 91.6 t -62.9 -42.49 96.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 O-C-N 121.739 -0.6 . . . . 2.66 109.533 179.147 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 72.2 mmtt -76.73 64.33 2.3 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 121.942 -0.474 . . . . 7.7 110.069 172.446 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 9.4 tp -76.1 164.68 3.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 N-CA-C 108.23 -1.026 . . . . 9.95 108.23 164.619 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 . . . . . 0 C--O 1.253 1.259 0 CA-C-O 117.708 -1.139 . . . . 11.36 109.95 171.333 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.2 ttt . . . . . 0 N--CA 1.469 0.521 0 N-CA-C 106.15 -1.796 . . . . 9.21 106.15 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 167.58 57.14 0.03 OUTLIER Glycine 0 CA--C 1.521 0.43 0 N-CA-C 106.67 -2.572 . . . . 3.05 106.67 -179.025 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -168.19 144.27 3.84 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.362 -0.977 . . . . 4.03 108.362 -158.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -145.58 90.94 0.15 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 107.908 -2.077 . . . . 2.13 107.908 178.149 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 4.2 p -81.23 133.47 29.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 N-CA-C 108.642 -0.873 . . . . 2.48 108.642 171.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 55.3 tp -146.28 137.92 24.77 Favored 'General case' 0 N--CA 1.446 -0.66 0 N-CA-C 108.129 -1.063 . . . . 3.16 108.129 176.585 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -106.64 126.99 52.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 124.496 1.118 . . . . 2.86 109.509 173.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -131.25 128.59 40.17 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.752 1.221 . . . . 1.54 108.107 176.34 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . 0.257 0.6 OUTLIER -79.79 115.04 21.52 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 C-N-CA 124.384 1.074 . . . . 3.14 108.301 173.813 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 m -101.92 84.25 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 128.077 2.551 . . . . 0.65 107.221 -170.277 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 ppt_? -75.91 139.2 41.5 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 118.7 -1.2 . . . . 6.56 107.902 -167.929 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 120.28 -31.27 5.33 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 124.685 1.136 . . . . 0.83 111.134 -170.577 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 17.0 mtm -57.17 126.88 29.22 Favored 'General case' 0 C--N 1.344 0.335 0 CA-C-N 118.949 1.374 . . . . 1.59 110.388 176.398 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -140.47 -6.54 1.17 Allowed 'General case' 0 CA--C 1.536 0.41 0 N-CA-C 114.073 1.138 . . . . 2.18 114.073 -177.355 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 p -163.03 168.4 21.07 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 120.288 1.403 . . . . 1.12 109.834 179.639 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.44 -38.86 14.37 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 125.227 1.411 . . . . 0.85 112.172 -178.285 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 12.8 m -43.47 -50.0 7.11 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 124.613 1.165 . . . . 1.43 111.612 172.131 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 59.7 m -68.02 -45.52 73.77 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 122.996 0.518 . . . . 0.71 110.536 -179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 67.1 t -52.59 -61.01 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 108.238 -1.023 . . . . 0.55 108.238 -176.311 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . 0.252 1.3 p-80 -70.43 -28.59 65.16 Favored 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 114.829 -1.078 . . . . 0.87 111.964 -175.278 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 mtpp -53.11 -58.62 6.38 Favored 'General case' 0 C--N 1.345 0.374 0 CA-C-N 119.446 1.021 . . . . 3.58 109.564 168.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 7.1 mt -59.62 -58.51 6.77 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.242 0 C-N-CA 119.739 -0.784 . . . . 0.77 109.732 -177.437 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -52.87 -62.23 1.78 Allowed 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 123.382 0.426 . . . . 2.52 109.865 -174.012 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.2 t -55.2 -52.27 63.87 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 122.919 0.488 . . . . 1.46 110.432 -176.327 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 5.7 t -69.57 -32.08 70.64 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 120.621 -0.432 . . . . 1.28 111.306 -171.011 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.9 mt -70.19 -46.83 63.78 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 120.09 -0.644 . . . . 1.84 111.122 172.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 30.8 p -66.89 78.28 0.12 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.54 0.736 . . . . 1.69 111.178 -176.683 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.76 -37.08 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 128.651 2.78 . . . . 4.21 108.763 -178.0 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -68.23 114.28 6.57 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.791 -0.818 . . . . 2.04 108.791 174.773 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -57.17 152.83 12.89 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 108.521 -0.918 . . . . 7.88 108.521 166.346 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 100.87 -60.15 0.64 Allowed Glycine 0 N--CA 1.444 -0.811 0 N-CA-C 108.575 -1.81 . . . . 1.73 108.575 -152.79 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -78.01 149.36 5.91 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 CA-C-N 119.541 1.67 . . . . 1.71 108.507 179.643 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 pp -121.75 -25.07 5.12 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 115.368 -0.833 . . . . 2.41 111.035 168.517 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -155.68 157.57 36.86 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-N 119.313 0.96 . . . . 2.66 108.502 172.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 45.0 t -139.78 149.79 43.97 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.929 -1.137 . . . . 2.14 107.929 165.593 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 13.7 p -144.05 137.01 27.31 Favored 'General case' 0 N--CA 1.455 -0.2 0 N-CA-C 107.249 -1.389 . . . . 2.12 107.249 156.071 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -125.06 154.27 32.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 119.317 0.962 . . . . 1.71 110.213 179.035 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -141.28 137.66 32.65 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.027 0.931 . . . . 0.72 111.083 -176.032 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 88.1 mt -68.7 -34.5 75.76 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.677 1.191 . . . . 2.31 110.688 179.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -40.34 -42.36 1.54 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.904 1.682 . . . . 1.09 113.82 -174.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 8.0 t -138.61 35.8 2.22 Favored 'General case' 0 N--CA 1.461 0.122 0 C-N-CA 123.086 0.554 . . . . 2.73 110.239 170.579 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.9 m120 42.23 46.93 3.98 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 127.314 2.245 . . . . 1.82 109.954 176.434 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 13.1 ptpt -106.43 149.13 27.34 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.767 0.827 . . . . 2.38 110.927 -168.269 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -125.54 118.81 26.56 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.021 1.329 . . . . 0.67 107.743 172.056 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -98.64 102.44 14.18 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 102.375 -3.194 . . . . 2.34 102.375 176.794 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.8 mp -95.83 139.04 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 106.193 -1.78 . . . . 1.26 106.193 176.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.1 mtmp? -122.87 115.74 22.47 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.288 -1.375 . . . . 3.39 107.288 169.214 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -121.66 161.72 22.0 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.837 1.655 . . . . 2.47 111.15 -173.051 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -92.29 119.81 67.95 Favored Pre-proline 0 N--CA 1.454 -0.273 0 C-N-CA 126.246 1.818 . . . . 3.26 107.817 176.704 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 76.6 Cg_endo -78.43 53.1 4.4 Favored 'Trans proline' 0 N--CA 1.456 -0.687 0 C-N-CA 122.893 2.395 . . . . 2.6 110.195 179.52 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.9 pt-20 -103.17 -43.6 5.43 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 125.984 1.714 . . . . 6.39 109.62 -179.588 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.06 -46.15 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 C-N-CA 124.753 1.221 . . . . 2.59 112.109 -172.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 2.2 tp -81.77 150.09 4.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 C-N-CA 124.033 0.933 . . . . 1.26 110.533 -167.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -121.62 -176.83 15.34 Favored Glycine 0 CA--C 1.533 1.158 0 N-CA-C 110.301 -1.12 . . . . 1.07 110.301 169.847 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -61.8 -38.47 59.53 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.454 2.103 . . . . 1.17 110.386 173.634 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.5 tpt180 -50.27 -50.71 49.4 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.372 1.069 . . . . 6.3 111.705 -178.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.64 -54.59 45.11 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.742 0.817 . . . . 3.12 109.153 -177.665 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 60.6 mt -53.58 -49.11 57.62 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 C-N-CA 123.853 0.861 . . . . 1.7 109.127 178.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 23.8 mt -52.81 -58.9 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 C-N-CA 123.451 0.701 . . . . 0.95 109.956 -178.672 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 4.1 m-70 -66.08 -34.61 78.45 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.158 0.504 . . . . 3.49 111.114 -176.608 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 72.0 m -57.13 -51.7 68.25 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.314 -0.625 . . . . 1.08 109.314 174.245 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 96.6 mt -68.78 -35.05 67.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 O-C-N 121.548 -0.72 . . . . 1.24 111.541 -176.441 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -50.06 -52.98 30.13 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 109.329 -0.619 . . . . 2.82 109.329 166.128 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.5 t -57.61 -43.88 85.08 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 122.475 0.31 . . . . 1.5 111.574 177.232 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 41.3 mt -61.54 -27.58 68.71 Favored 'General case' 0 C--O 1.237 0.414 0 O-C-N 121.207 -0.933 . . . . 1.67 112.395 176.387 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 114.55 35.69 1.39 Allowed Glycine 0 CA--C 1.526 0.733 0 C-N-CA 124.52 1.057 . . . . 1.17 112.924 167.761 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 51.9 m-85 -139.35 152.61 47.3 Favored 'General case' 0 C--O 1.225 -0.191 0 N-CA-C 108.08 -1.082 . . . . 1.98 108.08 173.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 88.1 mt-10 -96.93 113.82 63.58 Favored Pre-proline 0 CA--C 1.536 0.416 0 N-CA-C 108.877 -0.786 . . . . 3.39 108.877 176.741 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -90.3 122.29 0.95 Allowed 'Trans proline' 0 N--CA 1.452 -0.937 0 C-N-CA 123.596 2.864 . . . . 1.1 111.563 -177.989 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 71.6 m -116.93 132.53 56.68 Favored 'General case' 0 C--O 1.226 -0.161 0 N-CA-C 107.352 -1.351 . . . . 1.47 107.352 170.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 7.3 mp -56.99 133.08 54.61 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 119.088 0.858 . . . . 3.83 110.341 -179.555 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 90.5 t -70.57 -51.1 40.08 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 108.5 -0.926 . . . . 5.28 108.5 172.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -104.86 112.05 25.03 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 124.166 0.986 . . . . 5.88 109.256 -173.338 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . 0.283 3.4 tt 59.15 174.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.168 2.187 . . . . 9.09 112.78 176.465 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 . . . . . 0 C--O 1.256 1.408 0 N-CA-C 104.963 -2.236 . . . . 12.45 104.963 179.436 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.472 0.662 0 CA-C-O 119.478 -0.296 . . . . 9.66 111.795 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -139.09 64.0 0.55 Allowed Glycine 0 C--N 1.336 0.538 0 N-CA-C 106.99 -2.444 . . . . 2.95 106.99 -177.658 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -159.39 150.0 19.4 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.231 -1.396 . . . . 4.13 107.231 -156.899 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.42 118.68 0.66 Allowed Glycine 0 CA--C 1.525 0.671 0 N-CA-C 108.855 -1.698 . . . . 2.22 108.855 -175.297 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.4 m -81.45 139.89 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 108.302 -0.999 . . . . 2.85 108.302 178.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.3 mp -110.3 153.17 25.25 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 108.779 -0.823 . . . . 3.0 108.779 171.495 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.476 ' C ' HD23 ' A' ' 8' ' ' LEU . 23.5 mt-10 -126.86 138.61 53.35 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 123.993 0.917 . . . . 2.64 110.424 177.124 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.647 HD21 HD13 ' A' ' 46' ' ' ILE . 0.1 OUTLIER -142.52 140.72 31.91 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 124.186 0.994 . . . . 1.43 108.907 -179.77 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.5 t -76.57 127.04 37.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 105.205 -2.146 . . . . 1.18 105.205 173.743 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.6 m -114.69 88.31 1.13 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 C-N-CA 124.989 1.316 . . . . 0.65 107.606 -175.619 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 27.9 mtp-105 -77.04 137.5 39.0 Favored 'General case' 0 CA--C 1.528 0.105 0 N-CA-C 108.559 -0.904 . . . . 5.96 108.559 -173.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.68 -41.72 1.47 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 110.938 -0.865 . . . . 0.88 110.938 177.103 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 23.2 ptt? -68.88 152.2 45.59 Favored 'General case' 0 N--CA 1.453 -0.296 0 CA-C-N 117.906 0.853 . . . . 1.28 110.881 -176.761 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.8 t -152.34 1.15 0.32 Allowed 'General case' 0 CA--C 1.536 0.422 0 N-CA-C 114.392 1.256 . . . . 2.16 114.392 -175.124 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.7 p -162.33 164.8 27.24 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 120.18 1.355 . . . . 1.19 109.725 179.18 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.21 -41.14 12.37 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 125.169 1.388 . . . . 0.86 111.403 179.63 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.2 m -36.93 -51.83 0.92 Allowed 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 127.28 2.232 . . . . 2.17 112.152 170.174 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 55.8 m -72.5 -51.49 19.8 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.862 0.865 . . . . 0.83 110.983 176.588 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 75.2 t -46.97 -60.46 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 C-N-CA 125.199 1.4 . . . . 0.49 109.017 -171.879 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -65.54 -24.81 67.2 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.872 -1.058 . . . . 1.08 111.329 -175.746 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -65.33 -55.07 20.3 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.224 -1.028 . . . . 5.06 108.224 174.556 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 8.3 mt -58.05 -54.57 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.137 0 N-CA-C 109.271 -0.641 . . . . 0.86 109.271 -179.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -55.67 -59.39 4.91 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.928 0.491 . . . . 2.43 110.565 -177.521 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 31.5 t -53.24 -52.12 60.0 Favored 'General case' 0 N--CA 1.456 -0.164 0 N-CA-C 109.688 -0.486 . . . . 1.5 109.688 -179.872 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 10.2 t -59.0 -40.61 85.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 122.958 0.503 . . . . 0.94 111.376 -176.332 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 mt -65.16 -43.93 90.17 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 118.635 -0.698 . . . . 2.26 110.891 176.846 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 33.3 p -70.7 60.66 0.23 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.772 0.829 . . . . 1.7 112.057 178.966 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 61.1 mmtt -153.78 -50.33 0.09 Allowed 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 129.497 3.119 . . . . 7.42 107.709 -176.7 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -69.52 137.47 52.51 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 109.701 -0.481 . . . . 2.25 109.701 -177.403 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.1 mtt180 -56.69 150.88 15.0 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 109.463 -0.569 . . . . 6.3 109.463 174.058 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.39 -28.38 8.31 Favored Glycine 0 N--CA 1.447 -0.613 0 CA-C-O 117.609 -1.662 . . . . 0.72 112.675 178.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.589 HD11 HG23 ' A' ' 46' ' ' ILE . 0.2 OUTLIER -75.41 130.97 35.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 CA-C-N 120.861 2.331 . . . . 1.69 107.159 172.691 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 65.4 mt -96.71 -48.75 5.37 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 124.902 1.281 . . . . 2.42 108.479 172.121 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -156.38 147.53 22.24 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 118.838 0.744 . . . . 2.85 109.646 177.328 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.0 t -121.34 150.81 40.89 Favored 'General case' 0 CA--C 1.522 -0.117 0 N-CA-C 107.197 -1.409 . . . . 2.24 107.197 170.395 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 30.0 t -143.42 150.11 38.59 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 118.491 -1.284 . . . . 2.7 108.79 141.827 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 2.4 m -122.74 132.77 70.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 C-N-CA 123.737 0.815 . . . . 1.75 110.279 177.235 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -114.48 134.93 54.64 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.72 0.808 . . . . 0.71 110.569 -177.804 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.81 -34.58 77.04 Favored 'General case' 0 CA--C 1.529 0.159 0 C-N-CA 124.65 1.18 . . . . 2.21 110.349 177.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -39.33 -41.87 0.97 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.227 1.811 . . . . 1.24 113.922 -176.164 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.2 t -137.72 33.0 2.46 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-O 121.898 0.856 . . . . 3.01 110.026 173.447 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 72.4 m-20 31.22 64.19 0.19 Allowed 'General case' 0 N--CA 1.462 0.171 0 C-N-CA 128.08 2.552 . . . . 2.9 111.964 -174.86 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.72 135.07 36.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 CA-C-N 115.966 -0.561 . . . . 1.9 110.971 -166.487 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.12 140.78 34.94 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.604 1.962 . . . . 0.87 108.949 177.574 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 2.1 p-80 -109.21 141.15 41.89 Favored 'General case' 0 N--CA 1.444 -0.766 0 N-CA-C 106.652 -1.61 . . . . 3.54 106.652 158.012 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.647 HD13 HD21 ' A' ' 8' ' ' LEU . 5.1 mp -125.32 114.48 40.06 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.546 0 N-CA-C 105.837 -1.912 . . . . 1.49 105.837 176.173 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 57.5 mttt -93.4 99.59 12.07 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.217 -2.142 . . . . 3.39 105.217 171.975 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -125.99 167.07 15.81 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.047 1.339 . . . . 2.13 111.845 -179.863 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -77.73 109.62 10.33 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 125.958 1.703 . . . . 2.97 109.82 179.045 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -79.32 63.24 8.7 Favored 'Trans proline' 0 N--CA 1.458 -0.606 0 C-N-CA 123.363 2.709 . . . . 1.91 112.105 -167.888 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -156.74 -74.35 0.1 Allowed 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.968 0.907 . . . . 3.26 110.04 177.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 25.5 pt -58.38 -26.93 31.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.084 0.954 . . . . 2.13 113.229 -177.89 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 tt -135.44 162.91 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 C-N-CA 124.609 1.163 . . . . 1.0 108.297 -178.422 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -150.96 179.16 27.89 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 109.46 -1.456 . . . . 0.99 109.46 -174.029 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -59.13 -40.66 67.87 Favored 'Trans proline' 0 N--CA 1.451 -0.98 0 C-N-CA 122.795 2.33 . . . . 1.0 111.608 -172.204 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -59.88 -37.04 78.22 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 112.453 0.538 . . . . 7.19 112.453 -175.492 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -61.3 -50.96 70.89 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-O 121.341 0.591 . . . . 3.93 109.805 179.136 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 53.9 mt -55.23 -50.18 66.47 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.643 -0.873 . . . . 1.6 108.643 176.168 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 19.9 mt -54.63 -53.16 34.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 CA-C-O 119.382 -0.342 . . . . 0.66 110.206 -178.08 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -56.47 -43.76 79.89 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.275 0.559 . . . . 2.89 109.74 179.246 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 89.3 m -58.63 -53.96 52.4 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 116.034 -0.53 . . . . 0.78 110.331 179.622 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 45.3 mm -65.55 -39.98 86.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.456 0 O-C-N 121.335 -0.853 . . . . 1.97 111.186 -177.252 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 57.9 mt-10 -53.39 -48.92 68.22 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 109.6 -0.519 . . . . 2.98 109.6 169.733 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 m -61.6 -42.57 99.05 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.93 0.344 . . . . 2.09 111.93 178.479 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 55.9 mt -61.43 -36.83 81.45 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 118.518 0.599 . . . . 1.23 110.948 175.039 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 111.81 47.42 0.73 Allowed Glycine 0 CA--C 1.525 0.665 0 C-N-CA 123.97 0.795 . . . . 0.81 111.763 172.145 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 23.8 m-85 -134.86 160.86 36.9 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 106.571 -1.64 . . . . 2.05 106.571 168.116 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -97.84 105.5 27.68 Favored Pre-proline 0 CA--C 1.537 0.451 0 CA-C-O 118.234 -0.889 . . . . 3.26 109.774 -179.689 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -84.25 136.17 6.6 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 122.699 2.266 . . . . 1.56 110.123 176.852 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.9 t -146.79 129.84 16.42 Favored 'General case' 0 C--O 1.226 -0.176 0 N-CA-C 108.968 -0.752 . . . . 2.53 108.968 171.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.476 ' CD2' ' H ' ' A' ' 71' ' ' LEU . 1.7 mm? -54.33 127.74 28.55 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 124.939 1.295 . . . . 2.78 110.593 -174.66 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 3.0 p -87.76 -43.67 15.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 CA-C-N 118.311 0.505 . . . . 4.87 110.319 -179.694 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -162.94 -165.65 1.16 Allowed 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 126.482 1.913 . . . . 6.1 107.56 175.694 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 40.3 mm 76.18 -55.72 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.212 0 C-N-CA 126.815 2.046 . . . . 8.8 108.208 -165.541 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 . . . . . 0 C--O 1.252 1.214 0 N-CA-C 105.928 -1.879 . . . . 11.47 105.928 154.568 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.7 tpt . . . . . 0 N--CA 1.468 0.438 0 N-CA-C 108.667 -0.864 . . . . 7.85 108.667 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 177.28 170.38 39.59 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 107.438 -2.265 . . . . 2.64 107.438 177.815 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -52.58 150.96 4.57 Favored 'General case' 0 N--CA 1.455 -0.202 0 C-N-CA 124.408 1.083 . . . . 4.04 111.179 -177.248 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -149.64 156.06 26.59 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 108.869 -1.692 . . . . 1.83 108.869 173.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 p -142.18 128.91 19.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 106.945 -1.502 . . . . 3.01 106.945 170.309 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.8 mp -128.45 151.34 49.5 Favored 'General case' 0 N--CA 1.454 -0.23 0 N-CA-C 108.297 -1.001 . . . . 3.39 108.297 177.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -125.06 129.55 50.48 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.189 0.996 . . . . 3.12 109.983 -166.607 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.71 136.63 36.01 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 124.532 1.133 . . . . 1.37 108.603 -174.102 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 39.2 t -76.33 124.6 34.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 N-CA-C 104.671 -2.344 . . . . 1.44 104.671 174.387 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 m -106.31 67.53 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.71 0 N-CA-C 106.973 -1.491 . . . . 0.85 106.973 -178.611 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -76.72 132.93 39.58 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.818 -0.808 . . . . 5.59 108.818 -166.307 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 132.63 -47.66 1.0 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 109.399 -1.48 . . . . 0.65 109.399 -169.284 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.11 142.09 36.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 117.683 0.741 . . . . 1.36 109.392 -176.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 14.1 t -156.75 19.05 0.32 Allowed 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 113.529 0.937 . . . . 2.72 113.529 -173.795 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -158.78 153.73 25.06 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 119.355 0.98 . . . . 1.47 110.018 179.499 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -46.34 -37.7 7.83 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 126.105 1.762 . . . . 1.09 112.812 -173.706 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.3 t -47.01 -54.73 9.57 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.173 0.589 . . . . 1.87 110.167 174.541 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 60.9 m -69.02 -33.49 73.72 Favored 'General case' 0 N--CA 1.447 -0.624 0 O-C-N 122.18 -0.325 . . . . 0.8 110.903 -176.15 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 95.8 t -57.08 -60.76 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.197 -1.038 . . . . 0.69 108.197 -178.372 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -68.54 -30.18 68.92 Favored 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.426 -0.807 . . . . 1.72 111.104 -176.435 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -56.94 -59.34 5.19 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 118.911 0.778 . . . . 5.63 109.991 170.158 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.423 HG21 HG11 ' A' ' 37' ' ' VAL . 60.8 mt -52.17 -51.61 29.89 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 118.905 0.775 . . . . 0.99 108.975 -178.435 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -50.97 -64.24 0.87 Allowed 'General case' 0 N--CA 1.451 -0.422 0 O-C-N 123.991 0.807 . . . . 3.3 110.657 -179.679 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.0 m -58.38 -42.25 86.64 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.946 0.879 . . . . 1.97 111.209 -177.003 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.3 t -66.44 -39.11 88.69 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.299 1.039 . . . . 1.44 110.029 -174.478 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 59.8 mt -71.76 -55.24 8.0 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 118.708 -0.663 . . . . 2.01 112.1 173.005 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 35.9 p -64.13 74.65 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.975 1.31 . . . . 1.64 112.592 -167.484 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -174.88 -40.13 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 127.372 2.269 . . . . 3.68 110.076 -175.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.41 ' CE1' ' HB ' ' A' ' 32' ' ' ILE . 24.0 p80 -73.98 172.46 11.6 Favored 'General case' 0 C--N 1.343 0.318 0 CA-C-O 121.293 0.568 . . . . 1.86 112.097 -172.152 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 35.1 ptt180 -51.28 128.05 21.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.68 -0.691 . . . . 12.15 110.74 178.125 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.27 -15.23 7.17 Favored Glycine 0 CA--C 1.529 0.918 0 CA-C-O 117.583 -1.676 . . . . 0.75 116.692 160.086 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.41 ' HB ' ' CE1' ' A' ' 29' ' ' HIS . 0.0 OUTLIER -76.1 109.59 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 CA-C-N 121.805 2.802 . . . . 2.13 109.257 175.371 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 60.3 mt -78.35 -42.03 31.73 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.157 -0.683 . . . . 2.52 109.157 -178.613 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -157.41 158.92 36.76 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.718 0.69 . . . . 3.19 109.268 177.368 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 11.6 t -124.16 138.78 54.38 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 126.001 1.72 . . . . 2.23 106.602 179.625 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 17.1 m -144.52 104.53 4.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.344 -0.984 . . . . 2.26 108.344 166.619 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.497 HG12 ' CB ' ' A' ' 44' ' ' ALA . 1.5 m -101.98 138.4 26.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.425 0 O-C-N 123.42 0.45 . . . . 1.96 111.131 172.322 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -119.83 133.15 55.69 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.588 0.755 . . . . 0.9 109.208 171.474 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 pp -80.86 -33.67 34.27 Favored 'General case' 0 C--O 1.224 -0.249 0 CA-C-N 115.35 -0.841 . . . . 1.96 111.366 -169.425 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -54.41 -34.33 61.09 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 123.171 0.588 . . . . 1.62 112.248 178.121 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -104.97 2.73 29.96 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.098 1.359 . . . . 2.1 111.562 176.761 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 18.4 m120 41.24 44.28 2.22 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 127.21 2.204 . . . . 1.94 111.351 -172.769 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.2 tmmt? -135.97 136.13 40.13 Favored 'General case' 0 C--N 1.34 0.158 0 O-C-N 122.024 -0.423 . . . . 2.38 111.461 -165.332 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.497 ' CB ' HG12 ' A' ' 37' ' ' VAL . . . -98.51 139.28 34.49 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.653 1.981 . . . . 0.94 109.15 173.57 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -105.75 131.23 53.36 Favored 'General case' 0 N--CA 1.446 -0.659 0 N-CA-C 105.125 -2.176 . . . . 2.53 105.125 149.473 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 31.6 mm -115.57 131.01 69.21 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.455 0 N-CA-C 107.367 -1.345 . . . . 1.88 107.367 172.912 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 75.5 mttt -93.13 64.62 3.85 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 124.385 1.074 . . . . 3.18 108.97 175.81 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -88.34 141.58 28.43 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 112.744 0.646 . . . . 2.81 112.744 175.579 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -62.34 115.66 17.73 Favored Pre-proline 0 CA--C 1.536 0.428 0 N-CA-C 108.694 -0.854 . . . . 2.47 108.694 173.843 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -78.76 65.84 8.69 Favored 'Trans proline' 0 N--CA 1.456 -0.679 0 C-N-CA 122.78 2.32 . . . . 1.54 111.425 -168.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -162.18 -79.07 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.338 0.655 . . . . 3.52 112.137 -177.693 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -65.86 -34.82 72.85 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.25 0 O-C-N 121.528 -0.733 . . . . 2.83 111.12 -176.762 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 4.7 tp -105.31 150.05 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.234 -1.765 . . . . 1.18 106.234 170.88 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -141.25 170.43 24.65 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 110.352 -1.099 . . . . 0.68 110.352 -177.615 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -57.03 -43.4 54.26 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 123.482 2.788 . . . . 0.75 110.489 -177.485 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -57.23 -44.71 84.04 Favored 'General case' 0 C--O 1.225 -0.211 0 CA-C-N 118.247 0.476 . . . . 6.5 112.019 176.924 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -63.36 -49.15 74.98 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 108.972 -0.751 . . . . 3.84 108.972 -178.022 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.6 mm -50.57 -51.65 18.53 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.248 0 C-N-CA 122.877 0.471 . . . . 1.95 111.036 172.599 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 25.6 mt -57.42 -52.62 54.59 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 C-N-CA 123.284 0.634 . . . . 0.63 109.962 -178.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' HIS . . . . . . . . . . . . . 47.0 m170 -55.8 -44.64 78.0 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 122.343 1.068 . . . . 3.28 109.298 -179.612 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' THR . . . . . . . . . . . . . 59.1 m -61.18 -50.48 72.98 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 114.791 -1.095 . . . . 0.85 110.304 -178.895 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.4 mt -71.86 -44.49 67.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.129 0 CA-C-O 119.123 -0.465 . . . . 1.14 111.717 -175.526 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -56.31 -42.38 77.52 Favored 'General case' 0 C--N 1.338 0.109 0 CA-C-N 118.885 0.766 . . . . 2.92 110.427 -176.694 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 51.1 m -51.04 -28.67 10.75 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.673 0.99 . . . . 1.67 113.673 172.782 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 27.7 mt -77.68 -16.68 58.33 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.069 0.85 . . . . 1.05 112.051 178.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 92.8 31.26 8.8 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 123.902 0.763 . . . . 0.7 112.531 178.861 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -129.99 140.4 50.9 Favored 'General case' 0 C--O 1.226 -0.16 0 N-CA-C 105.394 -2.076 . . . . 1.98 105.394 167.846 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -87.59 111.25 40.6 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-O 117.985 -1.007 . . . . 2.82 109.586 -173.903 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -82.86 128.31 5.11 Favored 'Trans proline' 0 N--CA 1.454 -0.837 0 C-N-CA 122.958 2.438 . . . . 1.42 109.838 176.673 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 9.2 t -138.2 111.93 8.28 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.563 -0.903 . . . . 2.54 108.563 177.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -56.03 131.06 46.41 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 124.284 1.034 . . . . 2.6 110.985 -179.172 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 14.4 p -131.75 -51.12 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 112.746 0.646 . . . . 3.74 112.746 -173.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 13.3 tptp 56.73 -138.68 0.96 Allowed 'General case' 0 CA--C 1.539 0.526 0 CA-C-O 119.046 -0.502 . . . . 6.08 110.992 -166.283 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.4 mp -132.2 151.21 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 105.976 -1.861 . . . . 6.7 105.976 178.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 . . . . . 0 C--O 1.251 1.157 0 N-CA-C 105.012 -2.218 . . . . 10.32 105.012 173.219 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' CU1 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_